<SEC-DOCUMENT>0001213900-26-034900.txt : 20260327
<SEC-HEADER>0001213900-26-034900.hdr.sgml : 20260327
<ACCEPTANCE-DATETIME>20260326181013
ACCESSION NUMBER:		0001213900-26-034900
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		99
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260327
DATE AS OF CHANGE:		20260326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyngn Inc.
		CENTRAL INDEX KEY:			0001874097
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		ORGANIZATION NAME:           	06 Technology
		EIN:				462007094
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40932
		FILM NUMBER:		26799981

	BUSINESS ADDRESS:	
		STREET 1:		1344 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-924-5905

	MAIL ADDRESS:	
		STREET 1:		1344 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cyngn, Inc.
		DATE OF NAME CHANGE:	20210721
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ea0277796-10k_cyngn.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:54 UTC 2026 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:cyngn="http://cyngn.com/20251231" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-13613">10-K</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(Mark One)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="ixv-35"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric>
<b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the fiscal year ended <b><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-13614"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-13615">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-13616">2025</ix:nonNumeric></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="ixv-51"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric>
<b>TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the transition period from [____] to [____]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber" id="ixv-62"><b><span style="text-decoration:underline">001-40932</span></b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-71"><span style="font-size: 10pt"><b>CYNGN INC.</b></span></ix:nonNumeric></td></tr> <tr> <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Exact name of registrant as specified in its charter)</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-83"><span style="font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="padding-bottom: 1.5pt; text-align: center; width: 2%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-88"><span style="font-size: 10pt"><b>46-2007094</b></span></ix:nonNumeric></td></tr> <tr> <td style="text-align: center"><span style="font-size: 10pt">State or other jurisdiction of<br/>
incorporation or organization</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">(I.R.S. Employer<br/>
Identification No.)</span></td></tr> <tr> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td></tr> <tr> <td style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1" id="ixv-13617">1344 Terra Bella Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-13618">Mountain View</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressStateOrProvince" id="ixv-13619">CA</ix:nonNumeric></b></span></td> <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-109"><span style="font-size: 10pt"><b>94043</b></span></ix:nonNumeric></td></tr> <tr> <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone number, including
area code: <b><span style="text-decoration:underline"><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-13620">(650)</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-13621">924-5905</ix:nonNumeric></span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(b)
of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Title of Class</b></span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 2%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="padding-bottom: 1.5pt; vertical-align: top; width: 2%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle" id="ixv-146"><span style="font-size: 10pt">Common Stock, Par Value $0.00001</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol" id="ixv-150"><span style="font-size: 10pt">CYN</span></ix:nonNumeric></td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-154"><span style="font-size: 10pt">Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Securities registered pursuant to Section 12(g)
of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registered is a
well-known seasoned issuer, as defined in Rule 405 the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-13622">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark if the registrant is not
required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-13623">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant:
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the last 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-13624">Yes</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>
No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-13625">Yes</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span>
No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;
and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr> <td style="text-align: justify; width: 20%"><span style="font-size: 10pt">Large accelerated filer</span></td> <td style="text-align: left; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="width: 2%">&#160;</td> <td style="text-align: justify; width: 25%"><span style="font-size: 10pt">Accelerated filer</span></td> <td style="text-align: left; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-214"><span style="font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Smaller reporting company</span></td> <td style="text-align: left"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness" id="ixv-222"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: justify"><span style="font-size: 10pt">Emerging growth company</span></td> <td style="text-align: left"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-231"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by a check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="ixv-237"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="ixv-243"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-249"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s
executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). <ix:nonNumeric contextRef="c0" format="ixt-sec:boolballotbox" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" id="ixv-255"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span>
No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-262"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate market value of the voting and non-voting
common equity held by non-affiliates as of June 30, 2025 (the last business day of the registrant&#8217;s most recently completed second
fiscal quarter), computed by reference to the closing price for the common stock on such date ($14.40), as reported on the Nasdaq Capital
Market, was $<ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd" id="ixv-13626">101,365,430.40</ix:nonFraction>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares of Common Stock, $0.00001
par value, outstanding on March 26, 2026 was <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-13627">13,608,281</ix:nonFraction> shares.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DOCUMENTS INCORPORATED BY REFERENCE</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="ixv-279"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">None</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="vertical-align: top; text-align: justify; width: 8%">&#160;</td>
    <td style="vertical-align: top; text-align: justify; width: 84%">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center; width: 8%"><span style="font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center"><a href="#a_001"><span style="font-size: 10pt">PART I</span></a></td>
    <td style="vertical-align: bottom; text-align: center">1</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 1.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_002"><span style="font-size: 10pt">Business</span></a></td>
    <td style="vertical-align: bottom; text-align: center">1</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 1A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_003"><span style="font-size: 10pt">Risk Factors</span></a></td>
    <td style="vertical-align: bottom; text-align: center">16</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 1B.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_004"><span style="font-size: 10pt">Unresolved Staff Comments</span></a></td>
    <td style="vertical-align: bottom; text-align: center">36</td></tr>
  <tr>
    <td><span style="font-size: 10pt">Item 1C.</span></td>
    <td><a href="#a_005"><span style="font-size: 10pt">Cybersecurity</span></a></td>
    <td style="vertical-align: bottom; text-align: center">37</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 2.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_006"><span style="font-size: 10pt">Properties</span></a></td>
    <td style="vertical-align: bottom; text-align: center">37</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 3.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_007"><span style="font-size: 10pt">Legal Proceedings</span></a></td>
    <td style="vertical-align: bottom; text-align: center">37</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 4.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_008"><span style="font-size: 10pt">Mine Safety Disclosures</span></a></td>
    <td style="vertical-align: bottom; text-align: center">37</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_009"><span style="font-size: 10pt">PART II</span></a></td>
    <td style="vertical-align: bottom; text-align: center">38</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 5.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_010"><span style="font-size: 10pt">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></td>
    <td style="vertical-align: bottom; text-align: center">38</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 6.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_011"><span style="font-size: 10pt">[Reserved]</span></a></td>
    <td style="vertical-align: bottom; text-align: center">38</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 7.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_012"><span style="font-size: 10pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></td>
    <td style="vertical-align: bottom; text-align: center">38</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 7A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_013"><span style="font-size: 10pt">Quantitative and Qualitative Disclosures About Market Risk</span></a></td>
    <td style="vertical-align: bottom; text-align: center">46</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 8.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_014"><span style="font-size: 10pt">Financial Statements and Supplementary Data</span></a></td>
    <td style="vertical-align: bottom; text-align: center">46</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 9.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_015"><span style="font-size: 10pt">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></td>
    <td style="vertical-align: bottom; text-align: center">47</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 9A.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_016"><span style="font-size: 10pt">Controls and Procedures</span></a></td>
    <td style="vertical-align: bottom; text-align: center">47</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 9B.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_017"><span style="font-size: 10pt">Other Information</span></a></td>
    <td style="vertical-align: bottom; text-align: center">48</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 9C.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_018"><span style="font-size: 10pt">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></td>
    <td style="vertical-align: bottom; text-align: center">48</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_019"><span style="font-size: 10pt">PART III</span></a></td>
    <td style="vertical-align: bottom; text-align: center">49</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 10.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_020"><span style="font-size: 10pt">Directors, Executive Officers and Corporate Governance</span></a></td>
    <td style="vertical-align: bottom; text-align: center">49</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 11.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_021"><span style="font-size: 10pt">Executive Compensation</span></a></td>
    <td style="vertical-align: bottom; text-align: center">53</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 12.</span></td>
    <td style="vertical-align: top"><a href="#a_022"><span style="font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></td>
    <td style="vertical-align: bottom; text-align: center">59</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 13.</span></td>
    <td style="vertical-align: top"><a href="#a_023"><span style="font-size: 10pt">Certain Relationships and Related Transactions, and Director Independence</span></a></td>
    <td style="vertical-align: bottom; text-align: center">60</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 14.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_024"><span style="font-size: 10pt">Principal Accountant Fees and Services</span></a></td>
    <td style="vertical-align: bottom; text-align: center">60</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td style="text-align: center"><a href="#a_025"><span style="font-size: 10pt">PART IV</span></a></td>
    <td style="vertical-align: bottom; text-align: center">61</td></tr>
  <tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 15.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_026"><span style="font-size: 10pt">Exhibit and Financial Statement Schedules</span></a></td>
    <td style="vertical-align: bottom; text-align: center">61</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Item 16.</span></td>
    <td style="vertical-align: top; text-align: justify"><a href="#a_027"><span style="font-size: 10pt">Form 10-K Summary</span></a></td>
    <td style="vertical-align: bottom; text-align: center">64</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Annual Report on Form
10-K (this &#8220;Annual Report&#8221;) contains forward-looking statements. These statements are based on our management&#8217;s beliefs
and assumptions and on information currently available to our management. The forward-looking statements are contained principally under
the headings &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221;
and &#8220;Business.&#8221; Forward-looking statements include statements concerning:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our possible or assumed future
results of operations;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our business strategies;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our ability to attract and retain
customers;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our ability to sell additional
products and services to customers;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our cash needs and financing plans;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our competitive position;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our industry environment;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">our potential growth opportunities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">expected technological advances
by us or by third parties and our ability to integrate and commercialize them;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">the effects of wars, such as the
wars in Ukraine and the Middle East, natural disasters and pandemics, such as the Covid-19 pandemic;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">the effects of future regulation;
and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">the effects of competition.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.45in; text-align: justify; text-indent: -16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All statements in this Annual
Report that are not historical facts are forward-looking statements. We may, in some cases, use terms such as &#8220;anticipates,&#8221;
&#8220;believes,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221;
&#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221;
&#8220;would&#8221; or similar expressions that convey uncertainty of future events or outcomes to identify forward-looking statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The outcome of the events
described in these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause our
actual results, performance or achievements to be materially different from any future results, performances or achievements expressed
or implied by the forward-looking statements. These important factors include our financial performance and the other important factors
we discuss in greater detail in &#8220;Risk Factors.&#8221; You should read these factors and the other cautionary statements made in
this Annual Report as applying to all related forward-looking statements wherever they appear in this Annual Report. Given these factors,
you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s
beliefs and assumptions only as of the date on which the statements are made. We undertake no obligation to publicly update any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on such forward-looking statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Unless the context requires
otherwise, references in this Annual Report to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and Cyngn refer to CYNGN Inc. and
its consolidated subsidiaries.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise expressly
provided in this Annual Report, all historical per share data, number of shares issued and outstanding, stock awards, and other common
stock equivalents set forth herein relating to our common stock have been adjusted to give effect to a reverse stock split of our common
stock in a ratio of 1-for-150 effected on February 18, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>


</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART 1</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1. Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyngn Inc. is an autonomous
vehicle (&#8220;AV&#8221;) technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological
innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist
today. These challenges include labor shortages, high labor costs, and work safety.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We integrate our full-stack
autonomous driving software, DriveMod, onto vehicles manufactured by Original Equipment Manufacturers (&#8220;OEM&#8221;) by integration
directly into vehicle assembly. We design the DriveMod to be compatible with sensors and components from leading hardware technology providers
and integrate our proprietary AV software to produce differentiated autonomous vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Autonomous driving has common
technological building blocks that remain similar across vehicles and applications. By tapping into these building blocks, DriveMod is
designed to deliver autonomy to new vehicles via streamlined hardware/software integration. This vehicle-agnostic approach enables DriveMod
to expand to new vehicles and novel operational design domains (&#8220;ODD&#8221;). In short, nearly every industrial vehicle, regardless
of use case, can move autonomously using our technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our approach accomplishes
several primary value propositions:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-size: 10pt">Provide autonomous capabilities
to industrial vehicles built by established manufacturers that are already trusted by customers.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-size: 10pt">Generate continual customer value
by leveraging the synergistic relationship of autonomous vehicles and data.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-size: 10pt">Develop consistent autonomous
vehicle operation and user interfaces for diverse vehicle fleets.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-size: 10pt">Complement the core competencies
of existing industry players by introducing the leading-edge technologies of Artificial Intelligence (&#8220;AI&#8221;) &amp; Machine
Learning (&#8220;ML&#8221;), cloud/connectivity, sensor fusion, high- definition mapping, and real-time dynamic path planning &amp; decision-making.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our market positioning
as a technology partner to vehicle manufacturers creates a synergy with incumbent suppliers that already have established sales, distribution,
and service/maintenance channels. By focusing on industrial use cases and partnering with the incumbent OEMs in these markets, we believe
we can source and execute revenue-generating opportunities more quickly.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our long-term vision is for
our Enterprise Autonomy Suite (&#8220;EAS&#8221;)-which includes the DriveMod autonomous driving stack as well as the Cyngn Insight and
Cyngn Evolve tools for fleet management, analytics, and data collection-to become a universal autonomous driving solution with minimal
marginal cost for companies to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed
DriveMod software on more than ten different vehicle form factors that range from tow tractors and stand-on floor scrubbers to 14-seat
shuttles and electric forklifts in a combination of commercially released products, prototypes, and proof of concept projects, demonstrating
the extensibility of our AV building blocks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our recent progress contributes
to the validation of EAS with OEM partners and end customers. We also continue to build upon our ability to scale our products and generate
novel technological developments. The DriveMod Stockchaser with a 6,000-lb towing capacity became commercially available in early 2023
and was first commercially deployed with our partner-customer US Continental (&#8220;USC&#8221;), a California-based manufacturer of quality
leather and fabric care products. We then launched the DriveMod Forklift and the DriveMod Tugger as we continued to expand our vehicle-type
portfolio fleet through our OEM partnerships with BYD and Motrec, respectively. The DriveMod MT160 Tugger with a 12,000-lb towing capacity
was commercially released in 2024 in partnership with Motrec and is now deployed with multiple customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We secured paid projects with
leading global customers like Arauco, along with additional projects from big brands in the Global 500 and the Fortune 100. Paid development
projects of this nature are selectively pursued to springboard new products or technology advancements, yielding promising outcomes such
as the DriveMod Forklift. The primary focus of the company is to achieve and expand production deployments with its commercially released
DriveMod vehicles. As of the end of 2025, those commercial deployments include the named accounts of John Deere, G&amp;J Pepsi, Coats
Automotive, and USC, as well as other business awards that have not yet been publicly disclosed. Our patent portfolio expanded with 16
new U.S. patent grants in 2023 3 granted in 2024, and 2 granted in 2025 bringing the total grants to 24.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img1.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 0: Summary of recent Cyngn technical
and commercial milestones</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to continue to pursue
and win additional license agreements with companies that depend heavily on the use of material handling vehicles and that all recognize
the need for automation to i) compete in today&#8217;s economy, ii) combat the significant labor shortages and escalating costs, and iii)
improve safety. Our approach to securing these opportunities will be a continued direct sales effort coupled with increasing our network
of industrial vehicle dealers that already have significant sales of industrial vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview: Automation and Autonomy in Industry
5.0</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The fifth industrial revolution
is upon us with self-driving industrial vehicles operating alongside human workers and encompasses the benefits from the fourth industrial
revolution of smart factories and automated supply chain logistics, with big data connectivity. According to Research Nester, they forecast
the global industry 5.0 market to experience remarkable CAGR growth from 2022 - 2030 led by industrial internet of things, artificial
intelligence with the alliance of humans and collaborative robots.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As automation proliferates,
these industries will gradually shift to service-based models that will decrease upfront capital expenditures and create new revenue streams
while unlocking new value in the supply chain. Our AV technology is uniquely positioned to capitalize upon these changes by offering a
universal autonomy solution that can deliver self-driving capabilities and data insights to nearly every industrial vehicle on the market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Automation has long played
a role in industrial sectors. The larger industrial automation market has grown significantly by riding the wave of new technology and
innovation experienced during Industry 4.0. This consists of a wide range of technology solutions that provide varying levels of automation
for critical software control systems and industrial equipment. These components are essential to the operations and growth of global
markets such as manufacturing, distribution, transportation, construction, and mining. However, Industry 4.0 has its limitations in industrial
autonomy. With the convergence of AI/ML, robotics, connectivity, mapping and interoperability, autonomous vehicle technology is the next
leap-frog advancement in materials handling and supply chain logistics efficiency and safety propelling manufacturing into the Industry
5.0 phase.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img2.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 1: Illustration of the progression from
Industry 1.0 to Industry 5.0.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Automation Solutions for Industrial Equipment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Industrial Equipment market
covers a broad range of use cases and product categories, with automation solutions targeting Material Transport Equipment (&#8220;MTE&#8221;)
heavily utilized by the majority of industry market sectors. For our purposes, we can think of MTE to include all material handling equipment
directly related to material transit (this includes conveying equipment, monorail, hoists, storage &amp; retrieval, and industrial vehicles).
According to a Grand View Research report, the material handling equipment market was valued at $213.4 billion in 2021. They expect the
CAGR from 2022 to 2030 of 5.7% to be driven by increased worker safety awareness, rising requirements for managing bulk materials and
further adoption of Industry 4.0 initiatives with the use of IoT. Further with the rising need for reducing downtime and focus on improving
supply chain efficiency, self-driving industrial vehicles play an important role to achieve these objectives as manufacturing transitions
to Industry 5.0. Our belief is that these strong growth indicators will drive increased need for more advanced technology that will address
gaps in the current capabilities of automated MTE solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Historically, MTE automation
has been heavily weighted in solutions related to storage/retrieval systems and conveyors because more rigid and repetitive environments
are better suited for the limited capability of existing automation solutions. By contrast, industrial vehicles in the MTE category are
largely still driven manually. A March 2023 report released by MHI and Deloitte finds that 74% of supply chain leaders are increasing
their supply chain technology and innovation investments with 90% saying they are planning to spend more than $1 million, an 24% increase
from 2022 levels. Thirty-six percent plan to spend more than $10 million, up 19% from the prior year.&#160; According to an article by
Meteor Space, &#8220;Important Warehouse Automation Statistics you can&#8217;t Ignore,&#8221; the use of AI in warehouse management systems
has surged, with 70% of large-scale warehouses adopting AI-driven solutions by 2024 to optimize inventory management, demand forecasting,
and route planning.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Supply chain, logistics, and
manufacturing operators are increasingly facing labor shortages, rising costs, and operational inefficiencies, which we believe is accelerating
the adoption of automation technologies. Industry data (Descartes&#8217;s Study) indicates that approximately 76% of supply chain operations
are currently impacted by labor shortages, and in the United States there are significantly more job openings than available workers,
contributing to persistent workforce gaps. The manufacturing sector alone could face millions of unfilled positions over the next decade,
further increasing pressure on companies to automate repetitive and labor-intensive tasks. Industrial truck and material handling vehicle
operators represent a meaningful component of operating costs within warehouses and manufacturing facilities, with median annual wages
in the United States in the mid-$40,000 range, excluding overtime, benefits, and other employer-related costs, according to U.S. Bureau
of Labor Statistics data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to labor shortages
and rising labor costs, workplace safety expenses represent a significant financial burden for industrial operators. Worker injury claims
can average tens of thousands of dollars per incident, and total workplace injury costs in the United States exceed hundreds of billions
of dollars annually. &#160;According to the Economic Policy Institute, over
$250 billion&#160;are spent on workplace injuries each year.&#160; Autonomous industrial vehicles have the potential to reduce both
labor dependency and safety risks by automating repetitive material transport tasks, which may lower operating costs and improve productivity.
According to PWC&#8217;s &#8220;Industrial Mobility: How autonomous vehicles can change manufacturing&#8221; report, only 9% of manufacturers&#160;have
currently adopted autonomous technologies, but this is expected to grow as the benefits of improved efficiency and reduced costs become
more apparent. &#160;As a result, we believe automation is becoming increasingly essential for industrial operations, with a substantial
majority of manufacturing leaders identifying automation as critical to future success. Despite these trends, adoption of autonomous industrial
vehicle technology remains in the early stages, suggesting a significant opportunity for future market growth as organizations seek solutions
to workforce shortages, cost pressures, and supply chain resilience challenges.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Automating industrial vehicles will address the
following challenges:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Labor shortages</i> - The
hiring and retention of qualified workers is a critical concern for the markets that material transport vehicles operate within. In fact,
Deloitte&#8217;s 2020 and 2022 Material Handling Industry Report showed that over 50% of the 1,000 supply chain and manufacturing leaders
surveyed rated hiring and employee retention as their biggest challenge (source: MHI Deloitte Industry Report).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Difficulty in scaling -
</i>The traditional approaches to vehicle automation make scaling vehicle automation solutions difficult due to strains caused by service
lifecycle management and issues with dynamic deployability. Industrial automation customers are forced to coordinate operational components
from a variety of different vendors and lack a unifying architecture that allows the technology to scale effectively within and across
sites. Significant costs are also associated with expanding the scope of existing automation solutions as they are tightly coupled to
specific vehicles and often require an overhaul of the site infrastructure to overcome shortcomings in the automation technology. This
can be especially true in niche environments like mines, where the deployability challenges are compounded by unique sites that require
heterogeneous fleets. Furthermore, customer service, workforce training, and repair fall under service lifecycle management and must be
taken into account along with the technology in order to scale efficiently, according to the &#8220;Trends in Supporting and Scaling Modern
Automation&#8221; report by Ricoh &amp; ABI Research Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Lagging technological advancement
</i>- Manufacturers of material transport vehicles have core competencies in mechanical, electrical, and control systems while the end
users of the vehicles typically specialize in logistics, manufacturing, and material moving. There is limited expertise throughout the
material handling value chain in software algorithms, sensing, and high-performance computing. Considering the incumbents&#8217; gaps
in leading-edge AV and AI technologies and the pressure existing suppliers face to ship manually-operated vehicles that address the multi-billion
dollar demand that already exists, we believe it is unlikely that existing stakeholders will be able to invest in the technological advancements
that will solve the industry&#8217;s fundamental challenges.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>High barriers to adoption
</i>- Many solutions for automated material transport require an all-or-nothing commitment from customers: either make a major upfront
investment to overhaul operations for automation or postpone automation at the risk of falling behind competition. This all-or-nothing
approach to unlocking future return on investment (&#8220;ROI&#8221;) can be problematic for risk-averse companies that seek to adopt
automation solutions. Depending on fleet size, traditional automation solutions such as &#8220;robot-in-a-box&#8221; may command ROI horizons
of up to 4 years. Factoring in ancillary costs like installation, maintenance, on-site testing, integration, and deployment, can also
represent a significant annual cost burden, according to findings by Ricoh &amp; ABI Research Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To combat these challenges,
we have built an Enterprise Autonomy Suite for industrial vehicles that leverages advanced in-vehicle autonomous driving technology and
incorporates leading supporting technologies like data analytics, fleet management, cloud, and connectivity. EAS provides a differentiated
solution that we believe will drive pervasive adoption of industrial autonomy and create value for customers at every stage of their automation
growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Business Model: The Enterprise Autonomy Suite
for Industrial Vehicles</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A number of business models
have been developed to support industrial autonomy where software is the enabling technology that&#8217;s transforming supply chain logistics
under Industry 4.0 and 5.0. Software as a Service (SaaS) is the initial working business model for the company but this is not entirely
accurate as vehicle hardware plays an integrated role in automating materials handling. Autonomy requires both the movement of &#8220;bits&#8221;
(or software) and the movement of &#8220;atoms&#8221; (or hardware). Robots as a Service (RaaS) is a useful business model given the high
cost of AGVs and AMRs where industrial customers may want to explore different buying models for both software and hardware usage to align
with their needs for capital expenditures and operational expenditures. In our served markets where customers primarily purchase and own
their industrial vehicle fleet, we deliver the software that enables self-driving vehicle capability. As such, our EAS software is designed
to provide level-4 &#8220;high automation&#8221;, fully autonomous driving without the need for a human in the vehicle. Cyngn&#8217;s
business model is thereby more attuned to Driver as a Service (DaaS) as our EAS software integrated with the vehicle hardware enables
the customer to remove the human driver for self-driving functionality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our unique value proposition
stems from the concept that the growth of industrial autonomy requires an approach that deploys applied AV solutions within a system of
supportive resources rather than a technology feature that is tuned to a specific industrial vehicle.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some companies manufacture
standard industrial vehicles then integrate industrial automation software for rigid tasks. Others develop new vehicle platforms to enable
more advanced automation capabilities, limiting the AV technology to a narrow use case. We developed advanced autonomous vehicle software,
DriveMod, for industrial vehicles. DriveMod is a component of EAS that is operationally expansive, vehicle agnostic, and compatible with
indoor and outdoor environments. EAS centers around DriveMod&#8217;s on-vehicle AV software and is supported by our Cyngn Insight and
Cyngn Evolve technology and tools.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img3.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 2: The core components that make up our
EAS product offering.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Our approach drives value at every stage of
a company&#8217;s autonomy journey</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">EAS provides extensible industrial
autonomy solutions that can include data-driven actionable insights, partial autonomy to augment existing workflows and support human
drivers, and fully autonomous vehicle mobility. By offering flexible data and autonomous services through subscription-based business
models, we assuage the industry&#8217;s existing challenge of all-or-nothing adoption for autonomous vehicles. Installing DriveMod onto
any vehicle unlocks a collection of valuable product offerings that customers can activate over the air, creating lower barriers to entry
and enabling customers to benefit from novel data insights while adopting industrial AVs at their own pace. Our solutions also do not
require infrastructure investments to enable autonomous vehicle operation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>EAS galvanizes the relationship between AVs
and data</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our EAS combines core autonomous
vehicle technology with a suite of tools and products that strengthen the ties between industrial business operations and the positive
network effects that underpin the relationship between data and AVs. DriveMod uses data from advanced sensors to navigate AVs, creating
a de facto mechanism for rich data collection. Vehicles equipped with DriveMod provide the means for us to collect data then organize,
analyze, and expose customers to novel insights. This makes the data collected during vehicle operation a new type of asset that adopters
of AV technology can take advantage of. Data can be stored in cloud or on-premise servers, according to customer requirements. We intend
to have our customers own the data collected at their facilities and for Cyngn to have the rights to use that data for certain purposes,
such as testing simulation and development. These data assets present a new opportunity to reveal previously unknown insights about day-to-day
operational processes that impact safety, efficiency, vehicle maintenance, and growth.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img4.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 3: The EAS product flywheel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As the deployment of industrial
vehicles with DriveMod scales up, the amount and diversity of data flowing through Cyngn Insight expands, creating an accelerated feedback
loop and powers our ability to use Cyngn Evolve to further enhance DriveMod, and update the on-vehicle software over-the-air, resulting
in an ever-improving EAS offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Continual Improvement Drives Technology Advancement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DriveMod&#8217;s building
blocks enable a more consistent cadence of upgrades, improvements, and customer-specific feature development that can be deployed via
over-the-air updates. These capabilities ensure that the deployed system stays in sync with the changing application demands while allowing
customers to focus on monetary and operational ROI. Our EAS plugs into business operations by creating and collecting real-time data and
aggregating it into configurable analytics dashboards that inform customer operations as well as future DriveMod releases, creating a
data set specific to each customer from high-resolution data collected during their operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Our Approach Augments and Upskills Workforces</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Industrial vehicle autonomy
represents an opportunity to minimize the adverse impact that labor shortages, employee health, and safety have on a company&#8217;s core
operations. Autonomous vehicles can be relied upon to fill the voids that commonly create human resource issues like executing repetitive
tasks, working during undesirable hours, and operating in uncomfortable or hazardous environments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, existing employees
can be exposed to cutting-edge technology and develop new valuable career development opportunities. For instance, a manufacturing community
in Wisconsin successfully retrained their employees to be skilled in AMR maintenance after AMRs were introduced to replace traditional
conveyors, according to the article &#8220;Are Autonomous Mobile Robots at the Tipping Point&#8221; by AutomationWorld.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>We Designed for Scale</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">EAS provides a powerful solution
to scalability issues, especially for dynamic deployability and service lifecycle management. DriveMod&#8217;s vehicle-agnostic capability
to deploy AV technology on diverse vehicle fleets has been proven through its deployment on more than ten different vehicle form factors
that we have operated autonomously. DriveMod solutions have been commercially released for the Motrec MT160 Tugger, with BYD ECB50+ Forklift
targeted next. Other autonomous vehicles were deployed as prototypes or as a part of proof-of-concept project. More than five past deployments
have been at customer or beta customer sites. Other past deployments were part of our normal R&amp;D activities and product validation
that was performed with beta customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our AV development and testing
have included road vehicles that navigate complex dynamic environments. DriveMod is capable of perceiving more than 100 dynamic objects
per second and then using that perception information to navigate autonomously. This capability has been proven via road testing in difficult
driving settings like urban streets. In contrast, the industrial settings of our target market rarely encounter 100 dynamic actors per
minute, let alone per second. Scalability is further strengthened by EAS creating common interfaces and experiences that unify customer
data and AV operations within and across sites. Thus, proliferating our solutions with customers will be achieved by iteratively adding
onto an existing EAS, which minimizes the marginal cost associated with expanding AV operations. Additionally, the deployment of EAS allows
for<i>&#160;</i>all of the on-going administration, services, and vendors associated with managing the lifecycle of the system to be integrated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img5.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 4: Illustration of DriveMod&#8217;s ability
to utilize key subsystems across multiple environments and vehicle platforms<br/>
(left: off-road utility vehicle; right: indoor material handling vehicle).</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Products</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">EAS is a suite of technology
and tools that consists of three complementary categories: DriveMod, Cyngn Insight, and Cyngn Evolve.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>DriveMod: Industrial Autonomous Vehicle System</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We built DriveMod as a modular
software product that is compatible with various sensor and computer hardware components that are widely used throughout the autonomous
vehicle industry. Our software combined with sensors and components from industry-leading hardware providers covers the end-to-end requirements
that enable vehicles to operate autonomously with advanced navigation capabilities. The modularity of DriveMod allows our AV technology
to be compatible across vehicle platforms as well as indoor and outdoor environments. DriveMod can be retrofitted to existing vehicle
assets or integrated into a manufacturing partner&#8217;s vehicles at assembly, providing accessible options for our customers to integrate
leading-edge technology whether their AV adoption strategies are evolutionary or revolutionary.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The core vehicle-agnostic
DriveMod software stack is targeted and deployed to different vehicles through <i>DriveMod Kits</i>, which are the AV hardware systems
that take into account the specific needs of operating the DriveMod software on a specific target vehicle. Then, after prototyping and
productization, DriveMod kits streamline the integration of AV hardware and software onto vehicles at scale. The DriveMod Kit for Motrec
MT160 Tuggers are released to mass production and available at scale. Subsequently, we expect to create different instances of DriveMod
Kits to support the commercial release of new vehicles on the EAS platform, such as the electric forklifts and other industrial vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img6.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 5: Overview of Cyngn&#8217;s autonomous
vehicle technology (DriveMod)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DriveMod&#8217;s flexibility
combines with our network of manufacturing and service partners to support customers at different stages of autonomous technology integration.
This allows customers to grow the complexity and scope of their industrial autonomy deployments as their business transforms while continually
capturing returns throughout their transition to full autonomy. EAS will also grant customers access to over-the-air software upgrades,
ad hoc customer support, and flexible consumption based on usage and scale of operations. By lessening both the commercial and technical
burdens of traditional vehicle automation and industrial robotics investments, industrial AVs can become universally available to the
market, even reaching small and medium-sized businesses that may otherwise struggle to adopt Industry 4.0 and 5.0 technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cyngn Insight: Intelligent Control Center</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyngn Insight is the customer-facing
tool suite for managing AV fleets and aggregating data to extract business insights. Analytics dashboards surface data about the system&#8217;s
status, vehicle telemetry, and performance metrics. Cyngn Insight also provides tools to switch between autonomous, manual, and remote
operation when required. This flexibility allows customers to use the autonomous capabilities of the system in a way that is tailored
to their own operational environment. Customers can choose when to operate their DriveMod-powered vehicles autonomously and when to have
human operators operate the vehicles manually or remotely based on their own business needs. When combined, these capabilities and tools
make up the Cyngn Insight intelligent control center that enables flexible fleet management from any location.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyngn Insight&#8217;s tool
suite includes configurable cloud dashboards that aggregate diverse data streams at several levels of granularity (i.e., site, fleet,
vehicle, module, and component). We can collect data during &#8220;open loop&#8221; vehicle operation, meaning that the vehicles can be
operated manually while still collecting the rich data enabled by the advanced on-vehicle sensors and computers. Data can be used for
predictive maintenance, operational improvements, educating employees on digital transformation and more.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Cyngn Evolve: Data Optimization Tools</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyngn Evolve is our internal
tool suite that underpins the relationship between AVs and data. Through a unifying cloud-based data infrastructure, our proprietary data
tools strengthen the positive network effects derived from the valuable new data created by AVs. Cyngn Evolve and its data pipelines facilitate
AI/ML training and deployment, manage data sets, and support driving simulation and grading to test and validate new DriveMod releases,
using both real-world and simulated data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ea027779601_img7.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Figure 6: The Cyngn &#8220;AnyDrive&#8221; simulation
is part of the Cyngn Evolve toolchain. The simulation environment creates a digital version of the physical world. This allows for customer
data sets to be leveraged and augmented to achieve testing and validation prior to releasing new AV features.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As AV technology expertise
matures globally, there may be opportunities to monetize the sophisticated AV-centric tools of Cyngn Evolve. Currently, we believe that
AV development is confined to small groups of experts. Therefore, Cyngn Evolve is currently an internal EAS tool that we use to advance
DriveMod and Cyngn Insight, our customer-facing EAS products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>360&#176; Sales and Marketing</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are building a go-to-market
ecosystem that we believe to be highly leveraged by using our partners as the foundation of our growth strategy. We plan to utilize these
relationships to generate and cultivate customer demand, acquire new customers, and deliver additional services to our customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Key elements of our market
entry and expansion roadmap include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Focus: manufacturing and
distribution material handling vehicles</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Manufacturing and distribution
applications can be conducive to short deployment timelines due to the similar use of material handling vehicles across these environments.
We have already deployed DriveMod-powered industrial vehicles at multiple manufacturing and distribution facilities of varying sizes,
including facilities as large as 4 million square feet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Broaden: address other
industrial vehicle use cases</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The industries that utilize
material transport vehicles share trends, challenges, and opportunities. DriveMod has been architected to be vehicle agnostic and allow
for efficient expansion to industries such as mining, construction, yard operations, and agriculture.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Revenue Sources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We anticipate that our technology
will generate revenue through three main methods: deployment, EAS subscriptions, and DriveMod customization.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Deployment</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deploying our EAS requires
us and our integration partners to work with a new client to map the job site, gather data, and install our AV technology within their
fleet and site. New deployments yield project-based revenues that are assessed based on the scope of the deployment. Our major collaborators
in this area are our OEM partners, and we can reinforce our deployment capability with integration and services from third party partners.
Working directly with our OEM partners as well as with third party experts ensures that we can deploy our technology globally and at-scale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>EAS License</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">EAS is a comprehensive suite
of technologies comprised of DriveMod, our modular industrial vehicle autonomous driving software; Cyngn Insight, our customer-facing
fleet management and data analytics platform; and Cyngn Evolve, our internal AI and machine learning development and simulation infrastructure.
Together, these solutions create a foundation for extracting new and valuable enterprise data insights through advanced sensors, electronic
control units, and vehicle connectivity that power DriveMod&#8217;s autonomous functionality.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Through Cyngn Insight, we
monetize these data insights by offering configurable cloud dashboards for fleet and asset management, operational performance monitoring,
remote vehicle operations, and predictive analytics. Cyngn Evolve continuously enhances our AI models using real-world and synthetic data,
enabling ongoing performance improvements and validated software releases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Collectively, the data generated
and analyzed across the EAS suite not only drives customer value but also provides meaningful insights to OEM partners as they optimize
product roadmaps and integrate autonomous capabilities to meet the evolving demands of industrial automation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>DriveMod Customization and Non-Recurring Engineering
(&#8220;NRE&#8221;)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">DriveMod&#8217;s capability
as an AV software stack will continue to expand in several dimensions-most notably, in the number of vehicles that DriveMod can operate
autonomously and the maneuvers that a DriveMod-powered vehicle can execute. Targeting DriveMod to operate new vehicle types autonomously
as well as the expansion of autonomous maneuvers that can be executed by DriveMod are both customizations that may generate revenues from
OEMs or end customers through NRE contracts. New customizations yield project-based revenues that are assessed based on the scope of the
deployment. This revenue stream is substantiated by the commercial contract that was entered into with an end customer for deploying DriveMod
on electric forklifts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Go-to-Market Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">Our go-to-market
strategy hinges on strategic collaboration and is based on a set of three basic principles:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Collaborate with industrial vehicle OEMs and their dealer and service networks</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Land &amp; expand with end customers</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Partner instead of compete on adjacent enabling technology</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Collaborate - industrial vehicle OEMs</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our focus is on acquiring
new customers who are either (a) looking to embed our technology into their vehicle products or (b) upsell their existing clients with
our vehicle retrofits. We follow a named account coverage approach. After establishing a customer relationship with an OEM, we seek to
embed our technology into their product roadmap and expand our services to their many clients. We believe this category represents a substantial
opportunity to generate revenue as a single relationship with an OEM that can lead to revenue opportunities across the entire marketplace.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Land &amp; expand - end customers</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our go-to-market strategy
is to acquire new customers that use industrial vehicles in their mission-critical operations. We pursue this strategy by being hyper-focused
on building a robust pipeline of prospective customers (&#8220;land&#8221;) and utilizing strategic sales channels that will result in
coordinated opportunities to accelerate growth (&#8220;expand&#8221;). Our archetypal customers are corporations that deploy fleets of
heterogeneous industrial vehicles across many sites. DriveMod&#8217;s flexibility is intertwined with the wide-ranging applicability of
our EAS and creates the unique leveraged opportunity of expanding across vehicles and sites with these major customers. After an initial
win for a first AV deployment with a customer, we can expand within the site to additional vehicle platforms, then expand the use of similar
vehicles to other sites operated by the customer and finally repeat across new vehicles and sites.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Partner instead of compete - technology</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The scaling of Industrial
Autonomy will benefit from an ecosystem made up of different enabling technologies and services, such as hardware manufacturing, connectivity,
Internet of Things (&#8220;IoT&#8221;), and digital integration. Rather than trying to compete with other technology suppliers, we intend
to rely on our strategic collaborations that give both partners access to new markets and capabilities. For example, hardware partners
like Motrec and BYD provide complementary solutions that stand to benefit from Cyngn&#8217;s autonomy software. Thereby, we leverage our
R&amp;D resources with existing core competencies of our technology partners through collaboration, resulting in a more efficient asset-light
approach in product development and manufacturing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Technology</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Autonomous vehicles must integrate
a suite of technologies to generate operational value. Our core competencies are in DriveMod, the on-vehicle AV technology stack that
is underpinned by AI and robotics expertise and paramount to enabling autonomous mobility. With Cyngn Insight, EAS integrates analytics,
visual dashboards, connectivity, cloud services, and other traditional software systems that allow customers to interact with and extract
insights out of our advanced AV technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Mapping &amp; localization</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our proprietary system design
abstracts mapping and localization data so that DriveMod can use a variety of high-accuracy solutions to create the optimal mapping and
localization system for the given environment. Our mapping and localization system distills sensor data into contextually rich representations
of the physical world and extracts common insights like required stops and navigation boundaries. These common insights help to create
consistent AV operation across diverse sites, enabling our AVs to navigate both indoor and outdoor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Perception</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Granular, efficient perception
forms the basis of advanced AVs. Perception is one of the most complex subsystems, requiring specialized data infrastructure and engineering
expertise in AI/ML and high-performance computing. We have built a modular sensor fusion pipeline that runs on a low compute footprint
and creates the flexibility to customize our perception stack according to application requirements. Our perception architecture streamlines
DriveMod deployments on new vehicles. Our approach addresses common industry challenges like integrating different sensor modalities and
accounting for different sensor mounting positions. We have now integrated DriveMod into more than ten different vehicle platforms, utilizing
various combinations of Light Detecting and Ranging (&#8220;LiDAR&#8221;), camera, radar, ultrasonic, and positioning sensors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Path planning</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our system&#8217;s ability
to react and adjust to real-time changes creates a more efficient workflow than basic automation solutions that can only stop/go along
a rigid path and require constant human hand-holding. The Cyngn path planning system provides thousands of trajectory candidates per second,
enabling more complex paths to be navigated that may include advanced behavior like carefully nudging around obstacles or negotiating
intersections.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Decision making</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Cyngn decision engine
holds the logic and decision-making rules that govern driving behavior. The decision engine pulls together insights from mapping, perception,
and path planning to enable more complex vehicle maneuvers and automated conflict resolution. The system is extensible to introduce new
capabilities with logic that is designed to achieve a high level of abstraction, which enables us to adopt new driving behaviors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Actuation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A subsystem of our software
stack, Cyngn-by-Wire (&#8220;CbW&#8221;), addresses the basic requirements of mechanical vehicle components that must be met for DriveMod
to make a vehicle operate autonomously. Legacy electronic control units (&#8220;ECU&#8221;) that do not use Drive-by-Wire (&#8220;DbW&#8221;)
technology that enables software commands to electronically control vehicle actuation typically create a hurdle for integrating AV technology.
CbW addresses this issue by decoupling the hardware and software components of DbW systems. For vehicles with legacy ECU&#8217;s, CbW
allows customers to replace existing ECUs with DbW hardware that can be tuned to meet the needs of the selected vehicle platform using
CbW software. When vehicles have DbW ECUs already installed, the CbW software layer is configured and applied without the need for replacing
the hardware. Thus, CbW enables AV actuation across vehicle fleets with varying levels of vehicle age and sophistication.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competitive Environment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is an increasing demand
for autonomous vehicle solutions in an effort to increase safety, improve efficiency, and enhance productivity to meet the goals set out
by Industry 4.0 and 5.0. Autonomous vehicles are an enabling technology that gives us the opportunity to add more value to customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for automated vehicle
solutions is burgeoning, and the advanced technology required to enable autonomous solutions in industrial environments is still developing.
As a result, we face competition from a range of companies seeking to develop autonomous vehicle solutions. These competitors include
traditional industrial vehicle manufacturers (such as Crown Equipment&#8217;s automated forklifts or Toyota, Yale and Vecna Materials
Handling), robotics providers (such as Seegrid Corporation for pallet and tow AMRs), as well as large corporate competitors
that provide a broad range of software, service, and logistics solutions across many markets. These competitors are also working to advance
technology, reliability, and innovation in their development of new and improved solutions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will continue to face competition
from existing competitors and new companies entering the industrial autonomy landscape. Many of our competitors either have technical
or strategic barriers that limit their product offerings to specific deployment environments, operations protocols, or vehicle form factors.
It is our belief that it will take a substantial period of time to develop features that satisfy the dynamic needs of industry customers.
Additionally, larger corporate competitors are likely to encounter roadblocks due to competitive overlap with end customers, limiting
their ability to address the needs of the broader industrial market. With specific regard to manufacturing and distribution, a number
of competitors have already begun to deploy products, but we believe the benefits stemming from our modular software-centric approach,
technical expertise in the area of autonomous vehicles, and the ubiquitous applicability of EAS gives us the potential to displace current
offerings and capture a significant share of this rapidly growing market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Governmental and Environmental Regulations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regulatory considerations
contribute to our current strategic position that targets enterprise customers with operations mostly confined to private property. This
decreases our exposure to regulations, which mitigates some deployment risks. Typically, we will satisfy regulatory requirements by adhering
to the protocols of the site operator (the end customer).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The regulatory environment
for autonomous industrial vehicles is still being developed. In 2016, the United States Department of Transportation (&#8220;US DoT&#8221;)
issued regulations that require the submission of documentation covering specific topics related to autonomy and government regulators,
but these regulations are targeted towards road vehicles. As the autonomous industrial vehicle regulatory environment continues to develop,
it will be imperative not only to comply with applicable standards but to be an active participant in the development of new standards.
Outside of government standards, third party organizations, industrial workplace advocates, and industry groups have and will continue
to impose self-regulatory standards. In certain cases, these standards may be contractually applicable to our systems, products, and operations.
Thus, we expect and prepare to comply with various standards, including Occupational Safety and Health Administration (&#8220;OSHA&#8221;),
International Organization for Standardization (&#8220;ISO&#8221;), International Electrotechnical Commission (&#8220;IEC&#8221;), or
American National Standards Institute (&#8220;ANSI&#8221;) on a case-by-case basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. and international regulations
related to data privacy are also of great importance to our company&#8217;s products, operations, and culture. Like the autonomous vehicle
regulatory environment, the regulatory framework for data privacy, protection, and security worldwide is continuously evolving and developing.
As a result, interpretation and implementation standards and enforcement practices are likely to remain fluid for the foreseeable future.
As our company expands its operations, the collection, use, and protection of any and all data assets will be internally scrutinized to
ensure compliance with this changing landscape.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Decreasing the environmental
impact of industrial vehicles is a high priority. Research has shown that equipment utilization rate, configuration, and operational consistency
have a strong effect on the emissions released by industrial vehicle equipment (Source: Journal of the Air &amp; Waste Management Association).
A key focus of Cyngn&#8217;s EAS will be working to minimize the environmental impact of industrial vehicles through new data insights
that can contribute to more sustainable practices. Our historic vehicle platforms have primarily been electric vehicles (&#8220;EV&#8221;).
While electric drivetrains are not a requirement for DriveMod&#8217;s technology, EVs are often an application requirement since the vehicles
operate alongside humans in enclosed spaces.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Intellectual Property</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to drive impact
and growth within the autonomous industrial vehicle market largely depends on our ability to obtain, maintain, and protect our intellectual
property and all other property rights related to our products and technology. To accomplish this, we utilize a combination of patents,
trademarks, copyrights, and trade secrets as well as employee and third-party non-disclosure agreements, licenses, and other contractual
obligations. In addition to protecting our intellectual property and other assets, our success also depends on our ability to develop
our technology and operate without infringing, misappropriating, or otherwise violating the intellectual property and property rights
of third parties, customers, and partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our software stack has over
30 subsystems, including those designed for perception, mapping &amp; localization, decision making, planning, and control. As of March
26, 2026, we have 24 granted U.S. patents and submitted 2 pending U.S. patent and expect to continue to file additional patent applications
with respect to our technology in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Corporate Social Responsibility and Sustainability</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our mission is to deliver
the benefits of autonomous industrial vehicle technology to enhance the safety and operational efficiency of materials handling in a cost-effective
method in supply chain logistics. We seek to make the movement of goods in warehouse settings safer, faster, cheaper while reducing greenhouse
gas emissions through greater operating efficiencies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Human Capital Resources</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our team is composed of energetic,
motivated and highly experienced visionaries. They include machine vision, AI, and autonomous software engineers from the greatest universities
in the world. Together with a highly talented and skilled support team, we solve real-world industrial applications in autonomy. As of
March 26, 2026, we had 62 full-time employees. The majority of our employees are based in Silicon Valley, California.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our core values include focus
on impact, display curiosity, communicate proactively, apply good judgment, and demonstrate selflessness. We believe these values encourage
innovation and a team-oriented culture. Our employees have access to a wide range of training, different career paths, and, most importantly,
challenging and purposeful work. Our culture is also built on diversity, inclusion, camaraderie, and celebration. We organize regular
team building activities and public recognition forums to celebrate our diversity and invest in strong relationships.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to a positive
culture and career development, we offer a robust benefits package. This package includes a flexible vacation policy, access to a 401(k)
plan, premier health plan options and numerous voluntary benefits for employees and their dependents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporate History</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company was incorporated
in the State of Delaware on February 1, 2013, under the original name Cyanogen, Inc. or Cyanogen. The Company started as a venture funded
company with offices in Seattle and Palo Alto, aimed at commercializing CyanogenMod, direct to consumers and through collaborations with
mobile phone manufacturers. CyanogenMod was an open-source operating system for mobile devices, based on the Android mobile platform.
Cyanogen released multiple versions of its mobile operating system and collaborated with an ecosystem of companies including mobile phone
OEMs, content providers and leading technology partners from 2013 to 2015.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2016 the Company&#8217;s
management and board of directors, determined to pivot its product focus and commercial direction from the mobile device and telecom space
to industrial and commercial autonomous driving with the hiring of Lior Tal in June 2016 to serve as the company&#8217;s chief operating
officer. Mr. Tal, a seasoned executive of startup firms where prior to joining the company, co-founded Snaptu which later was acquired
by Facebook (currently known as Meta Platforms, Inc.), as well as held various leadership roles at Actimize, DiskSites and Odigo; all
of these companies which were also later acquired. Mr. Tal was promoted to chief executive officer in October 2016 and continues to serve
in this role along with chairman of the board. In May 2017, the Company changed its name to Cyngn Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Available Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our principal business address
is 1344 Terra Bella Avenue, Mountain View, CA 94043. We maintain our corporate website at <i>https://cyngn.com </i>(this website address
is not intended to function <i>as a hyperlink and the information contained on our website is not intended to be a part of this Annual
Report</i>). We make available free of charge on https://investors.cyngn.com/ our annual, quarterly, and current reports, and amendments
to those reports if any, as soon as reasonably practical after we electronically file such material with, or furnish it to, the SEC. We
may from time to time provide important disclosures to investors by posting them in the Investor Relations section of our website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is quoted
on the Nasdaq under the symbol &#8220;CYN&#8221;. We file annual, quarterly, and current reports, proxy statements and other information
with the U.S. Securities Exchange Commission (the &#8220;SEC&#8221;) and are subject to the requirements of the Securities and Exchange
Act of 1934, as amended (the Exchange Act). These filings are available to the public on the Internet at the SEC&#8217;s website at http://www.sec.gov.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1A. Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Technology, Business,
and Industry</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Autonomous driving is an emerging technology
and involves significant risks and uncertainties.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We develop and deploy a suite
of autonomous driving software products that are compatible with existing sensors and hardware to enable autonomous driving on industrial
vehicle platforms manufactured and designed by OEMs and other third-party industrial vehicle suppliers. Our autonomous driving technology
is highly dependent on internally developed software, as well as on partnerships with third parties such as industrial OEMs and other
suppliers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We partner with OEMs that
are seeking to manufacture purpose-built industrial vehicles capable of incorporating our autonomous driving technology. Collaborative
partnerships are established through mutually beneficial, non-binding memorandums of understanding or partnership agreements for the purpose
of joint go-to-market efforts. In addition to OEMs, we depend on other third parties to produce hardware components, and, in some cases
adjacent software solutions, that support our core suite of autonomous driving software products and tools. The timely development and
performance of our autonomous driving programs is dependent on the materials, cooperation, and quality delivered by these partners. Further,
we do not control the initial design of the industrial vehicles we work with and therefore have limited influence over the production
and design of systems for braking, gear shifting, and steering. There can be no assurance that these systems and supporting technologies
can be developed and validated at the high reliability standard required for deployment of autonomous industrial vehicles using our technology
in a cost-effective and timely manner. Our dependence on these relationships exposes us to the risk that components manufactured by OEMs
or other suppliers could contain defects that would cause our autonomous driving technology not to operate as intended.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our autonomous driving technology
is available for production release and is currently being licensed to customers. We plan to continue our scaled commercialization throughout
2025 and beyond. Although we believe that our algorithms, data analysis and processing, and artificial intelligence technology are promising,
we cannot assure you that our technology will achieve the necessary reliability for scaled commercialization of autonomous industrial
vehicles. For example, we are still improving our technology in terms of handling edge cases, unique environments, and discrete objects.
There can be no assurance that our data analytics and artificial intelligence could predict every single potential issue that may arise
during the operation of an autonomous industrial vehicle utilizing our autonomous vehicle technology. Furthermore, the release and adoption
of EAS and our other technologies and products may not be successful and may take longer than anticipated. If the development of EAS and
our other technologies and products is delayed or customers do not adopt and buy our solutions to the extent we anticipate, our business
and operating results will be adversely impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We have a limited operating history in a new market and face
significant challenges as our industry is rapidly evolving.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should consider our business
and prospects in light of the risks and challenges we face as a new entrant into a novel industry, including, among other things, with
respect to our ability to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">design, integrate, and deploy safe, reliable, and quality autonomous vehicle software products and tools for industrial vehicles with our partners on an ongoing basis;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">navigate an evolving and complex regulatory environment;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">successfully produce with OEM partners a line of purpose-built autonomous industrial vehicles on the timeline we estimate;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">improve and enhance our software and autonomous technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">establish and expand our customer base;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">successfully market our autonomous driving solutions and our other products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">properly price our products and services;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">improve and maintain our operational efficiency;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">maintain a reliable, secure, high-performance, and scalable technology infrastructure;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">attract, retain, and motivate talented employees;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">anticipate and adapt to changing market conditions, including technological developments and changes in competitive landscape; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">build a well-recognized and respected brand.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to address any
or all of these risks and challenges, our business may be materially and adversely affected. There are also a number of additional challenges
to the execution and adoption of autonomous vehicle technology in industrial markets, many of which are not within our control, including
market acceptance of autonomous driving, governmental licensing requirements, concerns regarding data security and privacy, actual and
threatened litigation (whether or not a judgment is rendered against us), and the general perception that an autonomous vehicle is not
safe because there is no human driver. There can be no assurance that the market will accept our technology, in which case our future
business, results of operations and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The autonomous industrial
vehicle industry is in its early stages and is rapidly evolving. Our autonomous driving technology has not yet been commercialized at
scale. We cannot assure you that we will be able to adjust to changing market or regulatory conditions quickly or cost-effectively. If
we fail to do so, our business, results of operations, and financial condition will be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business model has yet to be tested
and any failure to commercialize our strategic plans would have an adverse effect on our operating results and business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors should be aware
of the difficulties normally encountered by a relatively new enterprise that is beginning to scale its business, many of which are beyond
our control, including unknown future challenges and opportunities, substantial risks and expenses in the course of entering new markets
and undertaking marketing activities. The likelihood of our success must be considered in light of these risks, expenses, complications,
delays, and the competitive environment in which we operate. There is, therefore, substantial uncertainty that our business plan will
prove successful, and we may not be able to generate significant revenue, raise additional capital, or operate profitably. We will continue
to encounter risks and difficulties frequently experienced by early commercial stage companies, including securing market acceptance for
our product and service offerings, scaling up our infrastructure and headcount. We may encounter unforeseen expenses, difficulties, or
delays in connection with our growth. In addition, as a result of the capital-intensive nature of our business, we can be expected to
continue to sustain substantial operating expenses without generating sufficient revenue to cover expenditures. Any investment in our
company is therefore highly speculative and could result in the loss of your entire investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future business depends
in large part on our ability to continue to develop and successfully commercialize our suite of software products and tools. Our ability
to develop, deliver, and commercialize at scale our technology to support or perform autonomous operation of industrial vehicles is still
unproven.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology suite is currently
available on tuggers for production release. However, this technology will need to be continually developed and enhanced for further scaled
commercialization. Continued enhancement of our autonomous driving technology is and will be subject to risks, including with respect
to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to continue to enhance our data analytics and software technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">designing, developing, and securing necessary components on acceptable terms and in a timely manner;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to attract and retain customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to pay for research and development costs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to attract, recruit, hire, and train skilled employees;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to fund the development and commercialization of our technology; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to enter into strategic relationships with key members in the industrial vehicles and industrial automation industries and component suppliers.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We operate in a highly competitive market
and will face competition from both established competitors and new market entrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market for autonomous
industrial vehicles and industrial automation solutions is highly competitive. Many companies are seeking to develop autonomous driving
and delivery solutions. Competition in these markets is based primarily on technology, innovation, quality, safety, reputation, and price.
Our future success will depend on our ability to further develop and protect our technology in a timely manner and to stay ahead of existing
and new competitors. Our competitors in this market are working towards commercializing autonomous driving technology and may have substantial
financial, marketing, research and development, and other resources.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we also face
competition from traditional industrial vehicle and solution companies. Traditional vehicle and solution providers operating with human
drivers are still the predominant operators in the market. Because of the long history of such traditional companies serving our potential
customers and industries, there may be many constituencies in the market that would resist a shift towards autonomous industrial vehicles,
which could include lobbying and marketing campaigns, particularly because our technology will displace machine operators and drivers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the market leaders
in our target industries, such as Industrial Material Handling, may start, or have already started, pursuing large scale deployment of
autonomous industrial vehicle technology on their own. These companies may have more operational and financial resources than we do. We
cannot guarantee that we will be able to effectively compete with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also face competition
from component suppliers and other technology and industrial solution companies if they decide to expand vertically and develop their
own autonomous industrial vehicles, some of whom have significantly greater resources than we do. We do not know how close these competitors
are to commercializing autonomous driving systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many established and new market
participants have entered or have announced plans to enter the autonomous industrial vehicle market. Most of these participants have significantly
greater financial, manufacturing, marketing, and other resources than we do and may be able to devote greater resources to the design,
development, manufacturing, distribution, promotion, sale, and support of their products. If existing competitors or new entrants commercialize
earlier than expected, our competitive advantage could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Business collaboration with third parties
is subject to risks and these relationships may not lead to significant revenue.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Strategic business relationships
are and will continue to be an important factor in the growth and success of our business. We have alliances and partnerships, through
mutually beneficial non-binding memoranda of understanding or partnering arrangements with other companies in the industrial equipment,
automation and automotive industries to help us in our efforts to continue to enhance our technology, commercialize our solutions, and
drive market acceptance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Collaboration with these third
parties is subject to risks, some of which are outside our control. For example, certain agreements with our partners grant our partner
or us the right to terminate such agreements for cause or without cause. If any of our collaborations with third parties are terminated,
it may delay or prevent our efforts to deploy our software products and tools on purpose-built autonomous industrial vehicles at scale.
In addition, such agreements may contain certain exclusivity provisions which, if triggered, could preclude us from working with other
businesses with superior technology or with whom we may prefer to partner with for other reasons. We could experience delays to the extent
our partners do not meet agreed upon timelines or experience capacity constraints. We could also experience disagreement in budget or
funding for joint development projects. There is also a risk of other potential disputes with partners in the future, including with respect
to intellectual property rights. Our ability to successfully commercialize could also be adversely affected by perceptions about the quality
of our or our partners&#8217; vehicles or products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Financial Position and
Need for Additional Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Losses for the foreseeable future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incurred net losses of
$23.5 million and $33.3 million for the years ended December 31, 2025, and 2024, respectively. We have not recognized a substantial amount
of revenue to date, and we had an accumulated deficit of $216.8 million and $193.4 million as of December 31, 2025 and December 31, 2024,
respectively. We have developed and tested our autonomous driving technology but there can be no assurance that it will be commercially
successful at scale. Our potential profitability is dependent upon a number of factors, many of which are beyond our control. If we are
unable to achieve and sustain profitability, the value of our business and common stock may significantly decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect the rate at which
we will incur losses to be significantly higher in future periods as we:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">design, develop, and deploy our autonomous vehicle software products and tools on industrial vehicle platforms with OEM partners and end customers.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">seek to achieve and commercialize deployments of level 4 autonomy for industrial vehicles;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">seek to expand our commercial deployments, on a nationwide basis in the United States and internationally;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">expand our design, development, maintenance, and repair capabilities;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">respond to competition in the autonomous driving market and from traditional industrial solution providers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">respond to evolving regulatory developments in the nascent autonomous industrial vehicle and industrial automation markets;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">increase our sales and marketing activities; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">increase our general and administrative functions to support our growing operations and for being a public reporting company.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because we will incur the
costs and expenses from these efforts before we receive any substantial revenue, our losses in future periods will be significant. In
addition, we may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenue,
which would further increase our losses. In particular, we expect to incur substantial and potentially increasing research and development
(&#8220;R&amp;D&#8221;) costs as we continue to develop and enhance EAS and other technology and products for commercialization. While
our R&amp;D costs were $12.5 million and $11.3 million during the years ended December 31, 2025 and 2024, respectively, and are likely
to grow in the future, we have minimal recurring revenues. Further, because we account for R&amp;D as an operating expense, these expenditures
will adversely affect our results of operations in the future. Our R&amp;D program may not produce successful results, and our new products
may not achieve market acceptance, create additional revenue, or become profitable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a limited operating history, which
makes it difficult to forecast our future results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We were founded in 2013. As
a result of our limited operating history, our ability to accurately forecast our future results of operations is limited and subject
to a number of uncertainties, including our ability to plan for and model future growth. Our historical performance should not be considered
indicative of our future performance. Further, in future periods, our revenue growth could fluctuate for a number of reasons, including
shifts in our offering and revenue mix, slowing demand for our offering, increasing competition, decreased effectiveness of our sales
and marketing organization, and our sales and marketing efforts to acquire new customers, failure to retain existing customers, changing
technology, a decrease in the growth of our overall market, or our failure, for any reason, to continue to take advantage of growth opportunities.
We anticipate that we will encounter risks and uncertainties frequently experienced by growing companies in rapidly changing industries,
such as the risks and uncertainties described in this Annual Report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our assumptions regarding
these risks and uncertainties and our future revenue growth are incorrect or change, or if we do not address these risks successfully,
our operating and financial results could differ materially from our expectations, and our business could suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We expect fluctuations in our financial
results making it difficult to project future results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our results of operations
may fluctuate in the future due to a variety of factors, many of which are outside of our control. As a result, our past results may not
be indicative of our future performance. In addition to the other risks described herein, factors that may affect our results of operations
include the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in our revenue mix and related changes in revenue recognition;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in actual and anticipated growth rates of our revenue, customers, and key operating metrics;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">fluctuations in demand for or pricing of our product offerings;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to attract new customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to retain our existing customers, particularly large customers;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">customers and potential customers opting for alternative products, including developing their own in-house solutions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">investments in new offerings, features, and functionality;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">fluctuations or delays in development, release, or adoption of new features and functionality for our offering;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">delays in closing sales which may result in revenue being pushed into the next quarter;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in customers&#8217; budgets and in the timing of their budget cycles and purchasing decisions;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our ability to control costs;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the amount and timing of payment for operating expenses, particularly research and development and sales and marketing expenses;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">timing of hiring personnel for our research and development and sales and marketing organizations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the amount and timing of costs associated with recruiting, educating, and integrating new employees and retaining and motivating existing employees;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the effects of acquisitions and their integration;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">general economic conditions, both domestically and internationally, as well as economic conditions specifically affecting industries in which our customers participate;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the impact of new accounting pronouncements;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in revenue recognition policies that impact our technology license revenue;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in regulatory or legal environments that may cause us to incur, among other things, expenses associated with compliance;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the impact of changes in tax laws or judicial or regulatory interpretations of tax laws, which are recorded in the period such laws are enacted or interpretations are issued and may significantly affect the effective tax rate of that period;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the impact of global events, including the outbreak of war or conflicts</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">health epidemics or pandemics, such as the COVID-19 pandemic;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in the competitive dynamics of our market, including consolidation among competitors or customers; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">significant security breaches of, technical difficulties with, or interruptions to, the delivery and use of our offering.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of these and other factors,
or the cumulative effect of some of these factors, may cause our results of operations to vary significantly. If our quarterly results
of operations fall below the expectations of investors and securities analysts who follow our stock, the price of our common stock could
decline substantially, and we could face costly lawsuits, including securities class action suits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may need to raise additional funds and
these funds may not be available to us on attractive terms when we need them, or at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The commercialization of autonomous
vehicles is capital intensive. This includes autonomous industrial vehicles outfitted with our technology and purpose-built autonomous
industrial vehicles manufactured by OEMs we intend to partner with. To date, we have financed our operations primarily through the issuance
of equity securities in private and public placements. We may need to raise additional capital to continue to fund our commercialization
activities, sales and marketing efforts, enhancement of our technology and to improve our liquidity position. Our ability to obtain the
necessary financing to carry out our business plan is subject to a number of factors, including general market volatility, investor acceptance
of our business plan, regulatory requirements and the successful development of our autonomous technology. These factors may make the
timing, amount, terms, and conditions of such financing unattractive or unavailable to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may raise these additional
funds through the issuance of equity, equity related, or debt securities. To the extent that we raise additional financing by issuing
equity securities or convertible debt securities, our stockholders may experience substantial dilution, and to the extent we engage in
debt financing, we may become subject to restrictive covenants that could limit our flexibility in conducting future business activities.
Financial institutions may request credit enhancement such as third-party guarantee and pledge of equity interest in order to extend loans
to us. We cannot be certain that additional funds will be available to us on attractive terms when required, or at all. If we cannot raise
additional funds when we need them, our financial condition, results of operations, business, and prospects could be materially adversely
affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have incurred significant losses and continue to manage our
cash resources to support our ongoing operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company incurred net losses
of approximately $23.5 million and $33.3 million for the years ended December 31, 2025, and 2024, respectively. In addition, the Company
had accumulated deficits of approximately $216.8 million and $193.4 million as of December 31, 2025 and December 31, 2024, respectively,
and net cash used in operating activities was approximately $23.6 million and $19.2 million for the year ended December 31, 2025 and 2024,
respectively. As of December 31, 2025, the Company&#8217;s cash and cash equivalents balance was approximately $1.0 million and the short-term
investments balance was $33.7 million. As of December 31, 2024, the Company&#8217;s unrestricted cash and cash equivalents balance was
$23.6 million and no short-terms investments. Based on cash flow projections from operating, investing and financing activities and the
existing balance of cash and short-term investments, management is of the opinion that the Company has sufficient funds for sustainable
operations, and it will be able to meet its payment obligations from operations and related commitments for the 12 months following the
date these consolidated financial statements were issued.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to risks associated with
potential future acquisitions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have no current
acquisition plans, if appropriate opportunities arise, we may acquire additional assets, products, technology or businesses that are complementary
to our existing business. Any future acquisitions and the subsequent integration of new assets and businesses would require significant
attention from our management and could result in a diversion of resources from our existing business, which in turn could have an adverse
effect on our operations, and consequently our results of operations and financial condition. Acquired assets or businesses may not generate
the financial results we expect. Acquisitions could result in the use of substantial amounts of cash, potentially dilutive issuances of
equity securities, significant goodwill impairment charges, amortization expenses for other intangible assets and exposure to potential
unknown liabilities of the acquired business. Moreover, the costs of identifying and consummating acquisitions may be significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Business Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our success depends largely on the continued
services of our senior management team, technical engineers, and certain key employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely on our executive officers
and key employees in the areas of business strategy, research and development, marketing, sales, services, and general and administrative
functions. From time to time, there may be changes in our executive management team or key employees resulting from the hiring or departure
of executives or key employees, which could disrupt our business. We do not maintain key-man insurance for any member of our senior management
team or any other employee. None of the employment agreements and offer letters with our executive officers or other key personnel require
them to continue to work for us for any specified period and, therefore, they could terminate their employment with us at any time. The
loss of one or more of our executive officers or key employees could have a serious adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To execute our growth plan,
we must attract and retain highly qualified personnel. Competition for these personnel is intense in the technology industry, especially
for engineers with high levels of experience in artificial intelligence and designing and developing autonomous driving related algorithms.
Furthermore, it can be difficult to recruit personnel from other geographies to relocate to our California location. We may also need
to recruit highly qualified technical engineers internationally and therefore subject us to the compliance of relevant immigration laws
and regulations. We have, from time to time, experienced, and we expect to continue to experience, difficulty in hiring and retaining
employees with appropriate qualifications. Many of the companies with which we compete for experienced personnel have greater resources
than we have and can offer more attractive compensation packages for new employees. If we hire employees from competitors or other companies,
their former employers may attempt to assert that these employees or our company have breached their legal obligations, resulting in a
diversion of our time and resources and potentially in litigation. In addition, job candidates and existing employees often consider the
value of the share incentive awards they receive in connection with their employment. If the perceived value of our share awards declines,
it may adversely affect our ability to recruit and retain highly skilled employees. If we fail to attract new personnel on a timely basis
or fail to retain and motivate our current personnel, we may not be able to commercialize and then expand our solutions and services in
a timely manner and our business and future growth prospects could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to manage our growth effectively,
we may be unable to execute our business plan, maintain high levels of service, or adequately address competitive challenges.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to invest in our
growth for the foreseeable future. Any growth in our business is expected to place a significant strain on not only our managerial, administrative,
operational, and financial resources, but also our infrastructure. We plan to continue to expand our operations in the future. Our success
will depend in part on our ability to manage this growth effectively and execute our business plan. To manage the expected growth of our
operations and personnel, we will need to continue to improve our operational, financial, and management controls and our reporting systems
and procedures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely heavily on information
technology (&#8220;IT&#8221;) systems to manage critical business functions. To manage our growth effectively, we must continue to improve
and expand our infrastructure, including our IT, financial, and administrative systems and controls. In particular, we may need to significantly
expand our IT infrastructure as the amount of data we store and transmit increases over time, which will require that we both utilize
existing IT products and adopt new technology. If we are not able to scale our IT infrastructure in a cost-effective and secure manner,
our ability to offer competitive solutions will be harmed and our business, financial condition, and operating results may suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We must also continue to manage
our employees, operations, finances, research and development, and capital investments efficiently. Our productivity and the quality of
our solutions may be adversely affected if we do not integrate and train our new employees quickly and effectively or if we fail to appropriately
coordinate across our executive, research and development, technology, service development, analytics, finance, human resources, marketing,
sales, operations, and customer support teams. As we continue to grow, we will incur additional expenses, and our growth may continue
to place a strain on our resources, infrastructure, and ability to maintain the quality of our solutions. If we do not adapt to meet these
evolving challenges, or if the current and future members of our management team do not effectively manage our growth, the quality of
our solutions may suffer and our corporate culture may be harmed. Failure to manage our future growth effectively could cause our business
to suffer, which, in turn, could have an adverse impact on our business, financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to product liability or
warranty claims that could result in significant direct or indirect costs, including reputational harm, increased insurance premiums or
the need to self-insure, which could adversely affect our business and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our technology is used for
autonomous driving, which presents the risk of significant injury, including fatalities. We may be subject to claims if one of our or
a customer&#8217;s industrial vehicles is involved in an accident and persons are injured or purport to be injured or if property is damaged.
Any insurance that we carry may not be sufficient or it may not apply to all situations. If we experience such an event or multiple events,
our insurance premiums could increase significantly or insurance may not be available to us at all. Further, if insurance is not available
on commercially reasonable terms, or at all, we might need to self-insure. In addition, lawmakers or governmental agencies could pass
laws or adopt regulations that limit the use of autonomous driving or industrial automation technology or increase liability associated
with its use. Any of these events could adversely affect our brand, relationships with users, operating results, or financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our autonomous driving software fails
to perform as expected our ability to market, sell or lease our autonomous driving software could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our autonomous industrial
vehicle software products and tools as well as the vehicles, sensors, and hardware they utilize and are deployed on may contain defects
in design and manufacture that may cause them not to perform as expected or require repair. For example, our autonomous vehicle software
will require modification and updates over the life of the vehicle it is deployed on. Software products are inherently complex and often
contain defects and errors when first introduced. There can be no assurance that we will be able to detect and fix any defects in the
industrial vehicles&#8217; hardware or software prior to commencing user sales or during the life of the vehicle. Autonomous industrial
vehicles utilizing our suite of products and tools may not perform consistent with users&#8217; expectations or consistent with other
vehicles that may become available. Any product defects or any other failure of our software, supportive hardware, or deployment vehicle
platform or to perform as expected could harm our reputation, result in adverse publicity, lost revenue, delivery delays, product recalls,
product liability claims, and significant warranty and other expenses, and could have a material adverse impact on our business, financial
condition, operating results, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to establish and maintain
confidence in our long-term business prospects among users, securities and industry analysts, and within our industries, or are subject
to negative publicity, then our financial condition, operating results, business prospects, and access to capital may suffer materially.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Users may be less likely to
purchase or use our technology and the industrial vehicles it is deployed on if they are not convinced that our business will succeed
or that our service and support and other operations will continue in the long term. Similarly, suppliers and other third parties will
be less likely to invest time and resources in developing business relationships with us if they are not convinced that our business will
succeed. Accordingly, in order to build and maintain our business, we must maintain confidence among users, suppliers, securities and
industry analysts, and other parties in our long-term financial viability and business prospects. Maintaining such confidence may be particularly
complicated by certain factors including those that are largely outside of our control, such as our limited operating history at scale,
user unfamiliarity with our solutions, any delays in scaling manufacturing, delivery, and service operations to meet demand, competition
and uncertainty regarding the future of autonomous vehicles, and our performance compared with market expectations<b style="font-style: normal; font-weight: normal"><i style="font-style: normal; font-weight: normal">.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Natural disasters, outbreaks of infectious
diseases, terrorist attacks, wars and threats of war may negatively impact our operations, revenue, costs, and stock price.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Natural disasters such as
earthquakes, floods, severe weather conditions, outbreaks of infectious diseases in addition to COVID-19 or other catastrophic events
may severely affect our operations or those of our suppliers and customers. Acts of terrorism, as well as events occurring in response
or connection to them, including potential future terrorist attacks, rumors or threats of war, actual military conflicts or trade disruptions
impacting our domestic or foreign customers or suppliers, may negatively impact our operations by causing, among other things, delays,
or losses in the delivery of supplies or finished goods and decreased sales of our products. More generally, any of these events could
cause consumer confidence and spending to decrease and/or result in increased volatility in the worldwide financial markets and economy.
They also could result in economic recession either globally or in the markets in which we operate. Any of these occurrences could have
a significant adverse impact on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>International trade policies, including
tariffs, sanctions and trade barriers, may adversely affect our business, financial condition, results of operations and prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beginning in our fiscal year
2025, significant new and expanded tariffs, reciprocal tariffs and other trade restrictions have been imposed with selective tariff exemptions
impacting global trade.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Current or future tariffs
or other restrictive trade measures may raise the costs of raw materials, components or finished goods, which may adversely impact both
our product offerings and our operational expenses. Such cost increases may reduce our margins and require us to increase prices, which
could harm our competitive position, reduce customer demand and damage customer relationships.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Trade disputes, trade restrictions,
tariffs and other political tensions between the U.S. and other countries may also exacerbate unfavorable macroeconomic conditions including
inflationary pressures, foreign exchange volatility, financial market instability, and economic recessions or downturns, which may also
negatively impact customer demand for our products or services, delay purchases or renewals, limit expansion opportunities with customers,
limit our access to capital, or otherwise negatively impact our business and operations. Ongoing tariff policies, trade restrictions and
macroeconomic uncertainty have and may continue to contribute to volatility in the price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ongoing uncertainty regarding
trade policies may also complicate our short- and long-term strategic planning, and that of our partners and customers, including decisions
regarding hiring, product strategy, capital investment, supply chain design and geographic expansion. While we continue to monitor trade
developments, the ultimate impact of these risks remains uncertain and any prolonged economic downturn, escalation in trade tensions,
or deterioration in international perception of U.S.-based companies could materially and adversely affect our business, results of operations,
financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a material weakness in our internal
control over financial reporting, and our inability to remediate this weakness or otherwise implement and maintain effective internal
control over financial reporting, or the inability of our independent registered public accounting firm to provide an unqualified report
thereon, could have a material adverse effect on us.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we fail to maintain
an effective system of internal controls, we may not be able to accurately report our financial results. As a result, our
stakeholders could lose confidence in our financial reporting, which could adversely affect the results of our business and our
enterprise value. In connection with our assessment of internal control over financial reporting, we identified two material
weaknesses in our internal control over financial reporting as of December 31, 2025 (see Item 9A. <i>Controls and Procedures </i>for
additional detail). The deficiencies above led to two misstatements, one of which was corrected prior to the issuance of the prior
year&#8217;s financial statements, and the other lead to the restatement of the Affected Periods. These material weaknesses create a
reasonable possibility that material misstatements to our consolidated financial statements may not be prevented or detected in a
timely manner. Accordingly, management concluded that the Company&#8217;s internal control over financial reporting was not
effective as of December 31, 2025. The disclosure of these material weaknesses, even if quickly remediated, could reduce the
market&#8217;s confidence in our financial statements and harm our enterprise value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Intellectual Property,
Information Technology and Data Privacy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become subject to litigation brought
by third parties claiming infringement, misappropriation or other violation by us of their intellectual property rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The industry in which our
business operates is characterized by a large number of patents, some of which may be of questionable scope, validity or enforceability,
and some of which may appear to overlap with other issued patents. As a result, there is a significant amount of uncertainty in the industry
regarding patent protection and infringement. In recent years, there has been significant litigation globally involving patents and other
intellectual property rights. Third parties may in the future assert, that we have infringed, misappropriated or otherwise violated their
intellectual property rights. As we face increasing competition and as a public company, the possibility of intellectual property rights
claims against us grows. Such claims and litigation may involve one or more of our competitors focused on using their patents and other
intellectual property to obtain competitive advantage, or patent holding companies or other adverse intellectual property rights holders
who have no relevant product revenue, and therefore our own pending patents and other intellectual property rights may provide little
or no deterrence to these rights holders in bringing intellectual property rights claims against us. There may be intellectual property
rights held by others, including issued or pending patents and trademarks, that cover significant aspects of our technologies or business
methods, and we cannot assure that we are not infringing or violating, and have not infringed or violated, any third-party intellectual
property rights or that we will not be held to have done so or be accused of doing so in the future. In addition, because patent applications
can take many years until the patents issue, there may be applications now pending of which we are unaware, which may later result in
issued patents that our products may infringe. We expect that in the future we may receive notices that claim we or our collaborators
have misappropriated or misused other parties&#8217; intellectual property rights, particularly as the number of competitors in our market
grows.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To defend ourselves against
any intellectual property claims brought by third parties, whether with or without merits, can be time-consuming and could result in substantial
costs and a diversion of our resources. These claims and any resulting lawsuits, if resolved adversely to us, could subject us to significant
liability for damages, impose temporary or permanent injunctions against our products, technologies or business operations, or invalidate
or render unenforceable our intellectual property.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our technology is determined
to infringe a valid and enforceable patent, or if we wish to avoid potential intellectual property litigation on any alleged infringement,
misappropriation or other violation of third party intellectual property rights, we may be required to do one or more of the following:
(i) cease development, sales, or use of our products that incorporate or use the asserted intellectual property right; (ii) obtain a license
from the owner of the asserted intellectual property right, which may be unavailable on commercially reasonable terms, or at all, or which
may be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us; (iii) pay
substantial royalties or other damages; or (iv) redesign our technology or one or more aspects or systems of our autonomous industrial
vehicles to avoid any infringement or allegations thereof. The aforementioned options sometimes may not be commercially feasible. Additionally,
in our ordinary course of business, we agree to indemnify our customers, partners, and other commercial counterparties for any infringement
arising out of their use of our intellectual property, along with providing standard indemnification provisions, so we may face liability
to our users, business partners or third parties for indemnification or other remedies in the event that they are sued for infringement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also in the future
license third party technology or other intellectual property, and we may face claims that our use of such in-licensed technology or other
intellectual property infringes, misappropriates or otherwise violates the intellectual property rights of others. In such cases, we will
seek indemnification from our licensors. However, our rights to indemnification may be unavailable or insufficient to cover our costs
and losses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also may not be successful
in any attempt to redesign our technology to avoid any alleged infringement. A successful claim of infringement against us, or our failure
or inability to develop and implement non-infringing technology, or license the infringed technology on acceptable terms and on a timely
basis, could materially adversely affect our business and results of operations. Furthermore, such lawsuits, regardless of their success,
would likely be time-consuming and expensive to resolve and would divert management&#8217;s time and attention from our business, which
could seriously harm our business. Also, such lawsuits, regardless of their success, could seriously harm our reputation with users and
in the industry at large.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business may be adversely affected if
we are unable to adequately establish, maintain, protect, and enforce our intellectual property and proprietary rights or prevent third
parties from making unauthorized use of our technology and other intellectual property rights.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our intellectual property
is an essential asset of our business. Failure to adequately protect our intellectual property rights could result in our competitors
offering similar products, potentially resulting in the loss of our competitive advantage, and a decrease in our revenue which would adversely
affect our business prospects, financial condition, and operating results. Our success depends, at least in part, on our ability to protect
our core technology and intellectual property. We rely on a combination of intellectual property rights, such as patents, trademarks,
copyrights, and trade secrets (including know-how), in addition to employee and third-party nondisclosure agreements, intellectual property
licenses, and other contractual rights, to establish, maintain, protect, and enforce our rights in our technology, proprietary information,
and processes. Intellectual property laws and our procedures and restrictions provide only limited protection and any of our intellectual
property rights may be challenged, invalidated, circumvented, infringed or misappropriated. If we fail to protect our intellectual property
rights adequately, we may lose an important advantage in the markets in which we compete. While we take measures to protect our intellectual
property, such efforts may be insufficient or ineffective, and any of our intellectual property rights may be challenged, which could
result in them being narrowed in scope or declared invalid or unenforceable. Other parties may also independently develop technologies
that are substantially similar or superior to ours. We also may be forced to bring claims against third parties, or defend claims that
they may bring against us, to determine the ownership of what we regard as our intellectual property. However, the measures we take to
protect our intellectual property from unauthorized use by others may not be effective and there can be no assurance that our intellectual
property rights will be sufficient to protect against others offering products, services, or technologies that are substantially similar
or superior to ours and that compete with our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Litigation may be necessary
in the future to enforce our intellectual property rights and to protect our trade secrets. Our efforts to enforce our intellectual property
rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property.
Any litigation initiated by us concerning the violation by third parties of our intellectual property rights is likely to be expensive
and time-consuming and could lead to the invalidation of, or render unenforceable, our intellectual property, or could otherwise have
negative consequences for us. Furthermore, it could result in a court or governmental agency invalidating or rendering unenforceable our
patents or other intellectual property rights upon which the suit is based. We will not be able to protect our intellectual property if
we are unable to enforce our rights or if we do not detect unauthorized use of our intellectual property. Our inability to protect our
proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management&#8217;s attention
and resources, could delay the introduction and implementation of new technologies, result in our substituting inferior or more costly
technologies into our products or injure our reputation. Moreover, policing unauthorized use of our technologies, trade secrets, and intellectual
property may be difficult, expensive, and time-consuming, particularly in foreign countries where the laws may not be as protective of
intellectual property rights as those in the United States and where mechanisms for enforcement of intellectual property rights may be
weak. If we fail to meaningfully establish, maintain, protect, and enforce our intellectual property and proprietary rights, our business,
operating results, and financial condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in U.S. patent law could diminish
the value of patents in general, thereby impairing our ability to protect our products.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Changes in U.S. Patent law
may have a significant impact on our ability to protect our technology and enforce our intellectual property rights. For example, the
Leahy-Smith America Invents Act (the &#8220;AIA&#8221;) enacted in September 2011, resulted in significant changes in patent legislation.
An important change introduced by the AIA is that, as of March 16, 2013, the United States transitioned from a &#8220;first-to-invent&#8221;
to a &#8220;first-to-file&#8221; system for deciding which party should be granted a patent when two or more patent applications are filed
by different parties claiming the same invention. Under a &#8220;first-to-file&#8221; system, assuming the other requirements for patentability
are met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether
another inventor had made the invention earlier. A third party that files a patent application in the United States Patent and Trademark
Office (&#8220;USPTO&#8221;) after that date but before us could therefore be awarded a patent covering an invention of ours even if we
made the invention before it was made by the third party. Circumstances could prevent us from promptly filing patent applications on our
inventions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The AIA also includes a number
of significant changes that affect the way patent applications will be prosecuted and also may affect patent litigation. These include
allowing third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of
a patent by USPTO administered post-grant proceedings, including post-grant review, <i>inter partes</i> review, and derivation proceedings.
Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary
to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold
a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action.
Accordingly, a third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated
if first challenged by the third party as a defendant in a district court action. The AIA and its implementation could increase the uncertainties
and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could
have a material adverse effect on our business, financial condition, results of operations, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the standards applied
by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably. For example, there is no
uniform worldwide policy regarding patentable subject matter or the scope of claims allowable for business methods. As such, we do not
know the degree of future protection that we will have on our technologies, products, and services. While we will endeavor to try to protect
our technologies, products, and services with intellectual property rights such as patents, as appropriate, the process of obtaining patents
is time-consuming, expensive, and sometimes unpredictable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the U.S. Supreme
Court has ruled on several patent cases in recent years, such as Impression Products, Inc. v. Lexmark International, Inc., Association
for Molecular Pathology v. Myriad Genetics, Inc., Mayo Collaborative Services v. Prometheus Laboratories, Inc. and Alice Corporation Pty.
Ltd. v. CLS Bank International, either narrowing the scope of patent protection available in certain circumstances or weakening the rights
of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future,
this combination of events has created uncertainty with respect to the value of patents, once obtained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Depending on decisions by
the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that
could weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our patent applications may not issue as
patents, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot be certain that
we are the first inventor of the subject matter to which we have filed a particular patent application, or if we are the first party to
file such a patent application. If another party has filed a patent application to the same subject matter as we have, we may not be entitled
to the protection sought by the patent application. Further, the scope of protection of issued patent claims is often difficult to determine.
As a result, we cannot be certain that the patent applications that we file will issue, or that our issued patents will be broad enough
to protect our proprietary rights or otherwise afford protection against competitors with similar technology. In addition, the issuance
of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Our competitors may challenge or seek to invalidate
our issued patents, or design around our issued patents, which may adversely affect our business, prospects, financial condition or operating
results. Also, the costs associated with enforcing patents, confidentiality and invention agreements, or other intellectual property rights
may make aggressive enforcement impracticable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to protect our intellectual
property rights throughout the world.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Filing, prosecuting, maintaining,
defending, and enforcing patents and other intellectual property rights on our product candidates in all countries throughout the world
would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive
than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same
extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions
in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States
or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection or other intellectual
property rights to develop their own products and may export otherwise infringing, misappropriating, or violating products to territories
where we have patent or other intellectual property protection, but enforcement rights are not as strong as those in the United States.
These products may compete with our product candidates, and our patents or other intellectual property rights may not be effective or
sufficient to prevent them from competing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many companies have encountered
significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of some countries
do not favor the enforcement of patents and other intellectual property rights, which could make it difficult for us to stop the infringement,
misappropriation, or other violation of our intellectual property rights generally. Proceedings to enforce our intellectual property rights
in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could
put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing, and could provoke
third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded,
if any, may not be commercially meaningful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many countries, including
European Union countries, India, Japan, and China, have compulsory licensing laws under which a patent owner may be compelled under specified
circumstances to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies
or government contractors. In those countries, we may have limited remedies if patents are infringed or if we are compelled to grant a
license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities.
Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial
advantage from the intellectual property that we develop or license, which could adversely affect our business, financial condition, results
of operations, and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In addition to patented technology, we rely
on our unpatented proprietary technology, trade secrets, processes, and know-how.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely on proprietary information
(such as trade secrets, know-how, and confidential information) to protect intellectual property that may not be patentable, or that we
believe is best protected by means that do not require public disclosure. We generally seek to protect this proprietary information by
entering into confidentiality agreements, or consulting, services, or employment agreements that contain non-disclosure and non-use provisions
with our employees, consultants, contractors, scientific advisors, and third parties. However, we cannot guarantee that we have entered
into such agreements with each party that has or may have had access to our trade secrets or proprietary information and, even if entered
into, these agreements may be breached or may otherwise fail to prevent disclosure, third-party infringement or misappropriation of our
proprietary information, may be limited as to their term and may not provide an adequate remedy in the event of unauthorized disclosure
or use of proprietary information. We have limited control over the protection of trade secrets used by our third-party manufacturers
and suppliers and could lose future trade secret protection if any unauthorized disclosure of such information occurs. In addition, our
proprietary information may otherwise become known or be independently developed by our competitors or other third parties. To the extent
that our employees, consultants, contractors, and other third parties use intellectual property owned by others in their work for us,
disputes may arise as to the rights in related or resulting know-how and inventions. Costly and time-consuming litigation could be necessary
to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain protection for our proprietary information
could adversely affect our competitive business position. Furthermore, laws regarding trade secret rights in certain markets where we
operate may afford little or no protection to our trade secrets. If any of our trade secrets were to be lawfully obtained or independently
developed by a competitor or other third party, we would have no right to prevent them from using that trade secret to compete with us.
If any of our trade secrets were to be disclosed (whether lawfully or otherwise) to or independently developed by a competitor or other
third party, it could have a material adverse effect on our business, operating results, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also rely on physical and
electronic security measures to protect our proprietary information, but we cannot guarantee that these security measures provide adequate
protection for such proprietary information or will never be breached. There is a risk that third parties may obtain unauthorized access
to and improperly utilize or disclose our proprietary information, which would harm our competitive advantages. We may not be able to
detect or prevent the unauthorized access to or use of our information by third parties, and we may not be able to take appropriate and
timely steps to mitigate the damages (or the damages may not be capable of being mitigated or remedied).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We utilize open-source software, which may
pose particular risks to our proprietary software, technologies, products, and services in a manner that could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use open-source software
in our products and services and anticipate using open-source software in the future. We utilize a distribution of the open-source Linux
system, and tools such as ROS (open-source publish-subscribe tool) in the technical stack. Professional open-source license scanning systems
such as WhiteSource and ScanCode are used in both places. Both Continuous Integration and Continuous Deployment (&#8220;CI/CD&#8221;)
level open-source scan and overall system opensource scan is performed to protect the systems and our intellectual property. In the event
that our scanning and open-source check protocols fail, the Company could be negatively affected Some open-source software licenses require
those who distribute open-source software as part of their own software products to publicly disclose all or part of the source code to
such software product or to make available any modifications or derivative works of the open-source code on unfavorable terms or at no
cost. This could result in our proprietary software being made available in the source code form and/or licensed to others under open-source
licenses, which could allow our competitors or other third parties to use our proprietary software freely without spending the development
effort, and which could lead to a loss of the competitive advantage of our proprietary technologies and, as a result, sales of our products
and services. The terms of many open-source licenses to which we are subject have not been interpreted by U.S. or foreign courts, and
there is a risk that open-source software licenses could be construed in a manner that imposes unanticipated conditions or restrictions
on our ability to provide or distribute our products or services or retain our ownership of our proprietary intellectual property. Additionally,
we could face claims from third parties claiming ownership of, or demanding release of, the open-source software or derivative works that
we developed using such software, which could include our proprietary source code, or otherwise seeking to enforce the terms of, or alleging
breach of, the applicable open-source license. These claims could result in litigation and could require us to make our proprietary software
source code freely available, purchase a costly license, or cease offering the implicated products or services unless and until we can
re-engineer them to avoid breach of the applicable open-source software licenses or potential infringement. This re-engineering process
could require us to expend significant additional research and development resources, and we cannot guarantee that we will be successful.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the use of certain
open-source software can lead to greater risks than use of third-party commercial software, as open-source licensors generally do not
provide warranties or controls on the origin of software. There is typically no support available for open-source software, and we cannot
ensure that the authors of such open-source software will implement or push updates to address security risks or will not abandon further
development and maintenance. Many of the risks associated with the use of open-source software, such as the lack of warranties or assurances
of title, non-infringement, or performance, cannot be eliminated, and could, if not properly addressed, negatively affect our business.
We have processes to help alleviate these risks, including a review process for screening requests from our developers for the use of
open-source software, but we cannot be sure that all open-source software is identified or submitted for approval prior to use in our
products and services. Any of these risks could be difficult to eliminate or manage, and, if not addressed, could adversely affect our
ownership of proprietary intellectual property, the security of our vehicles, or our business, results of operations, and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Unauthorized control or manipulation of
systems in autonomous industrial vehicles may cause them to operate improperly or not at all, or compromise their safety and data security,
which could result in loss of confidence in us and our products, cancellation of contracts with future OEM or supplier partners.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There have been reports of
vehicles of certain automotive OEMs being &#8220;hacked&#8221; to grant access to and operation of the vehicles to unauthorized persons.
Our autonomous vehicle software products and tools as well as the vehicles they are deployed on contain or will contain complex IT systems
and are designed with built-in data connectivity. We are in the process of and will continue implementing security measures intended to
prevent unauthorized access to our information technology networks and systems. However, hackers may attempt to gain unauthorized access
to modify, alter, and use such networks and systems to gain control of, or to change the functionality of the autonomous industrial vehicles&#8217;
running our software, user interface and performance characteristics, or to gain access to data stored in or generated by our products.
As techniques used to obtain unauthorized access to or sabotage systems change frequently and may not be known until launched against
us or our third-party service providers, there can be no assurance that we will be able to anticipate, or implement adequate measures
to protect against, these attacks. Any such security incidents could result in unexpected control of or changes to the vehicles&#8217;
functionality and safe operation and could result in legal claims or proceedings and negative publicity, which would negatively affect
our brand and harm our business, prospects, financial condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our information technology systems or data,
or those of our service providers or customers or users could be subject to cyber-attacks or other security incidents, which could result
in data breaches, intellectual property theft, claims, litigation, regulatory investigations, significant liability, reputational damage
and other adverse consequences.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We continue to expand our
information technology systems as our operations grow, such as product data management, procurement, inventory management, production
planning and execution, sales, service and logistics, financial, tax and regulatory compliance systems. This includes the implementation
of new internally developed systems and the deployment of such systems in the U.S. and abroad. While, we maintain information technology
measures designed to protect us against intellectual property theft, data breaches, sabotage and other external or internal cyber-attacks
or misappropriation, our systems and those of our service providers are potentially vulnerable to malware, ransomware, viruses, denial-of-service
attacks, phishing attacks, social engineering, computer hacking, unauthorized access, exploitation of bugs, defects and vulnerabilities,
breakdowns, damage, interruptions, system malfunctions, power outages, terrorism, acts of vandalism, security breaches, security incidents,
inadvertent or intentional actions by employees or other third parties, and other cyber-attacks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.75pt">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent any security
incident results in unauthorized access or damage to or acquisition, use, corruption, loss, destruction, alteration or dissemination of
our data, including intellectual property and personal information, or our products, or for it to be believed or reported that any of
these occurred, it could disrupt our business, harm our reputation, compel us to comply with applicable data breach notification laws,
subject us to time consuming, distracting and expensive litigation, regulatory investigation and oversight, mandatory corrective action,
require us to verify the correctness of database contents, or otherwise subject us to liability under laws, regulations and contractual
obligations, including those that protect the privacy and security of personal information. This could result in increased costs to us
and result in significant legal and financial exposure and/or reputational harm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also rely on service providers,
and similar incidents relating to their information technology systems could also have a material adverse effect on our business. Our
ability to monitor our service providers&#8217; security measures is limited, and, in any event, malicious third parties may be able to
circumvent those security measures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, the implementation,
maintenance, segregation and improvement of these systems require significant management time, support and cost, and there are inherent
risks associated with developing, improving and expanding our core systems as well as implementing new systems and updating current systems,
including disruptions to the related areas of business operation. These risks may affect our ability to manage our data and inventory,
procure parts or supplies or manufacture, sell, deliver and service products, adequately protect our intellectual property or achieve
and maintain compliance with, or realize available benefits under, tax laws and other applicable regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.75pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, if we do not successfully
implement, maintain or expand these systems as planned, our operations may be disrupted, our ability to accurately and/or timely report
our financial results could be impaired and deficiencies may arise in our internal control over financial reporting, which may impact
our ability to certify our financial results. Moreover, our proprietary information, including intellectual property and personal information,
could be compromised or misappropriated and our reputation may be adversely affected. If these systems or their functionality do not operate
as we expect them to, we may be required to expend significant resources to make corrections or find alternative sources for performing
these functions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The costs to comply with, or our actual
or perceived failure to comply with, changing U.S. and foreign laws related to data privacy, security and protection, could adversely
affect our financial condition, operating results, and our reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In operating our business
and providing services and solutions to clients, we collect, use, store, transmit, and otherwise process employee, partner, and customer
data, including personal data, in and across multiple jurisdictions. We use the electronic systems within the autonomous industrial vehicles
that log information about each industrial vehicle&#8217;s use in order to aid us in vehicle diagnostics, repair, and maintenance, as
well as to help us collect data regarding operators&#8217; use patterns and preference in order to help us customize and optimize the
driving and operating experiences. The integrated autonomous industrial vehicles leveraging our software products and tools may also collect
personal information of drivers, operators and passengers, such as a voice command of a person, in order to aid the manual operation of
our industrial vehicles. When our autonomy enabled industrial vehicles are in operation, the camera, LiDAR, and other sensing components
of the vehicles will collect site and route view, mapping data, landscape images, and other LiDAR information, which may include personal
information such as license plate numbers of other vehicles, facial features of pedestrians, appearance of individuals, GPS data, geolocation
data, in order train the data analytics and artificial intelligence technology equipped in our industrial vehicles for the purpose of
identifying different objects, and predicting potential issues that may arise during the operation of our integrated industrial vehicles.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We plan to utilize systems
and applications that are spread over the globe, requiring us to regularly move data across national borders. As a result, we are subject
to a variety of laws and regulations in the United States, and other foreign jurisdictions as well as contractual obligations, regarding
data privacy, protection, and security. Some of these laws and regulations require obtaining data subjects&#8217; consent to the collection
and use of their data, honoring data subjects&#8217; request to delete their data or limit the processing of their data, providing notifications
in the event of a data breach, and setting up the proper legal mechanisms for cross-border data transfers. Some customers may refuse to
provide consent to our collection and use of their personal information, or may restrict our use of such personal information, and in
some cases it is not feasible to obtain consent from data subjects in the general public whose personal information may be captured by
our autonomous industrial vehicles, all of which may hinder our ability to train our data analytics and artificial intelligence technology,
and may harm the competitiveness of our technology. In many cases, these laws and regulations apply not only to the collection and processing
of personal information from third parties with whom we do not have any contractual relationship, but also to the sharing or transfer
of information between or among us, our subsidiaries and other third parties with which we have commercial relationships, such as our
service providers, partners, and customers. The regulatory framework for data privacy, protection, and security worldwide is continuously
evolving and developing and, as a result, interpretation and implementation standards and enforcement practices are likely to remain uncertain
for the foreseeable future. In particular, some of these laws and regulations may require us to store certain categories of data collected
from individuals residing in a jurisdiction only on servers physically located in such jurisdiction, and may further require us to conduct
security assessments and/or adopt other cross-border data transfer mechanisms in order to transfer such data outside of such jurisdiction.
With the continuously evolving and rapidly changing privacy regulatory regime, our ability to freely transfer data among our affiliates
and with our partners in different jurisdictions may be impeded, or we may need to incur significant costs in order to comply with such
requirements. In addition, the number of high-profile data breaches at major companies continues to accelerate, which will likely lead
to even greater regulatory scrutiny.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The scope and interpretation
of the laws and regulations that are or may be applicable to us are often uncertain and may be conflicting, particularly with respect
to foreign laws. For example, the E.U. General Data Protection Regulation (the &#8220;GDPR&#8221;), which became effective in May 2018,
greatly increased the European Commission&#8217;s jurisdictional reach of its laws and added a broad array of requirements for handling
personal data with respect to EU data subjects. EU member states are tasked under the GDPR to enact, and have enacted, certain implementing
legislation that adds to and/or further interprets the GDPR requirements and potentially extends our obligations and potential liability
for failing to meet such obligations. The GDPR, together with national legislation, regulations and guidelines of the EU member states
and the United Kingdom governing the processing of personal data, impose strict obligations and restrictions on the ability to collect,
use, retain, protect, disclose, transfer, and otherwise process personal data with respect to EU and UK data subjects. In particular,
the GDPR includes obligations and restrictions concerning the consent and rights of individuals to whom the personal data relates, the
transfer of personal data out of the European Economic Area or the United Kingdom, security breach notifications and the security and
confidentiality of personal data. Among other stringent requirements, the GDPR restricts transfers of data outside of the EU to third
countries deemed to lack adequate privacy protections (such as the U.S.), unless an appropriate safeguard specified by the GDPR is implemented.
A July 16, 2020 decision of the Court of Justice of the European Union invalidated a key mechanism for lawful data transfer to the U.S.
and called into question the viability of its primary alternative. As such, the ability of companies to lawfully transfer personal data
from the EU to the U.S. is presently uncertain. Other countries have enacted or are considering enacting similar cross-border data transfer
rules or data localization requirements. These developments could limit our ability to launch our products in the EU and other foreign
markets. The GDPR authorizes fines for certain violations of up to 4% of global annual revenue or &#8364;20 million, whichever is greater.
Such fines are in addition to any civil litigation claims by data subjects. Much remains unknown with respect to how to interpret and
implement the GDPR and guidance on implementation and compliance practices is often updated or otherwise revised. Given the breadth and
depth of changes in data protection obligations, including classification of data and our commitment to a range of administrative, technical
and physical controls to protect data and enable data transfers outside of the EU and the United Kingdom, our compliance with the GDPR&#8217;s
requirements will continue to require time, resources and review of the technology and systems we use to satisfy the GDPR&#8217;s requirements,
including as EU member states enact their legislation. Further, while the United Kingdom enacted the Data Protection Act 2018 in May 2018
that supplements the GDPR, and has publicly announced that it will continue to regulate the protection of personal data in the same way
post-Brexit, Brexit has created uncertainty with regard to the future of regulation of data protection in the United Kingdom.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S. federal government
and various states and governmental agencies also have adopted or are considering adopting various laws, regulations, and standards regarding
the collection, use, retention, security, disclosure, transfer, and other processing of sensitive and personal information. In addition,
many states in which we operate have laws that protect the privacy and security of sensitive and personal information. Certain state laws
may be more stringent or broader in scope, or offer greater individual rights, with respect to sensitive and personal information than
federal, international, or other state laws, and such laws may differ from each other, which may complicate compliance efforts. State
laws are changing rapidly and there is discussion in Congress of a new federal data protection and privacy law to which we would become
subject if it is enacted. All of these evolving compliance and operational requirements impose significant costs that are likely to increase
over time, may require us to modify our data processing practices and policies, and may divert resources from other initiatives and projects.
Furthermore, non-compliance with data privacy laws and regulations, or a major breach of our network security and systems, could have
serious negative consequences for our businesses and future prospects, including possible fines, penalties, and damages, reduced customer
demand for our products, and harm to our reputation and brand, all of which may have a material and adverse impact on our business, financial
condition, and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We make public statements
about our use and disclosure of personal information through our privacy policy, information provided on our website and press statements.
Also, we enter into contracts with third parties (such as our partners and clients) that contain provisions regarding the collection,
sharing, and processing of personal information. Although we endeavor to comply with our public statements and documentation as well as
our contractual and other privacy-related obligations, we may at times fail to do so or be alleged to have failed to do so. The publication
of our privacy policy and other statements that provide promises and assurances about data privacy and security can subject us to potential
government or legal action if they are found to be deceptive, unfair or misrepresentative of our actual practices. In addition, from time
to time, concerns may be expressed about whether our products and services compromise the privacy of clients and others. Any concerns
about our data privacy and security practices (even if unfounded), or any failure, real or perceived, by us to comply with our posted
privacy policies, contractual obligations, or any legal or regulatory requirements, standards, certifications, or orders, or other privacy
or consumer protection-related laws and regulations applicable to us, could cause our clients to reduce their use of our autonomous industrial
vehicles and could affect our financial condition, operating results, and our reputation, and may result in governmental or regulatory
investigations, enforcement actions, regulatory fines, criminal compliance orders, litigations, breach of contract claims, or public statements
against us by government regulatory authorities, our partners and/or clients, data subjects, consumer advocacy groups, or others, all
of which could be costly and have an adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, enforcement actions
and investigations by regulatory authorities related to data security incidents and privacy violations continue to increase. Non-compliance
could result in proceedings against us by data protection authorities, governmental entities or others, including class action privacy
litigation in certain jurisdictions, which would subject us to significant fines, penalties, judgments, and negative publicity, and may
otherwise affect our financial condition, operating results, and our reputation. Given the complexity of operationalizing the GDPR and
other data privacy and security laws and regulations to which we are subject, the maturity level of proposed compliance frameworks and
the relative lack of guidance in the interpretation of the numerous requirements of the GDPR and other data privacy and security laws
and regulations to which we are subject, we may not be able to respond quickly or effectively to regulatory, legislative, and other developments,
and these changes may in turn impair our ability to offer our existing or planned products and services and/or increase our cost of doing
business. In addition, if our practices are not consistent or viewed as not consistent with legal and regulatory requirements, including
changes in laws, regulations, and standards or new interpretations or applications of existing laws, regulations and standards, we may
become subject to audits, inquiries, whistleblower complaints, adverse media coverage, investigations, loss of export privileges, or severe
criminal or civil sanctions, all of which may affect our financial condition, operating results, and our reputation. Unauthorized access
or disclosure of personal or other sensitive or confidential data of Company (including data about third parties which the Company possesses),
whether through systems failure, employee negligence, fraud, or misappropriation, by the Company, our service providers or other parties
with whom we do business (if they fail to meet the standards we impose, or if their systems on which our data is stored experience any
data breaches or security incidents) could also subject us to significant litigation, monetary damages, regulatory enforcement actions,
fines, and criminal prosecution in one or more jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to our Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is a limited market for our common
stock that may make it more difficult to dispose of your stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is currently
listed on the Nasdaq Capital Market under the symbol &#8220;CYN&#8221;. There is a limited trading market for our common stock. Accordingly,
there can be no assurance as to the liquidity of any markets that may develop for our common stock, the ability of holders of our common
stock to sell shares of our common stock, or the prices at which holders may be able to sell their common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future sales of our common stock in the
public market could cause the market price of our common stock to decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of a substantial number
of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of
our common stock and could impair our ability to raise capital through the sale of additional equity securities. Many of our existing
equity holders have substantial unrecognized gains on the value of the equity they hold based upon the price of our initial public offering,
and therefore, they may take steps to sell their shares or otherwise secure the unrecognized gains on those shares. We are unable to predict
the timing of or the effect that such sales may have on the prevailing market price of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our stock price may be volatile, and the
value of our common stock may decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to our initial public
offering in October 2021, there was no public market for our common stock and our common stock is not actively traded. The lack of an
active market for our common stock may impair investors&#8217; ability to sell their shares at the time they wish to sell them or at a
price that they consider reasonable, may reduce the market value of their shares and may result in significant price and volume fluctuations.
The market price of our common stock may fluctuate or decline significantly in response to numerous factors, many of which are beyond
our control, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">actual or anticipated fluctuations in our financial condition or results of operations;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">variance in our financial performance from expectations of securities analysts;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in the pricing of the solutions on our platforms;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in our projected operating and financial results;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in laws or regulations applicable to our technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">announcements by us or our competitors of significant business developments, acquisitions or new offerings;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">sales of shares of our common stock by us or our shareholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">significant data breaches, disruptions to or other incidents involving our technology;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our involvement in litigation;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">future sales of our common stock by us or our stockholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in senior management or key personnel;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">the trading volume of our common stock;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">changes in the anticipated future size and growth rate of our market;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">general economic and market conditions; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">other events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broad market and industry
fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact the market price of
our common stock. In addition, technology stocks have historically experienced high levels of volatility. In the past, companies who have
experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the
target of this type of litigation in the future, which could result in substantial expenses and divert our management&#8217;s attention.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future securities issuances could result
in significant dilution to our stockholders and impair the market price of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Future issuances of shares
of our common stock could depress the market price of our common stock and result in dilution to existing holders of our common stock.
Also, to the extent outstanding options and warrants to purchase our shares of our common stock are exercised or options or other equity-based
awards are issued or become vested, there will be further dilution. The amount of dilution could be substantial depending upon the size
of the issuances or exercises. Furthermore, we may issue additional equity securities that could have rights senior to those of our common
stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We anticipate that we will need to raise
additional capital, and our issuance of additional capital stock in connection with financings, acquisitions, investments, our equity
incentive plans or otherwise will dilute all other stockholders.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to issue additional
capital stock in the future that will result in dilution to all other stockholders. We expect to grant equity awards to employees, directors
and consultants under our equity incentive plans. We may also raise capital through equity financings in the future. As part of our business
strategy, we may acquire or make investments in companies, products or technologies and issue equity securities to pay for any such acquisition
or investment. We may not be able to obtain additional capital if and when needed on terms acceptable to us, or at all. Further, if we
do raise additional capital, it may cause stockholders to experience significant dilution of their ownership interests and the per share
value of our common stock to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We do not intend to pay cash dividends for
the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price
of our common stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have never declared or
paid any cash dividends on our capital stock, and, subject to the discretionary dividend policy described in the section entitled &#8220;Dividend
Policy&#8221; of this Annual Report, we do not intend to pay any cash dividends in the foreseeable future. On September 29, 2023, our
board of directors declared a one-time special dividend of 10% on our issued and outstanding shares of our common stock to holders of
record on October 23, 2023. Any determination to pay dividends in the future will be at the discretion of our board of directors. Accordingly,
you may need to rely on sales of our common stock after price appreciation, which may never occur, as the only way to realize any future
gains on your investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an &#8220;emerging growth company,&#8221;
and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common
stock less attractive to investors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging-growth
company,&#8221; as defined in the JOBS Act, and we have elected to take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not &#8220;emerging growth companies,&#8221; including the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, or Section 404, reduced disclosure obligations regarding executive compensation
in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the Jumpstart
Our Business Startups (&#8220;JOBS&#8221;) Act, as an emerging growth company, we have elected to use the extended transition period for
complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our
consolidated financial statements will not be comparable to the financial statements of issuers who are required to comply with the effective
dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive
to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period
for complying with new or revised accounting standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will remain an emerging-growth
company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of our initial public offering; (2)
the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during
the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date we qualify as
a &#8220;large accelerated filer,&#8221; with at least $700 million of equity securities held by non-affiliates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict if investors
will find our common stock less attractive as a result of choosing to rely on these exemptions. For example, if we do not adopt a new
or revised accounting standard, our future results of operations will not be as comparable to the results of operations of certain other
companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may
be a less active trading market for our common stock, and our stock price may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Anti-takeover provisions in our charter
documents may discourage our acquisition by a third party, which could limit our stockholders&#8217; opportunity to sell their shares,
at a premium.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation includes provisions that could limit the ability of others to acquire control of our company. These provisions could
have the effect of depriving our stockholders of an opportunity to sell their shares at a premium over prevailing market prices by discouraging
third parties from seeking to obtain control in a tender offer or similar transaction. Among other things, the charter documents will
provide:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">certain amendments to our bylaws that will require the approval of two-thirds of the combined vote of our then-outstanding shares of our common stock; and</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">our board of directors has the authority, without further action by our stockholders, to issue preferred stock in one or more series and to fix their designations, powers, preferences, privileges, and relative participating, optional, or special rights, and the qualifications, limitations, or restrictions, including dividend rights, conversion rights, voting rights, terms.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated certificate of
incorporation designates the Court of Chancery of the State of Delaware and federal court within the State of Delaware as the exclusive
forum for certain types of actions and proceedings that our stockholders may initiate, which could limit a stockholder&#8217;s ability
to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated certificate
of incorporation provides that, subject to limited exceptions, the Court of Chancery of the State of Delaware will be exclusive forums
for any:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">derivative action or proceeding brought on our behalf;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">action asserting a claim against us, our directors or officers or employees arising pursuant to any provision of the DGCL, our amended and restated certificate of incorporation or amended and restated bylaws; or</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">other action asserting a claim against us, our directors or officers or employees that is governed by the internal affairs doctrine.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This choice of forum provision
does not apply to actions brought to enforce a duty or liability created under the Exchange Act. Our amended and restated certificate
of incorporation to be in effect after this offering also provides that the federal district courts of the United States are the exclusive
forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. We intend for this provision to
apply to any complaints asserting a cause of action under the Securities Act despite the fact that Section 22 of the Securities Act creates
concurrent jurisdiction for the federal and state courts over all actions brought to enforce any duty or liability created by the Securities
Act or the rules and regulations promulgated thereunder. There is uncertainty as to whether a court would enforce such a provision with
respect to claims under the Securities Act, and our stockholders will not be deemed to have waived our compliance with the federal securities
laws and the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital
stock shall be deemed to have notice of and to have consented to the provisions of our amended and restated certificate of incorporation
described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These choice of forum provisions
may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors,
officers, or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively,
if a court were to find these provisions of our amended and restated certificate of incorporation inapplicable to, or unenforceable in
respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such
matters in other jurisdictions, which could adversely affect our business and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The restatement of our previously issued
financial statements for the Affected Periods has resulted in unanticipated costs, stockholder litigation and regulatory actions, and
may adversely affect investor confidence, our stock price, our ability to raise capital in the future and our reputation. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">We incurred unanticipated costs
for accounting and legal fees in connection with the restatement of our financial statements for the fiscal year ended December 31, 2024.
The restatement may erode investor confidence in our company, our financial reporting, accounting practices and processes, and may raise
reputational issues for our business. The restatement may also negatively impact the trading price of our securities and make it more
difficult for us to raise capital on acceptable terms, or at all. In addition, the restatement and related material weaknesses in our
internal control over financial reporting may result in stockholder litigation against us and adverse regulatory consequences. These and
any future regulatory consequences, litigation, claims or disputes, whether successful or not, could subject us to additional costs, divert
the attention of our management, or impair our reputation. Each of these consequences could have a material adverse effect on our business,
results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1B. Unresolved Staff Comments</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1C. Cybersecurity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1" escape="true" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="ixv-3207"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Risk management and strategy</i></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize the critical
importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect
the confidentiality, integrity, and availability of our data.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Managing Material Risks &amp; Integrated Overall
Risk Management</i></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="ixv-3225"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have strategically integrated
cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management.
This <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" id="ixv-13628">integration</ix:nonNumeric> ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management
team works closely with our IT department to continuously evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.</p></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Oversee Third-party Risk</i></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" id="ixv-3236"><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because we are aware of the
risks associated with third-party service providers, we have implemented stringent processes to oversee and manage these risks. <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" id="ixv-13629">We conduct
thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with
our cybersecurity standards.</ix:nonNumeric> The monitoring includes annual assessments of the SOC reports of our providers and implementing complementary
controls. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation continuedAt="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7" id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Risks from Cybersecurity Threats</i></p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><ix:continuation id="_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" id="ixv-3249"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" id="ixv-13630">not</ix:nonNumeric> encountered cybersecurity
challenges that have materially impaired our operations or financial standing.</p></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 2. Properties</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our corporate headquarters
is located in Mountain View, California and acts as the main operational facility for our vehicle engineering, software engineering and
business units. We lease our corporate headquarters which contains approximately 39,600 square feet. We believe that our office space
is adequate for our current needs and, should we need additional space, we believe we will be able to obtain additional space on commercially
reasonable terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 3. Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are not a party to any
pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business
or otherwise material to the financial condition of our business. None of our directors, officers or affiliates are involved in a proceeding
adverse to our business or have a material interest adverse to our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 4. Mine Safety Disclosures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not Applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="margin: 0"><b>&#160;</b></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PART II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 5. Market for Registrant&#8217;s Common
Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Information with Respect to our Common Stock</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common stock is traded
on The Nasdaq Capital Market, LLC, or Nasdaq, and began trading under the symbol &#8220;CYN&#8221; on October 20, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Holders of Record</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2025, we
had 55 shareholders of record.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Dividend Policy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not declared or paid
cash dividends on our common stock and have no present intention of paying any cash dividends on our common stock. We currently intend
to retain all available funds and future earnings, if any, to fund the development and expansion of our business, and we do not anticipate
paying any cash dividends in the foreseeable future. On September 29, 2023, our board of directors declared a one-time special stock dividend
of 10% on our issued and outstanding shares of our common stock to holders of record on October 23, 2023. Any future determination regarding
the declaration and payment of dividends, if any, will be at the discretion of our board of directors and will depend on then-existing
conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and
other factors our board of directors may deem relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Recent Sales of Unregistered Securities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Issuer Purchases of Equity Securities</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company did not repurchase
any of its equity securities during its fiscal year ended December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 6. [Reserved]</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7. Management&#8217;s Discussion and Analysis
of Financial Condition and Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The objective of this Management&#8217;s
Discussion and Analysis is to allow investors to view the Company from management&#8217;s perspective, considering items that would have
a material impact on future operations. The following discussion and analysis summarizes the significant factors affecting our results
of operations and financial condition as of and during the years ended December 31, 2025 and 2024 and should be read in conjunction with
our consolidated financial statements and related notes included elsewhere in this Annual Report. This discussion contains forward-looking
statements based upon current plans, expectations and beliefs that involve risks and uncertainties. Our actual results and the timing
of certain events could differ materially from those anticipated in or implied by these forward-looking statements as a result of several
factors, including those discussed in the section captioned &#8220;Risk Factors&#8221; included under Part I, Item 1A and elsewhere in
this Annual Report. See also the section captioned &#8220;Forward-Looking Statements&#8221; in this Annual Report.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an autonomous vehicle
technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological innovation is
needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These
challenges include labor shortages, lagging technological advancements from incumbent vehicle manufacturers, and high upfront investment
commitment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Industrial sites are typically
rigid environments with consistent standards as opposed to city streets that have more variable environmental and situational conditions
and diverse regulations. These differences in operational design domains will be major factors that make proliferation of industrial AVs
in private settings achievable with less time and resources than AVs on public roadways. Namely, safety and infrastructure challenges
are cited as roadblocks that have delayed AVs from operating on public roadways at scale. Our focus on industrial AVs simplifies these
challenges because industrial facilities (especially those belonging to a single end customer that operates similarly at different sites)
share much more in common than different cities do. Furthermore, our end customers own their infrastructure and can make changes more
easily than governments can on public roadways.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With these challenges in mind,
we are developing an Enterprise Autonomy Suite (&#8220;EAS&#8221;) that leverages advanced in-vehicle autonomous driving technology and
incorporates leading supporting technologies like data analytics, asset tracking, fleet management, cloud, and connectivity. EAS provides
a differentiated solution that we believe will drive pervasive proliferation of industrial autonomy and create value for customers at
every stage of their journey towards full automation and the adoption of Industry 4.0.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">EAS is a suite of technologies
and tools that we divide into three complementary categories:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>DriveMod</i>, our modular industrial
vehicle autonomous driving software;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Cyngn Insight</i>, our customer-facing
tool suite for monitoring and managing AV fleets (including remotely operating vehicles) and generating/aggregating/analyzing data (including
the IoT gateway device); and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Cyngn Evolve</i>, our internal
tool suite and infrastructure that facilitates artificial intelligence AI and machine learning (&#8220;ML&#8221;) training to continuously
enhance our algorithms and models and provides a simulation framework (both record/rerun and synthetic scenario creation) to ensure that
data collected in the field can be applied to validating new releases.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Legacy automation providers
manufacture specialized industrial vehicles with integrated robotics software for rigid tasks, limiting automation to narrow uses. Unlike
these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles that have been purpose
built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible with indoor and outdoor
environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We understand that scaling
of autonomy solutions will require an ecosystem made up of different technologies and services that are enablers for AVs. Our approach
is to forge strategic collaborations with complementary technology providers that accelerate AV development and deployment, provide access
to new markets, and create new capabilities. Our focus on designing DriveMod to be modular will combine with our experience deploying
AV technology on diverse industrial vehicle form factors, which will be difficult for competitors to replicate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect our technology to
generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires us and our integration partners
to work with a new client to map the facility, gather data, and install our AV technology within their fleet and site. These deployments
typically result in revenue based on the overall scope of the project and the integrated solution delivered.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following deployment, we continue
to generate revenue through ongoing access to and use of our Enterprise Autonomy Suite (&#8220;EAS&#8221;), which includes software-enabled
functionality, monitoring, updates, and support. These arrangements provide customers with continuous access to our evolving autonomous
vehicle capabilities and are generally structured over a contractual term during which the customer receives and consumes the benefits
of the integrated solution.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will seek to achieve sustained
revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding suite of AV and
AI capabilities as organizations transition into full industrial autonomy.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although both the components
and the combined solutions of EAS are still under development, we have EAS licenses with paying customers and have piloted EAS for paid
customer trial and pilot deployments. We expect EAS to continually be developed and enhanced according to evolving customer needs, which
will take place concurrently while other completed features of EAS are commercialized. We expect annual R&amp;D expenditures in the foreseeable
future to exceed that of 2025. We also had limited paid deployments in 2025 that offset some of the ongoing R&amp;D costs of continually
developing EAS.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our go-to-market strategy
is to acquire new customers that use industrial vehicles in their mission-critical and daily operations by (a) leveraging the relationships
and existing customers of our network of strategic partners, (b) bringing AV capabilities to industrial vehicles as a software service
provider, and (c) executing a robust in-house sales and marketing effort to nurture a pipeline of industrial organizations. Our focus
is on acquiring new customers who are either looking (a) to embed our technology into their vehicle product roadmaps or (b) to apply autonomy
to existing fleets with our vehicle retrofits. In turn, our customers are any organizations that could utilize our EAS solution, including
OEMs that supply industrial vehicles, end customers that operate their own industrial vehicles, or service providers that operate industrial
vehicles for end customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As OEMs and leading industrial
vehicle users seek to increase productivity, reinforce safer working environments, and scale their operations, we believe we are uniquely
positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial uses. Our long-term vision is for EAS to
become a universal autonomous driving solution with minimal marginal cost for companies to adopt new vehicles and expand their autonomous
fleets across new deployments. We have already deployed DriveMod software on more than 10 different vehicle form factors that range from
stockchasers and forklifts to 14-seat shuttles and 5-meter-long cargo vehicles demonstrating the extensibility of our AV building blocks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our strategy upon establishing
a customer relationship with an OEM, is to seek to embed our technology into their vehicle roadmap and expand our services to their many
clients. Once we solidify an initial AV deployment with a customer, we intend to seek to expand within the site to additional vehicle
platforms and/or expand the use of similar vehicles to other sites operated by the customer. This &#8220;land and expand&#8221; strategy
can repeat iteratively across new vehicles and sites and is at the heart of why we believe industrial AVs that operate in geo-fenced,
constrained environments are poised to create value.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Critical Accounting Policies and Estimates
and Judgements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our consolidated financial
statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent
liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting
period. We continually evaluate our estimates and judgments. We base our estimates and judgments on historical experience and other factors
that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional
information becomes known. Besides the estimates identified below that are considered critical, we make many other accounting estimates
in preparing our consolidated financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported
amounts of assets, liabilities, revenues and expenses, as well as disclosures of contingent liabilities. These estimates and judgments
are also based on historical experience and other factors that are believed to be reasonable under the circumstances. Materially different
results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed
critical.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company considers costs
to develop software, warrants and share-based compensation to be critical accounting estimates and believes the associated assumptions
and estimates to have the greatest potential impact on our consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Costs to Develop Software</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company incurs costs related
to internally developed software. Based on the nature of the software the Company capitalizes software costs under the following guidance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Internal-Use Software</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company capitalizes certain
costs related to internal-use software, primarily consisting of direct labor and third-party vendor costs associated with creating the
software. Software development projects generally include three stages: the preliminary project stage (all costs are expensed as incurred),
the application development stage (certain costs are capitalized and certain costs are expensed as incurred) and the post-implementation/operation
stage (all costs are expensed as incurred). Costs capitalized in the application development stage include costs related to the design
and implementation of the selected software components, software build and configuration infrastructure, and software interfaces. Capitalization
of costs requires judgment in determining when a project has reached the application development stage, the proportion of time spent
in the application development stage, and the period over which the Company expects to benefit from the use of that software. Once the
software is placed in service, these costs are amortized on the straight-line method over the estimated useful life of the software,
which is generally three to five years. There is judgment involved in the determination of the useful life. Internal-use software is
classified as property and equipment in accordance with ASC 350, Intangibles - Goodwill and Other.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software to be Sold, Leased
or Otherwise Marketed</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for research
costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for
the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general
release to customers. Judgment is required in determining when technological feasibility of a product is established. We have determined
that technological feasibility for our software products is reached shortly after a working prototype is complete and meets or exceeds
design specifications including functions, features, and technical performance requirements. After technological feasibility is established,
judgment is required to determine the amount of payroll and stock-based compensation costs to be capitalized on the remaining development
efforts. These costs will continue to be capitalized until such time as when the product or enhancement is available for general release
to customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Computer software to be sold,
leased or otherwise marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater
of (a) the amount computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross
revenue for that product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining
estimated economic life of the product, not to exceed three years to five years and recorded as cost of revenue. Amortization will begin
when the product or enhancement is available for general release to customers. No amortization has begun for externally sold software,
as the software enhancement is still in development. Management evaluates the useful lives of these assets on a quarterly basis and tests
for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. No impairment charges
were associated with the Company&#8217;s sold, leased or otherwise marketed software for the year ended December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2025, management completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management
determined that projects previously capitalized as developed software no longer met the criteria for capitalization under&#160;ASC 985-20,
External-Use Software, resulting from new technical development issues that did not exist and could not have been reasonably anticipated
in prior periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result,  the Company revised its estimate regarding the point at which technological feasibility is achieved
for software development activities. This change in estimate was made to reflect management&#8217;s current expectations about the timing
and certainty of future technological milestones.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The change in estimate
was accounted for prospectively&#160;in accordance with ASC 250,&#160;Accounting Changes and Error Corrections,&#160;and did not
require restatement of prior-period financial statements. For the year ended December 31, 2025, the Company recognized a total of
$1.4 million related to costs originally capitalized in 2024 and $1.2 million related to costs capitalized during the first two
quarters of 2025 as research and development expense resulting from this change.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.25pt"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued to its
lead underwriter in the Company&#8217;s initial public offering consummated in October 2021, (the &#8220;IPO&#8221;), warrants to purchase
up to 9 shares of its common stock, exercisable at a price per share of $40,650 and expiring on October 19, 2026. Additionally, in connection
with the Private Placement offering completed on April 29, 2022, the Company issued warrants to purchase 426 shares of its common stock,
exercisable at a price per share of $140,625 and expiring on April 29, 2027. The Company accounts for warrants in accordance with ASC
480, Distinguishing Liabilities from Equity, depending on the specific terms of the warrant agreement. The Company determined the fair
value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments in consideration of the cashless
settlement provisions in the warrant agreements.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also applied
the guidance in ASC 340-10-S99-1, Other Assets and Deferred Costs, that states specific incremental costs directly attributable to a
proposed or actual offering of equity securities may properly be deferred and charged against the gross proceeds of the offering. The
Company treated the valuation of the warrants as directly attributable to the issuance of an equity contract and, accordingly, classified
the warrants as additional paid-in capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company issued Series
A warrants and Series B warrants in connection with securities purchase agreement on December 20, 2024. The Company accounts for warrants
in accordance with ASC 480, Distinguishing Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated
fair value of the Company&#8217;s warrant agreements has been determined to be Level 3 measurement, as certain inputs used to determine
the fair value of these agreements are unobservable. The Company determined the fair value of the warrants using the Monte Carlo pricing
model and treated the valuation as a liability in consideration of the variable number of the issuer&#8217;s equity shares in the warrant
agreements. The resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change
in fair value is recognized in the Company&#8217;s consolidated statements of operations under other income (expense). After shareholder
approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore, in accordance with ASC 815-40-35-8,
Derivatives and Hedging Reclassification of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified
into equity. The Series A warrants are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants
were re-measured utilizing the Black Scholes model immediately before exercise and were fully exercised in February 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-based Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company recognizes the
cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized
on a straight-line basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based
compensation cost and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines
the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of the Company&#8217;s
common stock, expected price volatility of the common stock, expected term, risk-free interest rates, and expected dividend yield.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We derive revenue from EAS
subscriptions with relative add-on offerings such as hardware revenue and other revenue (i.e., deployment costs). Revenue from these subscriptions
and add-ons are recognized monthly over the service contract life, beginning at the time that a customer acknowledges acceptance of the
service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2025, the Company recognized
$0.2 million of revenue, substantially all related to EAS subscriptions and hardware revenue. During 2024, the Company recognized $0.4
million of revenue, substantially all related to EAS subscriptions and hardware revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cost of Revenue</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cost of revenues consists
primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts
and hardware costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2025, the Company reported
cost of revenue of $0.1 million consisting primarily of deployment costs related to personnel costs and travel expenses. During 2024,
the Company reported cost of revenue of $0.5 million consisting primarily of deployment costs, related to personnel costs, travel expenses
and associated hardware costs to specific customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expense
consist primarily of internal engineering and development expenses, materials, labor and stock-based compensation and outsourced engineering
services related to development of the Company&#8217;s products and services. Research and development costs incurred during deployments
are capitalized and expensed when the associated contract revenue is recognized. All other research and development costs are expensed
as incurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Research and development expense
for the year ended December 31, 2025 increased by $1.2 million or 10.7% to $12.5 million from $11.3 million for the year ended December
31, 2024. The increase is primarily attributable to personnel related costs and expanded leased space.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and Administrative</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General, and administrative
expense consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and advertising costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General and administrative
expenses increased by approximately $1.9 million or 16.7% to $13.3 million for the year ended December 31, 2025 from $11.4 million for
the year ended December 31, 2024. The increase primarily relates to additional executive bonuses and advertising.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Interest income (Expenses), net</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interest income (expense),
net increased by $1.3 million to $0.2 million for the year ended December 31, 2025 from ($1.1 million) for the year ended December 31,
2024. Interest income consists primarily of interest earned of $0.2 million from the Company&#8217;s interest-bearing bank accounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Income (Expenses), net</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other income (expense), net
increased by $12.7 million to $2.2 million for the year ended December 31, 2025 from ($10.5 million) for the year ended December 31, 2024.
Other income consists primarily of fair value remeasurement of $1.1 million and realized gains earned on the Company&#8217;s short-term
investments of $0.9 million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Liquidity and Capital Resources</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s principal
source of liquidity is its cash and current maturities of short-term investments. Short-term investments consist of placements in U.S.
government securities with original maturities between three to nine months. As of December 31, 2025, the Company had unrestricted cash
of approximately $0.1 million and short-terms investments of $33.7 million. As of December 31, 2024, the Company had unrestricted cash
of approximately $23.6 million and no short-terms investments.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 23, 2024, the Company
entered into an underwritten agreement with Aegis Capital Corp. (&#8220;Aegis&#8221;), pursuant to which Aegis acted as the Company&#8217;s
underwriter on a firm commitment basis in connection with the sale by the Company of an aggregate of 3,333 shares of common stock in a
public offering, which included: (i) 1,320 shares of common stock, and (ii) pre-funded warrants to purchase 2,013 shares of common stock.
The pre-funded warrants had a nominal exercise price of $0.0015. Each share of common stock was sold at an offering price of $1,500, and
each pre-funded warrant was sold at an offering price of $1,499.85. The pre-funded warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on April 25, 2024. On May 3 2024, the Company closed on the sale of an additional 136 shares of common
stock, upon exercise by the underwriter of the over-allotment option. The Company received net proceeds of approximately $4.6 million,
after deducting the estimated offering expenses payable by the Company, including the placement agent fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 12, 2024, the
Company entered into a securities purchase agreement with certain investors pursuant to which we sold, in a private placement, senior
notes with an aggregate principal amount of $4,375,000 (the &#8220;Notes&#8221;), and received proceeds before expenses of $3,500,000.
As consideration for entering into the agreement, we issued a total of 2,701 shares of common stock of the Company to the Purchasers on
November 13, 2024. The principal amount of the Notes were repaid on December 23, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 12, 2024, the
Company implemented a cost reduction plan in order to reduce its average monthly cash burn from approximately $1.8 million per month to
approximately $1 million per month for 90 days. This included reducing staff from approximately 80 people to approximately 60 people,
temporarily suspending certain non-essential operations and reducing or eliminating all discretionary expenses. With the additional capital
raised in December 2024, the Company has resumed normal operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 20, 2024, the
Company entered into a securities purchase agreement for the sale and issuance of (i) 20,507 units at a public offering price per Unit
of $241.50 with each Unit consisting of one share of common stock, par value $0.00001 per share, one Series A warrant to purchase one
share of Common Stock at an exercise price of $301.875 per share and one Series B warrant to purchase one share of Common Stock at an
exercise price of $301.875 and (ii) 62,309 pre-funded units at a public offering price of $241.485 per Pre-Funded Unit, with each Pre-Funded
Unit consisting of one pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.015 per share, one Series
A Warrant and one Series B Warrant. The net proceeds to the Company from the Offering were approximately $18.2 million, after deducting
placement agent&#8217;s fees and the payment of other offering expenses associated with the offering that were payable by the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 30, 2024, the
&#8220;Company entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct
offering, 44,333 shares of its common stock, par value $0.015 per share at a purchase price of $90 per share and 55,667 pre-funded warrants
to purchase shares of Common Stock, at a purchase price of $89.985 per Pre-Funded Warrant. The Company received net proceeds of approximately
$8.1 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent
fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 26, 2025, the
Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell and issue,
in a registered direct offering, 192,496 shares of its common stock, par value $0.00001 per share, at a purchase price of $5.01 per
share and 2,801,516 pre-funded warrants to purchase shares of common stock, at a purchase price of $5.00999 per pre-funded warrant.
The Company received net proceeds of approximately $15.9 million from the offering, after deducting the estimated offering expenses
payable by the Company of $1.3 million, including the placement agent fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 27, 2025, the
Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell and issue,
in a registered direct offering, 313,564 shares of its common stock, par value $0.00001 per share, at a purchase price of $7.50 per
share and 1,979,769 pre-funded warrants to purchase shares of common stock, at a purchase price of $7.49999 per pre-funded warrant.
The Company received net proceeds of approximately $13.7 million from the offering, after deducting the estimated offering expenses
payable by the Company of $1.3 million, including the placement agent fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 5, 2025, the
Company entered into an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis Capital Corp. (the &#8220;Agent&#8221;),
under which the Company may, from time to time, sell shares of the Company&#8217;s common stock having an aggregate offering price of
up to $100,000,000 in &#8220;at the market&#8221; offerings through or to the Agent, as sales agent or principal. Sales of the shares
of common stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent
will receive a commission from the Company of up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2025, the Company
sold an aggregate of 935,114 shares of common stock pursuant to the Sales Agreement for gross proceeds of $5,778,031. The Company paid
a commission of $173,341 to Aegis Capital Corp., representing 3% of the gross proceeds, and $131,990 in issuance costs resulting in net
proceeds of approximately $5,472,691. The shares were issued at a par value of $0.00001 per share. The par value of the shares issued
was recorded as common stock, with the excess of net proceeds over par value recorded as additional paid-in capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s liquidity
is based on its ability to enhance its operating cash flow position, obtain capital financing from equity interest investors and borrow
funds to fund its general operations, research and development activities and capital expenditures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on cash flow projections
from operating, investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion
that the Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations
and related commitments for the 12 months following the date these consolidated financial statements were issued.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Cash Flows</span></i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Operating activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in operating
activities for the year ended December 31, 2025 was $23.6 million, an increase of approximately $4.4 million or 22.8% compared to $19.2
million for the year ended December 31, 2024. The increase is primarily attributed to an increase in inventory related to tuggers, the
fair value remeasurement of the warranty liabilities, and the security deposit for the new office location.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Investing activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash used in investing
activities for the year ended December 31, 2025 was $34.1 million, an increase of approximately $37.1 million compared to net cash provided
by investing activities of $2.9 million for the year ended December 31, 2024. The increase consists of short-term investment maturities
of $54.5 million, which were offset by short-term investment purchases of approximately $87.4 million, R&amp;D-related hardware equipment
purchases of approximately $1.2 million, and approximately $0.03 million in acquisition of intangible assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Financing activities</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net cash provided by financing
activities for the year ended December 31, 2025 was $35.1 million, a decrease of approximately $1.2 million compared to $36.3 million
for the year ended December 31, 2024. The decrease is due to the following net proceeds received in each year:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Proceeds from at-the-market equity financing, net of issuance costs</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,472,701</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from public issuance of common stock, net of offering costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,611,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>ATM, from May 2023 to July 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,789,427</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Placement agent agreement, December 8, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,811,014</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Proceeds from issuance of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,260,852</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from the Notes, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,801,265</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Repayment of the Notes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,375,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total financings</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">35,084,378</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,287,558</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company Status</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an &#8220;emerging-growth
company&#8221;, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage
of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including,
but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial
reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. As an emerging growth company we can also delay adopting
new or revised accounting standards until such time as those standards apply to private companies. We intend to avail ourselves of these
options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging growth company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will cease to be an emerging
growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of the initial public offering; (ii)
the first fiscal year after our annual gross revenue are $1.07 billion or more; (iii) the date on which we have, during the previous three-year
period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of any fiscal year in which the market value
of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year. We cannot predict
if investors will find our common stock less attractive if we choose to rely on these exemptions. If, as a result of our decision to reduce
future disclosure, investors find our common shares less attractive, there may be a less active trading market for our common shares and
the price of our common shares may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also a &#8220;smaller
reporting company&#8221;, meaning that the market value of our stock held by non-affiliates plus the aggregate amount of gross proceeds
to us as a result of the IPO is less than $700 million and our annual revenue was less than $100 million during the most recently completed
fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less
than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market
value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be
an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting
companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial
statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure
obligations regarding executive compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 7A. Quantitative and Qualitative Disclosures
About Market Risk</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a &#8220;Smaller Reporting
Company&#8221;, this Item and the related disclosure is not required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>Item
8. Financial Statements and Supplementary Data</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Stockholders and Board of Directors of</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CYNGN Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AuditorOpinionTextBlock-c0_cont_1" escape="true" name="dei:AuditorOpinionTextBlock" id="ixv-4006"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation id="_AuditorOpinionTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of CYNGN Inc. (the &#8220;Company&#8221;) as of December 31, 2025, the related consolidated statements of operations, stockholders&#8217;
equity and cash flows for the year ended December 31, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles
generally accepted in the United States of America.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal
control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-4038"><span style="font-variant: small-caps">CBIZ
CPAs P.C.</span></ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CBIZ CPAs P.C.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor
since 2021 (such date takes into account the acquisition of the attest business of Marcum <span style="font-variant: small-caps">llp</span>
by CBIZ CPAs P.C. effective November 1, 2024).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-13631">San Francisco, California</ix:nonNumeric><br/>
<span>March 26, 2026</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span>PCAOB ID NUMBER <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-13632">199</ix:nonNumeric>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 50; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the Stockholders and Board of Directors of</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CYNGN Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of CYNGN Inc. (the &#8220;Company&#8221;) as of December 31, 2024, the related consolidated statements of operations, stockholders&#8217;
deficit and cash flows for the year ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, based on our audit, the financial statements present fairly, in all material respects, the financial position of the Company
as of December 31, 2024, and the results of its operations and its cash flows for the year ended December 31, 2024, in conformity with
accounting principles generally accepted in the United States of America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Restatement of 2024 Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.85pt 0pt 0; text-align: justify">As discussed in Note 15 to the financial
statements, the accompanying financial statements as of December 31, 2024 and for the year then ended, have been restated to correct misstatements
surrounding the Company&#8217;s accounting for warrant liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17.85pt 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Explanatory Paragraph &#8211; Going Concern</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company has incurred significant losses
and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about
the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in
Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements are the responsibility
of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audit in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal
control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ <span style="font-variant: small-caps">Marcum LLP</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Marcum LLP</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have served as the Company&#8217;s auditor
from 2021 through 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-variant: small-caps">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Francisco, CA <b><br/>
</b>March 6, 2025 except for the effects of the restatement discussed in Note 15 to the consolidated financial statements, as to which
the date is November 14, 2025</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">PCAOB ID NUMBER 688</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 51; Options: NewSection; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED BALANCE SHEETS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.85pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024<br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">CURRENT ASSETS</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-13633">990,023</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="0" unitRef="usd" id="ixv-13634">23,617,733</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="0" unitRef="usd" id="ixv-13635">33,736,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-0; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts and other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="0" unitRef="usd" id="ixv-13636">1,544,213</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="0" unitRef="usd" id="ixv-13637">1,222,891</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd" id="ixv-13638">2,039,655</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="0" unitRef="usd" id="ixv-13639">150,241</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13640">1,518,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13641">592,090</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 18.25pt">TOTAL CURRENT ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-13642">39,828,412</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="0" unitRef="usd" id="ixv-13643">25,582,955</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">NON-CURRENT ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd" id="ixv-13644">3,268,196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd" id="ixv-13645">2,319,402</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Right-of-use asset, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd" id="ixv-13646">5,971,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="0" unitRef="usd" id="ixv-13647">297,918</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13648">466,223</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13649">1,895,074</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Security Deposit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SecurityDeposit" scale="0" unitRef="usd" id="ixv-13650">518,584</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 9.25pt">TOTAL ASSETS</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-13651">50,053,215</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="0" unitRef="usd" id="ixv-13652">30,095,349</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">CURRENT LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd" id="ixv-13653">217,439</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd" id="ixv-13654">247,778</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13655">1,658,015</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13656">769,180</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued expenses and other current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13657">2,615,734</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13658">2,105,036</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Current operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13659">312,365</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13660">317,344</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 18.25pt">TOTAL CURRENT LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13661">4,803,553</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13662">3,439,338</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Non-current operating lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="0" unitRef="usd" id="ixv-13663">6,495,256</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-2; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-13664">27,703,927</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-13665">11,298,809</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-13666">31,143,265</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 12)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">&#160;</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -9pt; padding-left: 9.25pt">Common stock, Par $<ix:nonFraction contextRef="c3" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-13667"><ix:nonFraction contextRef="c4" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-13668">0.00001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-13669">400,000,000</ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-13670">200,000,000</ix:nonFraction> shares authorized as of December 31, 2025 and December 31, 2024; <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-13671"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-13672">7,974,380</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-13673"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-13674">199,110</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-13675">80</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="0" unitRef="usd" id="ixv-13676">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" unitRef="usd" id="ixv-13677">255,576,797</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" unitRef="usd" id="ixv-13678">192,305,280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-13679">216,822,471</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-13680">193,353,198</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">TOTAL STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13681">38,754,406</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-13682">1,047,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 9.25pt">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-13683">50,053,215</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="0" unitRef="usd" id="ixv-13684">30,095,349</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.85pt; text-align: center">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 52; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024<br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; font-weight: bold; padding-bottom: 1.5pt">REVENUE</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd" id="ixv-13685">218,976</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd" id="ixv-13686">368,138</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">COSTS AND EXPENSES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Cost of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd" id="ixv-13687">135,749</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="0" unitRef="usd" id="ixv-13688">535,708</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Research and development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-13689">12,468,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" unitRef="usd" id="ixv-13690">11,259,641</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">General and administrative</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-13691">13,302,781</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="0" unitRef="usd" id="ixv-13692">11,400,864</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 18.25pt">TOTAL COSTS AND EXPENSES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd" id="ixv-13693">25,907,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="0" unitRef="usd" id="ixv-13694">23,196,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">LOSS FROM OPERATIONS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13695">25,688,241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13696">22,828,075</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OTHER INCOME (EXPENSE), NET</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest income (expense), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="0" unitRef="usd" id="ixv-13697">197,429</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="0" sign="-" unitRef="usd" id="ixv-13698">1,117,546</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-6; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantLiabilityIssuanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-13699">1,739,148</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value of warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-13700">1,136,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-13701">5,359,780</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on issuance of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-7; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-13702">2,344,147</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-13703">884,862</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-13704">53,117</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 18.25pt">TOTAL OTHER INCOME (EXPENSE), NET</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" unitRef="usd" id="ixv-13705">2,218,968</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-13706">10,507,504</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">NET LOSS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13707">23,469,273</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13708">33,335,579</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss per share attributable to common stockholders, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-13709"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-13710">5.17</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-13711"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-13712">2,521.41</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 9.25pt">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-13713"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-13714">4,540,481</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-13715"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-13716">13,221</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>


</div><!-- Field: Page; Sequence: 53; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217;
EQUITY (DEFICIT)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred Stock</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Stock</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Additional Paid-in</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total Stockholders&#8217;</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Capital</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deficit</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 47.5%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of December 31, 2023</span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-8; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#8211;</span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#8211;</span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c7" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-13717">5,147</ix:nonFraction></span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 6%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-10; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#8211;</span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13718">170,652,808</ix:nonFraction></span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-13719">160,017,619</ix:nonFraction></span></td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 0.5%">&#160;</td>
    <td style="width: 0.5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13720">10,635,189</ix:nonFraction></span></td>
    <td style="width: 0.5%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of at-the-market common stock, net of issuance costs $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="0" unitRef="usd" id="ixv-13721">138,572</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-11; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-12; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-13722">4,275</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-13; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd" id="ixv-13723">6,789,427</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-14; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd" id="ixv-13724">6,789,427</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of stock options and vesting of restricted stock units</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-15; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-16; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" unitRef="shares" id="ixv-13725">11</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-17; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" unitRef="usd" id="ixv-13726">597</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-18; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="0" unitRef="usd" id="ixv-13727">597</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings, net of offering costs $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="0" unitRef="usd" id="ixv-13728">1,864,594</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-19; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-20; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="shares" id="ixv-13729">189,677</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c12" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13730">2</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13731">12,414,451</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-21; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13732">12,414,453</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-22; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-23; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd" id="ixv-13733">2,449,191</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-24; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd" id="ixv-13734">2,449,191</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-25; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-26; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-27; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13735">33,335,579</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13736">33,335,579</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of December 31, 2024</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-28; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-29; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c16" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-13737">199,110</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13738">2</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13739">192,305,280</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-13740">193,353,198</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-13741">1,047,916</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of at-the-market common stock, net of issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-30; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-31; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-13742">935,114</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd" id="ixv-13743">10</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd" id="ixv-13744">5,472,691</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-32; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="0" unitRef="usd" id="ixv-13745">5,472,701</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of stock options and vesting of restricted stock units</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-33; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-34; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" unitRef="shares" id="ixv-13746">15</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-35; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-36; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-37; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassification of Series A warrants to equity in connection with the public offering</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-40; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13747">7,634,428</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-41; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13748">7,634,428</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise of Series B warrants in connection with the public offering, net of issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-42; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-43; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-13749">1,552,796</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-13750">16</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-13751">18,931,781</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-44; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-13752">18,931,797</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance of common stock in connection with the public offering</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-45; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-46; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="shares" id="ixv-13753">5,287,345</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13754">52</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13755">29,611,625</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-47; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" scale="0" unitRef="usd" id="ixv-13756">29,611,677</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-48; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-49; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd" id="ixv-13757">1,620,992</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-50; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="0" unitRef="usd" id="ixv-13758">1,620,992</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-51; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-52; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-53; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13759">23,469,273</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13760">23,469,273</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Balance as of December 31, 2025</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-54; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-55; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c24" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-13761">7,974,380</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13762">80</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13763">255,576,797</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-13764">216,822,471</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-13765">38,754,406</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 54; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-align: center; text-indent: -9pt">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended December 31,</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.25in; text-align: center; text-indent: -9pt">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024<br/>
Restated</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CASH FLOWS FROM OPERATING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13766">23,469,273</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-13767">33,335,579</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd" id="ixv-13768">1,189,794</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="0" unitRef="usd" id="ixv-13769">669,409</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" unitRef="usd" id="ixv-13770">1,620,992</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="0" unitRef="usd" id="ixv-13771">2,449,191</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized gain on short-term investments</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RealizedInvestmentGainsLosses" scale="0" unitRef="usd" id="ixv-13772">85,117</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-56; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion on short-term investments</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:AccretionOnShorttermInvestments" scale="0" unitRef="usd" id="ixv-13773">776,163</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:AccretionOnShorttermInvestments" scale="0" unitRef="usd" id="ixv-13774">113,072</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on disposed assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="0" sign="-" unitRef="usd" id="ixv-13775">16,607</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent impairment</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="0" unitRef="usd" id="ixv-13776">118,831</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrant liability</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-13777">1,136,677</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="0" unitRef="usd" id="ixv-13778">5,359,780</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in estimate of capitalized software</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RecapitalizationCosts" scale="0" unitRef="usd" id="ixv-13779">1,425,689</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant liability issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantLiabilityIssuanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-13780">1,739,148</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on issuance of warrants</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-13781">2,344,147</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest and amortization of debt issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="0" unitRef="usd" id="ixv-13782">1,177,174</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes in operating assets and liabilities:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts and other receivables</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="0" unitRef="usd" id="ixv-13783">321,322</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" scale="0" unitRef="usd" id="ixv-13784">452,006</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" unitRef="usd" id="ixv-13785">1,889,414</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="0" unitRef="usd" id="ixv-13786">150,241</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses, operating lease right-of-use assets, and other current assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd" id="ixv-13787">1,421,910</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="0" unitRef="usd" id="ixv-13788">44,035</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" sign="-" unitRef="usd" id="ixv-13789">30,339</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-13790">50,815</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="0" unitRef="usd" id="ixv-13791">888,834</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="0" sign="-" unitRef="usd" id="ixv-13792">667,680</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses, lease liabilities, and other current liabilities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd" id="ixv-13793">411,643</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd" id="ixv-13794">1,658,037</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NET CASH USED IN OPERATING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-13795">23,576,656</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-13796">19,196,081</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CASH FLOWS FROM INVESTING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of property and equipment</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-13797">1,230,536</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-13798">1,051,481</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition of intangible asset</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd" id="ixv-13799">29,061</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="0" unitRef="usd" id="ixv-13800">954,229</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal of assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="0" unitRef="usd" id="ixv-13801">265,940</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase of short-term investments</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="0" unitRef="usd" id="ixv-13802">87,387,311</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireShortTermInvestments" scale="0" unitRef="usd" id="ixv-13803">7,562,761</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from maturity of short-term investments</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="0" unitRef="usd" id="ixv-13804">54,512,501</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" scale="0" unitRef="usd" id="ixv-13805">12,237,761</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" sign="-" unitRef="usd" id="ixv-13806">34,134,407</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="0" unitRef="usd" id="ixv-13807">2,935,230</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CASH FLOWS FROM FINANCING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from at-the-market equity financing, net of issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" scale="0" unitRef="usd" id="ixv-13808">5,472,701</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" scale="0" unitRef="usd" id="ixv-13809">6,789,427</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants, net of issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" scale="0" unitRef="usd" id="ixv-13810">29,611,677</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" scale="0" unitRef="usd" id="ixv-13811">13,811,014</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" scale="0" sign="-" unitRef="usd" id="ixv-13812">1,025</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from issuance of warrants</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-13813">18,260,852</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds from the Notes, net of issuance costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-66; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="0" unitRef="usd" id="ixv-13814">1,801,265</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment of the Notes</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-67; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfNotesPayable" scale="0" unitRef="usd" id="ixv-13815">4,375,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance costs for stock dividend and restricted stock units</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-68; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="cyngn:IssuanceCostsForStockDividendAndRestrictedStockUnits" scale="0" unitRef="usd" id="ixv-13816">597</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NET CASH PROVIDED BY FINANCING ACTIVITIES</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-13817">35,083,353</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-13818">36,286,961</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net increase (decrease) in cash and cash equivalents</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" sign="-" unitRef="usd" id="ixv-13819">22,627,710</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="0" unitRef="usd" id="ixv-13820">20,026,110</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents, beginning of year</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-13821">23,617,733</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-13822">3,591,623</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents, end of year</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-13823">990,023</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-13824">23,617,733</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUPPLEMENTAL DISCLOSURE OF CASH FLOW:</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash paid during the period for interest and taxes</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-69; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-70; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition of right-of-use asset in exchange for new operating lease obligation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" scale="0" unitRef="usd" id="ixv-13825">6,589,332</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition of property and equipment included in accounts payable and accrued expenses</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" scale="0" unitRef="usd" id="ixv-13826">1,875</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-72; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -9pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>


</div><!-- Field: Page; Sequence: 55; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYNGN INC. AND SUBSIDIARIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Notes to Consolidated Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="ixv-6291"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cyngn Inc., together with its subsidiary (collectively,
&#8220;Cyngn&#8221; or the &#8220;Company&#8221;), was incorporated in Delaware in 2013. Our wholly owned subsidiary, Cyngn Singapore
PTE. LTD., is a Singaporean limited company organized in 2015. The Company is headquartered in Mountain View, CA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cyngn develops and deploys scalable, differentiated
autonomous vehicle technology for industrial organizations. Our full-stack autonomous driving software, (&#8220;DriveMod&#8221;), can
be integrated onto vehicles manufactured by Original Equipment Manufacturers (&#8220;OEM&#8221;) by integration directly into vehicle
assembly. The Enterprise Autonomy Suite (&#8220;EAS&#8221;) is designed to be compatible with sensors and components from leading hardware
technology providers and integrate our proprietary Autonomous Vehicle (&#8220;AV&#8221;) software to produce differentiated autonomous
vehicles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been operating autonomous vehicles
in production environments and in 2023 began licensing EAS commercially. Built and tested in difficult and diverse real-world environments,
DriveMod, the fleet management system and our proprietary Software Development Kit (&#8220;DriveMod Kit&#8221;) combine to create a full-stack
advanced autonomy solution designed to be modular, extendable, and safe. The Company operates in one business segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 25, 2024, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of <ix:nonNumeric contextRef="c27" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13827">1-for-5</ix:nonNumeric> to <ix:nonNumeric contextRef="c28" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13828">1-for-100</ix:nonNumeric>. On June 25, 2024, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a <ix:nonNumeric contextRef="c29" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13829">1-for-100</ix:nonNumeric> ratio, which reverse split became effective in the market on July 5, 2024. On January 30, 2025, the
Company&#8217;s stockholders voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding
shares of common stock within a range of <ix:nonNumeric contextRef="c30" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13830">1-for-5</ix:nonNumeric> to <ix:nonNumeric contextRef="c31" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13831">1-for-150</ix:nonNumeric>. On January 30, 2025, the Company&#8217;s Board of Directors determined
to effect the reverse stock split of the common stock at a <ix:nonNumeric contextRef="c32" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-13832">1-for-150</ix:nonNumeric> ratio, which reverse split became effective in the market on February
18, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All share and per share amounts and exercise prices
of stock options and warrants in the accompanying consolidated financial statements and notes to the consolidated financial statements
have been retroactively adjusted to reflect the reverse stock splits for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has incurred losses from operations
since inception. The Company incurred net losses of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd" id="ixv-13833">23.5</ix:nonFraction> million and $<ix:nonFraction contextRef="c5" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" sign="-" unitRef="usd" id="ixv-13834">33.3</ix:nonFraction> million for the years ended December 31, 2025
and 2024, respectively. Accumulated deficit amounted to approximately $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" sign="-" unitRef="usd" id="ixv-13835">216.8</ix:nonFraction> million and $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" sign="-" unitRef="usd" id="ixv-13836">193.4</ix:nonFraction> million as of December 31, 2025 and December
31, 2024, respectively. Net cash used in operating activities was approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" sign="-" unitRef="usd" id="ixv-13837">23.6</ix:nonFraction> million and $<ix:nonFraction contextRef="c5" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" sign="-" unitRef="usd" id="ixv-13838">19.2</ix:nonFraction> million for the year ended December
31, 2025 and 2024, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s liquidity is based on its
ability to increase its operating cash flow position, obtain capital financing from equity interest investors and borrow money to fund
its general operations, research and development activities, and capital expenditures. As of December 31, 2025, the Company&#8217;s unrestricted
cash and cash equivalents balance was approximately $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:UnrestrictedCashBalance" scale="6" unitRef="usd" id="ixv-13839">1.0</ix:nonFraction> million and short-term investments of approximately $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" unitRef="usd" id="ixv-13840">33.7</ix:nonFraction> million. As of December
31, 2024, the Company&#8217;s cash and cash equivalents balance was approximately $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" unitRef="usd" id="ixv-13841">23.6</ix:nonFraction> million and no short-terms investments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on cash flow projections from operating,
investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the
Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations and related
commitments for the 12 months following the date these consolidated financial statements were issued.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-6329"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-6333"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
as of and for the years ended December 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted
in the United States (&#8220;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
The consolidated financial statements include all normal adjustments necessary for a fair presentation of the Company&#8217;s financial
position at December 31, 2025 and 2024, and operating results and cash flows for the periods presented.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-6341"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-6349"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Foreign Currency Translation</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency for Cyngn
is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar
at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated
at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the consolidated
financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-6361"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements
in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported
amounts of revenue and expenses during the reporting period. The Company&#8217;s significant estimates and judgments include but are not
limited to internal-use software, warrants and share-based compensation. Management bases its estimates on historical experience and on
various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. Actual results could differ from those estimates.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_PriorPeriodReclassificationAdjustmentDescription-c0_cont_1" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="ixv-6369"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassifications</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation id="_PriorPeriodReclassificationAdjustmentDescription-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period balances for the consolidated
financial statement for December 31, 2024 have been reclassified to conform with the current year presentation. These reclassifications
relate to inventory and accounts and other receivables that were previously presented as prepaid expenses and other current assets, as
well as deferred revenue that was previously presented as accrued expenses and other current liabilities. These reclassifications had
no impact on previously reported net loss, total assets, or total shareholders&#8217; equity.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskCreditRisk-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskCreditRisk" id="ixv-6379"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ConcentrationRiskCreditRisk-c0_cont_2" id="_ConcentrationRiskCreditRisk-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times
exceeds federally insured limits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_ConcentrationRiskCreditRisk-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions
generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its
deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock-c0_cont_1" escape="true" name="cyngn:ConcentrationOfSupplierRiskPolicyTextBlock" id="ixv-6390"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Supplier Risk</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company generally utilizes suppliers for outside
development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of December
31, 2025 and December 31, 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="cyngn:CashAndShorttermInvestmentsPolicyPolicyTextBlock" id="ixv-6400"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Short-term Investments</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock-c0_cont_2" id="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers its bank accounts and all highly liquid investments
that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of December
31, 2025 and December 31, 2024, the Company had approximately $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="6" unitRef="usd" id="ixv-13842">1.0</ix:nonFraction> million of cash and $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShortTermInvestments" scale="6" unitRef="usd" id="ixv-13843">33.7</ix:nonFraction> million in short-term investments and $<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="6" unitRef="usd" id="ixv-13844">23.6</ix:nonFraction>
million of cash and no short-term investments, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers short-term investments to include marketable
U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government
treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;)
Accounting Standards Codification Topic (&#8220;ASC&#8221;) 320, Investments - Debt and Equity Securities<i>,</i> and recorded these securities
at amortized cost on the accompanying consolidated balance sheets as of December 31, 2025 and December 31, 2024.</p></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="ixv-6427"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Accounts and Other Receivable </i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivables are recorded at the invoiced
amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status
of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was <ix:nonFraction contextRef="c3" decimals="0" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" unitRef="usd" id="ixv-13845"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:fixed-zero" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" unitRef="usd" id="ixv-13846">zero</ix:nonFraction></ix:nonFraction> as of December 31,
2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic
conditions in order to determine expected trade credit losses on a prospective basis. <span style="-sec-ix-hidden: hidden-fact-79"><span style="-sec-ix-hidden: hidden-fact-80">No</span></span> credit losses were recorded as of December 31,
2025 and December 31, 2024. Other receivables primarily consist of Employee Retention Credit (&#8220;ERC&#8221;) claims related to 2020
and 2021.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ixv-6437"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurements</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting guidance under ASC Topic 820, Fair
Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major
asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price
representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the following fair value hierarchy
prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 1-Unadjusted quoted prices in
active markets for identical assets or liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 2-Observable inputs other than
Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 3-Unobservable inputs that are
supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_7" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities are considered to be fair
valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily
result in a change in the amount recorded on the consolidated balance sheets, assets and liabilities are considered to be fair valued
on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of
cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value
on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon
initial recognition.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of the Company&#8217;s cash
and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company&#8217;s
share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models
derived from independent external valuations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock" id="ixv-6465"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventory</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_2" id="_InventoryPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory consists of autonomous vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated
with the Company&#8217;s proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software and sold to customers as part of a fully integrated
autonomous vehicle solution. Substantially all assembly and integration activities are performed by third-party suppliers prior to receipt;
therefore, the Company classifies its inventory as finished goods and does not maintain separate classifications for raw materials or
work in process.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_InventoryPolicyTextBlock-c0_cont_3" id="_InventoryPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, and the Company is able to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.</p></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation id="_InventoryPolicyTextBlock-c0_cont_3"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br/>
The Company periodically reviews inventory for excess quantities, obsolescence, or other indicators that the carrying value may not be
recoverable. If the carrying value of inventory exceeds its net realizable value, the Company records a write-down to net realizable value,
with the adjustment recognized in cost of goods sold.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ixv-6495"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost less
accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the
Company&#8217;s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date
depreciation commences over the estimated useful lives of the respective assets. <ix:nonNumeric contextRef="c0" continuedAt="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock-c0_cont_1" escape="true" name="cyngn:ScheduleOfPropertyAndEquipmentTableTextBlock" id="ixv-13847">Depreciation is recorded on a straight-line basis over
each asset&#8217;s estimated useful life. Repair and maintenance costs are expensed as incurred.</ix:nonNumeric>&#160;</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock-c0_cont_1"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left">Property and Equipment</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center">Useful life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Automobiles (DMV-registered)</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c43" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13848">5</ix:nonNumeric> years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c44" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13849">5</ix:nonNumeric> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computers and equipment</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c45" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13850">5</ix:nonNumeric> years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal-use software</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c37" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13851">3</ix:nonNumeric> to <ix:nonNumeric contextRef="c38" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13852">5</ix:nonNumeric> years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c46" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13853">7</ix:nonNumeric> years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Leasehold improvements</td><td>&#160;</td> <td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-73">Shorter of 3 years or lease term</span></td></tr> </table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-6538"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Leases</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for leases in accordance with ASC 842, Leases.
All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified
asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance
in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the consolidated
balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office
space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining
term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="ixv-6546"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation id="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurs costs related to internally
developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_InternalUseSoftwarePolicy-c0_cont_1" escape="true" name="us-gaap:InternalUseSoftwarePolicy" id="ixv-6558"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Internal-Use Software costs</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_InternalUseSoftwarePolicy-c0_cont_2" id="_InternalUseSoftwarePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined when to capitalize its
internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the
software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized
based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in
estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing
the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining
the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs,
as well as subscription server and consulting costs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_InternalUseSoftwarePolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal-use software is classified as property
and equipment and is amortized on a straight-line basis over their estimated useful life of <ix:nonNumeric contextRef="c33" continuedAt="_PropertyPlantAndEquipmentUsefulLife-c33_cont_1" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13854">three</ix:nonNumeric> to <ix:nonNumeric contextRef="c34" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13855">five<ix:continuation id="_PropertyPlantAndEquipmentUsefulLife-c33_cont_1"> years</ix:continuation></ix:nonNumeric>. There is judgment involved
in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and
ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development
phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes
in circumstances occur that could impact the recoverability of these assets. <span style="-sec-ix-hidden: hidden-fact-81"><span style="-sec-ix-hidden: hidden-fact-82">No</span></span> impairment charges were associated with the Company&#8217;s
internal-use software for the years ended December 31, 2025 and 2024.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_1" escape="true" name="us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" id="ixv-6586"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software to be Sold, Leased
or Otherwise Marketed </i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_2" id="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for research costs of computer
software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once
technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred
to develop functionality for the Company&#8217;s software and internally built software platforms, as well as certain upgrades and enhancements
that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility
of a product is established. Management has determined that technological feasibility is established when a working model is complete.
After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation
costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the
product or enhancement is available for general release to customers.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_3" id="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer software to be sold, leased or otherwise
marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount
computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that
product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated
economic life of the product, not to exceed <ix:nonNumeric contextRef="c37" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13857">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="c38" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-13858">five years</ix:nonNumeric> and recorded as cost of revenue.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_4" id="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2025, management
completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_5" id="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company revised its estimate regarding the point at
which technological feasibility is achieved for software development activities. This change in estimate was made to reflect management&#8217;s
current expectations about the timing and certainty of future technological milestones.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in estimate was accounted for prospectively in accordance
with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements. For the
year ended December 31, 2025, the Company recognized a total of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:ResearchAndDevelopmentExpenseIncreaseDecrease" scale="6" unitRef="usd" id="ixv-13859">1.4</ix:nonFraction> million related to costs originally capitalized in 2024 and $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease" scale="6" unitRef="usd" id="ixv-13860">1.2</ix:nonFraction>
million related to costs capitalized during the first two quarters of 2025 as research and development expense resulting from this change.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-6606"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Long-Lived Assets and Finite Lived Intangibles</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has finite-lived intangible assets
consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives.
The patents and trademarks are amortized over <ix:nonNumeric contextRef="c3" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="ixv-13861">15</ix:nonNumeric> years.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_3" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets and
finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant
adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation
of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The
Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted
cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term
undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being
evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the
asset.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_4" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also identified that the long-lived
asset &#8220;Patents&#8221;, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and
identified expired international patent applications (&#8220;expired assets&#8221;) for the year ended December 31, 2024. The Company
determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying
value was set to its salvage value which is zero given no future cash flows.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2024, the Company
determined the existence of an impairment associated with the Company&#8217;s intangible asset &#8220;Patents&#8221; and accordingly recorded
an impairment charge of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AssetImpairmentCharges" scale="0" unitRef="usd" id="ixv-13862">118,831</ix:nonFraction> (see Note 6. Intangible Assets). For the year ended December 31, 2025, there were <span style="-sec-ix-hidden: hidden-fact-83">no</span> impairment charges.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-6639"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using the
asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A valuation allowance is provided when it is more
likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#8217;s lack of earnings history,
the net deferred tax assets have been fully offset by a valuation allowance as of December 31, 2025 and December 31, 2024 (see Note 11.
Income Taxes).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_4" id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no uncertain tax positions that would
require recognition in the consolidated financial statements. If the Company were to incur an income tax liability in the future, interest
on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management&#8217;s
conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of
or changes in tax laws, regulations and interpretations thereof as well as other factors.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). ASU 2023-09 expands the annual disclosure
requirements for income taxes, primarily related to the rate reconciliation and income taxes paid. The Company has adopted this guidance
on a prospective basis, which did not have a significant impact on the Company&#8217;s consolidated financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_1" escape="true" name="cyngn:CommonStockWarrantsPolicyTextBlock" id="ixv-6656"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation continuedAt="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_2" id="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issued to its lead underwriter in
the Company&#8217;s IPO warrants to purchase up to <ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-13863">9</ix:nonFraction> shares of the Company&#8217;s common stock. In addition, the Company issued <ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-13864">426</ix:nonFraction> common
stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants
as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_3" id="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also applied the guidance in ASC 340-10-S99-1, Other Assets
and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities
may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as
directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="cyngn_CommonStockWarrantsPolicyTextBlock-c0_cont_3"><p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The Company issued Series A warrants and Series B warrants in connection
with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company&#8217;s warrant
agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable.
The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in
consideration of the variable number of the issuer&#8217;s equity shares in the warrant agreements. The resulting warrant liabilities
are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company&#8217;s
consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and
the number of equity shares are now fixed. The Company concluded that these warrants are indexed to the Company&#8217;s own stock, require
settlement in a fixed number of shares, and do not contain provisions that could require net cash settlement or settlement in a variable
number of shares. Additionally, the warrant agreements do not include provisions that would require the Company to transfer assets. Accordingly,
the warrants meet the criteria for equity classification. Therefore, in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification
of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants
are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the
Black Scholes model immediately before exercise and were fully exercised in February 2025 (see Note 7. Capital Structure).</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ixv-6687"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-based Compensation</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation id="_ShareBasedCompensationOptionAndIncentivePlansPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes the cost of share-based
awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line
basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost
and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair
value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price
volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation
Expense<b>)</b>.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-6700"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net Loss Per Share Attributable to Common Stockholders</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes loss per share attributable
to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding.
Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised
into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only
if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see
Note 8. Net Loss per Share Attributable to Common Stockholders).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="ixv-6708"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development Expense</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses consists primarily
of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company
personnel involved in the development of the Company&#8217;s products and services, and allocated lease costs based on the approximate
square footage area used in research and development activities. Research and development costs are expensed as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_SellingGeneralAndAdministrativeExpensesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="ixv-6718"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and Administrative Expense</i></b></p></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation id="_SellingGeneralAndAdministrativeExpensesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expense consist primarily of personnel costs,
facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance
with ASC 720-35, Other Expense - Advertising Costs, other than trade show expenses which are deferred until occurrence of the future event.
<i>&#160;</i>Advertising costs for the years ended December 31, 2025 and 2024 were $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-13865">512,017</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdvertisingExpense" scale="0" unitRef="usd" id="ixv-13866">237,396</ix:nonFraction>, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="ixv-6730"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Commitments</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes a liability with regard to loss contingencies
when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of
loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount
within the range is a better estimate than any other amount the Company accrues the minimum amount in the range (see Note 12. Commitments
and Contingencies).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-6742"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Segment Reporting</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_2" id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates as one operating segment.
<ix:nonNumeric contextRef="c0" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription" id="ixv-6751">The Company&#8217;s <span style="-sec-ix-hidden: hidden-fact-78">chief operating decision maker</span> is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as <ix:nonFraction contextRef="c0" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" unitRef="pure" id="ixv-13867">one</ix:nonFraction> operating segment for the purposes of allocating resources,</ix:nonNumeric> making
operating decisions and evaluating financial performance.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_3" id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The one operating segment generates revenues from
subscriptions to its Enterprise Autonomy Service (&#8220;EAS&#8221;), product sales or leases of hardware, and other professional services
(i.e., deployment costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent
phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod
software, and demonstrations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the Company&#8217;s one segment, the executive
management team use revenue and net loss to allocate resources, both reported on the Consolidated Statement of Operations as Revenue and
Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to
evaluate the Company&#8217;s performance, establish compensation, monitor budget versus actual results, and decide the level of investment
in various operating activities and other capital allocation activities. The measure of segment assets is reported on the Consolidated
Balance Sheet as Total assets.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="ixv-6777"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_2" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenue in accordance
with ASC 606, Revenue from Contracts with Customers. <span style="font-style: normal; font-weight: normal">The Company generates revenue
from vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated with the Company&#8217;s
proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software, or leases of hardware, and other professional services. These offerings
are highly interdependent and integrated to provide customers with a fully functional autonomous industrial vehicle solution. Because
these components are not separately identifiable from one another in the context of the contract, the Company accounts for these combined
goods and services as a single performance obligation.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: normal"><i>&#160;</i></span></p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_3" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General Recognition Principle.</i> The Company
recognizes revenue when control of the combined autonomous vehicle and software solution is transferred to the customer in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for the goods and services.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_4" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Method of Measuring Progress. </i>Revenue associated
with the Company&#8217;s integrated autonomous vehicle solution is generally recognized over time because the customer simultaneously
receives and consumes the benefits provided by the Company&#8217;s performance as the services are performed.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_5" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures progress toward satisfaction
of the performance obligation using an output method based on the passage of time, recognizing revenue ratably over the contractual term,
which is typically three years. In accordance with ASC 606-10-55-17 through 55-18, the output method reflects the pattern in which control
of the promised goods and services is delivered to the customer, who receives continuous access to the integrated autonomous vehicle functionality,
including the software-enabled operation, monitoring, updates, and support necessary for the system to function as intended.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_6" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management believes that recognizing revenue on
a straight-line basis over the contract period faithfully depicts the Company&#8217;s performance in transferring control of the integrated
solution, as the customer receives and consumes the benefits of the solution evenly throughout the contract term.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_7" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Payment Terms.</i> Payment terms vary by customer
and contract but generally do not exceed 90 days.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_8" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Discounts.</i> The Company may offer pricing
discounts to certain customers, primarily to establish relationships with new customers. These discounts are reflected in the contractual
transaction price at contract inception. Revenue is recognized based on the discounted contract price and is accounted for in the same
manner as other contracts. The Company recognizes revenue from these arrangements ratably over the contract term, consistent with the
pattern in which the customer receives and consumes the benefits of the integrated autonomous vehicle solution.</p></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_9" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stand-Alone Selling prices</i>. The Company
also applies judgment in estimating stand-alone selling prices when allocating the transaction price to performance obligations. Stand-alone
selling prices are generally determined based on observable prices when available or, when not directly observable, are estimated using
management&#8217;s assessment of expected pricing for similar goods and services and market conditions.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_10" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_9"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Material Rights and Renewal Options.</i> The Company&#8217;s contracts
with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material
right, and therefore represent a separate performance obligation, requires judgment. The Company evaluates the pricing of each option
to determine whether it reflects the stand-alone selling price for the underlying goods or services or whether it provides the customer
with a discount that would not be available without entering into the initial contract.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_11" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In certain legacy customer contracts, the Company
has provided customers with the option to extend the contract term for an additional one-year period. Management evaluates these renewal
provisions to determine whether they provide a material right by comparing the renewal pricing to the expected stand-alone selling price
of the services at the time of renewal. This assessment requires judgment and includes consideration of expected pricing for similar services,
historical pricing practices, and market conditions.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_12" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_11"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a material right exists, the Company allocates a portion of the
transaction price to the option and recognizes the related revenue when the option is exercised or expires.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_13" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Significant financing component.</i> In certain
arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company&#8217;s
contracts with customer prepayment terms do not include a significant financing component because the prepayment terms are designed to
provide customers with contractual protections and billing convenience, not to provide financing to the customer or receive financing
from the customer.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_14" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Contract modifications. </i>The Company may modify contracts to
offer customers additional products or services. Each of the additional products and services is evaluated to determine whether it is
distinct from the goods or services transferred prior to the modification. The Company evaluates whether the contract price for the additional
products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these
cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification
does not reflect the stand-alone selling price for the modified goods or services, the Company accounts for the modification either (i)
on a prospective basis if the remaining goods and services are distinct from those already transferred, or (ii) on a cumulative catch-up
basis if the remaining goods and services are not distinct from those already transferred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_15" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Principal vs. Agent Considerations</i>. Judgment
is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation
of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., &#8220;gross&#8221;),
or we arrange for other parties to provide the service to the end-user and are an agent (i.e., &#8220;net&#8221;). In making this determination,
the Company considers several factors, including whether the Company is primarily responsible for fulfilling the promise to provide the
specified goods or services, bears inventory risk before the goods are transferred, and has discretion in establishing pricing for the
specified goods or services. This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts
and promotions offered to end-users to the extent they are not customers.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_16" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer transactions where the Company&#8217;s
role is to supply hardware to the dealer, the Company does not obtain control of the hardware before it is transferred to the end-user
and is not primarily responsible for the dealer&#8217;s fulfillment to end-users. Accordingly, hardware revenue in these arrangements
is recorded on a net basis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_17" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer and OEM transactions where our role
is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription
revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_18" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Cost to Obtain a Contract. </i>The Company capitalizes incremental
costs incurred to obtain contracts, principally sales commissions and third-party referral fees. These costs are amortized on a straight-line
basis over the contractual term and recognized in general and administrative expenses.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>&#160;</i></p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_19" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Costs to Fulfill a Contract</i>. The Company capitalizes such costs
when they are (i) incremental to obtaining that specific contract, (ii) expected to be recovered, and (iii) subject to an amortization
period exceeding one year. Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which
corresponds to the contractual term, and are recognized in cost of revenue. The Company evaluates capitalized fulfillment costs for impairment
at each reporting date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_20" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Deferred contract costs totaled $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="0" unitRef="usd" id="ixv-13868">767,007</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts" scale="0" unitRef="usd" id="ixv-13869">120,793</ix:nonFraction> as of December
31, 2025 and 2024, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. Amortization
of deferred contract costs recognized in cost of revenue during the years ended December 31, 2025 and 2024 was $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="0" unitRef="usd" id="ixv-13870">106,480</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiability" scale="0" unitRef="usd" id="ixv-13871">21,413</ix:nonFraction>, respectively.
No impairment losses were recognized in either period.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_21" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Taxes collected from customers</i>. The Company
collects and remits certain taxes assessed by governmental authorities on its revenue transactions, including sales, use, value-added,
and excise taxes. These taxes are presented on a net basis and excluded from reported revenue. Shipping and handling fees billed to customers
are included in net sales; the related costs are included in cost of revenue.</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_22" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Judgments and estimates. </i>Accounting for contracts recognized over time requires judgment in
estimating the transaction price, the measure of progress, and expected contract costs. Due to uncertainties
inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the
near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed.</p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_23" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="ixv-6901"><ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_24" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_25" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_24"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c48" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13872">17.1</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c50" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13873">36.8</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13874">11.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13875">73.2</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13876">19.1</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c56" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="pure" id="ixv-13877">12.3</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<ix:continuation continuedAt="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_26" id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_25"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US"><span style="font-size: 10pt">Below 10%</span></ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_RevenueFromContractWithCustomerPolicyTextBlock-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was $<ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" unitRef="usd" id="ixv-13878">209,452</ix:nonFraction> from these customers in accounts
receivable as of December 31, 2025 and $<ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="0" unitRef="usd" id="ixv-13879">274,699</ix:nonFraction> from these customers in accounts receivable as of December 31, 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="cyngn_CostOfRevenuePolicyTextBlock-c0_cont_1" escape="true" name="cyngn:CostOfRevenuePolicyTextBlock" id="ixv-6984"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cost of Revenue </i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="cyngn_CostOfRevenuePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue consists primarily of direct labor
and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the
contracts and hardware costs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-6994"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recent Accounting Standards</i></b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation
of Income Statement Expenses,&#8221; which requires the disaggregated disclosure of certain income statement items. ASU 2024-03 is effective
for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted.
The Company has not adopted this standard early and is currently evaluating the impact of this amendment on its consolidated financial
statements.</p></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="ixv-7007"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. Revenue and Contracts with Customers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Contract Balances</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timing differences between revenue recognized, billings, and customer
payments result in contract assets and contract liabilities. Contract assets represent revenue recognized in excess of amounts billed
to customers. Contract liabilities represent payments received from customers in advance of satisfying the related performance obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s contract balances consist primarily of accounts receivable
and deferred revenue (contract liabilities). Accounts receivable represents the Company&#8217;s unconditional rights to consideration
for goods and services transferred to customers. Contract liabilities represent amounts billed or collected in advance of satisfying performance
obligations and are recognized as revenue as the related performance obligations are satisfied. As of December 31, 2025 and 2024, deferred
revenue related to tugger sales totaled $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13880">1,658,015</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="0" unitRef="usd" id="ixv-13881">769,180</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognized from Prior Period Contract
Liabilities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2025 and 2024,
the Company recognized revenue of $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCostsCurrent" scale="0" unitRef="usd" id="ixv-13882">128,387</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredCostsCurrent" scale="0" unitRef="usd" id="ixv-13883">1,500</ix:nonFraction>, respectively, that was included in deferred revenue at the beginning of each respective
period. The Company did not recognize material revenue during the periods presented from performance obligations satisfied (or partially
satisfied) in prior periods other than amounts previously included in deferred revenue.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Remaining Performance Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the remaining performance
obligations on existing contracts are $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="0" unitRef="usd" id="ixv-13884">1,658,015</ix:nonFraction>, approximately <ix:nonFraction contextRef="c58" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-13885">25</ix:nonFraction>% of which is expected to be recognized in 2026, <ix:nonFraction contextRef="c59" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-13886">36</ix:nonFraction>% in 2027, <ix:nonFraction contextRef="c60" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure" id="ixv-13887">28</ix:nonFraction>% in
2028, and the remainder thereafter. This amount corresponds to the Company&#8217;s contract liability balance as of December 31, 2025,
as all remaining obligations relate to the passage of time on active contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2025 and 2024,
revenue was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd" id="ixv-13888">218,976</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="0" unitRef="usd" id="ixv-13889">368,138</ix:nonFraction>, respectively.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SupplementalBalanceSheetDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="ixv-7060"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. Balance Sheet Components</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Instruments</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Funds in the Company&#8217;s investment brokerage
account were held in cash equivalents, consisting of a money market account, along with short-term investments consisting of U.S. government
treasury bills, which are accounted for as held-to-maturity (&#8220;HTM&#8221;) securities, and classified as Level 1 in the hierarchy
of fair value measurements. HTM securities are carried at amortized cost and, as a result, are not remeasured to fair value on a recurring
basis. All of the Company&#8217;s short-term investments will mature within one year of December 31, 2025. <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShortTermDebtTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="ixv-13890">The Company does not expect
a credit loss for its short-term investments.</ix:nonNumeric></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<ix:continuation id="_ScheduleOfShortTermDebtTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2025</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2024</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Financial assets</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash equivalents:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Money market account</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="0" unitRef="usd" id="ixv-13891">929,165</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c62" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MoneyMarketFundsAtCarryingValue" scale="0" unitRef="usd" id="ixv-13892">23,274,834</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term investments:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S. government treasury bills</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:USGovernmentSecuritiesAtCarryingValue" scale="0" unitRef="usd" id="ixv-13893">33,736,091</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 9.25pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="0" unitRef="usd" id="ixv-13894">34,665,255</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="0" unitRef="usd" id="ixv-13895">23,274,834</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>



<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventory</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, allowing the Company to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.</p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2025 and 2024, inventory totaled $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" unitRef="usd" id="ixv-13896">2.0</ix:nonFraction> million and
$<ix:nonFraction contextRef="c4" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="6" unitRef="usd" id="ixv-13897">0.2</ix:nonFraction> million, respectively.</p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Prepaid expenses and other current assets</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ixv-7208"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses and other current assets are comprised of the following:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid Expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" unitRef="usd" id="ixv-13898">668,090</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="0" unitRef="usd" id="ixv-13899">303,803</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsCurrent" scale="0" unitRef="usd" id="ixv-13900">75,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DepositsAssetsCurrent" scale="0" unitRef="usd" id="ixv-13901">160,149</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13902">775,334</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13903">128,138</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total prepaid and expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13904">1,518,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="usd" id="ixv-13905">592,090</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment were reclassified to better
reflect their appropriate categories within the fixed asset register. These reclassifications did not have a significant impact on the
overall asset values or depreciation expense. <ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-13906">Property and equipment is comprised of the following:</ix:nonNumeric></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_PropertyPlantAndEquipmentTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Automobiles (DMV-registered)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13907">28,862</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13908">128,862</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13909">692,459</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13910">660,155</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13911">488,552</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13912">389,007</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Capitalized software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13913">1,592,092</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13914">950,832</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13915">73,494</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13916">66,182</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13917">175,417</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13918">221,977</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Testing equipment (Work in Progress)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13919">896,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13920">687,986</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9.25pt">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13921">3,947,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="usd" id="ixv-13922">3,105,001</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-13923">678,827</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="usd" id="ixv-13924">785,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd" id="ixv-13925">3,268,196</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="usd" id="ixv-13926">2,319,402</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense for the years ended December
31, 2025 and 2024 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="0" unitRef="usd" id="ixv-13927">234,909</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="0" unitRef="usd" id="ixv-13928">214,494</ix:nonFraction>, respectively.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Payable </i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts payable includes independent director
fees payable of $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="0" unitRef="usd" id="ixv-13929">42,500</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="0" unitRef="usd" id="ixv-13930">28,333</ix:nonFraction> as of December 31, 2025 and 2024, respectively.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Deferred Revenue</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue consists primarily of amounts
billed to customers for tugger sales and related services for which revenue has not yet been recognized. Revenue is recognized as the
Company satisfies its performance obligations in accordance with its revenue recognition policy.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, deferred revenue
related to tugger sales totaled $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="0" unitRef="usd" id="ixv-13931">1,658,015</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredRevenue" scale="0" unitRef="usd" id="ixv-13932">769,180</ix:nonFraction>, respectively.</p></ix:nonNumeric><div>

</div><p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_SupplementalBalanceSheetDisclosuresTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accrued Expenses and Other Current Liabilities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="ixv-7423"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses and other current liabilities
are comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CreditCardPayableCurrent" scale="0" unitRef="usd" id="ixv-13933">16,169</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:CreditCardPayableCurrent" scale="0" unitRef="usd" id="ixv-13934">2,050</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13935">563,770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13936">788,948</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrent" scale="0" unitRef="usd" id="ixv-13937">2,035,795</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrent" scale="0" unitRef="usd" id="ixv-13938">1,314,038</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13939">2,615,734</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="0" unitRef="usd" id="ixv-13940">2,105,036</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-7480"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Operating Leases</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease right-of-use assets and lease
liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments
consist of the fixed payments under the arrangement, less any lease incentives, such as tenant improvement allowances. Variable costs,
such as maintenance and utilities based on actual usage, are not included in the measurement of right-of-use (&#8220;ROU&#8221;) assets
and lease liabilities but are expensed when the event determining the amount of variable consideration to be paid occurs. As the implicit
rate of the leases is not determinable, the Company uses an incremental borrowing rate (&#8220;IBR&#8221;) based on the information available
at the lease commencement date in determining the present value of lease payments. Rather than relying on a single rate source, the Company
evaluated three data points calculated from the three standard methods to determine a reasonable, supportable, and entity-specific IBR
consistent with ASC 842. Based on this analysis, the rate applied is the median of the available supportable rates, which reflects a secured
borrowing assumption and balances entity-specific credit risk and market benchmarks. Lease expenses are recognized on a straight-line
basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases its office space in Mountain
View, California, under an operating lease agreement dated March 25, 2025, originally signed for a term of six and one half years that
commenced in May 2025. Monthly payments are approximately $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="0" unitRef="usd" id="ixv-13941">104,478</ix:nonFraction>. The lease includes common area maintenance costs that are paid separately
from rent based on actual costs incurred. The Company&#8217;s previous lease in Menlo Park, California ended in May 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also leases storage containers from
a third-party provider for use on-site in Mountain View, California, at a monthly rate of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="0" unitRef="usd" id="ixv-13942">141</ix:nonFraction> per unit. These arrangements are on a month-to-month
basis and are cancelable upon thirty (30) days&#8217; notice. Under the short-term lease practical expedient of ASC 842, the Company does not
recognize right-of-use assets or lease liabilities for these arrangements, and instead, lease payments are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s right-of-use asset, net balance
as of December 31, 2025 and 2024, respectively are presented on the Company&#8217;s consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-7494"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s future lease payments under
the non-cancellable lease as of December 31, 2025, which are presented as lease liabilities on the Company&#8217;s consolidated balance
sheet, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">For the year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating<br/> Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2026</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="0" unitRef="usd" id="ixv-13943">692,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="0" unitRef="usd" id="ixv-13944">1,434,193</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="0" unitRef="usd" id="ixv-13945">1,506,260</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="0" unitRef="usd" id="ixv-13946">1,551,040</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="0" unitRef="usd" id="ixv-13947">1,598,594</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">2031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="0" unitRef="usd" id="ixv-13948">1,367,166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Less: imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="0" unitRef="usd" id="ixv-13949">1,341,632</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Present value of lease liability</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="0" unitRef="usd" id="ixv-13950">6,807,621</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-7564"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Weighted-average remaining lease term (in years)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c3" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-13951">5.83</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonNumeric contextRef="c4" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-13952">0.42</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted-average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-13953">5.60</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-13954">4.87</ix:nonFraction></td><td style="text-align: left">%</td></tr> </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lease expense was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="0" unitRef="usd" id="ixv-13955">1,170,932</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="0" unitRef="usd" id="ixv-13956">678,037</ix:nonFraction> for
the years ended December 31, 2025 and 2024, respectively. The amortization of the operating lease right-of-use assets, which is included
in the lease expense, totaled $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" unitRef="usd" id="ixv-13957">915,451</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="0" unitRef="usd" id="ixv-13958">694,373</ix:nonFraction> for the years ended December 31, 2025 and 2024, respectively. The weighted average
discount rate is based on the incremental borrowing rate that is utilized to present value the remaining lease payments over the lease
term.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="ixv-7616"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. Intangible Assets, Net</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="ixv-7620"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross carrying amount and accumulated amortization
of separately identifiable intangible assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="18" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2025</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying Amount</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Market Value Adjustment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying Amount</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13959">521,302</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13960">71,079</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13961">450,223</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13962">45,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13963">29,000</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13964">16,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13965">566,302</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13966">100,079</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right; border-bottom: black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13967">466,223</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Market Value Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Impairment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Developed software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13968">1,425,689</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13969">1,425,689</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13970">611,072</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13971">41,856</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="cyngn:FiniteLivedIntangibleAssetsImpairment" scale="0" unitRef="usd" id="ixv-13972">118,831</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13973">450,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13974">45,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13975">26,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13976">19,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="0" unitRef="usd" id="ixv-13977">2,081,761</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="usd" id="ixv-13978">67,856</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:FiniteLivedIntangibleAssetsImpairment" scale="0" unitRef="usd" id="ixv-13979">118,831</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13980">1,895,074</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for each of the years ended
December 31, 2025 and 2024 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd" id="ixv-13981">32,223</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" unitRef="usd" id="ixv-13982">24,739</ix:nonFraction>, respectively. There was <span style="-sec-ix-hidden: hidden-fact-98"><span style="-sec-ix-hidden: hidden-fact-99">no</span></span> amortization expense for the developed software for the
years ended December 31, 2025 and 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 360, <i style="font-style: normal; font-weight: normal">Property, Plant, and Equipment</i>,
defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate
impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present. The Company determined
the Triggering Events in conjunction with preparation of its financial statements for the year ended December 31, 2025 provided such indication.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Next, the Company must review the long-lived assets
to define asset group(s) that would reflect the lowest level of assets to which discrete cash flows are identifiable, and test these asset
groups for impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In performing this review, the Company identified
that the long-lived asset &#8220;Patents&#8221;, which have international and U.S. based patents, as the asset group. The Company evaluated
its patents and identified expired international patent applications (&#8220;expired assets&#8221;) for the year ended December 31, 2024.
The Company determined there were no further plans to put resources toward these international patent applications. The group of expired
patents carrying value was set to its salvage value which is zero given no future cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2024, the Company
recorded a $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnDispositionOfAssets1" scale="0" unitRef="usd" id="ixv-13983">118,831</ix:nonFraction> impairment charge under gain (loss) on disposal assets, which is included in other income (expense) on its consolidated
statement of operations, to adjust the expiring assets salvage value of <ix:nonFraction contextRef="c4" decimals="0" format="ixt:fixed-zero" name="us-gaap:SalvageAndSubrogationRecoveriesValue" scale="0" unitRef="usd" id="ixv-13984">zero</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It was determined for all remaining <ix:nonNumeric contextRef="c5" name="us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination" id="ixv-13985"><ix:nonNumeric contextRef="c0" name="us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination" id="ixv-13986">long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets</ix:nonNumeric></ix:nonNumeric> were necessary as of December
31, 2025 and December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2025, management
completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company revised its estimate regarding the point at which technological feasibility is achieved for software development
activities. This change in estimate was made to reflect management&#8217;s current expectations about the timing and certainty of future
technological milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in estimate was accounted for prospectively
in accordance with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements.
For the year ended December 31, 2025, the Company recognized a total of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OtherResearchAndDevelopmentExpense" scale="6" unitRef="usd" id="ixv-13987">1.4</ix:nonFraction> million related to costs originally
capitalized in 2024 and $<ix:nonFraction contextRef="c75" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RecapitalizationCosts" scale="6" unitRef="usd" id="ixv-13988">1.2</ix:nonFraction> million related to costs capitalized during the first two quarters of 2025 as research and development expense
resulting from this change.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="ixv-7910"><ix:continuation id="_IntangibleAssetsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated amortization expense for all intangible
assets subject to amortization in future years is expected to be:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Years ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="0" unitRef="usd" id="ixv-13989">33,772</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="0" unitRef="usd" id="ixv-13990">33,772</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="0" unitRef="usd" id="ixv-13991">33,772</ix:nonFraction></td><td style="text-align: left"/></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="0" unitRef="usd" id="ixv-13992">33,772</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="0" unitRef="usd" id="ixv-13993">331,135</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="0" unitRef="usd" id="ixv-13994">466,223</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="ixv-7960"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. Capital Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, the Company
is authorized to issue <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-13995">400,000,000</ix:nonFraction> and <ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-13996">200,000,000</ix:nonFraction> shares of common stock, respectively, with a par value of $<ix:nonFraction contextRef="c3" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-13997">0.00001</ix:nonFraction> per share. As of
December 31, 2025 and 2024, the Company had <ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-13998"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-13999">7,974,380</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-14000"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14001">199,110</ix:nonFraction></ix:nonFraction> shares of common stock issued and outstanding, respectively. Holders
of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable
to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected
by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Preferred Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the Company amended its Certificate
of Incorporation and revised the number of preferred stock shares authorized for issuance to <ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-14002">10,000,000</ix:nonFraction> shares at a par value of $<ix:nonFraction contextRef="c81" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-14003">0.00001</ix:nonFraction>.
As of December 31, 2025 and December 31, 2024, there were <span style="-sec-ix-hidden: hidden-fact-100"><span style="-sec-ix-hidden: hidden-fact-101"><span style="-sec-ix-hidden: hidden-fact-102"><span style="-sec-ix-hidden: hidden-fact-103">no</span></span></span></span> shares of preferred stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reverse Stock Split</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 25, 2024, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of <ix:nonNumeric contextRef="c27" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14004">1-for-5</ix:nonNumeric> to <ix:nonNumeric contextRef="c28" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14005">1-for-100</ix:nonNumeric>. On June 25, 2024, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a <ix:nonNumeric contextRef="c29" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14006">1-for-100</ix:nonNumeric> ratio, which reverse split became effective in the market on July 5, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 30, 2025, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of <ix:nonNumeric contextRef="c30" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14007">1-for-5</ix:nonNumeric> to <ix:nonNumeric contextRef="c31" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14008">1-for-150</ix:nonNumeric>. On January 30, 2025, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a <ix:nonNumeric contextRef="c32" name="us-gaap:StockholdersEquityReverseStockSplit" id="ixv-14009">1-for-150</ix:nonNumeric> ratio, which reverse split became effective in the market on February 18, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s primary reasons for effecting
the reverse stock splits was to increase the per share price of our common stock to meet Nasdaq&#8217;s minimum bid price requirement
for continued listing on Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Offerings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 27, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, <ix:nonFraction contextRef="c84" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14010">313,564</ix:nonFraction> shares of its common
stock, par value $<ix:nonFraction contextRef="c84" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-14011">0.00001</ix:nonFraction> per share at a purchase price of $<ix:nonFraction contextRef="c84" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14012">7.50</ix:nonFraction> per share and <ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock" scale="0" unitRef="shares" id="ixv-14013">1,979,769</ix:nonFraction> pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $<ix:nonFraction contextRef="c85" decimals="5" format="ixt:num-dot-decimal" name="cyngn:PreFundedWarrantsPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14014">7.49999</ix:nonFraction> per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 30, 2025. The Company received net proceeds of approximately $<ix:nonFraction contextRef="c86" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" unitRef="usd" id="ixv-14015">13.7</ix:nonFraction> million from the offering,
after deducting the estimated offering expenses payable by the Company of $<ix:nonFraction contextRef="c87" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseOfferingCost" scale="6" unitRef="usd" id="ixv-14016">1.3</ix:nonFraction> million, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 26, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, <ix:nonFraction contextRef="c88" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-14017">192,496</ix:nonFraction> shares of its common
stock, par value $<ix:nonFraction contextRef="c89" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14018">0.00001</ix:nonFraction> per share at a purchase price of $<ix:nonFraction contextRef="c90" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14019">5.01</ix:nonFraction> per share and <ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock" scale="0" unitRef="shares" id="ixv-14020">2,801,516</ix:nonFraction> pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $<ix:nonFraction contextRef="c89" decimals="5" format="ixt:num-dot-decimal" name="cyngn:PreFundedWarrantsPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14021">5.00999</ix:nonFraction> per pre-funded warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 27, 2025. The Company received net proceeds of approximately $<ix:nonFraction contextRef="c91" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" unitRef="usd" id="ixv-14022">15.9</ix:nonFraction> million from the offering,
after deducting the estimated offering expenses payable by the Company of $<ix:nonFraction contextRef="c88" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseOfferingCost" scale="6" unitRef="usd" id="ixv-14023">1.3</ix:nonFraction> million, including the placement agent fees.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 30, 2024, the Company entered into
a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, <ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14024">44,333</ix:nonFraction> shares
of its common stock, par value $<ix:nonFraction contextRef="c92" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-14025">0.00001</ix:nonFraction> per share at a purchase price of $<ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14026">90</ix:nonFraction> per share and <ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock" scale="0" unitRef="shares" id="ixv-14027">55,667</ix:nonFraction> pre-funded warrants to purchase shares
of Common Stock, at a purchase price of $<ix:nonFraction contextRef="c93" decimals="3" format="ixt:num-dot-decimal" name="cyngn:PreFundedWarrantsPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14028">89.985</ix:nonFraction> per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on December 31, 2024. The Company received net proceeds of approximately $<ix:nonFraction contextRef="c94" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" unitRef="usd" id="ixv-14029">8.1</ix:nonFraction> million from the Offering,
after deducting the estimated offering expenses payable by the Company, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 20, 2024, the Company entered into
a securities purchase agreement for the sale and issuance of (i) <ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-14030">20,507</ix:nonFraction> units at a public offering price per Unit of $<ix:nonFraction contextRef="c96" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14031">241.50</ix:nonFraction> with each
Unit consisting of <ix:nonFraction contextRef="c97" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14032">one</ix:nonFraction> share of common stock, par value $<ix:nonFraction contextRef="c97" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14033">0.00001</ix:nonFraction> per share, <ix:nonFraction contextRef="c98" decimals="0" format="ixt-sec:numwordsen" name="cyngn:WarrantsToPurchase" scale="0" unitRef="shares" id="ixv-14034">one</ix:nonFraction> Series A warrant to purchase <ix:nonFraction contextRef="c98" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14035">one</ix:nonFraction> share of Common Stock
at an exercise price of $<ix:nonFraction contextRef="c99" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14036">301.875</ix:nonFraction> per share and <ix:nonFraction contextRef="c100" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-14037">one</ix:nonFraction> Series B warrant to purchase <ix:nonFraction contextRef="c100" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CommonUnitIssued" scale="0" unitRef="shares" id="ixv-14038">one</ix:nonFraction> share of Common Stock at an exercise price of $<ix:nonFraction contextRef="c101" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14039">301.875</ix:nonFraction><sup>)</sup>
and (ii) <ix:nonFraction contextRef="c96" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PrefundedUnitsAtAPublicOfferingPrice" scale="0" unitRef="shares" id="ixv-14040">62,309</ix:nonFraction> pre-funded units at a public offering price of $<ix:nonFraction contextRef="c102" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14041">241.485</ix:nonFraction> per Pre-Funded Unit, with each Pre-Funded Unit consisting of <ix:nonFraction contextRef="c103" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" unitRef="shares" id="ixv-14042">one</ix:nonFraction>
pre-funded warrant exercisable for <ix:nonFraction contextRef="c103" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14043">one</ix:nonFraction> share of Common Stock at an exercise price of $<ix:nonFraction contextRef="c96" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14044">0.015</ix:nonFraction> per share, <ix:nonFraction contextRef="c99" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14045">one</ix:nonFraction> Series A Warrant and <ix:nonFraction contextRef="c101" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14046">one</ix:nonFraction> Series
B Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders&#8217; equity within additional paid-in capital
and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on December 23,
2024. The net proceeds to the Company from the Offering were approximately $<ix:nonFraction contextRef="c104" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-14047">18.2</ix:nonFraction> million, after deducting placement agent&#8217;s fees
and the payment of other estimated offering expenses associated with the offering that are payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At issuance, the aggregate fair value of the
warrant liabilities exceeded the net proceeds received in the transaction. The Company needed the net proceeds in order to continue
to run operations. Accordingly, the Company recognized a loss on issuance of warrants of approximately $<ix:nonFraction contextRef="c105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" unitRef="usd" id="ixv-14048">2.3</ix:nonFraction> million in its
consolidated statement of operations for the year ended December 31, 2024. This amount reflects the excess of the fair value of the
warrant liabilities over the residual proceeds allocable to the other securities issued in the transaction. Subsequently, the
warrant liabilities will continue to be remeasured at fair value through earnings until they are exercised, expire, or are otherwise
settled. After shareholder approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore,
in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification of Contracts, the Series A warrants were re-measured
utilizing the Black Scholes model and reclassified into equity. The Series A warrants are included in equity in the consolidated
balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the Black Scholes model immediately before
exercise and were fully exercised in February 2025. In addition, approximately $<ix:nonFraction contextRef="c105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" scale="6" unitRef="usd" id="ixv-14049">1.7</ix:nonFraction> million of offering-related issuance costs
attributable to the warrant liabilities were recorded as expense in the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 23, 2024, the Company entered into an
underwritten Agreement with Aegis Capital Corp. (&#8220;Aegis&#8221;), pursuant to which Aegis acted as the Company&#8217;s underwriter
on a firm commitment basis in connection with the sale by the Company of an aggregate of <ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" unitRef="shares" id="ixv-14050">3,333</ix:nonFraction> shares of common stock in a public offering,
which included: (i) <ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" scale="0" unitRef="shares" id="ixv-14051">1,320</ix:nonFraction> shares of common stock, and (ii) pre-funded warrants to purchase <ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" scale="0" unitRef="shares" id="ixv-14052">2,013</ix:nonFraction> shares of common stock. The Pre-Funded
Warrants had a nominal exercise price of $<ix:nonFraction contextRef="c109" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14053">0.15</ix:nonFraction>. Each share of common stock was sold at an offering price of $<ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14054">1,500</ix:nonFraction>, and each Pre-Funded
Warrant was sold at an offering price of $<ix:nonFraction contextRef="c110" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14055">1,499.85</ix:nonFraction>. The Pre-Funded Warrants are classified as a component of permanent stockholders&#8217;
equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value.
The Company determined the fair value of the Series A and Series B warrants using the Monte Carlo pricing model and treated the valuation
as a liability in consideration of the variable number of the issuer&#8217;s equity shares in the warrant agreements. The offering closed
on April 25, 2024. On May 3 2024, the Company closed on the sale of an additional <ix:nonFraction contextRef="c111" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-14056">136</ix:nonFraction> shares of common stock, upon exercise by the underwriter
of the over-allotment option. The Company received net proceeds of approximately $<ix:nonFraction contextRef="c112" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd" id="ixv-14057">4.6</ix:nonFraction> million, after deducting the estimated offering
expenses payable by the Company, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>At the Market Equity Financing </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company entered into
an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis Capital Corp. (the &#8220;Agent&#8221;), under
which the Company may, from time to time, sell shares of the Company&#8217;s common stock having an aggregate offering price of up to
$<ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" unitRef="usd" id="ixv-14058">100,000,000</ix:nonFraction> in &#8220;at the market&#8221; offerings through or to the Agent, as sales agent or principal. Sales of the shares of common
stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent will receive
a commission from the Company of up to <ix:nonFraction contextRef="c114" decimals="3" format="ixt:num-dot-decimal" name="cyngn:CommissionProceedPercentage" scale="-2" unitRef="pure" id="ixv-14059">3.0</ix:nonFraction>% of the gross proceeds of any shares of common stock sold under the Sales Agreement. As of
December 31, 2025, a total of <ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14060">935,114</ix:nonFraction> shares of common stock were sold through Aegis Capital Corp. under the Sales Agreement. As of December
31, 2025, the Company has received net proceeds of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="0" unitRef="usd" id="ixv-14061">5,472,691</ix:nonFraction> after payment of commission fees of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesCommissionsAndFees" scale="0" unitRef="usd" id="ixv-14062">173,341</ix:nonFraction> and other related expenses
of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherLaborRelatedExpenses" scale="0" unitRef="usd" id="ixv-14063">131,990</ix:nonFraction>.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Private Placement Offering</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 12, 2024, the Company entered into
a Securities Purchase Agreement (&#8220;SPA&#8221;) with certain investors pursuant to which we sold, in a private placement, senior notes
with an aggregate principal amount of $<ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="0" unitRef="usd" id="ixv-14064">4,375,000</ix:nonFraction> (the &#8220;Notes&#8221;), and received proceeds before expenses of $<ix:nonFraction contextRef="c117" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="0" unitRef="usd" id="ixv-14065">3,500,000</ix:nonFraction>. The Notes
matured on <ix:nonNumeric contextRef="c117" format="ixt:date-monthname-day-year-en" name="us-gaap:DebtInstrumentMaturityDate" id="ixv-14066">February 12, 2025</ix:nonNumeric>, with <ix:nonFraction contextRef="c117" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" unitRef="pure" id="ixv-14067">20</ix:nonFraction>% interest rate. As consideration for entering into the SPA, we issued a total of <ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14068">2,701</ix:nonFraction> shares of
common stock of the Company to the Purchasers on November 13, 2024. The common stock and the Notes were recorded at the relative fair
values in accordance with ASC 470-20-25-2. The placement agent fee and other offering expenses were allocated based on the aforementioned
fair values as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. The amortization
of the debt discount and issuance costs was recorded in interest income (expense) on the consolidated statement of operations. As of December
31, 2024, the Notes were paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following warrants were outstanding as of
December 31, 2025, each of which is exercisable on a one-for-one basis for shares of the Company&#8217;s common stock (i.e., one warrant
for one share). All warrants contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock
dividends or other extraordinary dividends, or other similar changes in the Company&#8217;s common stock or capital structure, and none
of which have any participating rights for any losses. All Series B warrants, which were issued as a part of the December 20, 2024 public
offering, were fully exercised as of February 11, 2025 utilizing the cashless exercise provision in the warrant agreement. <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="ixv-14069">In addition,
on March 31, 2025, the Company reclassified the Series A warrants from liability to equity upon determining that the warrants no longer
required liability classification.</ix:nonNumeric></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation id="_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Securities into which warrants are convertible</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Common stock (Initial Public Offering)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14070">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14071">40,650</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center"><ix:nonNumeric contextRef="c119" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-14072">October 2026</ix:nonNumeric></td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14073">170,397</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Common stock (Private Placement)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14074">426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14075">140,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c121" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-14076">April 2027</ix:nonNumeric></td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c120" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14077">6,071,114</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock (Series A)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14078">517,598</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction contextRef="c122" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14079">48.30</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c123" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-14080">January 2030</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14081">7,634,428</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14082">518,033</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14083">13,875,939</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following warrants were outstanding as of
December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits,
stock dividends or other extraordinary dividends, or other similar changes in the Company&#8217;s common stock or capital structure, and
none of which have any participating rights for any losses:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities into which warrants are convertible</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants<br/>
outstanding</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise<br/>
Price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration<br/>
Date</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Initial Public Offering)</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14084">9</ix:nonFraction></span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14085">40,650</ix:nonFraction></span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center"><ix:nonNumeric contextRef="c125" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-8199"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2026</span></ix:nonNumeric></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c124" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14086">170,397</ix:nonFraction></span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Private Placement)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14087">426</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14088">140,625</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c127" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-8223"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2027</span></ix:nonNumeric></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14089">6,071,114</ix:nonFraction></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series A)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14090">277,778</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14091">90</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c129" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-8246"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2030</span></ix:nonNumeric></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14092">6,581,789</ix:nonFraction></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series B)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14093">82,816</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c130" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares" id="ixv-14094">301.875</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c131" name="cyngn:WarrantsAndRightOutstandingMaturityDate" id="ixv-8269"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2027</span></ix:nonNumeric></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14095">21,122,138</ix:nonFraction></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-14096">361,029</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14097">33,945,438</ix:nonFraction></span></td> <td>&#160;</td></tr> </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants in accordance
with ASC 480,&#160;<i style="font-style: normal; font-weight: normal">Distinguishing Liabilities from Equity</i>, depending on the specific terms of the warrant agreement. The Company&#160;determined
the fair value of the Initial Public Offering and Private Placement warrants&#160;using the Black-Scholes pricing model and treated the
valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements. The warrants are not
marked-to-market each reporting period, and thus there is no impact to earnings. Any future exercises of the warrants will be recorded
as cash received and recorded in cash, with a corresponding increase to common stock and additional paid-in capital in stockholders&#8217;
equity.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="ixv-8315"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions for
December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Initial<br/>
Public<br/> Offering<br/> Warrants</p><p style="margin: 0pt 0">(Oct 2021)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Private<br/>
Placement Warrants</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>(Apr 2022)</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c133" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14098">2.88</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c134" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14099">1.37</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c135" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14100">51.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c136" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14101">45.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c137" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14102">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c138" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14103">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c139" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14104">1.13</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c140" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14105">2.92</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 815-40-35-8, <i style="font-style: normal; font-weight: normal">Derivatives
and Hedging Reclassification of Contracts</i>, shareholder approval on January 30, 2025, initiated the price reset period, resulting
in a fixed exercise price for the warrants. <ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_2" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_1">As such, the Series A warrants were reclassified to equity and remeasured utilizing the
Black Scholes model with the following assumptions:</ix:continuation></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_3" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c141" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14107">14.75</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c142" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14108">183.38</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c143" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14109">4.96</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c144" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14110">4.30</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B warrants were re-measured
prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Series B<br/>
Warrants</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%"><span style="font-size: 10pt">Fair value of underlying securities</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c145" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14111">6.01</ix:nonFraction> &#8211; <ix:nonFraction contextRef="c146" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14112">32.19</ix:nonFraction> </span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c147" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14113">162.99</ix:nonFraction> &#8211; <ix:nonFraction contextRef="c148" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14114">190.53</ix:nonFraction></span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Expected term (in years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c149" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14115">2.46</ix:nonFraction> &#8211; <ix:nonFraction contextRef="c150" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14116">2.49</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c151" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14117">4.18</ix:nonFraction> &#8211; <ix:nonFraction contextRef="c152" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14118">4.30</ix:nonFraction></span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants in accordance
with ASC 480,&#160;<i style="font-style: normal; font-weight: normal">Distinguishing Liabilities from Equity</i>, depending on the specific terms of the warrant agreement. The Company
allocated the proceeds of the deal based on the fair values for the Series A and Series B warrants. The Company determined the fair value
of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of
the issuer&#8217;s equity shares in the warrant agreements for the year-ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series B<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c153" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14119">0.85</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c154" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14120">0.85</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c155" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14121">161.78</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c156" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14122">161.78</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c157" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14123">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c158" decimals="1" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14124">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14125">4.29</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c160" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" unitRef="pure" id="ixv-14126">4.29</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-8532"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. Net Loss Per Share Attributable to Common Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with ASC 260, basic and diluted
earnings per shares amounts, and weighted-average shares outstanding have been restated for all periods presented to reflect the effect
of these stock dividends. <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-14127">The following table summarizes the computation of basic and diluted loss per share:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="usd" id="ixv-14128">23,469,273</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="usd" id="ixv-14129">33,335,579</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Basic and diluted weighted average common shares outstanding</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-14130"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-14131">4,540,481</ix:nonFraction></ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-14132"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-14133">13,221</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-14134"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-14135">5.17</ix:nonFraction></ix:nonFraction></p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-14136"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-14137">2,521.41</ix:nonFraction></ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share is based upon the weighted
average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect of unvested restricted
stock awards and the convertible preferred stock; however, such items were not considered in the calculation of the diluted weighted average
common shares outstanding since they would be anti-dilutive.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise expressly provided in this Annual
Report, all historical per share data, number of shares issued and outstanding, stock awards, and other common stock equivalents set forth
herein relating to our common stock have been adjusted to give effect to a reverse stock split of our common stock in a ratio of 1-for-100
effected on July 3, 2024 and 1-for-150 effected on February 18, 2025.</p></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="ixv-8625"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. Stock-based Compensation Expense</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses stock-based compensation, including
restricted stock units, to provide long-term performance incentives for its employees and board directors. The Company measures employee
and director stock-based compensation awards based on the award&#8217;s estimated fair value on the date of grant. Forfeitures are recognized
as they occur. Expense associated with these awards is recognized using the straight-line attribution method over the requisite service
period for stock options, restricted stock units (&#8220;RSUs&#8221;) and restricted stock and is reported in our consolidated statements
of stockholders&#8217; equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company&#8217;s stock options
is estimated using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period
during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as
they occur. Stock options generally vest over <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-14138">four years</ix:nonNumeric> and have a contractual term of <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" id="ixv-14139">ten years</ix:nonNumeric>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the grant date fair value of options
requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different assumptions had
been used, stock-based compensation expense could have been materially different from the amounts recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The assumptions and estimates for valuing stock
options are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Fair value per share of Company&#8217;s
common stock.</i> Because there was no public market for Cyngn&#8217;s common stock prior to the IPO, its Board of Directors, with the
assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock options by
considering a number of objective and subjective factors, including its actual operating and financial performance, market conditions
and performance of comparable publicly traded companies, developments and milestones in the company, and the likelihood of achieving
a liquidity event among other factors. Since the Company&#8217;s common stock began publicly trading on the Nasdaq, the value of its
common stock underlying stock options or RSUs have been valued based on prevailing market prices.</span></td>
</tr></table></ix:nonNumeric><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Expected volatility</i>. Because
the Company&#8217;s common stock had no publicly traded history prior to the IPO, it estimated the expected volatility using a combination
of its stock price volatility and the stock price volatility of peer companies, for a period equal to the expected term of the options.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Expected term.</i> The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company estimates the expected term of options granted based upon the &#8220;simplified method&#8221; provided under <i>Staff Accounting Bulletin, Topic 14</i>, or SAB Topic 14.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Risk-free interest rate. </i>The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Estimated dividend yield. </i>The estimated dividend yield is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-14140">zero</ix:nonFraction>, as the Company does not currently intend to declare dividends in the foreseeable future.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Incentive Plans</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2013, the Company&#8217;s Board of
Directors adopted the 2013 Equity Incentive Plan (&#8220;2013 Plan&#8221;). The 2013 Plan authorizes the award of stock options, stock
appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the Company&#8217;s Board of
Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan replaces the 2013 Plan. However,
awards outstanding under the 2013 Plan will continue to be governed by their existing terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the shareholders of the Company
approved an amendment to the Company&#8217;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by <ix:nonFraction contextRef="c161" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-14141">334</ix:nonFraction>
shares of common stock. In June 2024, the shareholders of the Company approved an amendment to allow an annual increase to the 2021 Plan
equal to the least of (i) <ix:nonFraction contextRef="c162" decimals="2" format="ixt:num-dot-decimal" name="cyngn:CommonStockOutstandingPercentage" scale="-2" unitRef="pure" id="ixv-14142">15</ix:nonFraction>% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately
preceding fiscal year, or (ii) such lesser amount as determined by the Board. In December 2025, the shareholders of the Company approved
an amendment to the Company&#8217;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by <ix:nonFraction contextRef="c163" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" unitRef="shares" id="ixv-14143">4,000,000</ix:nonFraction> shares
of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and December 31, 2024,
approximately <ix:nonFraction contextRef="c164" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-14144">55,770</ix:nonFraction> and <ix:nonFraction contextRef="c165" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" unitRef="shares" id="ixv-14145">614</ix:nonFraction> shares of common stock were reserved and available for issuance under the 2021 Plan, respectively. Options
issued under the Plans generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" id="ixv-8718"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s stock options outstanding as well as stock options vested and exercisable as of December 31, 2025, and activity during
the year end then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average <br/>
exercise<br/>
price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average remaining<br/>
contractual<br/>
term<br/>
(years)</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
intrinsic<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2024</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-14146">1,151</ix:nonFraction></span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-14147">14,665.36</ix:nonFraction></span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c168" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-8770"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.37</span></ix:nonNumeric></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/forfeited</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" unitRef="shares" id="ixv-14148">227</ix:nonFraction></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-14149">19,438.45</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" unitRef="shares" id="ixv-14150">924</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-14151">13,475.78</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-8862"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></ix:nonNumeric></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and expected to vest at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" unitRef="shares" id="ixv-14152">924</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-14153">13,475.78</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="ixv-8888"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></ix:nonNumeric></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and exercisable at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" unitRef="shares" id="ixv-14154">764</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" unitRef="usdPershares" id="ixv-14155">13,264.58</ix:nonFraction></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="ixv-8914"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</span></ix:nonNumeric></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="ixv-8939"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s RSUs as of December 31, 2025, and activity during the year then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/> average<br/> grant date<br/> fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Unvested shares at December 31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c169" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-14156">20</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c169" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-14157">21,957.75</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">RSUs granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">RSUs vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c170" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-14158">20</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c170" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-14159">21,957.75</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">RSUs forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Unvested Shares at December 31, 2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of a stock option is estimated
using the Black-Scholes option-pricing model that takes into account as of the grant date the exercise price and expected life of the
option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free interest
rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all option grants
based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized in the
financial statements upon satisfaction of the requisite service or vesting requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no shares issued in 2025,
therefore no fair value was determined. The weighted average per share grant-date fair value of options granted during the year
ended December 31, 2025 and 2024 was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-14160">0</ix:nonFraction> and $<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-14161">5.59</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-9015"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following weighted average assumptions were
used in estimating the grant date fair values in December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Fair value of common stock</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-14162">0.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="0" unitRef="usdPershares" id="ixv-14163">1,521.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-14164">6.02</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-14165">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-14166">3.96</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-14167">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-14168">54.76</ix:nonFraction></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-14169">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-14170">0</ix:nonFraction></td><td style="text-align: left">%</td></tr> </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recorded stock-based compensation expense
from stock options and RSUs of approximately $<ix:nonFraction contextRef="c166" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-14171">1,620,992</ix:nonFraction> and $<ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="0" unitRef="usd" id="ixv-14172">2,449,191</ix:nonFraction>, during the years ended December 31, 2025 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, total stock-based compensation
cost related to outstanding unvested stock options that are expected to vest was $<ix:nonFraction contextRef="c3" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" unitRef="usd" id="ixv-14173">1.4</ix:nonFraction> million. This unrecognized stock-based compensation
cost is expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ixv-14174">1.3</ix:nonNumeric> years. Income tax benefits recognized from stock-based
compensation expense recognized for the year ended December 31, 2025 were immaterial due to cumulative losses and valuation allowances.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="ixv-9103"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. Retirement Savings Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective November 17, 2017, the Company established
the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the intention to provide a
measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement Income Security Act of
1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. The Company did not offer and has not provided a company
match for its 401(k) Plan.</p></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-9111"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ixv-9116"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Domestic and international pre-tax loss consists of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="0" sign="-" unitRef="usd" id="ixv-14175">23,469,273</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="0" sign="-" unitRef="usd" id="ixv-14176">33,335,579</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">International</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-14177">23,469,273</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="0" sign="-" unitRef="usd" id="ixv-14178">33,335,579</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2025 and 2024,
income tax expense attributable to operations is immaterial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-9169"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense differed from the amount computed
by applying the federal statutory income tax rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-14179">21</ix:nonFraction>% to pretax income for the years ended December 31, 2025 and 2024 as a result of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">US Federal Statutory Tax Rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-14180">4,928,547</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure" id="ixv-14181">21.00</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local Income Taxes (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" sign="-" unitRef="usd">211,513</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" unitRef="pure">0.90</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign Tax Effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="pure" id="ixv-14184">0.00</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tax Credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="0" unitRef="usd" id="ixv-14185">1,010,247</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" sign="-" unitRef="pure" id="ixv-14186">4.30</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-14187">4,421,241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" sign="-" unitRef="pure" id="ixv-14188">18.84</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nontaxable or Nondeductible Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Section 162m Limitation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c176" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" unitRef="usd" id="ixv-14189">262,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c176" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" sign="-" unitRef="pure" id="ixv-14190">1.12</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Warrant Revaluation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c177" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" unitRef="usd" id="ixv-14191">248,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c177" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" sign="-" unitRef="pure" id="ixv-14192">1.06</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c178" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" unitRef="usd" id="ixv-14193">236,687</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c178" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" sign="-" unitRef="pure" id="ixv-14194">1.01</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in unrecognized tax benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="0" unitRef="usd" id="ixv-14195">303,074</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" sign="-" unitRef="pure" id="ixv-14196">1.29</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Reconciling Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Deferred True Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="0" unitRef="usd" id="ixv-14197">622,366</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" scale="-2" sign="-" unitRef="pure" id="ixv-14198">2.65</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="0" unitRef="usd" id="ixv-14199">55,184</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" scale="-2" sign="-" unitRef="pure" id="ixv-14200">0.24</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-14201">0.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US"><i>For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.</i></ix:footnote></td></tr></table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>



</div><!-- Field: Page; Sequence: 76; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><ix:continuation id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="0" sign="-" unitRef="usd" id="ixv-14202">6,142,980</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="0" sign="-" unitRef="usd" id="ixv-14203">218,456</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="0" unitRef="usd" id="ixv-14204">180,319</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Foreign taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationTaxCredits" scale="0" unitRef="usd" id="ixv-14205">1,039,015</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nondeductible items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" scale="0" unitRef="usd" id="ixv-14206">26,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-14207">5,327,801</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred true up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="0" unitRef="usd" id="ixv-14208">1,165,581</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rate change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="0" unitRef="usd" id="ixv-14209">717,809</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other items</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="0" sign="-" unitRef="usd" id="ixv-14210">18,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes.
<ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-14211">Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<ix:continuation id="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets: <b>&#160;</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 76%; padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-14212">41,820,615</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="usd" id="ixv-14213">36,178,997</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development credits</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="0" unitRef="usd" id="ixv-14214">7,713,764</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="0" unitRef="usd" id="ixv-14215">7,006,591</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" unitRef="usd" id="ixv-14216">616,331</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="0" unitRef="usd" id="ixv-14217">880,481</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsFixedAssets" scale="0" sign="-" unitRef="usd" id="ixv-14218">365,067</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsFixedAssets" scale="0" sign="-" unitRef="usd" id="ixv-14219">181,103</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" unitRef="usd" id="ixv-14220">27,813</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="0" unitRef="usd" id="ixv-14221">452,339</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accruals and reserves</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="0" unitRef="usd" id="ixv-14222">441,240</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="0" unitRef="usd" id="ixv-14223">281,367</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="0" unitRef="usd" id="ixv-14224">155,914</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="0" unitRef="usd" id="ixv-14225">21,751</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsLeaseLiability" scale="0" unitRef="usd" id="ixv-14226">1,491,200</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsLeaseLiability" scale="0" unitRef="usd" id="ixv-14227">69,025</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized research costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsCapitalizedResearchCosts" scale="0" unitRef="usd" id="ixv-14228">3,761,293</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxAssetsCapitalizedResearchCosts" scale="0" unitRef="usd" id="ixv-14229">5,280,797</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd" id="ixv-14230">223</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="0" unitRef="usd" id="ixv-14231">8,639</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross deferred tax assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd" id="ixv-14232">55,663,326</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="usd" id="ixv-14233">49,998,884</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-14234">54,355,211</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="usd" id="ixv-14235">49,934,084</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="usd" id="ixv-14236">1,308,115</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="usd" id="ixv-14237">64,800</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxLiabilitiesRightOfUseAsset" scale="0" unitRef="usd" id="ixv-14238">1,308,115</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="cyngn:DeferredTaxLiabilitiesRightOfUseAsset" scale="0" unitRef="usd" id="ixv-14239">64,800</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred project costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax liabilities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" unitRef="usd" id="ixv-14240">1,308,115</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" unitRef="usd" id="ixv-14241">64,800</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly assesses the ability to realize
deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected
future taxable income on a jurisdiction by jurisdiction basis. In the event that the Company changes its determination as to the amount
of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income
taxes in the period in which such determination is made. The Company&#8217;s management believes that, based on a number of factors, it
is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the year ended
December 31, 2025, the Company has provided a valuation allowance against the Company&#8217;s U.S. net deferred tax assets. The net change
in the valuation allowance for the years ended December 31, 2025 and 2024 was an increase of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" unitRef="usd" id="ixv-14242">4,421,241</ix:nonFraction> and $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" unitRef="usd" id="ixv-14243">5,327,800</ix:nonFraction>, respectively.</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the Company had net operating loss carryforwards
for federal and state income tax purposes of approximately $<ix:nonFraction contextRef="c172" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd" id="ixv-14244">161,732,697</ix:nonFraction> and $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd" id="ixv-14245">120,845,916</ix:nonFraction>, respectively, which will begin to expire in
2034 and 2035 with $<ix:nonFraction contextRef="c174" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" scale="0" unitRef="usd" id="ixv-14246">126,395,500</ix:nonFraction> of our federal net operating loss carryforward lasting indefinitely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the Company had
federal and state research credit carryforwards of approximately $<ix:nonFraction contextRef="c172" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="0" unitRef="usd" id="ixv-14247">7,526,906</ix:nonFraction> and $<ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="0" unitRef="usd" id="ixv-14248">4,421,211</ix:nonFraction>, respectively. The federal research
credit carryforwards will begin to expire in 2033 while the California research credits carry forward have an indefinite life.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Internal Revenue Code of 1986, as amended,
imposes restrictions on the utilization of net operating losses in the event of an &#8220;ownership change&#8221; of a corporation. Accordingly,
a company&#8217;s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (&#8220;IRC
Section 382&#8221;). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one
year include, but are not limited to, a cumulative ownership change of more than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" unitRef="pure" id="ixv-14249">50</ix:nonFraction>% over a three-year period. Utilization of the federal
and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the
IRC Section 382 and similar state provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective for tax years beginning after December
31, 2021, the Tax Cuts and Jobs Act of 2017 eliminates the option to deduct research and development expenditures currently and requires
taxpayers to amortize such costs over a period of five or fifteen years. While it is possible that Congress may modify, defer, or repeal
such provision, we have no assurance that the provision will be modified, deferred or repealed. This legislation has accelerated the utilization
of our net operating losses in the U.S., but it has not impacted our current tax obligations.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In response to the COVID-19 pandemic, the Coronavirus
Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide
additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions
related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations,
and an option to defer payroll tax payments for a limited period. In 2023, we assessed our eligibility to claim a refund of employer taxes
available under the Employee Retention Credit provisions of the CARES Act. For the year ended December 31, 2023, we calculated eligible
credits of approximately $<ix:nonFraction contextRef="c175" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="0" unitRef="usd" id="ixv-14250">763,624</ix:nonFraction> provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses.
As of December 31, 2025 and 2024, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="ixv-9730"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reflects changes in gross
unrecognized tax benefits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Balance at beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14251">3,002,825</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14252">2,545,189</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase in balance related to tax positions taken during the current year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="0" unitRef="usd" id="ixv-14253">303,074</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="0" unitRef="usd" id="ixv-14254">445,293</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase in balance related to tax positions taken during prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="0" unitRef="usd" id="ixv-14255">12,343</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Decrease in balance related to prior year tax positions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Decrease in balance related to settlement with tax authorities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Balance at end of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14256">3,305,899</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14257">3,002,825</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, the total amount
of gross unrecognized tax benefits was $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14258">3,305,899</ix:nonFraction> and $<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="0" unitRef="usd" id="ixv-14259">3,002,825</ix:nonFraction>, respectively, which does not include any reserved interest or penalties.
As of December 31, 2025, $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="0" unitRef="usd" id="ixv-14260">3,305,899</ix:nonFraction> of the total unrecognized tax benefits, if recognized, would have an impact on the Company&#8217;s
effective tax rate. The Company estimates that there will be no material changes in its uncertain tax positions in the next 12 months.
The Company&#8217;s has not recorded any interest or penalties related to its unrecognized tax benefits for 2025 or 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company files income tax returns in the U.S.
federal and various state jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations
for years prior to 2021 for federal purposes and 2020 for state purposes, except in certain limited circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, due to the fact that the Company had loss and credits carried
forward in some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant
taxing authority through an adjustment to tax attributes carried forward to open years. The Company&#8217;s NOL and credit carryforwards from
all years may be subject to adjustment for three (or four for certain states) following the year in which utilized. The Company does not
anticipate that any potential tax adjustments will have a significant impact on our financial position or results of operations.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="ixv-9833"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12. Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legal Proceedings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company may become involved
in legal proceedings arising in the ordinary course of business. Regardless of outcome, litigation can have an adverse impact on us due
to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors. The assessment
as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves
significant judgment about future events, and the outcome of litigation, which is inherently uncertain.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, a former contractor of the Company
filed a complaint alleging breach of contract and related claims arising from certain professional services agreements entered into between
2021 and 2024. The complaint seeks approximately $<ix:nonFraction contextRef="c179" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyLossInPeriod" scale="0" unitRef="usd" id="ixv-14261">59,760</ix:nonFraction>&#160;in damages, plus interest, attorneys&#8217; fees, and costs. The matter
is in its early stages, and the Company is evaluating the claims and intends to respond accordingly. The Company has recorded an accrual
of approximately $<ix:nonFraction contextRef="c180" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualPayments" scale="0" unitRef="usd" id="ixv-14262">33,000</ix:nonFraction> in connection with the foregoing matters .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2025, a former employee filed a complaint with the U.S. Department
of Labor, Occupational Safety and Health Administration (&#8220;OSHA&#8221;), alleging retaliation in connection with the employee&#8217;s
internal reporting. To avoid litigation and minimize costs, the Company has agreed in principle, subject to final documentation, to a
one-time payment of $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligation" scale="0" unitRef="usd" id="ixv-14263">80,000</ix:nonFraction>&#160;to settle a contract dispute, which payment is included in accrued expenses as of December 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of a settlement agreement with a former placement agent,
the Company may be obligated to pay a maximum of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:SettlementAgreementAmount" scale="6" unitRef="usd" id="ixv-14264">2.3</ix:nonFraction>&#160;million cash fee and issue&#160;<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantsToPurchaseShares" scale="0" unitRef="shares" id="ixv-14265">370,114</ix:nonFraction>&#160;warrants to purchase shares of
the Company&#8217;s common stock in connection with the June 27 Offering and the June 26 Offering. However, the Company has informed the
former placement agent that it does not believe there is a basis for these obligations. The Company has not received a response from the
former placement agent and a resolution has not been reached as of the date of this filing. Since the Company is contesting the matter
and it has not accrued any liability related to it. While an unfavorable outcome is reasonably possible, the Company is unable to estimate
the possible loss at this time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to legal and regulatory actions that arise from
time to time. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss
is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. To avoid
litigation and minimize costs, the Company agreed in principle, subject to final documentation, to a one-time payment of $<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForLegalSettlements" scale="0" unitRef="usd" id="ixv-14266">500,000</ix:nonFraction> to settle
a contract dispute, of which payment was included in accrued expenses as of December 31, 2024 and paid out in March 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was no other material pending or threatened
litigation against the Company that remains outstanding as of December 31, 2025.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ConcentrationRiskDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="ixv-9856"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>13. Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s business operations, operating
results, and financial condition are vulnerable to certain risks and uncertainties including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Inflation and its related impact
on costs and expenditures on domestic and foreign-sourced materials and services;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Rising interest rates and its
impact on the equity markets, investment valuations, and interest rate-sensitive calculations such as discount rate assumptions used
in cash flow projections and going concern assessments;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Effects of the Russia-Ukraine
conflict such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Other factors beyond its control
such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.</span></td>
</tr></table></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 79; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation id="_ConcentrationRiskDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is unable to predict and quantify
at this time the extent of the related potential adverse effects but continuously monitors these risks and uncertainties on its future
operations and financial performance.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-9913"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14. Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>ATM </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 19, 2026, the Company has sold <ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares" id="ixv-14267">3,922,113</ix:nonFraction>
additional shares under the ATM Sales Agreement, for net proceeds of $<ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="0" unitRef="usd" id="ixv-14268">9,166,427</ix:nonFraction> after payment of commission and fees of $<ix:nonFraction contextRef="c181" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SalesCommissionsAndFees" scale="0" unitRef="usd" id="ixv-14269">283,498</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Registered Direct Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 16, 2026, the Company entered into a
securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, <ix:nonFraction contextRef="c182" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-14270">1,686,788</ix:nonFraction> shares
of its common stock, par value $<ix:nonFraction contextRef="c182" decimals="5" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-14271">0.00001</ix:nonFraction> per share at a purchase price of $<ix:nonFraction contextRef="c182" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14272">1.93</ix:nonFraction> per share and <ix:nonFraction contextRef="c182" decimals="0" format="ixt:num-dot-decimal" name="cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock" scale="0" unitRef="shares" id="ixv-14273">3,313,212</ix:nonFraction> pre-funded warrants to purchase
shares of Common Stock, at a purchase price of $ of $<ix:nonFraction contextRef="c182" decimals="5" format="ixt:num-dot-decimal" name="cyngn:PreFundedWarrantsPricePerShare" scale="0" unitRef="usdPershares" id="ixv-14274">1.92999</ix:nonFraction> per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component
of permanent stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase
price approximated the fair value. The offering closed on March 17, 2026. The Company received net proceeds of approximately $<ix:nonFraction contextRef="c183" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" unitRef="usd" id="ixv-14275">8.8</ix:nonFraction> million
from the offering, after deducting the estimated offering expenses payable by the Company of $<ix:nonFraction contextRef="c183" decimals="-4" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseOfferingCost" scale="6" unitRef="usd" id="ixv-14276">0.85</ix:nonFraction> million, including the placement agent
fees.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock-c0_cont_1" escape="true" name="cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" id="ixv-9931"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>15. Restatement of Previously Issued Audited
Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company restated its previously reported financial
statements for each of the period ended December 31, 2024. The adjustment resulted in an increase to warrant liability by $<ix:nonFraction contextRef="c184" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" unitRef="usd" id="ixv-14277">12.7</ix:nonFraction> million,
a decrease in equity balance by $<ix:nonFraction contextRef="c184" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="6" unitRef="usd" id="ixv-14278">12.7</ix:nonFraction> million and an adjustment from operating activities to financing activities on the statement of
cash flow as of December 31, 2024. The Company recognized a loss on the issuance of the Warrants of approximately $<ix:nonFraction contextRef="c184" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:GainLossOnIssuanceOfWarrant" scale="6" unitRef="usd" id="ixv-14279">2.3</ix:nonFraction> million and offering-related
issuance costs of approximately $<ix:nonFraction contextRef="c184" decimals="-5" format="ixt:num-dot-decimal" name="cyngn:OfferingRelatedIssuanceCosts" scale="6" unitRef="usd" id="ixv-14280">1.7</ix:nonFraction> million as of December 31, 2024.</p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="ixv-9936"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<br/>
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated
balances as of December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14281">15,012,361</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14282">12,691,566</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="0" unitRef="usd" id="ixv-14283">27,703,927</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-14284">18,501,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-14285">12,641,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="0" unitRef="usd" id="ixv-14286">31,143,265</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Additional paid-in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd" id="ixv-14287">200,863,551</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" sign="-" unitRef="usd" id="ixv-14288">8,558,271</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="0" unitRef="usd" id="ixv-14289">192,305,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-14290">189,269,903</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-14291">4,083,295</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="0" sign="-" unitRef="usd" id="ixv-14292">193,353,198</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="usd" id="ixv-14293">11,593,650</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-14294">12,641,566</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="0" sign="-" unitRef="usd" id="ixv-14295">1,047,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedIncomeStatementTableTextBlock" id="ixv-10025"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability issuance costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantLiabilityIssuanceCosts" scale="0" unitRef="usd" id="ixv-14296">0</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantLiabilityIssuanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-14297">1,739,148</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantLiabilityIssuanceCosts" scale="0" sign="-" unitRef="usd" id="ixv-14298">1,739,148</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-14299">0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-14300">2,344,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-14301">2,344,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income (expenses), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-14302">6,424,209</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-14303">4,083,295</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="0" sign="-" unitRef="usd" id="ixv-14304">10,507,504</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14305">29,252,284</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14306">4,083,295</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14307">33,335,579</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-14308"><ix:nonFraction contextRef="c184" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-14309">2,212.56</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-14310"><ix:nonFraction contextRef="c188" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-14311">308.85</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" sign="-" unitRef="usdPershares" id="ixv-14312"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares" id="ixv-14313">2,521.41</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:continuation id="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="ixv-10126"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Stockholders&#8217; Equity (Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" scale="0" unitRef="usd" id="ixv-14314">20,972,722</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" scale="0" sign="-" unitRef="usd" id="ixv-14315">8,558,270</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" scale="0" unitRef="usd" id="ixv-14316">12,414,453</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14317">29,252,284</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14318">4,083,295</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c191" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14319">33,335,579</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="srt:ScheduleOfCondensedCashFlowStatementTableTextBlock" id="ixv-10170"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14320">29,252,284</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14321">4,083,295</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-14322">33,335,579</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-14323">0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-14324">2,344,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="cyngn:LossOnIssuanceOfWarrants" scale="0" sign="-" unitRef="usd" id="ixv-14325">2,344,147</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantIssuanceCosts" scale="0" unitRef="usd" id="ixv-14326">0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantIssuanceCosts" scale="0" unitRef="usd" id="ixv-14327">1,739,148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="cyngn:WarrantIssuanceCosts" scale="0" unitRef="usd" id="ixv-14328">1,739,148</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses, lease liabilities, and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd" id="ixv-14329">10,642,938</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" sign="-" unitRef="usd" id="ixv-14330">9,652,581</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="0" unitRef="usd" id="ixv-14331">990,357</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-14332">9,493,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-14333">9,702,581</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="0" sign="-" unitRef="usd" id="ixv-14334">19,196,081</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" scale="0" unitRef="usd" id="ixv-14335">22,369,285</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" scale="0" sign="-" unitRef="usd" id="ixv-14336">8,558,271</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" scale="0" unitRef="usd" id="ixv-14337">13,811,014</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Proceeds from issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-14338">0</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-14339">18,260,852</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="0" unitRef="usd" id="ixv-14340">18,260,852</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-14341">26,584,380</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c190" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-14342">9,702,581</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="0" unitRef="usd" id="ixv-14343">36,286,961</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following this review, the Company completed a
comprehensive review of its previously issued financial statements. The Company is adjusting for certain out-of-period errors that were
not material, individually or in the aggregate, and are being corrected as part of the restatement. The Company corrected a duplicate
bill of $<ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="0" unitRef="usd" id="ixv-14344">50,000</ix:nonFraction> for issuance costs on an equity transaction, resulting in a decrease in accounts payable and an increase in additional
paid-in-capital. The Company also corrected for an immaterial reallocation of proceeds from equity issuances among common stock, common
warrants, and pre-funded warrants, related to a previous issuance in 2022, resulting in a reclassification within additional paid-in-capital
sub-accounts of $<ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="0" unitRef="usd" id="ixv-14345">88,024</ix:nonFraction>. This correction has no impact on total additional paid-in-capital, net loss, or total stockholders&#8217; equity.
The Company believes the adjustments were not material to any prior period, individually or in the aggregate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" id="ixv-10300"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c185" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd" id="ixv-14346">297,778</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c186" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" sign="-" unitRef="usd" id="ixv-14347">50,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="0" unitRef="usd" id="ixv-14348">247,778</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c184" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-14349">100,815</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c188" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" sign="-" unitRef="usd" id="ixv-14350">50,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c189" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="0" unitRef="usd" id="ixv-14351">50,815</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9. Changes in and Disagreements with Accountants
on Accounting and Financial Disclosure</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were no disagreements
related to accounting principles or practices, financial statement disclosure, internal controls or auditing scope or procedure during
the two fiscal years and their respective interim periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Information required by this
item is incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed on April 25, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9A. Controls and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Management&#8217;s Report on Disclosure
Controls and Procedures</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management, under the
supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Financial Officer
(our Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2025, the
end of our fiscal year covered by this report. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e)
and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company
that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission&#8217;s
rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information
required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to
the company&#8217;s management, including its principal executive and principal financial officers, or person performing similar functions,
as appropriate to allow timely decisions regarding required disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Management recognizes that
any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their
objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Based on the evaluation of our disclosure controls and procedures as of December 31, 2025, our Chief Executive Officer and Chief Financial
Officer have concluded that, as of such date, our disclosure controls and procedures are not effective as a result of the two material
weaknesses as described below.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Management&#8217;s Report on Internal Control
over Financial Reporting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management is responsible
for establishing and maintaining adequate internal control over financial reporting. Responsibility on estimates and judgments by management
are required to assess the expected benefits and related costs of control procedures. The objectives of internal control include providing
management with reasonable, but not absolute, assurance that assets are safeguarded against loss from unauthorized use or disposition,
and that transactions are executed in accordance with management&#8217;s authorization and recorded properly to permit the preparation
of consolidated financial statements in conformity with accounting principles generally accepted in the United States. Our management
assessed the effectiveness of our internal control over financial reporting as of December 31, 2025. In making this assessment, our management
used the criteria set forth in the report entitled &#8220;<i>Internal Control - Integrated Framework</i>&#8221; published by the Committee
of Sponsoring Organizations of the Treadway Commission (2013 framework). Our management has concluded that, as of December 31, 2025, our
internal control over financial reporting was not effective as a result of the two material weaknesses as described below. Our management
reviewed the results of their assessment with our Board of Directors.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Inherent Limitations on Effectiveness of
Controls</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Internal control over financial
reporting has inherent limitations which include but is not limited to the use of independent professionals for advice and guidance, interpretation
of existing and/or changing rules and principles, segregation of management duties, scale of organization, and personnel factors. Internal
control over financial reporting is a process which involves human diligence and compliance and is subject to lapses in judgment and breakdowns
resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management
override. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements on a
timely basis, however these inherent limitations are known features of the financial reporting process and it is possible to design into
the process safeguards to reduce, though not eliminate, this risk. Therefore, even those systems determined to be effective can provide
only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness
to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 82; Options: NewSection; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in Internal Control over Financial
Reporting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As reported in our Annual
Report on Form 10-K/A as of December 31, 2024, we identified two material weaknesses, the ineffective oversight of third parties engaged
to assist in the Company&#8217;s financial reporting process and lack of appropriate technical expertise to a complex accounting transaction.
During the first quarter of 2025, the material weakness of ineffective oversight of third parties engaged to assist in the Company&#8217;s
financial reporting process persisted. Management has revised the processes surrounding this material weakness, and while a new control
has been implemented, no relevant transactions occurred during the second, third and fourth quarters of 2025. Thus, the effectiveness
of the new control could not be tested and the material weakness remains unremediated as of December 31, 2025. The misinterpretation of
accounting guidance to a complex accounting transaction was identified in the third quarter of 2025 and plans to be fully remediated by
the first quarter of 2026. Notwithstanding this material weakness, management believes that the consolidated financial statements included
in this report fairly present, in all material respects, the Company&#8217;s financial position, results of operations and cash flows
for the periods presented in conformity with U.S. GAAP.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC defines &#8216;material
weakness&#8217; as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable
possibility that a material misstatement of the registrant&#8217;s annual or interim financial statements will not be prevented or detected
on a timely basis by the company&#8217;s internal controls. While we are in the process of adopting remediation procedures related to
this identified material weakness, there can be no assurance that such remedies will be effective. In addition, if this is not remediated,
we will be unable to certify that our internal control over financial reporting is effective. There can be no assurance that there will
not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to
maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or
results of operations. If we are unable to conclude that our internal control over financial reporting is effective, we could lose investor
confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could
be subject to sanctions or investigations by the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal
control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also
restrict our future access to the capital markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as described above,
there has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Management&#8217;s Remediation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to remediate the
first material weakness, we hired an additional third-party expert to review and validate the work performed by the initial third-party
expert for complex accounting transactions. For the second material weakness, we will hire a third-party expert to review the accounting
for complex transactions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9B. Other Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Rule 10b5-1 Trading Arrangement</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the three months ended
December 31, 2025, no director or officer of the Company <ix:nonNumeric contextRef="c192" format="ixt:fixed-false" name="ecd:NonRule10b51ArrAdoptedFlag" id="ixv-14352"><ix:nonNumeric contextRef="c192" format="ixt:fixed-false" name="ecd:Rule10b51ArrAdoptedFlag" id="ixv-14353">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c192" format="ixt:fixed-false" name="ecd:NonRule10b51ArrTrmntdFlag" id="ixv-14354"><ix:nonNumeric contextRef="c192" format="ixt:fixed-false" name="ecd:Rule10b51ArrTrmntdFlag" id="ixv-14355">terminated</ix:nonNumeric></ix:nonNumeric> a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule
10b5-1 trading arrangement,&#8221; as each term is defined in Item 408(a) of Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9C. Disclosure Regarding Foreign
Jurisdictions that Prevent Inspections</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span>&#160;</p><div>


</div><!-- Field: Page; Sequence: 83; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART III</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 10. Directors, Executive Officers and
Corporate Governance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the names and ages of our directors and executive officers. Our Board of Directors is currently comprised of four members. Our Board is
divided into three classes of directors, each serving a staggered three-year term. At each annual meeting of stockholders, a class of
directors is elected for a three-year term to succeed the class whose term is then expiring. Executive officers serve at the discretion
of the Board of Directors and are appointed by the Board of Directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr>
    <td style="border-bottom: black 1.5pt solid; text-align: left; vertical-align: bottom; padding-right: 1.3pt; width: 21%"><span style="font-size: 10pt"><b>Name</b>&#160;&#160;&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; padding-right: 1.3pt; text-align: center; width: 6%"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; border-bottom: black 1.5pt solid; padding-right: 1.3pt; text-align: center; width: 55%"><span style="font-size: 10pt"><b>Position</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="vertical-align: top; border-bottom: black 1.5pt solid; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center; width: 15%"><span style="font-size: 10pt"><b>Class of<br/>
Director</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Lior Tal</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">52</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Chief Executive Officer, Chairman of the Board of Directors and Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">I</span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Donald Alvarez*</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">61</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Chief Financial Officer and Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">I</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Natalie Russell</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">30</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Chief Financial Officer </span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">-</span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Martin Petraitis</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">71</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Vice President of Sales</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">-</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Ben Landen*</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">38</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Vice President of Business Operations</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">-</span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Karen Macleod</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">62</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">II</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">James McDonnell</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">71</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">II</span></td></tr>
  <tr>
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Ran Makavy</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">51</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">III</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top; padding-right: 1.3pt"><span style="font-size: 10pt">Colleen Cunningham*</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">63</span></td>
    <td style="vertical-align: bottom; padding-right: 1.3pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><span style="font-size: 10pt">III</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify"><i>Donald Alvarez, Ben Landen, and Colleen Cunningham departed
the Company in 2025.</i></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal occupations
and business experience for the past five years (and, in some instances, for prior years) of each of our directors and executive officers
are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Lior Tal</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Tal has served as the
Company&#8217;s Chief Executive Officer and a Director since October 2016. From June 2016 to October 2016, Mr. Tal served as the Company&#8217;s
Chief Operating Officer. Prior to joining the Company, Mr. Tal was the director of international growth and partnerships at Facebook where
he worked from April 2011 to June 2016. Mr. Tal co-founded Snaptu (acquired by Facebook) in September 2007 and was the vice president
of business development until May 2011. During his time at Snaptu, Mr. Tal helped grow the user base from launch to tens of millions of
users. Prior to co-founding Snaptu, Mr. Tal was a partner at Barzam, Tal, Lerer Attorneys at law &amp; Patent attorneys from March 2004
to August 2007. Mr. Tal has also held leadership roles at Actimize (acquired by NICE), DiskSites (acquired by EMC), and Odigo (acquired
by Comverse).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Tal holds an LLB in Law
and a BA in Business Management from Reichman University and an LLM in Law from Tel Aviv University. Mr. Tal&#8217;s executive and technology
industry experience qualify him to serve on the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Natalie Russell</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mrs. Russell has served as
the Company&#8217;s Chief Financial Officer since August&#160;12, 2025. She previously served as the Company&#8217;s Interim Chief Financial
Officer from June&#160;6, 2025 to August&#160;12, 2025. Mrs.&#160;Russell joined the Company in March&#160;2023 as Director of Accounting.
Prior to joining the Company, Mrs.&#160;Russell was a Technical Accounting Manager at SOAProjects, Inc., from December&#160;2022 to March&#160;2023,
where she specialized in technical accounting research and financial reporting for clients in the technology and life sciences industries.
Mrs.&#160;Russell began her career in the audit and assurance practice of Ernst&#160;&amp; Young from September&#160;2017 to December&#160;2022.
Mrs.&#160;Russell is a Certified Public Accountant in the state of California. She holds a Bachelor of Science in Business Administration
from the University of Dayton.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Martin Petraitis</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Petraitis has served
as the Company&#8217;s Vice President of Sales since November&#160;2024. On May&#160;6, 2025, the Company&#8217;s Board named Mr.&#160;Petraitis
as a named executive officer. Mr.&#160;Petraitis brings over two decades of leadership experience in scaling revenue within technology-driven&#160;sectors,
including automation, SaaS, and manufacturing systems. Prior to joining the Company, Mr.&#160;Petraitis led sales at Heartland Automation
from 2020 to 2024, where he successfully pivoted the company from product-based&#160;offerings to high-value, solutions-focused&#160;services
in the autonomous mobile robotics sector. His leadership in prior roles includes executive positions at Clearpath Robotics/OTTO Motors,
from 2016 to 2020, Segue Manufacturing Services, from 2012 to 2016 and Brooks Automation from 1998 to 2006, where he scaled revenue to
over $210M by championing strategic accounts and consultative sales methods. Mr.&#160;Petraitis holds an MSME and a BSME in mechanical
engineering from the University of Colorado Boulder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Non-Executive Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Karen Macleod</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Macleod has served as
a member of the Board since July 2021. Ms. Macleod was the Founder and CEO of The Arete Group, LLC from 2015 to 2021. Ms. Macleod was
the president of Tatum, Randstand Holdings NV Company from 2011 to 2014. Ms. Macleod was the president of Resources Connection, Inc. North
America from 2004 to 2009 and previously served in other capacities after joining the company in 1996. From 1985 to 1994, Ms. Macleod
was a senior manager at Deloitte. Ms. Macleod additionally has served on the board of directors of Track Group Inc. (OTCQX &#8212; TRCK)
since 2016 and currently chairs the Audit Committee. She also has served on the board of the Lakeland Hills YMCA since 2020 and currently
serves on the Executive Committee and as Chair of the Finance Committee. Additionally, since 2024 Ms. Macleod has served on the Board
and is Vice President of the Mountain Lakes Garden Club. Ms. Macleod served as a member of the board of directors and a member of the
audit committee of the FWA of New York from 2018 to 2021. From 1998 to 2009, Ms. Macleod served on the board of directors of RGP (NASDAQ
&#8212; RGP). From 2006 to 2013, Ms. Macleod served on the board of directors of Overland Solutions. Ms. Macleod holds a B.A. in Business
Economics from University of California, Santa Barbara.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.5in; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms. Macleod&#8217;s audit experience, Executive Leadership positions, prior
and current board experience and her role serving on audit committees qualify her to serve on the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>James McDonnell</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. McDonnell has served as
a member of the Board since September 2021. Mr. McDonnell was Senior Vice President of Sales and Marketing for Vispero, from 2017 to 2022.
Mr. McDonnell was VP of sales at Honeywell from 2013 to 2017. Mr. McDonnell served on the board of Asetek from 2014 to 2019. Mr. McDonnell
was SVP Sales &amp; Marketing at Intermec from 2010 to 2013. Prior to this, Mr. McDonnell was an SVP and served in many executive sales
and marketing roles at Hewlett-Packard from 1983 to 2009. Mr. McDonnell began his career at the General Electric Company from 1977 to
1983. Mr. McDonnell has a BS degree in Electrical engineering from Villanova University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. McDonnell&#8217;s prior
experiences in sales and marketing leadership within various technology companies and his experience in industrial markets qualify him
to serve on the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Ran Makavy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Makavy is a global business
leader, investor, and professional board director with approximately 30 years&#8217; experience in the engineering and product management
arena. In 2007, he started a company called Snaptu and sold it to Facebook in 2011, led growth in emerging markets at Facebook, started
internet.org, built the growth team at Lyft, then led the tech org and the ridesharing business and took the company public in 2019. He
has invested in over sixty startup companies since 2013. Mr. Makavy currently serves as lead investor to the Ran Makavy Angel Investment
Fund, and as an advisor to Passport Global, Dimension, Fora Travel, Argo, and Honeybook.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Makavy&#8217;s prior board experiences and
in business leadership within various ventures qualify him to serve on the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Composition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board currently consists of four directors, Lior Tal, Ran Makavy,
Karen Macleod, and James McDonnell. Mr. Makavy, Ms. Macleod and Mr. McDonnell are <i>&#8220;independent directors&#8221;</i> within the
meaning of the Listing Rules (the &#8220;Nasdaq Listing Rules&#8221;) of the Nasdaq Stock Market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Family Relationships</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No family relationships exist
between any of our officers or directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Role of Board of Directors in Risk Oversight
Process</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors has
extensive involvement in the oversight of risk management related to us and our business and accomplishes this oversight through the regular
reporting by the Audit Committee. The purpose of the Audit Committee is to assist the board of directors in fulfilling its fiduciary oversight
responsibilities relating to (1) the integrity of the Company&#8217;s financial statements, (2) the effectiveness of the Company&#8217;s
internal control over financial reporting, (3) the Company&#8217;s compliance with legal and regulatory requirements, and (4) the independent
auditor&#8217;s qualifications and independence. Through its regular meetings with management, including the finance, legal and internal
audit functions, the Audit Committee reviews and discusses all significant areas of our business and summarizes for the board of directors
all areas of risk and the appropriate mitigating factors. In addition, our board of directors receives periodic detailed operating performance
reviews from management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board evaluates the independence
of each nominee for election as a director of our Company in accordance with the Nasdaq Listing Rules. Pursuant to these rules, a majority
of our Board must be &#8220;independent directors&#8221; within the meaning of the Nasdaq Listing Rules, and all directors who sit on
our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Committees of the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
established an audit committee, a compensation committee, and a nominating and corporate governance committee. The composition and responsibilities
of each of the committees of our board of directors are described below. Members serve on these committees until their resignation or
until otherwise determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate
from time to time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee currently
consists of Ran Makavy, Karen Macleod and James McDonnell, with Ms. Macleod serving as the Chairperson. Each of Mr. Makavy, Ms. Macleod
and Mr. McDonnell, is independent under the rules and regulations of the SEC and the listing standards of the Nasdaq Stock Market applicable
to audit committee members. Our board of directors has determined that Ms. Macleod qualifies as an audit committee financial expert within
the meaning of SEC regulations and meets the financial sophistication requirements of the Nasdaq Stock Market. As a result of Colleen
Cunningham&#8217;s resignation from our board of directors effective December 31, 2025, the Audit Committee does not currently meet Nasdaq&#8217;s
requirement that the audit committee be comprised of at least three independent directors. The Company is within the applicable cure period
provided under Nasdaq Listing Rule 5605(c)(4) and intends to regain compliance within the prescribed timeframe.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Audit Committee has the
responsibility for, among other things, (i) selecting, retaining and overseeing our independent registered public accounting firm, (ii)
obtaining and reviewing a report by independent auditors that describe the accounting firm&#8217;s internal quality control, and any materials
issues or relationships that may impact the auditors, (iii) reviewing and discussing with the independent auditors standards and responsibilities,
strategy, scope and timing of audits, any significant risks, and results, (iv) ensuring the integrity of the Company&#8217;s financial
statements, (v) reviewing and discussing with the Company&#8217;s independent auditors any other matters required to be discussed by PCAOB
Auditing Standard No. 1301, (v1) reviewing, approving and overseeing any transaction between the Company and any related person and any
other potential conflict of interest situations, (vii) overseeing the Company&#8217;s internal audit department, (v) reviewing, approving
and overseeing related party transactions, and (viii) establishing and overseeing procedures for the receipt, retention and treatment
of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous
submission by Company employees of concerns regarding questionable accounting or auditing matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The members of our Compensation
Committee are Mr. Makavy, Ms. Macleod and Mr. McDonnell, with Mr. McDonnell serving as the Chairperson. Our Compensation Committee has
the responsibility for, among other things, (i) reviewing and approving the chief executive officer&#8217;s compensation based on an evaluation
in light of corporate goals and objectives, (ii) reviewing and recommending to the Board the compensation of all other executive officers,
(iii) reviewing and recommending to the Board incentive compensation plans and equity plans, (iv) reviewing and discussing with management
the Company&#8217;s Compensation Discussion and Analysis and related information to be included in the annual report on Form 10-K and
proxy statements, and (v) reviewing and recommending to the Board for approval procedures relating to Say on Pay Votes.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><!-- Field: Page; Sequence: 86; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nominating and Corporate Governance Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The members of our Nominating
and Corporate Governance Committee are Mr. Makavy, Ms. Macleod and Mr. McDonnell, with Mr. Makavy serving as the Chairperson. Our Nominating
and Corporate Governance Committee has the responsibility relating to assisting the Board in, among other things, (i) identifying and
screening individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors,
(ii) recommending to the Board the approval of nominees for director, (ii) developing and recommending to our board of directors a set
of corporate governance guidelines, and (iv) overseeing the evaluation of our board of director.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors has
adopted a Code of Business Conduct and Ethics (the &#8220;Code&#8221;). The Code applies to all of our directors, officers and employees.
We have made the Code available on our website https://investors.cyngn.com/corporate-governance-documents/. We intend to disclose future
amendments to, or waivers of, our Code, as and to the extent required by SEC regulations, at the same location on our website identified
above or in public filings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">On October 29, 2021, the Board of Directors entered
into indemnification agreements with each of its directors and executive officers (the &#8220;D&amp;O Indemnification Agreements&#8221;).
The D&amp;O Indemnification Agreements provide that the Corporation will indemnify each of its directors, executive officers, and such
other key employees against any and all expenses incurred by that director or executive officer because of his or her status as one of
the Corporation&#8217;s directors or executive officers, to the fullest extent permitted by Delaware law and the Corporation&#8217;s amended
and restated certificate of incorporation. In addition, the D&amp;O Indemnification Agreements provide that, to the fullest extent permitted
by Delaware law, the Corporation will advance all expenses incurred by its directors, executive officers, and other key employees in connection
with a legal proceeding involving his or her status as a director, executive officer, or key employee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitation of Liability and Indemnification
of Officers and Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our certificate of incorporation,
as amended and restated, limits the liability of directors to the maximum extent permitted by Delaware General Corporation Law (the &#8220;DGCL&#8221;).
The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties
as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide that we
will indemnify our directors and officers to the fullest extent permitted by law, and may indemnify employees and other agents. Our bylaws
also provide that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action
or proceeding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws, subject to the
provisions of the DGCL contain provisions which allow the corporation to indemnify any person against liabilities and other expenses incurred
as the result of defending or administering any pending or anticipated legal issue in connection with service to us if it is determined
that person acted in good faith and in a manner which he or she reasonably believed was in the best interest of the corporation. Insofar
as indemnification for liabilities arising under the Securities Act of 1933 as amended, or the Securities Act, may be permitted to our
directors, officers and controlling persons, we have been advised that in the opinion of the Securities and Exchange Commission, such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The limitation of liability
and indemnification provisions in our bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their
fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action,
if successful, might provide a benefit to us and our stockholders. Our results of operations and financial condition may be harmed to
the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">At present, there is no pending litigation or proceeding involving
any of our directors or officers as to which indemnification is required or permitted, and we are not aware of any threatened litigation
or proceeding that may result in a claim for indemnification.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Involvement in Certain Legal Proceedings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our directors and executive
officers have not been involved in any of the following events during the past ten years:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-size: 10pt">any bankruptcy petition filed
by or against such person or any business of which such person was a general partner or executive officer either at the time of the bankruptcy
or within two years prior to that time;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2.</span></td><td style="text-align: justify"><span style="font-size: 10pt">any conviction in a criminal
proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">3.</span></td><td style="text-align: justify"><span style="font-size: 10pt">being subject to any order,
judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily
enjoining him from or otherwise limiting his involvement in any type of business, securities or banking activities or to be associated
with any person practicing in banking or securities activities;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">4.</span></td><td style="text-align: justify"><span style="font-size: 10pt">being found by a court of competent
jurisdiction in a civil action, the SEC or the Commodity Futures Trading Commission to have violated a Federal or state securities or
commodities law, and the judgment has not been reversed, suspended, or vacated;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">5.</span></td><td style="text-align: justify"><span style="font-size: 10pt">being subject of, or a party
to, any Federal or state judicial or administrative order, judgment decree, or finding, not subsequently reversed, suspended or vacated,
relating to an alleged violation of any Federal or state securities or commodities law or regulation, any law or regulation respecting
financial institutions or insurance companies, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any
business entity; or</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">6.</span></td><td style="text-align: justify"><span style="font-size: 10pt">being subject of or party to
any sanction or order, not subsequently reversed, suspended, or vacated, of any self-regulatory organization, any registered entity or
any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with
a member.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Insider Trading Policy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-14356">adopted</ix:nonNumeric> an
insider trading policy governing the purchase, sale, and/or other disposition of its securities by its directors, officers, employees
and independent contractors that the Company believes is reasonably designed to promote compliance with insider trading laws, rules and
regulations, and the exchange listing standards applicable to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Directors, executive officers,
employees and other related persons may not buy, sell or engage in other transactions in the Company&#8217;s shares while aware of material
non-public information; buy or sell securities of other companies while aware of material non-public information about those companies
that they became aware of as a result of business dealings between the Company and those companies; or disclose material non-public information
to any unauthorized persons outside of the Company. The policy also restricts trading and other transactions for a limited group of Company
employees (including executives and directors) to defined window periods that follow the Company&#8217;s quarterly earnings releases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.85pt; text-align: justify">&#160;</p><div>

</div><div><a id="a_021"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 11. Executive Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table provides
information regarding the compensation earned by or paid to our named executive officers with respect to the years ended December 31,
2025 and 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Name and Principal Position</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fiscal Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Salary ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Bonus ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Stock Awards ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Option Award ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Non-Equity Incentive Plan Compensation</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Non-Qualified Deferred Compensation Earnings ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">All Other Compensation ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Total ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 19%; text-align: left">Lior Tal</td><td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center">2025</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">640,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">2,440,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">2,080,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">CEO</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in">Natalie Russell(1)</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">270,833</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in">CFO</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Martin Petraitis(2)</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">30,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">230,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Vice President of Sales</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Donald Alvarez(3)</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">136,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">286,154</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Former CFO</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">360,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Ben Landen(4)</td><td>&#160;</td>
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">196,346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">150,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">346,346</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-align: left">Former VP of Business Development</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">250,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">324,800</td><td style="text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Mrs. Russell was appointed as the Company&#8217;s Chief Financial
Officer on August 12, 2025. She previously served as the Company&#8217;s Interim Chief Financial Officer from June 6, 2025 to August
12, 2025 and Director of Accounting from March 2023 to June 2025.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Mr. Petraitis was named an executive officer on May 6, 2025.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Mr. Alvarez resigned as the Company&#8217;s Chief Financial
Officer effective June 6, 2025.</td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">Mr. Landen resigned as VP of Business Development effective
October 24, 2025.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Executive Employment Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Lior Tal</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January&#160;1, 2022, we
entered into an employment agreement with our Chief Executive Officer, Lior Tal, which agreement superseded and replaced the offer letter
entered into by and between the Company and Mr.&#160;Tal on April&#160;17, 2016.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Employment
Agreement, as compensation for his services as Chief Executive Officer of the Company, Mr. Tal will receive: (1) a salary of $500,000
per annum (the &#8220;Base Salary&#8221;) and commensurate benefits; (2) eligibility, subject to Mr. Tal&#8217;s continued employment
with the Company, to earn an annual performance based bonus in the target of 60% of his Base Salary; (3) eligibility, also subject to
Mr. Tal&#8217;s continued employment with the Company, to participate in the Company&#8217;s 2013 Equity Incentive Plan, the Company 2021
Incentive Plan, or any successor plan, subject to the terms of such plan; and (4) entitlement, also subject to Mr. Tal&#8217;s continued
employment with the Company, to reimbursement for all reasonable and necessary out-of-pocket business, entertainment, and travel expenses
incurred by Mr. Tal in connection with the performance of Mr. Tal&#8217;s duties as the Company&#8217;s Chief Executive Officer and the
Company&#8217;s expense reimbursement policies and procedures. On February 24, 2025, the Compensation Committee of the Board of Directors
of the Company approved a payment of $300,000 as a bonus, in accordance with Mr. Tal&#8217;s Employment Agreement. Additionally, the Compensation
Committee approved a discretionary bonus payment of $700,000 to Mr. Tal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the Company terminates
Mr. Tal&#8217;s employment without Cause (as defined in the Employment Agreement) or if Mr. Tal resigns for Good Reason (as defined in
the Employment Agreement) other than during the Protection Period (as defined below), and provided Mr. Tal complies with certain other
conditions outlined in the Employment Agreement, the Company will pay Mr. Tal severance, as outlined in the Employment Agreement, comprising
of: (a) the continued payment of his base salary for the first twelve months following the termination date, payable in accordance with
the Company&#8217;s standard payroll procedures; (b) a lump sum payment equal to the pro-rated amount of Mr. Tal&#8217;s target annual
bonus for the year of termination; (c) reimbursement of Mr. Tal for medical, vision and dental coverage under Consolidated Omnibus Budget
Reconciliation Act of 1985, as amended or comparable state law (&#8220;COBRA&#8221;) for the first twelve months after the termination
date; and (d) acceleration of the vesting of each of the Mr. Tal&#8217;s then-outstanding time-based equity awards as to 25% of the then-unvested
shares subject to each such award, effective as of the termination date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, pursuant to the
Employment Agreement, if immediately prior to, on or within 12 months after a Change of Control (the &#8220;Protection Period&#8221;),
the Company terminates Mr. Tal&#8217;s employment without Cause (as defined in the Employment Agreement), or if Mr. Tal resigns for Good
Reason (as defined in the Employment Agreement) during the Protection Period, the Company will pay Mr. Tal severance, as outlined in the
Employment Agreement, comprising of: (a) a lump sum payment equal to eighteen months of Mr. Tal&#8217;s base salary as in effect on the
date of his termination; (b) a lump sum payment equal to 150% of Mr. Tal&#8217;s target annual bonus as in effect on the date of his termination,
payable on the 60th day following the termination date; (c) reimbursement to Mr. Tal for medical, vision and dental coverage under COBRA
for the first eighteen months after the termination date; and (d) acceleration of the vesting of each of the Mr. Tal&#8217;s then-outstanding
time-based equity awards in full, effective as of the termination date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Tal&#8217;s receipt of
any severance payments or benefits will be subject to Mr. Tal&#8217;s continuing to comply with the terms of that certain Confidential
Information Agreement and the provisions of the Employment Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 6, 2025, the Company
entered into a letter agreement with Lior Tal, its CEO (the &#8220;Letter Agreement&#8221;), amending the Employment Agreement. Pursuant
to the Letter Agreement, Mr. Tal&#8217;s Employment Agreement was amended to provide for (i) a modification of his annual base salary
to $640,000 effective January 1, 2025, (ii) a modification of his annual bonus to be eligible to earn an annual performance bonus in the
target amount of up to $640,000 (the &#8220;Annual Bonus&#8221;), (iii) Mr. Tal shall be eligible to earn a special bonus for performance
for 2025 of up to $1,000,000 (&#8220;2025 Special Bonus&#8221;), payable in January 2026, and (iv) Mr. Tal shall be eligible to earn a
time-based 2025-2026 special bonus of up to $1,600,000 (the &#8220;2025-2026 Special Bonus&#8221;), payable in eight (8) quarterly installments
of $200,000, with the first installment to be paid following Q1 2025, subject to such terms included in the Letter Agreement. Unless otherwise
agreed in writing by the parties in a mutually executed amendment to the Employment Agreement, no special bonuses shall be paid after
2026, and the non-payment of any special bonus after 2026 shall not constitute &#8220;Good Reason&#8221; within the meaning of the Employment
Agreement. Neither the 2025 Special Bonus nor the 2025-2026 Special Bonus shall be included in the Severance or the CIC Severance as such
terms are defined in the Employment Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Natalie Russell</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 12, 2025, we entered
into an offer letter (the &#8220;Offer Letter&#8221;) with our Chief Financial Officer. Pursuant to the terms of the Offer Letter, Mrs.
Russell will receive an annual base salary of $250,000 and will be eligible to receive a pro-rated target discretionary annual bonus of
up to 20% of her base salary, based on the Company&#8217;s performance and her individual performance, subject to the Company&#8217;s
policy for paying bonus and the sole discretion of the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with Mrs. Russell&#8217;s
appointment, the Company also entered into a Severance and Change of Control Agreement (the &#8220;Severance Agreement&#8221;) with Mrs.
Russell. The Severance Agreement provides for a lump sum payment to the officer if the Company terminates the officer&#8217;s employment
without Cause (as defined in the Severance Agreement), or if the officer terminates its employment for Good Reason (as defined in the
Severance Agreement) or in the case of a Change of Control (as defined in the Severance Agreement) of the Company. The term, Change of
Control, includes the acquisition of Common Stock of the Company resulting in one person or company owning more than 50% of the outstanding
shares, a merger, consolidation or similar transaction resulting in the transfer of ownership of more than fifty percent (50%) of the
Company&#8217;s outstanding Common Stock, or a liquidation or dissolution of the Company or sale of substantially all of the Company&#8217;s
assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that, the Company
terminates the officer&#8217;s employment without Cause (as defined in the Severance Agreement), or if the officer terminates her employment
for Good Reason (as defined in the Severance Agreement), or in the event of a termination within sixty days before or six months following
the consummation of a Change of Control (as such events are defined in the Severance Agreement), then the Company will pay the officer
(i) a lump sum amount equal to six months of the officer&#8217;s then current base salary, plus (ii) the annual bonus, pro-rated based
on the officer&#8217;s termination date, or the lump sum amount equal to six months of the annual bonus if termination is as a result
of a Change of Control, that the officer is eligible to receive for the calendar year in which the officer&#8217;s termination occurs
assuming Company performance is achieved at target (100% for both Company and personal performance), which will be payable within the
period of time set forth in the Severance Agreement following the termination of employment, (iii) 25%, or 50% if termination is as a
result of a Change of Control, of the then-unvested equity awards issued to the officer by the Company will be vested as of officer&#8217;s
termination date or the Change of Control date (if later), and (iv) 6 months of COBRA premium payments based on the coverages in effect
as of the date of the officer&#8217;s termination of employment. All of the officer&#8217;s severance benefits are subject to her execution
of a release in a form reasonably acceptable to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Ben Landen</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 19, 2019, we
entered into an immediately effective offer letter with Mr. Ben Landen. Pursuant to Mr. Landen&#8217;s offer letter, he will serve as
our Senior Director of Business and Corporate Development. Mr. Landen&#8217;s offer letter shall continue until terminated by either the
Company or Mr. Landen. Pursuant to Mr. Landen&#8217;s offer letter, he will receive (i) an annual base salary of $220,000, and (ii) an
option to purchase 150,000 shares of the Company&#8217;s common stock at an exercise price of $0.23 per share, which is based on the Board
of Directors-approved fair market valuation as of March 31, 2019, as determined by an independent financial consultant. The option shall
vest and become exercisable over a four-year period with 25% vesting on the one-year anniversary of Mr. Landen&#8217;s employment start
date and the balance vesting equally after each additional one-month period for continuous service completed over the following 36 months,
subject to and in accordance with the terms of the Company&#8217;s 2013 Stock Incentive Plan. Mr. Landen&#8217;s options expire in November,
2029. The offer letter contains customary provisions relating to vacation, benefits, and non-compete. Subsequent to Mr. Landen&#8217;s
offer letter on December 24, 2021, his annual base salary was increased to $250,000. Mr. Landen&#8217;s employment agreement terminated
effective October 24, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Severance and Change of Control Agreements</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into a Severance
and Change of Control Agreement (the &#8220;Severance Agreement&#8221;) with Ben Landen, our Vice-President of Business Development. The
Severance Agreement provides for a lump sum payment to the officer if the Company terminates the officer&#8217;s employment without Cause
(as defined in the Severance Agreement), or if the officer terminates its employment for Good Reason (as defined in the Severance Agreement)
or in the case of a Change of Control (as defined in the Severance Agreement) of the Company. The term, Change of Control, includes the
acquisition of Common Stock of the Company resulting in one person or company owning more than 50% of the outstanding shares, a merger,
consolidation or similar transaction resulting in the transfer of ownership of more than fifty percent (50%) of the Company&#8217;s outstanding
Common Stock, or a liquidation or dissolution of the Company or sale of substantially all of the Company&#8217;s assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that, other than
during a Change of Control Period (as defined below), the Company terminates the officer&#8217;s employment without Cause (as defined
in the Severance Agreement), or if the officer terminates his employment for Good Reason (as defined in the Severance Agreement), or in
the event of a qualifying termination within sixty days before or six months following the consummation of a Change of Control (as such
events are defined in the Severance Agreement) (the &#8220;Change of Control Period&#8221;), then the Company shall pay the officer a
lump sum amount equal to (i) six months of the officer&#8217;s then current base salary, plus (ii) the annual bonus the officer is eligible
to receive for the calendar year in which the officer&#8217;s termination occurs assuming Company performance is achieved at target (100%
for both Company and personal performance) and pro-rated based on the officer&#8217;s termination date, which will be payable within the
period of time set forth in the Severance Agreement following the termination of employment, and (iii) 6 months of COBRA premium payments
based on the coverages in effect as of the date of the officer&#8217;s termination of employment. All of the officer&#8217;s severance
benefits are subject to his execution of a release in a form reasonably acceptable to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Landen&#8217;s severance
agreement terminated effective October 24, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Donald Alvarez</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 28, 2021, we entered
into an offer letter with Mr. Donald Alvarez, effective June 1, 2021. Pursuant to Mr. Alvarez&#8217;s offer letter, he serves as our Chief
Financial Officer. Mr. Alvarez&#8217;s offer letter shall continue until terminated by either the Company or Mr. Alvarez. Pursuant to
Mr. Alvarez&#8217;s offer letter, he will receive (i) an annual base salary of $250,000 for his first year of employment, which annual
base salary will increase to $300,000 upon the completion by the Company of an initial public offering, and (ii) a stock option to purchase
400,000 shares of the Company&#8217;s common stock at an exercise price of $2.88 per share, which option shall vest and become exercisable
over a four-year period with 25% vesting on the one-year anniversary of Mr. Alvarez&#8217;s employment start date and the balance vesting
equally after each additional one-month period for continuous service completed over the following 36 months, subject to and in accordance
with the terms of the Company&#8217;s 2013 Stock Incentive Plan. Mr. Alvarez&#8217;s options will expire in June 2031. The offer letter
contains customary provisions relating to vacation, benefits, and non-compete. Mr. Alvarez&#8217;s employment agreement terminated effective
June 6, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Severance and Change of Control Agreement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 15, 2024, we entered
into a Severance and Change of Control Agreement (the &#8220;Severance Agreement&#8221;) with Donald Alvarez, the Chief Financial Officer
of the Company. The Severance Agreement provides for a lump sum payment to the officer if the Company terminates the officer&#8217;s employment
without Cause (as defined in the Severance Agreement), or if the officer terminates its employment for Good Reason (as defined in the
Severance Agreement) or in the case of a Change of Control (as defined in the Severance Agreement) of the Company. The term, Change of
Control, includes the acquisition of Common Stock of the Company resulting in one person or company owning more than 50% of the outstanding
shares, a merger, consolidation or similar transaction resulting in the transfer of ownership of more than fifty percent (50%) of the
Company&#8217;s outstanding Common Stock, or a liquidation or dissolution of the Company or sale of substantially all of the Company&#8217;s
assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that, the Company
terminates the officer&#8217;s employment without Cause (as defined in the Severance Agreement), or if the officer terminates his employment
for Good Reason (as defined in the Severance Agreement), or in the event of a termination within sixty days before or six months following
the consummation of a Change of Control (as such events are defined in the Severance Agreement), then the Company will pay the officer
(i) a lump sum amount equal to six months of the officer&#8217;s then current base salary, plus (ii) the annual bonus, pro-rated based
on the officer&#8217;s termination date, or the lump sum amount equal to six months of the annual bonus if termination is as a result
of a Change of Control, that the officer is eligible to receive for the calendar year in which the officer&#8217;s termination occurs
assuming Company performance is achieved at target (100% for both Company and personal performance), which will be payable within the
period of time set forth in the Severance Agreement following the termination of employment, (iii) 25%, or 50% if termination is as a
result of a Change of Control, of the then-unvested equity awards issued to the officer by the Company will be vested as of officer&#8217;s
termination date or the Change of Control date (if later), and (iv) 6 months of COBRA premium payments based on the coverages in effect
as of the date of the officer&#8217;s termination of employment. All of the officer&#8217;s severance benefits are subject to his execution
of a release in a form reasonably acceptable to the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Alvarez&#8217;s severance
agreement terminated effective June 6, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 91; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Equity Awards at Fiscal Year-End</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table discloses
information regarding outstanding equity awards granted or accrued as of December 31, 2025, for our named executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="23" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Outstanding Equity Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="9" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options (#)<br/> Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Securities<br/> Underlying<br/> Unexercised<br/> Options (#)<br/> Unvested</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Exercise<br/> Price<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Expiration<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Shares or<br/> Units of Stock<br/> that have not<br/> Vested <br/> (#)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Market Value<br/> of Shares or<br/> Units of Stock<br/> that have not<br/> Vested <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 37%; text-align: left; text-indent: -8.1pt; padding-left: 8.6pt">Lior Tal (Chief Executive Officer)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">227</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right">1,950</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: center; padding-left: 5.35pt">4/5/27; 3/22/28</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">134</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">5/30/28</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">7/25/31</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">14,663</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">11/7/32</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">11/6/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -8.1pt; padding-left: 8.6pt">Natalie Russell Chief Financial Officer)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">8/07/33</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.35pt; vertical-align: top">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center; padding-left: 5.35pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective as of the first
quarter of 2026, each independent, non-employee director will receive annual cash compensation of $250,000, payable in equal quarterly
installments of $62,500, in lieu of the prior cash and equity components of the director compensation program. The all-cash structure
will remain in effect until the Board, upon recommendation of the Compensation Committee of the Board, determines that equity-based compensation
is again practicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Previously, each of our
independent directors received annual cash compensation of $35,000. In addition, the chairperson of the Audit Committee,
Compensation Committee and Nominating and Governance Committee received an annual compensation of $20,000, $20,000 and $10,000,
respectively; and the lead independent director received an annual cash compensation of $15,000. Each independent director received
(i) an initial award of $270,000 in restricted stock units of the Company to which shall be awarded on May 1<sup>st</sup> of each
fiscal year and which will vest monthly over three (3) years, and (ii) an annual award of $180,000 in restricted stock units of the
Company, which shall be granted on May 1<sup>st</sup> of each fiscal year and which will vest in its entirety one (1) year from the
grant date.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the summary compensation information (described above) for each of our non-employee directors for the fiscal year ended December 31, 2025:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td colspan="29" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">DIRECTOR COMPENSATION</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fees<br/> Earned&#160;or<br/> Paid in<br/> Cash<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock<br/> Awards<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option<br/> Awards<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Non-Equity<br/> Incentive<br/> Plan<br/> Compensation<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nonqualified<br/> Deferred<br/> Compensation Earnings<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other<br/> Compensation<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left; text-indent: -7.95pt; padding-left: 8.45pt">Karen Macleod</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">255,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">193.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">255,193.20</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -7.95pt; padding-left: 8.45pt">Colleen Cunningham</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,193.20</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -7.95pt; padding-left: 8.45pt">James McDonnell</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">193.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">260,193.20</td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) Ms. Cunningham resigned as a member of the
board of directors effective December 31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Actions to Recover Erroneously Awarded Compensation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At no time during the last
fiscal year was the Company required to prepare an accounting restatement that required recovery of an erroneously awarded compensation
pursuant to our Clawback Policy.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policies and Practices related to the Grant
of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information (&#8220;MNPI&#8221;)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has a strict policy
of not issuing options or allowing its insiders to conduct stock trades at times, subject to any allowable trades that might occur pursuant
to a 10b5-1 Trading Plan, where MNPI is known or a material transaction is anticipated to occur. Each insider and employee of the Company
is required to read and sign the Company&#8217;s Insider Trading Policy, which prescribes certain set periods that prohibit insider trading.
Other than as established for black-out periods associated with our quarterly and annual financial statement filings, our executive management
will also issue notices of black-out trading periods if they are aware of material transactions which they anticipate closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The timing of equity award
grants is determined with consideration to a variety of factors, including but not limited to, the achievement of pre-established performance
targets, market conditions and internal milestones. The Company does not follow a predetermined schedule for the granting of equity awards&#894;
instead, each grant is considered on a case-by-case basis to align with the Company&#8217;s strategic objectives and to ensure the competitiveness
of our compensation packages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the timing
and terms of an equity award, the Board or the Compensation Committee may consider MNPI to ensure that such grants are made in compliance
with applicable laws and regulations. The Board&#8217;s or the Compensation Committee&#8217;s procedures to prevent the improper use of
MNPI in connection with the granting of equity awards include oversight by legal counsel and, where appropriate, delaying the grant of
equity awards until the public disclosure of such MNPI.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is committed to
maintaining transparency in its executive compensation practices and to making equity awards in a manner that is not influenced by the
timing of the disclosure of MNPI for the purpose of affecting the value of executive compensation. The Company regularly reviews its policies
and practices related to equity awards to ensure they meet the evolving standards of corporate governance and continue to serve the best
interests of the Company and its stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the year ended December
31, 2024, no options were granted to our named executive officers within four business days prior to, or one business day following, the
filing or furnishing of a periodic or current report by us that disclosed MNPI.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_022"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 12. Security Ownership of Certain Beneficial
Owners and Management and Related Stockholder Matters</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
certain information with respect to the beneficial ownership of our voting securities as of February, 2026 by (i) any person or group
beneficially owning more than 10% of any class of voting securities; (ii) our directors, and; (iii) each of our named executive officers;
and (iv) all executive officers and directors as a group as of the date of February, 2026. The information presented below regarding beneficial
ownership of our voting securities has been presented in accordance with the rules of the Securities and Exchange Commission and is not
necessarily indicative of ownership for any other purpose. Under these rules, a person is deemed to be a &#8220;beneficial owner&#8221;
of a security if that person has or shares the power to vote or direct the voting of the security or the power to dispose or direct the
disposition of the security. A person is deemed to own beneficially any security as to which such person has the right to acquire sole
or shared voting or investment power within 60 days through the conversion or exercise of any convertible security, warrant, option or
other right. More than one person may be deemed to be a beneficial owner of the same securities. Unless otherwise indicated, the address
of all listed stockholders is c/o Cyngn Inc., 1344 Terra Bella Avenue, Mountain View, CA 94043.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Beneficial Owner</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common<br/>
Stock <br/>
Beneficially<br/>
Owned</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage&#160;of<br/>
Common <br/>
Stock<sup>(1)</sup></b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Directors and Officers:</i></b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Tal<sup>(2)</sup></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">682</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;*</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalie Russell<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Petraitis</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Karen Macleod<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James McDonnell<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Executive Officers and Directors as a Group (5 persons)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">706</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficial owners of more than 5%:</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities affiliated with Empery Asset Management, LP. <sup>(6)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,375,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">We have based our calculation of the percentage of beneficial ownership
on 13,608,281 shares of common stock outstanding on March 19, 2026. We have deemed shares of common stock subject to stock options that
are currently exercisable or exercisable within 60 days of March 19, 2026 to be outstanding and to be beneficially owned by the person
holding the stock option for the purpose of computing the percentage ownership of that person. We did not deem these shares outstanding,
however, for the purpose of computing the percentage ownership of any other person.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes 34 shares of common
stock held directly and 586 shares of common stock issuable upon the exercise of stock options that are exercisable within 60 days of
March 19, 2026.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Represents shares of common
stock underlying 2 options to purchase shares of common stock of the Company which are vested and currently exercisable and shares underlying
options which will become exercisable within 60 days of March 19, 2026.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes 9&#160;shares of common
stock held directly, and 2 option to purchase shares of common stock of the Company which are vested and currently exercisable and shares
underlying options which will become exercisable within 60&#160;days of&#160;&#160;March 19, 2026.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Includes 9&#160;shares of common
stock held directly, and 1 option to purchase shares of common stock of the Company which are vested and currently exercisable and shares
underlying options which will become exercisable within 60&#160;days of&#160;&#160;March 19, 2026.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents 1,375,000 issued pursuant to that certain Securities Purchase Agreement from a registered direct offering closed on March 17, 2026, to three funds affiliated with Empery Asset Management, LP (&#8220;Empery&#8221;), for which Empery exercises voting and investment authority with respect to such securities. The principal business address for Empery Asset Management, LP 1 Rockefeller Plaza, Suite 1205, New York, New York 10020.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Securities Authorized for Issuance under Equity
Compensation Plans</b></p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
the equity compensation plans under which our securities may be issued as of December 31, 2025 and does not include grants made or cancelled
and options exercised after such date. The securities that may be issued consist solely of shares of our Common Stock and all plans were
approved by stockholders of the Company.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt">&#160;</span></p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Plan Category</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> securities&#160;to&#160;be<br/> issued upon<br/> exercise of<br/> outstanding<br/> options, warrants<br/> and rights<br/> (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> average exercise<br/> price of<br/> outstanding<br/> options,<br/> warrants<br/> and rights<br/> (b)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of<br/> securities remaining<br/> available for future<br/> issuance under equity<br/> compensation plans<br/> (excluding securities<br/> reflected in column<br/> (a)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10.25pt">Equity compensation plans approved by security holders</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">924</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">13,475.78</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;<span style="font-size: 10pt">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 13. Certain Relationships and Related
Transactions, and Director Independence</b></p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as set forth below
or under Item 11 (Executive Compensation), there has not been, nor is there any proposed transactions, where we were or will be a party
in which the amount involved exceeded or will exceed the lesser of $120,000 or one percent of the average of our total assets as at the
year-end for the last two completed fiscal years, and to which any of our directors, executive officers or beneficial holders of more
than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or
will have a direct or indirect material interest.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Amended and Restated Investor Rights Agreement</b></p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin: 0pt 0">We are parties to that certain second amended and restated investor
rights agreement dated December 24, 2014, entered into with our certain of our stockholders, including an entity with which a former director
is affiliated. These stockholders are entitled to rights with respect to the registration of their shares following our initial public
offering on October 22, 2021.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policies and Procedures for Related Party Transactions</b></p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">We have adopted a formal, written related party
transactions policy that provides that transactions with directors, officers and holders of five percent or more of our voting securities
and their affiliates, each a related party must be approved by our audit committee. Pursuant to this policy, the audit committee will
have the primary responsibility for reviewing and approving or disapproving &#8220;related party transactions,&#8221; which are transactions
between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed the lesser of (i)&#160;$120,000
or (ii)&#160;one percent of the average of our total assets for the last two completed fiscal years, and in which a related person has
or will have a direct or indirect material interest. For purposes of this policy, a related person will be defined as a director, executive
officer, nominee for director, or greater than 5% beneficial owner of our common stock, in each case since the beginning of the most recently
completed year, and their immediate family members.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Independence</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board evaluates the independence
of each nominee for election as a director of our Company in accordance with the Nasdaq Listing Rules. Pursuant to these rules, a majority
of our Board must be &#8220;independent directors&#8221; within the meaning of the Nasdaq Listing Rules, and all directors who sit on
our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board currently consists
of three directors, Lior Tal, Karen Macleod, and James McDonnell. Ms. Macleod and Mr. McDonnell are <i>&#8220;independent directors&#8221;</i>
within the meaning of the Listing Rules of the Nasdaq Stock Market.</p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 14. Principal Accountant Fees and Services</b></p><div>

</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.4in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
the fees billed by CBIZ CPAs P.C. and Marcum LLP for the fiscal years ended December 31, 2025 December 31, 2024, inclusive of out-of-pocket
expenses. All fees described below were pre-approved by the audit committee.</p><div>
</div><p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended <br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fee Category</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Marcum LLP</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">154,440</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related fees<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">114,400</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total Marcum LLPfees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">268,840</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>CBIZ CPAs P.C.</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">249,080</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">124,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related fees<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,250</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55,120</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9.25pt">Total CBIZ CPAs P.C. fees</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">286,330</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">179,920</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 9.25pt">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total fees</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">286,330</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">448,760</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Audit fees consist of fees for
professional services rendered in connection with the annual audit of our consolidated financial statements, the review of our quarterly
condensed consolidated financial statements and consultations on accounting matters directly related to the audit.</span></td>
</tr></table><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Audit-related fees consist of
fees for professional services rendered in connection with the submission of our Registration Statements on Form S-8, Form S-3, Form
S-1 and engagement administration.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 95 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_025"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART IV</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 15. Exhibits, Financial Statement Schedules</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">a)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Financial Statements</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Financial statements for our
Company are listed in the index under Item 8 of this document.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">All financial statement schedules
are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">b)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Exhibits</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit<br/>
Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-1_cyngninc.htm"><span style="font-size: 10pt">Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.1 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-2_cyngninc.htm"><span style="font-size: 10pt">Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.2 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.3</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-3_cyngninc.htm"><span style="font-size: 10pt">Second Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.3 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-4_cyngninc.htm"><span style="font-size: 10pt">Third Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.4 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex3-5_cyngninc.htm"><span style="font-size: 10pt">Fourth Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.5 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021060692/f10q0921ex3-6_cyngninc.htm"><span style="font-size: 10pt">Fifth Amended and Restated Certificate of Incorporation of Registrant incorporated by reference to Exhibit 3.6 to the Company&#8217;s Quarterly Report on Form 10-Q filed with the SEC on November 19, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.7</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390023090604/ea189005ex3-8_cyngninc.htm"><span style="font-size: 10pt">Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of the Registrant, incorporated by reference to Exhibit 3.8 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-275530) filed with the SEC on November 28, 2023.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.8</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390024060172/ea020916301ex3-1_cyngn.htm"><span style="font-size: 10pt">Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on July 9, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025021260/ea022999201ex3-9_cyngn.htm">Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation dated January 30, 2025, incorporated by reference to Exhibit 3.9 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 3, 2025.</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390025012916/ea023077801ex3-1_cyngn.htm"><span style="font-size: 10pt">Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation dated February 7, 2025 incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on February 12, 2025.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">3.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021050661/fs12021a1ex3-8_cyngninc.htm"><span style="font-size: 10pt">Amended and Restated Bylaws of Registrant, incorporated by reference to Exhibit 3.8 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">3.12</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390024041809/ea020573401ex3-1_cyngninc.htm"><span style="font-size: 10pt">Amendment No. 1 to Amended and Restated Bylaws, effective May 7, 2024, incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 10, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">3.13</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390026010347/ea027492801ex3-1_cyngn.htm">Amended and Restated Bylaws of Cyngn Inc., effective January 27, 2026, incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on January 30, 2026.</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">4.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex4-1.htm"><span style="font-size: 10pt">Description of Registrant&#8217;s Securities </span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-2_cyngninc.htm"><span style="font-size: 10pt">Offer Letter between the Company and Ben Landen dated as of September 18, 2019 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-3_cyngninc.htm"><span style="font-size: 10pt">Offer Letter between the Company and Donald Alvarez dated as of May 28, 2021 incorporated by reference to Exhibit 10.3 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify; width: 9%"><span style="font-size: 10pt">10.3</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021046495/fs12021ex10-4_cyngninc.htm"><span style="font-size: 10pt">2013 Equity Incentive Plan incorporated by reference to Exhibit 10.4 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-5_cyngninc.htm"><span style="font-size: 10pt">2021 Incentive Plan incorporated by reference to Exhibit 10.5 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.5</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390024008500/ea191922ex4-2_cyngninc.htm"><span style="font-size: 10pt">Amendment to 2021 Equity Incentive Plan incorporated by reference to Exhibit 4.2 to the Company&#8217;s Registration Statement on Form S-8 filed with the SEC on January 31, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390024045655/ea0205714-02.htm"><span style="font-size: 10pt">Amendment to 2021 Equity Incentive Plan incorporated by reference to the Company&#8217;s Proxy Statement filed with the Securities and Exchange Commission on May 21, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.7</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline;text-decoration: none"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1874097/000121390025118354/ea0268580-8k_cyngn.htm">Amendment to 2021 Equity Incentive Plan incorporated by reference to the Company&#8217;s Current Report on Form 8-K filed with the Securities and Exchange Commission on December 4, 2025.</a></span></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.8</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-6_cyngninc.htm"><span style="font-size: 10pt">Second Amended and Restated Investors&#8217; Rights Agreement dated as of December 24, 2014 incorporated by reference to Exhibit 10.6 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390021053094/fs12021a2ex10-7_cyngninc.htm"><span style="font-size: 10pt">Form of Indemnification Agreement to be entered into with the Registrant and each of its officers and directors incorporated by reference to Exhibit 10.7 to the Company&#8217;s Amendment to the Registration Statement on Form S-1 (No. 333-259278) filed with the SEC on October 15, 2021.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022000964/ea153553ex10-1_cyngn.htm"><span style="font-size: 10pt">Employment Agreement by and between Cyngn Inc. and Lior Tal dated as of January 1, 2023 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 6, 2023.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-1_cyngninc.htm"><span style="font-size: 10pt">Engagement Letter dated April 27, 2022 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 29, 2022.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.12</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-2_cyngninc.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 29, 2022.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.13</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-3_cyngninc.htm"><span style="font-size: 10pt">Form of Warrant incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 29, 2022.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.14</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-4_cyngninc.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 29, 2022.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.15</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390022022807/ea159118ex10-5_cyngninc.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrants incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 29, 2022.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.16</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390023044508/ea179173ex1-2_cyngninc.htm"><span style="font-size: 10pt">ATM Sales Agreement by and between the Company and Virtu Americas LLC, dated May 31, 2023 incorporated by reference to Exhibit 1.2 to the Company&#8217;s Registration Statement on Form S-3 filed with the SEC on May 31, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.17</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390023094816/ea189860ex10-1_cyngn.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated December 8, 2023 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 11, 2023</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.18</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390023094816/ea189860ex10-2_cyngn.htm"><span style="font-size: 10pt">Form of Pre-funded Warrant incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 11, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.19</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1874097/000121390024020777/f10k2023ex10-17_cyngninc.htm"><span style="font-size: 10pt">Form of Severance and Change of Control Agreement incorporated by reference to Exhibit 10.17 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 7, 2024.</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify; width: 9%"><span style="font-size: 10pt">10.20</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024044811/ea020638601ex10-1_cyngn.htm"><span style="font-size: 10pt">Severance and Change of Control Agreement by and between Cyngn Inc. and Donald Alvarez dated May 15, 2024 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 17, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.21</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024096917/ea022084501ex10-1_cyngn.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement dated November 12, 2024 incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 12, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.22</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024096917/ea022084501ex10-2_cyngn.htm"><span style="font-size: 10pt">Form of Note dated November 12, 2024 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 12, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.23</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024096917/ea022084501ex10-3_cyngn.htm"><span style="font-size: 10pt">Form of Registration Rights Agreement dated November 12, 2024 incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 12, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.24</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024096917/ea022084501ex10-4_cyngn.htm"><span style="font-size: 10pt">Form of Lock-Up Agreement incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 12, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.25</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024096917/ea022084501ex10-5_cyngn.htm"><span style="font-size: 10pt">Form of Placement Agent Agreement incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on November 12, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.26</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024111988/ea022567701ex4-1_cyngn.htm"><span style="font-size: 10pt">Form of Pre-funded Warrant incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 23, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.27</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024111988/ea022567701ex4-2_cyngn.htm"><span style="font-size: 10pt">Form of Series A Warrant incorporated by reference to Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 23, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.28</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024111988/ea022567701ex4-3_cyngn.htm"><span style="font-size: 10pt">Form of Form of Series B Warrant incorporated by reference to Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 23, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.29</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024111988/ea022567701ex10-1_cyngn.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 23, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">10.30</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024111988/ea022567701ex10-2_cyngn.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated December 19, 2024 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 23, 2024.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">10.31</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024114074/ea022640501ex4-1_cyngn.htm"><span style="font-size: 10pt">Form of Pre-funded Warrant incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 31, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.32</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024114074/ea022640501ex10-1_cyngn.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 31, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.33</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024114074/ea022640501ex10-2_cyngn.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated December 30, 2024 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on December 31, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.34</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025021260/ea022999201ex10-33_cyngn.htm"><span style="font-size: 10pt">Amendment to Employment Agreement by and between Cyngn Inc. and Lior Tal dated March 6, 2025 incorporated by reference to Exhibit 10.33 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 6, 2025.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.35</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex4-1_cyngn.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 27, 2025</span></a><span style="font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.36</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex4-1_cyngn.htm"><span style="font-size: 10pt">Form of Pre-Funded Warrant incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 30, 2025</span></a><span style="font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.37</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex10-1_cyngn.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement by and between the Company and the Purchasers incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 27, 2025</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.38</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex10-2_cyngn.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated June 26, 2025 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 27, 2025</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.39</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex10-1_cyngn.htm"><span style="font-size: 10pt">Form of Securities Purchase Agreement by and between the Company and the Purchasers incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 30, 2025</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.40</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex10-2_cyngn.htm"><span style="font-size: 10pt">Placement Agent Agreement between the Company and Aegis Capital Corp. dated June 26, 2025 incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on June 30, 2025</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">10.41</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025085094/ea025562501ex1-2_cyngn.htm"><span style="font-size: 10pt">At-The-Market Issuance Sales Agreement by and between Cyngn Inc. and Aegis Capital Corp., dated September 5, 2025, incorporated by reference to Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on September 5, 2025</span></a><span style="font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">10.42</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025077501/ea025346501ex10-1_cyngn.htm"><span style="font-size: 10pt">Offer Letter, dated August 12, 2025, between Cyngn Inc. and Natalie Russell, incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 15, 2025.</span></a></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; width: 9%"><span style="font-size: 10pt">10.43</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025077501/ea025346501ex10-2_cyngn.htm"><span style="font-size: 10pt">Severance and Change of Control Agreement, dated August 12, 2025, between Cyngn Inc. and Natalie Russell, incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 15, 2025</span></a><span style="font-size: 10pt">.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">19.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390025021260/ea022999201ex19-1_cyngn.htm"><span style="font-size: 10pt">Insider Trading Policy, effective October 14, 2021 incorporated by reference to Exhibit 19.1 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 6, 2025.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">21.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024020777/f10k2023ex21-1_cyngninc.htm"><span style="font-size: 10pt">List of Subsidiaries of the Registrant incorporated by reference to Exhibit 21.1 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 7, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">23.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex23-1.htm"><span style="font-size: 10pt">Consent of CBIZ CPAs P.C.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">23.2*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex23-2.htm">Consent of Marcum LLP</a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">31.1*</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex31-1.htm"><span style="font-size: 10pt">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">31.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex31-2.htm"><span style="font-size: 10pt">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">32.1**</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="ea027779601ex32-1.htm"><span style="font-size: 10pt">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) or 15d-14(b) of the Securities Exchange Act, as amended, and 18 U.S.C. Section 1350.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">97</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1874097/000121390024020777/f10k2023ex97_cyngninc.htm"><span style="font-size: 10pt">Cyngn Inc. Clawback Policy, effective November 7, 2023 incorporated by reference to Exhibit 97 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 7, 2024.</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.INS</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">101.SCH</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.CAL</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">101.DEF</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-size: 10pt">101.LAB</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-size: 10pt">101.PRE</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">**</span></td><td style="text-align: justify"><span style="font-size: 10pt">Furnished herewith.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_027"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 16. Form 10-K Summary</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 99; Value: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with Section 13 or 15(d) of the
Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>CYNGN INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 37%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt">/s/ Lior Tal </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Lior Tal</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer and Chairman of the Board</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(Principal Executive Officer)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: March 26, 2026</span></td>
    <td><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-size: 10pt">/s/ Natalie Russell </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Natalie Russell </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(Principal Financial and Accounting Officer)</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the Exchange Act, this Report
has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt"><b>Signature</b></span></td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt"><b>Title</b></span></td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt"><span style="font-size: 10pt">/s/ Lior Tal</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Chief Executive Officer and Director</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">March 26, 2026</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Lior Tal</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">(Principal Executive Officer)</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt"><span style="font-size: 10pt">/s/ Natalie Russell</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Chief Financial Officer and Director</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">March 26, 2026</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Natalie Russell</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt"><span style="font-size: 10pt">/s/ Karen Macleod</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">March 26, 2026</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Karen Macleod</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt"><span style="font-size: 10pt">/s/ Ran Makavy</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">March 26, 2026</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Ran Makavy</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; padding-right: 1.3pt"><span style="font-size: 10pt">/s/ James McDonnell</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">Director</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center"><span style="font-size: 10pt">March 26, 2026</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 1.3pt"><span style="font-size: 10pt">James McDonnell</span></td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt">&#160;</td>
    <td style="padding-right: 1.3pt; text-align: center">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Page; Sequence: 100; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

































































































































































</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c4" id="hidden-fact-0" name="us-gaap:ShortTermInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-1" name="us-gaap:SecurityDeposit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-2" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-3" name="us-gaap:WarrantsAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-6" name="cyngn:WarrantLiabilityIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-7" name="cyngn:LossOnIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-8" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-9" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-10" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-11" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-12" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-13" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-14" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-15" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-16" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-17" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-18" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-19" name="cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-20" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-21" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-22" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-23" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-24" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-25" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-26" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-27" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-28" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-29" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-31" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-32" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-34" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-35" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-36" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-37" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-38" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-39" name="cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-40" name="cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-41" name="cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-42" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-43" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-44" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-45" name="cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-46" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-47" name="cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-48" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-49" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-50" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-51" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-52" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-53" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-54" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-55" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-56" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-57" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-58" name="us-gaap:AssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-59" name="us-gaap:RecapitalizationCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-60" name="cyngn:WarrantLiabilityIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-61" name="cyngn:LossOnIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-62" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-63" name="us-gaap:ProceedsFromSaleOfProductiveAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-64" name="cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-65" name="us-gaap:ProceedsFromIssuanceOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-66" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-67" name="us-gaap:RepaymentsOfNotesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-68" name="cyngn:IssuanceCostsForStockDividendAndRestrictedStockUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-69" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-70" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-71" name="cyngn:AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-72" name="cyngn:AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c47" id="hidden-fact-73" name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">http://fasb.org/us-gaap/2025#UsefulLifeTermOfLeaseMember</ix:nonNumeric>
<ix:nonFraction contextRef="c49" id="hidden-fact-74" name="us-gaap:ConcentrationRiskPercentage1" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-75" name="us-gaap:ConcentrationRiskPercentage1" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-76" name="us-gaap:ConcentrationRiskPercentage1" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-77" name="us-gaap:ConcentrationRiskPercentage1" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-78" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-79" name="us-gaap:ProvisionForOtherCreditLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-80" name="us-gaap:ProvisionForOtherCreditLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c35" id="hidden-fact-81" name="us-gaap:AssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c36" id="hidden-fact-82" name="us-gaap:AssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-83" name="us-gaap:AssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c62" id="hidden-fact-84" name="us-gaap:USGovernmentSecuritiesAtCarryingValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c76" id="hidden-fact-85" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c76" id="hidden-fact-86" name="cyngn:FiniteLivedIntangibleAssetsImpairment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c77" id="hidden-fact-87" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c77" id="hidden-fact-88" name="cyngn:FiniteLivedIntangibleAssetsImpairment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-89" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-90" name="cyngn:FiniteLivedIntangibleAssetsImpairment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-91" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-92" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-93" name="cyngn:FiniteLivedIntangibleAssetsImpairment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c79" id="hidden-fact-94" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-95" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-96" name="cyngn:FiniteLivedIntangibleAssetsImpairment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-97" name="cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-98" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-99" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-100" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-101" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-102" name="us-gaap:PreferredStockSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-103" name="us-gaap:PreferredStockSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-106" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-107" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-108" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-109" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-110" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-111" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-112" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-113" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-114" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-115" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-116" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-117" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-118" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-119" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-120" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xsi:nil="true"></ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-121" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-122" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-123" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-124" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-125" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-126" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-127" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-128" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-129" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-130" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-131" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-132" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-133" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-134" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-14494">0001874097</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-14495">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-14496">FY</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="cyngn-20251231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><ix:relationship xmlns="" fromRefs="hidden-fact-74 hidden-fact-75 hidden-fact-76 hidden-fact-77" toRefs="ix_0_footnote"/>
<ix:relationship xmlns="" fromRefs="ix_0_fact ix_1_fact" toRefs="ix_1_footnote"/>
<xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2026-03-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-25</xbrli:startDate>
    <xbrli:endDate>2024-06-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-25</xbrli:startDate>
    <xbrli:endDate>2024-06-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-06-25</xbrli:startDate>
    <xbrli:endDate>2024-06-25</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-30</xbrli:startDate>
    <xbrli:endDate>2025-01-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerCMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerCMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerDMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerDMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerEMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerEMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2026-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2027-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2028-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:MachineToolsAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:MachineToolsAndEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:TestingEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:TestingEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:DevelopedSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:DevelopedSoftwareMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-27</xbrli:startDate>
    <xbrli:endDate>2025-06-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-27</xbrli:startDate>
    <xbrli:endDate>2025-06-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-26</xbrli:startDate>
    <xbrli:endDate>2025-06-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-06-26</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-06-26</xbrli:startDate>
    <xbrli:endDate>2025-06-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-30</xbrli:startDate>
    <xbrli:endDate>2024-12-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-20</xbrli:startDate>
    <xbrli:endDate>2024-12-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-23</xbrli:startDate>
    <xbrli:endDate>2024-12-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-23</xbrli:startDate>
    <xbrli:endDate>2024-04-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-23</xbrli:startDate>
    <xbrli:endDate>2024-04-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-04-23</xbrli:startDate>
    <xbrli:endDate>2024-04-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-04-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-04-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-05-03</xbrli:startDate>
    <xbrli:endDate>2024-05-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-05-03</xbrli:startDate>
    <xbrli:endDate>2024-05-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:AtTheMarketEquityFinancingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-05</xbrli:startDate>
    <xbrli:endDate>2025-09-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-05</xbrli:startDate>
    <xbrli:endDate>2025-09-05</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:AegisCapitalCorpMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:PrivatePlacementOfferingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-11-12</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:PrivatePlacementOfferingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-11-12</xbrli:startDate>
    <xbrli:endDate>2024-11-12</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwentyTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-12-31</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">cyngn:TwoZeroThreeFourMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2025-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-31</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:Section162mLimitationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:WarrantRevaluationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:OtherPermanentDifferencesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-05-01</xbrli:startDate>
    <xbrli:endDate>2025-05-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:SalesAgreementWithAegisCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-19</xbrli:startDate>
    <xbrli:endDate>2026-03-19</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:RegisteredDirectOfferingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2026-03-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:RegisteredDirectOfferingMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-03-16</xbrli:startDate>
    <xbrli:endDate>2026-03-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsRestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsPreviouslyReportMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:RestatedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001874097</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-10-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
<!-- [WMV6][iHbLFUTv/nH1kFOiSiOVCkOzWmROndXNO8ZuGd0NHxZT4Fy78Y8S3lrnH92PIjgvi4NLKYawMABWnRCmZ3e8+CI76jZg/sANglK9zLK8YjhOYc2uMXzL19DAJBiHR7bwZ+k4mre5iuOfxp+Kna6ozC0X/YimRseNdFnP6lb3XNcEDU2hParqtaIYaZ6I+V6uCVl93I8RAdjnOb+RpYvTt/WyuyQeVNWQNnCaCt+Sx6X6ygsoxiLwBooPigZZPQU9btldGbNGYczuQsWhXy54l9NtJz6cy220z7ry4AAg11w6InBLEjXGgAFnDvzeOzhfXL2E3g==] CSR-->
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea027779601ex4-1.htm
<DESCRIPTION>DESCRIPTION OF REGISTRANT'S SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF THE REGISTRANT&rsquo;S SECURITIES
REGISTERED PURSUANT<BR>
TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cyngn Inc. has one class of
securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;): its
common stock, par value $0.00001 per share (&ldquo;common stock&rdquo;). The following description of our capital stock is a summary and
does not purport to be complete. The following description is subject to and qualified in its entirety by reference to our restated certificate
of incorporation and amended and restated bylaws, each of which is incorporated by reference as an exhibit to our Annual Report on Form
10-K of which this Exhibit is a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We encourage you to read our
restated certificate of incorporation, amended and restated bylaws and the applicable provisions of the Delaware General Corporation Law
(the &ldquo;DGCL&rdquo;) for more information. References herein to &ldquo;we,&rdquo; &ldquo;our,&rdquo; &ldquo;us,&rdquo; and &ldquo;the
Company&rdquo; refer solely to Cyngn Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our authorized capital stock
consists of 410,000,000 shares of capital stock, par value $0.00001 per share, of which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">400,000,000 shares are designated
as common stock; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">10,000,000 shares are designated
as preferred stock.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors is
authorized, without stockholder approval except as required by the listing standards of the Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;),
to issue additional shares of our capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each holder of common stock
is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our
restated certificate of incorporation and amended and restated bylaws do not provide for cumulative voting rights. Because of this, the
holders of a plurality of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing
for election, if they should so choose. With respect to matters other than the election of directors, at any meeting of the stockholders
at which a quorum is present or represented, the affirmative vote of a majority of the voting power of the shares present in person or
represented by proxy at such meeting and entitled to vote on the subject matter shall be the act of the stockholders, except as otherwise
required by law. The holders of a majority of the stock issued and outstanding and entitled to vote, present in person or represented
by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Dividends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to preferences that
may be applicable to any then-outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may
be declared from time to time by our board of directors out of legally available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Liquidation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of our liquidation,
dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution
to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted
to the holders of any then-outstanding shares of preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Rights and Preferences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common stock
have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our
common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by
the rights of the holders of shares of any series of our preferred stock that we may designate in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Preferred Stock</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our restated certificate of
incorporation contains provisions that permit our board of directors to issue, without any further vote or action by the stockholders,
shares of preferred stock in one or more series and, with respect to each such series, to fix the number of shares constituting the series
and the designation of the series, the voting rights (if any) of the shares of the series, and the powers, preferences or relative, participation,
optional and other special rights, if any, and any qualifications, limitations or restrictions, of the shares of such series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea027779601ex23-1.htm
<DESCRIPTION>CONSENT OF CBIZ CPAS P.C
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by reference
in the Registration Statements on Form S-3 (File No. 333-290079), Form S-8&nbsp;(File No. 333-262130), Form S-8 (File No.
333-276792), Form S-8 (File No. 333-286030), and Form S-8 (File No. 3333-293025) of our report dated March 26, 2026, with respect to
the consolidated financial statements of CYNGN, Inc. included in this Annual Report on Form 10-K for the year ended December 31,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ <FONT STYLE="font-variant: small-caps">CBIZ CPAs P.C. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">San Francisco, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 26, 2026</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>ea027779601ex23-2.htm
<DESCRIPTION>CONSENT OF MARCUM LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-decoration: underline solid">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We consent to the
incorporation by reference in the Registration Statements on Form S-3 (File No. 333-290079), Form S-8 (File No. 333-262130), Form
S-8 (File No. 333-276792), Form S-8 (File No. 333-286030), and Form S-8 (File No. 3333-293025) of our report dated March 6, 2025,
except for the effects of the restatement discussed in Note 15 to the consolidated financial statements, as to which the date is
November 14, 2025, which includes an explanatory paragraph as to the Company&rsquo;s ability to continue as a going concern, with
respect to our audit of the consolidated financial statements of CYNGN, Inc. as of December 31, 2024, and for the year ended
December 31, 2024, which report is included in this Annual Report on Form 10-K for the year ended December 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">/s/ Marcum LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Marcum LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">San Francisco, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">March 26, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ea027779601ex31-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULES 13A-14 AND 15D-14</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Lior Tal, certify that:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">I have reviewed this Annual Report on Form 10-K of Cyngn Inc.;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">d.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Disclosed in this report any changes in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">5)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-size: 10pt">Date: March 26, 2026</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt"><I>/s/ Lior Tal</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Lior Tal</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer, Chairman of the Board of</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Directors and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




























































</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ea027779601ex31-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULES 13A-14 AND 15D-14</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Natalie Russell, certify that:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">I have reviewed this Annual Report on Form 10-K of Cyngn Inc.;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">c.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">d.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Disclosed in this report any changes in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">5)</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify; width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">a.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and~</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">b.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Date: March 26, 2026</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; padding-right: 1.05pt"><FONT STYLE="font-size: 10pt"><I>/s/ Natalie Russell</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Natalie Russell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">Chief Financial and Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 1.05pt">&nbsp;</TD>
    <TD STYLE="padding-right: 1.05pt"><FONT STYLE="font-size: 10pt">(Principal Financial Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ea027779601ex32-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Annual Report of Cyngn Inc. (&ldquo;Company&rdquo;)
on Form 10-K for the year ending December 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (&ldquo;Report&rdquo;),
the undersigned, in the capacities and on the date indicated below, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the knowledge of each of the undersigned:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 26, 2026</FONT></TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Lior Tal</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Tal</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, Chairman of the Board of Directors and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Natalie Russell</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalie Russell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ea027779601_img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %? G # 2(  A$! Q$!_\0
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MTSX[?MO?LB?LPZMX#T+]H?\ :+^$WP9U7XH0:A=?#VU^(7C#2_#?_"7VNE+
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M1110 4444 %%%% !1110 4444 %?,TG[&_[,DW[3L'[9LOP?\+R?M06W@_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]?\ &@"6BHMY]!^O^-&\^@_7_&@"6BHMY]!^O^-&\^@_7_&@"6BHMY]!^O\
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MGX0\%_"9_$=M\0[-/#'B27X0Z5X>U+6/$<VBZDUKXNN;CR]'73W\F#0\;?\
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MPVZ:WXEFMG:;4/&NF0Q*^B^/G$:#4[N?RE\2J!J(6[N'GOG_ #6BC8,I;J2
M!QC!XP>3UR>IR>W2O7/A;\5?$?PFUF^N]'MM*USP]XBM/[)\<^ /$D#:AX.\
M>>'Y#F;2=?TX.A\Y.9-*UFRD@UG0;Y8K[2;VVFB!/NYI0Q57#I5*%!*G2=.F
MXT*5&5/6\/9>PHT5[D?=<9<ZGS7^+4ZJ,*=.?[F3IJ3;<8VY9ZM\M2%DNZC*
MR<;)+30\PM;?9=VI7<P:\M%).Q0<W$0VD-['OZ\<5]U_&GP]>:-\7?@A%HFA
M+X@U.^?5ETS1)FB5-5U1/$!BMK>3SC'"T*SNDDBR.L96,Y>/ 8<1XI^"'@O6
M?"3?'/X)G7-=^&]O/!>>,/ FH:Q:3^._@GJ$MWBWL?%<-M;33ZWX"O+J,P^'
M/B!!%#!<Q[-/U^#3-3*BX]S\!6&E_M:>*O!UK\0;U_!6JZ3?ZC%X0UOPG'=(
M$EN;JVU&71+N*>XNH#%JLBWS1:DZQ2V,B(R2^4IMW_GKC?*\;E_%7#''&)JQ
MPW#/"N4\1PS^47B*V+@\REEU+"U:> PU"M5KTZ+C4GB*BLL/AX5JTU[.E-Q_
M0N#\OQ7$-+'\)9715?/,^K89951JUJ.%H5JN$H8O$5*3Q.(JTJ4*U6%%4L-3
M<XNOB*E&A%^TK4XO]5?^"6$W[47@_P#;5_8>\7:AKGA?P_X8UGXXZ#H4VE6-
MY:3:E=^'/$172]>TIOL"AF?4=,NWM;@S-(DB+(&D<,[+_I6.!D#L ,#TP>/Y
M"O\ .@_X)P_LQ_#3P1^VK^R/J6H:IXZE\8:/\?/"DT&@:MXW&J6&EWFG,7LY
M38V]LFZ&.[CF-S*[QVTJ36T,;.)"D?\ HOOU'T_J:PXGJX7$8C!8C"3A6HUL
M)[2%>FX.G6A.<9TIPE#24)4ZL90E=\T9Q>S*P>3YKD;Q&!SC"U,'BX5Y-T*S
M7M8*-Z4U.'-*4)*K2J1<9VDG!IK09U.!R?3O17X8?\%>OB?K7ACXK?L1?##X
MI?'CXC_LI?L+_%GQE\3K/]IC]H+X6^);_P  ZU!XN\/^%K._^#'PG\3?%72[
M6>_^%G@GXA:S+K+:IXDBN=*CO[S2;/1)M4M4O=U?'/CS_@I-?_L$> ?A=8?L
MN_&#Q1_P4 _9O_:"T[XT?!+]E_XE_$G5O$/Q1^(<7[=]MXM\,Z;\*/@SJ/Q+
M,6@-XT^#5Y8:_?\ V+5;NVNM1,/AG58;3QQJ2/;I;?,':?U*Y'K_ )Z?SXHK
M^834_P#@I_\ \%"_AA\6O%^H>.K/]GKXE_"[X8?M\?#O]@'Q-\)O ?PZ\9Z!
M\3?&GC#QW\ M+^(;>.?"OC:]\=:QH]DMGXYDOM,TOPW<>&[O[?HLT$4M_%?1
MB67Y<UG_ (+I?MHZ5X5?Q+H/Q-_8F^(WB'QI^RKK7QZ7X9>#_ 'Q!77_ -F7
MX@GXZ?"GX86/PC^,;7OQ#75=8U+P[IWCK5X/$$=SHO@W6KG7](GF@L+?2A:2
MWH!_8[D9QD9SC&><^F/6E/'7CZ\5_/MXO_::_:N\8_LH?\%6O@S\8_VBO@_\
M"?CC^R9X@\/^!/#G[7WP[\'>/?!_@?3=#^)?@+P;\0-&US5?"]O>?$'Q7X1U
M/2;3Q#=^$=3\2:'<:Q_9ZS0>)[:"W>TD1?RF^&W_  4^^+/[(/PE^-7A[X16
MWB/XK^+8_BI^S-X/USXWZG^UWJG_  4!_8[^$VA?%;3O%4=_XY\->/O$MW\/
MM9\.>+]3N]$C_P"$F^''C#QQI>CZ?J.K:#>7VKZ':B:WE /[8LCU'/3WHK^7
M7PA_P5U_;!\<W?[./@WXB>*?V//V+KGQC\*?&'Q2U#XX?&]-0\:_"3]I:?PU
M\6S\/-'\#? V?P;\1H=&\-Z_JWAY(O%?BC3)/&/C/7]"N]0M].T;2]9M;>>[
M'._$S_@NE\;/"'A:+P_HU]^SY=_'[P_\6O\ @I+X3^(?PON-*UP^(O#'@K]E
MKX6^.?'?P+\1:EX3_P"$L@U_2++QE-HOA^ZU+6[Y!IWBC2+^4Z!]BD?S+< _
MJKR/4?G^'\^*7(]17\F7QK_X*Z?\%(O@+XN_9K^&6K^'?V>O&7C/XH_L^_#G
M]I=M?F\%R?#;P-\87^*?B#2K6W^ ?PZU;QO\8]-30-7\"Z3<&'4_%R7'C#Q!
MJ^LZKI,O_"#6&E++.WW%^Q9_P4O^/OQC_P""A?Q)_94^/5M\-/#=A-#\5;KX
M7^"_A7I>D?$>#3=-^'%[X?<_\)M\8/"_Q,UNXT#Q19Z9J=S9^)_#GCGX7>"(
M)/$X&F>%-3U>*"1Y #]Z^^.^,X[X]<>E%?P#2?'7_@K->_L%?M(^$/#'Q@^+
MUU\,/BM<_M9?M;:?^V._BC69O&7[/_PX_9F^*GC?P?X]_9HT7Q$T[:E8ZEX\
M\3Z#\.AX%:"]MSI?AGQ1XKAL(UBL/]%_4W7_ /@L9\5M ^&>J? _5/%GPJTO
MX]_\-3>"OV=-%\&Z@=9M?BUJ7[-?BW]D73OB1'\:[;3YO$<>J7GB&Y\53:A-
M8_$*"#_A&BUL(#ICW@+. ?U6X.<=\X_'&<?7'/TYZ4E?P7C]L3]LOP?\)M6M
M/B'^U=H7B#X::U_P13^ ?QG\&?!SQU<?$#1/%7Q-\4:IXPN])\67WA;QMH7Q
M-\,>(]0^+=C>6\NM>./&OATS:E/X3GTO1IM,L(K>XU6;]"/!_P#P6 _:CUSQ
MKJG@^;QY^S/XNL+K]K+XE_L<Q?LM> M"\86G[5GAGX;Z/X(N+O3?VG9/$<WC
MK78Y- \"K&=;\5W.H^$K'2+K18IIK?7X-<6.U< _K([X[^G?\J*_BZ_9;_X+
M#?MQ>%9OV*?V=/"G@3POX^LH?@M^R9=ZRWQAU>SM/B7^U&/C=J-[;^.?&7@7
MXB>*_B#X;%O<^#(4DBTNRTGPK\0KW6M;T^[M/$<FAK<V=?VBGZYH **** "B
MBB@ HHHH 0_U'\Q5@=!]!5<]/Q7^8JPO0?0?RH 6BBB@ HHHH :W;_>%?RB_
MM]_MX?'S]G3]J3XK_"KX1_L:?&#XYP0ZZFMW/CO27M-'\')-K^F6=Y#9Z9J
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M.3:JI(HXZ/\ :=\2WOQ1_8,3XA_M%CP:G[0\_P 0?%CZ3X2\)>*_#OB0:?\
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MMYYH?&5OIUW/%#/>R06&JWKM$4EA>?8IN-PRI\^_8\TSX&:%X;\2:AJGP<\
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MV3]?\*Z==:%HUAX2^)OCCX3P:M/X>U2[NY/^%@ZE(NHW1-U-"Z>D? /X7?\
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MW?:W-<O-9)<WEWJ]S;PS+:M9R6MA<Z9;26L20"&**::S\DPR;'EV>>V3]@_
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M7L+$,LEDD-IX>L;C2'A^R,D3/8OJ%]$!.)621I>IV,,;]EG_ (*!_M+?#?\
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M\(>*U646[MX9U\).S;5A;^R;P"5FY*B,G>6 .-N>U?YJGP9M_$^I_P#!2O\
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MHK"ZT^S:[GO4NK@]E+\;_P#@IM\+M;^%/P[U3P3^P/\ $'Q/XA^&WC34]8\
M> /!?[.=A;>$_'[:%K=QX!\-_$#Q/JGQ1TFUN_$6B^(;31M*U#0/!.AA+QM2
MLC9ZC=H+RYA_$LMJ?2$K\5_ZRXOQ'P6(P.'Q;KKAC!\,XK'9'3R^G44I8.4'
M15>A+ZM#DEB5B/:0FW6EM8_T SWQ&^@LO#"CP'PW]%WCB?%,\ECAZ_BCFWBA
M@\OXII\0/!\D\XIX7 X?'Y)BL-_:3>)_LNKEU#!5,+;#QE2K?[4_Y!+8>%],
M2Y@A^%FLPWMD\D.I1ZG)K%O<VL\<EU%>VR?9;QD@F@EB,)2[MKHH+([U\S+5
M]0?!7QAX3\+^.-%U5_A;IL5MI.D:U/=7VLZGXGM[C3[F+1KV87LLH\0:7 BI
MYY2:XW6\A:!8H4>0&*?WO]NB_P#BA:_M@_M(Z-X(N=(T_P ,:?\ $?5IY--%
M_:V5MIGB^6STJ;XAZ+HVF00O9165AXYUGQ/I]@+:66 :?;!$OF2-/,^8?%WB
MGQFW@7XA:+>M:66K6_@34Y=0;3/&%O;6TFEW%G8KJUE<:?>2M)JDESI\R^9I
M]M,;J:21GC5X89(C_H)E>9>WRC"8NI1M'&9?AZ\\-5I5523KT(3E2DYM\U.;
M<X^\[N,DW9NQ_FI6=/#9C[.A.K3JX;%OV.)I\L*L)T*KE2K4N6[IU82A"4)Q
M_AS3E&S22\^_;+_:ZN/CW>>%M$TWQ%J^G^"O".E>(YM)TS4;_7O$&F)XCG6W
MBFMO#]S=W=Y/]BU9;&UA2YGCBBM)<_:+JXA56C_.&+5I=X:59,C);=MP#DDY
M)?IDDD8X!/'%=M\1/'/B[Q_=: =5FL]5B\(>%X=(L42RTO28--\-V$JDQM'I
MT6G?;94,G$\[7-_*SY=W5#M\HUC7M OIDM] L3;16K3Q^=)'<)<WZ"5G\V_1
M[V]MEN8OFB061BB:)4+"23<YK!9G@,"J>$P-&GE^&4G4IX6E!4L*IU9.=545
M%N/-*IS2<$FK*]^B]K,Z^9\05*^:YOCJF8XR7L<+4Q6*K1GC9TJ%/DH3K)4:
M3J*-."ISKOWZE6:<_><F_K[X'?&'Q#\+/&-GJ?PS\02:7K.L:-:Z=>:A?Z19
M2K:7MW+$+FVMH[D7BO!;R[1#?JD4\R[L11J=I^D=9_;,^-EZ/$G@^^^)GC'5
MM7LY+IGFM-<OETUA;GS+K;;0FV4P1PEE:)45X]GR*RHP/YIZ7%J6D7NC7-S+
M;Q/J>D)J^G/9ZE:7<D5I)/+%$UP+*XE?3KP26TC&RNQ!>1)Y<DD*K+&6[FSU
M8V5P;Q6VWADDF-TAVSF65&CED,G#L\D;NC,2259E.0QKLQ+R'$XV.88G*\HQ
M&8*G1BL=B<OPE?%.-!25&FL15P]2KR4[^["]D]=]O6R[CCBK)>'Y<*8'B+B'
M#9(\?4QJRO!YOC,/EREB(16*?U+#UJ5.-6O.%*52HY?O'!<\+IR?K6I^,9O'
M,=QJ>N7HU2Y8HLEU)>O=22!V*X9Q(9%(; (+;DR&(!(K].?V-KV'3/V6OVE_
M"$$49.F>,_AWXJ6.-B8TBUHV.G2A-Y>0XEM6^9F)+#YB237Y$^$WM9M7@T^V
MM;:&"[,JO;01)&DA*%]SK&%W,&0-N^\"/E]*_4[]@33CJ'B#XO?!S4]4O&M?
MBCX,TW58-5=+62XT6Y\!^(+*_BLHK9?LRW\5_;ZI(NYRT]N+(,?,#2.G\G_2
MRI8W,_#;/,91Y)87*UA,UQ5-1C3]G0P.+HRJRI1I4X12IT:E:HHJ#E-WBKZ)
M?V;]#/CSA_ >(W#V6YGAZN'SO-,;4RK 9@G6Q$*TL=AJE/V>*J3JSFZE:<(0
MOS*G&,5\+=W^U'_!*'^U;GX]_""TT[35NA-\7/"LVH3S7:VT&F:9;)J-Q-?2
M':SW$SRV\=E9VL*[YKR[@5FCB$DB_P!U;]1]/ZFOXD?V ?#,OPH_:%^$-GI>
MMRWPUWXJ^"--B?\ LN0R-;/K:->,ZJ^U7^R^8X<,?*6-Y,';BO[;GZCZ?U-?
MR)]&BEA7P1F^/PRA)9AQ9G,Y8B$W/ZQ"@Z-&A.4;VI3A2GR.G92CM+F:NOO_
M *?.,JUO&/*<'*JZE++N"<GIT8.E[-T7B:V(Q%>+;2E4=2O!U>:3;47&-HI*
M)^7G_!0K_@HU/^P[XT_9P^'NE_#'P?X_\1?M&ZE\2++2-4^(OQW\!?L\> ?"
MT7PU\-VOB749-?\ 'WQ%7^P(KG5;>Z6TTBQ::*XO+U?(@65V"GC?AK_P6D_8
MTU[]GOX(_'?XQ^)[WX"3_&ZP\:ZGHW@/7--UGQ_J^EZ%\.O%^H>"/&/C^[U7
MX;Z1XBTT?"*PUO3_ #+3XJW1L/"-_IUW9WD5ZJNZ1^D?MX?\$];S]L[Q_P#L
MX?$_0_C5;?!_QA^S9J7Q'OO#IUCX,^!?CEX6\1P_$KPW;>&M5MM>\'?$"X@T
M5GL+6U2XTR[$4TT%R?,7:0"?CS0/^"&&F?#?P3I&@?!7]L+XJ?#/Q;KWP?\
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M@:[J/AJ]^$'PZB^%OP]^)WA_Q_?746K-J6F>%(O*U7PQ>:=+I6LWDKW+W=J
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M*3<FVVW?;_./^(7PBU;6=4NKO4;N\N(S(["%XGV.6)(,C-G# <A1DG([CGS
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M_(D1Q#,K0;D/^B9<_P#!+/\ 8RO0/M7PWO;@9!._7[SYL=F*%20>XSBJ3_\
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MV@/#WB76?"VI:KX2GEMXDU/0M67PK';VVM:-<RS)#+#&\@S/;&,1W(4D"3L
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MQS>W6F^"O&.HV4SV]Y8>%/$5[:3QG$D%U:Z/>3V\T9[/%+&KJ?[P!K_'@O\
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M "FO^"LWPY\-3?\ !3_]N34;W3U@O-?^/WB6XENE4QR3O'%:CS(W1H9/,90
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MRU33KJ"^TW4K2VO]/O[619[2]LKV%+BTNK:>,M'-!<P21RPR(Q62-U920PH
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M+\9O"+''^S=.020<8[#'<<\<5_H%OU'T_J:_@L_8'M8%_;)_9ED DW?\+?\
M"; ;=J@I<L0I[<'C& ,"O[TWZCZ?U-?QM]*O_DK>&.G_ !C5;_U;U;G^A/T!
ML7+&<#>($Y6]SC3!Q5E9<KX=HM):6T::?GV&45Q/Q"^)7P[^$GA/5/'GQ3\=
M^$/AOX)T18WU?Q=XZ\1Z3X5\-Z:)7\N$7NLZW=V6GV[328CA22X5I7(2,,Q
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M#)*QC]_\!Z]X9T:7Q&FM>(["P>X\3S7L,.K:A%'-#%=VFG2Q00K,^5A!.(4
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MPUYNO:C.-?TZXM4U!+2RN]7\<ZAH]U>6EG(@CF:P7*(CAP\<A(+YVDE5!/\
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M#P]I-Q?:\OBG09M$M]'1OU-_X*&_#+]L?PYX=_8R_P""@?[*WP*U#QS^VO\
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MRD_'#]G+]MWXG?";]O\ ^'7Q<^%?[?\ \1OVCOB#\#OBWX4^$5[X5\=Z'/\
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M[4--L)(K>9'C_>2B@#^3OP'_ ,$1OVLO 7P7O/#.B7/[.FG^*/$_Q4^%]_\
M%KP!)XTU3Q)\./B1X ^&/PTUGP1I.O>%+WQ/\!K[3_A!\0FUG5+;4;V\T?P-
MXAU/7O"UL/#VL>)'NXUU"3[%_P""6?\ P2*\<_L;?%;PQ\5_C]<?!3XF^*/
MW['WPC_9X\#^(M'L-2\1>)O!?B;P+\2_C#XJUW4/"VL>*O#MA<:)H5[X7\?Z
M!X?L+K2FL-1>+2[S3Y+2UTM8(9?W_HH **** "BBB@ HHHH XOXDG_BW7C[K
M_P B3XL_30;^O\:*.T7^T=254Y_M*_(()Y_TRXSR2!SWR,@CC)Q7^RY\2/\
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MQI4J--5*E2K5G+EA"G3@ISE*4ME&+\[:M?M__P $0_BU>_#GXT^.OAU-%/\
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MTE56%T50Y7=&?OYKU;1?^"C6@6T4$=[\+K^!(T1$33->M9(8XXU"+'&9[:#
M1  JX  7&<#-?W=]'G-.%^%\RS#B+B3-(9?7E@:>7973EA<3.HX55".,Q%2>
M'HU5%RC2A"$>9/EFWI:S_P K?IPY)XE>(.19-P7P!D-7.\+3S6OG'$.(I8[+
M\.Y5,-[>GEF#A3Q6,PTI-RQ%?$U)0BX+DITW><]/U+L-,MP<+&549VC"XY)(
MSG& ,#)!KK;.R0;4^0#_ ("IQP1C:3G'0<_TKX7^'/[=GP'\:7-M8:KJ.L>
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MAK_P0A^.WPEA^"WCWPI\6? 'B#XM>#?BQ^VQXL\7>$_BCXE^(OQ!_9ZTF/\
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MH **** $/3\5_F*L+T'T'\JKGI^*_P Q5A>@^@_E0 M%%% !1110 5_F'_\
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M&/CQX%MM)N))-2ET+5-62PTRWG=2S$Z5?2VNH:9<1&3YV@1[=CGY,@$_DO\
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M<+LE^!?C$JKF157XO>/EVMD'"XU<$*",JH.T<X&":X#XG?MH_ME^,/",MO\
M"7XP:+\./'M@TOV:36?AWX<\0:3KJJ0Z036VH1Q/9W_#10/#,MO.'R\8D"D_
MF%^TE_P6)_X*1_#W3/B=I7A7XG^&M/\ %'@N3288V?X6^$[V6"5+'3+K58FL
M[JR=99)2]Z\,>V5RKHL <*H/Y/Q!C\TX7S3!Y'GF%S#"8K'YO3RC QC4IUJ%
M>6(K8:AA,;3G"48/ XR>*BL/5C*I-SI8BC4IT<135&?Z9PGGV2<:4:];(\3"
MJ\+@ZF.Q=/$4I8:IAZ=%2=2G-SYHRK)0NHPDU)2A*+DKM?KB/^#8O_@C[D8^
M OC$$%B#_P +>\?\9'S?\Q@\'&3[^E:FF?\ !L__ ,$?],U&ROW_ &>-?U5+
M*82G3=7^*?CZ^TJ\4')M[^S_ +:B%Q;N0-\1=<\<BOXS?#/_  <^?\%>H?$7
MQ M_$/QE\!ZIH/AOS[?,/P>^'MAJ-ELDW12V-PFE_9Y[XHNTQ7MO/;.AEW1I
M)Y;I][_!G_@X(_X*1^//@M)X^'QK\(:GJ::YK=I;3WOP8\$Z9)+;V%S$D5O=
M:5#'<P(T6YXFDCF9KA0)55#\M=N?T\9PWERS+'UF\,\7#!\E"I*5;VLIU8<_
M)*%.]).D]4^JM>]E[^"C_:&)6$HQM-QYU*HDJ?1I.2YFG9IJUU;5/1G]Y?P,
M_9^^"G[-/P^TCX5_ /X9>#_A/\.]$5AI_A7P9HUOI.GK*Y_>7=X\8:[U34)L
M 3:EJES>W\RJJRW+A%"^QX'H*_";_@E]_P %?K;]KCQ%9_ KXZ:3HW@[XZW.
MB3ZOX3U+0EDM?#/Q+M-,LEO-8@M+&X>1](\3Z?;"74)M-29[.]L5FFL1&UN]
MN/W6+@ '!^8 C\<8S^?O7D8''X?,L/#%X:HZM*HY+GDFI*<).,XS4FY*2DG>
M^^YK5I3H3=.I%QDNEK)J\DG%]8NS::_ 7:OI_.C8OI^I_P :B+')Y(_$T9/J
M?S-=AF2[%]/U/^-&Q?3]3_C463ZG\S1D^I_,T 2[%]/U/^-&Q?3]3_C463ZG
M\S1D^I_,T 2[%]/U/^-&Q?3]3_C463ZG\S1D^I_,T 2[%]/U/^-&Q?3]3_C4
M63ZG\S1D^I_,T 2[%]/U/^-&Q?3]3_C463ZG\S1D^I_,T 2[%]/U/^-&Q?3]
M3_C463ZG\S1D^I_,T 2[%]/U/^-&Q?3]3_C463ZG\S1D^I_,T 2[%]/U/^-&
MQ?3]3_C463ZG\S1D^I_,T 2[%]/U/^-&Q?3]3_C463ZG\S1D^I_,T 2[%]/U
M/^-&Q?3]3_C463ZG\S1D^I_,T 3!0.@I:B5R.N3^/2I: "BBB@ HHHH 1AN&
M/Z9K\[?B9X3@U7QYXIO)]SR3ZI)N<@-\L2)$BC/*JD:JJ@=!WK]$Z^'OBUK&
MG>#S\0O&.LB[;2?#-EK?B/4UL;9KR^.G:/92W]X+.TCQ)=71M[=Q! GS2R81
M3D@U^7^*E*E7R7 0K0C."S*,K25TFL-5]ZVSM=[WTZ'Z;X69C4RS/,PQ%*;I
MSEE;I\T6U+E>*HN45;5IVBW'JTK:ZGA$OPZMI<[$7[K?P_7 R ?7/3&?RKYE
M\+_#J'3OB_\ '<F$*+O5OAM=K@ ;A#\.M*M&/3LT+@XSTYKZY^$?Q7\&_&BP
MUK4/!\>MQP:#=Z?9WRZWIT>GR%]3L%U*SDMECNKKSH9+9QN+^5+%*K121(RF
MN)CTF6/XW?%*W 81WOAOX=ZK&0, [;35=)<],')L=IX!^7'.!7\^XK)\NE1;
MA0IIN47S<L91E&[DK)Q]U.7+))7V\C^C,KXRS".,]C6Q-1*,9IPFY1E"?NI.
M2YKWY9-6=WKYG _%#1M \-_#*Y\:ZYJ=KX>T'PG:ZEK?B37+]F33M)T#1;>^
MO+_4;QD5W2WM(&EFN'57;8@"H3Q7\]_QS_X* _L _&V.QT*[^)>F>.?"7A_4
M7O["?3[7Q%;6FI:LL#VQU.+R&T^:XMTAEDBL&F7:R.TZH&<$?IA_P6=_;P^$
M?[%/[%WC'PAXF%GXI^+WQ]\+^+OA[\,?AFMY''>WUMKNGW&E:WXUUM!OFL?"
MGAJWNVFDN3$3J6I_9M*M-SR3-#_F]>&=>U708C%926ZQM&(_WUA9W)*>0T&(
MUN()1#@,2HC*A'"R+AT5A]QPKX;X;,9?ZQ6^K8NG3P^'P?ML-2Q.&G3C3<:E
M6-*<X6JQDVE.[M&3W>WQG%'BCB\-1J\-Q;KX.KB\5B<:\/B)X;&*]:,J5)UU
M&=Z$G%.5)IQFE9^ZK/\ NV^ '[7_ .S5>^$(O ?PPU[3O$-UIK,GA7P5-KHT
MCQ%>M<7):32=+;Q1=_Z9^\=WL+;[23EC!'A2JK[3>:AX?\;?%KX61P6=]H/B
M+3]&\=2ZWX1\0V7V'Q+I"R1^&7B>YM1OCNK60<Q7EE+<6<O.V;Y<#^)3]G/X
M<^!?C=XFL_A]XY^+FI_!KQ7J300^ O&DVGQZEX3N=88F2WT3Q'-'=66HZ)<7
M5PT8T[6H)9H?/VVTZPDQO7Z?^+[C]H[X:>-? /A?XA^,?'R>);;Q#I'PNL_%
MT_Q"\7W6KZ[X<N] O;HS>&[^;4'^PZ--<:3%/);VT\8>WMUBF1PJA>/.?#F%
M/-JV(HYI3I5Z]*K4JT'@IX:@I1I2E*OAN2O[.<9N+52DG*2FMUS/E]#(O%"L
MLHHX;$Y5B,7AL*Z5+"UI8VCB*[ASJ*PM>U&%:$L.G^XJU6H.G\49<JO_ $T?
M%#]C72_B%+9ZYI=Q-X<\0Z?]MFTO4ETJSU:.S>^<32RVMO?(%MVE*1@F&1-J
M@^7']W;\7_'G]DGQGXX\5_#6X\<^(-6NO%V@6-YH.G>,?#,:>'&U+2=/^U:H
ML.N6$4EQ9SR++=/-L6,P3O&JM:)M:4_DI\3KSXM67P\\=:M'\5OBO(=)\):_
M?07]U\0O%TIMKJPTZ>:WEB=]5*JT<T2['1248+U[?I7H_P"UOX];]@_]G'QP
MOC"_D^(WAZ'0_#GBSQEJ.G+K.I3W4GAF8RC55N+._P#-N;P"W>&_FC,EQ&@:
M1UD?Y]L.X9'@,)B:F.J8VG[>KADZ&':E2<,-3KQ@N>=3W:T)22;<5S0:=G:_
MD8N&-X@Q^.H8? 8; U.2A7MB<3=5H5\15P_M?<C"SI22<[J_).+CU.4N_#=C
M\,+AO^$VTKQ;>Z/<6<$">)/#]Y/):Q- \I":]I@NI9]/N)_-W/<6;7>G[8D)
M>WDF-O%=N?%W@*WTN\@L/#GBK6++5[<&2&YU836+>8 UO=6Y1;D+*, QSV[J
MX5F7S!P1?_96\?WWQB\:>/[/XH>,Y+[0-+\#R:^ES?VT6BV>E7 U:QA&K/.M
ME:VUO%'#/)',;K-JJ28F"@@UMCP2=&L[?0=&2?4K#2H_L5A=G9*UQ91,1;3O
M.BI"YFBVR;X0$?<&4;37Z]P/F5#-J?-AL/6;A:+52%Y/WN7W;-P;35W&[DNJ
M/YT\2L#B<BQ=2AC\3AYRE#GC]7FX0Y91YDI*<(33_OI6TLFV>22?$S0_#UQH
M\ND?!TW4']I64=IJ5YK]Y#>+=V\ULYF^R1VLDT+I(?-MF:=FD"%EDW(<?WZ>
M&;N6_P##'AN^F!$U[H.DW<H))(DN=/MIG!)Y)#.1D\GOS7\(]YX!U.>2V$EI
M"I^V6<H\U\%72YB<,'3.PJ><Y  R",$Y_NT\)J4\)^%D8@LGAW158@Y!*Z;:
M@D'N,C@U^L8^EB*>&P3K0Y(2]LJ5Z<(/1QYHMI*3Y6U\6U[K<_+>#<;A\5BL
MX5&;FZ:PKF_:SJ7;E7BOB;C=*-G))726KL;W^?Z_@,<DG@#K5>&\M+E!+;7,
M%S$SM&LEM-'/&9$.'3?"SKO0\,N=RGJ!7Y6_\%E]!^-GB3]B37M/^#FF?%+Q
M#H\/Q2^$&H_M">%?@=<WUI\9_%?[+MAXUT^X^.7A_P"&4FES0:O+XBU#PBMP
M)K/195UC4-%BU:PTPF\N8D;\G/$/Q^_9O_8X_9Z^)?[:G_!+?X7_ !^^'/P5
M_9V^*WP+\7_MB?#GQC\/?BIX)\!?'+X+WMMKWA7QAX=^%EC^T 3<:=\1O!$N
MN:/X@\8:]X.T[2[J\O\ 3+.PUC4]5\]T3R3[X_J]HK^1?QS\;/\ @L=9^&?&
M/CFY^._Q5\.>+/ 7_!/7PC^V_IGP_P#!_P  _!'B;P=XH^+WQ!_:&\93Z9^S
MIJMW)X&OM5U.+PE\&SX8\*ZUH'AK5X?%DTL+>(IKI+B1GGYWXM?\%$_V^/"O
M[0'AG3?&7QK^+OPD^+GB_P#;:E^$>C_LBVG[-NFR?!6^_9ENOA7XA\3^ /''
MASXRZMX*U*]\0^+_ !G>6FFZM<1VGC:35'U"2]\-#POI@TZ1W /["OZ<GZ#J
M?PJK!?6-T\D=K>VEU)%CS4MKF&=X@3@&18G=D!/&6 &>.M?SZ?\ !.;XL_M_
M7?Q*^%_A;]IOXG?%#XR^$?VB?^";^F?M,>(F\>_!OP]\//\ A2GQ[3QFGAK4
MOAIH>I>$?"WA]8QJ/AW5([J;PKXK>Z\2076EMJL BANIK>+^?/\ 9D^#/[?O
M[+WPY_8L_:!^%/[/J>#_ (MWW[,7[9GCWP!XI\$>'/CCXC^*OQU^,FCCQ%8^
M'/@E^U_X4\87D'A70Y$\.W,_Q(\!%M.BL_%FM>&-'\+Z;>6U]=.)0#_0AI"0
MHR>GT)_EFOY /AC^V_\ \%+=4^ &G^(_B%\;/B-I?[/FM?M)?#7PA\2OVI/"
MO[/FH>,?VE_@)X'U3X5ZSK_CW2]0^&S?!3PUH5[H$GQ2M_"WAR/QMI'PX\72
M> K#7-6TG4SJMSIL>H#>U/\ ;5_X*CR_MF?!WX9> _B3XPU7X2ZE:_LQ/\&O
M$WQ=_9[U3P%X9_:L^'GC&":3X\^+?B;I&C_"G5=7\$^/M.*W]AI^FQ>(_AC9
M>"9].T?4-2T6^M-;DD4 _K4T[4]-U>TBO])U"RU2QGWF"^TZZ@O;.?RY&BD\
MFZMGE@E\N5'BD\N1MDB.C896 O5_'_\  OXU_P#!43X5_"C]E;X+_##PIXPT
MW2/VXK/6_AG\/=?LO@KH7AW2?V)_B/X%_:@\:WGQ8^(?C?1_^$3MK*ST'QI^
MS_/-K_A>U\56DUGJ7C;3X[BT=TU0Q3,\#_ML?\%@M<^*/[5.A>(?'L/PT\0>
M!O"'[3L'B#P%\1?@AXJUK1/A+IW@S7(M*^!'Q)^%"^!_@_>W'C"XU?3%LK[4
MEOO%_CB#QC%K]SKNG>';&'P]-IL@!_7_ "2Q1 F61(U5&D9G8*B(@+.[NV%1
M% )9F(  R34:7=K)$D\5Q#+!)&9DGBD22!XE!+2K,A:-HP <N&*C!YX./YRO
M@[^U!9?%C_@ES^T7X[_;[^&O[3_QU\(?##XER:3>:3;>&M9O_$W[04&GR>%-
M4\+Z3\)8?A7X#^$/B;Q?\/[KQ1=KHFJ7_B#P/H,+JFL6GB%;[2-/GFF_/OPC
MX%_:^^(/["WB[X5?LI?#'Q9KO[-WQA^(WQ[^,/[37PT^&?C_ ,9_!?Q7^SKX
M9U7PC!>^ ?V,?@=>_'+PUX8\6:MX;N;B*Q\1_%;QKX+M?(O[VYUGP?X ^RQ7
M\C( ?V=?:;8P_:1<0&VV>9]H$J&#R]I8R><&,?EA06:3=L502S "A+JVE@CN
MHKB"6UEC$L5S'*DEO)$PW++',C-&\97YA(K%"OS XYK^'+PWX;_:BT7X1?\
M!/S6?B+XQ_:T^$6E^-?^"-W[0_PEL?@QIW@2^\9^'O$'Q@T/P]I-OH'P]\9:
MAI?@?5_$'A+7_C+HR'Q3+<>++_2O%F@W&F0Z-I.NZ<?MEG+^I'_!/W2?VU],
M\!?$+]C7XC>/_B3\6? WB3_@DU\#/B-\)]<^)7PYTOP!J7PU^,OQ$\&>,OAU
MKWP9TWQ5H.BZ'#?6VA#3="OI+'Q/<7_C/0Y)4GU&\*2>;( ?TBK=6SF(+<0,
M9QF#$L9\\;=V82&Q-\OS'R]W'/2FB\M#<&S%U;?;!'YQM//B^U"'./--MO\
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MFB:I;/G9<:?JNEW%U8WD#X^66WGD0]B:^L/,-NB@@@9(P!U)X _$TN#Z'\J
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MG4-=TNSU_4/#6@RVT&N>(;/2+BZCOKC0]&EO+2/5=5B@:QT][JW6ZGB::,,
M==17.6/C#PIJ>OW_ (5TWQ+H&H>)M*TO3M;U3P_8ZSIUWK>F:-K)G71]7U#2
MK>YDOK+3-7-K<C2[^Y@CM=0-M/\ 9)9A#(5Z.@ HHHH **** "BBB@ HHHH
M0]/Q7^8JPO0?0?RJN>GXK_,587H/H/Y4 +1110 4444 (W3\1^AS_2OY@_\
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M_>;>MT?GK^UI^U+\8/VU/CYXQ_: ^->M2:GXI\67C)IVDQ32MH/@GPS;RO\
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M=SYU6<G*LJG-SJ4XQG%/EFYM<[_#O_@K9\)_%'B'XN?L1_&GQW^S[X]_:_\
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MZ^%7@_Q!XET#PUXBTO1-'F^(.FZ/\0+C7;"P6VLGFT\_:=(+A+94C\*\6?\
M!/;]I']B_P"%.M?M)^%[G6M8^)GQE\%?LY?LZ>)/ 7_!/?X3ZK^S#I'PM^&N
ME:Y_PE'B;XO_ ! \+^ 8?B-\0?B%XZM+UHO#7B35O"NA6_B?^Q[AXXS;1"]9
M/WZ\+?\ !0[]DCQK\=+3]G#PC\35U_XK7?Q#\;?"ZQTG3-#URZT>Y\9?#KX<
M:)\6?&5E:^)XK%O#TMIH_@CQ#I.I/J4>H&PNKFY;3[2>:\M[B&+ZK/Q#^'J:
M0?$)\>>"TT 7EU8'76\4Z(-'&H6:,][9'4S??8Q>6J*[W5L9O.@57:5%"DT
M?R\?\$^_AM_P4?\ VF?B7X0\._MC?%;]NOX4?#CP/^R/X_CL+RRU"_\ A/\
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M%!JWA*_MM0TZ73X)%N9[:RMEN+PS0P_;OPW^)GP^^,/@O0/B/\+/&7A[X@>
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M)PV?4D5HI9$>-E0)+.S9B:4-YD*X)4Y^XZ,?W3\X+;"2O3I[_3[>TN1;R!B
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MCC\!?C OC?QWX6^*=[H6GR:C-X6^(?A!IO#TWCH6\VI7+F"PU?2Y]&\^W?\
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MV^75]-MX8=5>QTV]C@M[^XMX+J"XA^T1?,/P_P#VB/V-/C?\9]$^$&N_L7?
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M3[&RT*QLO'5N;K4$O+6*\FN=*TK2-/O-3N3$>^OO^"('['\FF-H^@>,/VD/
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MOVWO'/P^^%GP[34M;\#2>,/#&F2^%I/ [6>D7'BSPK9VXLK*Z2[M=^I)/,L
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MB_\ H-P__@%;_P"0#_6?#?\ 0)7_ /!E/_(_UQ]Q_N']?\*-Q_N']?\ "O\
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MK_(X_P"'J?\ P4T_Z/\ ?VLO_#R>)_\ Y(H_X>I_\%-/^C_?VLO_  \GB?\
M^2*/]3<7_P!!N'_\ K?_ " ?ZSX;_H$K_P#@RG_D?ZX^X_W#^O\ A1N/]P_K
M_A7^1Q_P]3_X*:?]'^_M9?\ AY/$_P#\D4?\/4_^"FG_ $?[^UE_X>3Q/_\
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MX5_D<?\ #U/_ (*:?]'^_M9?^'D\3_\ R11_P]3_ ."FG_1_O[67_AY/$_\
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M\*-Q_N']?\*_R./^'J?_  4T_P"C_?VLO_#R>)__ )(H_P"'J?\ P4T_Z/\
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MLO\ P\GB?_Y(H_U-Q?\ T&X?_P  K?\ R ?ZSX;_ *!*_P#X,I_Y'^N/N/\
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MJ:G?Z9<6:R6YZ75O'?[&^GVR?\([\+9==OI]2\0O(^KZ?XVLK+3_  U_8V?
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$?=G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ea027779601_img2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $Y ? # 2(  A$! Q$!_\0
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M+OAKYPQ5_G_L^_?S/+_XBKQ:M/\ B%/%>FFJI7TTU][?OYW/U[^U)ZK^8_\
MBJ/M2>J_F/\ XJOR%_X9F_X*6_\ 1W'A/_PC+7_Y0U$?V9_^"E,>?^,NO#1]
M<^#;<\>O_(OG_/XT?ZF</K_FO.&OG3Q*_P#=<3\5N+5OX4\4KY4__DC]?OM$
M?^Q_X[_\51]HC_V/_'?_ (JOQ_\ ^&:?^"EO_1WGAC_P@X/_ )GZR++X)?\
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M_P#\S]8_ZF</?]%YPU_X!B/_ )G#_B*W%NW_ !"GBG[J?Z29^O\ ]I3^\O\
MWU_]E[?S]31]I3^\O_?7_P!E[?S]37Y"_P##,O\ P4L_Z.\\,_\ A'6?_P S
M]'_#,O\ P4L_Z.\\,_\ A'6?_P S];?ZFY!_T7G#'_@O%_\ S,'_ !%7BW_H
MU/%7W4O_ )(_7K[2G]Y?^^O_ ++V_GZFC[2G]Y?^^O\ [+V_GZFOQHU'X)?\
M%!=$N=-L-;_;8\ :->ZO<?8M'M-7\*Z)IFI7VHD#":-')M;7CAN8F3<,$,H(
MP-C_ (9I_P""E?\ T=YX:_\ "#M__F?I_P"IF0?]%YPQ\H8E_E0:V:_+H+_B
M*W%G_1J>*ONA_GON?K]]HC_V/_'?_BJ/M$?^Q_X[_P#%5^0W_#,O_!2S_H[S
MPS_X1UG_ /,_2?\ #,__  4M_P"CN?#'_A'6W_S/4?ZG9._^:^X9_P#!>*_^
M9RO^(K<6=?"GBKY*E_\ )'Z]?:4]5_[Z'M_M>W^<FE^TI_>7_OK_ .R]OY^I
MK\@?^&9_^"E7_1WOAO\ \(VW_P#F?IG_  S/_P %+_\ H[GPU_X1UO\ _,]2
M_P!3<@_Z+SAC_P  Q7_S.+_B*W%G_1J>*ONI_P"9^P'VB/\ V/\ QW_XJC[1
M'_L?^.__ !5?CU_PSG_P4C\[R/\ AL#PG]H_Y]?^$-M\>O3_ (1_=U]NO%6/
M^&9_^"E4@!_X:Z\-CTQX-MQ^O_"/C_/X4_\ 4W)_^B^X:M_U[Q.W_A.'_$5^
M+/\ HU/%/W4__DC]??M*>J_]]#V_VO;_ #DTOVE/[R_]]?\ V7M_/U-?C!XC
M^"G_  4%\'Z;/JWBK]N#X;^&='M[H6IU+Q%X6T3PYIRY&0&UK72PW=0!DY(.
MW)!K8@_9O_X*272">W_;!\*7%N>A_P"$.MQ^7_$@ST_V:3X-X?5K\><,:].3
M$Z_^6^E_.W47_$5N+=?^-4\4Z7Z4U^OD]KG[#?:E_P!G_OH?_%?YY]LGVI?]
MG_OI?_BO\\^V?R!_X9I_X*5_]'>>&O\ P@[?_P"9^G?\,V?\%*?^CN?#7_A
MP?\ S/5/^IW#_P#T5G#/KRXC[_\ =_F'_$5^+?\ HU/%/W4__DC]??M2>J_F
M/_BJ/M2>J_F/_BJ_'[_AF?\ X*7_ /1W/AK_ ,(ZW_\ F>J;_AF;_@I9_P!'
M>>&O_",M/_F?K/\ U,X?_P"B[X9_\ Q/_P SC_XBMQ9_T:GBK[J?_P D?KW]
MJ3U7\Q_\51]J3U7\Q_\ %5^0G_#,W_!2S_H[SPU_X1EI_P#,_2_\,S?\%+?^
MCN/"?_A&6O\ \H:/]3.'_P#HN^&O_!>)_P#F<?\ Q%7BWIX4\5?=3_\ DC]>
MOM2>J_F/_BJ/M*>J_F/_ (JOQ@UWX,_M^>&9-+A\0_MO_#?PW<:K>&TT>TU[
M0=$TUM9U/;N_L;1EU\!M>;! " &3G[F V-[_ (9I_P""EO\ T=YX8_\ "#@_
M^9^C_4OA_P#Z+OAE^D,0[];?P+_U;>XO^(K\6=/"GBK[H=[=_P"O34_8#[4O
M^S_WT/\ XK_//MD^U+_L_P#?2_\ Q7^>?;/Y!_\ #,W_  4K_P"CO/#G_A&6
M_P#\S])+^S9_P4ICZ_M=>&OQ\&6_\QX>/_UL5?\ J=P__P!%9PSZ\N)^_P#W
M?YA_Q%?BS_HU7%7W4_\ Y(_7[[4GJOYC_P"*H^U)ZK^8_P#BJ_'G_AF[_@I+
M)]W]L#PIGV\'6XS_ .4 ?YS^%S_AF;_@I;_T=QX3_P#",M?_ )0U'^IG#S_Y
MKSAKY0Q+M_Y;@O%;BU[>%/%+_P#!?_R1^O7VI/5?S'_Q5'VI/5?S'_Q5?D)_
MPS-_P4L_Z.\\-?\ A&6G_P S]0_\,T_\%+?^CO/#'_A!P?\ S/T?ZF</_P#1
M=\-?^"\3^N'!^*W%O_1J>*ONI_I)G[ _:4_O+_WU_P#9>W\_4T?:4_O+_P!]
M?_9>W\_4U^0O_#,O_!2S_H[SPS_X1UG_ /,_1_PS+_P4L_Z.\\,_^$=9_P#S
M/UM_J;D'_1><,?\ @O%__,P?\15XM_Z-3Q5]U+_Y(_7K[4GJOYC_ .*H^TIZ
MK^8_^*K\A/\ AF;_ (*6?]'>>&O_  C+3_YGZ/\ AF;_ (*6?]'>>&O_  C;
M3_YGZQ_U,R#IQYPTO/V>)T\_]WZ;_(?_ !%;BS_HU/%7W4O_ )(_7G[2H'S!
M5]B5Y[_WO7.!ZU7D8%PTVTH>FP9Y]\9[]>/?UK\CS^S+_P %+#R?VO/#/'3/
M@ZT)_#_BGS7G/BGXA_MN?L<^(O GB+XX_$;PS\7_ (.^)O%VE>"_$AL]&_LS
M4_#[:XS+'K3>7X>'F(KJ08Q(%(!4X#'.O^HN$Q3^K91Q7PSG>:\LG",8UHRD
MXQE.R=6C3CS<L'&*NFW;5ZVYJ_B[C,L2Q?$? '%.1Y0W&#J24)1BYRC%.?(W
M:/-)-ZK2]D]#]MYQ!''-<-)T&03@@>@_'WY '2L^XUG2K$#[=J6GP3^MU>#3
ML<\9W$'/0$X)X/UI]G/'?:;;2R-NBO+4G<.^0#D]3C)Q^!]*_BQ_;5_9:/[:
M?_!>OQK^S#KGQ1^(7PYT+Q-\*/"_B8:[X)U!-]F^@_#'^W53^R)&5"[M\H=W
M56+ EAG)^ Q57%X27)*TW&3IV5]6I.+LKW2YHR5FNFI^AYQGJRS!Y5B\#EOM
M/[<Y.77E?[R,9T[M:IOFBVVMVWT/[1AXAT27.-=TD]3SJ.D]^_,IY]QC)Y^D
MG]LZ"<9US2SCD?Z9I0Q_Y$/M7\O$G_!L)\-(QD_MO?M'C/7%II/]?$*_AD?S
M%?/G[2G_  0C_9N_94^'=Q\4_BC^W)^UC_PBMIJVG:,W_"*:!_PD6K#4];=D
M0B,>(&RKE6RQ*;1C:'.0%AZ.-Q>*6%P>5IW=KIWO)INRLW>3L]-7UL>1BN*<
M_P JPGUK&9-3MO9\006ETOAM'35+:UWRW3/[!O\ A(/#6?*.N:1GI_R$].QC
M.>F/4?G@^AK0MA&TDA7YG )!Y_F>3C\AU&.M?P&?ME?\$^/#W["/B_\ 8#^(
M'PU_:#^,7Q7TG]HOXQ>!=8L1XUOCX>%EI.A:UX"U_0"3H/B"/:Q77,LH#!#E
M=[_>/]^EBDR"W+2D@)AACGID_@1T/'?I1AZV+C.>$Q<%S)VEK>]F[)^6EGIY
M=#V.&N(\7FW]IX7&97_8W+RV?.IJ7/%2B[QWYEJG9WO=:&_1116Y]@%%%% !
M1110)[/T?Y,_,_\ X*K?\F=?$'_KZ\,?^G[1*^RO@D?,^%?PZ/KX'\+'\]%C
M7\_7BOC;_@JO)C]CKX@GIFZ\,CU_YC^AL?QY'6OL'X*S0Q?"?X:9(,W_  @_
MACKZC0XB/R.[(XX/UK[G'M+PRR1O3_C).(KMV5E[*A:]VM.U].Q^)9<TO'+B
MQ72_XQ?AMQ5TG\4[N*NO)MQ7JSVZBJT4N8P?0?A_CC]32^?[?I_]>OA5'1>[
MT7V?)>1^VW7=?>O\RQ7Y'?\ !3'_ ()R?%/]O:;X477PT_;S_:1_8G;X86?B
MI]8M?@1K6I:;IWCQ?$$F@>2^NK#XI\)G'A@:%((FVD,FL2&0HP K]:?/]OT_
M^O6?>3?Z+<?]>?';GVZG_"GR_P!W_P E_P" ,_SLO^"*W[&W[:O_  4\D_:X
MOO&/_!7;]O+X8']F#XZ:9\,-'_L#XK>,_$A\6:>6\0%=;UG^W_$Z#?LT(!5;
M<F2Y8 [=OL?@C_@HM\#?^";?_!Q)_P %B/BC\<1\1?%5OXL\)^%_AY\//A_\
M./#I\9>-_'7CED^$.N1Z+H>D^9#'"8]$T;5VDDED2-(V8LZEE=?LO_@T2DA%
MA_P5?\K'GG]LK2S@YY'_ !7N".Q'7ZG]'?\ !-?PEX7UW_@Z7_X+":YK.DZ)
MK>N^"_ASIUYX4UB_M(]2U#0KW6]2^!&B:P^C2'+:*_\ 83GPT[!D8(%(E,>Z
M,%O+\/\ @ ?NO_P3W_X*\?LG_P#!1SX(?$CXZ?!^^\4^#-(^"UU>6WQG\,?%
M;28_"_B;X9M#H2^)$U77I4FF\,GPZ^@+KDA\1Q>)_+A'AZYCGC\PL#^?\O\
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MY- \2^*A+X;=UUF2Z\32C_A,9V7P[N@+@(-&#_@[$_X)Q-XLADF^''[86G_
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MZWC91X@VMYC:_KGF*#$%_MYM@_>$K^[_ /PC6@&3_D%Z?Z[OLIR>HSGZ'/T
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M" _\)/XXTUSH']LZ-K1;Q"ZXVZ)H6\>4&8I&6:3#[_WA_P"$4T'_ *!>G_\
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M^2F?_P R[_U8?^KGC?\ ]'!X7_\ $8?_ ,F?S,>*=(_X(E^//C'??M >,O\
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M_A+41?:=XV'C\Z%K>O[0!X>C\6?\)KHN#)^Z9@@&6:/=\O:M_P $T?VFK?\
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MC\.OVVOAI<?"G5[S_0['XFZ1"]_\,M?(ZA9H]TD?/WL!B/NX SC]9I[L>9Y
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M3\1< 9OEG#7'<5G639S/V7#'%<(KF@TU%0XEDXI1GM%57RJH_?UYFU^PP [
M?A2_\M?\_P!ZB!@81@@Y4D<CTS5BOA^NMDT[/R?5??\ \,?NJ::3C;E:NG'X
M6GJFK:-6:L]5:Q69=QC'U_\ 0C52^N-D1XP <#OC'I_]?Z\=*O+G:K$'@D'U
M]OPS_/BO-OB;XOT_P#X(\4>,=3(%CX9T75]>NVP?N:7IDTSKZ@D(RCG@\UT8
M:B\7BJ>#C%SE.=.$4M'*<YJ*2?SBFULF[K0Y,TQ>&RG+\RQ^*:4*5&I4;=[6
MA"4DVUM;EN]==.Y^5O[8?B;Q5^U)\>_!_P"Q-X O+C3_  UIHT[QG\?_ !!I
M5V$:R\*,2RZ$-PW*SJJ>8K\;]<\,L0 M?JO\.O 'AGX>^"O#W@?PEI5MHOAS
MPSI"Z+I%A9@;(M/ 5@@(R<$\[B6).<8! 'YM_P#!,/P#>ZMX(\=_M,^,,S>-
M?C[XPU;Q0+JY &H#PL-5=- 1@,$*JEB , ,J<]*_6&.,0H<8+#^7('X8R#T'
MYFOL..,50P>)H\(Y54OE.24J2JSORJMQ'.$/[>FU&S<?:ODI<\I6A':[<C\E
M\)LEQ69RS7Q&SI*6=<8U:CH<ZO*CPS2G..01I<S?LG[.+E/V?LW=N[MO%#:>
M5C]Z>AZ ''^?Z_6F7[@6[$-&>GWB2.G;IG ]NG ZFK<IS#,3W'ZDG_/TKYR\
M4_M%?L_>%?$VH?#;QY\</@]X=\<&R#7O@OQ!\1O!OAOQ/:Z9K(PK-H>N^(O,
M?< ,;5967;M!5@K?#1PV*F_]CC*4EK91E.22U>T9RLMK]#]D>(AA;*32MU;6
M[T3U?7T/X)_^"GWB#XC?\%1/^"Z?P0^#'_!-#]N/Q9K=SJGPE;P=XJ\<?#[Q
MKKFE_#/]G"STAO$(^.?]A:UH4_AN;7[=M T)/$OBZWCG9O%GBK7H=/A:$"W$
M/T/^TK_P:M?$+]DKX">/OV@OV"/VZ_VB-2_:2\*?#GQ3K'C;19T?P<?BSX5_
MLC^VO'>AZ!K7@&:W\2:++XF168>$O%,OBU/&4JF":4<5\-_M#^*OV5?^#=/_
M (+O?#?QE^SE<?$3XI_":X^$@U[X_P#@KQ3/#=^)M!TOXW3:[_;,?PM\0GP]
MX1\.>(!#X8/A_P 5^#\2F.257\&R^,8UFD,?[O?ML?\ !TY_P3LT#]E7Q?=_
MLK>-?%GQF^._CWP)XBT;X?>#8OA_XS\'KX+\2Z]I1B&M?$_6O$BP1L/"W]L2
M^)0GA63Q4K21,BLC[Y%=K7O[MM)-Z<KV;=[6L[O6VQTKWK;N_17=[]%:_?HA
MO_!J5^U1\*O&_P"P9X:_9LU']IN\^(W[17@[Q#\3O%5Y\!_%5ZDOC/X3_"_1
M];\/Z!I,7@N"7?\ \6\_MK6M"\1+(S2,OB_Q/<1,(RN'_K7G4&'#<X _E_AP
M?7GUK^$K_@V%^#O["GP _9\'_!0[Q1\6?&DW[3WQ%NOB9\#?&&DZK:ZL_@7P
MKI+^+_#WB%=$T31DT"0Z[*1H>@>*Y_$Y\7$1.TD(2)P8XO[=[;QOX8>'PW=/
MXBT2&'Q(X301=7J9UAF174:."P.60A@%W,00< %37S.*XKX8>;2RQ\3T8YKD
M[:JT7.$>;FM%QE3YH\SU4-8MW7?5]$LLQTL+&4LJF\JJN48R<)>])IRDHODL
MVES5'RO2*;T2T\V_:$^!'@[X_?"OQ!\,_&D(?3]3M6%I=@@ZCH>J(VW1]9T5
MP"%D1LG!P2PVG&6V_'W_  3S^,WBVPMO'7[)?Q;E!^)WP$N_L&F7MR-I\0>
MRJIH.N$CKE%$3Y&[&P9 45^G@(NI5)Q.&7!!Q@$# SSQTQSTZ5^0W[;^G/\
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MVL^(?B+H^H'X=^%KO4_%'C'7_$#^,#X<OUT31M#USQQ\9_'&A> /$A\4^/\
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MAHDNL^#TUJ95D7PZR2+XF\&1LFZ"X2>W+.8O,;]6_@99>%/ '_!.;]GGPO\
MLF1?VAX!^.7A'5?'W[1DMMY7B7QU)\39$\-MX@;QF?#CL_AV,L?*=9!$S>#X
M2WEE!%*_\Y?2VPG"?"_T=<W\2> %Q4LYSM5>944YJA*4JCJ).$).FJ5256WP
MN*B^RM^E>#.)S_,_$/*N&<[]G*,>72<HJ-2,7T;DKN48I+=-M75KGK7P#_9@
M\>_M&^$O#'A;P#X=^&_P3^"'P>TE?#/@_P .^$_"7_"-^!M!W,FLZX="T/06
M U_Q"6*_\50,!F)(!=CF;]IG]F#XV_ /3/#4WB_Q?J?C3X=:7>*?#WB'2M5U
MI3X3U0J"I&BD;=$7 *[T9U!!7.5*C]4O^"=7C?P=JO[.7ASP]X?GMQK?@Z;4
M](\2Z;:E?MZ:GJVN.S:LZGY\NKLY8 C:C9(V@-N?\% ?&_AS0OV<_&NAZU-;
M'5O%\>FZ)X=TMC\U]JC:U&54#N2/F)(XP,\XK_*3_B$O"F9^#DO%3%<7<42X
MVCPU_K1+B'_6EW]JI<ZP]6DJUTY3BJ3A."GJTXWW_K2AQAQ!A>-?]4</DT5D
M:KRH2X;EATUR2O"5:-1TM&Z<I5N93Y>2ZO:]O8/V=?C;\+OBSX8T_2? 7C!?
M$>H>&O#WAH:S:75ZS^)K$;<I_;H^7#$+\PP1D,!DD&O&?^"F'A6'Q7^QQ\5;
MD0@WWABQTWQ/I%T0-PU31-:1DQC'W0"".N67TX\K_P"";'PC\/\ AOP+_P +
M?L?$]SK6O^.]&_L;6-#MB#I6@'0]6D']D&,,"=>0[0^YDY.,%3O/TY^W+/#9
M_LE_'/SL$6_PZU;)&,XV2$<=?O8Z'^=?Z ?1<XDS_B#)?#SB#.,N_L?-JBX;
MBI\W/ST[PI>U=I2YE*$E.H]6^:5[NUOY<^D1E.5X7(/$/*\&I2RF'#O$,[37
MO*I&*J<J<HQ3:J1Y*<]KI6E;5]W^S=XK_P"$R^ OPB\3E_.FU_X=^&;VY<,,
MR-)HL;N<'[I+N_KG! '-/^/'BR?PA\'/B=XBMT#:AH/P]\4:O:G=@C4H]$D=
M'XQTD15"^Y)SS7Y+_LX?LU_MG>)/@=\,=4\#_M<7G@+PSJGA+2+WPYX4_P"$
M6T?4AH6F[,KI&]@%(5?E+!CM/R9R"!L?';]EW]L[0/@[\1O$/C#]K[4O%F@:
M5X1\47_B+P^/#$>FKKFF'1)/^)1E2=F1O7/#'?C')K^GZ_ O#O\ K<[\?<,-
M_P"L[FX*.?7N\1*3CI0]FO>?LG9\O.KVY&ZA_,G_ !$SC7_B%W+A. .)^7_5
M-0=5RR/E]G_8'LO;:U.;E<;3YKWTT=_=/K?_ ()>>%XO#?[(7PZO!$!?>,%\
M1>-;[('&J:]K4S/C/JNP>PS7OG[57QWT#]F;X%>._C;XCA-U8>#-+DO;72FO
MTL3KFKLZZ1HFAHQ!!_X2.201QC!\LJ!@D5P?_!/V6*;]D?X&-"1@^ X-ON1O
M!'X$Y[\>N3CYY_X+'>"O$'C7]A[QQ/H5C/J=QX$UCPMX_P!7TJSP#?Z5H.L;
M]:0$#G$;%L=LD]S7R>8X;"9IXCU<)CI*45Q/5C+5J,U&=2$%=N-N>,(I.33]
MY.]VFOU_PY?]F^%'"SPD;2EPO3DXI1NI33E->ZM7&4YWM=73MH?EO\6/"WPO
MT[X,Z-^VE_P64_;#UWX/^'_B9.VH?#CX.^'O$>M^&='\/)K2/X@T+1-"T3P\
MC^)_$7B)?#<;-)L5A#&"\FW*;_H#]F/_ ()\_P#!+7]L7X4:)\:/V:/B_P#$
M7XL?#S5KG4[2UUWPY\8M;==.U9@#KNBZUH[1QOH6O!F _P"$;\60J<%7,8!P
M/Q1_X.7/V8/V@/V^_@I^P=^US^R/X0\6?M!_!_P'\/O$WA[QM\/?A7I>N^)O
M$7A+Q#XA?0=7?6U\&Z"O_"13;/[#?PW<?9TFN;-]#M%9(A<P33_6_P#P:[?\
M$^?VN_V<_P!BG]KR[^.>@^(_@9J/[45_IEK\'_#'BBWD\.^-?#QT#P7K_AX_
M$S7_  ^9(Y] :;6?$6D&!9(6\7*WAWS)%200H^&8<2Y]A<74^I3>40C4J0A&
MG2IQIQC2E*FJ<(QI2;Y(QBFYSE+F?,THN"/K\NRG*L5A$\8TY-*4E[1IMO76
M\T];OI;I?<]5\.^!?^""'B[]IF;]C_PM^V/KFM?'QM6_X1VQ\*VGQ;UW^S-2
M\:B4P'P?H/CH^&AX7\0Z_P"<K1'PROC!U\Q&B&9/E'O?[7O[%W_!(W]@WP+I
M_P 2OVJ_CE\2/A!X9UW57TGP[_:OQ'\9:EXE\4ZI&GFOHFC:'X=\.OXJU\K'
MNE8A6144N[JN"?X4?@[_ ,$1?^"ITG[=G@O]GB?]G3XK^&/&/@_XN^&[S5_C
MM=>&=;L/A1X>TO0/%\.K_P#"R=(^*N%\.Z_"L!/BFW\N6?Q=(%2-8(W\]$_I
M;_X.WO\ @GY^V!^T5XK_ &7/VB/@3\-/'?QX^'/PY\$^*?AGXP\%_#SP[K?C
M'Q+X4\1ZUX@&O+XSC\%Z )_$3:-XL@1+2:3PY'+%%)X?\.EX-C0..?\ ULXH
M3_Y&]2[[N+_.C;T5K6V39T_ZOY3_ -"]6[\S^_\ B?/_ (!^Q'P _P""=_\
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M,7_K_P -0YL3&3C&EG=^:<J%1TK/#2BY<\FG+6#DV_:.S2_!N#/$OC7">&6
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M]M>V%M?6\>(+M?M@'!Y;)![9/ICCCWK^0/\ :#_;5^-G[9O[(7AOPA\"M/\
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M4Z*-"_L#;X>_X1\KN,+1_)C:R$KY6?Q]_;N_X):W/[:G[7WP2^*WQ%M_A_\
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M_M/6_ WCG2?#Z+JZ(5Q_Q3FOZ1- [[]Z[HQ&CLQ(_J%FNHHP1=";&>,=!S^
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M"SE_9M&.<2A"G3Q,(05:$%!1ES590<I7:YTG*R4FN5M)GSK^S7^SOX=_9Q\
M?\(3X>OKG6;V\N9-5\0^(;RT6PU'7M4;[TD@!V@9 51OQC.2NX@?,/\ P5-\
M7C0_V5]?\'V!5O$'Q6\1^&?A[I-H"<WLNNZQ&NW&,8"ALY[L,9YQ^DDMP+.
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M)(;N,D?44^TIYI!!"\=>021QTZ8YP>XK\?O^"@7B&]^.'C_X.?L6^#]US?\
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MKX;^&%S:?$FTU;5=&T_3+KP9XZ\2'R=,T/7K8MK1?04"3)(L11B[H[1Q!/\
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M[NHJ-'1VLS]V(%$#>9)M  QCL,'N ,?ACU.15\R(#E=N3UY/]2?\CI7X+_\
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M4_8[_:.\3>#---V;T_#;XD(WBGPJ#CD$*#*N>@.PKC&6!KQ\_P#!:K1B"/\
MA0_B 9Z[?%V@+D^N1'G]:5?^"U6C*,#X$>(2,_Q>+]!;\,F*OK\J\*/'K)\/
M*A0X3K5,IFN6IAZT:=:C45_M4JWM8J5].>$X2L]=?>7Y)Q-](#Z)?$T7C,5Q
M=2H9P]?]9\*JN'XBB^BYJ3AS1@VK*<)Z1UNG8]D;XJ_\%1O 2FP\0_L_?#CX
ML6]L.?$7AOQ*-*DOL_\ 4#8;E/'(P,>F*F@_:E_X*+ZKFQTW]BVPTZXX N]9
M\91KIGX%40_3G]17D+?\%J](/_- =;SC&?\ A,-#_P#B?Y8'M5<_\%I=!/\
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M7TGOHJ<3X=8;B#BVCG$XW4:BIR52#L[2A4@H3@T[23A4BVXJ]UH>N1_LM_\
M!07X11RP?!O]J+3O&V@6S!;'0/BWH:ZMJ0L,G"C7D+L&X(#8 //(YK2_X3'_
M (*NZ:OV7_A6'P,UF8<B['B";3L=0,(/$)QSW"^E>(#_ (+5Z0/^:$:_[_\
M%6Z ,^_^K_I5W_A]-IO_ $0?73]?%^@_TC%?30\./&G$)K-/"KAO-IO>=2C0
M4FTK)S5&K24G=-MM7;;OIH?GK\9_HUT++)O&[BK(XW_AQK5II)O:',YM-*RC
MYJ+W/6;GPE_P5<\?LL&H>//@]\*K"X_X^3I&FRZOJ*DC&598V0''H<C\:W/!
M?_!,/0]7UJU\8_M*_%7QY^T'XIMF^U+:>(KD6/A=3DK_ ,@".1 >1V<8/')X
MKP+_ (?3Z+_T0;71]/%NB9_7(_2D_P"'TVB?]$(\0?AXNT#'ZQD_K4UO#OQX
M="6'RG@F&0.:LWP]A\+SRB_LSJKVE646K*SJ<JLVE?5:X;Q?^BM'%1Q7$'B-
MQ/QM)6:7$U7/I04E9W5)3A"R:3MRVM:_NJS_ &J\'^#/#W@?2+70/#&CZ;H.
MB:6GV2RTS2[%-/L;-%&2(TC51MRP/R*3SC/.:ZF&*9I.#D>N<?3KSD?7-?A6
M?^"TVC1=/@1K_P#X5V@'O[Q'/K^ ]*C;_@M5I!Z? KQ"/IXN\/\ _P :KXC%
M?1^\:<7+GQO"5><[W<I.,I.^_,W5YDV][R[W3LC]4PGTN?HTY1A(X/ \6TH0
MCK",*;BH):I1Y%%+E2LN6*>F][W_ 'M,L6/E<'DC[V#UY/Y]N<>N*>9=JA@&
M(]./T'3L3_GG\F?V:/\ @I[X#^/GQ)L?A;KO@K6? &NZXA;PW=:M?:3?:9KC
MK@C1S(C@C70,AHMC%NS8X/ZN(<N2#ZD>_IP:_.N).&>(>"\U63\2Y3+*:D8<
M\8U7JT]MM%%R]WF5TFM^K_?^ O$7A#Q+R?\ UCX-S:.=91=1<H6YHRLKQ:W3
M\G9^I;;[R?3^:C-?&/\ P4%_Y,Y_:!_[$+4_Y&OLYOO+]/\ V45\8_\ !07_
M ),X_: ]_ 6IX]^#T]:Z^"$O]<>$+I6_UFR'FOM;ZWA[\U]+=^;3N</BXW_Q
M"_Q$<6TUPAQ+RM7NI?V%7Y;-:I\VUFG?;4_D'A\C_2//Z?K^/ZYS^'>OISQ#
M^R-\6_#FA>-O$4DWA;4;;X>:MX;T?Q':Z5</J&H_\3G1O#^M'6CO4!?#_A5=
M?T1O&6>70/)'E5)KY9FA_'[)_D_G]?3GT_0:3]MHR^+H/$]AX*N[:P'CK3/$
MWB/3+K5ESXK\+GX9:#X#USP:%(9<H=$'B@;P5) R#D@_ZM^)^8<?96\D7!=/
MFI.@W4<(0DW42H<E/7_GY%U(II-*7*Y2BEK_ ,\GAEEOAABJF<OQ'S649>TJ
M<EG)-7G4U]V/,[:72>JOWT\PA_9!\?\ F_V7/XQ^&]MXFN_%_B?P!X;\+7=[
MK&FZCXL\3^!<G73HA/ASI@9[C'4]ZX"T^ GC^[U3PQH?GZ-;ZCXP^'/B7XL6
M9NPQ^P:9H?\ ;@US1=:..?$"_P!BC)'RJ0V3\K >^ZA^U7\/M1U71O%6N_"_
MQ9JGB?P9\7/'/Q:\""T\6Z-IOAFPU?QP6UW1-)UP[BVO_P#"+%D&/"I;;MX)
M+,3C:5^T]X7?1_#WB+5O"/B74?C+X7^'/CCX3Z-=V6K_ /%MK[3?&KZ[(-8U
MS1#GQ-_;[_VR X*YP6PPR"OYO0SSQY<?]KR>I)N27O4J34>:*:DTIN/LXRNY
M2=Y)NSC*%F??8GAOZ._-;"9O+E?G4=U=]]6[6T[O>]S@Y_V8;^T\3> _!6M?
M%KX;^'_&'CRR\-7=IX=U3_A,/[5LG\;Z1_Q(]#7/AU5#E]9P-S 9^\0<XWM,
M_9"\5:O>Z]IFF?$SX3W]_H/CG_A69W7GC ?VW\3QHFO:^W@K1C_PCA Q_8AS
MAB,*V"1C-F\_:/\ !]IX7^!.AZ5I7C_Q%_PJ_P"(_ACX@"[^(.L:+J>IV.EZ
M%MQ\,_!&NZ  ?^$>&, >*SC'4GC;N> /VR+[P!-XXNM*\+:C/9_$7XZ:O\6/
M$, NM&)O/ GB#1M<T,_#,*S%3XAW:Q&?^$G\*@@E0"2"0U/$^.^)P?US"49N
M26L73R*"ERY])/W9-3C>E%)1:UBTU)<RY>_#9/X"X;%M8N;>4Z\KYI-J4LBN
MG9.W\5\S:5^;HWH_&]<_9X\<>&_"6H>/[[5/"?\ P@]KX<\,ZQ:>(+2[']F:
M[JNNZT= _P"$-T3J!XA\*>(M#UL^->^&!P#D#E]7^%/BG2/A3I/Q>GO?#USH
M&N>(D\-VFE:5<OJ/B.QU)]'<!=:T<CR]!<&-BZ*Q:,%&=5$D9.UXC^+$.L_!
M?0/@]I7]MVVD>%_BGXG\9V8N]8&HZ9_9>N;O["T7KD_\(GG@<]\=36_IOQ-^
M%%E\#K#X67WA#QY<ZK_PG6D_$W5M?M-6T;3?#@U<%M"?1]%;?@J?#?\ ;0"A
M 00Y+MN 3[_#9CXJ83+\KQ6.RQU)_P"M+4U&G3O_ *MJG-.4DIVCSRM+FLY)
MVC&'++W?SK,<E\(\7G&:87*,T?L5PQ>+;DH_ZP\\6U%M6DE3O&R:3O=M6L\C
M3O@)XJUGX:W/Q&AUSPW;7 \.>*/B!H_@B[_MC_A)=<\!^!M:_L+7?&0 QCJ,
M #'/'/%>(1,8IK<$\W%V!T _D><?3I[U]:P_M!>#M+^']SHFA>#O%FF>,-#\
M"?$_X,^!?M>L:/\ \(S8>!/'/C)=<&M:WD\>(?"BJ/RZ$MFODG,'VJWMX/\
MCW-X/R^G'KZ^^*]'AC,>,,TR7C'_ %QRGD@E7?"UX**Y.2O9:6V7(W*2;NIK
M:S.#.<OX)PN?<&_ZH3E*;K87VK3;;FJV&YN:S?VN=ZOL_)?W%>"H\^"_"^9O
MW_\ PCNGC/!)(TIAGGIZ^H%5?B+&8_A]XT'FG_D5M4!]!MTEUSVSG;GKWK0\
M$Y_X1'PN2,9TG3O_ $U.?ZU1^)/_ "(GCC_L7]4_]-#G^5?Y&TFWQ'3OUXKI
MW72SXCC?_MVS?]VWD?\ 11BKKPZ;5^;_ %*?>_-_JHUNO>O?SYK^9_#K-_J_
MW$'_ !ZX]NF?7_Z]?3_A3]E3XG>+]"N-=\-7_AS42OPM'Q9L])QK7]IW_AC^
MV-=T3^Q1G.?$'_$D S@C(QV-?,!_Y;_A_6OK[1_VJ[[PMX.TG0O"VA:CHWB?
MPWX$\!^"M(U\ZOHI^Q:GX&^)@\<_VP1R#X=. #D<@XQWK_7#C/$<>83(\B_U
M BFG2@ZEX*2LL/3=G>UDYW3LFTFW;17_ .>#@G#^'N*XLSW">)+E'*OK%=PE
M>2FI?6:]FKM--.S2NM4C T?]F+Q7J>EW&MZWXY^'/@S1K72?AE>G5O%=]K&G
M+?-\5M&&M^"-&.[PZ!N)&UA][*X;[IQSMW^SU\2],U;PUH.MPZ-HFL^)OBWJ
M7P;M+.ZNR?L/B71_[$UQ=;7C:WAXC6-&&T$D<9 W*3[MXO\ VJOA;\1K[Q[!
MX_\ A/XWB\,^,+KX.W=GH7@SQ%HFFO9:I\*M%U[_ (DQ_MP1H/#I_MH9"(JG
MT&*KV'[6W@_Q-J]CXB^*?@[Q7=ZAX0^-/_"Y/AQ:>#-5T;3]+.J?V+H.@Z%X
M,UX:_MWCPG_8NB9\2DJ#V9.<_FE#B/QZ2GBL7D\Y):1C[&DXN]*<5R*-1.3]
MKR.?,DDE:-XMM?IF)X5^CJK_ %/-Y<FMK2FK1OHVG>R4+VTZ][I^-:S^S[?^
M%="T#7/''Q,\%>"O^$GUC5++1[35;/6-2^WZ7H6M?V#KNL?VYH/AP<\@Y/'(
MYZXZVY_91US3];\0:+>_%GX3VMSX.\)Z?X]\7ZH3XN&G:%X8UIM#70SK8_X1
MX@_\)8=99A@EMHR0,$51UG]H'0[OX-?$CP'/I/C34-:^(^K+K.M:7XAU71=3
M^&_@;Q+KFM-K^M:OX(T4_P#%4'7U,A\-* <;F)& S$]-8?M;Z[X>^(OQ(^(O
M@?1M4T?Q!XR^'?PS\ >&VOO[%U1M U3P0^AN-7ULYQKZ^*!HOEH/X44*>E5B
M<3X[SPTL5@\JE%<U2*?LZ-FOW3A-*3=312J15U:<HSE)**AS<U#+/H\+%99]
M=S23RE+5>_S72GSIV6U^75V:35K,YK4_V2OBIIEYJ4%]?>#+>Q\+WGCFS\8Z
MO]J;^R_ NJ>"='.N?\3PXPQ\5^'-;T0^#!DE%PSX# GB/AG\$-5^*_ACQ1KG
MASQ]X M?$_A?2=3\3#X?:M>:QI_B2_\ #&B.!K>L'DGP_EL#[NWN3UQVOBS]
MH:Q\0:+^TWX?T71-;T6P^/OB3P-XG^QW?B-=2&A-HNL+KNO:.,@LK>*U#*-I
M VNP(/&,_P"''Q9^&W@GX2_$CP3>^%_'MMX[^(J:E8WGC[PIJNC::P\-$G^Q
MO!Q?Q P_XIS;@>-%"C'S9+ J5]_"XSQ@AP_FCQU&J\U>*X7C&%&G1D_8/V<Z
MTYQ=2"5.*=2C4Y'*JN52A&7,SYG%Y=X-2XB<<%4MD_\ JSQ+*\I2_BN4EP\X
MW4O?O:;NO\5WJ9/P@_9]\1?%[1KG7+'Q'X3\-VUUXC/@SPC:^+,:;J7COQT-
M&.O_ -BZ(<]#X=';/(.:\1FF^QW0@\@_:+7_ $*[M#_RX:IGG'7T_GGW^QOA
M]^T1\*_A_9V&G1?#GQJVG>#_ !WIGQ:\"V=IXCT;4M2/CK0_!G_"/Z[HFNZV
M2<^'3D>)SS@\\<XKXRO)Y[NYN;R>?_2+N]U.^O?LF<_\3S6CKOO_ 'L]?3BO
ML>$\QX\S;/>+O[?RK^QLE6'OPPI0@FI>RFIQD[SO>TY-OK*T7967R'&&6>'F
M59;P@^&,SEG6<>TI_P"LR4967[RFXI62V;BM-%RWW/[ ?V"O^30_V>CW/@'1
M\^_[M>M?7;D_8YSW\M_YRU\A?L$<_LB?L^XYQX%TK/ME!C/I7UZW%G-GJ(W.
M/H9:_P D^+5;C#BC_LJ,=:VW^_XF]K:6;3VT/^B?PQ=_"OA%N]WP;P^W>][_
M .K\+IWN[JRO=WOOJ?Q4_M)S#_AH7XW03?Z__A;_ (Z^UW73_F-9Z$=!@<<<
M$>]:OPN_9M\>_&*#PC<^%]4\+:=;>+]7\3^&;3^W;A[%['5/ ^C'7==&M)&K
M.QR#PJDC.XX4$C)_:?\ ^3B?CL./]*^+WCKOC_F,@_S]/:NP^&/[0UE\/O &
MD^")_#>N76H:6/C%>_VK::OHYQ_PM+P8W@;1#QCH#D\?+C)/I_JC+$\7X7PE
MX*GP5"+SB5#"\[48M1@\)2=[/EBTI*"47+9VV3M_@#5PO ^*\8O$5<?9K)9/
M_K9Q,K7DI-?ZPU%%)M<R7*VDTK65XD'AW]E_X@:Q:W%_JNM^$_!=AI>C^/-:
M\1W7BLZQGPGI?PHUK0-!\=#6_P"P?#JC@:YZCU)SS61XP_9X^('@G0O&_B.^
MO?"FI:!X%T?P)K7]K:3>?VEIGBWPQXYUK^PM#UGP3@D#)!YY!/3.0:]]U']L
MK1?$>F:3I?C_ ,!^);NXO/@KXG^$WCK5?"NK:)INI:WJ6N:QX>4^,=!_MX*6
M\0$Z$[Y<LP9SSL"JO(']H_P%XDT;Q?\ #+Q3X(\6:)\&+GP)X$^'_ARS\/ZQ
MHVI>.-#TKX4ZRVO#6<Z__P A_P#X2PD'/S'Y2I&22/C*/$7CNL3.6+RBI915
MJ:HTYI\LDYN*33E*<8RM&]DG%Q3J>Z_M<3P[]&UOZKA,UDTW?FO-73[MWMH[
M7OKKJHM7Y?Q+^RIXQ\%V'C#5?''C?P5X3L/"][IFB'5KNS\8ZEIU]XHUSP;H
M/CHZ-_Q(/#@.@#_A'=<X(!.,>PJ[;?LH:YJMYX$MM*^*_P *=9N?B7I>I>(_
M#?V;_A+\/X8T2/6Y-<UR,KX>;*8T@)E@A#JX ( 9^YC_ &L/"UYXB^*OC&]\
M+>/EU'QU;?\ "-V?P_\ ^$CT5OAKKOAC0O!H\"Z*/&RMOV^(?"ZZ*_B1CX3(
M8(YVMD9KS_P%^TE#X(UK]GO73X8U6[N/@I\.O'7@^[6VO!MUK4_'"ZVO]KI@
M< G6#(<DG?(Y!Q@#F_M'QYQ=[97.+3EI[&G&+;IMQLY-O2;BVU=.47!>YS,\
M]9;X!87&/FE*64-+=SYKJ24G\XJ3L]>N]B)OV2?B;=7-A%X7U;P7XV&IKX#O
M]'N_#U[K)^W>!/BF - ^)O\ R+G/A[_B1ZX/&@[C(&,5P_PT^#NH?$_QKJ_@
M/1?'O@/3]8M-6_L;2/MG]LG3O%FIA=?)&A_V#X=_Y%W_ (D9_P"*H![8 S7J
MMU^U1J=UXUO_ (AZAI/B,^+_ !/\ +_X.^.[O2M7&GZ9KOBJ/2DT;0?&O]AM
MN_X1XAERI'*\;<%0:X;]G3XH>'?@OXA_X2_59OB(;G.EFRTKP#JVC6&E^*M.
M7YM8\'^-U\0%2?#Z.%889"" 596P1[^78GQCCD&<XS%PDLUC"BJ$(4H2G*I*
M<E5T<HQ<81C3C9J,+5'.4DHOD\;-<N\$,9Q!E:RF4XY/)34Y2<]+1?+)WN[I
MRE+6]E%VO=7Y3X?_  AUWQYK/C"RN/$7ASP5I'PZL_MOB_Q5X@/_ !+-#/\
M;/\ 8. =";&?^$A'&6'3ZUQ'B_POXC^'7C7Q!X(\1PVUOK_AB[U.SU<VI_XE
MA&./[$/4\$C!/![\5]"^$/B_\+=-@\<Z%XH^'7BS3?#/Q0LC_P )U;>"O$6C
M,MAJVA>,QX[T$^"5U]E_L'PYG_BF"%*9' VD;J\8^+/C6?XC?$7QO\1)['^S
M1XPU<7G]DD\V   Y/<]/?K7U7"&<\?8OBW,\)G>42CD;P\4N:"TJ.*3:FKWT
MYV[>[;E:=Y-'R7&V2>&65<+98^&LUEG>=.J[I*5U%SOK:*T6B5]='V/Z&O\
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M5?OU%U'UD/X@'!_"OP$_X(JY_M']H.8=SX' P.YB\0@?XGGIGBOW]C'/_ Y
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M'[_HI7PR_P"_>N?X?7\O<9_I1VN.R\>Q[?\ ZOT]J,/Z+^1_SV_3VI/Z4?C
M_P#F>/YX6@__ &X7_$@_T=>N3\2_^)))?A;3TZ;=#^;/_ASG^T%_T4WX<_\
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M_!9+7Y\/.-2+GGU2?O0FIQ]UI7]Z$;I-7::ZE;1[*WTO3+&RM_\ 46]F+2V
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M_2E@>@_S_P#J'Y4F!Z?Y_P @?D*P_P")F_%[6^=IW_Z<TNFU_>UMT[=+%?\
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MC_X34O\ (7_$A_T?UMD_$W_B1O\ ^0/YK/\ ASE\?O\ HI7PS_[]:Y_A4_\
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M?I6N?#'X2Z)K&J:QI?ABSTF[L]&&IW_BC7?^0%HO_8Q>+/T^M'U7A?\ Y_\
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M+#^W=:_L#0O[<USGW/M5?Q5^S3^SU#X7\83P?!7P!;7%KX;\4?8_^*;_ ./
M?V*?_K_YXIQPG#^*E]54^(VW:W[FG&[NFO>C.]KI72OHV<N8XGQ!P>#S+&2R
MKAIQ@NLY-I6UM=-IV4K/>Z1^DEI-#/#!-9S?:+:Z4DL#TQWZ@\#!'XY-:;R(
MK! <1K&!D],D9+9).2.Q/H>V:^:/V/(2_P"R]\"Y&_U__"K_  D!ZX.C1GV'
M7./?\:ZC]H>ZO].^ WQ>U+2[V:PU32?AQXXO;*\MKGYK+4H]!UQHY!S@,DP!
M!(&TCY=I49\OV$</F4L$F[.4H6DG=.+Y;_XKIZ;[GM4,YF^'89N\N:E'AU5'
M&+23:B_=YM;)R;2OK:S<G8]KAFCWDB00],<+@GZC _SUXXG,X/6>W/X8_D!7
MY2_#WX)Z5XD^'W@?Q'JOQ-_:'N=0U[P?X7UJ]_XOQXR_Y"FNZ+H'OQVYY^IS
M6A>_!_X9:;K6C^'-5^-/QCTWQ!KUGJE[H_AZ[_:0\9:;J>OZ7H7_ "'=:T/0
M_P#A)/\ BH!X3_#ODUZL\MRUNV)S:$+;ITKV\M)1::VL^IXV79UQ5C<'];PG
M"<9)_P#4_@D]K73AVULKV/U*\\?\_%O_ -\+_P#$T>>/^>]O_P!\+_\ $U^8
MGAOX)^ ?&.@Z1XI\&_%SXZ>+?"^O?\>7B'PG^T'XRU/PS?>AT37,C(SVR/K5
MG6/@-X.T'2]0US7/B;\?=$T?2K,WMYJVK?'CQEINF6&F9_XGG_$\R._/7/TJ
M?[-R7_H;K_P2K?\ IWY^C6O1=']H\:_]$BO_ !((?_('Z9><O_/:W_(_Y[#\
MJ/.3_GM;?]\G_/8?E7Y?>%?@S\.?'F@Z?XJ\#_&GXV>-O"^J<Z/XA\)_M(>,
MO$GAF_\ ^XYX?\2>^.?Q[YFUCX)^ -!U3POH6N?%SXZ:)K'C+6-4\,>#])U;
M]H3QEIVI^+?%&A:*==UW1=#!\2_\5!XA_P"$<T/7/P_.G_9N2_\ 0XC_ ."I
M?_+2?[9XT_Z)&'_B00_^0/T[\Y/^>UM_WR?\]A^5'G+_ ,]K;\OI_@/RK\U;
MS]G7PKIMK<:K??$[]H;3='M?^/S5KOX[^,M-TRPSQC@\?EGL??-T'X*_#_Q(
MVO)X=^+OQSUM_#'B)O#7B-=)^//C+46T/Q.A4-H^MJ23_P )"I903@[2Z@GD
M9/[-R7_H<+_P2W^'MM?3KMU'_;/&G_1(P_\ $AA_\K/TWED@6+Y;BU SD@ =
M#VZYR?; XJ#$?][]$_QK\X9OV=?#D&()_'_[0]L?^GOX\^,@/R_S^F:KS?LZ
MZ'Y5QY'Q-_:'MKBTL^,?'CQF./UY^F*Z*.5Y/-_[+FT[MO;(YQ=WYJI?7:^O
M?UPQ.<\68.+QF+X448I/5<0)I*S=[6MHM;>5NI^G-JRM&K*<@$ X]CZ=?6I@
MOWP>_./H?_KFOE+]C#4M6UG]FSX2ZCKFLZCKNK77A.%[S5M6OO[5U*_<R2J"
M^J @N0J)\PR<)M&W:#7U3/D12GU0Y^OKZ>F?8>E>'B*/U7%SPB=[2E%.VJM)
M:V\[MV?73I8^ERK,?[2RC YMRV<J3J<M[VM&=U>ROK#EN].O4I^=;C_EN![?
MY8?RIB72M)AKBW/;KS[\8.,'&1U-?DS\// ^J?$V7XG^(?$7QA^/EK-:?&OX
MG^%[.S\._%/6/#6EV&E:#K6-"&AZ%T(VX XX QCM7H7_  H"Q_Z+3^TQ_P"'
MK\8UZN)R;+,-_O6:J+TLG&3LW;HGLKV3LNY\G@.*>*LUPTL5@^$XRBI22;X@
MBKI3DKI.+2NDM%=*]M3]+!/Q_K!T]%]_?_./K1]I_P!L?]\+[_X?H<]\_FE_
MPH>W_P"BT?M,_P#A]_&7^/N?SJS-\ 8(9?(G^-/[3-MR/^:\:SZ_Y]>GK67]
MG99_T-J=O\,MOO[';_;/%C_YI*/SS^/_ ,@?I)]I_P!L?]\+[_X?H<]\GVG_
M &Q_WPOO_A^ASWS^;7_"AX/^BU?M,_\ A[/&?O[>Y_,U!_PH>W_Z+1^TU_X?
M?QE[^_N?S-/^SLM_Z&U/_P !D']L<6?]$E#_ ,/\?_D#]*OM2?WU_P"^1_C[
M?I[4?:5_OK_WR/\ 'V_3VK\U?^%#V_7_ (71^TQY'K_PNSQC_/\ S^5)_P *
M,L#Q_P +O_:8\^Z'^AC_ (7QK..>O&< =SU]:/[.RS_H;Q_\G_S%_;'&G_1(
MPM_V/Z?_ ,@?I7]I/_/4?]^U]_?W_P X%0R79$>?,!!Z@*H[],\Y/X>V:_-K
M_A0UM_T6?]IG_P /OXR_QJ?_ (4-!_T6G]IC_P /9XS_ ,*:RW+9.RS6#NTM
M%+J[=NMS"6=\613D^%$E%.3?]OQTLF[VY%>UKVZVMU/T7M[A).%(Z]N>?\.#
MBGPS>;_G_/'7M7P?^QL=<@\3?M)^#M<\<>-?&FC^!/BII>C>'+SQOXD/B35+
M+2SX,\/ZTJG6L!BI>?><D;=N3R:^[I[7S8##YQP!D\#/8].X_+'>O,S# 1R[
M%K")MI\J;;;?O1C+S>L9IZO1W70]KAW.,7G>4_VKB8J+7/:&EE*$I1L^5)-*
M4;-VU3[L\H\6?&CX/^ M631?&7Q!\(^%]=-D+T:5K_B'2=(?^S@Y&\B5Q\@Q
MQP2V01N4@G(_X:C_ &=AT^-?PO(]!X[T($?4F;!/Y=*^6O%/A;PUK_[7/Q6.
MM>&]"\2"V^"?P=-G_;VCZ)J2V+?\)OX_+,/[>^7EB2<'J<YY->:?'/XM?L:?
MLWW7@^Q^.$'PW\ 7'Q&UC^Q? ?VSX5ZSXD_X2W5/^@+H?_"/_#CQ=_Q470?\
M(MVS7JK+\AP%*$L7.K#GA&HHQM?WTF])*26KMHK7TOU/#P^8<6YE+-<1@EPT
MXPG*$%*4^9<K<4I-6;DE;FM9WN[)V/O+_AJ+]GG_ *+C\+Q_W/.B?_'31_PU
M%^SS_P!%Q^%__A<Z)_\ ':^//AEKW[+OQ@^'&C_%7X=6/P>UOX?:Y>&SL_$-
MUX;\':<2!K)T'&N+KV3H)'B/0^%P<G! R%(K:GXN_9/T'XNV'[/^JP_";3/C
M/JOAMO&EI\/KOPCI']J6'A=B2=9UMAX<_P"$:\/ ?V+KFW_A*SX-_P"$RXV[
M0% 5N'-;?ZR=U:%*S[?8=D]EO96>IV*EXA67N\*[+[.>?I*WW>B/LS_AJ+]G
MG_HN/PO_ /"YT3_X[1_PU%^SS_T7'X7_ /A<Z)_\=KYU_P"$;^!'V6XO_P"P
M_@G_ &?:C[;>7?V3X:_V98<?]!SCT!SUQ]*Q]8_X9K\-Z]X7\*^(X/@5HGBC
MQYK'_",>#_#VK6?@W3?$WBWQ1_8O]O?V+H>A]_\ BG-#'B@ GK1;AS_JI?\
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MBSX=:)XW+-XM^6/QEX^/@ERJ!F'U#^W'^R)^TI^T?\?/V;OB9\%_CCHGP=\
M?!H:G>>/=*-YXQTWQ/KYUW6O^0,=<\/ #Q#X>/AS7/\ D5O%8 ] !T^(-'^+
M7_!4+P3\0?&&J^(X/'_C_3]!\8?&3PQ_PD.K?LQ^,O[,^$OPOUW]H+P#_87Q
M.T/P/X>^)'_",?M  _!;7-<\4>"/"V?^$T_Y&?\ XKCG-?5'[*/QX_X*3>-O
MC!X'TK]I/X.>&_!/PWU[_A*/#&L:3:_#?6O#>IZ#_87P7\ ^/-"^)W_"<?\
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MXW?]DH\?_P#J%:Y7-?L<?\FO? 7_ +)CX1_],4%=+^T[_P D ^-W_9*/'_\
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MO7_^*"]O#M2_X)%_M7ZQ?Z??:K^U1IMSJ&@^#_%'_"!^+-6\8?'W_A)O@O\
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ML?!G''_%)#_TX7%?5-P3Y,_)_P!1Z^HYKY6_8@_Y-7^#'_8I?^Y"XKZHN/\
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M?#D?"SQ2K(@;=)\40S-A GU]^SK\*_\ @HOJ_P"W_P##?XQ?M;6_BS7/AO\
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MNZWH?Q4_Y%?_ (2(>'=<'_";^*<<#'@;VKPFW=ZO=]7W?F??GF^I_P#!6?\
M9[T?0KCQA?> /C9;>![JT^.^L^!/%EUX;\&Z;IGQ*\,?LWZSH'@3QSK7@?\
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M_MFDZM>?V;IG]EZ[XTT#P'_Q//\ P>?EU]O2/@[_ ,D@^$^/^B;^!/\ U"]
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MGAS_ (0[XDZG\"O#8\0^!-%\$Z;?>*-?T;0/[>/PK)\.8_X1OQ5X<UW0R?%
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ML;_LMVD_^JU\.5]\I_Q\'_?7_P!%U\#?LB_\E4_;&_[+=I/_ *K7PY7WRO\
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M_P"$B\6>(]<T/_BEL_\ (EC_ (3G@UH:;_P6\T.\TNYU6_\ V-/C'INGW7A
M^)_#9M/C!\&]2U/Q;_;GP8_X7OX%T7GQ(/\ D;/AUH6N#U\%_P!@<]J^V--^
M//\ P3\\5>//^$5US5?V;]$^)&J?&S5/#/@^T\;V?PTTSQ-\2_B@-%T#/C3P
M/_T, \6?\2/PO_PE//\ A7\;?&S]A+_A4.L_$70]"^"?Q]^&^D_%_P "?L_>
M);3X3^&_!OC;^P?'GCGQGH'PFT+1=<Y_YE3^V]$&3@_\(9^= &?\7_VZK'3?
MV&/#'[7OP=G\$^+9_$]Y^SI]L\/7GB0^-M,T'2_CG\3? 6@Z[HNN_P#"/_\
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M\ SV_P"&E_A9S_P'7Z[:'[/]OM_M&?L_VS_3,_C_ /6_SBM,1_R)\M_QS_\
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M?\.0V^4'>WIUMMUL;&#\R9ZC@]/3I^'\O:OE+]M([?V6/CM'R0?A=XP.??\
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M7Q;\.6WBVW_9]\8>*/&G@_PGJMGHVI>&=>U37?!?_"!_\5QH9X\0?\(GZ?\
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M24GRVUBU?32RO??9.Q[+^Q#C_AEKX0G^YX;#?GJ-R,#]#]<_C]47/S07)'>
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M#QUK]O\ _A5G[:4/_,[_ +.'I_R(?C'GW_Y&7W_7.*/^%3_MI?\ 0Z_L]?\
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MQGTOQ1I6J>,?C%X3MO%&L>/-9UC_ (1*\T;3O[0_X6K\:/\ A>^NZ)KFA_\
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M_C?_ *DL5^A/_##?PX_Z*3\>_P#P[GC3_P"/4?\ ##?PX_Z*3\>__#N>-/\
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M75O8^S]KSW^&WLO?WM;?N7XH;>.3]T!SD$ Y'7@9X]L_EWJQE% Y  X')/\
M6OQ9\;?\%A_A3X;\4:OI'A;X>>,O&>EZ7=W]E_PD5E<Z19:7?,F"1HC2R;I
M2/O'8^.2<G-<K_P^I\('[WP3\:-]=:T/_P"*/X?UK]@PO@1XN8W"0QF"X.Q4
MJ=2,)QFU3BK2C&2O&5>,TW&2=N1VOW32_GK-/I;> 64XV>"QWB%AXU:<I0DF
MI2Y90E*+5XQ>BE%I:K;31H_='>OK^A_PHWKZ_H?\*_"__A]3X,_Z(AXT_P#!
MWH7^-'_#ZGP9_P!$0\:?^#O0O\:W_P")?_%]W_XPS%7ZZT/_ )H_,Y_^)O\
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MT?B#0OU]RK>__@'4_='<OJ/\_P#Z_P"?H:-R^H_S_P#K_GZ&OPN_X?5>#_\
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M)D5"F<87 89.^OT4T+]E_P"#GA6/X;G2]!O;8_"W5/%&M^"!_;^MWHL=5\<
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M<5KIIKKRWTUUV[:G\^87F7+I*^FFJ_E_4_<'_@BU-##KGQZAGG EN&\#-;Y
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M[KENW>QY'%^RQ\5#J%S8F^^'%OH]KX<TOQG:>-[OQWHY\#:[X9UW6/[#T/\
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M(Q.*QF+JXW%2_>5:LZ\];N56I/FJ3>]VY2=M>M]=S^R,MRO!Y1E&79-@HO\
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M4+Y0]?\ QT?X>_\ G!H\H?WC_P!\#V]O?_.#7K_\32^,._\ ;=+777#Z?/\
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MW;RL/_BG]X _]"KB?_Q(I?\ R!_+Y_PZ"_:F_P"@[\,/_!QK?_S->X_.IO\
MAS]^U/\ ]!WX7?\ @WUG_P"9JOZ?O)7^\?\ OA?\:/)7^\?^^%_QIOZ4OB__
M -#JG\Z-_P#V_P#0U_XI_P#@!_T*>*/_ !(9?_('\P7_  Z"_:E_Z#OPP_\
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M+KDB^/%\:+*&H \S\0?\%M;[PKX@^*NH^(?V1O'>E?"3]FOX#?!SXS?M3?%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ea027779601_img3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $_ DL# 2(  A$! Q$!_\0
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M .>$'^?PJ>B@"#R;?_GA!_G\*/)M_P#GA!_G\*GHH @\FW_YX0?Y_"CR;?\
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M[X;/BS_B9:7X\\!_VU_Q/=$T/0^GB >$_I_S'^W.?5_B=\8(-8M;>?PKJO\
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M?G5/$@TSXE?"DZ'K7A[6]==]<&/^%A_#](X=87<Z_P#":HF$5_&2DX^]IO\
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MJ=  \.:WH8'A55'@PG01E!DX_1*BM_K6+\O_  %?YGC_ .JN6:>]+3^_4_\
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MY'^%'_".7O\ S\6__?(_PKN** .'_P"$<O?^?BW_ .^1_A1_PCE[_P _%O\
M]\C_  KN** .'_X1R]_Y^+?_ +Y'^%'_  CE[_S\6_\ WR/\*[BB@#A_^$<O
M?^?BW_[Y'^%'_".7O_/Q;_\ ?(_PKN** .'_ .$<O?\ GXM_^^1_A1_PCE[_
M ,_%O_WR/\*[BB@#A_\ A'+W_GXM_P#OD?X4?\(Y>_\ /Q;_ /?(_P *[BB@
M#A_^$<O?^?BW_P"^1_A1_P (Y>_\_%O_ -\C_"NXHH X?_A'+W_GXM_^^1_A
M1_PCE[_S\6__ 'R/\*[BB@#A_P#A'+W_ )^+?_OD?X4?\(Y>_P#/Q;_]\C_"
MNXHH X?_ (1R]_Y^+?\ [Y'^%'_".7O_ #\6_P#WR/\ "NXHH X?_A'+W_GX
MM_\ OD?X4?\ ".7O_/Q;_P#?(_PKN** .'_X1R]_Y^+?_OD?X4?\(Y>_\_%O
M_P!\C_"NXHH X?\ X1R]_P"?BW_[Y'^%,_X1G4_^?V#_ +Y;_P"(KNZ* "D/
M((]0:6D(R"/4$?G0!2>-AO9221%M'/4G@]2>.<9_I0D3$([9SLVL#V(_3(XP
M>^:^7?VL_CY>?LW_  UL_'=EX?A\43WGBC1O#:Z9)?K8%FU9=5*2+*49<JT*
MI@@[@7R#C([KX"_%:;XP_"/P3\2;C2X]'G\6:<;Q]+@NOMRV3"^DL-BS!0D@
M7RU9F480_(Q.#72Z&*^IK$VC9R<$_1/3\+[[];'SE'B#)ZW$-3A.,W_;%/"K
M/)T];*C*2BI.5[+5V47:ZO:_3W5>@^@_E2T@.0#Z@'\Z6N8^C"BBB@ HHHH
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M\/?$+>%=<74+[5/CIXRT/P'X"75= ^R?V_I"S^(]=TB*Y,@CEA63?^\80D_
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MHNDVW@NXUW0O#OBF?P](_A?0WT#POK;VUS!!XID@>Z6.TBN)' /@K]F+Q/\
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MOT!3@]IP?I*+_)L6BBBD4%%%% !11D>H_P __K'YT9'J/\__ *Q^= !1110
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M/%WC("3^WI?+$L4#K^QA\0Z'D_\ $]T,\G_F)V'_ ,?H_P"$BT+_ *#FB?\
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MS>UTY[KIO-K[O734Z.BL#_A(O#__ $'M&_\ !KIO_P <H_X2+P__ -![1O\
MP:Z;_P#'*XSZ3FC_ #1^]?YF_16!_P )%X?_ .@]HW_@UTW_ ..4?\)%X?\
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M+^U;WUMO^^F_^*_SCZY/[5O?6V_[Z;_XK_./KD^L_P!_\$']GX=[9:_DK_\
MM[/+?^&9OV>O^B%_"'_PW?A#W_Z@GN/R]Z/^&9OV>O\ HA?PA_\ #=^$/?\
MZ@GN/R]Z]2_M6]];;_OIO_BO\X^N3^U;WUMO^^F_^*_SCZY/K/\ ?_!!_9]#
M_H6_^2__ '0\M_X9F_9Z_P"B%_"'_P -WX0]_P#J">X_+WH_X9F_9Z_Z(7\(
M?_#=^$/?_J">X_+WKU+^U;WUMO\ OIO_ (K_ #CZY/[5O?6V_P"^F_\ BO\
M./KD^L_W_P $']GX?_H6O[O_ +<\M_X9F_9Z_P"B%_"'_P -WX0]_P#J">X_
M+WH_X9F_9Z_Z(7\(?_#=^$/?_J">X_+WKU+^U;WUMO\ OIO_ (K_ #CZY/[5
MO?6V_P"^F_\ BO\ ./KD^L_W_P $']GX?_H6O[O_ +<\M_X9F_9Z_P"B%_"'
M_P -WX0]_P#J">X_+WH_X9F_9Z_Z(7\(?_#=^$/?_J">X_+WKU+^U;WUMO\
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M^12T'V_Z=/\ ./I1_P *3^$7_1-_ G_A):#_ /(G^>?;/9?VM>_].W_?3?\
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M?FW_ ,7_ )_ 5'UC%=Y_?_P#I639:E99=&R5E;:R5E;WMK+3R.-_X4G\(O\
MHF_@3_PDM!_^1/\ //MD_P"%)_"+_HF_@3_PDM!_^1/\\^V>R_M:]_Z=OS;_
M .+]_P#.!1_:M[_T[?\ ?3?_ !='UC%=Y_>O_D1_V/EW_0N6GD]/3WOR.-_X
M4G\(O^B;^!/_  DM!_\ D3_//MD_X4G\(O\ HF_@3_PDM!_^1/\ //MGL_[6
MO?\ IU_-O?\ VO?_ #@4?VM>_P#3K^;>_P#M>_\ G H^L8KO+[_^ ']CY;_T
M+X_>_P#Y(XS_ (4G\(O^B;^!/_"2T'_Y$_SS[9/^%)_"+_HF_@3_ ,)+0?\
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MDMM:>%?BAHC_  ^U.[6.,L?[&U76RF@73R8*Q0VOB>:5GVA4W;37U5XHTO\
M97^!4_PY\%3_  N\ >&X?B!XH'@_PSI7A[X8Z''IEA-%"L+ZKK8L]%CAT3PZ
MDR:+X9G\070, NM<\/Q,?(>.6+Q']J#_ ()0_L2_M5Z'J5CXV^!WA#PIXHN+
M5X[3XC_#G2=*\$>-K5VY68WVA00KK2@C:T7B."_11@1J!DKI%Y8VDZ<X7MK>
M#O=:737G_P .<C?B)A+O#YKPQG3C?FH_V#*FTU\4%)5':[3C&4KVE9M[I_?B
MH"5P05<$HZL&5L=NAQ]#^M 3._*LNPXY_B]", Y_SUK^8OX2_&G]HW_@C?\
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MW_:.F7N?X003\O P5)4D>HJUY0R55EW@9QD9&>Y &<$X_P FOR:USP[\3_\
M@GOXBM?%7A;5=7^(_P"S+KNJB#Q%X=U.19=3\!JX $UM(0N^$G*[S&F[@/&
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M;:)X&\2>,/#'BTB&+QSK_BAI6D0-&H*R[+[D?TH>5-Z?H/\ "D^QW'J/R_\
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M"V9YM,_X3WXR_"WX1?%L_'+X::S)HA_L/7D^*OAP^._ACXJ\,6[K:IXJU_=
M1 MHRT/C3KOQN^/?[.^N_MXZ=;^+O#?P9_:V_:P^%L?CWPIXUL_C%IR> O\
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MV_!#XXVFU8OB7\*?"GB^XBLE"QQ:EK6BG^V(50<!8=<;58TQR5C!/);'B/\
MP5DUC1?#_P#P3G_:\N]:"?9/^%.Z[9#.<M?ZV8=$TMEST/VJXBW>@&!WKBO^
M".FE:IH7_!-']DJQUII3<R_#E-8M%YS'INNZUKOB#1<G.0?)F1E& ?F&>'I.
M7-EG32JXIO5N,H1LTV^FE_NTN982/U+Q)S&GAM/[7X6ISE%)*,9T\X<'-P24
M8MQ<M>5-IZNR/TFJ?SKC_GN/\_C7/^*_$NA^"/#NO^,?%6JV^B^&/#&DZIK.
ML:O=CC3]+());KCA3@YY.%SR:YKP)\5O!'Q/@U"Y\'7>NZA!IATP7B:SX/\
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M@OPE!XS\0^*M-T_PSJ7]DC2-9L_^)DNN-KC+_8O]B?V"LO\ ;TGBE&2:)?#
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M@_X1".6YN(IY4M9K9\_X=^-?"_P6^)U[X\^(_P -Q\.M%\;_  OO_$?@K0=
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MK[P)J9\;Z]J+>$?#'@OQNVM>-O!AUG9N"GX=ZRWA=V( \8*I=P$^8?I-110
M4444 :UI_P >UO\ [O\ 1JM55M/^/:W_ -W^C5:H **** "BBB@ HHHH SKS
M_70?7^IJ#R/?]?\ ZU6+K_CYMO\ @7\ZKT 'D>_Z_P#UJK7%M!/'/#/!;7,-
MSTM;O'((Q@D@94D9Z]>A];-%--K9M>C:_)HF4(S7+.,91U?+*,9*[ZVE&2OY
MVOYGD'_"A_@K_:?]M_\ "GOA5_;.,_VQ_P *]\)_VEG/_0:_L MC\>G?->JV
M]O;V44$,$%M;PVW'V2UQD#L!C  SS@=P<GI5JBGSR_FE][_S.=8+ 81W5*DI
M/K&E2B]7_=I)_B%%%%3UOU[]?O.K]59^:[/NO)Z>1P7Q$L_ \_@OQ ?B8-&/
M@*ULQJ_B1M>"_P!FKI>B,NN,VM&0[=J$;V7YLA.$=B%;R>'3_P!G?]IV*^UJ
M&ST?X@WNAVNEZ!>:HL.L^'O$VAQIKD>OZ1%)(O\ PC'B3P_CQ!HZ>(E\LQRL
M\;/"6C&T>C_&+PO:^./AIXR\,7'A33_&XUK0VMCX3U/7Y?#]AKH^9V5-;0.^
MAD\!/$,<;29 "J28UKX:G^$?QYU>]L;GQ7X?^('CGX2:1J<0/P5\;_%[1]0^
M(VNW_P#9>ONVL:OXWT4/;Z_X<\,^)AH:>$?"WB;QCYVUO$/CF21'2U\&H >]
M:K\,?V7/#>KZ9\,Y_"?A/2]3T/X>>(@NDW4>IG2-$\ ^//&LRZX-<UB>0>'
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M3KFQT.P\'W.G:WHWACP[X>^PW"ZSH_@R;P*KZYK<FORQ:Y&?#VLN8FD\'_\
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M5:JI:?\ 'L/H?_015N@ HHHH **** "BBB@#/NO^/FV_X%_.J]6+K_CYMO\
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MH_#^T^'7Q)8W/BKP4EP=<T:'QH?"Q\&O)&=,=&E?Q,!(H!D5_E6I/V!/VYO
MW[0GC[XA_#73?'UQX]U_4=2\1_%S2$N[YM0_X1'POK6LZ1M\&0$ B+0O#4DZ
MQ>$I3_K+9I$;&-PWOCY:-=? C]HSX<>"_A[+XF^(7B#QQ\3?#7@]K+2M'L=0
MEU'Q NB>/2VL:YKS*B@MXXU=UG+3"2,/&L<9;S3^'?\ P3^^'W[4W[!'[0&I
M?%+XH?L8?'KQ-X?U7X:ZKX*(^&8^&?BC4?[4.LZ!C<B_$I<JRZ'RN[D'&17T
MF79)B,7E68XIJ#J?\N*;E%5)M*[]C!R4IV>C<(SMK?1:?*9GF69X3.<LPF%<
M/[)E_$;E#F])-ROO>U[+\;_V'DG'.&&?\\C^O/M3<CT'Z_XU^5D'_!5?P1;N
M;?Q!^R9^W1X>N< _Z;^S[)J/.>A.A^);OC'7"CM]1]'? C]M3X7?M#:[#X>\
M'>&_BWH=_-HAUT-X^^%^O^"]/;3%7DG4=;2.-W;&0BD[S@ ;C7EXC(\YPF'>
M*Q>5XB$$E^]<&J3NKKEJ-\KTU>F^A]''%X9Z1J0=^B:;5_*,F?9E%%%>>= P
M$@ G)ZY&/<#_ /4/\*^7_P!J']J'X<_LI?#*W^)_Q.U9=#\.7?BOPUX)MM6N
MK;7[RQLM9\93-;Z3_:D?ASPWXO\ $<<*RKEWB\-S,I9(I$7>KM]&WE]::=:W
M-_?S0VEC;6S75S=75PJV=LB 98M)M55&2<X /&,,RJ?YEO\ @J#\7/AS\7/B
M-X-L+[Q!X3^)W@#PU:ZO;ZAX'\/_ !5U?3--O]9G\;Z!H_@K6@/#K./^$B\)
MRNWBC =P!\JDJ :^KX*X1QW&>;_4<%&?)&$IU:JA-PIP@FY)R47&+LG+WI*R
MBW9WL?'<9\6X/@W*EC<4XRG.2A2@Y*\YR:44ES<SO)QCHG\1^UT_[=/[+GA^
M?2]"^)7QN^&_PQ\=7KFSN/ OCCQ?HGAKQ1I]^=7.B^3)H^MSPS<7 /(#KLD4
M,K'<5^P8'21#(K!HI%#;N0< \8!QZ>QQZXK_ ";_ (G?\%&M<UCQOJ,__" 6
MW]H>&+S[%H^K7>L:SJ7V#^PM:_XD9_XJ#/\ G]?ZHO\ @C7_ ,'!?QT_;B_:
MB^&'[('QG^#?@2*]U[P%\0+_ %+XO^'=9U32[_5=5\"Z"-;1Y?!CPOH,0\3*
MO[HV\\"Q\_*PX'5Q?P]PSE&%RZ7#/%#S^I34UQ&G2BEAJ\6H*G!QIV4'*,U*
M4Y<UTHVY7<CA'/>*,X^OSXAX;6107+*B_:)JI"23BU>;<KQE%KDYFKKY_P!?
MHZ#'H*6@8P,=,<?2BOBC[0*\B^+OQF^&OP,\)GQI\4/$T'A/PQ]LCTPZH]EJ
ME\OV^5G5(W718)I5),;YS&G(8;E92M>N$@$ GD]*^>OC7$M[XA^ 5E#-]GF_
MX79IM\#]F#!ET7P5X^=N"0 N3M7G[N",*<T!^NWGZ'R_X(_X*N?L+>/Y-8BT
MKXZ:#HS:7K0\.?:?%.DZOIFG7.K2L7TU8)9(1O61N1N,+-DDM%A2/Q"\8?\
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MXDRZ3H@\-Z,[$_$!_%?AAM)R?$8+1P++XR'[J%XD7L9>7_@7_P!J'M_+\/\
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M.VCUMUL];?<_R/Z&Z:VVULK+;HNB[+HK(J?(0O08R0",G //&<>WT!K\8_\
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M]^S+X]T*\\>:=\0F\#>/?#6@->Z-XQ7QMX:TK4'^%_@+7GTC1-<;J@.M1A@
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M5\0VC0QQN&01H"Q'W=6+J&IZ5ID#7&L:AIUC;65O]K%SJ%U"FU8_E&H_.RC
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M^%OAE:>*/'VE:/XM_P"$T\6^)O _P6C^%.MZ7X@D/B/CPYXH6/1_$HD28>+
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)10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ea027779601_img4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $> -T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BC(/0@T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4457FF\K_/\_;IVH L4$9!'J,5Y5J7B_P=HUSK]CJG
MB'1-.N?"ND:=KOB076LZ-IIT+PT=Y_MG6MS*- \/$:*WS%@#U^7.1DZC\<?@
M_H]UXGL=6^(_@C3KCP;HW]L^)[2Z\1Z.O]A:9M +:SF0E!G)QECCH2<L0#V(
M  8%+TZ?S_QKQ71?CO\ ![5]7\/Z%I?C[PUJ6M>*+,7OAW2[+5O[0U+4=-P"
M6"[F(!)/#$D 8);AC/\ &#XV_#/X#^"=>^(OQ;\8:)\/_!&@C_3O$/B&]&G:
M:@P<$D]=Q^7(4YP3T!JHQE.2C&+E)Z))-MMZ+1)O>VR.7$XB."C];QCC""B]
M;I)))W=VTK_/\3V498D-GC)X[?Y]/7IWJ+!'W1UZ\_EU^I_3.>_X3#_@X!_8
M3_X2C^P_M/QA_L7[3]@_X37_ (5KK/\ PC6[/WL[AXD]\>1[]/EK]6/AY^T+
M\)OBG\.--^+/@'QMHGBSP#J=F+O1_$6CWBZBE_A,_P!D!?,+#7BPV!.7RV,;
M1OKMQF29OEL?K6+RNI",DFI)2ZI:W:<4VM;-*3ULKJS\C+^(\FS67U;!9G%S
MVT:OHWIWW5M/(^B=X]#^G^-9%YJ5EIL0GO[VUT^#'6ZNP/7D98\?0GISCI7R
MMXO^.VJZC^X\'P_V=IY(LSJUWQJ.X 9*J2=O(R.2<G)+'FO$M2U*^UFZ\_5;
MZYU&X_Z>[S'MZ_\ UCSUK@/H3[6U3XR^ =.E\C^W/M5QW_LFU.H?^@CGDFN8
M/[0?A0R8AL-:(/4&RXX]/\Y_6OD#_EEVMK?/T_\ UY_0FCS_ -U_T[_7G_>Z
MXZ__ *\4 ?:UI\=O \\HAN)M1TYO^GNS*_AGG'ZD=ABNVTGQYX/UD[=+\0Z;
M=3D?\>XO%RIX['\\C/7G';\\Z/\ 4RF?_/;'O_+VYYH _3W>/0_I_C3Z_/[P
MY\1_&'AR8&#5+BYL >-*N^WKR?7VY[=J^CO!?QD\.^)9;>PU1O[$U?!'V;/_
M !+[S<#DJQ#<]P&'7.6P,  ]SHIF\>A_3_&GT %%%% !1110 4444 %%%% !
M1110 4Q^@^O]#3Z* /S,_:N_9J^"/B3Q%XH^*GQ;^*=SX"L/'?AOP)\,6LAA
M?#FNC0M9\0>(/#^AZX"2OB'0#XB*>)CX6,B*3H)?Y00*\D\:?L[_  <U]V\/
M7W[26C:;X9N]&\<_'+PC8V>E:0_CA-,UO6-"E\<^,F\:ACXB\=?#_P#>'<^5
M$@,(:1QX0B _0+XX?">^^*UI\/[C2_&%SX(U[X=^/--^(6C:P/#FC>)<ZD-%
MU_05TG^Q==&T!TUS<IRNT8 R3Q\[^&OV,/"WA?7_  ]XKTCXB^/CJ_@W=8^'
MC>-HW_"-:;X8UP^(%\=:&-#565_#_BM_&VN^)G7>NPCPSU_X1$ FVH'E'P3^
M#7PLTCXO>$?B9\._VDM$\:7WCSPWXJO-'TO5K5=4\3_%C2="\9#7M>UW1=<T
M#Q'X177CX3.N:+X6'B@>#Y!@!FQED7\%_P#@X'^-?C#Q3^TUX(^ 7VV6U\ ?
M#GP+IWC3^R4_Y!>H>//'4C$:WKV /F\*>'=$+>"QCB1G.3R3_2?H/[%_AGP_
MXE^'7C&R^)GCU=?^'>D^ /#'A!O^),-,LO#7@?\ MU-<T1M$P%)\6C7=73QH
M=Q9B=@'R@5^5'_!;K]@#QA\>8_"/[17P6L?^$C^)/@S2#X,\8?#NUX\4>//"
MNXZX&\$ DGQ!XA\+,KLOAC;AU!QR#7V_ 688+"\195B\<DXWY6I1BTFW974D
MUWU:^=M3X#Q'R_&YIPY+"8)RYK-^[=.RNW?E=]?F?R)5^U'_  1)^*GB/1_C
M=\0?@?\ ;KG_ (0?QEX#U3X@_P!D_P#/AX\T+6O^0T?3Q'U/X^E?D?\ \*W^
M)W]O?\(K_P *Q\?CQ1=?\R]_PAVL_P!IXX_ST]_2OZ2/^"5/[#7CC]GJP\4?
M&GXQ6/\ 8GQ(\>:/_P (QX;\)_\ ,3\)>%^/^0Y_U,7BS_H5L]17[KQ]F>2R
MX=S6W(VU[J3A>[5U9)M]=D?A/AUD>=1XCRMR4U%2?,Y*:6C=T^9);)VN?L1Y
MW7S_ *]?KGM]?Y8KV^T^$(AT+2/$/B+7+;PY8@!M96ZLP#SD+WXS@XSZ=<5X
MQ#-/9RV]Q!_Q\6O^<>Y_/GZUU%YX\\8ZE%<07VN75S;W7_+IZ_K].GO[5_)F
M'W7KI]Z/ZUVT[:?=H=Q_;WPD\-X_LKPKJ7B2X_Z"VK?XG'_UZ/\ A<$'_+CX
M(\)6\'_7GR3VZ #\1VZ#->+PPSS?\>$!N>.EI_GOTXK8A\-:YT_L/6^__,'_
M !_Q]L>];@7_ !3XD_X2G4QJATO3=%Q9@?9=*QDXXR0 !D\D@ #VQFN8K0GT
M?581^_TK4[8?]/=G[_\ ZN>YZUGT %6/)OHOW\]C<_9_^7/_ $//MTZ9_3^5
M5Z^@/AO\3M*T'PQJ&E^(R;DVEV?L8^Q\'2SCJ/48QVQS[4 5/AS\8[[0I;?0
M_%!N9])R+2TO+K_D)69 ( ?^\N"!U'08(KZYAO(+N*WG@(N+>Y&;:Y&"#G//
M0$#(.#QG!&,BOACQYX)_L&3^W+*^_MKPOKW^FVFJ@Y'(!QV'?KU/6NX^#?Q'
MN-(O8?"FMS_:-(NP1HUYU&GM@E=&(/7!QZ^@(XH ^P:*** "BBB@ HHHH **
M** "BBB@ HHHH *K^1[_ *__ %JL44 59"(AYTQ&!P<<8XZ?IZXKX/\ B;XN
MF\4^)[B8"X&CZ8?L>D[0 "QX9N_)/)ZGG)-?4'Q9\2#PYX1OC /^)AJ?_$GL
MOJP/3KU!([@YZ"OAFSLYYKNWL8.;C[9]BL\_KS_GCW---IIK1IIJVEK>E@:3
MW2?JD_SN6/-'^O\ /MOM'3[7D_VIZ?R[8Z57SYTOG];C_G[Z9_\ U?3C\A7K
M'Q.L]#\-6OA_P=8P6QU#2[/[;K&J_P#U^21_3BO-].TV^U>^M[*RA^TZA=7?
MV*SM#Q@>_P!!W/Y]:,3B\;BU9RDXZ7O)M/U3DUT[=Q*&"B[QA&+[J,4[^L8I
M[^8:;H^JZO?P:7I5C<7,]UDFUSC@<_R_*OI[PA\"-+L\WOB^8:E<7/\ S";;
MC2[$^W4DC\LGO@X](^'OP^LO!.F>3Q<:K<@F\O#R2>P'. .A)YR<>^?0OW7^
M=M);#,RRT'1--B\FQTK3K:#LEO9H/PRJL?U]ZVZ** *L\$,P'FPB?\,CN..<
M<?\ UZ\_\1_#'P?XEAG-]I5O;3XYN[7 8<DY(X'L1@5Z510!\+^//A-KGA#-
M]!_Q.] &,W9_Y"EA_P#6[9Z<8SU%>3U^FTL,,\1@FB!AQT)X&/7'(_'_  -?
M&'Q?^''_  CEW<>(M#_Y &IW8^V6EKC_ $'4\G!ZD@$@XS@\<XH K_#+Q)90
M_:/!&MYN?#&NYL\76!_8>J8(V\CIG!R"I! RV,@\!XD\-WWA77=0T.?_ $;[
M*/\ 0[PG_D(?KC_)K F_U)^@_E7H_C;Q5I7BK0?!]]Y__%46MI_8NL<8QG_.
M<]1^ - 'TO\ "#QJ/%6@FWOO^0QH1-E?>I(P >V3T&.GTQ7L-?!WPF\1_P#"
M.>,=/\\"WM]4_P")->;N1N4AE)[\$ COG![5]XT %%%% !1110 4444 %%%%
M !1110 4457H ^3_ -H/4O.U[1]*_P"?6T:]_4GC\3^->?\ P?TW^TO&^GSS
M_P#'OI=E_;77]?\ (_EFK'Q@O/MGQ!\0#C_1?[+LN_3KS^G^<9Z?X-6EZ/\
MA+[Z"RN;BW/AP6-EDXR<$@#/L#QUQ0!Y!XCUB?7M>UC5)QQJEV+VS'8<=O\
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M_HROB'S_ "8KDG_ET(Q^&?Y_AZU]Z_";3ETWP!X?ASDW%G]L/(X\PKC^0Z4
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M S]EML@&].!C"D'KG..,#KG@5\0>._&M]XUU@:I<,;>PM !H^EG&ZR(&,M@
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M>%9[:YM[JS^Q:QX>N_\ B9:9KVE]NG_UNW- 'Q]\)?B=X_\ ^"?OQDM_BWX
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M . !QZ=<#(JQ##YO^?\ //7O7\O_ /P4"_X*6?%OQ5\4?&'PD^!'C'4OAO\
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MZ/C0F&%!&=H)([ FO9\0./\ !\1X195E*?+S<]Y7VNVDE*[NK_+INSY?PXX
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M($]S:#[6"  NH +N!]^&/T(!Z5_FY?M""^\$?%'P/\3M#_T;4+7^R]:L[O\
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MYD_5H=H_='_Y$Y6+1M+LKN_OH+'3[:_U,?Z9=6MJHU&^P."Q^\?_ !X9Z@$
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M+D?@._M7X\?MW?MEP> =%N="T.X-UXOU2T-GX/\ #Q.?L&XD_P#"9ZYV 4'
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M/Y=CTX//XCG^AFF;!ZG]/\* /Y O$O[ ?Q^T":X_LJ#PWXMM\\7>DZQ_9O\
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M'AKXE>%_C'^V%>>$H-'\!ZQI7B?PY\'/#VL'Q)_;GB;0CG1&\<:V%;PT_A\
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M[GQ;8GX/>)OA=X<U?1_%NCZ?JG_"=Z#HPU[0/C-HVB:\./$/BOQ'+KGAD*Q
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M ,(Y^V$MK\5[;5;CXG6NL?:_#%]X.U32=9&HZ9KND)HOA\:]X,5?^$C\(_\
M"/CQ5XD.LJ?%7A+'C-=PR<X!_2;X6S>)9?A]X(/C'2AHOBC_ (1S2O\ A(M(
M_P"$B/B3^S]3V'*?V\#_ ,3[+ G>>F=F"=HH ]4HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IFP>I_3_"GT4 %5_)A_YX_P#CI_QJQ10!
M7\F'_GC_ ..G_&CR(/\ GE#^0_\ B:L44 ,V#U/Z?X4;!ZG]/\*?10!7\F'_
2 )X_^.G_ !JQ110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ea027779601_img5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $S B$# 2(  A$! Q$!_\0
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MM'_'+]K#XA:]8>%OV=/$GPN^''PO/B32K+6/B#_PDFL>)/''BS2_[:_XGO\
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M )X0?Y_"CR;?_GA!_G\*GHH @\FW_P">$'^?PH\FW_YX0?Y_"IZ* (/)M_\
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MECKFC75A<C4OLEW_ &MI!TO_ (DCE=<Y P3P2PS\@(9@JD$EGV?W/_(.:/\
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M_L[Z[X2D^&>G_#KQ/#I/@#PQXL\#>(_%WPRU>W^W:19ZEX,;YM7^%NMQLO\
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MV%IG_/(_^!$O^-;61UR,>N:,C.,C/IGF@+_UZ[??T[F+_86F?\\C_P"!$O\
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M .!3T?V#I?\ SQ/_ (%/6S119]_Z^\#&_L'2_P#GB?\ P*>C^P=+_P">)_\
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MR2E;)&GRR<4I6EORN5F];-,_E$O;']O#2?@5I'_!1>^_9#T"V\5Z%^U%JO\
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MKJ>))?$Z>'G^-F@>'_"O@SPQ&CVZ2)&S@@*6\C^/OQE\>?\ !2']B7X[?\%
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M^.?BCX&E\<2>+_%7]N^&_AT/&OBI?,#"3Q<R0SQNB^$;>/PG_@F'XJ^,E_\
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M1\)>'?$VC:1_PEDGBJ8:[X>E?5+BW\6W%U;JUM)'*;,-;K+'(_JTNT?N_P"
M<_\ K!A/[UN]NB=F]^C=O^!J?I]17YR?$_XW_'7X&:2TOB?Q-\/?B)J7BWX;
M>./&/AV?1O"&I^'K#PMXD\"_V!-K$KH?$\]SK/P[CT37)HQXGG^RW"W-OX>2
M6+'BB,UZ-\:OB[\7O#?Q%NO 7PNT>'5@GPU\,^+KOR/#2>(O$>E6&L?$R7PU
MKFM:/HK^)?#!\0+X:T(&YB\-I*LTLGD9D;>T4B^KO31:WUMVMY'1_;.%UU>E
MD_5WMW[=WIJ?:M%?$[_M"ZMHO[//C?XA)K%CXV\:>"?$<7@V\?7O"6L?"E=
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MNV[7S?\ F%5Z**WC'EOK>YSW?=_>_P#,****H HHHH ****#HL%%&1ZC_/\
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M_*O%_P#A;\7_ $)=O_X-E_PJ;_A;%C_T*$/X:LG_ ,0:Z%EV,5K4I>B]G_\
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MXQ^/7WJ8XG#II24KK33E:WMO=?=9V[MG2UZ?=8P/[3_V?\_E5?\ M/\ V?\
M/Y56GO-$AQY]D.1_S]G\SS_3]*W/[*T7^R3J4-CYX^R?;!;?:6PWR!B,Y(X&
M02?0@<UU?7,&OLOY<OZRT.:S[/[G_D8G]I_[/^?RH_M/_9_S^5?$_AO]L;2M
M8U[^PY_A9;:;_IGV'[5_PF&LXY_[EK(Z^OX5SOQO_;0B^$.L?V2OPHT>_-UX
M;_X2;1[[4_B/JOAS3;_2_7Y_##J3GMM_ XQ6']MY2M^9/U7^1Y^)RW-\4_\
M8[J]M[Z;]+?EW/T"_M/_ &?\_E5B*\/;G_\ 6,\?R&?YYK\]?AC^W?X"^)&G
MZ8)_#W@KPWK%S9_;;XZO\1U_X1K0P!CG71X:"Z_R<G:!T &T<5Z]XJ_:R^$.
M@:;!/9:SX(NKXKJ(N[.[\6ZQIFGV&G*3O=G_ .$<*,'&T!1$NPJQ!^8!8EG>
M4V=I-:.^E^APKAOB1]?_ $KO_3/KN&]] ?R_/V^@S_C5GS_;_/Y_Y]:^ M'_
M &L/'5[XM\ >%1\#;"Z_X3WP?J'C.RN]*\=:IJ8TWPPG_(&UK6L>%P3X?E4E
M7+%@O!14YW>W:=\9]9\2.W_"+^!]/&G8POB37_$6K:7I]\N/F.D;O#3>(')Z
M@^0@0#&#DD\%'.LJQ"E+#S22NVY+E6B;;N[+HWOK;3SZJF4YU@)PIUXSJ5)2
MBHPIQG.;E*45&RA&;OS2BKVT>KV9]*B11_" >?4]?QY_*D9PHSD=<<_R_P#K
M\X[U^4'AO_@K=^SEK?QQU;]G"RU2QU?XLZ)JWB31=8TS3+OQ2-/LM1T$%M97
M=J_A:(,$WY4*2.3R5))^Y?"/QUL_$OB$:%=^'5TZ*XL_MJWL&K#4\\C.=@7'
M3J.G?)KERW-\IS%RA@\RIYFU)I\KC[K3::Y;17NM-7UV/I<XX<XAR&O'#Y_E
M-3)\SE2C5@^(83]^G.$9PE#1*TH3BXW:3YHZW/?:*3/^HF@_TFWN>?SZ=_8C
M\#Z'*U[B:>W]=&FNEFK'SVO6U_+;U7D^GE8****8!1110 4444 =!1117GGL
M!1110 5\X_M<C5V_96_:4.A7,^GZM_PHCXH'2;NS'_$PL]1_X0C7V21.3R'\
MLJ0V.7*YX-?1DGW5_P ]VKQWXUW4"_!?XP3SP?:K:V^''CLW-F ,72C0M<7:
M#U )4G\2.V:Y<6W'#5)?RQ;NKK9/_+O^!T897<%YQ_.*_&]OST/\YNS^#'Q-
M\-^$K?PYI7BKX@:)J&EWGV[^UO['UG4B=+_Z O\ G\^M8_V/]H7P'X\M_%>A
M_$VYU+1_L>E_\2GQ#9ZSX;_L'_J"Z'^'7GZXYK^CC7OC+^SGX/T;S_$?P=TW
M_A(+71_MUF;36/\ D/?]07 _STY[5\KZE^U%\,O$=AJ&JV/P(\):(;J\^Q6>
MDZM_Q,OM_7\<<\_J.HKX/#\2X9-XMREHVOBENFUK[UMT?38C+$[>ZM4M+*^J
M7EYGYGWG[9G[<_@GQ'H__" :Y_:7A>U_Y#%W=^//^)G?\?49]>M?4'PK_P""
MM'[=W@_P1H\^N>![GXD7'_"2?8=8_M;1_P#B9V&E_P#<O]<8_+Z8KZXUZ'X<
MZE:Z/?6'P=^TW%U_RZ:3X/T;_0/3\^?>H-!ALM3M=0T/PY^ROHFI7 _TW[)X
MA\-_V;]@YY_ST]32_P!=FG=2=UJO>?35=?)&/^K:?;7?3O\ +S+_ ()_X+2?
M%N;Q3X7G\<?LO>)--^$]U=ZK9>)/%EI9ZS_PDW]I_P!B\?V'H9X]_P#ZU>\>
M-_\ @N%\ ?!_@/3]5@^&7Q1U/XD76L:797GPSN]'_P"$;%AI>N]=:_X3CGPQ
MW]>WXUC^ _A[\:;RU_LK2OV;/ &FZ?\ ;/MMI_IG]FZ;_P!@7C_/(KTC7OV8
M_B+XJET\:K\,OA=IMO:WG^F9O/[2_P#4@SQW_6MO^(HYNNUEYQV7_ 0?ZEX-
M[_G_ ,$_,?\ :0_X.'/'%G\0=''[+W@?PE<_"_2KS2_[8_X6;9ZS_P )-XMU
M3G^W=$_XI_\ Y%_P[CK].]>\:;_P<C_!W^WO$&B:Y^SUX_\ [0M;/PN?!]IX
M=UC1O$NIZ]JFO?\ (=T4]/\ A'P/TZ>U?8!_X)U^%=>^SG58+;P3<6O_ "&+
M3X96?@W3?MXZ?\3S_BF_T'KU-?%_QF_X)R_ >SNO&%]X5\.:EX;U'5-'U2R\
M2>(+0:-INI^+M+T+/_,<_P"$;_XI_P#[E,]>YKT<-XHM+ZYC+NR>B;ULF[63
MZV:VZGE5N$/:5*>!PEESU(0YII\J4YPBY/E][E2DW*WO<JE;6Q_0QX/^.7PR
M\8>'/#_BK0_&.B7.C^*-'TK6K.[^V]/\_I[\BO6--UFQO/\ 43VUS;]/]$O/
MQ_SZ_2OXJ/@#K'[1GPK^*EM\.="_:9^(_AOPOX,T?3/$_AOX?6FL:/J7@=O"
M^O8QHA'_  CA'']N'&%!^8Y)P,?I_IOC;]J'X>:#]@\.?$W6]2TZUO-5O;.[
MN]'\&^)-3_[ O_,H]L>*/3MBOIL@\4,IX@A45Y9(^6HE=^\WRS2:N[W;LU;6
M[3WL>OXL^$&,\*ZN5T'Q3PSQKE/$%#GMPU_;<:G#$I4>9*4L[LN>+E9N+:4D
MVM+'Z;_M)?$SXP> /AOXA^)>C>+_  U!IMMK'V+PYX<O%&GKJ&J#6_["_L0C
M0,@X.#R."/6OS(_9&^(_A3QO^VV? Q^&/[,IU\ZQX\^V?&WX4?VS_P ++.J?
M\3_^W0?[?[<<CD$9!':OS7_;>_:0_:3^+7BCP/\ L]:KXCUOPWX'T&TU/X@Z
MQXW\$>&_^$;U/3_%']B_\2+_ (GGB#_F7?\ A(\_^#_MV_/_ .&W@/XM_!_X
M@V_Q&^!_Q5^&^I?$"ZL_%'_"87=WX\\&Z;J=_P#\)W_8']O:UH?_ !4G_%/_
M /")]>XS7YOF."R#%3EB\1@:F=YM[3A]I\0U<_22=1WE!0J*&UFM+?#S:'\V
M9?X9\&9AED\WS^I6S?.%4R%PCQ%.KGEO?E\*A.FHM)1U2O&T;_"K?WC^/)O!
M_@F_\,6)\5W-MK'BC6#9#_A(?&&M:E]NTK&O]=#YS[=., Y[:7@GQ5H?AO5?
MB1_;FN:)HGA?2_$FE_9-7N[S^S=,_M37?H?TX-?PC6?[+O[;.L2ZQ/8_M)_\
M);J']CXT?_A'O'GC+QOJ?A+^WM:T#_H7_P#A+O\ (/X\OXD_9O\ VH='\.6]
MCXQ^*GQC\27%K>?;?[)M+/QEINF>IQ_PD'B3W_SV_6LDQCPJS+"97EMM([SE
M9:1NHN<GHM;=;+74^CR;)LKRK%YIA,+S-*UOBY4ETBI-VLM$KZ*RZ']^?P!_
M;1^"OQ$_; ^(_P"R1X(U2[UWXD?#KP-J'B?QY=6)/_",Z$=!UWP]H T5L<_V
M]G70T@SS&&SD9!_21F _S_G^E?PQ_P#!NQ\._B+I7[=?QKUJ_MO&6C:_JO[-
MWB@ZQXT\>:EX/\7RZB5^)_@ A8](\.RPE#QR?-08X+;2<_VB1^$_&=S&QOOB
MEXD+8&/[ \.^#;(+QW,WA[Q3D#.,;U//YZ8N^(Q+EB7&+TOI>*:5E\+5^W;2
MY]?A\2\,K87+)/=)-O=K?5]]]#UC<O\ >7\Q[_X'\C59W5!F1E@ Z%2,=QVS
M[]?3FO+S\+[*5 -0\4_$#5#V6Z\;ZW9C.>W_  CTMISWYQUZ5-;?"/X=H/\
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M)/\ V;_PB6ED\Z+_ $YQGMBO-_B=\-M#\86&L:'XJTK[3]JT?_3!C^S=,O\
M2L_\@7\>_I[UT8?KA'YM:>K.'$?6XXW*L;A8MI2BYQ27,XQDG))>[JTG:]M;
M7:5VOP?TV&?7OVD?B!_8<^FZEX/NO@/X#UK[7X>_L7^T]?\ ^)UH'_(#_P"Y
MC_MS^7%?HA>S0:/_ &?!!!<_:+7C[7_R$O3Z]QZ\5R\/[*WP \$ZSH_B/0_#
MG_")>(-+LO\ F$V>L_V9Z_\ 0R?YXJOJ6CWUY+<?8=5N;:WM;S[:+2TL\?\
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MZ]/3].G_ -8UA]9Z7_'_ ()T?5]+Z_UYV/L?_A,8(9;?]]R#_GO^'^<5\?\
MQ4^+6E:QXDUBQ^W6USJ&E^#_ /CTS_QX?\3K_..>W:N7U+XG^1%^_G''OSG_
M #S[5\;Z_H\%G\1O''C'^U;FYN/&7@_PO97EI_SX#0N0/KU]?2N','_LT'YK
M_P!*1]-PKA<)BLUF\6K/DGJEK\&5I:K7;SZOOK\O_P#!3/4Y]7^/_P"RA_94
M%L+?5/$FE67]DW7.FW^J?\)GH/\ R'.>P&><?CU'[[_LK:]HE[X\\8Z5H?\
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MQ]NOOM/B'_ES^R6?_$LX'^>GX5YO\9O&T&F^%_#\\\^HZW<:GK&EV7V2T/\
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M+L?LEI>'_D*_3ZU^D'B2SOIM&UBWL8+:UT_5++[%9W=W9_VEIG_4=//;C_\
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M_9><X]^?\_S_ #-?E]^R+^V-^SUX/_9X^&^AZY\6_A+;?V7H^J67_)5/!O\
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M3IUKZO\ ^"<O@ZQ^&'ASP1X L9[FYM]"UGXH7UY]K&/^)IKH_MX<_G^?'O\
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M5NMO=/RO.>/^)L'F^:8/!99PYG*R5JTN(Y3BW=K6%G'FDKWC;FU44?0&I?\
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MO[>L/^A/\(_^ G_UZY6BOATW9:O9=7V7F?1;^?3>YT7]O6'_ $)_A'_P$_\
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M^VM8L_3_ #]?TY_6ODW]LBSU"']B7]MS^R;;[5?W7[+/QY^RVOV4Z@;W4O\
MA5OB+G 'S_-M78> 6#]4 /?B<2OJ3OV;?FDK_IUO]YP1BY8Z,4M9222T6K:2
MU>BU:U>BO=Z(_P N'1_#=]>:7;ZI?3VVB:/_ -!;5O\ E_/_ % _^A@Z\G_Z
MU=1H]G!-%<7'A6QMK;3[7/VSXA>+!_Q++'_L!8/T_P"AQ\:8ZU7F,.FZK]N\
M?_:?%WB"US_Q3W]L?\>'_8<US\O^*6\)\\\<T7DVJ^*HK?5?$E]_8GA?2_\
M0K.TM+,Z;IE@?^@+X'T/_P"O[>M? OB3*8MIMIIO=6U3?=^1^[87P5\0\;@H
M8W!95=3C%P?^L61^\I*+ND]]&M-6MGJF:&FB?4M4N(/ ]O<ZGK'_ !^ZQ\0_
M$/\ RX:7U_MOG_D7_#N??\ZQ[S7K'0?M%CX5GN=2U"YS_;'C>[_Y"=__ -@,
M_P#,O^'<Y_ZG0CWS5;7O%7]I6%OX<T.Q_P"$;\'VO^G?V3:?\O\ J9/_ "&M
M<US_ )F#Q%Z_Y%<Q#!/>75O8P0W-S<77^A6=I^'7^?X?6I_UMRGR_KYG3_Q
M3Q/M?^R8[7_Y*+(^U^BO]VO;4ZCP3X5@\27^H7VJSW.F^#_"]G_;7C#5N?\
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M[6O[)7C_ /9I^.?B_P"&5OX<\2:WX6M;S^VO ?B&TT?6=2_M[PQKO_(#[_\
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M4L6R"H()[W^V9_\ GQNO_ P_XU7FU[['CS_]&_Y<O]+O/\??M]?:C7N_O?\
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M_).WKJGIZ]-^A^M8GZ(G"<=?]?N)W;_JG,D4'R][9LO==M;6?*W:SL?U9?\
M!7/]K_7/@;\$=(\*^ ?$=MIWQ(^(NL?8M'N[3^QM2_L'PQH0_P")[K6<'/3G
MH./>OYIKW]LS]K?4K:XG_P"%X?$C[/:G_C[TF\_LW[!_X3X_SZUQ_P 3]8L?
M%7QCT?PYY]S_ ,(_I>L:7X8O/LEYZ:T?[=Y[?7J:^\-'^#_@#P3:^(-*OM#M
MKJWNM8_T/P]]L_\ 3YK@YR<\Y.?K7K8+Q$X@G2J+"0CDR<*B=\_B^92A43WC
M*U[O2^E[=#RL?]'W)N&,!5CA/%/B9RSVE4@N&N&^&H2E#FA4IJ;E+-6XZR4F
MU**NG9K1GK'QW\2>./"O[)9US_A*O$G_  G'_"-^!#>>+#K&LCQ-_:FNC0"/
M^)YVZ=^H_*ORO\!^,?BKXP\6V\$_Q4^)%M;VEGJE[XDU8>/-9_T#POQ_;O\
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M=\6>(M"\;(?"_BK)9O$&[8JDA?U[^Q^W_CU6/L?[WKS^GT_/OZ]\UT?6//\
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MSI%EIS-'HWQ?\/2:K&(E9Y_ 2MJOPM\2MX.\3B2;?'XEC\O=L!+^:_K^O^'
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MN_FV+11170< 4445T'.%%%% '04445XY] %%%% !1110!^;_ .T3_P $FO\
M@GS^U9XYG^*_QI_9J\+:_P#$R[3=K'BO0]8\7^"=6U\X)"^(#X4\0^%4\0GD
M#_BI(Y!QD!AS7F?C[_@A_P#\$U/B1J&GZAXP^ 4^IS:3HYT72K0?$?XFV&G6
M.EC^!57Q+PWN=V,8"FOULHK/V4>WX+_(-3\5O^(?C_@E'_T;//\ ^'2^)GO_
M -3/]/U]>(/^(?\ _P""47_1LMQ_X=+XF>__ %,_T_7UX_:BJ_D>_P"O_P!:
MK^KKR^Y?Y'._KA^+O_#@;_@E-_T;-<?^'3^)G_S3U[1\&/\ @DC^P)^SW?\
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MHH **** "BBB@ HHHH ****#G"BBB@ HHHH **** "BBB@ HHHH *K_\LO\
M/]VBBKA^L?U ****U.<**** "BBB@ HHHH **** *]%%% !1110 4444 %%%
>% !11170<X4444 %%%% !1110!7HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ea027779601_img6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %) DD# 2(  A$! Q$!_\0
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M]Q;>^3C\NG^<TODV_P#SP@_S^%-A_P!5!]/ZBK- $'DV_P#SP@_S^%'DV_\
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M@_S^%'DV_P#SP@_S^%3>3<?\\!_G\*/)N/\ G@/\_A3L^S^Y_P"0N>'\\/\
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M'_+Q_P ?WV3'..O\^.GMFD\FX_YX#_/X46?9_<_\@YX?S1_\"C_\D0^3;_\
M/"#_ #^%'DV__/"#_/X5/#-Y\7GP?Z3;]/\ 1/\ )_KGCM119]G]S_R'S1_F
MC_X%'_,@\FW_ .>$'^?PH\FW_P">$'^?PJ>']]GR?;]?IC.?_P!='D>_Z_\
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M?:4W^N/U'\Z6BL-SOP^'>%ZWTZMZ=]6W_P #T"BBB@Z HHHH **** "BBB@
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M=']BX7O+[WVMW/E6Z^ GC'5;ZYGOOBEKFEZ1<7SW9T?P_K/B\G"DJK?)XG<
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M &-'_"/7G_/Q!_WQ_P#8UV-% ''?\(]>?\_$'_?'_P!C1_PCUY_S\0?]\?\
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M4 <=_P (]>?\_$'_ 'Q_]C1_PCUY_P _$'_?'_V-=C10!QW_  CUY_S\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBDR/4?F* (%))/R=#[_KSQ]?;KZK]TXVGJ.G&.>W.?QYQVI&&>?,P
M/Q]?H,?3->-?$OXW>!OA?:@:]J1FU-E)M=#T[-]JMZ>RQVX ;W)=DQ_M<5O1
MPN(Q<HX?"0<IM**24I-*V_165]6VEYGFX_,L'E>&EBL=CHPIQ_F:2EUY4MV^
MB25V]CUV.2.)6D=1$H)&YF))Y)R 2/S/>LK3?$&B:OYXTO4]/U%K"X-K="UN
MX[PVLH',;LK,5D(P/^^N3M-?AW^T+^W\U[=ZMX>L=4,+V8(NO!?A:]W:I&"
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M2:??JNB>A]]D_$.39]A/K.69E%2^U3G[LDU92CRR<7=.ZVZ=3T;^TK$?\O\
M;_F/_BJ/MUE_S^V__?0_^+K@?(]_U_\ K4>1[_K_ /6KS].Y[71/H^O1^CV^
MYGH7]HV7_/Y;_P#?8_\ BJ/[1LO^?RW_ .^Q_P#%5Y[Y'O\ K_\ 6H\CW_7_
M .M32;T2;?9)M_<DV)M15Y-17>327WMI?B>A?VC9?\_EO_WV/_BJ/[1LO^?R
MW_[['_Q5>>^1[_K_ /6H\CW_ %_^M2&>A?VC9?\ /Y;_ /?8_P#BJ/[1LO\
MG\M_^^Q_\57GOD>_Z_\ UJ/(]_U_^M0!Z%_:-E_S^6__ 'V/_BJ/[1LO^?RW
M_P"^Q_\ %5Y[Y'O^O_UJ/(]_U_\ K4 >A?VC9?\ /Y;_ /?8_P#BJ/[1LO\
MG\M_^^Q_\57GOD>_Z_\ UJ/(]_U_^M0!Z%_:-E_S^6__ 'V/_BJ/[1LO^?RW
M_P"^Q_\ %5Y[Y'O^O_UJ/(]_U_\ K4 >A?VC9?\ /Y;_ /?8_P#BJ/[1LO\
MG\M_^^Q_\57GOD>_Z_\ UJ/(]_U_^M0!Z%_:-E_S^6__ 'V/_BJ/[1LO^?RW
M_P"^Q_\ %5Y[Y'O^O_UJ/(]_U_\ K4 >A?VC9?\ /Y;_ /?8_P#BJ/[1LO\
MG\M_^^Q_\57GOD>_Z_\ UJ/(]_U_^M0!Z%_:-E_S^6__ 'V/_BJ/[1LO^?RW
M_P"^Q_\ %5Y[Y'O^O_UJ/(]_U_\ K4 >A?VC9?\ /Y;_ /?8_P#BJ/[1LO\
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MY??#VZN-5L=<_L3'-YF\_P")9?\ N#U_,'DU]_\ [.W[=][H0MX(=5M_[/\
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M^8_P]^ /Q-^,%KXHM]<T+4OL_A?QAXHT6S\0GQA_PC>I_P#0!UW^P_I_8?\
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M[&YTJX^)F+:ZLS9 6G@_.I>$M+T/6M>UW0M&^%FN?\))_P )-X?8G6R?&_\
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MV(-2U/5]0U/5/BYJFEW.O77B?7/%]]X7\.KI=_K^J:[J_B#7MJMKGB2<^'M
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MKJ^S7Y!_'G7K+0=+^(/P]T;XV>+O$_PDMK?]G;QCX@\9ZWXW/C34?A'XT?\
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M,1X.4I)(B+K^'M:N-,^!W[,FC:YX_P#B[X_\??'_ ,)Z!XWNM=U/XX:Y\/\
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MFG$Q^T2(D<TI" R,1'6]I7A[0M(3;H^EZ?I*FUTZTQIULMEC3](:3^R("%0
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M/V^J>$M%U!=! 48_L+S('710<9+0B/ISC ROK,7]E7UULNNGGJ<\>'L:FO\
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MK-17+%2:C)\J^%:2/<O%7AOPYX#\;_!;P=X<^S7/V6\\+7MYJWVS^TM3O_\
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M_(?XTM5ZZ#G+N\>A_3_&GUG_ /+7_/\ >J??+Z#]/\: +-%5_-A]?U/^-6*
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M'[<&H^-=6O\ 0? WP4U/4;O^U='T+2+[Q!XP/AW2[[5-:)W/K2R>'G\4^']
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M#&PDD"JH?2@^//P;N+>RNX/B-X/GM]4U2_T:PDMM:@OQ>:EI+$30QF%G;S(
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MHWFQK'[0OP?TFYTZT'CGP]?W6HW/AS":5JUO?O9:;XB\S^Q];U5HY_W.BRL
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M^^'?CJZTS6XK'4+?2+S2=7\&2ZEXY\"L-#$F@ZSL\.%_$.A+'X'T4'Q4B_\
M":$:,FWQPP9@.0T_]B#PQ:Z5JV@Q>)EMK3Q-X<O=$\5R6'A#37#:I/K&LZXF
ML^"O^$BUSQ7_ ,("DD^ORCQIX>M_.M_&D,9>9H65D%B+]AWP??Z7XN77?%&I
M3:YXZG\-W=WK^@:'HOA]] ET#7/'.MR1^#DA69- T'Q'-XVFAN/#:3S1P;<B
M242R&';F5OC?W+^NE]W][NE;R_#_ (!V_ACX8?#'Q=X9\(^%O"?CJ7Q78_!1
MM4^'R7;WVE^(U;POK.CZ!#K'@_79"DT.LFX^'IM_#$&O;O-C5Y9299Q)&KQ^
MRWX6+VM^OC#XBIXETS3SX7TWQR=6T=O$=K\/1HEQH*_#B*X3PZ%3P^;?5]1N
M"\\7_"5KXS;_ (2M;M[D@1>E_!;X1?\ "HM-\4VS:YINM7GB[Q(/$]]_9'A+
M1?!6EV4G]@Z)H3PZ7H6@1M&D7E:+$X9I=SM(  NP%_<JR>(:VDOO^\7U=>7]
M?(^8-'_9>^%>D7QB2TU#4O!]M8>*=.TGX;:K>#4?!&BR^-M'.@^-]2CT8J59
MO$V@F9)(Y&"QMXB\4LK;O%=RB7/&W[./PY\;2>&XI(-1\/Z5H/A@^!)=!\-W
M4>DZ;K7@4ZCH>M-X-U,)"\L6@C5]#TM2?#S038>2W:7RW.SZ-WMZ_H/\*-[>
MOZ"E]8E_-K_B_3:_G;_@;>Q7\K^[_@'P+JG[#?@/Q!JWAW^U_$OB;6M$\,^&
M1X<TB]U2YTG4/$FDQ:)KNBZYX"T?23+X;B\._P!@>%_+UL/#XKMO%[>)CK[_
M &H[%#/ZCIO[+/@C0M&UOPYX;UCQ3X9\.ZW=^%M:NO#^A/H6G:?#XU\%#PNV
MC>-M+4>&U:'Q$A\$Z(6A5V\%RK;*?^$-#.I7ZK^0\GO]:/W?^=U'UO$]_P O
MZN9?5X>?W+_(^-M'_9,\#V6O>,GUG4=9UCPEXR\*>)/#G_"(WAAL]&T2?QO!
M-I?C;5M"AT5(]%T23Q#X=CMM#98;>VG1CX@>.1E\4W4:SS?L@> M4U?4M9UW
MQ9X]US5O$G]FVGCFYO=8T/=X[TO0=8T76O#VE>(%_P"$=9X$\.OH&DQV[>$A
MX2W1JVX[G,:_87[O_.ZC]W_G=1]:Q/=?@/ZO#N_N1\8P_L>^!;:Q-K8^*O'M
M@D]G]CF6TU;16L#IT>KZ-K6EZ.-#_P"$>/AX>&HWT6.(^&%M?^$5PTL?V5]Z
MFH8?V)_A)_P@5S\+[B\\8W/PVNGLK^X\#76KQG3F\0KI8T0:LNM-HJ^)#*]L
MJAY/M2QB4"=HPF8$^U/W?^=U'[O_ #G^M'UO$]U^']>G;H+ZO#S^Y?Y'RMX2
M_95\ ^!]9\+^(M#O-7M-8\+0ZDANH;;0],/BO5-;@UW29=6\<#PUX>\+CQ'.
ML>MRN YA7Y0V63;))YYH7["OPS&A_#Z#QOK7B7QOXN\"^&/#7@__ (2+5AHH
MTZ^\*Z#HB:"G@MM _P"$=/AW_A''.[!6$^-@=JMXUR#N^\*K2R@#]>?\_D/Q
M-'UG%/JWZ6\]-MAK#T+J^GGS/\CC/ 7@W0OAUX5T[P?X7AE@T72)-3-E:W!)
M,9UG5Y];D5B0"=D^K2KG:N>00""*[2BBLC<**** "B?M^']:*/(]_P!?_K4/
M9^C_ "8&?!W_ !_I11_RU_S_ 'JL5P/=^K_-G05_]5_G.<_EZ>W3\[%5Z*W
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M?=?!_P +_P!CW=IX/_M(?\Q_^W?^9C/_ #,?KZ>W%?Q[H.N?$/Q;X/TK0_\
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M;TZ_^&.L:IHOCNTU6\_LW4M"U/0\'=GN,:WH>,<'/&:7U=]G]S^_8/=_N_\
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MFB@#8&_XG?AO@90R<_I_[0GPBU3QEXU\ ?\ "4VMAKW@7Q(OAK5SJNW3DO\
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MH36]XD9M#XGAM_\ A)XBSP<J(Y=K_AE?X5-:FVDMO%$]S>/]EUGQ"OBG5_\
MA(=;\,MHZ:++X+U[65D2?7O T^B:7H^A2>&V#P^1"K$1RO),_4Z3\!OAEHNK
MW^KPZ")+6[LM3L+;PMJ%U]O\$:#I^O,!XS7P_P""YA_PC>C+XN9V/B_R[9H[
MIU XCD:&6[X7S^]_Y^G?KY$_[5Y?@;.H_%[X>66I>'M,F\0-<ZCXCT(>*-,C
MTW1];U%5\->4CKKFJMH]O(FB^'U\SB;Q$]O#O9XS(9(G"\';_M7? "ZDAD3X
MC:;#%=VT=U'?75KJ^GZ9I;%O$:OINNZG+HL,/AW7PG@[Q"TOAWQ))!>R#0V1
M;=N-W4>-_@CX&\?ZM=ZEKD>N0S:IX87PEKEMH7B'6O#6G>*O#2MKPTG1M=31
M+I#K$?A]==UU[2,@) =:N'8O&R1IR%A^R5\#;;0M3\.3^%)]9T_7-6&MZRNK
M:QJTIUG5B/$)?5I2L_S.O_":ZYRFU<RJ,.$9RO\ 9+:WO\@_VORL<];_ +9G
MP=-AX_U"YN_$5FW@2]U6SDTJ?PUK'_"4ZZVAZ)-K>N'0_!90>)9A$FCZNL:O
M;KDQ;W+;M@W)?VLO@_%-X8L;K6-:AU?Q1>>"+1-+M?#VL:A)H#>/-'UW7- U
M?6'CMU\KPP\.@:[O\6E9O"R'2)$CN!Y:N^;=_L>?!JXBUAYX/&%QK^N7.I2Z
MKXTD\::Q)XUO6US1M;T'66;6C<QLO]NZ%KFK>'YVVQCR9(Q%ME7>MW3/V1?@
MKH]W<S66BZK;-<W_ (?O J>)-9?[*F@?\)(;?18QYRG^P@/&>O"2,D@G6IL&
M(!2'_L?F'^U^7X&W8?M.? [4?#"^--,\=VNK:!+XFTWP=&VC:7K6K:K+XEUR
MS76]#TN+0M%\/3:^T_B/1637TS:A# R,%9/-49FM_M4?!KP_<6,"^(K_ %NX
MU<^$KW2(?"N@:]XD.HZ1XWU_0O#NC:SHL>@^'Y?[:T9-9\0:$/&%Q$\[>%7U
MG_3)(E$*U6N/V5? *>"_"'@7PIK/B[P;H_@[XA^&?'MA<^'=99-?,GAO2#X>
MTG1_[8(>1-";0V$+(QF*)&-I+F12MC^R%\$M%OYM5TC1-7T&Y%M8Z?I3:7XA
MUE%T$)KG@?Q CZ(3,QB4ZWX \$RDON!&AQGY!D*?[)WE_P #3?\ $/\ :_(O
M> _VK?@U\0(O#,&E>);O3M?\3WHM;+PIJND:LOB)EQEM4%LD# >&U8 IXK!?
MPJ5(7[5GY:M:G^T[\#M"FUN+7O'MA82>&=9UC1[Q;G2M807>KZ!K0\.:UI.A
M$:#O\1ZQX>\0!M EM_#9NI5F=3)O<?)/?_LT?">YN-"G&@W\!\+WOA>\L8+7
M6=55;K_A";DZWH/F)YQW&WUITE8!D$Q1@K(9%5>1?]CWX6ZN=<E\7R^)/%5[
MJ/CGQWX^\/7=_P"(M5+^ ]5\<^-O^$[U@^!C'*$\/@Z_'HQV(K'_ (D\#H%4
M2)1_LE^MO^#T[JVX?[5Y?AL=Q;_M'_!6\\/:YXOL?'>G:EX8T+6/#7A^;7=.
MM=1OM+N_$?C5M%7P_HVB26T$C>(=9N4UW0I%B\-FY\L:[;[XTF:54S;[]I[X
M%6NH:SX?/Q%TJ]U_0YUTJ\\.Z7!K&J>)KS4G,;2Z-H>E:)"\WB37%$9$J^&T
MNF\.2E/M"00[L[M_\&OA[/X-\1?#R"RGTSPYXHOEU;6$TFZ.G_\ $R"Z)HI=
M'4\&3^QH0P8%?W3*N2X*^<:9^RE\&-*34#X;T75_#4YOM*UG1[G0/$6K6&I^
M$=35R+C5?!.N)+_PDF@2>*U61/&Q#E?&##,BR[&#;JCA=_?W=NFFEF^W5]UV
M=TV?[5Y?@;VI_M1?!:S>YM9?&VZYM]1%C:0VOA_Q;>MK>I?:6T@Z9H:IX6E7
MQ";89;Q8GA59F\*.0EZ8]\MQ6AX;_:*^&GC#Q]X:^'?A'6;KQ1>^*/#?B;Q/
M9Z]I-IJ;>&DTG0&\/I*AUPJ8AK;IXTT%C\Q<H[G$3A E#3?V<?A?I>O6'B6#
M3=7N[[3-9;6?#5GJNO:Y?:=X2U37)_[<US^PM&>1UT!O%>OD>)/&@* 338D4
MI&WEI/X%_9T^&'PV\0:1XE\):;J^G2Z!I.KZ/I.D#Q#J]_X9T&/7CH/]N:MI
M&BN[H/$'B9-#T/SG&6D 8HB$;)-&L&DTN=NSLW:U[:-VMI?5]]>ZOC_M=^F^
MNO2^I]%58K/@[_C_ $JQ7*;EBBCR/?\ 7_ZU6*AS2VU^?_  ****R.@QIO\
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M'=2T^[^)/CVS/B&]TKQIX=TW0?#&B:VSZ)HF6+'7_$(^';'Q.BYV^,5PJ;5
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M7])_U^!H45G^?[?I_P#7H\_V_3_Z]*W3Y'3L6)^WX?UK&O+S$OD=OISC_/\
MD9JQJ%[]CM?/(Z_IGIGZ_KG\*X\WGN>"#P,9KS<?BXX?EPRM>2OY[^K[:['H
M9=AGB;MK:_1V^_\ X-CH?];_ )QC'Y^OOU_*OY'O^O\ ]:L^&;_/^?U&?<&M
M#S_;]/\ Z]8K%?WOQ_\ MCH>%L_A_"WYQ*_D>_Z__6HAFN(/?]>??\JL45T
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MNH8C:?A;6/V(?C]\5+^WT/PKX!MM$N+KQ)X7LKO5O$/C#^S?[!TO^Q>^A_\
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M^C_)@<GXGF$.EA>IN+I%SGU&?Y <=R*\[KOO%O\ QY6O_7XO\A7G/G^WZ?\
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M7L+:RVVLMON6GX'D/7=74NFZ?R=T_N9#^Z_SMH\J'T_0_P"%2YA_YZQ?D/\
MXJH/M-A_S^0_^!G_ -E3LR?K,5I=+RNORYAWD>_Z_P#UJ*A^W6/_ #]0=_\
ME['O_M>P_P G@^W6/_/U!_X%CW_VO8?Y/#Y7VO\ UZG.\9@NLZ:\W.'ZS1\<
M?'SX\?$WX3^*)X=.\$Z=K?@'3? =YXU\1ZJ-+U\ZEIQ\.KKOB#75?7"T7AG0
M=_A_19$\'DQ>*&N/%C"WN(R@Q7B__"\OVB(9='L/#GPMT#P1H$M]\,?%,*:3
M\+_B1XDTW0? OC76M$77=!UQ_#S1G1?B'_PC^N\)X>\*21I-'XBE.R6)9%_1
M;4T\.ZU9SZ=JJZ3J6GW8*W.FZG'I]]87@(_CAE0JYSC!=3@@'9T-:W]JZ7_S
M^P?^!,?^/^<GVQLG*R_X3FW;?WM?.VQSO%X)?\S2DNNM2DOSFC\W-#_:#_:_
M\0:=?:A8? S0?#MQ:+XJO&LO$GA_XEZIJ-J=$.A,/!DHT <^($_MV3R/$2E+
M7Q:-$?R+>,A"GVS\,-?\9>(/#$DOC_28-$\1:5XB\0^&K]M/MM7TW2M;&A:X
MVBZ7K.BZ5KA>==$\16ZB>,R-M+2((I<$/#Z)_;.F_P#/_9]_^7E/?_;]A^='
M]LZ;_P _]GW_ .7E/?\ V_8?G1)5'HLNG'7=*5_QO_7F1_:F7+_F<4?_  90
M_P#EI?HK,_M[2_\ G\MO_ J/_P"*H_M[2_\ G\MO_ J/_P"*J?JV+_EG_P"
MS_\ D!?V[E'_ $-J'_@ZA_\ +"AJ_AK0?$<%O9^(=#TC7X;:X2[M;37M*TK4
MHQJ,9.S5DB<-$IP2"R1I+@\$$@5T59G]NZ-_S^6W_@7%_P#%>W\_4T?V[HIX
M^V6W_@7%[?[?^>?4TOJ^+_DJ?^ 3_P#D1_V[DW3-\.O2M0_^6FE@>_YG_&C
M]_S/^-8\OB+0X1FXU?3(1_M:K&I[_P!YE_S^&6_\)3X<_P"AATK_ ,&FF?\
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M' _3CG_]9_+N:[OJV-T_X2Y=/YCC^L8)[9G&7R3_ "3-#[9[_P#CM6/MGO\
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M67X^TT]>F_0X^;P3X<FB\B?0[:YM_P!?U[\')Z'\36?_ ,*P\#?]"[:_G_\
M6KT"CR/?]?\ ZU<^(Q&*Q7^]V^5M?/\ 7<[\/PMD.%_W3ACARVUW*=UYI.>_
M9=&DNAY[_P *W\&_]"Y;_F*7_A7O@[_H!VGY_P#UZ]!\CW_7_P"M1Y'O^O\
M]:L#7^QLK_Z%EO2<K+T][;MY6.(_X5[X7_Z EM^7_P!:I_\ A _"W_0#M_\
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MN[OJVG\K-Z'Z;G629/GN%6$S?*X9TH2C)<R2BG&2<96:2]UQ4MKNS743XS?
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MJ/(]_P!?_K58\CW_ %_^M1Y'O^O_ -:L+/L_N?\ D!7\CW_7_P"M1Y'O^O\
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MHESHMP3Q_9%W^/)SCWS@>I%<?H/[-_Q&^%EU<7WP6^-/BWPE]I_X_+2TO/\
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M4[_^P_\ F"_]"QR<_7\L>;^*O@GX5\;$>3!_9EQ:G[;FTX^P?]1K\S^=>O\
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K*'7OY7T_ _)LUKSK8A\_3L244B]!]!_*EKU#R@HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ea027779601_img7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea027779601_img7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $: 8<# 2(  A$! Q$!_\0
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MM'QY_P %1/CAXWE\+WW_  KGX7>$M0T&STO1;R[\/?\ "9:E_;W@/0_!>O\
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M6)OB-X]\3?#WXDVNO^-O%NK+IMGX76UCN]8/^AJWC0J5[<L/EX]:*X?3?/\
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M/^'?"?I].U?T@?\ !3+_ ((;_L:_LU>$M8\'?LA>,?VAOC'^U1JEYI=EX/\
MA[>:QX-\2>&;#5-=UO&A:+K@_P"$;/\ Q41'0#G!Y )K]5OV-/V(/A+_ ,$Q
M_P!E+XO_  0GU;3M2_;/^(OP?TSQI^T?\5K2\_LP>$],U[6] _L/X,>"==ZG
M R% (7DDAF"E>A<OE9;[:!^I_%1^V]^R+/\ L@?M%^)_@OH?CZY^->CZ#9:5
M?6?Q,M?#8\.:;XL)Q_;HT0C(_P"$>'B/ X)!Z D<U\L3>&_%4,5O//X<UO[/
M=?\ 'G=_8_\ C_[X_EC\Z^^/VQ?'>J_M:?M5ZQJO@[P/\2/%G_$XTOX2?"OP
M_I/_ !+=,_X1?0O^)#_Q(N/^9M_XGGB@?6O5_P!HK]C^^^#/PY_9OT+XT^*O
M 'PMU#2_!_BC_BD_[9^)?C;Q-_:FNZU_;W_-/_#?^>N*YDUBL6\)A'&RW?NV
MTWN[Z>K://Q&98/"XSZEBG=NVB=WTMHFWJ[/;H?E!>:;?V<5O/?6-S;6]W_Q
MY7=W9Y^W\\^U5\_]-_T_^O7ZD?#WX&_"3XJ?LO\ Q8TJ#XC6UUX@^ ^L:7\3
MO#>K?V/\2]-TS0?"_CO_ (D6N_V[_P )!X;_ .$G\0'//_%)]A7[C?\ !$K_
M ((V_P#!/W]M[]GKQ?X__:%L?$7C_P 6W7Q?\5>&/ FK>"/%_P 3/!.G'PSH
M>C+_ &WC1/$! VXWY'))*X( (/3]6CM[O;I_D='UGL_37ITZ]C^/&BO]*>\_
MX-<?^"36HQ":R\$?'2WA/_/G\8/&0SZX!\.,??D^F?;F+S_@U-_X);?Z1Y _
M:9MO^O3XJ:R/Q_Y%OL?\^A]65]EIOMIZZ:?@%_,_S?ZKWG_'M=?Y[5_HP7G_
M  ::_P#!-B\_X\?'_P"U%;?7XD:-J7K_ -2WD^_Y5Y?XV_X-+_V'[.+3_P#A
M'?C?^U%;?VIK&F65[]K\2>#M3^P:7G_B>:USX;!'')&, YQG&3T8?#VQ3?1I
M^FSZ[=.C_06+?NSUZ2_*9_(1^V[_ ,D"_P""9_\ V:9JG_JS=?K\[J_NO^*O
M_!N!X<_:HL/AOX'\'?M3ZW\./"_[)FD>*/V??#=KX@\!Z+XV\3>*]*'C,Z__
M &WKF6 P?[< X!(..@R:\@_X@^8/^6_[>MS_ .&3^G_4R?3KZ5PO=^K_ #9P
M9+_R*?\ MYV\M9_<?Q7T5_:Q-_P9\Z5#^_'[>NI=!_S1,=/4_P#%2?Y!'3%<
M_-_P:1^%+/F?]O76^/\ JB6?_=D]?\BM]M7HEN_3<]BZ6KV6K?DM7^!_&/17
M].%Y_P $-_\ @G/IMU<6-]_P65\ VMQ:WFIV-Y9GX5Z+_P A30LY_P"9E[=2
M>F.A)XJO_P .0_\ @FC_ ,O'_!:3P!;<_P#1-]%Q_P"I(?\ /:N9YCE*NGFR
M4E?32]U?2U^ZL>=_;>4)V>:1T=FM.CLU^:/Y]_@#^SW\:?VJ/B7I_P '?V>O
MASJ/Q1^)&J:/JNM6GA/2?^);_P 2O0N==UK7.>F.OZ=L??/[.O\ P2O^)O[2
MWP;\/^.?"NJ^&_#?B#_A//'GACQ):>++/6=2_P"0%K8T$?V'_P (_P!O^$C_
M +<^F?S_ *+?V>?V</V$_P#@D_\ LJ_&CXG?"7]L'P[^T;\</VH+(>"_ ?C9
M](7P3JE_X#T+']N^"O ^B(T@R.YW8R?ER#QD_P#!,?QMX.TR_P#''P(GUS3=
M#\8>%_&'_%-^$_M@_P"$FO\ 2QHO]O:[K7_A1ZYKGKG]:^I\.O\ 5W-LV<<W
MFG>\5[RZW2TYNNA^7^+'%V:\/Y2L9PW*+:LW:46WWO:3]3\)[S_@CS^T9KW[
M1O\ PI;X2?"NU^*.H:7\-_"_Q.\2:39^)/\ A&M2U[PO_;7]@^.O^1@[_P#"
M1_YYKO\ XD?\&['_  4F\*Z]X@'A7X.7/C_PO:_V7>Z/JUIXP\&_VG?Z5_T!
M?[#_ .$D_3^M?TL_M%?$[X'_ +-/BW1_C]\5/^$DMKCQ1H^J?".S\0^$]'_M
M+4SI?]M?V\-%[^_M7+Z]_P %;OV98?AIX?\ B;X5G^*.M^(/ ?\ Q;Z\TG_A
M&]9TS^T/^)+_ &]X%_MS_/MTSCS^-J&3Y#Q$\'@I*SNTN;O_ -O6O9HZ?#?C
M_!Y_PXL7G+2SG2]W;71=6EN?P[?%[]G'QM\"OB5XF^$_Q?TS4?AS\3?!]V+3
MQ%X*U]@=1LE8 AE89!4C!!!(((P<8->@WG[!/[5&F^';CQCJO[.?[0__  B]
MK9F]O/$)^%>L_P!F?V7_ -!K/\P??I7]BW[6G['W_!/?_@LY\/\ X7_M7ZK^
MU0WP?\?_ +-GPZTNR_:#\0^"/ B^-OM?A;;_ &]H>B^.-#^4G7_";+_R-'[Q
M@TF !& $_9;X!_\ !3W_ ()Q>%?#W@;X,:#^V5X0\:ZB+/PSX6\(6M[::T&O
MU.CI_8>BJ5\-XY"9&>^P]F4_,/&8/7WX];W:5M_[VA^D+,\$[? KVWE%;^K/
M\M/_ (0^Q_TCR+[6[D6N/MGV31]9_P! ^G\_Z5C_ -F^%?\ 2(/^$JMOM'_7
MY^?3Z\8Z_6O]AWX<> ?V6=7U;QCXA^'/PK^'']K^/+QM9\>:J/ASI&G2>+]2
MVD#6=;=O#RMK\AX.\MGN6#'<-^;]D#]DG4?/,_[,WP#N#<W9O3<'X0>"LG4_
M[Y8^',C!YSNQ@D$$D8[L-+!XK"Z-7WW73;2]_P"K;G1H]MC_ !X[/PW\,KR'
MSQ\3=-TVX[Z1=WFBZ:?3_B1_I[5Z1K'[.L$$5Q-X5\<Z)XDM_L7VW[)=ZQHW
M]IW^??VK_5M\5?\ !,7_ ()[^-O$,WC#QC^QO^SEXC\0W-F+,ZQ=_"K0MW]E
M]=K#84((."5 / VGG-?._P ;/^".?_!/?XD?"_Q/\.]"_9F^$OPON-4T?5#I
M'BKX>^#AX<\2^$M3 ;^PM90^'RG]OMX4;:?^$88LI5< +NW#HE_N37E+UVE\
M^QT7/\XKXD:#/H__  3L^$]C/]I^T6O[3GQ0LORT70![_AGZBOSWA_<Q9YST
MY_R/\<\<5_4-_P %ZOV'=#_X)_?L_?LP_!S0_B-K?Q'_ +2\9>//&6L>+-6\
M-Z-X;U/4-4V^'F_Y 7A_V.._OW _F!KYGAM>]FR[RM\VW][U6F_D?7\5RYEP
MHXNZ_P!5WWW3L].]T^@4458AL[Z\B\^QTK4M1MQ_Q^_9+/6-2Z\=^_\ C^%>
M]BL5@\&G+&M1BMY-J,8^K;271ZR78^02;V3?HF_R3*]5YIH(9?(GGMK;'_/W
MZ_CV_/&*['1O!OB/7O$>@:)_8?BS3;;7M8TO1?[6/A#6-1-@-=UH'^VO^1<Z
M^PY[8YP/[WOV?/V"/^"?G['_ .S5K^B#]CWPY^T?X_M-'.M7OQ+^-WAO1/$G
MB7Q!X\.BC[V5W>'_  Z.WA967J=V>@\5Y]DR:3S>DG+X8N=*[5[:+VC?9;?>
M/ZJ_Y7_X"_UBC_/XM//U*6W@TJQU+4KBZXL[32;/^TM3O\8Z_P!/J*G^QZMY
M7G?V7J77_GS_ /K?ACI^%?W[_LQ_\$\?"W[#=Y\6/VYM5\'>'-,^._[5/B/2
M_!GP3\*^'O#8_LO]EOX7Z]HI&NZQH>A8)/B(<LQRH&5P3D@?E3\3O^"-O@[X
MD>,M'TJR^*GBW_B5V>J6=G:'P?\ \2R__MW6]?U[7=;/N?[<']17Z#PCPMB.
M.,)FN-R:<)?V'\7+*$M;=>63UW=GKY'P'%?B-P_P7C%@LW3O*W*DF[M[6TUU
M:_ _EG_LW58<B>QU(W'_ %Y_Y[_K],UGWD,]G+Y%[!<VUQ_SZ7?T&/Y$?3UK
M^E?XV?\ !)>QA^*'['_[.?A77/$GC;Q/\4+3Q1\)/#7BSQ#9_P#"-^!M!.A_
M\3[_ (KC7/#WAOQ?XGP/[<Z]N_K7VCKW_!MG\</'GP;T:#5O''[/'_"V? =Y
M_8MEXL_X23QD=,UWX7\G0M%UW_BF\?\ "1>$QW/?BOC\[G@>'LX>!SC-X1DO
MBCSP3CZKF36O=(]_),YPO$.#_MC!1E9VMI*UFM.G9H_COA\*^,;R*WGL? _C
M_4K>ZQ]CO+3P%XRU+3+_ .G_ !31_GUSGK6E_P (3\0/^B<_$C_PVWC'_P"9
MNO\ 73_8Z^",WP"_9I^"WP6\2'P%J7_"N/A9X$\&6>K>';;2%^WZGH6D#0]=
MXU[PZ >5'7/RET("LZG\Z_&'_!?O]B?X?>+O$_@#Q7^SG^V=IOBCP9K.J>&?
M$=G:?LFZSJ/V#5-"XY&[!'.1D<#D#H:YXYYP[.ZAFT)6WM*+LO/WK+YM'KVQ
MG5?@_P#(_P S[_A OB/_ -$S^*'_ (;CQG_\SE9^H^%?%6@VOV[7?!WC;PYI
M_P#QY?VMXA\'ZSINF=_^8YX@\-XS[=1VYK_7-_9=_;0^$O[5GPNM?BU\/?@Q
M\8]#\+:GK.J:)I%I\1?A9I'@WQ/J"Z$?FUD:*9 Q\/G^%V+[3T5AQ7YD_P#!
MPGJ/PD\4_P#!-?XLCQS\+/&VG#X<^(_ ?C/PUG2&\-Z;_P ).NM?V%H0.NZ
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MKUYI>BZ/I5K\1M:U'4K_ %/7>/[&Y'?/7/I]*_TQ?CS\)]$^,O[-?A[QA?\
MASPSXD\3^#]&_MD'Q%X<T;Q&S:<,MKJ!?$ P?D#$G=G@X'<?E3_PKWX5PZII
M^N6/PS^%W]H:7=Z7K5EJUI\-_!O]IZ#JG_,"UK0^/U_6N[B'Z6.$X6AE>,QG
M"=67]N05N5W47RJRE[LK*[2LG!WOK>QSX;)/K6E]%^';:V]C]"/@G\1_VO?
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M8O!WP1UK6O!VE_&#2_@OX#U>\\1Z/INI>+-4Y_MW6N 3S[9R,9P,X\._9O\
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MQ:\'^%[W3/&6K_#+Q#X<T73=,\6X_P"0)HFMZYX?_P"9>R#N YP#GC-?9/\
MP5/\>ZMH_B?X7_L]>%K>U\-?"CPOX<TSQ->:1I!_L[2[\ G00>0/^*>\*#!(
MQA3\H) W']C=:_:H_9O^&.JVWA;QY\8O!'ASQ1::-II^QZO?%=2.FX^4-A')
M!SR0>/O;7(K^5K_@O-^T)HGQ)^(OP6^!_P"S;XWT3Q;\6?VC++4_A\=6\.ZS
M_:8\!^!/[9_XGWC/6\@'0 /#G3IGC@5YT<IP3G&*R:/,VHQ]V*OS22Z03LVU
M>U]+B<N5.3=E%-MMNRM=ZMNW2Y^'_P"T?^U1KFF^#?BA^T+X<\1ZWINCVO\
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MD?2OYSIM2GTV6WU6#_F%WFEWO<_\@']>OM].M?HC_P %1-'_ .,D-'\<0?\
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M%9M)7VV=DWIY_B?-<./"7S;!X/H[_BWI_2,Z\AG^,'[#.GZK!/<_\)Q^QO\
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MIC'A<(HWBF^EW9-V[ZV_$_N0_:$\2:5>>#;_ %6?5M-TW3M+\2>%[+[7=_\
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MY_GK7/\ V;C'BWA+-Z7>E^GH]%_6AT/,L)]4;TU6CZZIVWZ;._G\C^<__@Y
M\5?\)A^US\+_ !6+#^S+?7OAOX\O?L@_Y<,^-?\ ZW]*_GG_ .6O^?[U?T0?
M\%8O!.J_MC?%#X/^/_@#XR^"?C;3]!\!^*-%UC_B]GPT\-_8-4_X33_B1?\
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MW7S>VFKZ'V'U;R_#_@']'/[!'[;WB/X\:#X7^-/BKQ&-;\8:I_98\8:M:?\
M$M^WZ7G_ (D6M=OR_P"H!^%?TC:'\1S<7WA^]O;^V&CZ]:+HW S]A\4*P8KS
MQ\P!4_7UK^#'_@EA\#?VJ/V;Y=0\#_'#PKX;\-^#_MFJV7VN[^,'PTU'_B5Z
M[G'_ #,F/^*3\1_U'/;^K#X)_'CX9:;X2U#PK\1_BI\-]-^R_P"A6=W_ ,)C
MHW3_ )@6M<?T_45M_KMP]M_:B?I9A]67;\/^ ?K+XCU6#0M#UC5IY3Y&DZ1J
MFL$_W1H:"0].HSA3[U\P_L^>,?&6O>%OAO/XIURYU*YU3X;'QIXB^V6>-2)U
MW6O^)#G R!_PCN0<9P.1GI7Y_P#[4_\ P4&\10_#7Q3\+/@1X<^$OQ;\5>*?
MAOJ>B6GQ#N_VD/AGX)\#V'B;7 =!"ZYHGB#Q'_PE&T$LPR>K$C@XKTG]FC]M
MCX'GPY<7WQ;\<?!/X)^(-!\-^%_!=GX(N_CQ\-/&V=+T+13_ ,3K^W/#_KC_
M #WZ</Q%E.+3MF;=TW9)]G;H<[PZ71>EUK]_?;YG\^W_  >"Q7!T;]DG/&+[
MQX/QQX?Y^O/Z<8K^(#_EK_G^]7]KW_!S=\2/ W[5VE?LOV/[.?CWP#\8=0\+
MZOX[O=77P3XPT34S8<#@X=@<?=)W'D?Q#!/\A!_9[^+?]J:?X5GT/1--UG53
M_H5I=^)-&P/^HUQCG]?7W\GA[,L'S9M?I)M<W2S?O:[.RO=:^9]YF.49IFF3
M\++"9?%\JDFW4@GRIRTDN?16MH].JO?7]$?^"'G[/?Q;^-G_  4=_9_\8_"N
M"YMO#_[/OC#2_C1\5/%EY9_\2S0?"^A8QHG'_,Q>+/\ D5_! _.O[Z/!_P ?
MO#D/[55O^SG\,M*T31/!^@Z/XHUKQ):>'C_9NE_\)1_;1UW^Q3_G\Z_$?]D7
MXS?L(_\ !-_]BC_A4GP)^-/@GXD?M >*#_;7Q4\;Z39_V;JFO?%#7?\ F-=O
M^*=\)]/!'^17S_\ #W]M+P/\)?'@^)OASXJ>&_\ A,-+_M3_ (FVK?\ $R^W
M_P!NC_B>CM_^HUZV(XBRC1?VHNBM9?=M\CPO]5N(+_\ (MAN_M1[OS/E_P#X
M+D?&"?X/^*?BS\#_  K]I'CCXM?$CQ196=I:?\A.P\!Z[C_U+1_GFOR__;8L
MX/V=?V<_V7_V--*G^RZS:Z/_ ,+H^,'_ &-&O'_B1?VY]?\ 'K7J'C#XA7W[
M5W_!2+4/VHOVMO$?A+P3X M?&']M6=W=ZQHVFZ9_9?@3_D1=%_L,?]#9G_A*
M#S^%?)_[5%G\5/VD/VD?BS\5-*T*VU+3]4UC[%X;^R>)-&_T#P'_ ,P+D_3^
MM=[S/*(QNY))J]W))/2]];)]^INN%\TT_P"$Z%]-IQO^$CX8F_U)^@_E7[S_
M /! 'PW_ &Q^T9\>=<GG^S6_A?X/Z78_:\_]!WQIZ?\ ZCVK\CO^&8_CO-^_
M/@>YN>3TUC1OZ_SSQWQ7[<_\$>=-'[.M_P#'C5?CA/;?#?4/&1\!V7ARTU;_
M (F7]H ?V^._3_BHZ62\29,L8T\UAUW<=-UU[6/KN#.#<U7$$L8\MBERO5SB
MD_=?>:7_  Q],?M=>&]*\2>#O@__ &KXJ_X1O[5\;/'GV/5[O_D&6/\ ;NM?
MX>_IBOYC_CEIL&@_&3XHZ5!??VE_9?C#5++^ULC_ $__ /5_3UK]J/VZIM<^
M*G[.?P_\*_#G5;G6_&%I\8/%'BC6-)TF\Y_X1?7=:U_^PC_C^N!7X[3?L]_'
M":7S[CPM]IN+K^U/]+N]8T8_\@+_ )#O.1G'MSSQ@XIYCQ'D[Q?NYK&2N](V
M:O?^[=:['%GO#V:?VO.V61LW+:4;;RMM*S_$\)F.8NV.?]$]AC_(K]3_ !Y#
M_P -.?\ !.'X?_$V""VU+XD?L;>)/^$+\=]?[3O_ (7Z[SH6L_E_8>/_ *^:
M^%O^&=OC%#%Y\_A7[-_H7]M?\AC1O^07^F/?G^=?>/[ >L0? WQO\0? 'Q^U
M7PWX;^"_QX^&^J>&/$EWJWB31M2TS^U.FA:WW]O?V Q3PV8X/%W?*N^JWL[]
MNN_Z'SSX7S2[_P"$Z&[^W'S_ +QU_P#P1M_:=U7X,_M#^#_ 'VC[3IWC+Q)I
M?]CZ3=_\OXUW6O[!U[11S[?\)1^'%?Z*_P <?BTW@+XVZ/H=Q/./#&J>'?#-
ME>6ESG%@I8E>O\6TC=C@MG&1T_RH;3PKXJ^$'Q:M_$?PK\5>$M2U#X8?$C^V
MO ?C?2?&&C?V;_Q(M:/]A:T.G7_.<YK^MCX#_P#!6/X<_$[P1Y_[5_[0OA+3
M/B1_Q*_^*A\0ZQHW]IW^EZ[_ ,P7_BGQG_BD_K^==/\ :.#Z17]=]#G_ -5\
M_>V70?I.#_\ ;F?=7_!;#_@EK8_MX?!L_$SX5Z';?\-,?";1]4OOAO>6AY^+
M/AC_ )COPQUP=<'IX)XZ?3C_ #SKRSOM,O\ 4-)U6QN=-UC2[S[#K&DW>/\
M0-5!_P")[HHS_GZ\5_H[_!G_ (+ ?L!Z;X7_ .$<\?\ [6WPNTT:7_H.CZM]
MM_M+/Z=.O^0,?S$?\%L?!/[#'QR^)=O^U#^Q-^T+\'/$OQ!\97GV'X\?"?2-
M8_LW[?J?_,"^)NA_\)!G@?\ ,[9]QZ #S'"ZVCKKW\_(/]6,_6KRZ"75\\5I
MUUYNUS\%[+]]X#^)_D#C['X"_+^V_<=OZ]\T5Z!;^';SP9X9\?ZOJ_B#1-(6
MXM/"MI:PVGB71M1^UJ-;#&0G(QM&6S[>U%?'XM/&5YU[27.]K2Z771(_H[@R
MI@<%PYEV'G.FI0INZ<Z=TV]=Y]TSL+'Q]IEC=:Q9:I\'_@[XUT^TUGQ19@^(
M/"&M+J?]F#6C@C7/#Y'(R<'.>3CJ:7[?\(+ZYN)M6_9UT:WMAGCPIX]\9^&^
M#Q_S,)\7 ?YSGBNV\-Z;^SU>?VA!XJ@^,=MK%UK'B>]O+OPG>>#1IG]J?VU_
MS _^$@[<?I780^&OV7IHO(@\?_'[3;BU_P"@MX#\&ZEZ'_F7_$A]\?ES7T&)
MQF-^N-N;OJ_XC\[?;?XZG\"YC_9>$Q7(LKG&&UHN7*ELWRKW=-](K8\G^Q_
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MG_H%_"GP7]?^AB_H.M<_-H/]@^$KG[/]JMKCPO\ !/[%]/%'Q7UK_$=O\*]
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MZ=N@:SJTT'W;O3+/@^@S_3_.:*Z+Q1+#:>!186TYN;JV.DBZ]<DX&#SWQ_\
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M?G^IY#^MZ[=>WF>@3> _B-90_P#(@6UM;W0S]KU;QAX-TWJ>_P#]?^F#L?\
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MMG?T]_\ /2L,3B/[5QGUW?S>MWW_ %W.?#8GZK@WA%:S3::VZ]=CZHT>&?\
MMJX\_K=>#OMMG_GT]^>_?%=1\2/$D_AN+X/ZK/!;:E;VO@__ (\[O_D&7_\
MQ.^V/S_#FMCPW]AFO_!\\'_+UX/^Q8_^OQ^/&/I6OXV@TJ;1OA?]NTK3;FW^
MQZI9?:[O_EP_XG7]*WQ>'7U)W:UC+1O^Z^[/*RW$VQMKV]Y?^E?+\S]&8?$F
MJ^*OV"O@OKGARQT3PG;W>L?%"RUC2;2S_M+3/[+_ +%U_P#Y 9_D.W6OF?\
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M?PW\&_B1JM]!<VQ_X0_5+*SN[O\ ZCO^/^'>NPT?X>W'A7X?> #/8VUMI_\
MP@?A>]%W]C_Z@I//.!7YQQMBO[+PSPFEY/U;N]-;MO?S/H,ESJW#WU):63M;
M3:^EU;I8\OUB\\[4/(@G/'\OSQ_D=:\G\533Z98:A?7'_'O:V>JWOX>_3\_K
MZ5W&L3'[5<>1D9O?]#Z_Y]NW<_7S_P",$T^C_"_Q!JL]O_S!_L77J3_4C_\
M417R_"?_ "-+VT6NVBT3[67X%86[PB>]_5[M'/\ [ >CSWFC>./$<\'^CZIK
M'V(=>OXX&>?_ -9K](-!_<W_ )'D<]O\^_UXQ[U\[_L*^%?['^ ]AJL\'_(4
M_M6][8_Q]3^GK7U!IMG/#JGG_P#/U><^O7/7K[?7D=:_+^-LR^M\19JELFUO
MHK.W31;'Z-A<-_PDI^GZ=M38O8<76H7_ /Q\X_XG7_7AJG]B_P#$B_+^W/P]
MJX_6(9YK74+&#/\ HO\ :GV.[Z?] #P'H7\S]/Y]QK'^M\^#_G[_ -,M.?\
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M23_:?[8^*'B3_A--8QT_LO7<G_)__77I&CZ/I6O?MB>,+[%M<^%_@WX/U/\
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M':6F /[4_L7\>_OS^>-#]AOX)^./A[\6K?7/''@>VU+P?=>#_%&BZQ_Q./\
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ME8K%-+-5I&R739V6_6RU\S^8+4O@#X.UC[/?6/@?3+;6-!_TVSN[2S_X\/\
M/KWKY/\ BU\)9X;#4)[[^TLVMG_GU/&?T[5_5OX\^&/@#Q3J<^N'1+:"  9:
MTLP"3T)(  !/)X &3TKX1^*G@_\ 9EANM7\.:[JNF_VA]C_TRT^Q_P#$SZ>G
M^<^_4_4?ZN87$ZZII;.ZU2VW7;H?F6=XK%X5Z2OJ]4]U=Z[MZG\TWPW_ &8_
MB-\8+#6-<\ Z'IMSX?T&[^Q7GB'Q#XDT;PWX9_X2C(/]BZ'KGB#_ )&#MZ?G
M7BWC;X5^,='\>7&E3Z5;:=<>%[/[%K%I=7G_ !X?_7]Z_='XAZQ^SUH.EZ?X
M'\#_ !4T33=.M;S5/MFD_8]9_P! _MWCC_J8A^/]:\/^+7PW^ /Q)U2XURQ^
M+?ANYU@:/I>B_P#'Y_9IO_["X]OS-?'9+A^(<1Q%FN#QF6<N3+2+YDMMFG=7
MV3T/E<RXT>681)W?=:M].FK_  /QG_;2\B']FDZ$)]-U*Y\4>,/ ?@O_ $/_
M +#7M_C^':OJ#]H3PK/X;\)>&/#D_P#HUOH/@_PO8X_Y\,:+V![?T_7P?]J[
MX#WUGJGP/L?!T_\ PEOA<_&#PMK7CR[M+P_V9H.EZ%W]?;IU[5]4?M">-O"W
MC"76/[#\8Z)J5O=?]/G72^_^>/S-?C/C!AL9_K%E6$P2;BFKM7DE9K1N*:TM
M;5[GZ3PWQ%A,7P\L4TTW:ZLT];7TLGUOMT/B^S_9I^+?B30='\8Z'\.O$ESX
M7UZ\^VZ->?\ $FTW4]>TO@:[_8>B<>)_$'/-?*_[;%G_ ,(W\.;C0_(^S7%S
M>:79?9._^>/R]*_5CXG?'[P!\8/&7PG\53^.--\$V_@/1_"]E>>'KO\ MG_B
M0_V%_8&@_P#$CXSZ?SK\O_\ @H1K]C\0OB#X?G\*P?VGX?U[XD?VUK%WI-G_
M ,2NPTOMCKSCU/ZUQ\*K&1Q&;7TM![Z;1=[7MV>W4^PPN8X1\N$PF9O7E>SU
M^%M;=+M'VA^SWX/_ .$<^"/@?2O(^SFZ\'Z7>_B.V>W^3CFNHFA@TV_N.?\
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MZO:?V-_PC/BTY_XD>M:'_P )!Z>_]:^J/BUX5GT'P'X@U70]6TWPEK%K9_\
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M?B/^T5^UUXQ_:<\1_#?_ (3'0_AOX M_!MG_ &+9^'OA[X/T;P1X9T'^W?\
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M]&Z_\?9'^?Y_TKW?JW^U^7X>FQ_-^=XE?6W\]/DSN+/4O'&L?\@32K;1+?\
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M%[>]\*_"2YMOLNC:I?66K7?_ !+?M_\ 86/^)U_U,'OGO^%>#_LE_88?VM/
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M -KC]E/P1%^R]^T=]BU/4UN+?X)?% X^V9V_\45KQ ;I@Y)&,#D8)S7\I?\
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M-_AE%7M;IM;4]:3BG9M+UMMTW1\?Z/>3B+R+>W^SC[9JG_'W_P!AK_\ 7_\
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M],<=#^!XZU\I+@+,$G?D5D[_ !*^C\S]IPWTEN$L5T:Z6M]_3Y?(_5;]I:>
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MX0?Q;J7B"ZT?[;9VFDZ/K/\ R%-"_P"8+[=\]/IUK^:AOV:/VJ(.)OV?/BS
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MO?\ H)_V7^?4#^GX?/\ ^VQXV@\8?'VXT*Q^S#1_A?H^E^"]'M+3K_U'>O\
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MVK[59ZI_Z>AQ^IZ?A7]&7[#'[0?C#X@_!RWTGQ3?7-U?^! -&%W_ ,Q/^RR
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M1TI+#O\ K_ACO=OP_#_ACZXUGXR_'":ZN;'_ (3_ ,?W5O:]_P"V-9_E_/\
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MKE'FA>36KCS6BVUUDOA/K#6/B=I5E^T%]NTJ^MKGP/\ LT_"K2[+1_LMX?\
MD*?V)_CZU^=\WC"?6)=8\8ZY/]IU"ZO-4\3WEW_V'?Y\=/\ ./+[SQ5XC\!^
M$?''A6" _P!G>/+S2[*\U;_F)V'_ $'>>?T_PKR_Q[XPGTWP1<6,!^S7%U>?
M8OLF?K_];K^6!BOPG@/PN7!6<9IC++1OE3MHKNW+=::=8M'^BF/\1\+X@\-Y
M2L'JY1CSVZNT>9M*V[;?O(ZCPI>036NH>(YY_LUQ=WFJ7MYU]\?I_B/?\G_&
MUY/\6?C=<>1_I-N=8XN\=<GI^8[?ETKV";XJ:KH\7CC_ (FMSHD']CZKHO\
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M$'Q-U7[3<_:M8U3Q/_GU'<#I5?QYK%O\,?V5?#_@?2_]&\0>/+S2[*\M._\
M9?'7I^7''IS7O'P3_LKX)_LJ^*/B--;_ &;4+71_]#_Z?_\ /X8Y^E?R/G>8
M>]F>,PD7?.W_ *MK1W23UE&ZNMG[T;?XC]8PN7>ZL+&UDKWZ:)/?;\3\SO\
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M.O7^O2F#_EW]O_K]^G]>>G+ZE>3Z]=<?UZCV_P#UGID=*[C0=-@_U'V?%O\
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M$7EGX@NKSP9_PLSQ9I6<$Z'H9('A\ $D^*/%F3@?*K$8K^A[PA_P3A_X)9?
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M;S</<T<?=5.?1]UZ'IX[ZJ\1*S>T?A4&MO[SO?\ K<_*;7IKB;Q9XH_Y]_\
MA,/$XO+O_N-=_P!>GYYHA^PP_OS!]HN>W_03X_#OSQ^7-&O:E!+XC\40#_H9
M/%''K_Q._P#/\JQYIO)B[6]Q^>>/\\X_"OWW$]?G_P"W'X9B<-]_]/\ J[^9
MU&)YI>?0_P#'J?\ ]7K]/SJQYT]Y+^XG_P!'.?\ 2S_7I[CL*Y>SFGO#Y$$_
MV;C\/\]<GITSUKH(?/\ ]'_?G[1:YLOM?\L_SZ5Y&(PSNM^G?NGT_P _F<YL
M0S0?ZB" W/\ UZ<CG_..?QH\Z"&4_N/](Y]?P_SV]N]>:\\G]Q!_Q\<^G;\N
M#W/X9KGM2U.#1_W\_P#Q\77X<9^GM[_T.ZPNVG;IZ>0_JS[/\?\ (T;S7X--
M^T3WW%P/^//TZYXQ_GT[UX_J5Y?:]=9\_P#T?&2,?Y_R.:KWEY?>);K]QC[/
MGF[^GU/'7_/2NHAA@A_<9Z<_C[_7J/2O0PV&^J^?WNWSU_JW0G%8GZHF]-OT
M?]>1H:;9B'/D?UX]_P AC'YUZ!IMG/#_ %]<XS_GC\*Y_3;/I.!Z'K]??\^?
M3BNXLYN_U_\ KC'\SG^E>@?D'$N9?6^;7^;]=M3J=(_U)^B_RKU#2/\ 6S_4
M?RKS;3/W/V?VQTXZ_GU]_7FNXTV\/FX_Q/Z'K_GTX^@RS[7]=S\7S5W;\VWW
M[GL&FS?\>\'G^G^>GY_E7I&@S>=)_K_Z>G^>#TZGO7B^F3?Z5_H__'O^OM[?
MAW_GW&FWA\SSX)^OU[__ *OPZU]1ANGR_P#;3\OS+#[Z]6]_7<^@/#<T\-UU
M_P!'Z8_SV_\ U?3WC0;S]U[?Y_(?_K]Z^5]-U*'RB/\ 2?M/OT_SQ[>O:O6/
M#>I7$.//_P"/?'\_I]>W6O9PN\?5?G$_-\[PW;^OZ_X<^L/#>I3S?\O'^C]\
M_EU^F/P["O:--U+SI?/[_P#3H/Z?7\?R-?*^FZEC[//!./L^/\_A_P#KZ]?8
M-!U+_CVR?Q_S^!_7TKZ]8G1*_1=?)>9^;YEAO]KNUIZ?\"WX'T!#K$\T5O!_
MR\77U_S^O/05/>33^;]A\@W/Y\X'7].G]>O$:/J7VS]__P#JQTXS_G^==A9_
MZ9+Y_K]/\.,8_3CIQZ&&UM?^MCP$W'&IWY>5W3VLT[W3TVM?Y'RS\0OV4_@7
M\3?$6H^*/'WPM\.ZUJUT=UY<V;'3-2OVX!.,XR!@9]..W'H_PM^"O@+X6Z9_
M8?PT\'Z+X4TC[8+W.EG<;_4QP!KA)/0<<_AP*]WELX)OW_./^/+[)_\ KZ?I
MUZ]*V--TV"&[M[>#[-_GJ./P/H*G#8/ K%MJ$>K^""W>NO)W2/L\Q\0^*,3D
MZR;%\75O['ARJ,?:U='!6C%+VFG+LK))7=K7=Z^D:;Y,7[^QTVY]/M=GVY],
MY[?3]:](L]"T/4HO(U7PIX;_ -%XS_PC>C?Y_P ^]:&FZ; /L_\ R\__ *CZ
M]?IT!KT"SL_Z\?SY_P ]N*]#$QAK[L>OV8^?]T^?PW%/$V*VSNK96L_:U;N*
MM9_Q&]4D8^F^&_"OE6__ !1WAO'?/AO1O\_Y[UV&FZ/H?_0N>&N.EI_8^C?_
M *^O\_:M"ST?O_GZ?X\^M=!9Z;U_+/\ G\^/Q/6N?DA_)'_P&/\ \B?89;G^
M>.R><U==&G4JO_V^QGV</DR_N+'3;;_KULM%Y_PXSS^=>,?%/]CO]F[]H+5+
M#7/C=\)?#OCW6-,L_L-GJUT3IFIL,YP?^$>QGGMT'OGGZ?L[."']_P _X$_3
MZ<GBNHLX8.O?'^??\OQ YI\N"Q:^J8R,=-?AB[VV^S;HK?(^WR3/\\RK&+&X
M/.:M_*I4OJFFE[]];M/79M;7/,?V=_V7_@5^SE87]E\&/AIX=\!'75"ZO=Z7
M:$ZG?*/NC6]<)X49X'0=A7V-IL_2#'T_IS^77Z^E>;Z/!!^O^>O?M_DX["SO
M#YO^3S_G\N>/7!1C'W<&DDKII))65ULDE^!]_0S7&X^3QV/G*I-V;E.4IR;T
MO=SG.3TL]7?1=DEZ!Y_M^G_UZ//]OT_^O7/PZE^]_P \_GSQTZDT?;/?_P =
MH/6_M-=CH/.\_B#/^'\R/_UCM5>:\_=>WT[?KS^''3BN?FO/^F_^?\\C'X=Z
MS_MGO_X[1]6\OZ^XYL3F2TLUZJWWG037GK_+\N/YC\?>L>:;_)_S^0SZDFL>
M;6.H_P ^N/\ #CUQZUCWFI=/SQ_G\N?P'2@\C$YEY_UO<T)KSU_E^7'\Q^/O
M7,7FI>3S_C^GM^F>A]:UYJ4'^D>1]>F?Z#_)Q7'WFL=O\_7_  X]*Z#Y_%9E
MY_._KYFA>7GG?U//'/\ /]<]JX?4M2\G[1UQW_/\O\]#5B\U*#I_GC@<C^7;
M]*\_U+4O\0/\_EQ_C7.?G^=YG_5_Z\V9^L7GG?SZC/?\<CCTKQ_Q5-_SPG^I
M_KS^&*ZC6-8@A_U\_0'\@>.V>WX=:\7U+4?^/F?S_7C\_?Z8_,#O0?D^=XGZ
MUBO\O+7[M#C]>F[#\Q_^O],>U<_\*KRQT[X\?""^U6^MM-TZU^,'@.]O-6N[
MS^S=,_Y#6/7Z9_.J^O:E_P ?$\_Z_P R?UZ>_K7A_B2\@O.OU[8_GT_GCUKS
M\SPWUO!VO9V?==UW/J^#\R63X_)\<]HS@Y>2C.+>VNT7N?V-_''Q?\1M1U#1
MOBQ\$?#EUX;T?PS9'PY\2/B%K^CRG4O%?PQUQPSZSX(\'9 \0KX4=U\3Q^)"
M(]R*ZJC1JRILZY^S-\)/$?QC^$.MZXNH^/=?UKP+X[U@_%?5=9U;_A.+W4L>
M'3H6MZ'KFX?\(ZJ*V?!2^%0I !VJR[&?^=#]E_\ X*R_'7]G$VG@GXD07'Q^
M^#$UK]EN?#_B*[!\=>']-(*EM"UP@_V]X>*,Z'PQXKPP1W4%0QS]Y6__  56
M_9NTV'P_8^&/BG<:)I-KX<\>V7@35=?TC6CJ7PT\+^.6T'^V]&US0\*1XB^%
M*C6_#'@I>1XR)\,H&<*&;\0S++,9A<6TDK.^R?5OM===S_5O@CQ:X&SW 0Q4
M\V47&$(N$G:THPBG:+EM[MGI<^]-*U+XQR_%X>.-2@UG]HWX!? "^U#POX%U
MC2M/TF3XE'XFJQT3Q#XR.B*R?\)__P (H@?PK')X58>,4E?Q*Q20D1/_ !E_
M\%BOCOX6M_\ @K+\=?B+X=OK3Q)X'U/P;\+K$ZK8@C4= U70O!9&O#6@<8\0
M9^Z.O05^@W[8O_!<OXJ:EX/A^ 7[#6BW?P,^%^AV9T6[^*WB,A?BYK:[44ZQ
MH2J%'@$;D+_\)5+YCJTCA7"81?Y>_B/#?:]J&L:YKFK:EK?B#7;S4[[5]7U:
M[&IZGKVJ:Y_R'=:US6\X(SC'!^E>;F?#?]K8)X/%K=.ZZ/1V;TL];;W-,Y\8
M\HPF-C@^')-KF7-*_2ZZWUZ]4OP/#OCQXON_B)8^./$+_:;E&O=+%L>GRMK0
M#=QV)Z'T!HK(UW6KGP9X3\06J:>+RRU$:9(J=!9E-9+A,_[1'ZBBODL'P?B<
MMH1PBY;0<FM;:2>FS[)'Z7EO'-3,\)3QD8RFJBLW%JUTHW6LEW/%O$FI?8_%
MOC&?_J</%'KQC6O;W]!U^M9\-YYW[_Z]\X_SZ?3K76^([*S_ .$M\8?Z):_\
MC?XH_P"7>+_H.?[E;/V&R^S6W^AVO\/_ "[Q>G^Y7O'LXO\ WI_UT9R-G>>3
M_0\\\_S_ %SGBM";7O)B_<=,'_Z_].U;\-C9>2/]#M>A_P"7>+T_W*K"QLO)
MN/\ 0[7_ ,!XO?\ V*YFKGDO=^K_ #9@WGBL0Q?E[?KVKR_[9?:Q+<"?_D'\
M^GKCM_GT[5Z-J=E9<?Z):_\ @/%[?[%:^A65G]EN/]$M>G_/O%Z#_8I8:C%M
MZ]?\W_P#HPW3^NQQ5GY%G]G\CD__ *\?YXYXQTQU$)\[I.!_G^7_ .OI6]9V
M-EQ_H=K_ !?\N\7_ ,170PV-EYL'^AVO7_GWB]/]RO2/G\V_?\REI:Z^[0P+
M/4H(?\>G./7/'\O3UKH--UF#_EOSW_7OC/\ ^OITJ[#96?G?\>EKU/\ R[Q>
MO^Y70_8;+_GSM?\ P'B_^(K?#;+T_1'YSF>5X:TKIZ7Z^K^7R)+/5(#SYP\@
M=_8=..G]?3%=MH^L0'_EOV_S_/H/4^V<32+*R_Y]+7KC_CWBZ9/'W*[+3K&R
M\T?Z':]?^?>+T_W*]'#;KU_5'YMFF3877?6]_P 3H=-UF#GFV.?UX]>_I^O?
MGN+.\@F_U'K_ /6]_>N=L[&RX_T.U_B_Y=XO_B*[?2+*R_Y]+7KC_CWBZ9/'
MW*^HPVR_KL?FV9Y+A5WZW_'S_K0]#T?4I_LO[_[-^./I_GUKN-'U+R;K]_/W
MX]_\\#GJ>:\\TRRLO-M_]$M>G_/O%Z?[E>I:=8V7FC_0[7K_ ,^\7I_N5UX:
MM+73;_-K^OZ9^?YWDN%6%;L[J7Z_\ ]@\-ZP)K40>>.G\OQ_GW]J]9T>\_>G
M]_\ 7_/)_P ]Q7FO@ZQLO)_X\[7_ (_/^?>+V_V*]OTRRLO-M_\ 1+7I_P ^
M\7I_N5]1AJTM=//]/^"?E>=48K1:;*]D=WH^I7!B\C_1L_TX_IZ^@]Z] TV[
MGAB\CS^.OM_6L73+*R^;_1+7_P !XO?_ &*] T>QLO)/^AVO_@/%Z_[E>QAJ
MTM=//]#X#,:,=7>W4TH9C/$1^('X\?YSWR>:Z#3?/AE_U&?\\?X?U%:^G6-E
MYH_T.UZ_\^\7I_N5U^F65E\W^B6O_@/%[_[%=RW7JOS/E\QHQL^V]OZT_ VM
M!O/.BX@ZX_+IG_#^?6NXLYN_U_\ KC'\SG^E8NF6-E]FMO\ 0[7O_P N\7H/
M]BNPTVSM/*/^BV__ 'XB]O\ 9K?$[/T_1GH9+2CM=OU];&E9WO[K_(_3\N._
MOCC8L[RWA^F?\Y]O_P!7K6=9_P"J/T'\Q6S!W_'^E<Y^A98E[VB^Y>?D=!#J
M4$W?'T]/\\_YYV(;S_IO_G_/)S^/:N6A_P!</J?YUT-GV_X%0?8X5:Q]5^<3
MT#39H/*^G7I_7/J.OIT[UT'G?NO\XZ?3/3M^N:Q]-_U,'^>YKH)^WX?UH/N,
M+M'T7Y1*_P!L\GGK^GX_ACICW[9JO_:?^S_G\J)^WX?UK'G[?A_6@Z,3U^?_
M +<:$^L0?CQQ_GZYY_K6?-K'_'Q^/3\O7\!^'TK+\F'RO]5%_P!^U_NY]/7G
MZU3G[?A_6@\K$UI*W^?R+$VL?NOW'OS_ (=,GZ<]^:SYM8\X=?Z9//T[\]>/
MRJO#_P O'X5R?DP^;_JHO^_:_P!['IZ<?2@\[%5I)7\K_H7)M2\D?O\ M^?T
M[>O^37/ZEK'G?E^O/7GCG]15^\_U0^A_F:Q;R&'S1^ZBZG_EFOH?:@^#S/-<
M2N;WEI?\+_=MT.2O-8[?Y^O^''I7'ZQK!A'_ !\?Y[>_Y8]:ZZ[L[3/_ !ZV
MW?\ Y81>N/[OIQ7#ZQ8V7G#_ $.U_P# >+_XBN<_.,SS7%7=Y7LW\_OO8\QU
M[6)YOU_SS^?_ .K%>7ZQJ7G#R(/LOMT_S_D^XKV[4[*RX_T2U_\  >+V_P!B
MO)]3LK+C_1+7_P !XO;_ &*Z#SJ-*-=KG;U:]=;-ZGC.O:D/*_?BV[_SZ=>E
M>/Z]>>=]HG\_\3V]_7^7/:O=O$EE9\?Z):_^ \7^U_L>P_*O+M1LK(Q'-I:G
MC_GWB]1_L5PXJM)+;HW^G]:'Z'@\KPU#%)13>BMVU7;7L>(ZE+Y,1_X]C^?X
M_P#UZ\8UZ?\ >_\ +MQ_+_/KS]:^CM3LK+C_ $2U_P# >+V_V*\?UBQLO.'^
MAVO_ (#Q?_$5\-BM9.^NKWUZON?<Y"W%VBVE=:)M+==$TOP/G'7L_P#;M^/_
M .O^E>+:_P"?-]H_<=OL7?\ #\/\]Z^L-1L;+S3_ *':]?\ GWB]/]RO-M7L
M;+]__H=K_P" \7O_ +%<N)V?I^C/U;+&]7=WLM;N^W>]SX"^,&FY\*7$XXS>
MZ9V]<CMQWQTS17L_Q<L;+_A -6_T.U^]I7_+O%_T&O\ <HKY#%_QY_+\C^I^
."I/_ %;R_5ZP;^]H_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>cyngn-20251231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:53 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofShortTermInvestmentsTable" roleURI="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPropertyandEquipmentTable" roleURI="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" roleURI="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFederalStatutoryIncomeTaxRateTable" roleURI="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <calculationLink xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_SecurityDeposit" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfRevenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="cyngn_WarrantLiabilityIssuanceCosts" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetImpairmentCharges" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_RecapitalizationCosts" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cyngn_AccretionOnShorttermInvestments" xlink:href="cyngn-20251231.xsd#cyngn_AccretionOnShorttermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cyngn_AccretionOnShorttermInvestments" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cyngn_WarrantLiabilityIssuanceCosts" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="18" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="cyngn_CreditCardPayableCurrent" xlink:href="cyngn-20251231.xsd#cyngn_CreditCardPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="cyngn_CreditCardPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="8" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:role="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1" weight="1"/>
<!-- [WMV6][hAZvtRnFC6N4w1ax+R4qWD4f3+zyHL9nRAU1oJmq0U35R1wwCk9t//XOR7WyleNK+hz9M6MpC1CSLqg1Glzr2IpolJr1lGUFkhV45cTTcHLOJWhzj+M34BB8fz/jl4zHja6XHFUT4N9nAt4aqVgNbGPoliEFI3TXN8S9Ryyie1mjeqCWMilGW2kTBDsFMHmcI0DspN3oxe8lD6jV534Ty4dB+WrWNVkOboVbzA6PDpSONofaBuKfvySYb77NH6NI8sl660S7+VTTRa6cothiCkbi3Jf2q9SUXVa+BW8i6b4UgLK2FL24KuB1IzDa4g642/cZZ0Q=] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>cyngn-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:53 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ShareholdersEquityType2or3" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_DescriptionofBusiness" roleURI="http://cyngn.com/role/DescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPolicies" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RevenueandContractswithCustomers" roleURI="http://cyngn.com/role/RevenueandContractswithCustomers"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponents" roleURI="http://cyngn.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeases" roleURI="http://cyngn.com/role/OperatingLeases"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNet" roleURI="http://cyngn.com/role/IntangibleAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructure" roleURI="http://cyngn.com/role/CapitalStructure"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpense" roleURI="http://cyngn.com/role/StockBasedCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RetirementSavingsPlan" roleURI="http://cyngn.com/role/RetirementSavingsPlan"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxes" roleURI="http://cyngn.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CommitmentsandContingencies" roleURI="http://cyngn.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RisksandUncertainties" roleURI="http://cyngn.com/role/RisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SubsequentEvents" roleURI="http://cyngn.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatements" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_AccountingPoliciesByPolicy" roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponentsTables" roleURI="http://cyngn.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeasesTables" roleURI="http://cyngn.com/role/OperatingLeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNetTables" roleURI="http://cyngn.com/role/IntangibleAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructureTables" roleURI="http://cyngn.com/role/CapitalStructureTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpenseTables" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxesTables" roleURI="http://cyngn.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsTables" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPercentagesofTotalRevenueTable" roleURI="http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofShortTermInvestmentsTable" roleURI="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPropertyandEquipmentTable" roleURI="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable" roleURI="http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofLeaseCostTable" roleURI="http://cyngn.com/role/ScheduleofLeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable" roleURI="http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" roleURI="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofSecuritiesWarrantsareConvertibleTable" roleURI="http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFairValueofWarrantsTable" roleURI="http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofBasicandDilutedLossPerShareTable" roleURI="http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofStockOptionsVestedandExercisableTable" roleURI="http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestrictedStockUnitsandActivityTable" roleURI="http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable" roleURI="http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofDomesticandInternationalPreTaxLossTable" roleURI="http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFederalStatutoryIncomeTaxRateTable" roleURI="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofGrossUnrecognizedTaxBenefitsTable" roleURI="http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedBalanceSheetTable" roleURI="http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementsofOperationsTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementofStockholdersEquityDeficitTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementofCashFlowsTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofBalanceSheetandCashFlowsTable" roleURI="http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_DescriptionofBusinessDetails" roleURI="http://cyngn.com/role/DescriptionofBusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RevenueandContractswithCustomersDetails" roleURI="http://cyngn.com/role/RevenueandContractswithCustomersDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponentsDetails" roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeasesDetails" roleURI="http://cyngn.com/role/OperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNetDetails" roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructureDetails" roleURI="http://cyngn.com/role/CapitalStructureDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpenseDetails" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxesDetails" roleURI="http://cyngn.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CommitmentsandContingenciesDetails" roleURI="http://cyngn.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SubsequentEventsDetails" roleURI="http://cyngn.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd#eedm1" roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd#eedm" roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_SecurityDeposit" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockValue" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostsAndExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="cyngn_WarrantLiabilityIssuanceCosts" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AccretionOnShorttermInvestments" xlink:href="cyngn-20251231.xsd#cyngn_AccretionOnShorttermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_AccretionOnShorttermInvestments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RecapitalizationCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_WarrantLiabilityIssuanceCosts" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_InterestPaidNet" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" order="37" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/DescriptionofBusiness" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RevenueandContractswithCustomers" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/BalanceSheetComponents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/OperatingLeases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IntangibleAssetsNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/CapitalStructure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpense" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RetirementSavingsPlan" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedBenefitPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedBenefitPlanAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RisksandUncertainties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockWarrantsPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockWarrantsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_CommonStockWarrantsPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CostOfRevenuePolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CostOfRevenuePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_CostOfRevenuePolicyTextBlock" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="27" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/OperatingLeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/CapitalStructureTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerAMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="cyngn_CustomerAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerBMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="cyngn_CustomerBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerCMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="cyngn_CustomerCMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerDMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerDMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="cyngn_CustomerDMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerEMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="cyngn_CustomerEMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AutomobilesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_AutomobilesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_MachineToolsAndEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_MachineToolsAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cyngn_MachineToolsAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TestingEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_TestingEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="cyngn_TestingEquipmentMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="cyngn_CreditCardPayableCurrent" xlink:href="cyngn-20251231.xsd#cyngn_CreditCardPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="cyngn_CreditCardPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofLeaseCostTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_PatentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_FiniteLivedIntangibleAssetsImpairment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsImpairment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="cyngn_FiniteLivedIntangibleAssetsImpairment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_SeriesBMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsAndRightOutstandingMaturityDate" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsAndRightOutstandingMaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="cyngn_WarrantsAndRightOutstandingMaturityDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofFairValueofWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_RangeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_BlackScholesModelMember" xlink:href="cyngn-20251231.xsd#cyngn_BlackScholesModelMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="cyngn_BlackScholesModelMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_MonteCarloPricingModelMember" xlink:href="cyngn-20251231.xsd#cyngn_MonteCarloPricingModelMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="cyngn_MonteCarloPricingModelMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_InitialPublicOfferingWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_InitialPublicOfferingWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_InitialPublicOfferingWarrantsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrivatePlacementWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_PrivatePlacementWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesAWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_SeriesAWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesBWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_SeriesBWarrantsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharePrice" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="us-gaap_DeferredTaxAssetDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="us-gaap_DeferredTaxAssetDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_Section162mLimitationMember" xlink:href="cyngn-20251231.xsd#cyngn_Section162mLimitationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetDomain" xlink:to="cyngn_Section162mLimitationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantRevaluationMember" xlink:href="cyngn-20251231.xsd#cyngn_WarrantRevaluationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetDomain" xlink:to="cyngn_WarrantRevaluationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_OtherPermanentDifferencesMember" xlink:href="cyngn-20251231.xsd#cyngn_OtherPermanentDifferencesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetDomain" xlink:to="cyngn_OtherPermanentDifferencesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="21" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsFixedAssets" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsFixedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_DeferredTaxAssetsFixedAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsLeaseLiability" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_DeferredTaxAssetsLeaseLiability" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsCapitalizedResearchCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_Liabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_StockholdersEquity" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="cyngn_WarrantLiabilityIssuanceCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsPreviouslyReportMember" xlink:href="cyngn-20251231.xsd#cyngn_AsPreviouslyReportMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsPreviouslyReportMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_RestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_RestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="srt_CondensedCashFlowStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsPreviouslyReportMember" xlink:href="cyngn-20251231.xsd#cyngn_AsPreviouslyReportMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsPreviouslyReportMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="cyngn_LossOnIssuanceOfWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="cyngn_WarrantIssuanceCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementAdjustmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="cyngn_AsRestatedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AccountsPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AutomobilesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_AutomobilesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/DescriptionofBusinessDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_DescriptionofBusinessDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="srt_RangeAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_UnrestrictedCashBalance" xlink:href="cyngn-20251231.xsd#cyngn_UnrestrictedCashBalance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_UnrestrictedCashBalance" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_ShortTermInvestments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_Cash" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShortTermInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForOtherCreditLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ProvisionForOtherCreditLosses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:href="cyngn-20251231.xsd#cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AdvertisingExpense" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RevenueandContractswithCustomersDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_RevenueandContractswithCustomersDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="cyngn_RevenueandContractswithCustomersDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_RevenueandContractswithCustomersDetailsTable" xlink:to="srt_StatementScenarioAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_DeferredCostsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_Revenues" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/BalanceSheetComponentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_BalanceSheetComponentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="cyngn_BalanceSheetComponentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_InventoryNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_Depreciation" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/OperatingLeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IntangibleAssetsNetDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IntangibleAssetsNetDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="cyngn_IntangibleAssetsNetDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IntangibleAssetsNetDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IntangibleAssetsNetDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_DevelopedSoftwareMember" xlink:href="cyngn-20251231.xsd#cyngn_DevelopedSoftwareMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="cyngn_DevelopedSoftwareMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalvageAndSubrogationRecoveriesValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalvageAndSubrogationRecoveriesValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_SalvageAndSubrogationRecoveriesValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_RecapitalizationCosts" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/CapitalStructureDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_CapitalStructureDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="srt_RangeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockOfferingsMember" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOfferingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="cyngn_CommonStockOfferingsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AtTheMarketEquityFinancingMember" xlink:href="cyngn-20251231.xsd#cyngn_AtTheMarketEquityFinancingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cyngn_AtTheMarketEquityFinancingMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrivatePlacementOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementOfferingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cyngn_PrivatePlacementOfferingMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesAWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_SeriesAWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesBWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_SeriesBWarrantMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreFundedWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="cyngn_PreFundedWarrantsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_WarrantMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_AegisCapitalCorpMember" xlink:href="cyngn-20251231.xsd#cyngn_AegisCapitalCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cyngn_AegisCapitalCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreFundedWarrantsPricePerShare" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_PreFundedWarrantsPricePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsToPurchase" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchase"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_WarrantsToPurchase" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonUnitIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssued" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrefundedUnitsAtAPublicOfferingPrice" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedUnitsAtAPublicOfferingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_PrefundedUnitsAtAPublicOfferingPrice" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommissionProceedPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommissionProceedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="cyngn_CommissionProceedPercentage" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesCommissionsAndFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="35" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cyngn_StockBasedCompensationExpenseDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwoThousandTwentyOnePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoThousandTwentyOnePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="cyngn_TwoThousandTwentyOnePlanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwentyTwentyOneEquityIncentivePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwentyTwentyOneEquityIncentivePlanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="cyngn_TwentyTwentyOneEquityIncentivePlanMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockOutstandingPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOutstandingPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cyngn_CommonStockOutstandingPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="cyngn_IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IncomeTaxesDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwoZeroThreeFourMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoZeroThreeFourMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AwardDateDomain" xlink:to="cyngn_TwoZeroThreeFourMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_OtherExpenses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommitmentsandContingenciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CommitmentsandContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="cyngn_CommitmentsandContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DamagesFromProductDefectsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_DamagesFromProductDefectsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyAccrualPayments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractualObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ContractualObligation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SettlementAgreementAmount" xlink:href="cyngn-20251231.xsd#cyngn_SettlementAgreementAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="cyngn_SettlementAgreementAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsToPurchaseShares" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchaseShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="cyngn_WarrantsToPurchaseShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForLegalSettlements" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cyngn_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_RegisteredDirectOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_RegisteredDirectOfferingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="cyngn_RegisteredDirectOfferingMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_SalesAgreementWithAegisCapitalMember" xlink:href="cyngn-20251231.xsd#cyngn_SalesAgreementWithAegisCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="cyngn_SalesAgreementWithAegisCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesCommissionsAndFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreFundedWarrantsPricePerShare" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="cyngn_PreFundedWarrantsPricePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:to="srt_RestatementAxis" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain_0" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_GainLossOnIssuanceOfWarrant" xlink:href="cyngn-20251231.xsd#cyngn_GainLossOnIssuanceOfWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="cyngn_GainLossOnIssuanceOfWarrant" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="cyngn_OfferingRelatedIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_OfferingRelatedIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="cyngn_OfferingRelatedIssuanceCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UsefulLifeTermOfLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UsefulLifeTermOfLeaseMember"/>
<!-- [WMV6][Q8VEXJONudykNGVUBeI5MbV2fxgPfzrwEmDvGf6YdC2Wck7FkgVWoc/LectUJtbNGS5FvvxC9hMijvqdcYNLfAD12BMFVfp7eahW32xcPSaY3V5Q8AjbStV9RnBkY8uLKtsOpJRt5sHSmPsrX4adlTDlVFyKurMzjklVKoVIx5PHy7Awyss5rBZGHPOYJr+nzZ2xDCtcKew6+CxGfmQm68MLMh7B8pOpiOiV+LGxJ/4FZ77IlFANSaK3+kdaVIEfYfKu3tbmD0OlSL9E+Rhb0tok6Bs1qWoIkxPRo5sOEWmwUJ6Vd23fitG+OrZD0PGfLHUReuEj] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:to="us-gaap_UsefulLifeTermOfLeaseMember" order="1" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>cyngn-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:53 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">TOTAL CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">TOTAL CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL STOCKHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">TOTAL COSTS AND EXPENSES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">LOSS FROM OPERATIONS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">TOTAL OTHER INCOME (EXPENSE), NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl0" xml:lang="en-US">Total other income (expenses), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">NET LOSS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US">Net cash used in operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net cash provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents, end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract_lbl" xml:lang="en-US">Description of Business [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:to="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue and Contracts with Customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xml:lang="en-US">Balance Sheet Components [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Total prepaid and expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Total property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Total accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesOperatingAbstract_lbl" xml:lang="en-US">Operating Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeasesOperatingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US">Schedule of Future Lease Payments Under the Non Cancellable Lease [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">Schedule of Lease Cost [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Intangible Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl" xml:lang="en-US">Schedule of Estimated Amortization Expense for All Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1" xml:lang="en-US">Net Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Capital Structure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_lbl" xml:lang="en-US">Auction Market Preferred Securities, Stock Series [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl0" xml:lang="en-US">Loss per share:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US">Schedule of Basic and Diluted Loss Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Stock-Based Compensation Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Schedule of Stock Options Vested and Exercisable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Shares, outstanding at Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, outstanding at Ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value, outstanding at Ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Shares, Unvested shares beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0" xml:lang="en-US">Shares, Unvested shares ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value, beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Weighted-average grant date fair value, ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US">Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedBenefitPlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanAbstract_lbl" xml:lang="en-US">Retirement Savings Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanAbstract" xlink:to="us-gaap_DefinedBenefitPlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Domestic and International Pre-Tax Loss [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_lbl" xml:lang="en-US">Valuation Allowance by Deferred Tax Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Total, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract_lbl" xml:lang="en-US">Schedule of Gross Unrecognized Tax Benefits [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Balance at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl0" xml:lang="en-US">Balance at end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl1" xml:lang="en-US">Unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl" xml:lang="en-US">Restatement of Previously Issued Audited Financial Statements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_AccountingChangesAndErrorCorrectionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermInvestments_lbl0" xml:lang="en-US">Short-term investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US">Accounts and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right-of-use asset, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl0" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Non-current operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY (DEFICIT)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, Par $0.00001; 400,000,000 and 200,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 7,974,380 and 199,110 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional paid in capital common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Accumulated deficits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">REVENUE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">OTHER INCOME (EXPENSE), NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xml:lang="en-US">Interest income (expense), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantLiabilityIssuanceCosts_lbl" xml:lang="en-US">Warrant liability issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantLiabilityIssuanceCosts" xlink:to="cyngn_WarrantLiabilityIssuanceCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_WarrantLiabilityIssuanceCosts_lbl0" xml:lang="en-US">Warrant liability issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantLiabilityIssuanceCosts" xlink:to="cyngn_WarrantLiabilityIssuanceCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_LossOnIssuanceOfWarrants_lbl" xml:lang="en-US">Loss on issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossOnIssuanceOfWarrants" xlink:to="cyngn_LossOnIssuanceOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_LossOnIssuanceOfWarrants_lbl0" xml:lang="en-US">Loss on issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossOnIssuanceOfWarrants" xlink:to="cyngn_LossOnIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="cyngn_LossOnIssuanceOfWarrants_lbl1" xml:lang="en-US">Loss on issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossOnIssuanceOfWarrants" xlink:to="cyngn_LossOnIssuanceOfWarrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Basic weighted average common shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Diluted weighted average common shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Issuance of at-the-market common stock, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Issuance of at-the-market common stock, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0" xml:lang="en-US">Net proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl1" xml:lang="en-US">Net proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Exercise of stock options and vesting of restricted stock units (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl" xml:lang="en-US">Issuance of common stock in connection with the public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl" xml:lang="en-US">Issuance of common stock in connection with the public offering (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Net of offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Issuance of units at a public offering price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl" xml:lang="en-US">Reclassification of Series A warrants to equity in connection with the public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Exercise of Series B warrants in connection with the public offering, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Aggregate offering price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Exercise of Series B warrants in connection with the public offering, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0" xml:lang="en-US">Issuance of units at a public offering price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Patent impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetImpairmentCharges_lbl0" xml:lang="en-US">Impairment charge</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Change in fair value of warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RecapitalizationCosts_lbl" xml:lang="en-US">Change in estimate of capitalized software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecapitalizationCosts" xlink:to="us-gaap_RecapitalizationCosts_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RecapitalizationCosts_lbl0" xml:lang="en-US">Decrease in capitalized software costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecapitalizationCosts" xlink:to="us-gaap_RecapitalizationCosts_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Accretion of interest and amortization of debt issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Accrued expenses, lease liabilities, and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Disposal of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl" xml:lang="en-US">Proceeds from maturity of short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl" xml:lang="en-US">Proceeds from at-the-market equity financing, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:to="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl" xml:lang="en-US">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl" xml:lang="en-US">Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Proceeds from issuance of warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">Issuance of warrants (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from the Notes, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl" xml:lang="en-US">Acquisition of right-of-use asset in exchange for new operating lease obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:to="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:to="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Exercise of stock options and vesting of restricted stock units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xml:lang="en-US">Realized gain on short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AccretionOnShorttermInvestments" xlink:href="cyngn-20251231.xsd#cyngn_AccretionOnShorttermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_AccretionOnShorttermInvestments_lbl" xml:lang="en-US">Accretion on short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AccretionOnShorttermInvestments" xlink:to="cyngn_AccretionOnShorttermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xml:lang="en-US">Loss on disposed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US">Accounts and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses, operating lease right-of-use assets, and other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Acquisition of intangible asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchase of short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of the Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl" xml:lang="en-US">Issuance costs for stock dividend and restricted stock units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:to="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid during the period for interest and taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Description of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of Asset&#8217;s Estimated Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of Percentages of Total Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentages of total revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">Revenue and Contracts with Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xml:lang="en-US">Balance Sheet Components</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xml:lang="en-US">Schedule of Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CashEquivalentsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_CashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CashEquivalentsAbstract_lbl" xml:lang="en-US">Cash equivalents:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CashEquivalentsAbstract" xlink:to="cyngn_CashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermInvestmentsAbstract_lbl" xml:lang="en-US">Short-term investments:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ShortTermInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue_lbl" xml:lang="en-US">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositsAssetsCurrent_lbl" xml:lang="en-US">Short-term Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accrued Expenses and Other Current Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CreditCardPayableCurrent" xlink:href="cyngn-20251231.xsd#cyngn_CreditCardPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CreditCardPayableCurrent_lbl" xml:lang="en-US">Credit card payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CreditCardPayableCurrent" xlink:to="cyngn_CreditCardPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Accrued payroll</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Operating Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Lease Payments under the Non-Cancellable Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2028</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2029</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2030</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">2031</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted-average remaining lease term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted-average discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Gross Carrying Amount and Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Carrying Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl" xml:lang="en-US">Fair Market Value Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:to="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Amortization Expense for All Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2028</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2029</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">Thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Capital Structure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Securities Warrants are Convertible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Number of warrents in an unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Warrant nominal exercise price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsAndRightOutstandingMaturityDate" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsAndRightOutstandingMaturityDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl" xml:lang="en-US">Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsAndRightOutstandingMaturityDate" xlink:to="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrants measurement input</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Basic and Diluted Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net loss attributable to common stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-based Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Options Vested and Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted-average remaining contractual term (years), outstanding at Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Shares, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0" xml:lang="en-US">Aggregate intrinsic value, Granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted- average exercise price, Granted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Shares, Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, Exercised (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value, Exercised (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, Cancelled/forfeited (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Shares, vested and expected to vest at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining contractual term (years), vested and expected to vest at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Shares, vested and exercisable at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price, vested and exercisable at ending balance (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average exercise price, vested and exercisable at ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units and Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Shares, RSUs granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value, RSUs granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Shares, RSUs forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value, RSUs forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Fair value of common stock (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Estimated dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">Retirement Savings Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Domestic and International Pre-Tax Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">United States</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">International</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Federal Statutory Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">US Federal Statutory Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">US Federal Statutory Tax Rate, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Federal statutory income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and Local Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State and Local Income Taxes, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign Tax Effects, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign Tax Effects, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in Valuation Allowance, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_NontaxableOrNondeductibleItemsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_NontaxableOrNondeductibleItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_NontaxableOrNondeductibleItemsAbstract_lbl" xml:lang="en-US">Nontaxable or Nondeductible Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NontaxableOrNondeductibleItemsAbstract" xlink:to="cyngn_NontaxableOrNondeductibleItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Nondeductible items, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Nondeductible items, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Change in unrecognized tax benefits, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">Change in unrecognized tax benefits, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_OtherReconcilingItemsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_OtherReconcilingItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_OtherReconcilingItemsAbstract_lbl" xml:lang="en-US">Other Reconciling Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OtherReconcilingItemsAbstract" xlink:to="cyngn_OtherReconcilingItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Deferred True Up, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Deferred True Up. Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl" xml:lang="en-US">Other. Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Other, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Stock based compensation, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Rate change, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Research and development credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsFixedAssets" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsFixedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsFixedAssets_lbl" xml:lang="en-US">Fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsFixedAssets" xlink:to="cyngn_DeferredTaxAssetsFixedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl" xml:lang="en-US">Accruals and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsLeaseLiability" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsLeaseLiability_lbl" xml:lang="en-US">Lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsLeaseLiability" xlink:to="cyngn_DeferredTaxAssetsLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsCapitalizedResearchCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl" xml:lang="en-US">Capitalized research costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" xlink:to="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Gross deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Gross Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Increase in balance related to tax positions taken during the current year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Increase in balance related to tax positions taken during prior years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xml:lang="en-US">Decrease in balance related to prior year tax positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Decrease in balance related to settlement with tax authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Risks and Uncertainties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl" xml:lang="en-US">Restatement of Previously Issued Audited Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:to="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Schedule of Restated Balance Sheet</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of Restated Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl" xml:lang="en-US">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:to="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of Restated Statement of Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantIssuanceCosts_lbl" xml:lang="en-US">Warrant issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantIssuanceCosts" xlink:to="cyngn_WarrantIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl" xml:lang="en-US">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Schedule of Balance Sheet and Cash Flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_FiniteLivedIntangibleAssetsImpairment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsImpairment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl" xml:lang="en-US">Impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsImpairment" xlink:to="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Shares, Cancelled/forfeited</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Shares, RSUs vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-average grant date fair value, RSUs vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl" xml:lang="en-US">Tax Credits, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xml:lang="en-US">Tax Credits, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl" xml:lang="en-US">Right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl" xml:lang="en-US">Deferred project costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerAMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CustomerAMember_lbl" xml:lang="en-US">Customer A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerAMember" xlink:to="cyngn_CustomerAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerBMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CustomerBMember_lbl" xml:lang="en-US">Customer B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerBMember" xlink:to="cyngn_CustomerBMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerCMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CustomerCMember_lbl" xml:lang="en-US">Customer C [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerCMember" xlink:to="cyngn_CustomerCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerDMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerDMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CustomerDMember_lbl" xml:lang="en-US">Customer D [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerDMember" xlink:to="cyngn_CustomerDMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CustomerEMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CustomerEMember_lbl" xml:lang="en-US">Customer E [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerEMember" xlink:to="cyngn_CustomerEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AutomobilesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AutomobilesMember_lbl" xml:lang="en-US">Automobiles (DMV-registered) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_MachineToolsAndEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_MachineToolsAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_MachineToolsAndEquipmentMember_lbl" xml:lang="en-US">Machinery, tools and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MachineToolsAndEquipmentMember" xlink:to="cyngn_MachineToolsAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computers and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Capitalized software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl0" xml:lang="en-US">Internal-use Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl1" xml:lang="en-US">Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_TestingEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_TestingEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TestingEquipmentMember_lbl" xml:lang="en-US">Testing equipment (Work in Progress) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TestingEquipmentMember" xlink:to="cyngn_TestingEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl" xml:lang="en-US">Developed software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">Initial Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">Public Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAMember_lbl" xml:lang="en-US">Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAMember" xlink:to="us-gaap_SeriesAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBMember_lbl" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBMember" xlink:to="us-gaap_SeriesBMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Fair value of underlying securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Expected volatility [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Expected term (in years) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Risk-free interest rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_InitialPublicOfferingWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_InitialPublicOfferingWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_InitialPublicOfferingWarrantsMember_lbl" xml:lang="en-US">Initial Public Offering Warrants (Oct 2021) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_InitialPublicOfferingWarrantsMember" xlink:to="cyngn_InitialPublicOfferingWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrivatePlacementWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants (Apr 2022) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrivatePlacementWarrantsMember" xlink:to="cyngn_PrivatePlacementWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesAWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SeriesAWarrantsMember_lbl" xml:lang="en-US">Series A Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesAWarrantsMember" xlink:to="cyngn_SeriesAWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesBWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SeriesBWarrantsMember_lbl" xml:lang="en-US">Series B Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesBWarrantsMember" xlink:to="cyngn_SeriesBWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_BlackScholesModelMember" xlink:href="cyngn-20251231.xsd#cyngn_BlackScholesModelMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_BlackScholesModelMember_lbl" xml:lang="en-US">Black-Scholes Model [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BlackScholesModelMember" xlink:to="cyngn_BlackScholesModelMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_MonteCarloPricingModelMember" xlink:href="cyngn-20251231.xsd#cyngn_MonteCarloPricingModelMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_MonteCarloPricingModelMember_lbl" xml:lang="en-US">Monte Carlo Pricing Model [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MonteCarloPricingModelMember" xlink:to="cyngn_MonteCarloPricingModelMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_Section162mLimitationMember" xlink:href="cyngn-20251231.xsd#cyngn_Section162mLimitationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_Section162mLimitationMember_lbl" xml:lang="en-US">Section 162m Limitation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_Section162mLimitationMember" xlink:to="cyngn_Section162mLimitationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantRevaluationMember" xlink:href="cyngn-20251231.xsd#cyngn_WarrantRevaluationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantRevaluationMember_lbl" xml:lang="en-US">Warrant Revaluation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantRevaluationMember" xlink:to="cyngn_WarrantRevaluationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_OtherPermanentDifferencesMember" xlink:href="cyngn-20251231.xsd#cyngn_OtherPermanentDifferencesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_OtherPermanentDifferencesMember_lbl" xml:lang="en-US">Other Permanent Differences [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OtherPermanentDifferencesMember" xlink:to="cyngn_OtherPermanentDifferencesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">As Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl0" xml:lang="en-US">As Previously Report [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl1" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RestatementAdjustmentMember_lbl" xml:lang="en-US">Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RestatementAdjustmentMember_lbl0" xml:lang="en-US">Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AsRestatedMember_lbl" xml:lang="en-US">As Restated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AsRestatedMember" xlink:to="cyngn_AsRestatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AsPreviouslyReportMember" xlink:href="cyngn-20251231.xsd#cyngn_AsPreviouslyReportMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AsPreviouslyReportMember_lbl" xml:lang="en-US">Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AsPreviouslyReportMember" xlink:to="cyngn_AsPreviouslyReportMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_RestatedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RestatedMember_lbl" xml:lang="en-US">Restated [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatedMember" xlink:to="cyngn_RestatedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Jurisdiction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xml:lang="en-US">Loss Contingency Nature [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and equipment, useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Useful life of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl" xml:lang="en-US">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_UnrestrictedCashBalance" xlink:href="cyngn-20251231.xsd#cyngn_UnrestrictedCashBalance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_UnrestrictedCashBalance_lbl" xml:lang="en-US">Unrestricted cash balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashBalance" xlink:to="cyngn_UnrestrictedCashBalance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Allowance for credit losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForOtherCreditLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProvisionForOtherCreditLosses_lbl" xml:lang="en-US">Credit losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForOtherCreditLosses" xlink:to="us-gaap_ProvisionForOtherCreditLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:href="cyngn-20251231.xsd#cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl" xml:lang="en-US">Increase to research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:to="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease_lbl" xml:lang="en-US">Decrease in capitalized software costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" xlink:to="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xml:lang="en-US">Finite lived intangibles amortized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0" xml:lang="en-US">Warrants of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xml:lang="en-US">Description of CODM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xml:lang="en-US">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of operating segment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_lbl" xml:lang="en-US">Deferred contract costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:to="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Revenue from customer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCostsCurrent_lbl" xml:lang="en-US">Deferred contract costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCurrent" xlink:to="us-gaap_DeferredCostsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Remaining performance obligations, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Monthly payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Monthly storage cost per unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Lease expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Gain (loss) on disposal assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalvageAndSubrogationRecoveriesValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalvageAndSubrogationRecoveriesValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalvageAndSubrogationRecoveriesValue_lbl" xml:lang="en-US">Salvage value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalvageAndSubrogationRecoveriesValue" xlink:to="us-gaap_SalvageAndSubrogationRecoveriesValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination_lbl" xml:lang="en-US">Description of impairment charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" xlink:to="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Offering price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl" xml:lang="en-US">Pre-funded warrants to purchase shares of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl0" xml:lang="en-US">Pre-funded warrants to purchase shares of common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreFundedWarrantsPricePerShare" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PreFundedWarrantsPricePerShare_lbl" xml:lang="en-US">Pre funded warrants price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreFundedWarrantsPricePerShare" xlink:to="cyngn_PreFundedWarrantsPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl" xml:lang="en-US">Offering expenses payable (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl0" xml:lang="en-US">Offering expenses payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Public offering price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsToPurchase" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchase"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantsToPurchase_lbl" xml:lang="en-US">Warrant purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchase" xlink:to="cyngn_WarrantsToPurchase_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonUnitIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonUnitIssued_lbl" xml:lang="en-US">Common Unit, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrefundedUnitsAtAPublicOfferingPrice" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedUnitsAtAPublicOfferingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl" xml:lang="en-US">Pre-funded units at a public offering price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedUnitsAtAPublicOfferingPrice" xlink:to="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xml:lang="en-US">Offering-related issuance costs (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl" xml:lang="en-US">Pre-funded warrant exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:to="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of additional shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Share sold (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommissionProceedPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommissionProceedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommissionProceedPercentage_lbl" xml:lang="en-US">Gross proceeds, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommissionProceedPercentage" xlink:to="cyngn_CommissionProceedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Net proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0" xml:lang="en-US">Net proceeds from sale</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesCommissionsAndFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalesCommissionsAndFees_lbl" xml:lang="en-US">Commission fees (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalesCommissionsAndFees_lbl0" xml:lang="en-US">Payment of commission and fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl" xml:lang="en-US">Other related expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Aggregate principal amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds received (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl" xml:lang="en-US">Contractual term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of shares authorized for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockOutstandingPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOutstandingPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockOutstandingPercentage_lbl" xml:lang="en-US">Common stock outstanding percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockOutstandingPercentage" xlink:to="cyngn_CommonStockOutstandingPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserved and available for issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted average per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation expense (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Outstanding unvested stock options (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted-average period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xml:lang="en-US">Federal and state income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xml:lang="en-US">Federal and state research credit carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl" xml:lang="en-US">Ownership percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xml:lang="en-US">Total unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xml:lang="en-US">Complaint seeks in damage amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyLossInPeriod" xlink:to="us-gaap_LossContingencyLossInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyAccrualPayments_lbl" xml:lang="en-US">Accrual expences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualPayments" xlink:to="us-gaap_LossContingencyAccrualPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractualObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractualObligation_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SettlementAgreementAmount" xlink:href="cyngn-20251231.xsd#cyngn_SettlementAgreementAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SettlementAgreementAmount_lbl" xml:lang="en-US">Settlement agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SettlementAgreementAmount" xlink:to="cyngn_SettlementAgreementAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_WarrantsToPurchaseShares" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchaseShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_WarrantsToPurchaseShares_lbl" xml:lang="en-US">Warrants to purchase shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchaseShares" xlink:to="cyngn_WarrantsToPurchaseShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xml:lang="en-US">One-time payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl" xml:lang="en-US">Decrease in equity balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_GainLossOnIssuanceOfWarrant" xlink:href="cyngn-20251231.xsd#cyngn_GainLossOnIssuanceOfWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_GainLossOnIssuanceOfWarrant_lbl" xml:lang="en-US">Loss on the issuance of the Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainLossOnIssuanceOfWarrant" xlink:to="cyngn_GainLossOnIssuanceOfWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_OfferingRelatedIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_OfferingRelatedIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_OfferingRelatedIssuanceCosts_lbl" xml:lang="en-US">Offering-related issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OfferingRelatedIssuanceCosts" xlink:to="cyngn_OfferingRelatedIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Issuance costs on an equity transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl" xml:lang="en-US">Concentration of Supplier Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Cash and Short-term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:to="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts and Other Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Operating Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xml:lang="en-US">Costs to Develop Software</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xml:lang="en-US">Internal-Use Software costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_lbl" xml:lang="en-US">Costs to Develop Software to be Sold, Leased or Otherwise Marketed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:to="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-Lived Assets and Finite Lived Intangibles</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockWarrantsPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockWarrantsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockWarrantsPolicyTextBlock_lbl" xml:lang="en-US">Common Stock Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockWarrantsPolicyTextBlock" xlink:to="cyngn_CommonStockWarrantsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Commitments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CostOfRevenuePolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CostOfRevenuePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CostOfRevenuePolicyTextBlock_lbl" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CostOfRevenuePolicyTextBlock" xlink:to="cyngn_CostOfRevenuePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery, tools and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Internal-Use Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DevelopedSoftwareMember" xlink:href="cyngn-20251231.xsd#cyngn_DevelopedSoftwareMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_DevelopedSoftwareMember_lbl" xml:lang="en-US">Developed Software [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DevelopedSoftwareMember" xlink:to="cyngn_DevelopedSoftwareMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommonStockOfferingsMember" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOfferingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_CommonStockOfferingsMember_lbl" xml:lang="en-US">Common Stock Offerings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockOfferingsMember" xlink:to="cyngn_CommonStockOfferingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesAWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SeriesAWarrantMember_lbl" xml:lang="en-US">Series A Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesAWarrantMember" xlink:to="cyngn_SeriesAWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SeriesBWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SeriesBWarrantMember_lbl" xml:lang="en-US">Series B Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesBWarrantMember" xlink:to="cyngn_SeriesBWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PreFundedWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PreFundedWarrantsMember_lbl" xml:lang="en-US">Pre-Funded Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreFundedWarrantsMember" xlink:to="cyngn_PreFundedWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AtTheMarketEquityFinancingMember" xlink:href="cyngn-20251231.xsd#cyngn_AtTheMarketEquityFinancingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AtTheMarketEquityFinancingMember_lbl" xml:lang="en-US">At the Market Equity Financing [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AtTheMarketEquityFinancingMember" xlink:to="cyngn_AtTheMarketEquityFinancingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_AegisCapitalCorpMember" xlink:href="cyngn-20251231.xsd#cyngn_AegisCapitalCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_AegisCapitalCorpMember_lbl" xml:lang="en-US">Aegis Capital Corp. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AegisCapitalCorpMember" xlink:to="cyngn_AegisCapitalCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_PrivatePlacementOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementOfferingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_PrivatePlacementOfferingMember_lbl" xml:lang="en-US">Private Placement Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrivatePlacementOfferingMember" xlink:to="cyngn_PrivatePlacementOfferingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwoThousandTwentyOnePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoThousandTwentyOnePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TwoThousandTwentyOnePlanMember_lbl" xml:lang="en-US">2021 Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwoThousandTwentyOnePlanMember" xlink:to="cyngn_TwoThousandTwentyOnePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwentyTwentyOneEquityIncentivePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwentyTwentyOneEquityIncentivePlanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TwentyTwentyOneEquityIncentivePlanMember_lbl" xml:lang="en-US">2021 Equity Incentive Plan [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwentyTwentyOneEquityIncentivePlanMember" xlink:to="cyngn_TwentyTwentyOneEquityIncentivePlanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_TwoZeroThreeFourMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoZeroThreeFourMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_TwoZeroThreeFourMember_lbl" xml:lang="en-US">Two Zero Three Four [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwoZeroThreeFourMember" xlink:to="cyngn_TwoZeroThreeFourMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DamagesFromProductDefectsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DamagesFromProductDefectsMember_lbl" xml:lang="en-US">Damages from Product Defects [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DamagesFromProductDefectsMember" xlink:to="us-gaap_DamagesFromProductDefectsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SalesAgreementWithAegisCapitalMember" xlink:href="cyngn-20251231.xsd#cyngn_SalesAgreementWithAegisCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_SalesAgreementWithAegisCapitalMember_lbl" xml:lang="en-US">Sales Agreement with Aegis Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SalesAgreementWithAegisCapitalMember" xlink:to="cyngn_SalesAgreementWithAegisCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RegisteredDirectOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_RegisteredDirectOfferingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cyngn_RegisteredDirectOfferingMember_lbl" xml:lang="en-US">Registered Direct Offering [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RegisteredDirectOfferingMember" xlink:to="cyngn_RegisteredDirectOfferingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xml:lang="en-US">Concentration Risk Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NameOfMajorCustomerDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xml:lang="en-US">Customer [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xml:lang="en-US">Concentration Risk Benchmark [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Schedule of Percentages of Total Revenue [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Schedule of Short-Term Investments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_lbl" xml:lang="en-US">Auction Market Preferred Securities, Stock Series, Title [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Schedule of Securities Warrants are Convertible [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xml:lang="en-US">Valuation Approach and Technique [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xml:lang="en-US">Measurement Input Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Schedule of Fair Value of Warrants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable_lbl" xml:lang="en-US">Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:to="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetDomain_lbl" xml:lang="en-US">Deferred Tax Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetDomain" xlink:to="us-gaap_DeferredTaxAssetDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementDomain_lbl" xml:lang="en-US">Revision of Prior Period [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementTable_lbl" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl" xml:lang="en-US">Schedule of Restated Balance Sheet [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementTable_lbl" xml:lang="en-US">Condensed Income Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems_lbl" xml:lang="en-US">Schedule of Restated Statements of Operations [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable_lbl" xml:lang="en-US">Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:to="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems_lbl" xml:lang="en-US">Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedCashFlowStatementTable_lbl" xml:lang="en-US">Condensed Cash Flow Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_CondensedCashFlowStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl" xml:lang="en-US">Schedule of Restated Statement of Cash Flows [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="srt_CondensedCashFlowStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl" xml:lang="en-US">Error Correction [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies - Schedule of Asset&#8217;s Estimated Useful Life (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl0" xml:lang="en-US">Property and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DescriptionofBusinessDetailsTable_lbl" xml:lang="en-US">Description of Business (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DescriptionofBusinessDetailsTable" xlink:to="cyngn_DescriptionofBusinessDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DescriptionofBusinessDetailsLineItems_lbl" xml:lang="en-US">Description of Business (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DescriptionofBusinessDetailsLineItems" xlink:to="cyngn_DescriptionofBusinessDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RevenueandContractswithCustomersDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RevenueandContractswithCustomersDetailsTable_lbl" xml:lang="en-US">Revenue and Contracts with Customers (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RevenueandContractswithCustomersDetailsTable" xlink:to="cyngn_RevenueandContractswithCustomersDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RevenueandContractswithCustomersDetailsLineItems_lbl" xml:lang="en-US">Revenue and Contracts with Customers (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RevenueandContractswithCustomersDetailsLineItems" xlink:to="cyngn_RevenueandContractswithCustomersDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_BalanceSheetComponentsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_BalanceSheetComponentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_BalanceSheetComponentsDetailsTable_lbl" xml:lang="en-US">Balance Sheet Components (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BalanceSheetComponentsDetailsTable" xlink:to="cyngn_BalanceSheetComponentsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl0" xml:lang="en-US">Balance Sheet Components [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Statement of Income Location, Balance [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IntangibleAssetsNetDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IntangibleAssetsNetDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IntangibleAssetsNetDetailsTable_lbl" xml:lang="en-US">Intangible Assets, Net (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IntangibleAssetsNetDetailsTable" xlink:to="cyngn_IntangibleAssetsNetDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl0" xml:lang="en-US">Intangible Assets, Net [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related and Nonrelated Parties [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CapitalStructureDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CapitalStructureDetailsTable_lbl" xml:lang="en-US">Capital Structure (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CapitalStructureDetailsTable" xlink:to="cyngn_CapitalStructureDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US">Capital Structure [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockBasedCompensationExpenseDetailsTable_lbl" xml:lang="en-US">Stock-Based Compensation Expense (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockBasedCompensationExpenseDetailsTable" xlink:to="cyngn_StockBasedCompensationExpenseDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl0" xml:lang="en-US">Stock-based Compensation Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateDomain_lbl" xml:lang="en-US">Award Date [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateDomain" xlink:to="us-gaap_AwardDateDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Jurisdiction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_IncomeTaxesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IncomeTaxesDetailsTable" xlink:to="cyngn_IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_IncomeTaxExaminationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xml:lang="en-US">Loss Contingency, Nature [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_CommitmentsandContingenciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CommitmentsandContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommitmentsandContingenciesDetailsTable_lbl" xml:lang="en-US">Commitments and Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommitmentsandContingenciesDetailsTable" xlink:to="cyngn_CommitmentsandContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xml:lang="en-US">Commitments and Contingencies [LIne Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_SubsequentEventsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SubsequentEventsDetailsTable" xlink:to="cyngn_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Events [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable_lbl" xml:lang="en-US">Restatement of Previously Issued Audited Financial Statements (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:to="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl0" xml:lang="en-US">Restatement of Previously Issued Audited Financial Statements [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_AccretionOnShorttermInvestments_lbl0" xml:lang="en-US">Accretion on short-term investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AccretionOnShorttermInvestments" xlink:to="cyngn_AccretionOnShorttermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl0" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:to="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl0" xml:lang="en-US">Acquisition of right-of-use asset in exchange for new operating lease obligation.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:to="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy regarding cash and short term investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:to="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CommissionProceedPercentage_lbl0" xml:lang="en-US">Commission Proceed Percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommissionProceedPercentage" xlink:to="cyngn_CommissionProceedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CommonStockOutstandingPercentage_lbl0" xml:lang="en-US">Percentage of common stock outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockOutstandingPercentage" xlink:to="cyngn_CommonStockOutstandingPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CommonStockWarrantsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for common stock warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockWarrantsPolicyTextBlock" xlink:to="cyngn_CommonStockWarrantsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for concentration of supplier risk policy.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CostOfRevenuePolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for cost of revenue.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CostOfRevenuePolicyTextBlock" xlink:to="cyngn_CostOfRevenuePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_CreditCardPayableCurrent_lbl0" xml:lang="en-US">Represents the amount of credit card payable current.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CreditCardPayableCurrent" xlink:to="cyngn_CreditCardPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl0" xml:lang="en-US">The amount of capitalized research costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" xlink:to="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetsFixedAssets_lbl0" xml:lang="en-US">Fixed assets .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsFixedAssets" xlink:to="cyngn_DeferredTaxAssetsFixedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxAssetsLeaseLiability_lbl0" xml:lang="en-US">The amount of lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsLeaseLiability" xlink:to="cyngn_DeferredTaxAssetsLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl0" xml:lang="en-US">The amount of right of use asset.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl0" xml:lang="en-US">Exercise of pre-funded warrants in connection with the public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl0" xml:lang="en-US">Represents the amount of finite lived intangible assets fair market value adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:to="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl0" xml:lang="en-US">The amount of finite lived intangible assets impairment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsImpairment" xlink:to="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_GainLossOnIssuanceOfWarrant_lbl0" xml:lang="en-US">Loss issuance of the Warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainLossOnIssuanceOfWarrant" xlink:to="cyngn_GainLossOnIssuanceOfWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl0" xml:lang="en-US">The amount of issuance costs for stock dividend and restricted stock units .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:to="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl0" xml:lang="en-US">Issuance of common stock upon exercise of pre-funded warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:to="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_LossOnIssuanceOfWarrants_lbl2" xml:lang="en-US">Loss on issuance of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossOnIssuanceOfWarrants" xlink:to="cyngn_LossOnIssuanceOfWarrants_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_OfferingRelatedIssuanceCosts_lbl0" xml:lang="en-US">The amount of offering-related issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OfferingRelatedIssuanceCosts" xlink:to="cyngn_OfferingRelatedIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PreFundedWarrantsPricePerShare_lbl0" xml:lang="en-US">Pre-funded warrants price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreFundedWarrantsPricePerShare" xlink:to="cyngn_PreFundedWarrantsPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl0" xml:lang="en-US">Pre-funded units at a public offering price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedUnitsAtAPublicOfferingPrice" xlink:to="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl1" xml:lang="en-US">Pre-funded warrants to purchase shares of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl0" xml:lang="en-US">Proceeds from at-the-market equity financing, net of issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:to="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl0" xml:lang="en-US">Proceeds from public issuance of common stock and pre-funded warrants .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl0" xml:lang="en-US">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants net of issuance costs .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl0" xml:lang="en-US">Proceeds from public issuance of common stock and pre-funded warrants, net of offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl0" xml:lang="en-US">Amount of increase (decrease) in research and development expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:to="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl0" xml:lang="en-US">The entire disclosure of previously issued interim financial statements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:to="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of property and equipment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_SettlementAgreementAmount_lbl0" xml:lang="en-US">The amount of  settlement agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SettlementAgreementAmount" xlink:to="cyngn_SettlementAgreementAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl0" xml:lang="en-US">Exercise of pre-funded warrants in connection with the public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl0" xml:lang="en-US">Issuance of common stock and pre-funded warrants in connection with the public offering, net of offering cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:to="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl0" xml:lang="en-US">Reclassification of Series A warrants to equity and exercise of Series B warrants in connection with the public offering.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_UnrestrictedCashBalance_lbl0" xml:lang="en-US">Unrestricted cash balance .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashBalance" xlink:to="cyngn_UnrestrictedCashBalance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WarrantIssuanceCosts_lbl0" xml:lang="en-US">Amount of warrant issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantIssuanceCosts" xlink:to="cyngn_WarrantIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WarrantLiabilityIssuanceCosts_lbl1" xml:lang="en-US">Warrant liability issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantLiabilityIssuanceCosts" xlink:to="cyngn_WarrantLiabilityIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl0" xml:lang="en-US">Expiration date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsAndRightOutstandingMaturityDate" xlink:to="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WarrantsToPurchase_lbl0" xml:lang="en-US">Number of warrants or rights outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchase" xlink:to="cyngn_WarrantsToPurchase_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_WarrantsToPurchaseShares_lbl0" xml:lang="en-US">Number of warrants to purchase shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchaseShares" xlink:to="cyngn_WarrantsToPurchaseShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_InitialPublicOfferingWarrantsMember_lbl0" xml:lang="en-US">Initial Public Offering Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_InitialPublicOfferingWarrantsMember" xlink:to="cyngn_InitialPublicOfferingWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cyngn_PrivatePlacementWarrantsMember_lbl0" xml:lang="en-US">Private Placement Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrivatePlacementWarrantsMember" xlink:to="cyngn_PrivatePlacementWarrantsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">chief operating decision maker</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UsefulLifeTermOfLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UsefulLifeTermOfLeaseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UsefulLifeTermOfLeaseMember_lbl" xml:lang="en-US">Shorter of 3 years or lease term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UsefulLifeTermOfLeaseMember" xlink:to="us-gaap_UsefulLifeTermOfLeaseMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfRestatedBalanceSheetAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedBalanceSheetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfRestatedBalanceSheetAbstract_lbl" xml:lang="en-US">Schedule Of Restated Balance Sheet Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfRestatedBalanceSheetAbstract" xlink:to="cyngn_ScheduleOfRestatedBalanceSheetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract_lbl" xml:lang="en-US">Schedule Of Restated Statements Of Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract" xlink:to="cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl0" xml:lang="en-US">Computer Software, Intangible Asset [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SalesAgreementWithAegisCapitalMember_lbl0" xml:lang="en-US">Sales Agreement With Aegis Capital Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SalesAgreementWithAegisCapitalMember" xlink:to="cyngn_SalesAgreementWithAegisCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantsToPurchase_lbl1" xml:lang="en-US">Warrants To Purchase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchase" xlink:to="cyngn_WarrantsToPurchase_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl0" xml:lang="en-US">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract_lbl" xml:lang="en-US">Schedule Of Gross Carrying Amount And Accumulated Amortization Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract" xlink:to="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl0" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl2" xml:lang="en-US">Prefunded Warrants To Purchase Shares Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:to="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl0" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl0" xml:lang="en-US">Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Schedule Of Restated Statement Of Cash Flows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract" xlink:to="cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl0" xml:lang="en-US">Realized Investment Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantsToPurchaseShares_lbl1" xml:lang="en-US">Warrants To Purchase Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsToPurchaseShares" xlink:to="cyngn_WarrantsToPurchaseShares_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Property And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentAbstract" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CustomerDMember_lbl0" xml:lang="en-US">Customer DMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerDMember" xlink:to="cyngn_CustomerDMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract_lbl" xml:lang="en-US">Schedule Of Federal Statutory Income Tax Rate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract" xlink:to="cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl1" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PreFundedWarrantsPricePerShare_lbl1" xml:lang="en-US">Pre Funded Warrants Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreFundedWarrantsPricePerShare" xlink:to="cyngn_PreFundedWarrantsPricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonUnitIssued_lbl0" xml:lang="en-US">Common Unit, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders&apos; Equity Note, Warrants or Rights [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl1" xml:lang="en-US">Asset Impairment Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl0" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfShortTermInvestmentsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfShortTermInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfShortTermInvestmentsAbstract_lbl" xml:lang="en-US">Schedule Of Short Term Investments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfShortTermInvestmentsAbstract" xlink:to="cyngn_ScheduleOfShortTermInvestmentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl0" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RestatedMember_lbl0" xml:lang="en-US">Restated Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatedMember" xlink:to="cyngn_RestatedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_GainLossOnIssuanceOfWarrant_lbl1" xml:lang="en-US">Gain Loss On Issuance Of Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_GainLossOnIssuanceOfWarrant" xlink:to="cyngn_GainLossOnIssuanceOfWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SeriesBWarrantMember_lbl0" xml:lang="en-US">Series BWarrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesBWarrantMember" xlink:to="cyngn_SeriesBWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SeriesAWarrantMember_lbl0" xml:lang="en-US">Series AWarrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesAWarrantMember" xlink:to="cyngn_SeriesAWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockOutstandingPercentage_lbl1" xml:lang="en-US">Common Stock Outstanding Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockOutstandingPercentage" xlink:to="cyngn_CommonStockOutstandingPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCurrent_lbl0" xml:lang="en-US">Deferred Costs, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCurrent" xlink:to="us-gaap_DeferredCostsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl0" xml:lang="en-US">Costs and Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl0" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl0" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl1" xml:lang="en-US">Stock Issued During Period Value Reclassification Of Series AWarrants To Equity And Exercise Of Series BWarrants In Connection With The Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AutomobilesMember_lbl0" xml:lang="en-US">Automobiles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AutomobilesMember" xlink:to="us-gaap_AutomobilesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl1" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TwoZeroThreeFourMember_lbl0" xml:lang="en-US">Two Zero Three Four Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwoZeroThreeFourMember" xlink:to="cyngn_TwoZeroThreeFourMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl0" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract_lbl" xml:lang="en-US">Schedule Of Percentages Of Total Revenue Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract" xlink:to="cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl0" xml:lang="en-US">Accounts and Other Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl0" xml:lang="en-US">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl1" xml:lang="en-US">Acquisition Of Rightofuse Asset In Exchange For New Operating Lease Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:to="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_OtherPermanentDifferencesMember_lbl0" xml:lang="en-US">Other Permanent Differences Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OtherPermanentDifferencesMember" xlink:to="cyngn_OtherPermanentDifferencesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl0" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl0" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination_lbl0" xml:lang="en-US">Impaired Intangible Asset, Method for Fair Value Determination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" xlink:to="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TestingEquipmentMember_lbl0" xml:lang="en-US">Testing Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TestingEquipmentMember" xlink:to="cyngn_TestingEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl0" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl1" xml:lang="en-US">Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:to="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue_lbl0" xml:lang="en-US">Money Market Funds, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl0" xml:lang="en-US">Software and Software Development Costs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl0" xml:lang="en-US">Patents [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl2" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl0" xml:lang="en-US">Accrued Payroll Taxes, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl0" xml:lang="en-US">Trademarks [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesCommissionsAndFees_lbl1" xml:lang="en-US">Sales Commissions and Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesCommissionsAndFees" xlink:to="us-gaap_SalesCommissionsAndFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl1" xml:lang="en-US">Restatement Of Previously Issued Interim Financial Statements Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:to="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AccretionOnShorttermInvestments_lbl1" xml:lang="en-US">Accretion On Shortterm Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AccretionOnShorttermInvestments" xlink:to="cyngn_AccretionOnShorttermInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBMember_lbl0" xml:lang="en-US">Series B [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBMember" xlink:to="us-gaap_SeriesBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl3" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsFixedAssets_lbl1" xml:lang="en-US">Deferred Tax Assets Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsFixedAssets" xlink:to="cyngn_DeferredTaxAssetsFixedAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl0" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DevelopedSoftwareMember_lbl0" xml:lang="en-US">Developed Software Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DevelopedSoftwareMember" xlink:to="cyngn_DevelopedSoftwareMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl0" xml:lang="en-US">Condensed Cash Flow Statement [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAMember_lbl0" xml:lang="en-US">Series A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAMember" xlink:to="us-gaap_SeriesAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_MachineToolsAndEquipmentMember_lbl0" xml:lang="en-US">Machine Tools And Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MachineToolsAndEquipmentMember" xlink:to="cyngn_MachineToolsAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl0" xml:lang="en-US">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractualObligation_lbl0" xml:lang="en-US">Contractual Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl0" xml:lang="en-US">Revenue Benchmark [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualPayments_lbl0" xml:lang="en-US">Loss Contingency Accrual, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualPayments" xlink:to="us-gaap_LossContingencyAccrualPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl0" xml:lang="en-US">Costs and Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl0" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl0" xml:lang="en-US">Payments for Legal Settlements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl2" xml:lang="en-US">Previously Reported [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RecapitalizationCosts_lbl1" xml:lang="en-US">Recapitalization Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecapitalizationCosts" xlink:to="us-gaap_RecapitalizationCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl0" xml:lang="en-US">Security Deposit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Equity [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CashEquivalentsAbstract_lbl0" xml:lang="en-US">Cash Equivalents Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CashEquivalentsAbstract" xlink:to="cyngn_CashEquivalentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SeriesAWarrantsMember_lbl0" xml:lang="en-US">Series AWarrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesAWarrantsMember" xlink:to="cyngn_SeriesAWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl0" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_Section162mLimitationMember_lbl0" xml:lang="en-US">Section162m Limitation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_Section162mLimitationMember" xlink:to="cyngn_Section162mLimitationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl1" xml:lang="en-US">Proceeds From Public Issuance Of Common Stock And Prefunded Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl0" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SeriesBWarrantsMember_lbl0" xml:lang="en-US">Series BWarrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SeriesBWarrantsMember" xlink:to="cyngn_SeriesBWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AsRestatedMember_lbl0" xml:lang="en-US">As Restated Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AsRestatedMember" xlink:to="cyngn_AsRestatedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_lbl0" xml:lang="en-US">Amount of Deferred Costs Related to Long-Term Contracts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:to="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantRevaluationMember_lbl0" xml:lang="en-US">Warrant Revaluation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantRevaluationMember" xlink:to="cyngn_WarrantRevaluationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AsPreviouslyReportMember_lbl0" xml:lang="en-US">As Previously Report Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AsPreviouslyReportMember" xlink:to="cyngn_AsPreviouslyReportMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl2" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate During Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl1" xml:lang="en-US">Finite Lived Intangible Assets Impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsImpairment" xlink:to="cyngn_FiniteLivedIntangibleAssetsImpairment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Inventory, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl0" xml:lang="en-US">Number of Operating Segments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_RegisteredDirectOfferingMember_lbl0" xml:lang="en-US">Registered Direct Offering Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_RegisteredDirectOfferingMember" xlink:to="cyngn_RegisteredDirectOfferingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract_lbl" xml:lang="en-US">Schedule Of Securities Warrants Are Convertible Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract" xlink:to="cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl1" xml:lang="en-US">Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:to="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl1" xml:lang="en-US">Stock Issued During Period Shares Exercise Of Prefunded Warrants In Connection With The Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalvageAndSubrogationRecoveriesValue_lbl0" xml:lang="en-US">Salvage and Subrogation Recoveries, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalvageAndSubrogationRecoveriesValue" xlink:to="us-gaap_SalvageAndSubrogationRecoveriesValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl0" xml:lang="en-US">Repayments of Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue_lbl0" xml:lang="en-US">US Government Securities, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl2" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestmentsAbstract_lbl0" xml:lang="en-US">Short-Term Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_ShortTermInvestmentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl0" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0" xml:lang="en-US">Research and Development Expense [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl0" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl1" xml:lang="en-US">Finite Lived Intangible Assets Fair Market Value Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:to="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl0" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_InitialPublicOfferingWarrantsMember_lbl1" xml:lang="en-US">Initial Public Offering Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_InitialPublicOfferingWarrantsMember" xlink:to="cyngn_InitialPublicOfferingWarrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl1" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl1" xml:lang="en-US">Stock Issued During Period Value Issuance Of Common Stock And Prefunded Warrants And Exercise Of Prefunded Warrants In Conn</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:to="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl0" xml:lang="en-US">Accounts Receivable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CustomerCMember_lbl0" xml:lang="en-US">Customer CMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerCMember" xlink:to="cyngn_CustomerCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Other Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAdjustmentMember_lbl1" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAdjustmentMember" xlink:to="srt_RestatementAdjustmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_LossOnIssuanceOfWarrants_lbl3" xml:lang="en-US">Loss On Issuance Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_LossOnIssuanceOfWarrants" xlink:to="cyngn_LossOnIssuanceOfWarrants_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl1" xml:lang="en-US">Deferred Tax Liabilities Right Of Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="cyngn_DeferredTaxLiabilitiesRightOfUseAsset_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_NontaxableOrNondeductibleItemsAbstract_lbl0" xml:lang="en-US">Nontaxable Or Nondeductible Items Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_NontaxableOrNondeductibleItemsAbstract" xlink:to="cyngn_NontaxableOrNondeductibleItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl1" xml:lang="en-US">Exercise Of Prefunded Warrants In Connection With The Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:to="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl0" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl1" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0" xml:lang="en-US">Payments to Acquire Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US">Accounts Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_MonteCarloPricingModelMember_lbl0" xml:lang="en-US">Monte Carlo Pricing Model Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_MonteCarloPricingModelMember" xlink:to="cyngn_MonteCarloPricingModelMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl0" xml:lang="en-US">Machinery and Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl2" xml:lang="en-US">Software Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl0" xml:lang="en-US">Debt Issuance Costs, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_UnrestrictedCashBalance_lbl1" xml:lang="en-US">Unrestricted Cash Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_UnrestrictedCashBalance" xlink:to="cyngn_UnrestrictedCashBalance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_OtherReconcilingItemsAbstract_lbl0" xml:lang="en-US">Other Reconciling Items Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OtherReconcilingItemsAbstract" xlink:to="cyngn_OtherReconcilingItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CustomerEMember_lbl0" xml:lang="en-US">Customer EMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerEMember" xlink:to="cyngn_CustomerEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PrivatePlacementOfferingMember_lbl0" xml:lang="en-US">Private Placement Offering Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrivatePlacementOfferingMember" xlink:to="cyngn_PrivatePlacementOfferingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Derivative Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl0" xml:lang="en-US">Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl1" xml:lang="en-US">Prefunded Units At APublic Offering Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrefundedUnitsAtAPublicOfferingPrice" xlink:to="cyngn_PrefundedUnitsAtAPublicOfferingPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockOfferingsMember_lbl0" xml:lang="en-US">Common Stock Offerings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockOfferingsMember" xlink:to="cyngn_CommonStockOfferingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_lbl0" xml:lang="en-US">Contract with Customer, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_BlackScholesModelMember_lbl0" xml:lang="en-US">Black Scholes Model Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_BlackScholesModelMember" xlink:to="cyngn_BlackScholesModelMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract_lbl" xml:lang="en-US">Schedule Of Restated Statement Of Stockholders Equity Deficit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract" xlink:to="cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PrivatePlacementWarrantsMember_lbl1" xml:lang="en-US">Private Placement Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PrivatePlacementWarrantsMember" xlink:to="cyngn_PrivatePlacementWarrantsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl0" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Maximum Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl1" xml:lang="en-US">Proceeds From Atthemarket Equity Financing Net Of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:to="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_OfferingRelatedIssuanceCosts_lbl1" xml:lang="en-US">Offering Related Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_OfferingRelatedIssuanceCosts" xlink:to="cyngn_OfferingRelatedIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CostOfRevenuePolicyTextBlock_lbl1" xml:lang="en-US">Cost Of Revenue Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CostOfRevenuePolicyTextBlock" xlink:to="cyngn_CostOfRevenuePolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AtTheMarketEquityFinancingMember_lbl0" xml:lang="en-US">At The Market Equity Financing Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AtTheMarketEquityFinancingMember" xlink:to="cyngn_AtTheMarketEquityFinancingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl0" xml:lang="en-US">Interest Income (Expense), Nonoperating</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl0" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract_lbl" xml:lang="en-US">Schedule Of Balance Sheet And Cash Flows Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract" xlink:to="cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl0" xml:lang="en-US">Loss Contingency, Loss in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyLossInPeriod" xlink:to="us-gaap_LossContingencyLossInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl0" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl0" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl1" xml:lang="en-US">Research And Development Expense Increase Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:to="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoninterestExpenseOfferingCost_lbl1" xml:lang="en-US">Offering Cost, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseOfferingCost" xlink:to="us-gaap_NoninterestExpenseOfferingCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl0" xml:lang="en-US">Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl0" xml:lang="en-US">Advertising Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsLeaseLiability_lbl1" xml:lang="en-US">Deferred Tax Assets Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsLeaseLiability" xlink:to="cyngn_DeferredTaxAssetsLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl1" xml:lang="en-US">Deferred Tax Assets Capitalized Research Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_DeferredTaxAssetsCapitalizedResearchCosts" xlink:to="cyngn_DeferredTaxAssetsCapitalizedResearchCosts_lbl1"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract_lbl" xml:lang="en-US">Schedule Of Restricted Stock Units And Activity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract" xlink:to="cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_SettlementAgreementAmount_lbl1" xml:lang="en-US">Settlement Agreement Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_SettlementAgreementAmount" xlink:to="cyngn_SettlementAgreementAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantIssuanceCosts_lbl1" xml:lang="en-US">Warrant Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantIssuanceCosts" xlink:to="cyngn_WarrantIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommonStockWarrantsPolicyTextBlock_lbl1" xml:lang="en-US">Common Stock Warrants Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommonStockWarrantsPolicyTextBlock" xlink:to="cyngn_CommonStockWarrantsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl1" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl0" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl1" xml:lang="en-US">Issuance Costs For Stock Dividend And Restricted Stock Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:to="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl2" xml:lang="en-US">Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl0" xml:lang="en-US">Concentration Risk, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl0"/>
    <loc xlink:type="locator" xlink:label="cyngn_ScheduleOfFairValueOfWarrantsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfFairValueOfWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfFairValueOfWarrantsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of Warrants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfFairValueOfWarrantsAbstract" xlink:to="cyngn_ScheduleOfFairValueOfWarrantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_PreFundedWarrantsMember_lbl0" xml:lang="en-US">Pre Funded Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_PreFundedWarrantsMember" xlink:to="cyngn_PreFundedWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl0" xml:lang="en-US">Contract with Customer, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl0" xml:lang="en-US">Other Labor-related Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl1" xml:lang="en-US">Proceeds From Public Issuance Of Common Stock And Prefunded Warrants Net Of Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantLiabilityIssuanceCosts_lbl2" xml:lang="en-US">Warrant Liability Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantLiabilityIssuanceCosts" xlink:to="cyngn_WarrantLiabilityIssuanceCosts_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Cash And Shortterm Investments Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:to="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl0" xml:lang="en-US">Private Placement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0" xml:lang="en-US">Retirement Benefits [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl0" xml:lang="en-US">Operating Lease, Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl0" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl1" xml:lang="en-US">Short-Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_AegisCapitalCorpMember_lbl0" xml:lang="en-US">Aegis Capital Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_AegisCapitalCorpMember" xlink:to="cyngn_AegisCapitalCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CustomerBMember_lbl0" xml:lang="en-US">Customer BMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerBMember" xlink:to="cyngn_CustomerBMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TwentyTwentyOneEquityIncentivePlanMember_lbl0" xml:lang="en-US">Twenty Twenty One Equity Incentive Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwentyTwentyOneEquityIncentivePlanMember" xlink:to="cyngn_TwentyTwentyOneEquityIncentivePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl1" xml:lang="en-US">Concentration Of Supplier Risk Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock" xlink:to="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl1" xml:lang="en-US">Warrants And Right Outstanding Maturity Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_WarrantsAndRightOutstandingMaturityDate" xlink:to="cyngn_WarrantsAndRightOutstandingMaturityDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl0" xml:lang="en-US">Proceeds from Sale of Productive Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Property And Equipment Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:to="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl2" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease_lbl0" xml:lang="en-US">Capitalized Computer Software, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" xlink:to="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl1" xml:lang="en-US">Increase (Decrease) in Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0" xml:lang="en-US">Condensed Income Statement [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl0" xml:lang="en-US">Deferred Tax Assets, Deferred Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl0" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl0" xml:lang="en-US">Customer Concentration Risk [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CustomerAMember_lbl0" xml:lang="en-US">Customer AMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CustomerAMember" xlink:to="cyngn_CustomerAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl0" xml:lang="en-US">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_TwoThousandTwentyOnePlanMember_lbl0" xml:lang="en-US">Two Thousand Twenty One Plan Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_TwoThousandTwentyOnePlanMember" xlink:to="cyngn_TwoThousandTwentyOnePlanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl0" xml:lang="en-US">Cost of Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForOtherCreditLosses_lbl0" xml:lang="en-US">Provision for Other Credit Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForOtherCreditLosses" xlink:to="us-gaap_ProvisionForOtherCreditLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_lbl0" xml:lang="en-US">Software to be Sold, Leased, or Otherwise Marketed, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:to="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl0" xml:lang="en-US">Proceeds from Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl0" xml:lang="en-US">Debt Instrument, Maturity Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CreditCardPayableCurrent_lbl1" xml:lang="en-US">Credit Card Payable Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CreditCardPayableCurrent" xlink:to="cyngn_CreditCardPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl0" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US">Nonoperating Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl0" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DamagesFromProductDefectsMember_lbl0" xml:lang="en-US">Damages from Product Defects [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DamagesFromProductDefectsMember" xlink:to="us-gaap_DamagesFromProductDefectsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl0" xml:lang="en-US">Assets, Noncurrent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_CommissionProceedPercentage_lbl1" xml:lang="en-US">Commission Proceed Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_CommissionProceedPercentage" xlink:to="cyngn_CommissionProceedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsCurrent_lbl0" xml:lang="en-US">Deposits Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsCurrent" xlink:to="us-gaap_DepositsAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl1" xml:lang="en-US">Proceeds From Public Issuance Of Common Stock And Prefunded Warrants And Exercise Of Prefu</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:to="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
<!-- [WMV6][sUKsyj7eML2flDBSo//QHkEcZmGywhFxBYIuwdrixCERqAl4eH+wvhRBSbntNw+JK4L43QcJx4zZEljY+OyZsT+KW5Zm1RkhcqYba+cgOGJgCV6uLD1VMyDX0LeKHyOFOS2a+l27rXHQ4XHpkuMGUSAWKsgc4zoWL+lutSX9yhZMOlkKSINA9bhQnNO1tFMgHahdMUhdy60JcZ5mI6vkp0yjCOOz2oErONlyMRIOR5eDfQOhIc/Li5UBxsZlyQHzxp/CvcjjI7OX0GC7GdEgR64OqZP+IpLc/+Y7NOLJyYQEaApRBdirBrLvHRo7tKps8/t7FJc=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>cyngn-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:53 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedBalanceSheet" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedIncomeStatement" roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ShareholdersEquityType2or3" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ConsolidatedCashFlow" roleURI="http://cyngn.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_DescriptionofBusiness" roleURI="http://cyngn.com/role/DescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPolicies" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RevenueandContractswithCustomers" roleURI="http://cyngn.com/role/RevenueandContractswithCustomers"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponents" roleURI="http://cyngn.com/role/BalanceSheetComponents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeases" roleURI="http://cyngn.com/role/OperatingLeases"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNet" roleURI="http://cyngn.com/role/IntangibleAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructure" roleURI="http://cyngn.com/role/CapitalStructure"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholders" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpense" roleURI="http://cyngn.com/role/StockBasedCompensationExpense"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RetirementSavingsPlan" roleURI="http://cyngn.com/role/RetirementSavingsPlan"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxes" roleURI="http://cyngn.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CommitmentsandContingencies" roleURI="http://cyngn.com/role/CommitmentsandContingencies"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RisksandUncertainties" roleURI="http://cyngn.com/role/RisksandUncertainties"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SubsequentEvents" roleURI="http://cyngn.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatements" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_AccountingPoliciesByPolicy" roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponentsTables" roleURI="http://cyngn.com/role/BalanceSheetComponentsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeasesTables" roleURI="http://cyngn.com/role/OperatingLeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNetTables" roleURI="http://cyngn.com/role/IntangibleAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructureTables" roleURI="http://cyngn.com/role/CapitalStructureTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpenseTables" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxesTables" roleURI="http://cyngn.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsTables" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPercentagesofTotalRevenueTable" roleURI="http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofShortTermInvestmentsTable" roleURI="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" roleURI="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofPropertyandEquipmentTable" roleURI="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable" roleURI="http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofLeaseCostTable" roleURI="http://cyngn.com/role/ScheduleofLeaseCostTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable" roleURI="http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" roleURI="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofSecuritiesWarrantsareConvertibleTable" roleURI="http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFairValueofWarrantsTable" roleURI="http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofBasicandDilutedLossPerShareTable" roleURI="http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofStockOptionsVestedandExercisableTable" roleURI="http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestrictedStockUnitsandActivityTable" roleURI="http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable" roleURI="http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofDomesticandInternationalPreTaxLossTable" roleURI="http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofFederalStatutoryIncomeTaxRateTable" roleURI="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable" roleURI="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofGrossUnrecognizedTaxBenefitsTable" roleURI="http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedBalanceSheetTable" roleURI="http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementsofOperationsTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementofStockholdersEquityDeficitTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofRestatedStatementofCashFlowsTable" roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_ScheduleofBalanceSheetandCashFlowsTable" roleURI="http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_DescriptionofBusinessDetails" roleURI="http://cyngn.com/role/DescriptionofBusinessDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RevenueandContractswithCustomersDetails" roleURI="http://cyngn.com/role/RevenueandContractswithCustomersDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_BalanceSheetComponentsDetails" roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_OperatingLeasesDetails" roleURI="http://cyngn.com/role/OperatingLeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IntangibleAssetsNetDetails" roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CapitalStructureDetails" roleURI="http://cyngn.com/role/CapitalStructureDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_StockBasedCompensationExpenseDetails" roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_IncomeTaxesDetails" roleURI="http://cyngn.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_CommitmentsandContingenciesDetails" roleURI="http://cyngn.com/role/CommitmentsandContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_SubsequentEventsDetails" roleURI="http://cyngn.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="cyngn-20251231.xsd#cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails" roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#ai" roleURI="http://xbrl.sec.gov/dei/role/document/AuditInformation"/>
  <presentationLink xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SecurityDeposit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_SecurityDeposit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ConsolidatedIncomeStatement" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostOfRevenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostsAndExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="WarrantLiabilityIssuanceCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="LossOnIssuanceOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="4.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ConsolidatedCashFlow" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AccretionOnShorttermInvestments" xlink:href="cyngn-20251231.xsd#cyngn_AccretionOnShorttermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccretionOnShorttermInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AssetImpairmentCharges" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RecapitalizationCosts" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="WarrantLiabilityIssuanceCosts" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="LossOnIssuanceOfWarrants" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfNotesPayable" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceCostsForStockDividendAndRestrictedStockUnits" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="IssuanceCostsForStockDividendAndRestrictedStockUnits" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" xlink:href="cyngn-20251231.xsd#cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/DescriptionofBusiness" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RevenueandContractswithCustomers" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/BalanceSheetComponents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/OperatingLeases" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IntangibleAssetsNet" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/CapitalStructure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpense" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RetirementSavingsPlan" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DefinedBenefitPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedBenefitPlanAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IncomeTaxes" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/CommitmentsandContingencies" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RisksandUncertainties" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SubsequentEvents" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/AccountingPoliciesByPolicy" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConcentrationOfSupplierRiskPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ConcentrationOfSupplierRiskPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashAndShorttermInvestmentsPolicyPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CashAndShorttermInvestmentsPolicyPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InternalUseSoftwarePolicy" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockWarrantsPolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockWarrantsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CommonStockWarrantsPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostOfRevenuePolicyTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_CostOfRevenuePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="CostOfRevenuePolicyTextBlock" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentTableTextBlock" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyAndEquipmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/OperatingLeasesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/CapitalStructureTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IncomeTaxesTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedIncomeStatementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedIncomeStatementTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfCondensedCashFlowStatementTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="srt_ScheduleOfCondensedCashFlowStatementTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPercentagesOfTotalRevenueAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPercentagesOfTotalRevenueAbstract" xlink:to="us-gaap_ConcentrationRiskTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MajorCustomersAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="srt_MajorCustomersAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CustomerAMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="CustomerAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerBMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="CustomerBMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerCMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="CustomerCMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerDMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerDMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="CustomerDMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerEMember" xlink:href="cyngn-20251231.xsd#cyngn_CustomerEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="CustomerEMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesRevenueNetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_SalesRevenueNetMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfShortTermInvestmentsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfShortTermInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermDebtLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CashEquivalentsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_CashEquivalentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="CashEquivalentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MoneyMarketFundsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashEquivalentsAbstract" xlink:to="us-gaap_MoneyMarketFundsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestmentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermInvestmentsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_USGovernmentSecuritiesAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_USGovernmentSecuritiesAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermInvestmentsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_DepositsAssetsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfPropertyAndEquipmentAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AutomobilesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_AutomobilesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MachineToolsAndEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_MachineToolsAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="MachineToolsAndEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TestingEquipmentMember" xlink:href="cyngn-20251231.xsd#cyngn_TestingEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="TestingEquipmentMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="CreditCardPayableCurrent" xlink:href="cyngn-20251231.xsd#cyngn_CreditCardPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="CreditCardPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_OperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofLeaseCostTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCostAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PatentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_PatentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TrademarksMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_TrademarksMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_ComputerSoftwareIntangibleAssetMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedIntangibleAssetsFairMarketValueAdjustment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsFairMarketValueAdjustment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedIntangibleAssetsImpairment" xlink:href="cyngn-20251231.xsd#cyngn_FiniteLivedIntangibleAssetsImpairment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="FiniteLivedIntangibleAssetsImpairment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfSecuritiesWarrantsAreConvertibleAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSecuritiesWarrantsAreConvertibleAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_SeriesAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesBMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis" xlink:to="us-gaap_SeriesBMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsAndRightOutstandingMaturityDate" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsAndRightOutstandingMaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="WarrantsAndRightOutstandingMaturityDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofFairValueofWarrantsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfWarrantsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfFairValueOfWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfWarrantsAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputSharePriceMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationTechniqueDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BlackScholesModelMember" xlink:href="cyngn-20251231.xsd#cyngn_BlackScholesModelMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="BlackScholesModelMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MonteCarloPricingModelMember" xlink:href="cyngn-20251231.xsd#cyngn_MonteCarloPricingModelMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="MonteCarloPricingModelMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="InitialPublicOfferingWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_InitialPublicOfferingWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="InitialPublicOfferingWarrantsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PrivatePlacementWarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesAWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesAWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesBWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesBWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestrictedStockUnitsAndActivityAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract"/>
    <loc xlink:type="locator" xlink:label="StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestrictedStockUnitsAndActivityAbstract" xlink:to="StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfFederalStatutoryIncomeTaxRateAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFederalStatutoryIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceByDeferredTaxAssetAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="us-gaap_DeferredTaxAssetDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Section162mLimitationMember" xlink:href="cyngn-20251231.xsd#cyngn_Section162mLimitationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="Section162mLimitationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantRevaluationMember" xlink:href="cyngn-20251231.xsd#cyngn_WarrantRevaluationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="WarrantRevaluationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherPermanentDifferencesMember" xlink:href="cyngn-20251231.xsd#cyngn_OtherPermanentDifferencesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowanceByDeferredTaxAssetAxis" xlink:to="OtherPermanentDifferencesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTable" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationTaxCredits" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NontaxableOrNondeductibleItemsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_NontaxableOrNondeductibleItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="NontaxableOrNondeductibleItemsAbstract" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NontaxableOrNondeductibleItemsAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NontaxableOrNondeductibleItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherReconcilingItemsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_OtherReconcilingItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="OtherReconcilingItemsAbstract" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherReconcilingItemsAbstract" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherReconcilingItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherReconcilingItemsAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherReconcilingItemsAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsFixedAssets" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsFixedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsFixedAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsLeaseLiability" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsLeaseLiability" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsCapitalizedResearchCosts" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxAssetsCapitalizedResearchCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="DeferredTaxAssetsCapitalizedResearchCosts" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="cyngn-20251231.xsd#cyngn_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="DeferredTaxLiabilitiesRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestatedBalanceSheetAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedBalanceSheetAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestatedBalanceSheetAbstract" xlink:to="srt_CondensedBalanceSheetStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_Liabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_StockholdersEquity" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestatedStatementsOfOperationsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedIncomeStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestatedStatementsOfOperationsAbstract" xlink:to="srt_CondensedIncomeStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementTable" xlink:to="srt_CondensedIncomeStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="WarrantLiabilityIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantLiabilityIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="WarrantLiabilityIssuanceCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="LossOnIssuanceOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedIncomeStatementsCaptionsLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract"/>
    <loc xlink:type="locator" xlink:label="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract" xlink:to="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsPreviouslyReportMember" xlink:href="cyngn-20251231.xsd#cyngn_AsPreviouslyReportMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsPreviouslyReportMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_RestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="RestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" xlink:to="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" xlink:href="cyngn-20251231.xsd#cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestatedStatementOfCashFlowsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementTable" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedCashFlowStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestatedStatementOfCashFlowsAbstract" xlink:to="srt_CondensedCashFlowStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsPreviouslyReportMember" xlink:href="cyngn-20251231.xsd#cyngn_AsPreviouslyReportMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsPreviouslyReportMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementTable" xlink:to="srt_CondensedCashFlowStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="LossOnIssuanceOfWarrants" xlink:href="cyngn-20251231.xsd#cyngn_LossOnIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="LossOnIssuanceOfWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_WarrantIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="WarrantIssuanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" xlink:href="cyngn-20251231.xsd#cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedCashFlowStatementsCaptionsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ScheduleOfBalanceSheetAndCashFlowsAbstract" xlink:href="cyngn-20251231.xsd#cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalanceSheetAndCashFlowsAbstract" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAdjustmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsRestatedMember" xlink:href="cyngn-20251231.xsd#cyngn_AsRestatedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="AsRestatedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AutomobilesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AutomobilesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_AutomobilesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_MachineryAndEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_ComputerEquipmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/DescriptionofBusinessDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionofBusinessDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DescriptionofBusinessDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_DescriptionofBusinessDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract" xlink:to="DescriptionofBusinessDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsTable" xlink:to="DescriptionofBusinessDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrestrictedCashBalance" xlink:href="cyngn-20251231.xsd#cyngn_UnrestrictedCashBalance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="UnrestrictedCashBalance" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_ShortTermInvestments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DescriptionofBusinessDetailsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_AccountsReceivableMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShortTermInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShortTermInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProvisionForOtherCreditLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ProvisionForOtherCreditLosses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AssetImpairmentCharges" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ResearchAndDevelopmentExpenseIncreaseDecrease" xlink:href="cyngn-20251231.xsd#cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="ResearchAndDevelopmentExpenseIncreaseDecrease" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdvertisingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AdvertisingExpense" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfOperatingSegments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RevenueandContractswithCustomersDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenueandContractswithCustomersDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RevenueandContractswithCustomersDetailsLineItems" xlink:href="cyngn-20251231.xsd#cyngn_RevenueandContractswithCustomersDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="RevenueandContractswithCustomersDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsTable" xlink:to="RevenueandContractswithCustomersDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_DeferredCostsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenueandContractswithCustomersDetailsLineItems" xlink:to="us-gaap_Revenues" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/BalanceSheetComponentsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="BalanceSheetComponentsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_BalanceSheetComponentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="BalanceSheetComponentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetComponentsDetailsTable" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_InventoryNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_Depreciation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/OperatingLeasesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesOperatingAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_LeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesOperatingAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IntangibleAssetsNetDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsNetDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IntangibleAssetsNetDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IntangibleAssetsNetDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DevelopedSoftwareMember" xlink:href="cyngn-20251231.xsd#cyngn_DevelopedSoftwareMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="DevelopedSoftwareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsNetDetailsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalvageAndSubrogationRecoveriesValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalvageAndSubrogationRecoveriesValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_SalvageAndSubrogationRecoveriesValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RecapitalizationCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecapitalizationCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_RecapitalizationCosts" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/CapitalStructureDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="CapitalStructureDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CapitalStructureDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="CapitalStructureDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_PrivatePlacementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AtTheMarketEquityFinancingMember" xlink:href="cyngn-20251231.xsd#cyngn_AtTheMarketEquityFinancingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="AtTheMarketEquityFinancingMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrivatePlacementOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_PrivatePlacementOfferingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="PrivatePlacementOfferingMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_PreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockOfferingsMember" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOfferingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStockOfferingsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="srt_RangeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AegisCapitalCorpMember" xlink:href="cyngn-20251231.xsd#cyngn_AegisCapitalCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AegisCapitalCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeriesAWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesAWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesAWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SeriesBWarrantMember" xlink:href="cyngn-20251231.xsd#cyngn_SeriesBWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="SeriesBWarrantMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsMember" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="PreFundedWarrantsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_WarrantMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalStructureDetailsTable" xlink:to="us-gaap_ClassOfStockLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PrefundedWarrantsToPurchaseSharesOfCommonStock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsPricePerShare" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PreFundedWarrantsPricePerShare" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchase" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchase"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="WarrantsToPurchase" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonUnitIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonUnitIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonUnitIssued" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedUnitsAtAPublicOfferingPrice" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedUnitsAtAPublicOfferingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="PrefundedUnitsAtAPublicOfferingPrice" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" xlink:href="cyngn-20251231.xsd#cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="CommissionProceedPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommissionProceedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="CommissionProceedPercentage" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesCommissionsAndFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="StockBasedCompensationExpenseDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_StockBasedCompensationExpenseDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="StockBasedCompensationExpenseDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_PlanNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyOnePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoThousandTwentyOnePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwoThousandTwentyOnePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwentyTwentyOneEquityIncentivePlanMember" xlink:href="cyngn-20251231.xsd#cyngn_TwentyTwentyOneEquityIncentivePlanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="TwentyTwentyOneEquityIncentivePlanMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_EmployeeStockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedCompensationExpenseDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockOutstandingPercentage" xlink:href="cyngn-20251231.xsd#cyngn_CommonStockOutstandingPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="CommonStockOutstandingPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/IncomeTaxesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_AwardDateAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardDateDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoZeroThreeFourMember" xlink:href="cyngn-20251231.xsd#cyngn_TwoZeroThreeFourMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardDateAxis" xlink:to="TwoZeroThreeFourMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_IncomeTaxExaminationLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_OtherExpenses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExaminationLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="CommitmentsandContingenciesDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_CommitmentsandContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsandContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyNatureDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DamagesFromProductDefectsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DamagesFromProductDefectsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_DamagesFromProductDefectsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsandContingenciesDetailsTable" xlink:to="us-gaap_OtherCommitmentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_LossContingencyAccrualPayments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractualObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_ContractualObligation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SettlementAgreementAmount" xlink:href="cyngn-20251231.xsd#cyngn_SettlementAgreementAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="SettlementAgreementAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantsToPurchaseShares" xlink:href="cyngn-20251231.xsd#cyngn_WarrantsToPurchaseShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="WarrantsToPurchaseShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_PaymentsForLegalSettlements" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/SubsequentEventsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SalesAgreementWithAegisCapitalMember" xlink:href="cyngn-20251231.xsd#cyngn_SalesAgreementWithAegisCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="SalesAgreementWithAegisCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="RegisteredDirectOfferingMember" xlink:href="cyngn-20251231.xsd#cyngn_RegisteredDirectOfferingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="RegisteredDirectOfferingMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SalesCommissionsAndFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SalesCommissionsAndFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrefundedWarrantsToPurchaseSharesOfCommonStock" xlink:href="cyngn-20251231.xsd#cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PrefundedWarrantsToPurchaseSharesOfCommonStock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PreFundedWarrantsPricePerShare" xlink:href="cyngn-20251231.xsd#cyngn_PreFundedWarrantsPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="PreFundedWarrantsPricePerShare" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseOfferingCost" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NoninterestExpenseOfferingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_NoninterestExpenseOfferingCost" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:href="cyngn-20251231.xsd#cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:to="srt_RestatementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_ScenarioPreviouslyReportedMember" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" xlink:to="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossOnIssuanceOfWarrant" xlink:href="cyngn-20251231.xsd#cyngn_GainLossOnIssuanceOfWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="GainLossOnIssuanceOfWarrant" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OfferingRelatedIssuanceCosts" xlink:href="cyngn-20251231.xsd#cyngn_OfferingRelatedIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="OfferingRelatedIssuanceCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/Cover" xlink:type="extended"/>
<!-- [WMV6][8ebuLMx0Gm8cMJ2EfKfIFF1lz4FM3ChAfys7STuB0rFdktaIcA2pm5aaoBcRiYnQx78VN7wHxFHuWYS50eQsnqHgmd7LsR/MXGDqD5yK+t3VlBedV/olSprke7/RiAlT4FQk/mgfRmi17BdoiCrZmyD+m0pBWmob+BwQIHiegyMu+S0lYgolNBC+cFMFR8HkrkTeHIkMdIek9nx60SFVLXGzktnxlKEkrihKaAM9Wc69TSqPZ72zy0ih1KZ6VvSaTKlnbU2W7KbgExFsU21+Cb0APZsEx64rrBslG+mRCDpLkLNmKdRlZUggngbHq8JXF6GJtg==] CSR-->
  <presentationLink xlink:role="http://xbrl.sec.gov/dei/role/document/AuditInformation" xlink:type="extended"/>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>19
<FILENAME>cyngn-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Mar 26 20:49:53 UTC 2026 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2025" targetNamespace="http://cyngn.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:cyngn="http://cyngn.com/20251231" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20251231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20251231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20251231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cyngn-20251231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet" id="cyngn_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals" id="cyngn_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedIncomeStatement" id="cyngn_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ShareholdersEquityType2or3" id="cyngn_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals" id="cyngn_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>995305 - Statement - Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ConsolidatedCashFlow" id="cyngn_r_ConsolidatedCashFlow">
        <link:definition>995306 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DescriptionofBusiness" id="cyngn_r_DescriptionofBusiness">
        <link:definition>995307 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPolicies" id="cyngn_r_SummaryofSignificantAccountingPolicies">
        <link:definition>995308 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RevenueandContractswithCustomers" id="cyngn_r_RevenueandContractswithCustomers">
        <link:definition>995309 - Disclosure - Revenue and Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponents" id="cyngn_r_BalanceSheetComponents">
        <link:definition>995310 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/OperatingLeases" id="cyngn_r_OperatingLeases">
        <link:definition>995311 - Disclosure - Operating Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNet" id="cyngn_r_IntangibleAssetsNet">
        <link:definition>995312 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructure" id="cyngn_r_CapitalStructure">
        <link:definition>995313 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders" id="cyngn_r_NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>995314 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpense" id="cyngn_r_StockBasedCompensationExpense">
        <link:definition>995315 - Disclosure - Stock-Based Compensation Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RetirementSavingsPlan" id="cyngn_r_RetirementSavingsPlan">
        <link:definition>995316 - Disclosure - Retirement Savings Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxes" id="cyngn_r_IncomeTaxes">
        <link:definition>995317 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CommitmentsandContingencies" id="cyngn_r_CommitmentsandContingencies">
        <link:definition>995318 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RisksandUncertainties" id="cyngn_r_RisksandUncertainties">
        <link:definition>995319 - Disclosure - Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SubsequentEvents" id="cyngn_r_SubsequentEvents">
        <link:definition>995320 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements" id="cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatements">
        <link:definition>995321 - Disclosure - Restatement of Previously Issued Audited Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/AccountingPoliciesByPolicy" id="cyngn_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables" id="cyngn_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponentsTables" id="cyngn_r_BalanceSheetComponentsTables">
        <link:definition>996002 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/OperatingLeasesTables" id="cyngn_r_OperatingLeasesTables">
        <link:definition>996003 - Disclosure - Operating Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNetTables" id="cyngn_r_IntangibleAssetsNetTables">
        <link:definition>996004 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructureTables" id="cyngn_r_CapitalStructureTables">
        <link:definition>996005 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" id="cyngn_r_NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>996006 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpenseTables" id="cyngn_r_StockBasedCompensationExpenseTables">
        <link:definition>996007 - Disclosure - Stock-Based Compensation Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxesTables" id="cyngn_r_IncomeTaxesTables">
        <link:definition>996008 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables" id="cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsTables">
        <link:definition>996009 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DescriptionofBusinessDetails" id="cyngn_r_DescriptionofBusinessDetails">
        <link:definition>996010 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails" id="cyngn_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996011 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife" id="cyngn_r_SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife">
        <link:definition>996012 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset&#8217;s Estimated Useful Life (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable" id="cyngn_r_ScheduleofPercentagesofTotalRevenueTable">
        <link:definition>996013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RevenueandContractswithCustomersDetails" id="cyngn_r_RevenueandContractswithCustomersDetails">
        <link:definition>996014 - Disclosure - Revenue and Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/BalanceSheetComponentsDetails" id="cyngn_r_BalanceSheetComponentsDetails">
        <link:definition>996015 - Disclosure - Balance Sheet Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofShortTermInvestmentsTable" id="cyngn_r_ScheduleofShortTermInvestmentsTable">
        <link:definition>996016 - Disclosure - Balance Sheet Components - Schedule of Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable" id="cyngn_r_ScheduleofPrepaidExpensesandOtherCurrentAssetsTable">
        <link:definition>996017 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofPropertyandEquipmentTable" id="cyngn_r_ScheduleofPropertyandEquipmentTable">
        <link:definition>996018 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable" id="cyngn_r_ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable">
        <link:definition>996019 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/OperatingLeasesDetails" id="cyngn_r_OperatingLeasesDetails">
        <link:definition>996020 - Disclosure - Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable" id="cyngn_r_ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable">
        <link:definition>996021 - Disclosure - Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofLeaseCostTable" id="cyngn_r_ScheduleofLeaseCostTable">
        <link:definition>996022 - Disclosure - Operating Leases - Schedule of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IntangibleAssetsNetDetails" id="cyngn_r_IntangibleAssetsNetDetails">
        <link:definition>996023 - Disclosure - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable" id="cyngn_r_ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable">
        <link:definition>996024 - Disclosure - Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable" id="cyngn_r_ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable">
        <link:definition>996025 - Disclosure - Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CapitalStructureDetails" id="cyngn_r_CapitalStructureDetails">
        <link:definition>996026 - Disclosure - Capital Structure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable" id="cyngn_r_ScheduleofSecuritiesWarrantsareConvertibleTable">
        <link:definition>996027 - Disclosure - Capital Structure - Schedule of Securities Warrants are Convertible (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofFairValueofWarrantsTable" id="cyngn_r_ScheduleofFairValueofWarrantsTable">
        <link:definition>996028 - Disclosure - Capital Structure - Schedule of Fair Value of Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable" id="cyngn_r_ScheduleofBasicandDilutedLossPerShareTable">
        <link:definition>996029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/StockBasedCompensationExpenseDetails" id="cyngn_r_StockBasedCompensationExpenseDetails">
        <link:definition>996030 - Disclosure - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable" id="cyngn_r_ScheduleofStockOptionsVestedandExercisableTable">
        <link:definition>996031 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable" id="cyngn_r_ScheduleofRestrictedStockUnitsandActivityTable">
        <link:definition>996032 - Disclosure - Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable" id="cyngn_r_ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable">
        <link:definition>996033 - Disclosure - Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/IncomeTaxesDetails" id="cyngn_r_IncomeTaxesDetails">
        <link:definition>996034 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable" id="cyngn_r_ScheduleofDomesticandInternationalPreTaxLossTable">
        <link:definition>996035 - Disclosure - Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable" id="cyngn_r_ScheduleofFederalStatutoryIncomeTaxRateTable">
        <link:definition>996036 - Disclosure - Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" id="cyngn_r_ScheduleofDeferredTaxAssetsandLiabilitiesTable">
        <link:definition>996037 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable" id="cyngn_r_ScheduleofGrossUnrecognizedTaxBenefitsTable">
        <link:definition>996038 - Disclosure - Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/CommitmentsandContingenciesDetails" id="cyngn_r_CommitmentsandContingenciesDetails">
        <link:definition>996039 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/SubsequentEventsDetails" id="cyngn_r_SubsequentEventsDetails">
        <link:definition>996040 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails" id="cyngn_r_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails">
        <link:definition>996041 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable" id="cyngn_r_ScheduleofRestatedBalanceSheetTable">
        <link:definition>996042 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable" id="cyngn_r_ScheduleofRestatedStatementsofOperationsTable">
        <link:definition>996043 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable" id="cyngn_r_ScheduleofRestatedStatementofStockholdersEquityDeficitTable">
        <link:definition>996044 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable" id="cyngn_r_ScheduleofRestatedStatementofCashFlowsTable">
        <link:definition>996045 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable" id="cyngn_r_ScheduleofBalanceSheetandCashFlowsTable">
        <link:definition>996046 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://cyngn.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xs:element name="ScheduleOfPercentagesOfTotalRevenueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract"/>
  <xs:element name="ScheduleOfShortTermInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfShortTermInvestmentsAbstract"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPropertyAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract"/>
  <xs:element name="ScheduleOfSecuritiesWarrantsAreConvertibleAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract"/>
  <xs:element name="ScheduleOfFairValueOfWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfFairValueOfWarrantsAbstract"/>
  <xs:element name="ScheduleOfRestrictedStockUnitsAndActivityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract"/>
  <xs:element name="ScheduleOfFederalStatutoryIncomeTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract"/>
  <xs:element name="ScheduleOfRestatedBalanceSheetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfRestatedBalanceSheetAbstract"/>
  <xs:element name="ScheduleOfRestatedStatementsOfOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract"/>
  <xs:element name="ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract"/>
  <xs:element name="ScheduleOfRestatedStatementOfCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract"/>
  <xs:element name="ScheduleOfBalanceSheetAndCashFlowsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract"/>
  <xs:element name="CashEquivalentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CashEquivalentsAbstract"/>
  <xs:element name="NontaxableOrNondeductibleItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_NontaxableOrNondeductibleItemsAbstract"/>
  <xs:element name="OtherReconcilingItemsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_OtherReconcilingItemsAbstract"/>
  <xs:element name="WarrantLiabilityIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantLiabilityIssuanceCosts"/>
  <xs:element name="LossOnIssuanceOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_LossOnIssuanceOfWarrants"/>
  <xs:element name="StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering"/>
  <xs:element name="ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
  <xs:element name="StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering"/>
  <xs:element name="AccretionOnShorttermInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AccretionOnShorttermInvestments"/>
  <xs:element name="ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts"/>
  <xs:element name="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu"/>
  <xs:element name="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant"/>
  <xs:element name="IssuanceCostsForStockDividendAndRestrictedStockUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits"/>
  <xs:element name="AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation"/>
  <xs:element name="AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses"/>
  <xs:element name="RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock"/>
  <xs:element name="ConcentrationOfSupplierRiskPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ConcentrationOfSupplierRiskPolicyTextBlock"/>
  <xs:element name="CashAndShorttermInvestmentsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock"/>
  <xs:element name="CommonStockWarrantsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockWarrantsPolicyTextBlock"/>
  <xs:element name="CostOfRevenuePolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CostOfRevenuePolicyTextBlock"/>
  <xs:element name="ScheduleOfPropertyAndEquipmentTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock"/>
  <xs:element name="CreditCardPayableCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CreditCardPayableCurrent"/>
  <xs:element name="FiniteLivedIntangibleAssetsFairMarketValueAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment"/>
  <xs:element name="FiniteLivedIntangibleAssetsImpairment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_FiniteLivedIntangibleAssetsImpairment"/>
  <xs:element name="WarrantsAndRightOutstandingMaturityDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantsAndRightOutstandingMaturityDate"/>
  <xs:element name="StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable"/>
  <xs:element name="DeferredTaxAssetsFixedAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsFixedAssets"/>
  <xs:element name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsLeaseLiability"/>
  <xs:element name="DeferredTaxAssetsCapitalizedResearchCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxAssetsCapitalizedResearchCosts"/>
  <xs:element name="DeferredTaxLiabilitiesRightOfUseAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DeferredTaxLiabilitiesRightOfUseAsset"/>
  <xs:element name="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable"/>
  <xs:element name="RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems"/>
  <xs:element name="StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn"/>
  <xs:element name="WarrantIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantIssuanceCosts"/>
  <xs:element name="ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable"/>
  <xs:element name="DescriptionofBusinessDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_DescriptionofBusinessDetailsTable"/>
  <xs:element name="DescriptionofBusinessDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DescriptionofBusinessDetailsLineItems"/>
  <xs:element name="UnrestrictedCashBalance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_UnrestrictedCashBalance"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="ResearchAndDevelopmentExpenseIncreaseDecrease" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease"/>
  <xs:element name="RevenueandContractswithCustomersDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_RevenueandContractswithCustomersDetailsTable"/>
  <xs:element name="RevenueandContractswithCustomersDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RevenueandContractswithCustomersDetailsLineItems"/>
  <xs:element name="BalanceSheetComponentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_BalanceSheetComponentsDetailsTable"/>
  <xs:element name="IntangibleAssetsNetDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_IntangibleAssetsNetDetailsTable"/>
  <xs:element name="CapitalStructureDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_CapitalStructureDetailsTable"/>
  <xs:element name="PrefundedWarrantsToPurchaseSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock"/>
  <xs:element name="PreFundedWarrantsPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PreFundedWarrantsPricePerShare"/>
  <xs:element name="WarrantsToPurchase" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantsToPurchase"/>
  <xs:element name="PrefundedUnitsAtAPublicOfferingPrice" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PrefundedUnitsAtAPublicOfferingPrice"/>
  <xs:element name="IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares"/>
  <xs:element name="CommissionProceedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommissionProceedPercentage"/>
  <xs:element name="StockBasedCompensationExpenseDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_StockBasedCompensationExpenseDetailsTable"/>
  <xs:element name="CommonStockOutstandingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockOutstandingPercentage"/>
  <xs:element name="IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_IncomeTaxesDetailsTable"/>
  <xs:element name="CommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_CommitmentsandContingenciesDetailsTable"/>
  <xs:element name="SettlementAgreementAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SettlementAgreementAmount"/>
  <xs:element name="WarrantsToPurchaseShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantsToPurchaseShares"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_SubsequentEventsDetailsTable"/>
  <xs:element name="RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable"/>
  <xs:element name="GainLossOnIssuanceOfWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_GainLossOnIssuanceOfWarrant"/>
  <xs:element name="OfferingRelatedIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cyngn_OfferingRelatedIssuanceCosts"/>
  <xs:element name="AegisCapitalCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AegisCapitalCorpMember"/>
  <xs:element name="AsPreviouslyReportMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AsPreviouslyReportMember"/>
  <xs:element name="AsRestatedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AsRestatedMember"/>
  <xs:element name="AtTheMarketEquityFinancingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_AtTheMarketEquityFinancingMember"/>
  <xs:element name="BlackScholesModelMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_BlackScholesModelMember"/>
  <xs:element name="CommonStockOfferingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CommonStockOfferingsMember"/>
  <xs:element name="CustomerAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CustomerAMember"/>
  <xs:element name="CustomerBMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CustomerBMember"/>
  <xs:element name="CustomerCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CustomerCMember"/>
  <xs:element name="CustomerDMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CustomerDMember"/>
  <xs:element name="CustomerEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_CustomerEMember"/>
  <xs:element name="DevelopedSoftwareMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DevelopedSoftwareMember"/>
  <xs:element name="InitialPublicOfferingWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_InitialPublicOfferingWarrantsMember"/>
  <xs:element name="MachineToolsAndEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_MachineToolsAndEquipmentMember"/>
  <xs:element name="MonteCarloPricingModelMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_MonteCarloPricingModelMember"/>
  <xs:element name="OtherPermanentDifferencesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_OtherPermanentDifferencesMember"/>
  <xs:element name="PreFundedWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PreFundedWarrantsMember"/>
  <xs:element name="PrivatePlacementOfferingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PrivatePlacementOfferingMember"/>
  <xs:element name="PrivatePlacementWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_PrivatePlacementWarrantsMember"/>
  <xs:element name="RegisteredDirectOfferingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RegisteredDirectOfferingMember"/>
  <xs:element name="RestatedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_RestatedMember"/>
  <xs:element name="SalesAgreementWithAegisCapitalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SalesAgreementWithAegisCapitalMember"/>
  <xs:element name="Section162mLimitationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_Section162mLimitationMember"/>
  <xs:element name="SeriesAWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SeriesAWarrantMember"/>
  <xs:element name="SeriesAWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SeriesAWarrantsMember"/>
  <xs:element name="SeriesBWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SeriesBWarrantMember"/>
  <xs:element name="SeriesBWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_SeriesBWarrantsMember"/>
  <xs:element name="TestingEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TestingEquipmentMember"/>
  <xs:element name="TwentyTwentyOneEquityIncentivePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TwentyTwentyOneEquityIncentivePlanMember"/>
  <xs:element name="TwoThousandTwentyOnePlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TwoThousandTwentyOnePlanMember"/>
  <xs:element name="TwoZeroThreeFourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_TwoZeroThreeFourMember"/>
  <xs:element name="WarrantRevaluationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_WarrantRevaluationMember"/>
<!-- [WMV6][Vzky0rKVcGMKJqEtXYe/GJETcoB/TYQ8+I26zUUZse0EEXhDNAqcUqrWN/nPgxbw+wT/Vabe3sSmX00ePNsZ3PZnqiU+bobpuTn0uK1D/sP/ENGdHkGKCjNREZFERkMKVFtWvjl67zVSaTjTU98DatoKMbyNiUMsM+02YdpNKZrkkOagGFYb8BjsEvOuLdeJAz6ld2YFP2PqIlAkc0A1YYGQyLzU8kfKZEUm+lzORggu6oTYxn/dNJMqEYGDwvWC0cQCwmFiuOCGXOlRD6WqINs39BPJiY2u2dpVHS2HPixD9i9mCPjCgrMSfZV/KAW/esRpCmE=] CSR-->
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cyngn_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 26, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">None</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYNGN INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001874097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2007094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,365,430.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1344 Terra Bella Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">924-5905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,608,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">CBIZ
CPAs P.C.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheet of CYNGN Inc. (the &#8220;Company&#8221;) as of December 31, 2025, the related consolidated statements of operations, stockholders&#8217;
equity and cash flows for the year ended December 31, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles
generally accepted in the United States of America.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 990,023<span></span>
</td>
<td class="nump">$ 23,617,733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">33,736,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and other receivables</a></td>
<td class="nump">1,544,213<span></span>
</td>
<td class="nump">1,222,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">2,039,655<span></span>
</td>
<td class="nump">150,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,518,430<span></span>
</td>
<td class="nump">592,090<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">TOTAL CURRENT ASSETS</a></td>
<td class="nump">39,828,412<span></span>
</td>
<td class="nump">25,582,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>NON-CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,268,196<span></span>
</td>
<td class="nump">2,319,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">5,971,800<span></span>
</td>
<td class="nump">297,918<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">466,223<span></span>
</td>
<td class="nump">1,895,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security Deposit</a></td>
<td class="nump">518,584<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">50,053,215<span></span>
</td>
<td class="nump">30,095,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">217,439<span></span>
</td>
<td class="nump">247,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,658,015<span></span>
</td>
<td class="nump">769,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">2,615,734<span></span>
</td>
<td class="nump">2,105,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liability</a></td>
<td class="nump">312,365<span></span>
</td>
<td class="nump">317,344<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">TOTAL CURRENT LIABILITIES</a></td>
<td class="nump">4,803,553<span></span>
</td>
<td class="nump">3,439,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liability</a></td>
<td class="nump">6,495,256<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">27,703,927<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">11,298,809<span></span>
</td>
<td class="nump">31,143,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS&#8217; EQUITY (DEFICIT)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, Par $0.00001; 400,000,000 and 200,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 7,974,380 and 199,110 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">255,576,797<span></span>
</td>
<td class="nump">192,305,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(216,822,471)<span></span>
</td>
<td class="num">(193,353,198)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL STOCKHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="nump">38,754,406<span></span>
</td>
<td class="num">(1,047,916)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</a></td>
<td class="nump">$ 50,053,215<span></span>
</td>
<td class="nump">$ 30,095,349<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in Shares)</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in Shares)</a></td>
<td class="nump">7,974,380<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in Shares)</a></td>
<td class="nump">7,974,380<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">REVENUE</a></td>
<td class="nump">$ 218,976<span></span>
</td>
<td class="nump">$ 368,138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">135,749<span></span>
</td>
<td class="nump">535,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">12,468,687<span></span>
</td>
<td class="nump">11,259,641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">13,302,781<span></span>
</td>
<td class="nump">11,400,864<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">TOTAL COSTS AND EXPENSES</a></td>
<td class="nump">25,907,217<span></span>
</td>
<td class="nump">23,196,213<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">LOSS FROM OPERATIONS</a></td>
<td class="num">(25,688,241)<span></span>
</td>
<td class="num">(22,828,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>OTHER INCOME (EXPENSE), NET</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">197,429<span></span>
</td>
<td class="num">(1,117,546)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantLiabilityIssuanceCosts', window );">Warrant liability issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,739,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="nump">1,136,677<span></span>
</td>
<td class="num">(5,359,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,344,147)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">884,862<span></span>
</td>
<td class="nump">53,117<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">TOTAL OTHER INCOME (EXPENSE), NET</a></td>
<td class="nump">2,218,968<span></span>
</td>
<td class="num">(10,507,504)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET LOSS</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in Dollars per share)</a></td>
<td class="num">$ (5.17)<span></span>
</td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in Dollars per share)</a></td>
<td class="num">$ (5.17)<span></span>
</td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)</a></td>
<td class="nump">4,540,481<span></span>
</td>
<td class="nump">13,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares)</a></td>
<td class="nump">4,540,481<span></span>
</td>
<td class="nump">13,221<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantLiabilityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantLiabilityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders&#8217; Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 170,652,808<span></span>
</td>
<td class="num">$ (160,017,619)<span></span>
</td>
<td class="nump">$ 10,635,189<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of at-the-market common stock, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,789,427<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,789,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of at-the-market common stock, net of issuance costs (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Exercise of stock options and vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(597)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(597)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Exercise of stock options and vesting of restricted stock units (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering', window );">Issuance of common stock in connection with the public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">12,414,451<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,414,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering', window );">Issuance of common stock in connection with the public offering (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">189,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,449,191<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,449,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(33,335,579)<span></span>
</td>
<td class="num">(33,335,579)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">192,305,280<span></span>
</td>
<td class="num">(193,353,198)<span></span>
</td>
<td class="num">(1,047,916)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">199,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Issuance of at-the-market common stock, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">5,472,691<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,472,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Issuance of at-the-market common stock, net of issuance costs (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">935,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering', window );">Reclassification of Series A warrants to equity in connection with the public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,634,428<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,634,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Exercise of Series B warrants in connection with the public offering, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">18,931,781<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,931,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Exercise of Series B warrants in connection with the public offering, net of issuance costs (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,552,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Exercise of stock options and vesting of restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Exercise of stock options and vesting of restricted stock units (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering', window );">Issuance of common stock in connection with the public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">29,611,625<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,611,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering', window );">Issuance of common stock in connection with the public offering (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,287,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,620,992<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,620,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(23,469,273)<span></span>
</td>
<td class="num">(23,469,273)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 255,576,797<span></span>
</td>
<td class="num">$ (216,822,471)<span></span>
</td>
<td class="nump">$ 38,754,406<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,974,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of pre-funded warrants in connection with the public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of pre-funded warrants in connection with the public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Series A warrants to equity and exercise of Series B warrants in connection with the public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parentheticals) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 03, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,572<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net of offering costs</a></td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 1,864,594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,189,794<span></span>
</td>
<td class="nump">669,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,620,992<span></span>
</td>
<td class="nump">2,449,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized gain on short-term investments</a></td>
<td class="num">(85,117)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_AccretionOnShorttermInvestments', window );">Accretion on short-term investments</a></td>
<td class="num">(776,163)<span></span>
</td>
<td class="num">(113,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss on disposed assets</a></td>
<td class="nump">16,607<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Patent impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">118,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="num">(1,136,677)<span></span>
</td>
<td class="nump">5,359,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecapitalizationCosts', window );">Change in estimate of capitalized software</a></td>
<td class="nump">1,425,689<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantLiabilityIssuanceCosts', window );">Warrant liability issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,739,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,344,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Accretion of interest and amortization of debt issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,177,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and other receivables</a></td>
<td class="num">(321,322)<span></span>
</td>
<td class="num">(452,006)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(1,889,414)<span></span>
</td>
<td class="num">(150,241)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses, operating lease right-of-use assets, and other current assets</a></td>
<td class="num">(1,421,910)<span></span>
</td>
<td class="num">(44,035)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(30,339)<span></span>
</td>
<td class="nump">50,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">888,834<span></span>
</td>
<td class="num">(667,680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses, lease liabilities, and other current liabilities</a></td>
<td class="nump">411,643<span></span>
</td>
<td class="nump">1,658,037<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH USED IN OPERATING ACTIVITIES</a></td>
<td class="num">(23,576,656)<span></span>
</td>
<td class="num">(19,196,081)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,230,536)<span></span>
</td>
<td class="num">(1,051,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible asset</a></td>
<td class="num">(29,061)<span></span>
</td>
<td class="num">(954,229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Disposal of assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">265,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(87,387,311)<span></span>
</td>
<td class="num">(7,562,761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">54,512,501<span></span>
</td>
<td class="nump">12,237,761<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES</a></td>
<td class="num">(34,134,407)<span></span>
</td>
<td class="nump">2,935,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts', window );">Proceeds from at-the-market equity financing, net of issuance costs</a></td>
<td class="nump">5,472,701<span></span>
</td>
<td class="nump">6,789,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu', window );">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants, net of issuance costs</a></td>
<td class="nump">29,611,677<span></span>
</td>
<td class="nump">13,811,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant', window );">Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</a></td>
<td class="num">(1,025)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">18,260,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from the Notes, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,801,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of the Notes</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4,375,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits', window );">Issuance costs for stock dividend and restricted stock units</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">35,083,353<span></span>
</td>
<td class="nump">36,286,961<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(22,627,710)<span></span>
</td>
<td class="nump">20,026,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of year</a></td>
<td class="nump">23,617,733<span></span>
</td>
<td class="nump">3,591,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of year</a></td>
<td class="nump">990,023<span></span>
</td>
<td class="nump">23,617,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest and taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation', window );">Acquisition of right-of-use asset in exchange for new operating lease obligation</a></td>
<td class="nump">6,589,332<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses', window );">Acquisition of property and equipment included in accounts payable and accrued expenses</a></td>
<td class="nump">$ 1,875<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_AccretionOnShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion on short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_AccretionOnShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition of property and equipment included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition of right-of-use asset in exchange for new operating lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issuance costs for stock dividend and restricted stock units .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from at-the-market equity financing, net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public issuance of common stock and pre-funded warrants .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants net of issuance costs .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantLiabilityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantLiabilityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480095/942-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480035/942-10-S99-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecapitalizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecapitalizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract', window );"><strong>Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cyngn Inc., together with its subsidiary (collectively,
&#8220;Cyngn&#8221; or the &#8220;Company&#8221;), was incorporated in Delaware in 2013. Our wholly owned subsidiary, Cyngn Singapore
PTE. LTD., is a Singaporean limited company organized in 2015. The Company is headquartered in Mountain View, CA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cyngn develops and deploys scalable, differentiated
autonomous vehicle technology for industrial organizations. Our full-stack autonomous driving software, (&#8220;DriveMod&#8221;), can
be integrated onto vehicles manufactured by Original Equipment Manufacturers (&#8220;OEM&#8221;) by integration directly into vehicle
assembly. The Enterprise Autonomy Suite (&#8220;EAS&#8221;) is designed to be compatible with sensors and components from leading hardware
technology providers and integrate our proprietary Autonomous Vehicle (&#8220;AV&#8221;) software to produce differentiated autonomous
vehicles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been operating autonomous vehicles
in production environments and in 2023 began licensing EAS commercially. Built and tested in difficult and diverse real-world environments,
DriveMod, the fleet management system and our proprietary Software Development Kit (&#8220;DriveMod Kit&#8221;) combine to create a full-stack
advanced autonomy solution designed to be modular, extendable, and safe. The Company operates in one business segment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 25, 2024, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024. On January 30, 2025, the
Company&#8217;s stockholders voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding
shares of common stock within a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company&#8217;s Board of Directors determined
to effect the reverse stock split of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February
18, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All share and per share amounts and exercise prices
of stock options and warrants in the accompanying consolidated financial statements and notes to the consolidated financial statements
have been retroactively adjusted to reflect the reverse stock splits for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has incurred losses from operations
since inception. The Company incurred net losses of approximately $23.5 million and $33.3 million for the years ended December 31, 2025
and 2024, respectively. Accumulated deficit amounted to approximately $216.8 million and $193.4 million as of December 31, 2025 and December
31, 2024, respectively. Net cash used in operating activities was approximately $23.6 million and $19.2 million for the year ended December
31, 2025 and 2024, respectively.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s liquidity is based on its
ability to increase its operating cash flow position, obtain capital financing from equity interest investors and borrow money to fund
its general operations, research and development activities, and capital expenditures. As of December 31, 2025, the Company&#8217;s unrestricted
cash and cash equivalents balance was approximately $1.0 million and short-term investments of approximately $33.7 million. As of December
31, 2024, the Company&#8217;s cash and cash equivalents balance was approximately $23.6 million and no short-terms investments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on cash flow projections from operating,
investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the
Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations and related
commitments for the 12 months following the date these consolidated financial statements were issued.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Summary of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
as of and for the years ended December 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted
in the United States (&#8220;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
The consolidated financial statements include all normal adjustments necessary for a fair presentation of the Company&#8217;s financial
position at December 31, 2025 and 2024, and operating results and cash flows for the periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Foreign Currency Translation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency for Cyngn
is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar
at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated
at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the consolidated
financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements
in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported
amounts of revenue and expenses during the reporting period. The Company&#8217;s significant estimates and judgments include but are not
limited to internal-use software, warrants and share-based compensation. Management bases its estimates on historical experience and on
various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. Actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period balances for the consolidated
financial statement for December 31, 2024 have been reclassified to conform with the current year presentation. These reclassifications
relate to inventory and accounts and other receivables that were previously presented as prepaid expenses and other current assets, as
well as deferred revenue that was previously presented as accrued expenses and other current liabilities. These reclassifications had
no impact on previously reported net loss, total assets, or total shareholders&#8217; equity.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times
exceeds federally insured limits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions
generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its
deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Supplier Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company generally utilizes suppliers for outside
development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of December
31, 2025 and December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Short-term Investments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers its bank accounts and all highly liquid investments
that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of December
31, 2025 and December 31, 2024, the Company had approximately $1.0 million of cash and $33.7 million in short-term investments and $23.6
million of cash and no short-term investments, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers short-term investments to include marketable
U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government
treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;)
Accounting Standards Codification Topic (&#8220;ASC&#8221;) 320, Investments - Debt and Equity Securities<i>,</i> and recorded these securities
at amortized cost on the accompanying consolidated balance sheets as of December 31, 2025 and December 31, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Accounts and Other Receivable </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivables are recorded at the invoiced
amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status
of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was zero as of December 31,
2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic
conditions in order to determine expected trade credit losses on a prospective basis. <span style="-sec-ix-hidden: hidden-fact-79"><span style="-sec-ix-hidden: hidden-fact-80">No</span></span> credit losses were recorded as of December 31,
2025 and December 31, 2024. Other receivables primarily consist of Employee Retention Credit (&#8220;ERC&#8221;) claims related to 2020
and 2021.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting guidance under ASC Topic 820, Fair
Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major
asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price
representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the following fair value hierarchy
prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 1-Unadjusted quoted prices in
active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 2-Observable inputs other than
Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 3-Unobservable inputs that are
supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities are considered to be fair
valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily
result in a change in the amount recorded on the consolidated balance sheets, assets and liabilities are considered to be fair valued
on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of
cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value
on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon
initial recognition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of the Company&#8217;s cash
and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company&#8217;s
share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models
derived from independent external valuations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventory</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory consists of autonomous vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated
with the Company&#8217;s proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software and sold to customers as part of a fully integrated
autonomous vehicle solution. Substantially all assembly and integration activities are performed by third-party suppliers prior to receipt;
therefore, the Company classifies its inventory as finished goods and does not maintain separate classifications for raw materials or
work in process.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, and the Company is able to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br/>
The Company periodically reviews inventory for excess quantities, obsolescence, or other indicators that the carrying value may not be
recoverable. If the carrying value of inventory exceeds its net realizable value, the Company records a write-down to net realizable value,
with the adjustment recognized in cost of goods sold.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost less
accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the
Company&#8217;s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date
depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over
each asset&#8217;s estimated useful life. Repair and maintenance costs are expensed as incurred.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left">Property and Equipment</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center">Useful life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Automobiles (DMV-registered)</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computers and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal-use software</td><td>&#160;</td> <td style="text-align: center">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: center">7 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Leasehold improvements</td><td>&#160;</td> <td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-73">Shorter of 3 years or lease term</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for leases in accordance with ASC 842, Leases.
All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified
asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance
in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the consolidated
balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office
space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining
term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurs costs related to internally
developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Internal-Use Software costs</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined when to capitalize its
internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the
software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized
based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in
estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing
the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining
the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs,
as well as subscription server and consulting costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal-use software is classified as property
and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved
in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and
ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development
phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes
in circumstances occur that could impact the recoverability of these assets. <span style="-sec-ix-hidden: hidden-fact-81"><span style="-sec-ix-hidden: hidden-fact-82">No</span></span> impairment charges were associated with the Company&#8217;s
internal-use software for the years ended December 31, 2025 and 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software to be Sold, Leased
or Otherwise Marketed </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for research costs of computer
software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once
technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred
to develop functionality for the Company&#8217;s software and internally built software platforms, as well as certain upgrades and enhancements
that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility
of a product is established. Management has determined that technological feasibility is established when a working model is complete.
After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation
costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the
product or enhancement is available for general release to customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer software to be sold, leased or otherwise
marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount
computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that
product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated
economic life of the product, not to exceed three years to five years and recorded as cost of revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2025, management
completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company revised its estimate regarding the point at
which technological feasibility is achieved for software development activities. This change in estimate was made to reflect management&#8217;s
current expectations about the timing and certainty of future technological milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in estimate was accounted for prospectively in accordance
with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements. For the
year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally capitalized in 2024 and $1.2
million related to costs capitalized during the first two quarters of 2025 as research and development expense resulting from this change.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Long-Lived Assets and Finite Lived Intangibles</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has finite-lived intangible assets
consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives.
The patents and trademarks are amortized over 15 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets and
finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant
adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation
of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The
Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted
cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term
undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being
evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the
asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also identified that the long-lived
asset &#8220;Patents&#8221;, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and
identified expired international patent applications (&#8220;expired assets&#8221;) for the year ended December 31, 2024. The Company
determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying
value was set to its salvage value which is zero given no future cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2024, the Company
determined the existence of an impairment associated with the Company&#8217;s intangible asset &#8220;Patents&#8221; and accordingly recorded
an impairment charge of $118,831 (see Note 6. Intangible Assets). For the year ended December 31, 2025, there were <span style="-sec-ix-hidden: hidden-fact-83">no</span> impairment charges.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using the
asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A valuation allowance is provided when it is more
likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#8217;s lack of earnings history,
the net deferred tax assets have been fully offset by a valuation allowance as of December 31, 2025 and December 31, 2024 (see Note 11.
Income Taxes).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no uncertain tax positions that would
require recognition in the consolidated financial statements. If the Company were to incur an income tax liability in the future, interest
on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management&#8217;s
conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of
or changes in tax laws, regulations and interpretations thereof as well as other factors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). ASU 2023-09 expands the annual disclosure
requirements for income taxes, primarily related to the rate reconciliation and income taxes paid. The Company has adopted this guidance
on a prospective basis, which did not have a significant impact on the Company&#8217;s consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issued to its lead underwriter in
the Company&#8217;s IPO warrants to purchase up to 9 shares of the Company&#8217;s common stock. In addition, the Company issued 426 common
stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants
as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also applied the guidance in ASC 340-10-S99-1, Other Assets
and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities
may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as
directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The Company issued Series A warrants and Series B warrants in connection
with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company&#8217;s warrant
agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable.
The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in
consideration of the variable number of the issuer&#8217;s equity shares in the warrant agreements. The resulting warrant liabilities
are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company&#8217;s
consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and
the number of equity shares are now fixed. The Company concluded that these warrants are indexed to the Company&#8217;s own stock, require
settlement in a fixed number of shares, and do not contain provisions that could require net cash settlement or settlement in a variable
number of shares. Additionally, the warrant agreements do not include provisions that would require the Company to transfer assets. Accordingly,
the warrants meet the criteria for equity classification. Therefore, in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification
of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants
are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the
Black Scholes model immediately before exercise and were fully exercised in February 2025 (see Note 7. Capital Structure).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes the cost of share-based
awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line
basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost
and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair
value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price
volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation
Expense<b>)</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net Loss Per Share Attributable to Common Stockholders</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes loss per share attributable
to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding.
Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised
into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only
if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see
Note 8. Net Loss per Share Attributable to Common Stockholders).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development Expense</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses consists primarily
of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company
personnel involved in the development of the Company&#8217;s products and services, and allocated lease costs based on the approximate
square footage area used in research and development activities. Research and development costs are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and Administrative Expense</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expense consist primarily of personnel costs,
facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance
with ASC 720-35, Other Expense - Advertising Costs, other than trade show expenses which are deferred until occurrence of the future event.
<i>&#160;</i>Advertising costs for the years ended December 31, 2025 and 2024 were $512,017 and $237,396, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Commitments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes a liability with regard to loss contingencies
when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of
loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount
within the range is a better estimate than any other amount the Company accrues the minimum amount in the range (see Note 12. Commitments
and Contingencies).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Segment Reporting</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates as one operating segment.
The Company&#8217;s <span style="-sec-ix-hidden: hidden-fact-78">chief operating decision maker</span> is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources, making
operating decisions and evaluating financial performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The one operating segment generates revenues from
subscriptions to its Enterprise Autonomy Service (&#8220;EAS&#8221;), product sales or leases of hardware, and other professional services
(i.e., deployment costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent
phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod
software, and demonstrations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the Company&#8217;s one segment, the executive
management team use revenue and net loss to allocate resources, both reported on the Consolidated Statement of Operations as Revenue and
Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to
evaluate the Company&#8217;s performance, establish compensation, monitor budget versus actual results, and decide the level of investment
in various operating activities and other capital allocation activities. The measure of segment assets is reported on the Consolidated
Balance Sheet as Total assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenue in accordance
with ASC 606, Revenue from Contracts with Customers. <span style="font-style: normal; font-weight: normal">The Company generates revenue
from vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated with the Company&#8217;s
proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software, or leases of hardware, and other professional services. These offerings
are highly interdependent and integrated to provide customers with a fully functional autonomous industrial vehicle solution. Because
these components are not separately identifiable from one another in the context of the contract, the Company accounts for these combined
goods and services as a single performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: normal"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General Recognition Principle.</i> The Company
recognizes revenue when control of the combined autonomous vehicle and software solution is transferred to the customer in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for the goods and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Method of Measuring Progress. </i>Revenue associated
with the Company&#8217;s integrated autonomous vehicle solution is generally recognized over time because the customer simultaneously
receives and consumes the benefits provided by the Company&#8217;s performance as the services are performed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures progress toward satisfaction
of the performance obligation using an output method based on the passage of time, recognizing revenue ratably over the contractual term,
which is typically three years. In accordance with ASC 606-10-55-17 through 55-18, the output method reflects the pattern in which control
of the promised goods and services is delivered to the customer, who receives continuous access to the integrated autonomous vehicle functionality,
including the software-enabled operation, monitoring, updates, and support necessary for the system to function as intended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management believes that recognizing revenue on
a straight-line basis over the contract period faithfully depicts the Company&#8217;s performance in transferring control of the integrated
solution, as the customer receives and consumes the benefits of the solution evenly throughout the contract term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Payment Terms.</i> Payment terms vary by customer
and contract but generally do not exceed 90 days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Discounts.</i> The Company may offer pricing
discounts to certain customers, primarily to establish relationships with new customers. These discounts are reflected in the contractual
transaction price at contract inception. Revenue is recognized based on the discounted contract price and is accounted for in the same
manner as other contracts. The Company recognizes revenue from these arrangements ratably over the contract term, consistent with the
pattern in which the customer receives and consumes the benefits of the integrated autonomous vehicle solution.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stand-Alone Selling prices</i>. The Company
also applies judgment in estimating stand-alone selling prices when allocating the transaction price to performance obligations. Stand-alone
selling prices are generally determined based on observable prices when available or, when not directly observable, are estimated using
management&#8217;s assessment of expected pricing for similar goods and services and market conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Material Rights and Renewal Options.</i> The Company&#8217;s contracts
with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material
right, and therefore represent a separate performance obligation, requires judgment. The Company evaluates the pricing of each option
to determine whether it reflects the stand-alone selling price for the underlying goods or services or whether it provides the customer
with a discount that would not be available without entering into the initial contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In certain legacy customer contracts, the Company
has provided customers with the option to extend the contract term for an additional one-year period. Management evaluates these renewal
provisions to determine whether they provide a material right by comparing the renewal pricing to the expected stand-alone selling price
of the services at the time of renewal. This assessment requires judgment and includes consideration of expected pricing for similar services,
historical pricing practices, and market conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a material right exists, the Company allocates a portion of the
transaction price to the option and recognizes the related revenue when the option is exercised or expires.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Significant financing component.</i> In certain
arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company&#8217;s
contracts with customer prepayment terms do not include a significant financing component because the prepayment terms are designed to
provide customers with contractual protections and billing convenience, not to provide financing to the customer or receive financing
from the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Contract modifications. </i>The Company may modify contracts to
offer customers additional products or services. Each of the additional products and services is evaluated to determine whether it is
distinct from the goods or services transferred prior to the modification. The Company evaluates whether the contract price for the additional
products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these
cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification
does not reflect the stand-alone selling price for the modified goods or services, the Company accounts for the modification either (i)
on a prospective basis if the remaining goods and services are distinct from those already transferred, or (ii) on a cumulative catch-up
basis if the remaining goods and services are not distinct from those already transferred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Principal vs. Agent Considerations</i>. Judgment
is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation
of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., &#8220;gross&#8221;),
or we arrange for other parties to provide the service to the end-user and are an agent (i.e., &#8220;net&#8221;). In making this determination,
the Company considers several factors, including whether the Company is primarily responsible for fulfilling the promise to provide the
specified goods or services, bears inventory risk before the goods are transferred, and has discretion in establishing pricing for the
specified goods or services. This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts
and promotions offered to end-users to the extent they are not customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer transactions where the Company&#8217;s
role is to supply hardware to the dealer, the Company does not obtain control of the hardware before it is transferred to the end-user
and is not primarily responsible for the dealer&#8217;s fulfillment to end-users. Accordingly, hardware revenue in these arrangements
is recorded on a net basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer and OEM transactions where our role
is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription
revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Cost to Obtain a Contract. </i>The Company capitalizes incremental
costs incurred to obtain contracts, principally sales commissions and third-party referral fees. These costs are amortized on a straight-line
basis over the contractual term and recognized in general and administrative expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Costs to Fulfill a Contract</i>. The Company capitalizes such costs
when they are (i) incremental to obtaining that specific contract, (ii) expected to be recovered, and (iii) subject to an amortization
period exceeding one year. Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which
corresponds to the contractual term, and are recognized in cost of revenue. The Company evaluates capitalized fulfillment costs for impairment
at each reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Deferred contract costs totaled $767,007 and $120,793 as of December
31, 2025 and 2024, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. Amortization
of deferred contract costs recognized in cost of revenue during the years ended December 31, 2025 and 2024 was $106,480 and $21,413, respectively.
No impairment losses were recognized in either period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Taxes collected from customers</i>. The Company
collects and remits certain taxes assessed by governmental authorities on its revenue transactions, including sales, use, value-added,
and excise taxes. These taxes are presented on a net basis and excluded from reported revenue. Shipping and handling fees billed to customers
are included in net sales; the related costs are included in cost of revenue.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Judgments and estimates. </i>Accounting for contracts recognized over time requires judgment in
estimating the transaction price, the measure of progress, and expected contract costs. Due to uncertainties
inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the
near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Below 10%</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was $209,452 from these customers in accounts
receivable as of December 31, 2025 and $274,699 from these customers in accounts receivable as of December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cost of Revenue </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue consists primarily of direct labor
and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the
contracts and hardware costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recent Accounting Standards</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation
of Income Statement Expenses,&#8221; which requires the disaggregated disclosure of certain income statement items. ASU 2024-03 is effective
for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted.
The Company has not adopted this standard early and is currently evaluating the impact of this amendment on its consolidated financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue and Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue and Contracts with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue and Contracts with Customers</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. Revenue and Contracts with Customers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Contract Balances</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Timing differences between revenue recognized, billings, and customer
payments result in contract assets and contract liabilities. Contract assets represent revenue recognized in excess of amounts billed
to customers. Contract liabilities represent payments received from customers in advance of satisfying the related performance obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&#8217;s contract balances consist primarily of accounts receivable
and deferred revenue (contract liabilities). Accounts receivable represents the Company&#8217;s unconditional rights to consideration
for goods and services transferred to customers. Contract liabilities represent amounts billed or collected in advance of satisfying performance
obligations and are recognized as revenue as the related performance obligations are satisfied. As of December 31, 2025 and 2024, deferred
revenue related to tugger sales totaled $1,658,015 and $769,180, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognized from Prior Period Contract
Liabilities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2025 and 2024,
the Company recognized revenue of $128,387 and $1,500, respectively, that was included in deferred revenue at the beginning of each respective
period. The Company did not recognize material revenue during the periods presented from performance obligations satisfied (or partially
satisfied) in prior periods other than amounts previously included in deferred revenue.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Remaining Performance Obligations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the remaining performance
obligations on existing contracts are $1,658,015, approximately 25% of which is expected to be recognized in 2026, 36% in 2027, 28% in
2028, and the remainder thereafter. This amount corresponds to the Company&#8217;s contract liability balance as of December 31, 2025,
as all remaining obligations relate to the passage of time on active contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2025 and 2024,
revenue was $218,976 and $368,138, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. Balance Sheet Components</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Financial Instruments</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Funds in the Company&#8217;s investment brokerage
account were held in cash equivalents, consisting of a money market account, along with short-term investments consisting of U.S. government
treasury bills, which are accounted for as held-to-maturity (&#8220;HTM&#8221;) securities, and classified as Level 1 in the hierarchy
of fair value measurements. HTM securities are carried at amortized cost and, as a result, are not remeasured to fair value on a recurring
basis. All of the Company&#8217;s short-term investments will mature within one year of December 31, 2025. The Company does not expect
a credit loss for its short-term investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2025</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2024</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Financial assets</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash equivalents:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Money market account</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">929,165</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">23,274,834</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term investments:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S. government treasury bills</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">33,736,091</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 9.25pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">34,665,255</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">23,274,834</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventory</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, allowing the Company to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.</p>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2025 and 2024, inventory totaled $2.0 million and
$0.2 million, respectively.</p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Prepaid expenses and other current assets</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses and other current assets are comprised of the following:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid Expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">668,090</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">303,803</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,006</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,149</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">775,334</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128,138</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total prepaid and expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,518,430</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">592,090</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment were reclassified to better
reflect their appropriate categories within the fixed asset register. These reclassifications did not have a significant impact on the
overall asset values or depreciation expense. Property and equipment is comprised of the following:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Automobiles (DMV-registered)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">28,862</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">128,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">692,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">660,155</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,552</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">389,007</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Capitalized software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,592,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">950,832</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,182</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,417</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221,977</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Testing equipment (Work in Progress)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">896,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">687,986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9.25pt">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,947,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,105,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(678,827</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(785,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,268,196</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,319,402</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense for the years ended December
31, 2025 and 2024 was $234,909 and $214,494, respectively.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Payable </i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts payable includes independent director
fees payable of $42,500 and $28,333 as of December 31, 2025 and 2024, respectively.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Deferred Revenue</i></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred revenue consists primarily of amounts
billed to customers for tugger sales and related services for which revenue has not yet been recognized. Revenue is recognized as the
Company satisfies its performance obligations in accordance with its revenue recognition policy.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, deferred revenue
related to tugger sales totaled $1,658,015 and $769,180, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accrued Expenses and Other Current Liabilities</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses and other current liabilities
are comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,169</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,050</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">788,948</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,035,795</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,314,038</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,615,734</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,105,036</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Operating Leases</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating lease right-of-use assets and lease
liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments
consist of the fixed payments under the arrangement, less any lease incentives, such as tenant improvement allowances. Variable costs,
such as maintenance and utilities based on actual usage, are not included in the measurement of right-of-use (&#8220;ROU&#8221;) assets
and lease liabilities but are expensed when the event determining the amount of variable consideration to be paid occurs. As the implicit
rate of the leases is not determinable, the Company uses an incremental borrowing rate (&#8220;IBR&#8221;) based on the information available
at the lease commencement date in determining the present value of lease payments. Rather than relying on a single rate source, the Company
evaluated three data points calculated from the three standard methods to determine a reasonable, supportable, and entity-specific IBR
consistent with ASC 842. Based on this analysis, the rate applied is the median of the available supportable rates, which reflects a secured
borrowing assumption and balances entity-specific credit risk and market benchmarks. Lease expenses are recognized on a straight-line
basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases its office space in Mountain
View, California, under an operating lease agreement dated March 25, 2025, originally signed for a term of six and one half years that
commenced in May 2025. Monthly payments are approximately $104,478. The lease includes common area maintenance costs that are paid separately
from rent based on actual costs incurred. The Company&#8217;s previous lease in Menlo Park, California ended in May 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also leases storage containers from
a third-party provider for use on-site in Mountain View, California, at a monthly rate of $141 per unit. These arrangements are on a month-to-month
basis and are cancelable upon thirty (30) days&#8217; notice. Under the short-term lease practical expedient of ASC 842, the Company does not
recognize right-of-use assets or lease liabilities for these arrangements, and instead, lease payments are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s right-of-use asset, net balance
as of December 31, 2025 and 2024, respectively are presented on the Company&#8217;s consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s future lease payments under
the non-cancellable lease as of December 31, 2025, which are presented as lease liabilities on the Company&#8217;s consolidated balance
sheet, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">For the year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating<br/> Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2026</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">692,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,434,193</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,506,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,551,040</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,594</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">2031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,367,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Less: imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,341,632</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Present value of lease liability</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,807,621</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Weighted-average remaining lease term (in years)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.42</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted-average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.60</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.87</td><td style="text-align: left">%</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lease expense was $1,170,932 and $678,037 for
the years ended December 31, 2025 and 2024, respectively. The amortization of the operating lease right-of-use assets, which is included
in the lease expense, totaled $915,451 and $694,373 for the years ended December 31, 2025 and 2024, respectively. The weighted average
discount rate is based on the incremental borrowing rate that is utilized to present value the remaining lease payments over the lease
term.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>6. Intangible Assets, Net</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross carrying amount and accumulated amortization
of separately identifiable intangible assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="18" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2025</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying Amount</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Market Value Adjustment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying Amount</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">521,302</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(71,079</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450,223</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">566,302</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100,079</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right; border-bottom: black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,223</span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Market Value Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Impairment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Developed software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,425,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,425,689</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41,856</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(118,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">450,385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,081,761</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,856</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(118,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,895,074</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for each of the years ended
December 31, 2025 and 2024 was $32,223 and $24,739, respectively. There was <span style="-sec-ix-hidden: hidden-fact-98"><span style="-sec-ix-hidden: hidden-fact-99">no</span></span> amortization expense for the developed software for the
years ended December 31, 2025 and 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 360, <i style="font-style: normal; font-weight: normal">Property, Plant, and Equipment</i>,
defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate
impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present. The Company determined
the Triggering Events in conjunction with preparation of its financial statements for the year ended December 31, 2025 provided such indication.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Next, the Company must review the long-lived assets
to define asset group(s) that would reflect the lowest level of assets to which discrete cash flows are identifiable, and test these asset
groups for impairment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In performing this review, the Company identified
that the long-lived asset &#8220;Patents&#8221;, which have international and U.S. based patents, as the asset group. The Company evaluated
its patents and identified expired international patent applications (&#8220;expired assets&#8221;) for the year ended December 31, 2024.
The Company determined there were no further plans to put resources toward these international patent applications. The group of expired
patents carrying value was set to its salvage value which is zero given no future cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2024, the Company
recorded a $118,831 impairment charge under gain (loss) on disposal assets, which is included in other income (expense) on its consolidated
statement of operations, to adjust the expiring assets salvage value of zero.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It was determined for all remaining long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets were necessary as of December
31, 2025 and December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2025, management
completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company revised its estimate regarding the point at which technological feasibility is achieved for software development
activities. This change in estimate was made to reflect management&#8217;s current expectations about the timing and certainty of future
technological milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in estimate was accounted for prospectively
in accordance with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements.
For the year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally
capitalized in 2024 and $1.2 million related to costs capitalized during the first two quarters of 2025 as research and development expense
resulting from this change.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated amortization expense for all intangible
assets subject to amortization in future years is expected to be:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Years ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,772</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">331,135</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,223</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Capital Structure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. Capital Structure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, the Company
is authorized to issue 400,000,000 and 200,000,000 shares of common stock, respectively, with a par value of $0.00001 per share. As of
December 31, 2025 and 2024, the Company had 7,974,380 and 199,110 shares of common stock issued and outstanding, respectively. Holders
of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable
to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected
by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Preferred Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the Company amended its Certificate
of Incorporation and revised the number of preferred stock shares authorized for issuance to 10,000,000 shares at a par value of $0.00001.
As of December 31, 2025 and December 31, 2024, there were <span style="-sec-ix-hidden: hidden-fact-100"><span style="-sec-ix-hidden: hidden-fact-101"><span style="-sec-ix-hidden: hidden-fact-102"><span style="-sec-ix-hidden: hidden-fact-103">no</span></span></span></span> shares of preferred stock issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reverse Stock Split</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 25, 2024, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 30, 2025, the Company&#8217;s stockholders
voted to authorize the Company&#8217;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company&#8217;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February 18, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s primary reasons for effecting
the reverse stock splits was to increase the per share price of our common stock to meet Nasdaq&#8217;s minimum bid price requirement
for continued listing on Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Offerings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 27, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 313,564 shares of its common
stock, par value $0.00001 per share at a purchase price of $7.50 per share and 1,979,769 pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $7.49999 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 30, 2025. The Company received net proceeds of approximately $13.7 million from the offering,
after deducting the estimated offering expenses payable by the Company of $1.3 million, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 26, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 192,496 shares of its common
stock, par value $0.00001 per share at a purchase price of $5.01 per share and 2,801,516 pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $5.00999 per pre-funded warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 27, 2025. The Company received net proceeds of approximately $15.9 million from the offering,
after deducting the estimated offering expenses payable by the Company of $1.3 million, including the placement agent fees.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 30, 2024, the Company entered into
a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 44,333 shares
of its common stock, par value $0.00001 per share at a purchase price of $90 per share and 55,667 pre-funded warrants to purchase shares
of Common Stock, at a purchase price of $89.985 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on December 31, 2024. The Company received net proceeds of approximately $8.1 million from the Offering,
after deducting the estimated offering expenses payable by the Company, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 20, 2024, the Company entered into
a securities purchase agreement for the sale and issuance of (i) 20,507 units at a public offering price per Unit of $241.50 with each
Unit consisting of one share of common stock, par value $0.00001 per share, one Series A warrant to purchase one share of Common Stock
at an exercise price of $301.875 per share and one Series B warrant to purchase one share of Common Stock at an exercise price of $301.875<sup>)</sup>
and (ii) 62,309 pre-funded units at a public offering price of $241.485 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one
pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.015 per share, one Series A Warrant and one Series
B Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders&#8217; equity within additional paid-in capital
and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on December 23,
2024. The net proceeds to the Company from the Offering were approximately $18.2 million, after deducting placement agent&#8217;s fees
and the payment of other estimated offering expenses associated with the offering that are payable by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At issuance, the aggregate fair value of the
warrant liabilities exceeded the net proceeds received in the transaction. The Company needed the net proceeds in order to continue
to run operations. Accordingly, the Company recognized a loss on issuance of warrants of approximately $2.3 million in its
consolidated statement of operations for the year ended December 31, 2024. This amount reflects the excess of the fair value of the
warrant liabilities over the residual proceeds allocable to the other securities issued in the transaction. Subsequently, the
warrant liabilities will continue to be remeasured at fair value through earnings until they are exercised, expire, or are otherwise
settled. After shareholder approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore,
in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification of Contracts, the Series A warrants were re-measured
utilizing the Black Scholes model and reclassified into equity. The Series A warrants are included in equity in the consolidated
balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the Black Scholes model immediately before
exercise and were fully exercised in February 2025. In addition, approximately $1.7 million of offering-related issuance costs
attributable to the warrant liabilities were recorded as expense in the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 23, 2024, the Company entered into an
underwritten Agreement with Aegis Capital Corp. (&#8220;Aegis&#8221;), pursuant to which Aegis acted as the Company&#8217;s underwriter
on a firm commitment basis in connection with the sale by the Company of an aggregate of 3,333 shares of common stock in a public offering,
which included: (i) 1,320 shares of common stock, and (ii) pre-funded warrants to purchase 2,013 shares of common stock. The Pre-Funded
Warrants had a nominal exercise price of $0.15. Each share of common stock was sold at an offering price of $1,500, and each Pre-Funded
Warrant was sold at an offering price of $1,499.85. The Pre-Funded Warrants are classified as a component of permanent stockholders&#8217;
equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value.
The Company determined the fair value of the Series A and Series B warrants using the Monte Carlo pricing model and treated the valuation
as a liability in consideration of the variable number of the issuer&#8217;s equity shares in the warrant agreements. The offering closed
on April 25, 2024. On May 3 2024, the Company closed on the sale of an additional 136 shares of common stock, upon exercise by the underwriter
of the over-allotment option. The Company received net proceeds of approximately $4.6 million, after deducting the estimated offering
expenses payable by the Company, including the placement agent fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>At the Market Equity Financing </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 5, 2025, the Company entered into
an At-The-Market Issuance Sales Agreement (the &#8220;Sales Agreement&#8221;) with Aegis Capital Corp. (the &#8220;Agent&#8221;), under
which the Company may, from time to time, sell shares of the Company&#8217;s common stock having an aggregate offering price of up to
$100,000,000 in &#8220;at the market&#8221; offerings through or to the Agent, as sales agent or principal. Sales of the shares of common
stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent will receive
a commission from the Company of up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. As of
December 31, 2025, a total of 935,114 shares of common stock were sold through Aegis Capital Corp. under the Sales Agreement. As of December
31, 2025, the Company has received net proceeds of $5,472,691 after payment of commission fees of $173,341 and other related expenses
of $131,990.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Private Placement Offering</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 12, 2024, the Company entered into
a Securities Purchase Agreement (&#8220;SPA&#8221;) with certain investors pursuant to which we sold, in a private placement, senior notes
with an aggregate principal amount of $4,375,000 (the &#8220;Notes&#8221;), and received proceeds before expenses of $3,500,000. The Notes
matured on February 12, 2025, with 20% interest rate. As consideration for entering into the SPA, we issued a total of 2,701 shares of
common stock of the Company to the Purchasers on November 13, 2024. The common stock and the Notes were recorded at the relative fair
values in accordance with ASC 470-20-25-2. The placement agent fee and other offering expenses were allocated based on the aforementioned
fair values as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. The amortization
of the debt discount and issuance costs was recorded in interest income (expense) on the consolidated statement of operations. As of December
31, 2024, the Notes were paid in full.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following warrants were outstanding as of
December 31, 2025, each of which is exercisable on a one-for-one basis for shares of the Company&#8217;s common stock (i.e., one warrant
for one share). All warrants contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock
dividends or other extraordinary dividends, or other similar changes in the Company&#8217;s common stock or capital structure, and none
of which have any participating rights for any losses. All Series B warrants, which were issued as a part of the December 20, 2024 public
offering, were fully exercised as of February 11, 2025 utilizing the cashless exercise provision in the warrant agreement. In addition,
on March 31, 2025, the Company reclassified the Series A warrants from liability to equity upon determining that the warrants no longer
required liability classification.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Securities into which warrants are convertible</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Common stock (Initial Public Offering)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center">October 2026</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">170,397</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Common stock (Private Placement)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">426</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">140,625</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">April 2027</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6,071,114</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock (Series A)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517,598</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">48.30</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: center; padding-bottom: 1.5pt">January 2030</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,634,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">518,033</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,875,939</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following warrants were outstanding as of
December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits,
stock dividends or other extraordinary dividends, or other similar changes in the Company&#8217;s common stock or capital structure, and
none of which have any participating rights for any losses:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities into which warrants are convertible</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants<br/>
outstanding</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise<br/>
Price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration<br/>
Date</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Initial Public Offering)</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,650</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2026</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,397</span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Private Placement)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">426</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,625</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2027</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,071,114</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series A)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">277,778</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2030</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,581,789</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series B)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,816</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">301.875</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2027</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,122,138</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">361,029</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,945,438</span></td> <td>&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants in accordance
with ASC 480,&#160;<i style="font-style: normal; font-weight: normal">Distinguishing Liabilities from Equity</i>, depending on the specific terms of the warrant agreement. The Company&#160;determined
the fair value of the Initial Public Offering and Private Placement warrants&#160;using the Black-Scholes pricing model and treated the
valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements. The warrants are not
marked-to-market each reporting period, and thus there is no impact to earnings. Any future exercises of the warrants will be recorded
as cash received and recorded in cash, with a corresponding increase to common stock and additional paid-in capital in stockholders&#8217;
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions for
December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Initial<br/>
Public<br/> Offering<br/> Warrants</p><p style="margin: 0pt 0">(Oct 2021)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Private<br/>
Placement Warrants</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>(Apr 2022)</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.88</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.37</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.92</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under ASC 815-40-35-8, <i style="font-style: normal; font-weight: normal">Derivatives
and Hedging Reclassification of Contracts</i>, shareholder approval on January 30, 2025, initiated the price reset period, resulting
in a fixed exercise price for the warrants. As such, the Series A warrants were reclassified to equity and remeasured utilizing the
Black Scholes model with the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183.38</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.96</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.30</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B warrants were re-measured
prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Series B<br/>
Warrants</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%"><span style="font-size: 10pt">Fair value of underlying securities</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt">6.01 &#8211; 32.19 </span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">162.99 &#8211; 190.53</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Expected term (in years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.46 &#8211; 2.49</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4.18 &#8211; 4.30</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for warrants in accordance
with ASC 480,&#160;<i style="font-style: normal; font-weight: normal">Distinguishing Liabilities from Equity</i>, depending on the specific terms of the warrant agreement. The Company
allocated the proceeds of the deal based on the fair values for the Series A and Series B warrants. The Company determined the fair value
of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of
the issuer&#8217;s equity shares in the warrant agreements for the year-ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series B<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.85</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161.78</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161.78</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.29</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.29</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. Net Loss Per Share Attributable to Common Stockholders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with ASC 260, basic and diluted
earnings per shares amounts, and weighted-average shares outstanding have been restated for all periods presented to reflect the effect
of these stock dividends. The following table summarizes the computation of basic and diluted loss per share:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(23,469,273</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Basic and diluted weighted average common shares outstanding</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">4,540,481</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,221</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">(5.17</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,521.41</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share is based upon the weighted
average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect of unvested restricted
stock awards and the convertible preferred stock; however, such items were not considered in the calculation of the diluted weighted average
common shares outstanding since they would be anti-dilutive.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise expressly provided in this Annual
Report, all historical per share data, number of shares issued and outstanding, stock awards, and other common stock equivalents set forth
herein relating to our common stock have been adjusted to give effect to a reverse stock split of our common stock in a ratio of 1-for-100
effected on July 3, 2024 and 1-for-150 effected on February 18, 2025.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>9. Stock-based Compensation Expense</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-Based Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses stock-based compensation, including
restricted stock units, to provide long-term performance incentives for its employees and board directors. The Company measures employee
and director stock-based compensation awards based on the award&#8217;s estimated fair value on the date of grant. Forfeitures are recognized
as they occur. Expense associated with these awards is recognized using the straight-line attribution method over the requisite service
period for stock options, restricted stock units (&#8220;RSUs&#8221;) and restricted stock and is reported in our consolidated statements
of stockholders&#8217; equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Company&#8217;s stock options
is estimated using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period
during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as
they occur. Stock options generally vest over four years and have a contractual term of ten years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the grant date fair value of options
requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different assumptions had
been used, stock-based compensation expense could have been materially different from the amounts recorded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The assumptions and estimates for valuing stock
options are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Fair value per share of Company&#8217;s
common stock.</i> Because there was no public market for Cyngn&#8217;s common stock prior to the IPO, its Board of Directors, with the
assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock options by
considering a number of objective and subjective factors, including its actual operating and financial performance, market conditions
and performance of comparable publicly traded companies, developments and milestones in the company, and the likelihood of achieving
a liquidity event among other factors. Since the Company&#8217;s common stock began publicly trading on the Nasdaq, the value of its
common stock underlying stock options or RSUs have been valued based on prevailing market prices.</span></td>
</tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt"><i>Expected volatility</i>. Because
the Company&#8217;s common stock had no publicly traded history prior to the IPO, it estimated the expected volatility using a combination
of its stock price volatility and the stock price volatility of peer companies, for a period equal to the expected term of the options.</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Expected term.</i> The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company estimates the expected term of options granted based upon the &#8220;simplified method&#8221; provided under <i>Staff Accounting Bulletin, Topic 14</i>, or SAB Topic 14.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><i>Risk-free interest rate. </i>The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in"><span style="font-size: 10pt">&#9679;</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Estimated dividend yield. </i>The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable future.</span></td></tr> </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Equity Incentive Plans</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2013, the Company&#8217;s Board of
Directors adopted the 2013 Equity Incentive Plan (&#8220;2013 Plan&#8221;). The 2013 Plan authorizes the award of stock options, stock
appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2021, the Company&#8217;s Board of
Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021 Plan replaces the 2013 Plan. However,
awards outstanding under the 2013 Plan will continue to be governed by their existing terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, the shareholders of the Company
approved an amendment to the Company&#8217;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 334
shares of common stock. In June 2024, the shareholders of the Company approved an amendment to allow an annual increase to the 2021 Plan
equal to the least of (i) 15% of the outstanding common stock on a fully diluted basis as of the end of the Company&#8217;s immediately
preceding fiscal year, or (ii) such lesser amount as determined by the Board. In December 2025, the shareholders of the Company approved
an amendment to the Company&#8217;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 4,000,000 shares
of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and December 31, 2024,
approximately 55,770 and 614 shares of common stock were reserved and available for issuance under the 2021 Plan, respectively. Options
issued under the Plans generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s stock options outstanding as well as stock options vested and exercisable as of December 31, 2025, and activity during
the year end then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average <br/>
exercise<br/>
price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average remaining<br/>
contractual<br/>
term<br/>
(years)</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
intrinsic<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2024</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,151</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,665.36</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.37</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/forfeited</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(227</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,438.45</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">924</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,475.78</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and expected to vest at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">924</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,475.78</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and exercisable at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">764</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,264.58</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s RSUs as of December 31, 2025, and activity during the year then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/> average<br/> grant date<br/> fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Unvested shares at December 31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">21,957.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">RSUs granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">RSUs vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,957.75</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">RSUs forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Unvested Shares at December 31, 2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of a stock option is estimated
using the Black-Scholes option-pricing model that takes into account as of the grant date the exercise price and expected life of the
option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free interest
rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all option grants
based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized in the
financial statements upon satisfaction of the requisite service or vesting requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no shares issued in 2025,
therefore no fair value was determined. The weighted average per share grant-date fair value of options granted during the year
ended December 31, 2025 and 2024 was $0 and $5.59, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following weighted average assumptions were
used in estimating the grant date fair values in December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Fair value of common stock</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,521.00</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.02</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.96</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">54.76</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recorded stock-based compensation expense
from stock options and RSUs of approximately $1,620,992 and $2,449,191, during the years ended December 31, 2025 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, total stock-based compensation
cost related to outstanding unvested stock options that are expected to vest was $1.4 million. This unrecognized stock-based compensation
cost is expected to be recognized over a weighted-average period of approximately 1.3 years. Income tax benefits recognized from stock-based
compensation expense recognized for the year ended December 31, 2025 were immaterial due to cumulative losses and valuation allowances.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Savings Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAbstract', window );"><strong>Retirement Savings Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Savings Plan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. Retirement Savings Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective November 17, 2017, the Company established
the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the intention to provide a
measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement Income Security Act of
1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. The Company did not offer and has not provided a company
match for its 401(k) Plan.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. Income Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Domestic and international pre-tax loss consists of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(23,469,273</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(33,335,579</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">International</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,469,273</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,335,579</td><td style="text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2025 and 2024,
income tax expense attributable to operations is immaterial.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense differed from the amount computed
by applying the federal statutory income tax rate of 21% to pretax income for the years ended December 31, 2025 and 2024 as a result of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">US Federal Statutory Tax Rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,928,547</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local Income Taxes (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(211,513</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.90</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign Tax Effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tax Credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,010,247</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.30</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,421,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18.84</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nontaxable or Nondeductible Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Section 162m Limitation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">262,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.12</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Warrant Revaluation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">248,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.06</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.01</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in unrecognized tax benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303,074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.29</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Reconciling Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Deferred True Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">622,366</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.65</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55,184</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.24</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify"><i>For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.</i></td></tr></table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,142,980</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(218,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Foreign taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,039,015</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nondeductible items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,970</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,327,801</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred true up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,165,581</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rate change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717,809</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other items</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,029</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes.
Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets: <b>&#160;</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 76%; padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,820,615</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,178,997</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development credits</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,713,764</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,006,591</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">616,331</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">880,481</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(365,067</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(181,103</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,813</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,339</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accruals and reserves</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,240</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281,367</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,914</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,751</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,491,200</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,025</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized research costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,761,293</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,280,797</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,639</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross deferred tax assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,663,326</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,998,884</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(54,355,211</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(49,934,084</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,308,115</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,800</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,308,115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,800</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred project costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax liabilities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,308,115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,800</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly assesses the ability to realize
deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected
future taxable income on a jurisdiction by jurisdiction basis. In the event that the Company changes its determination as to the amount
of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income
taxes in the period in which such determination is made. The Company&#8217;s management believes that, based on a number of factors, it
is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the year ended
December 31, 2025, the Company has provided a valuation allowance against the Company&#8217;s U.S. net deferred tax assets. The net change
in the valuation allowance for the years ended December 31, 2025 and 2024 was an increase of $4,421,241 and $5,327,800, respectively.</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the Company had net operating loss carryforwards
for federal and state income tax purposes of approximately $161,732,697 and $120,845,916, respectively, which will begin to expire in
2034 and 2035 with $126,395,500 of our federal net operating loss carryforward lasting indefinitely.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025, the Company had
federal and state research credit carryforwards of approximately $7,526,906 and $4,421,211, respectively. The federal research
credit carryforwards will begin to expire in 2033 while the California research credits carry forward have an indefinite life.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Internal Revenue Code of 1986, as amended,
imposes restrictions on the utilization of net operating losses in the event of an &#8220;ownership change&#8221; of a corporation. Accordingly,
a company&#8217;s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (&#8220;IRC
Section 382&#8221;). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one
year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the federal
and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the
IRC Section 382 and similar state provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective for tax years beginning after December
31, 2021, the Tax Cuts and Jobs Act of 2017 eliminates the option to deduct research and development expenditures currently and requires
taxpayers to amortize such costs over a period of five or fifteen years. While it is possible that Congress may modify, defer, or repeal
such provision, we have no assurance that the provision will be modified, deferred or repealed. This legislation has accelerated the utilization
of our net operating losses in the U.S., but it has not impacted our current tax obligations.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In response to the COVID-19 pandemic, the Coronavirus
Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide
additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions
related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations,
and an option to defer payroll tax payments for a limited period. In 2023, we assessed our eligibility to claim a refund of employer taxes
available under the Employee Retention Credit provisions of the CARES Act. For the year ended December 31, 2023, we calculated eligible
credits of approximately $763,624 provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses.
As of December 31, 2025 and 2024, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reflects changes in gross
unrecognized tax benefits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Balance at beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,002,825</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,545,189</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase in balance related to tax positions taken during the current year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303,074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">445,293</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase in balance related to tax positions taken during prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,343</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Decrease in balance related to prior year tax positions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Decrease in balance related to settlement with tax authorities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Balance at end of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,305,899</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,002,825</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2025 and 2024, the total amount
of gross unrecognized tax benefits was $3,305,899 and $3,002,825, respectively, which does not include any reserved interest or penalties.
As of December 31, 2025, $3,305,899 of the total unrecognized tax benefits, if recognized, would have an impact on the Company&#8217;s
effective tax rate. The Company estimates that there will be no material changes in its uncertain tax positions in the next 12 months.
The Company&#8217;s has not recorded any interest or penalties related to its unrecognized tax benefits for 2025 or 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company files income tax returns in the U.S.
federal and various state jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations
for years prior to 2021 for federal purposes and 2020 for state purposes, except in certain limited circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, due to the fact that the Company had loss and credits carried
forward in some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant
taxing authority through an adjustment to tax attributes carried forward to open years. The Company&#8217;s NOL and credit carryforwards from
all years may be subject to adjustment for three (or four for certain states) following the year in which utilized. The Company does not
anticipate that any potential tax adjustments will have a significant impact on our financial position or results of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>12. Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Legal Proceedings</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, the Company may become involved
in legal proceedings arising in the ordinary course of business. Regardless of outcome, litigation can have an adverse impact on us due
to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors. The assessment
as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves
significant judgment about future events, and the outcome of litigation, which is inherently uncertain.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2025, a former contractor of the Company
filed a complaint alleging breach of contract and related claims arising from certain professional services agreements entered into between
2021 and 2024. The complaint seeks approximately $59,760&#160;in damages, plus interest, attorneys&#8217; fees, and costs. The matter
is in its early stages, and the Company is evaluating the claims and intends to respond accordingly. The Company has recorded an accrual
of approximately $33,000 in connection with the foregoing matters .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2025, a former employee filed a complaint with the U.S. Department
of Labor, Occupational Safety and Health Administration (&#8220;OSHA&#8221;), alleging retaliation in connection with the employee&#8217;s
internal reporting. To avoid litigation and minimize costs, the Company has agreed in principle, subject to final documentation, to a
one-time payment of $80,000&#160;to settle a contract dispute, which payment is included in accrued expenses as of December 31, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of a settlement agreement with a former placement agent,
the Company may be obligated to pay a maximum of $2.3&#160;million cash fee and issue&#160;370,114&#160;warrants to purchase shares of
the Company&#8217;s common stock in connection with the June 27 Offering and the June 26 Offering. However, the Company has informed the
former placement agent that it does not believe there is a basis for these obligations. The Company has not received a response from the
former placement agent and a resolution has not been reached as of the date of this filing. Since the Company is contesting the matter
and it has not accrued any liability related to it. While an unfavorable outcome is reasonably possible, the Company is unable to estimate
the possible loss at this time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to legal and regulatory actions that arise from
time to time. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss
is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. To avoid
litigation and minimize costs, the Company agreed in principle, subject to final documentation, to a one-time payment of $500,000 to settle
a contract dispute, of which payment was included in accrued expenses as of December 31, 2024 and paid out in March 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was no other material pending or threatened
litigation against the Company that remains outstanding as of December 31, 2025.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>13. Risks and Uncertainties</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s business operations, operating
results, and financial condition are vulnerable to certain risks and uncertainties including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Inflation and its related impact
on costs and expenditures on domestic and foreign-sourced materials and services;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Rising interest rates and its
impact on the equity markets, investment valuations, and interest rate-sensitive calculations such as discount rate assumptions used
in cash flow projections and going concern assessments;</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Effects of the Russia-Ukraine
conflict such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-size: 10pt">Other factors beyond its control
such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is unable to predict and quantify
at this time the extent of the related potential adverse effects but continuously monitors these risks and uncertainties on its future
operations and financial performance.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14. Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>ATM </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 19, 2026, the Company has sold 3,922,113
additional shares under the ATM Sales Agreement, for net proceeds of $9,166,427 after payment of commission and fees of $283,498.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Registered Direct Offering</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 16, 2026, the Company entered into a
securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 1,686,788 shares
of its common stock, par value $0.00001 per share at a purchase price of $1.93 per share and 3,313,212 pre-funded warrants to purchase
shares of Common Stock, at a purchase price of $ of $1.92999 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component
of permanent stockholders&#8217; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase
price approximated the fair value. The offering closed on March 17, 2026. The Company received net proceeds of approximately $8.8 million
from the offering, after deducting the estimated offering expenses payable by the Company of $0.85 million, including the placement agent
fees.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Restatement of Previously Issued Audited Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock', window );">Restatement of Previously Issued Audited Financial Statements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>15. Restatement of Previously Issued Audited
Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company restated its previously reported financial
statements for each of the period ended December 31, 2024. The adjustment resulted in an increase to warrant liability by $12.7 million,
a decrease in equity balance by $12.7 million and an adjustment from operating activities to financing activities on the statement of
cash flow as of December 31, 2024. The Company recognized a loss on the issuance of the Warrants of approximately $2.3 million and offering-related
issuance costs of approximately $1.7 million as of December 31, 2024.</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<br/>
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated
balances as of December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">15,012,361</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">12,691,566</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">27,703,927</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,501,699</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,641,566</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,143,265</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Additional paid-in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,863,551</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,558,271</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">192,305,280</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(189,269,903</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(193,353,198</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,593,650</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,641,566</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,047,916</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability issuance costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,739,148</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,739,148</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income (expenses), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,424,209</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,507,504</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,212.56</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308.85</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,521.41</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Stockholders&#8217; Equity (Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">20,972,722</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(8,558,270</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">12,414,453</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,739,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,739,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses, lease liabilities, and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,642,938</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,652,581</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">990,357</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,493,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,702,581</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,196,081</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,369,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,558,271</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,811,014</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Proceeds from issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,260,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,260,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,584,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,702,581</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,286,961</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following this review, the Company completed a
comprehensive review of its previously issued financial statements. The Company is adjusting for certain out-of-period errors that were
not material, individually or in the aggregate, and are being corrected as part of the restatement. The Company corrected a duplicate
bill of $50,000 for issuance costs on an equity transaction, resulting in a decrease in accounts payable and an increase in additional
paid-in-capital. The Company also corrected for an immaterial reallocation of proceeds from equity issuances among common stock, common
warrants, and pre-funded warrants, related to a previous issuance in 2022, resulting in a reclassification within additional paid-in-capital
sub-accounts of $88,024. This correction has no impact on total additional paid-in-capital, net loss, or total stockholders&#8217; equity.
The Company believes the adjustments were not material to any prior period, individually or in the aggregate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">297,778</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">247,778</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">100,815</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">50,815</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of previously issued interim financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Risk management and strategy</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We recognize the critical
importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect
the confidentiality, integrity, and availability of our data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Managing Material Risks &amp; Integrated Overall
Risk Management</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have strategically integrated
cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management.
This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management
team works closely with our IT department to continuously evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Oversee Third-party Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because we are aware of the
risks associated with third-party service providers, we have implemented stringent processes to oversee and manage these risks. We conduct
thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with
our cybersecurity standards. The monitoring includes annual assessments of the SOC reports of our providers and implementing complementary
controls. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Risks from Cybersecurity Threats</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not encountered cybersecurity
challenges that have materially impaired our operations or financial standing.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have strategically integrated
cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management.
This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management
team works closely with our IT department to continuously evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not encountered cybersecurity
challenges that have materially impaired our operations or financial standing.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Basis of Presentation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements
as of and for the years ended December 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted
in the United States (&#8220;GAAP&#8221;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;).
The consolidated financial statements include all normal adjustments necessary for a fair presentation of the Company&#8217;s financial
position at December 31, 2025 and 2024, and operating results and cash flows for the periods presented.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Principles of Consolidation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Foreign Currency Translation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional and reporting currency for Cyngn
is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar
at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated
at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the consolidated
financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements
in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported
amounts of revenue and expenses during the reporting period. The Company&#8217;s significant estimates and judgments include but are not
limited to internal-use software, warrants and share-based compensation. Management bases its estimates on historical experience and on
various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period balances for the consolidated
financial statement for December 31, 2024 have been reclassified to conform with the current year presentation. These reclassifications
relate to inventory and accounts and other receivables that were previously presented as prepaid expenses and other current assets, as
well as deferred revenue that was previously presented as accrued expenses and other current liabilities. These reclassifications had
no impact on previously reported net loss, total assets, or total shareholders&#8217; equity.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times
exceeds federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash maintained with domestic financial institutions
generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its
deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ConcentrationOfSupplierRiskPolicyTextBlock', window );">Concentration of Supplier Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Supplier Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company generally utilizes suppliers for outside
development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of December
31, 2025 and December 31, 2024.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock', window );">Cash and Short-term Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cash and Short-term Investments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers its bank accounts and all highly liquid investments
that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of December
31, 2025 and December 31, 2024, the Company had approximately $1.0 million of cash and $33.7 million in short-term investments and $23.6
million of cash and no short-term investments, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considers short-term investments to include marketable
U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government
treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;)
Accounting Standards Codification Topic (&#8220;ASC&#8221;) 320, Investments - Debt and Equity Securities<i>,</i> and recorded these securities
at amortized cost on the accompanying consolidated balance sheets as of December 31, 2025 and December 31, 2024.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts and Other Receivable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Accounts and Other Receivable </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivables are recorded at the invoiced
amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status
of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was zero as of December 31,
2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic
conditions in order to determine expected trade credit losses on a prospective basis. <span style="-sec-ix-hidden: hidden-fact-79"><span style="-sec-ix-hidden: hidden-fact-80">No</span></span> credit losses were recorded as of December 31,
2025 and December 31, 2024. Other receivables primarily consist of Employee Retention Credit (&#8220;ERC&#8221;) claims related to 2020
and 2021.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting guidance under ASC Topic 820, Fair
Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major
asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price
representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the following fair value hierarchy
prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 1-Unadjusted quoted prices in
active markets for identical assets or liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 2-Observable inputs other than
Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Level 3-Unobservable inputs that are
supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities are considered to be fair
valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily
result in a change in the amount recorded on the consolidated balance sheets, assets and liabilities are considered to be fair valued
on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of
cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value
on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon
initial recognition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of the Company&#8217;s cash
and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company&#8217;s
share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models
derived from independent external valuations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventory</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory consists of autonomous vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated
with the Company&#8217;s proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software and sold to customers as part of a fully integrated
autonomous vehicle solution. Substantially all assembly and integration activities are performed by third-party suppliers prior to receipt;
therefore, the Company classifies its inventory as finished goods and does not maintain separate classifications for raw materials or
work in process.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, and the Company is able to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><br/>
The Company periodically reviews inventory for excess quantities, obsolescence, or other indicators that the carrying value may not be
recoverable. If the carrying value of inventory exceeds its net realizable value, the Company records a write-down to net realizable value,
with the adjustment recognized in cost of goods sold.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment is stated at cost less
accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the
Company&#8217;s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date
depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over
each asset&#8217;s estimated useful life. Repair and maintenance costs are expensed as incurred.&#160;</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left">Property and Equipment</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center">Useful life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Automobiles (DMV-registered)</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computers and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal-use software</td><td>&#160;</td> <td style="text-align: center">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: center">7 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Leasehold improvements</td><td>&#160;</td> <td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-73">Shorter of 3 years or lease term</span></td></tr> </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Operating Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Leases</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for leases in accordance with ASC 842, Leases.
All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified
asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance
in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the consolidated
balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office
space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining
term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Costs to Develop Software</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company incurs costs related to internally
developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal-Use Software costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Internal-Use Software costs</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determined when to capitalize its
internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the
software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized
based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in
estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing
the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining
the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs,
as well as subscription server and consulting costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal-use software is classified as property
and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved
in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and
ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development
phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes
in circumstances occur that could impact the recoverability of these assets. <span style="-sec-ix-hidden: hidden-fact-81"><span style="-sec-ix-hidden: hidden-fact-82">No</span></span> impairment charges were associated with the Company&#8217;s
internal-use software for the years ended December 31, 2025 and 2024.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy', window );">Costs to Develop Software to be Sold, Leased or Otherwise Marketed</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Costs to Develop Software to be Sold, Leased
or Otherwise Marketed </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for research costs of computer
software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once
technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred
to develop functionality for the Company&#8217;s software and internally built software platforms, as well as certain upgrades and enhancements
that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility
of a product is established. Management has determined that technological feasibility is established when a working model is complete.
After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation
costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the
product or enhancement is available for general release to customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Computer software to be sold, leased or otherwise
marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount
computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that
product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated
economic life of the product, not to exceed three years to five years and recorded as cost of revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2025, management
completed a review of the Company&#8217;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the Company revised its estimate regarding the point at
which technological feasibility is achieved for software development activities. This change in estimate was made to reflect management&#8217;s
current expectations about the timing and certainty of future technological milestones.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The change in estimate was accounted for prospectively in accordance
with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements. For the
year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally capitalized in 2024 and $1.2
million related to costs capitalized during the first two quarters of 2025 as research and development expense resulting from this change.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets and Finite Lived Intangibles</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Long-Lived Assets and Finite Lived Intangibles</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has finite-lived intangible assets
consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives.
The patents and trademarks are amortized over 15 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets and
finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant
adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation
of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The
Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted
cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term
undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being
evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the
asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also identified that the long-lived
asset &#8220;Patents&#8221;, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and
identified expired international patent applications (&#8220;expired assets&#8221;) for the year ended December 31, 2024. The Company
determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying
value was set to its salvage value which is zero given no future cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2024, the Company
determined the existence of an impairment associated with the Company&#8217;s intangible asset &#8220;Patents&#8221; and accordingly recorded
an impairment charge of $118,831 (see Note 6. Intangible Assets). For the year ended December 31, 2025, there were <span style="-sec-ix-hidden: hidden-fact-83">no</span> impairment charges.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Income Taxes</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes using the
asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A valuation allowance is provided when it is more
likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#8217;s lack of earnings history,
the net deferred tax assets have been fully offset by a valuation allowance as of December 31, 2025 and December 31, 2024 (see Note 11.
Income Taxes).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no uncertain tax positions that would
require recognition in the consolidated financial statements. If the Company were to incur an income tax liability in the future, interest
on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management&#8217;s
conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of
or changes in tax laws, regulations and interpretations thereof as well as other factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;). ASU 2023-09 expands the annual disclosure
requirements for income taxes, primarily related to the rate reconciliation and income taxes paid. The Company has adopted this guidance
on a prospective basis, which did not have a significant impact on the Company&#8217;s consolidated financial statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CommonStockWarrantsPolicyTextBlock', window );">Common Stock Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Common Stock Warrants</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company issued to its lead underwriter in
the Company&#8217;s IPO warrants to purchase up to 9 shares of the Company&#8217;s common stock. In addition, the Company issued 426 common
stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants
as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also applied the guidance in ASC 340-10-S99-1, Other Assets
and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities
may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as
directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.</p><p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The Company issued Series A warrants and Series B warrants in connection
with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company&#8217;s warrant
agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable.
The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in
consideration of the variable number of the issuer&#8217;s equity shares in the warrant agreements. The resulting warrant liabilities
are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company&#8217;s
consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and
the number of equity shares are now fixed. The Company concluded that these warrants are indexed to the Company&#8217;s own stock, require
settlement in a fixed number of shares, and do not contain provisions that could require net cash settlement or settlement in a variable
number of shares. Additionally, the warrant agreements do not include provisions that would require the Company to transfer assets. Accordingly,
the warrants meet the criteria for equity classification. Therefore, in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification
of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants
are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the
Black Scholes model immediately before exercise and were fully exercised in February 2025 (see Note 7. Capital Structure).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Stock-based Compensation</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes the cost of share-based
awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line
basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost
and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair
value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price
volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation
Expense<b>)</b>.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net Loss Per Share Attributable to Common Stockholders</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company computes loss per share attributable
to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding.
Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised
into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only
if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see
Note 8. Net Loss per Share Attributable to Common Stockholders).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Research and Development Expense</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development expenses consists primarily
of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company
personnel involved in the development of the Company&#8217;s products and services, and allocated lease costs based on the approximate
square footage area used in research and development activities. Research and development costs are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative Expense</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and Administrative Expense</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expense consist primarily of personnel costs,
facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance
with ASC 720-35, Other Expense - Advertising Costs, other than trade show expenses which are deferred until occurrence of the future event.
<i>&#160;</i>Advertising costs for the years ended December 31, 2025 and 2024 were $512,017 and $237,396, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Commitments</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes a liability with regard to loss contingencies
when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of
loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount
within the range is a better estimate than any other amount the Company accrues the minimum amount in the range (see Note 12. Commitments
and Contingencies).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Segment Reporting</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates as one operating segment.
The Company&#8217;s <span style="-sec-ix-hidden: hidden-fact-78">chief operating decision maker</span> is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources, making
operating decisions and evaluating financial performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The one operating segment generates revenues from
subscriptions to its Enterprise Autonomy Service (&#8220;EAS&#8221;), product sales or leases of hardware, and other professional services
(i.e., deployment costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent
phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod
software, and demonstrations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the Company&#8217;s one segment, the executive
management team use revenue and net loss to allocate resources, both reported on the Consolidated Statement of Operations as Revenue and
Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to
evaluate the Company&#8217;s performance, establish compensation, monitor budget versus actual results, and decide the level of investment
in various operating activities and other capital allocation activities. The measure of segment assets is reported on the Consolidated
Balance Sheet as Total assets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenue Recognition</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for revenue in accordance
with ASC 606, Revenue from Contracts with Customers. <span style="font-style: normal; font-weight: normal">The Company generates revenue
from vehicle units, including tuggers equipped with DriveMod Kits (&#8220;DMKs&#8221;), which are integrated with the Company&#8217;s
proprietary Enterprise Autonomy Suite (&#8220;EAS&#8221;) software, or leases of hardware, and other professional services. These offerings
are highly interdependent and integrated to provide customers with a fully functional autonomous industrial vehicle solution. Because
these components are not separately identifiable from one another in the context of the contract, the Company accounts for these combined
goods and services as a single performance obligation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>General Recognition Principle.</i> The Company
recognizes revenue when control of the combined autonomous vehicle and software solution is transferred to the customer in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for the goods and services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Method of Measuring Progress. </i>Revenue associated
with the Company&#8217;s integrated autonomous vehicle solution is generally recognized over time because the customer simultaneously
receives and consumes the benefits provided by the Company&#8217;s performance as the services are performed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company measures progress toward satisfaction
of the performance obligation using an output method based on the passage of time, recognizing revenue ratably over the contractual term,
which is typically three years. In accordance with ASC 606-10-55-17 through 55-18, the output method reflects the pattern in which control
of the promised goods and services is delivered to the customer, who receives continuous access to the integrated autonomous vehicle functionality,
including the software-enabled operation, monitoring, updates, and support necessary for the system to function as intended.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management believes that recognizing revenue on
a straight-line basis over the contract period faithfully depicts the Company&#8217;s performance in transferring control of the integrated
solution, as the customer receives and consumes the benefits of the solution evenly throughout the contract term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Payment Terms.</i> Payment terms vary by customer
and contract but generally do not exceed 90 days.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Discounts.</i> The Company may offer pricing
discounts to certain customers, primarily to establish relationships with new customers. These discounts are reflected in the contractual
transaction price at contract inception. Revenue is recognized based on the discounted contract price and is accounted for in the same
manner as other contracts. The Company recognizes revenue from these arrangements ratably over the contract term, consistent with the
pattern in which the customer receives and consumes the benefits of the integrated autonomous vehicle solution.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Stand-Alone Selling prices</i>. The Company
also applies judgment in estimating stand-alone selling prices when allocating the transaction price to performance obligations. Stand-alone
selling prices are generally determined based on observable prices when available or, when not directly observable, are estimated using
management&#8217;s assessment of expected pricing for similar goods and services and market conditions.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Material Rights and Renewal Options.</i> The Company&#8217;s contracts
with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material
right, and therefore represent a separate performance obligation, requires judgment. The Company evaluates the pricing of each option
to determine whether it reflects the stand-alone selling price for the underlying goods or services or whether it provides the customer
with a discount that would not be available without entering into the initial contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In certain legacy customer contracts, the Company
has provided customers with the option to extend the contract term for an additional one-year period. Management evaluates these renewal
provisions to determine whether they provide a material right by comparing the renewal pricing to the expected stand-alone selling price
of the services at the time of renewal. This assessment requires judgment and includes consideration of expected pricing for similar services,
historical pricing practices, and market conditions.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a material right exists, the Company allocates a portion of the
transaction price to the option and recognizes the related revenue when the option is exercised or expires.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Significant financing component.</i> In certain
arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company&#8217;s
contracts with customer prepayment terms do not include a significant financing component because the prepayment terms are designed to
provide customers with contractual protections and billing convenience, not to provide financing to the customer or receive financing
from the customer.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Contract modifications. </i>The Company may modify contracts to
offer customers additional products or services. Each of the additional products and services is evaluated to determine whether it is
distinct from the goods or services transferred prior to the modification. The Company evaluates whether the contract price for the additional
products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these
cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification
does not reflect the stand-alone selling price for the modified goods or services, the Company accounts for the modification either (i)
on a prospective basis if the remaining goods and services are distinct from those already transferred, or (ii) on a cumulative catch-up
basis if the remaining goods and services are not distinct from those already transferred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Principal vs. Agent Considerations</i>. Judgment
is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation
of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., &#8220;gross&#8221;),
or we arrange for other parties to provide the service to the end-user and are an agent (i.e., &#8220;net&#8221;). In making this determination,
the Company considers several factors, including whether the Company is primarily responsible for fulfilling the promise to provide the
specified goods or services, bears inventory risk before the goods are transferred, and has discretion in establishing pricing for the
specified goods or services. This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts
and promotions offered to end-users to the extent they are not customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer transactions where the Company&#8217;s
role is to supply hardware to the dealer, the Company does not obtain control of the hardware before it is transferred to the end-user
and is not primarily responsible for the dealer&#8217;s fulfillment to end-users. Accordingly, hardware revenue in these arrangements
is recorded on a net basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In dealer and OEM transactions where our role
is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription
revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Cost to Obtain a Contract. </i>The Company capitalizes incremental
costs incurred to obtain contracts, principally sales commissions and third-party referral fees. These costs are amortized on a straight-line
basis over the contractual term and recognized in general and administrative expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i>Costs to Fulfill a Contract</i>. The Company capitalizes such costs
when they are (i) incremental to obtaining that specific contract, (ii) expected to be recovered, and (iii) subject to an amortization
period exceeding one year. Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which
corresponds to the contractual term, and are recognized in cost of revenue. The Company evaluates capitalized fulfillment costs for impairment
at each reporting date.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Deferred contract costs totaled $767,007 and $120,793 as of December
31, 2025 and 2024, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. Amortization
of deferred contract costs recognized in cost of revenue during the years ended December 31, 2025 and 2024 was $106,480 and $21,413, respectively.
No impairment losses were recognized in either period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Taxes collected from customers</i>. The Company
collects and remits certain taxes assessed by governmental authorities on its revenue transactions, including sales, use, value-added,
and excise taxes. These taxes are presented on a net basis and excluded from reported revenue. Shipping and handling fees billed to customers
are included in net sales; the related costs are included in cost of revenue.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Judgments and estimates. </i>Accounting for contracts recognized over time requires judgment in
estimating the transaction price, the measure of progress, and expected contract costs. Due to uncertainties
inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the
near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Below 10%</span></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was $209,452 from these customers in accounts
receivable as of December 31, 2025 and $274,699 from these customers in accounts receivable as of December 31, 2024.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CostOfRevenuePolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cost of Revenue </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenue consists primarily of direct labor
and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the
contracts and hardware costs.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recent Accounting Standards</i></b></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In November 2024, the FASB issued ASU 2024-03, &#8220;Disaggregation
of Income Statement Expenses,&#8221; which requires the disaggregated disclosure of certain income statement items. ASU 2024-03 is effective
for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted.
The Company has not adopted this standard early and is currently evaluating the impact of this amendment on its consolidated financial
statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding cash and short term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommonStockWarrantsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommonStockWarrantsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ConcentrationOfSupplierRiskPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for concentration of supplier risk policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ConcentrationOfSupplierRiskPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CostOfRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CostOfRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/730/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-4<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479953/718-10-S50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred to (1) establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed; and (2) produce product masters after establishing technological feasibility. This accounting policy also may apply to purchased computer software. This policy also may address the entity's amortization policy for its capitalized computer software costs and how it evaluates such capitalized costs for impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock', window );">Schedule of Asset&#8217;s Estimated Useful Life</a></td>
<td class="text">Depreciation is recorded on a straight-line basis over
each asset&#8217;s estimated useful life. Repair and maintenance costs are expensed as incurred.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom; "> <td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left">Property and Equipment</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center">Useful life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Automobiles (DMV-registered)</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Computers and equipment</td><td>&#160;</td> <td style="text-align: center">5 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Internal-use software</td><td>&#160;</td> <td style="text-align: center">3 to 5 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td> <td style="text-align: center">7 years</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Leasehold improvements</td><td>&#160;</td> <td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-73">Shorter of 3 years or lease term</span></td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Percentages of Total Revenue</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">17.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer B</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer C</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Customer D</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Customer E</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.3</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Below 10%</span></td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Components [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text">The Company does not expect
a credit loss for its short-term investments.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2025</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><b>December&#160;31,<br/> 2024</b></td>
    <td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Financial assets</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Level</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Amount</td>
    <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Cash equivalents:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Money market account</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">929,165</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: center">1</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td>
    <td style="width: 9%; text-align: right">23,274,834</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term investments:</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">U.S. government treasury bills</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">33,736,091</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">1</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8210;</span></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 9.25pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">34,665,255</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">23,274,834</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prepaid expenses and other current assets are comprised of the following:</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid Expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">668,090</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">303,803</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Short-term Deposits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,006</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">160,149</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">775,334</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">128,138</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total prepaid and expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,518,430</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">592,090</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">Property and equipment is comprised of the following:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">December&#160;31,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Automobiles (DMV-registered)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">28,862</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">128,862</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Machinery, tools and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">692,459</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">660,155</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computers and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,552</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">389,007</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Capitalized software</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,592,092</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">950,832</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66,182</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">175,417</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221,977</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Testing equipment (Work in Progress)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">896,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">687,986</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9.25pt">Property and equipment, gross</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,947,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,105,001</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(678,827</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(785,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total property and equipment, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,268,196</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,319,402</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accrued expenses and other current liabilities
are comprised of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,<br/> 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Credit card payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,169</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,050</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">563,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">788,948</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued payroll</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,035,795</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,314,038</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt">Total accrued expenses and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,615,734</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,105,036</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Lease Payments under the Non-Cancellable Lease</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s future lease payments under
the non-cancellable lease as of December 31, 2025, which are presented as lease liabilities on the Company&#8217;s consolidated balance
sheet, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">For the year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Operating<br/> Lease</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 87%; text-align: left">2026</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">692,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,434,193</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,506,260</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,551,040</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2030</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,594</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">2031</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,367,166</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Less: imputed interest</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,341,632</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-size: 10pt">Present value of lease liability</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,807,621</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Weighted-average remaining lease term (in years)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5.83</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">0.42</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Weighted-average discount rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">5.60</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">4.87</td><td style="text-align: left">%</td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Gross Carrying Amount and Accumulated Amortization</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross carrying amount and accumulated amortization
of separately identifiable intangible assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="18" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As of December 31, 2025</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross Carrying Amount</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated Amortization</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Market Value Adjustment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net Carrying Amount</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">521,302</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(71,079</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">450,223</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,000</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">566,302</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100,079</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right; border-bottom: black 1.5pt solid"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,223</span></td>
    <td>&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Market Value Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Impairment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Carrying Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Developed software</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,425,689</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,425,689</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Patents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,072</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(41,856</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(118,831</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">450,385</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">45,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(26,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,081,761</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,856</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(118,831</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,895,074</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense for All Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Estimated amortization expense for all intangible
assets subject to amortization in future years is expected to be:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Years ended December 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2026</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,772</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left"></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">2029</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,772</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">331,135</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">466,223</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Capital Structure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Securities Warrants are Convertible</a></td>
<td class="text">In addition,
on March 31, 2025, the Company reclassified the Series A warrants from liability to equity upon determining that the warrants no longer
required liability classification.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Securities into which warrants are convertible</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiration<br/> Date</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Common stock (Initial Public Offering)</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,650</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center">October 2026</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">170,397</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Common stock (Private Placement)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">426</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">140,625</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: center">April 2027</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6,071,114</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock (Series A)</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517,598</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">48.30</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: center; padding-bottom: 1.5pt">January 2030</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,634,428</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">518,033</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="text-align: right; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,875,939</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following warrants were outstanding as of
December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits,
stock dividends or other extraordinary dividends, or other similar changes in the Company&#8217;s common stock or capital structure, and
none of which have any participating rights for any losses:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities into which warrants are convertible</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants<br/>
outstanding</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise<br/>
Price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration<br/>
Date</b></span></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Initial Public Offering)</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,650</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 2026</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,397</span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Private Placement)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">426</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,625</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 2027</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,071,114</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series A)</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">277,778</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2030</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,581,789</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock (Series B)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,816</span></td> <td>&#160;</td> <td>&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">301.875</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 2027</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,122,138</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">361,029</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,945,438</span></td> <td>&#160;</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions for
December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Initial<br/>
Public<br/> Offering<br/> Warrants</p><p style="margin: 0pt 0">(Oct 2021)</p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><p style="margin-top: 0; margin-bottom: 0">Private<br/>
Placement Warrants</p>

<p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>(Apr 2022)</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.88</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.37</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.0</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.92</td><td style="text-align: left">%</td></tr>
  </table>As such, the Series A warrants were reclassified to equity and remeasured utilizing the
Black Scholes model with the following assumptions:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183.38</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.96</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.30</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the Series B warrants were re-measured
prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Series B<br/>
Warrants</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 89%"><span style="font-size: 10pt">Fair value of underlying securities</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-size: 10pt">$</span></td>
    <td style="width: 8%; text-align: right"><span style="font-size: 10pt">6.01 &#8211; 32.19 </span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Expected volatility</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">162.99 &#8211; 190.53</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Expected term (in years)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.46 &#8211; 2.49</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-size: 10pt">Risk-free interest rate</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4.18 &#8211; 4.30</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company used the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series A<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Series B<br/> Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Fair value of underlying securities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.85</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161.78</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161.78</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.29</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.29</td><td style="text-align: left">%</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share Attributable to Common Stockholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Loss Per Share</a></td>
<td class="text">The following table summarizes the computation of basic and diluted loss per share:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Years Ended<br/> December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Net loss attributable to common stockholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(23,469,273</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Basic and diluted weighted average common shares outstanding</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">4,540,481</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,221</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">(5.17</p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(2,521.41</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock', window );">Schedule of Stock Options Vested and Exercisable</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s stock options outstanding as well as stock options vested and exercisable as of December 31, 2025, and activity during
the year end then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average <br/>
exercise<br/>
price</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-<br/>
average remaining<br/>
contractual<br/>
term<br/>
(years)</b></span></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate<br/>
intrinsic<br/>
value</b></span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2024</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,151</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,665.36</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.37</span></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</span></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancelled/forfeited</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(227</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,438.45</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">924</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,475.78</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and expected to vest at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">924</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,475.78</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.41</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested and exercisable at December 31, 2025</span></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">764</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,264.58</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</span></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td>&#160;</td></tr> </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units and Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information about
the Company&#8217;s RSUs as of December 31, 2025, and activity during the year then ended:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-<br/> average<br/> grant date<br/> fair value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Unvested shares at December 31, 2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">21,957.75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">RSUs granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">RSUs vested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(20</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21,957.75</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">RSUs forfeited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Unvested Shares at December 31, 2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following weighted average assumptions were
used in estimating the grant date fair values in December 31, 2025 and 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">&#160;</span>&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Fair value of common stock</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,521.00</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected term (in years)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">6.02</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Risk-free rate</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">3.96</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Expected volatility</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">54.76</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Dividend yield</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Domestic and International Pre-Tax Loss</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Domestic and international pre-tax loss consists of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024 <br/> Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">United States</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(23,469,273</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(33,335,579</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">International</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(23,469,273</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(33,335,579</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Federal Statutory Income Tax Rate</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Income tax expense differed from the amount computed
by applying the federal statutory income tax rate of 21% to pretax income for the years ended December 31, 2025 and 2024 as a result of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">US Federal Statutory Tax Rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,928,547</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">21.00</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State and Local Income Taxes (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(211,513</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.90</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Foreign Tax Effects</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Tax Credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,010,247</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.30</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Change in Valuation Allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,421,241</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18.84</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nontaxable or Nondeductible Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Section 162m Limitation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">262,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.12</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Warrant Revaluation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">248,946</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.06</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 9pt">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">236,687</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.01</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in unrecognized tax benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303,074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.29</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Reconciling Items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-left: 9pt">Deferred True Up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">622,366</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.65</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 9pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">55,184</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.24</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>


<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify"><i>For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.</i></td></tr></table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/>
2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Federal tax at statutory rate</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,142,980</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">State income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(218,456</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,319</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Foreign taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax credits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,039,015</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Nondeductible items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,970</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,327,801</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Deferred true up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,165,581</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rate change</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717,809</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other items</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,029</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets: <b>&#160;</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 76%; padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,820,615</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,178,997</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development credits</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,713,764</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,006,591</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangibles</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">616,331</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">880,481</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(365,067</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(181,103</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock based compensation</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,813</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,339</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accruals and reserves</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,240</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">281,367</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155,914</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,751</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,491,200</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69,025</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized research costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,761,293</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,280,797</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,639</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross deferred tax assets</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,663,326</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,998,884</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 18.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(54,355,211</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(49,934,084</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,308,115</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,800</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax liabilities:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,308,115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,800</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred project costs</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 8.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax liabilities</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,308,115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64,800</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 16.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net deferred tax assets</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Gross Unrecognized Tax Benefits</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table reflects changes in gross
unrecognized tax benefits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Balance at beginning of year</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,002,825</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,545,189</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase in balance related to tax positions taken during the current year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">303,074</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">445,293</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Increase in balance related to tax positions taken during prior years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,343</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Decrease in balance related to prior year tax positions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Decrease in balance related to settlement with tax authorities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Balance at end of year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,305,899</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,002,825</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Restatement of Previously Issued Audited Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Restated Balance Sheet</a></td>
<td class="text"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<br/>
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated
balances as of December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">15,012,361</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">12,691,566</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">27,703,927</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,501,699</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,641,566</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,143,265</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Additional paid-in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200,863,551</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,558,271</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">192,305,280</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficits</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(189,269,903</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(193,353,198</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders&#8217; equity (deficit)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,593,650</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(12,641,566</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,047,916</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock', window );">Schedule of Restated Statements of Operations</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Warrant liability issuance costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,739,148</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,739,148</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total other income (expenses), net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(6,424,209</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(10,507,504</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss per share attributable to common stockholders, basic and diluted</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,212.56</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(308.85</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,521.41</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit)</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Stockholders&#8217; Equity (Deficit)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">20,972,722</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(8,558,270</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">12,414,453</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock', window );">Schedule of Restated Statement of Cash Flows</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(29,252,284</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(4,083,295</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(33,335,579</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss on issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,344,147</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant issuance costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,739,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,739,148</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses, lease liabilities, and other current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,642,938</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,652,581</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">990,357</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,493,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,702,581</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,196,081</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,369,285</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,558,271</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">13,811,014</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Proceeds from issuance of warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,260,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,260,852</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">26,584,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,702,581</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36,286,961</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Balance Sheet and Cash Flows</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Balance Sheet</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">297,778</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">247,778</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Statement of Cash Flows</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As<br/> Previously<br/> Reported</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustments</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Accounts Payable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">100,815</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(50,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">50,815</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedCashFlowStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedCashFlowStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 30, 2025</div></th>
<th class="th"><div>Jun. 25, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">1-for-150<span></span>
</td>
<td class="text">1-for-100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(216,822,471)<span></span>
</td>
<td class="num">(193,353,198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,576,656)<span></span>
</td>
<td class="num">(19,196,081)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_UnrestrictedCashBalance', window );">Unrestricted cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,736,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 990,023<span></span>
</td>
<td class="nump">$ 23,617,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">1-for-5<span></span>
</td>
<td class="text">1-for-5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DescriptionofBusinessDetailsLineItems', window );"><strong>Description of Business (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">1-for-150<span></span>
</td>
<td class="text">1-for-100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DescriptionofBusinessDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DescriptionofBusinessDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_UnrestrictedCashBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrestricted cash balance .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_UnrestrictedCashBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 23,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investment</a></td>
<td class="nump">33,736,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForOtherCreditLosses', window );">Credit losses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">118,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease', window );">Increase to research and development expense</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease', window );">Decrease in capitalized software costs</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite lived intangibles amortized</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 512,017<span></span>
</td>
<td class="nump">237,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Description of CODM</a></td>
<td class="text">The Company&#8217;s chief operating decision maker is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">chief operating decision maker<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts', window );">Deferred contract costs</a></td>
<td class="nump">$ 767,007<span></span>
</td>
<td class="nump">120,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 106,480<span></span>
</td>
<td class="nump">21,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock (in Shares) | shares</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Internal-Use Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charge</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Revenue from customer</a></td>
<td class="nump">$ 209,452<span></span>
</td>
<td class="nump">$ 274,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Internal-Use Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Internal-Use Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Summary of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock (in Shares) | shares</a></td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(d)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480095/942-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 942<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480035/942-10-S99-6<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-5<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-6<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 93: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 94: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 95: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 96: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 97: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-3<br><br>Reference 98: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 99: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 100: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 101: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 102: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 103: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 104: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 105: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br><br>Reference 106: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476151/220-40-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForOtherCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to credit loss from transactions other than loan and lease transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForOtherCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Asset&#8217;s Estimated Useful Life (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles (DMV-registered) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery, tools and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">Shorter of 3 years or lease term<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Schedule of Percentages of Total Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentages of total revenue</a></td>
<td class="nump">17.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Schedule of Percentages of Total Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentages of total revenue</a></td>
<td class="nump">36.80%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Schedule of Percentages of Total Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentages of total revenue</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="nump">73.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Schedule of Percentages of Total Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentages of total revenue</a></td>
<td class="nump">19.10%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer E [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Schedule of Percentages of Total Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentages of total revenue</a></td>
<td class="nump">12.30%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-size: 10pt">Below 10%</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-18<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cyngn_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cyngn_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cyngn_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cyngn_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cyngn_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cyngn_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cyngn_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cyngn_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cyngn_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cyngn_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue and Contracts with Customers (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2028</div></th>
<th class="th"><div>Dec. 31, 2027</div></th>
<th class="th"><div>Dec. 31, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RevenueandContractswithCustomersDetailsLineItems', window );"><strong>Revenue and Contracts with Customers (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 1,658,015<span></span>
</td>
<td class="nump">$ 769,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred contract costs</a></td>
<td class="nump">128,387<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">1,658,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 218,976<span></span>
</td>
<td class="nump">$ 368,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RevenueandContractswithCustomersDetailsLineItems', window );"><strong>Revenue and Contracts with Customers (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligations, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RevenueandContractswithCustomersDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RevenueandContractswithCustomersDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems', window );"><strong>Balance Sheet Components [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 2,039,655<span></span>
</td>
<td class="nump">$ 150,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">234,909<span></span>
</td>
<td class="nump">214,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="nump">42,500<span></span>
</td>
<td class="nump">28,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">$ 1,658,015<span></span>
</td>
<td class="nump">$ 769,180<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedBalanceSheetStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Short-Term Investments (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Financial assets</a></td>
<td class="nump">$ 34,665,255<span></span>
</td>
<td class="nump">$ 23,274,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CashEquivalentsAbstract', window );"><strong>Cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MoneyMarketFundsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">929,165<span></span>
</td>
<td class="nump">23,274,834<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestmentsAbstract', window );"><strong>Short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentSecuritiesAtCarryingValue', window );">Short-term investments</a></td>
<td class="nump">$ 33,736,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MoneyMarketFundsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MoneyMarketFundsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_USGovernmentSecuritiesAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt (bills, notes or bonds) that are issued by the government of the United States which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_USGovernmentSecuritiesAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Schedule of Prepaid Expenses and Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expenses</a></td>
<td class="nump">$ 668,090<span></span>
</td>
<td class="nump">$ 303,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term Deposits</a></td>
<td class="nump">75,006<span></span>
</td>
<td class="nump">160,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">775,334<span></span>
</td>
<td class="nump">128,138<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and expenses and other current assets</a></td>
<td class="nump">$ 1,518,430<span></span>
</td>
<td class="nump">$ 592,090<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 3,947,023<span></span>
</td>
<td class="nump">$ 3,105,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(678,827)<span></span>
</td>
<td class="num">(785,599)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">3,268,196<span></span>
</td>
<td class="nump">2,319,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember', window );">Automobiles (DMV-registered) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">28,862<span></span>
</td>
<td class="nump">128,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_MachineToolsAndEquipmentMember', window );">Machinery, tools and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">692,459<span></span>
</td>
<td class="nump">660,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers and equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">488,552<span></span>
</td>
<td class="nump">389,007<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,592,092<span></span>
</td>
<td class="nump">950,832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">73,494<span></span>
</td>
<td class="nump">66,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">175,417<span></span>
</td>
<td class="nump">221,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_TestingEquipmentMember', window );">Testing equipment (Work in Progress) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 896,147<span></span>
</td>
<td class="nump">$ 687,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AutomobilesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_MachineToolsAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_MachineToolsAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_TestingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cyngn_TestingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract', window );"><strong>Schedule of Accrued Expenses and Other Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CreditCardPayableCurrent', window );">Credit card payable</a></td>
<td class="nump">$ 16,169<span></span>
</td>
<td class="nump">$ 2,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">563,770<span></span>
</td>
<td class="nump">788,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll</a></td>
<td class="nump">2,035,795<span></span>
</td>
<td class="nump">1,314,038<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 2,615,734<span></span>
</td>
<td class="nump">$ 2,105,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CreditCardPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of credit card payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CreditCardPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Monthly payments</a></td>
<td class="nump">$ 104,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Monthly storage cost per unit</a></td>
<td class="nump">141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">1,170,932<span></span>
</td>
<td class="nump">$ 678,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 915,451<span></span>
</td>
<td class="nump">$ 694,373<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Schedule of Future Lease Payments Under the Non Cancellable Lease [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 692,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">1,434,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">1,506,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">1,551,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2030</a></td>
<td class="nump">1,598,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2031</a></td>
<td class="nump">1,367,166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,341,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liability</a></td>
<td class="nump">$ 6,807,621<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Schedule of Lease Cost (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Schedule of Lease Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">5 years 9 months 29 days<span></span>
</td>
<td class="text">5 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">4.87%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 32,223<span></span>
</td>
<td class="nump">$ 24,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Gain (loss) on disposal assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,831<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalvageAndSubrogationRecoveriesValue', window );">Salvage value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination', window );">Description of impairment charges</a></td>
<td class="text">long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets<span></span>
</td>
<td class="text">long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecapitalizationCosts', window );">Decrease in capitalized software costs</a></td>
<td class="nump">1,425,689<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecapitalizationCosts', window );">Decrease in capitalized software costs</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyngn_DevelopedSoftwareMember', window );">Developed Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Intangible Assets, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the method used by the entity to determine the fair value of the impaired intangible asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecapitalizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecapitalizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalvageAndSubrogationRecoveriesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated amount as of the balance sheet date to be received by an insurer from the sale of property (usually damaged) on which the insurer has paid a total claim to the insured and has obtained title to the property and the right of an insurer to pursue any course of recovery of damages, in its name or in the name of the policyholder, against a third party who is liable for costs relating to an insured event that have been paid by the insurer. Estimated salvage and subrogation is generally deducted from the liability for unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479224/944-40-30-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479224/944-40-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalvageAndSubrogationRecoveriesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyngn_DevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyngn_DevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 566,302<span></span>
</td>
<td class="nump">$ 2,081,761<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(100,079)<span></span>
</td>
<td class="num">(67,856)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment', window );">Fair Market Value Adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsImpairment', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(118,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">466,223<span></span>
</td>
<td class="nump">1,895,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">521,302<span></span>
</td>
<td class="nump">611,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(71,079)<span></span>
</td>
<td class="num">(41,856)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment', window );">Fair Market Value Adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsImpairment', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(118,831)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">450,223<span></span>
</td>
<td class="nump">450,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(29,000)<span></span>
</td>
<td class="num">(26,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment', window );">Fair Market Value Adjustment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsImpairment', window );">Impairment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Developed software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,425,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment', window );">Fair Market Value Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_FiniteLivedIntangibleAssetsImpairment', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,425,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of finite lived intangible assets fair market value adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_FiniteLivedIntangibleAssetsImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finite lived intangible assets impairment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_FiniteLivedIntangibleAssetsImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-38<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-31<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-29<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-20<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 24: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 26: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479876/805-20-55-14<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Schedule of Estimated Amortization Expense for All Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2026</a></td>
<td class="nump">$ 33,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2027</a></td>
<td class="nump">33,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2028</a></td>
<td class="nump">33,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2029</a></td>
<td class="nump">33,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Thereafter</a></td>
<td class="nump">331,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 466,223<span></span>
</td>
<td class="nump">$ 1,895,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 05, 2025</div></th>
<th class="th"><div>Jun. 27, 2025</div></th>
<th class="th"><div>Jun. 26, 2025</div></th>
<th class="th"><div>Jan. 30, 2025</div></th>
<th class="th"><div>Dec. 30, 2024</div></th>
<th class="th"><div>Dec. 23, 2024</div></th>
<th class="th"><div>Dec. 20, 2024</div></th>
<th class="th"><div>Nov. 12, 2024</div></th>
<th class="th"><div>Jun. 25, 2024</div></th>
<th class="th"><div>May 03, 2024</div></th>
<th class="th"><div>Apr. 23, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,974,380<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,974,380<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock', window );">Pre-funded warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,979,769<span></span>
</td>
<td class="nump">2,801,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_PreFundedWarrantsPricePerShare', window );">Pre funded warrants price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.49999<span></span>
</td>
<td class="nump">$ 5.00999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses payable (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of units at a public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Public offering price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant nominal exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_PrefundedUnitsAtAPublicOfferingPrice', window );">Pre-funded units at a public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Issuance of units at a public offering price (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,864,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of warrants (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 18,260,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares', window );">Pre-funded warrant exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate offering price (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,931,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CommissionProceedPercentage', window );">Gross proceeds, percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,472,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Commission fees (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLaborRelatedExpenses', window );">Other related expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesAWarrantMember', window );">Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant nominal exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301.875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrents in an unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesBWarrantMember', window );">Series B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant nominal exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301.875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrents in an unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_PreFundedWarrantsMember', window );">Pre-Funded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant nominal exercise price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares', window );">Pre-funded warrant exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrents in an unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518,033<span></span>
</td>
<td class="nump">361,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of warrants (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Offering-related issuance costs (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of units at a public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,552,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Public offering price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate offering price (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock [Member] | Series A Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsToPurchase', window );">Warrant purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock [Member] | Series B Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Common Unit, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cyngn_AegisCapitalCorpMember', window );">Aegis Capital Corp. [Member] | Common stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">935,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cyngn_CommonStockOfferingsMember', window );">Common Stock Offerings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,700,000<span></span>
</td>
<td class="nump">$ 15,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Public offering price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of units at a public offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Public offering price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 241.485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Issuance of units at a public offering price (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,499.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_AtTheMarketEquityFinancingMember', window );">At the Market Equity Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate offering price (in Dollars)</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_PrivatePlacementOfferingMember', window );">Private Placement Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Capital Structure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds received (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 12,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommissionProceedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission Proceed Percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommissionProceedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of pre-funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PreFundedWarrantsPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PreFundedWarrantsPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PrefundedUnitsAtAPublicOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded units at a public offering price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PrefundedUnitsAtAPublicOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants to purchase shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantsToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantsToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for cost associated with issuance of security by investment company. Includes, but is not limited to, legal fee pertaining to share offered for sale, registration fee, underwriting, printing prospectus, and initial fee for listing on exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLaborRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of labor-related expenses classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLaborRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesAWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesAWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesBWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesBWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cyngn_AegisCapitalCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cyngn_AegisCapitalCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cyngn_CommonStockOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cyngn_CommonStockOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_AtTheMarketEquityFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cyngn_AtTheMarketEquityFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_PrivatePlacementOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cyngn_PrivatePlacementOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure - Schedule of Securities Warrants are Convertible (Details) - Warrant [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Schedule of Securities Warrants are Convertible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">518,033<span></span>
</td>
<td class="nump">361,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value</a></td>
<td class="nump">$ 13,875,939<span></span>
</td>
<td class="nump">$ 33,945,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesAMember', window );">Series A [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Schedule of Securities Warrants are Convertible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">517,598<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price</a></td>
<td class="nump">$ 48.3<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsAndRightOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">January 2030<span></span>
</td>
<td class="text">January 2030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value</a></td>
<td class="nump">$ 7,634,428<span></span>
</td>
<td class="nump">$ 6,581,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember', window );">Series B [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Schedule of Securities Warrants are Convertible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 301.875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsAndRightOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">July 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,122,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Schedule of Securities Warrants are Convertible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price</a></td>
<td class="nump">$ 40,650<span></span>
</td>
<td class="nump">$ 40,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsAndRightOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">October 2026<span></span>
</td>
<td class="text">October 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value</a></td>
<td class="nump">$ 170,397<span></span>
</td>
<td class="nump">$ 170,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Schedule of Securities Warrants are Convertible [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">426<span></span>
</td>
<td class="nump">426<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price</a></td>
<td class="nump">$ 140,625<span></span>
</td>
<td class="nump">$ 140,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsAndRightOutstandingMaturityDate', window );">Expiration Date</a></td>
<td class="text">April 2027<span></span>
</td>
<td class="text">April 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Fair value</a></td>
<td class="nump">$ 6,071,114<span></span>
</td>
<td class="nump">$ 6,071,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantsAndRightOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantsAndRightOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis=us-gaap_SeriesBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Schedule of Fair Value of Warrants (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Initial Public Offering Warrants (Oct 2021) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">2.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Private Placement Warrants (Apr 2022) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">1.37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">14.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Black-Scholes Model [Member] | Minimum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">6.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Black-Scholes Model [Member] | Maximum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">32.19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Monte Carlo Pricing Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">0.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Fair value of underlying securities [Member] | Monte Carlo Pricing Model [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">0.85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Initial Public Offering Warrants (Oct 2021) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Private Placement Warrants (Apr 2022) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">183.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Black-Scholes Model [Member] | Minimum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">162.99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Black-Scholes Model [Member] | Maximum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">190.53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Monte Carlo Pricing Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">161.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Expected volatility [Member] | Monte Carlo Pricing Model [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">161.78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Initial Public Offering Warrants (Oct 2021) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Private Placement Warrants (Apr 2022) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Black-Scholes Model [Member] | Minimum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">2.46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Black-Scholes Model [Member] | Maximum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">2.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Monte Carlo Pricing Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected term (in years) [Member] | Monte Carlo Pricing Model [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Initial Public Offering Warrants (Oct 2021) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">1.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Private Placement Warrants (Apr 2022) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">2.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Black-Scholes Model [Member] | Minimum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Black-Scholes Model [Member] | Maximum [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Monte Carlo Pricing Model [Member] | Series A Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate [Member] | Monte Carlo Pricing Model [Member] | Series B Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Schedule of Fair Value of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">4.29<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_InitialPublicOfferingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_InitialPublicOfferingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesAWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesAWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=cyngn_BlackScholesModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=cyngn_BlackScholesModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesBWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cyngn_SeriesBWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=cyngn_MonteCarloPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=cyngn_MonteCarloPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Schedule of Basic and Diluted Loss Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">4,540,481<span></span>
</td>
<td class="nump">13,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">4,540,481<span></span>
</td>
<td class="nump">13,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="num">$ (5.17)<span></span>
</td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="num">$ (5.17)<span></span>
</td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1', window );">Contractual term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Estimated dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average per share (in Dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Outstanding unvested stock options (in Dollars)</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense (in Dollars)</a></td>
<td class="nump">$ 1,620,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,449,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cyngn_TwoThousandTwentyOnePlanMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_CommonStockOutstandingPercentage', window );">Common stock outstanding percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved and available for issuance</a></td>
<td class="nump">55,770<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cyngn_TwentyTwentyOneEquityIncentivePlanMember', window );">2021 Equity Incentive Plan [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based Compensation Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares authorized for issuance</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_CommonStockOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_CommonStockOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum term of the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482943/710-10-55-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cyngn_TwoThousandTwentyOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cyngn_TwoThousandTwentyOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cyngn_TwentyTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cyngn_TwentyTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Schedule of Stock Options Vested and Exercisable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, outstanding at Ending balance</a></td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price, outstanding at Ending balance (in Dollars per share)</a></td>
<td class="nump">$ 14,665.36<span></span>
</td>
<td class="nump">$ 13,475.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term (years), outstanding at Ending balance</a></td>
<td class="text">7 years 4 months 13 days<span></span>
</td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding at Ending balance (in Dollars)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares, vested and expected to vest at ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,475.78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term (years), vested and expected to vest at ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 4 months 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Shares, vested and exercisable at ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price, vested and exercisable at ending balance (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,264.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average exercise price, vested and exercisable at ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted- average exercise price, Granted (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Aggregate intrinsic value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price, Exercised (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Exercised (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Cancelled/forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price, Cancelled/forfeited (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,438.45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details) - Restricted Stock Units (RSUs) [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Unvested shares beginning balance | shares</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, beginning balance | $ / shares</a></td>
<td class="nump">$ 21,957.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, RSUs granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, RSUs granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, RSUs vested | shares</a></td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, RSUs vested | $ / shares</a></td>
<td class="num">$ (21,957.75)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, RSUs forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, RSUs forfeited | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Unvested shares ending balance | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, ending balance | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Fair value of common stock (in Dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text"> <span></span>
</td>
<td class="text">6 years 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">3.96%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">54.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,327,800<span></span>
</td>
<td class="nump">$ 4,421,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="nump">$ 763,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 2,545,189<span></span>
</td>
<td class="nump">$ 3,305,899<span></span>
</td>
<td class="nump">$ 3,002,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Total unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,305,899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Federal and state income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,732,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Federal and state research credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,526,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Federal and state income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,845,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Federal and state research credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,421,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=cyngn_TwoZeroThreeFourMember', window );">Two Zero Three Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Federal and state income tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126,395,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=cyngn_TwoZeroThreeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=cyngn_TwoZeroThreeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Schedule of Domestic and International Pre-Tax Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">$ (23,469,273)<span></span>
</td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems', window );"><strong>Effective Income Tax Rate Reconciliation [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">US Federal Statutory Tax Rate, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (4,928,547)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (6,142,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">US Federal Statutory Tax Rate, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and Local Income Taxes, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (211,513)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(218,456)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and Local Income Taxes, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.90%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock based compensation, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">180,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign Tax Effects, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCredits', window );">Tax Credits, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (1,010,247)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,039,015)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax Credits, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation Allowance, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,421,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,327,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in Valuation Allowance, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(18.84%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Rate change, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">717,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_NontaxableOrNondeductibleItemsAbstract', window );"><strong>Nontaxable or Nondeductible Items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible items, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Change in unrecognized tax benefits, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 303,074<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in unrecognized tax benefits, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.29%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_OtherReconcilingItemsAbstract', window );"><strong>Other Reconciling Items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Deferred True Up, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 622,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,165,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Deferred True Up. Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2.65%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other. Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 55,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(18,029)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.24%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_Section162mLimitationMember', window );">Section 162m Limitation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_NontaxableOrNondeductibleItemsAbstract', window );"><strong>Nontaxable or Nondeductible Items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible items, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 262,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible items, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.12%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_WarrantRevaluationMember', window );">Warrant Revaluation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_NontaxableOrNondeductibleItemsAbstract', window );"><strong>Nontaxable or Nondeductible Items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible items, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 248,946<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible items, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.06%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_OtherPermanentDifferencesMember', window );">Other Permanent Differences [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_NontaxableOrNondeductibleItemsAbstract', window );"><strong>Nontaxable or Nondeductible Items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Nondeductible items, Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 236,687<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Nondeductible items, Percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1.01%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><i>For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.</i></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_NontaxableOrNondeductibleItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_NontaxableOrNondeductibleItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_OtherReconcilingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_OtherReconcilingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_Section162mLimitationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_Section162mLimitationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_WarrantRevaluationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_WarrantRevaluationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_OtherPermanentDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceByDeferredTaxAssetAxis=cyngn_OtherPermanentDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 41,820,615<span></span>
</td>
<td class="nump">$ 36,178,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development credits</a></td>
<td class="nump">7,713,764<span></span>
</td>
<td class="nump">7,006,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">616,331<span></span>
</td>
<td class="nump">880,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsFixedAssets', window );">Fixed assets</a></td>
<td class="num">(365,067)<span></span>
</td>
<td class="num">(181,103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="nump">27,813<span></span>
</td>
<td class="nump">452,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Accruals and reserves</a></td>
<td class="nump">441,240<span></span>
</td>
<td class="nump">281,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">155,914<span></span>
</td>
<td class="nump">21,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">1,491,200<span></span>
</td>
<td class="nump">69,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DeferredTaxAssetsCapitalizedResearchCosts', window );">Capitalized research costs</a></td>
<td class="nump">3,761,293<span></span>
</td>
<td class="nump">5,280,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">8,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">55,663,326<span></span>
</td>
<td class="nump">49,998,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(54,355,211)<span></span>
</td>
<td class="num">(49,934,084)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">1,308,115<span></span>
</td>
<td class="nump">64,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right of use asset</a></td>
<td class="num">(1,308,115)<span></span>
</td>
<td class="num">(64,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts', window );">Deferred project costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(1,308,115)<span></span>
</td>
<td class="num">(64,800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsCapitalizedResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capitalized research costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsCapitalizedResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed assets .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract', window );"><strong>Schedule of Gross Unrecognized Tax Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 3,002,825<span></span>
</td>
<td class="nump">$ 2,545,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase in balance related to tax positions taken during the current year</a></td>
<td class="nump">303,074<span></span>
</td>
<td class="nump">445,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase in balance related to tax positions taken during prior years</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">12,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in balance related to prior year tax positions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Decrease in balance related to settlement with tax authorities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 3,305,899<span></span>
</td>
<td class="nump">$ 3,002,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Accrual expences</a></td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_SettlementAgreementAmount', window );">Settlement agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantsToPurchaseShares', window );">Warrants to purchase shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">One-time payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember', window );">Damages from Product Defects [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies [LIne Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Complaint seeks in damage amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_SettlementAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of  settlement agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_SettlementAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantsToPurchaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants to purchase shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantsToPurchaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 19, 2026</div></th>
<th class="th"><div>Mar. 16, 2026</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Registered Direct Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,686,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock', window );">Pre-funded warrants to purchase shares of common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,313,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_PreFundedWarrantsPricePerShare', window );">Pre funded warrants price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.92999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseOfferingCost', window );">Offering expenses payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_SalesAgreementWithAegisCapitalMember', window );">Sales Agreement with Aegis Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Events [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Share sold (in Shares)</a></td>
<td class="nump">3,922,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from sale</a></td>
<td class="nump">$ 9,166,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Payment of commission and fees</a></td>
<td class="nump">$ 283,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PreFundedWarrantsPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PreFundedWarrantsPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded warrants to purchase shares of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseOfferingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for cost associated with issuance of security by investment company. Includes, but is not limited to, legal fee pertaining to share offered for sale, registration fee, underwriting, printing prospectus, and initial fee for listing on exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseOfferingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cyngn_RegisteredDirectOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cyngn_RegisteredDirectOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cyngn_SalesAgreementWithAegisCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cyngn_SalesAgreementWithAegisCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements (Details) - Previously Reported [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Restatement of Previously Issued Audited Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liability</a></td>
<td class="nump">$ 12,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Decrease in equity balance</a></td>
<td class="nump">12,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_GainLossOnIssuanceOfWarrant', window );">Loss on the issuance of the Warrants</a></td>
<td class="nump">2,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_OfferingRelatedIssuanceCosts', window );">Offering-related issuance costs</a></td>
<td class="nump">1,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Issuance costs on an equity transaction</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid in capital common stock</a></td>
<td class="nump">$ 88,024<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_GainLossOnIssuanceOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss issuance of the Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_GainLossOnIssuanceOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_OfferingRelatedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering-related issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_OfferingRelatedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479567/321-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Balance Sheet [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">$ 15,012,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,501,699<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">200,863,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficits</a></td>
<td class="num">(189,269,903)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">11,593,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Balance Sheet [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">12,691,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,641,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="num">(8,558,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficits</a></td>
<td class="num">(4,083,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">(12,641,566)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Balance Sheet [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liability</a></td>
<td class="nump">27,703,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">31,143,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">192,305,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficits</a></td>
<td class="num">(193,353,198)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">$ (1,047,916)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedBalanceSheetStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Report [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statements of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantLiabilityIssuanceCosts', window );">Warrant liability issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses), net</a></td>
<td class="num">(6,424,209)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,252,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (2,212.56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (2,212.56)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statements of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantLiabilityIssuanceCosts', window );">Warrant liability issuance costs</a></td>
<td class="num">$ (1,739,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="num">(2,344,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses), net</a></td>
<td class="num">(4,083,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (4,083,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (308.85)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (308.85)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedIncomeStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statements of Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantLiabilityIssuanceCosts', window );">Warrant liability issuance costs</a></td>
<td class="num">$ (1,739,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="num">(2,344,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expenses), net</a></td>
<td class="num">(10,507,504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in Dollars per share) | $ / shares</a></td>
<td class="num">$ (2,521.41)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantLiabilityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant liability issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantLiabilityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedIncomeStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedIncomeStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems', window );"><strong>Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn', window );">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</a></td>
<td class="nump">$ 20,972,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(29,252,284)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsPreviouslyReportMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems', window );"><strong>Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn', window );">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</a></td>
<td class="num">(8,558,270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(4,083,295)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_RestatedMember', window );">Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems', window );"><strong>Schedule of Restated Statement of Stockholders&#8217; Equity (Deficit) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn', window );">Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings</a></td>
<td class="nump">12,414,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (33,335,579)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock and pre-funded warrants in connection with the public offering, net of offering cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsPreviouslyReportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsPreviouslyReportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_RestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_RestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statement of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (29,252,284)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantIssuanceCosts', window );">Warrant issuance costs</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses, lease liabilities, and other current liabilities</a></td>
<td class="nump">10,642,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">9,493,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts', window );">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</a></td>
<td class="nump">22,369,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">26,584,380<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsPreviouslyReportMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statement of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(4,083,295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">2,344,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantIssuanceCosts', window );">Warrant issuance costs</a></td>
<td class="nump">1,739,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses, lease liabilities, and other current liabilities</a></td>
<td class="num">(9,652,581)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">9,702,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts', window );">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</a></td>
<td class="num">(8,558,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">18,260,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">9,702,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedCashFlowStatementsCaptionsLineItems', window );"><strong>Schedule of Restated Statement of Cash Flows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(33,335,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_LossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">2,344,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_WarrantIssuanceCosts', window );">Warrant issuance costs</a></td>
<td class="nump">1,739,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses, lease liabilities, and other current liabilities</a></td>
<td class="nump">990,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="nump">19,196,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts', window );">Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants</a></td>
<td class="nump">13,811,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of warrants</a></td>
<td class="nump">18,260,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">$ 36,286,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_LossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_LossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public issuance of common stock and pre-funded warrants, net of offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyngn_WarrantIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of warrant issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyngn_WarrantIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyngn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedCashFlowStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedCashFlowStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsPreviouslyReportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsPreviouslyReportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">$ 297,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts Payable</a></td>
<td class="nump">100,815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts Payable</a></td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=cyngn_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">247,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts Payable</a></td>
<td class="nump">$ 50,815<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=cyngn_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=cyngn_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>193</ContextCount>
  <ElementCount>414</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Stockholders??? Equity (Deficit) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Stockholders??? Equity (Deficit) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Revenue and Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RevenueandContractswithCustomers</Role>
      <ShortName>Revenue and Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Operating Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/OperatingLeases</Role>
      <ShortName>Operating Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Stock-Based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpense</Role>
      <ShortName>Stock-Based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Retirement Savings Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RetirementSavingsPlan</Role>
      <ShortName>Retirement Savings Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RisksandUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995320 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995321 - Disclosure - Restatement of Previously Issued Audited Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponents</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Operating Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/OperatingLeasesTables</Role>
      <ShortName>Operating Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/OperatingLeases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructure</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Stock-Based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpenseTables</Role>
      <ShortName>Stock-Based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpense</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/DescriptionofBusiness</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset???s Estimated Useful Life (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Asset???s Estimated Useful Life (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Revenue and Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RevenueandContractswithCustomersDetails</Role>
      <ShortName>Revenue and Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/RevenueandContractswithCustomers</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Balance Sheet Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/BalanceSheetComponentsDetails</Role>
      <ShortName>Balance Sheet Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/BalanceSheetComponentsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Balance Sheet Components - Schedule of Short-Term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofShortTermInvestmentsTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Short-Term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofPropertyandEquipmentTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/OperatingLeasesDetails</Role>
      <ShortName>Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/OperatingLeasesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable</Role>
      <ShortName>Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Operating Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofLeaseCostTable</Role>
      <ShortName>Operating Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IntangibleAssetsNetTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable</Role>
      <ShortName>Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable</Role>
      <ShortName>Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Capital Structure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CapitalStructureDetails</Role>
      <ShortName>Capital Structure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/CapitalStructureTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Capital Structure - Schedule of Securities Warrants are Convertible (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable</Role>
      <ShortName>Capital Structure - Schedule of Securities Warrants are Convertible (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Capital Structure - Schedule of Fair Value of Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofFairValueofWarrantsTable</Role>
      <ShortName>Capital Structure - Schedule of Fair Value of Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/StockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/StockBasedCompensationExpenseTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable</Role>
      <ShortName>Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable</Role>
      <ShortName>Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable</Role>
      <ShortName>Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/IncomeTaxesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable</Role>
      <ShortName>Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996036 - Disclosure - Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable</Role>
      <ShortName>Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996038 - Disclosure - Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable</Role>
      <ShortName>Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996039 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/CommitmentsandContingencies</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996040 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/SubsequentEvents</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996041 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996042 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996043 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996044 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders??? Equity (Deficit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders??? Equity (Deficit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ea0277796-10k_cyngn.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996046 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable</Role>
      <ShortName>Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cyngn-20251231.xsd</File>
    <File>cyngn-20251231_cal.xml</File>
    <File>cyngn-20251231_def.xml</File>
    <File>cyngn-20251231_lab.xml</File>
    <File>cyngn-20251231_pre.xml</File>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ea0277796-10k_cyngn.htm">ea0277796-10k_cyngn.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ea027779601_img1.jpg</File>
    <File>ea027779601_img2.jpg</File>
    <File>ea027779601_img3.jpg</File>
    <File>ea027779601_img4.jpg</File>
    <File>ea027779601_img5.jpg</File>
    <File>ea027779601_img6.jpg</File>
    <File>ea027779601_img7.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2025</BaseTaxonomy>
    <BaseTaxonomy items="804">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="41">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>101
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0277796-10k_cyngn.htm": {
   "nsprefix": "cyngn",
   "nsuri": "http://cyngn.com/20251231",
   "dts": {
    "schema": {
     "local": [
      "cyngn-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "cyngn-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cyngn-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "cyngn-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyngn-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0277796-10k_cyngn.htm"
     ]
    }
   },
   "keyStandard": 372,
   "keyCustom": 42,
   "axisStandard": 25,
   "axisCustom": 0,
   "memberStandard": 40,
   "memberCustom": 32,
   "hidden": {
    "total": 138,
    "http://fasb.org/us-gaap/2025": 106,
    "http://cyngn.com/20251231": 29,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 193,
   "entityCount": 1,
   "segmentCount": 74,
   "elementCount": 858,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 804,
    "http://xbrl.sec.gov/dei/2025": 41,
    "http://xbrl.sec.gov/cyd/2025": 7,
    "http://xbrl.sec.gov/ecd/2025": 5,
    "http://fasb.org/srt/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://cyngn.com/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "5",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R5": {
     "role": "http://cyngn.com/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://cyngn.com/role/ShareholdersEquityType2or3",
     "longName": "995304 - Statement - Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "shortName": "Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c8",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c8",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals",
     "longName": "995305 - Statement - Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parentheticals)",
     "shortName": "Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://cyngn.com/role/ConsolidatedCashFlow",
     "longName": "995306 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://cyngn.com/role/DescriptionofBusiness",
     "longName": "995307 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "995308 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://cyngn.com/role/RevenueandContractswithCustomers",
     "longName": "995309 - Disclosure - Revenue and Contracts with Customers",
     "shortName": "Revenue and Contracts with Customers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://cyngn.com/role/BalanceSheetComponents",
     "longName": "995310 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://cyngn.com/role/OperatingLeases",
     "longName": "995311 - Disclosure - Operating Leases",
     "shortName": "Operating Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://cyngn.com/role/IntangibleAssetsNet",
     "longName": "995312 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://cyngn.com/role/CapitalStructure",
     "longName": "995313 - Disclosure - Capital Structure",
     "shortName": "Capital Structure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders",
     "longName": "995314 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://cyngn.com/role/StockBasedCompensationExpense",
     "longName": "995315 - Disclosure - Stock-Based Compensation Expense",
     "shortName": "Stock-Based Compensation Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://cyngn.com/role/RetirementSavingsPlan",
     "longName": "995316 - Disclosure - Retirement Savings Plan",
     "shortName": "Retirement Savings Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://cyngn.com/role/IncomeTaxes",
     "longName": "995317 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://cyngn.com/role/CommitmentsandContingencies",
     "longName": "995318 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://cyngn.com/role/RisksandUncertainties",
     "longName": "995319 - Disclosure - Risks and Uncertainties",
     "shortName": "Risks and Uncertainties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://cyngn.com/role/SubsequentEvents",
     "longName": "995320 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements",
     "longName": "995321 - Disclosure - Restatement of Previously Issued Audited Financial Statements",
     "shortName": "Restatement of Previously Issued Audited Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c192",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c192",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://cyngn.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "cyngn:ScheduleOfPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "cyngn:ScheduleOfPropertyAndEquipmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://cyngn.com/role/BalanceSheetComponentsTables",
     "longName": "996002 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://cyngn.com/role/OperatingLeasesTables",
     "longName": "996003 - Disclosure - Operating Leases (Tables)",
     "shortName": "Operating Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://cyngn.com/role/IntangibleAssetsNetTables",
     "longName": "996004 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://cyngn.com/role/CapitalStructureTables",
     "longName": "996005 - Disclosure - Capital Structure (Tables)",
     "shortName": "Capital Structure (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
     "longName": "996006 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://cyngn.com/role/StockBasedCompensationExpenseTables",
     "longName": "996007 - Disclosure - Stock-Based Compensation Expense (Tables)",
     "shortName": "Stock-Based Compensation Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://cyngn.com/role/IncomeTaxesTables",
     "longName": "996008 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables",
     "longName": "996009 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Tables)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://cyngn.com/role/DescriptionofBusinessDetails",
     "longName": "996010 - Disclosure - Description of Business (Details)",
     "shortName": "Description of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c32",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "cyngn:UnrestrictedCashBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R39": {
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "996011 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ix:continuation",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife",
     "longName": "996012 - Disclosure - Summary of Significant Accounting Policies - Schedule of Asset\u2019s Estimated Useful Life (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Asset\u2019s Estimated Useful Life (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c43",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c43",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable",
     "longName": "996013 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Percentages of Total Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c48",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c48",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://cyngn.com/role/RevenueandContractswithCustomersDetails",
     "longName": "996014 - Disclosure - Revenue and Contracts with Customers (Details)",
     "shortName": "Revenue and Contracts with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:DeferredCostsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://cyngn.com/role/BalanceSheetComponentsDetails",
     "longName": "996015 - Disclosure - Balance Sheet Components (Details)",
     "shortName": "Balance Sheet Components (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:InventoryNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable",
     "longName": "996016 - Disclosure - Balance Sheet Components - Schedule of Short-Term Investments (Details)",
     "shortName": "Balance Sheet Components - Schedule of Short-Term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable",
     "longName": "996017 - Disclosure - Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
     "longName": "996018 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable",
     "longName": "996019 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "cyngn:CreditCardPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "cyngn:CreditCardPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://cyngn.com/role/OperatingLeasesDetails",
     "longName": "996020 - Disclosure - Operating Leases (Details)",
     "shortName": "Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable",
     "longName": "996021 - Disclosure - Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)",
     "shortName": "Operating Leases - Schedule of Future Lease Payments under the Non-Cancellable Lease (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://cyngn.com/role/ScheduleofLeaseCostTable",
     "longName": "996022 - Disclosure - Operating Leases - Schedule of Lease Cost (Details)",
     "shortName": "Operating Leases - Schedule of Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://cyngn.com/role/IntangibleAssetsNetDetails",
     "longName": "996023 - Disclosure - Intangible Assets, Net (Details)",
     "shortName": "Intangible Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable",
     "longName": "996024 - Disclosure - Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Gross Carrying Amount and Accumulated Amortization (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable",
     "longName": "996025 - Disclosure - Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Estimated Amortization Expense for All Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://cyngn.com/role/CapitalStructureDetails",
     "longName": "996026 - Disclosure - Capital Structure (Details)",
     "shortName": "Capital Structure (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c85",
      "name": "cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
     "longName": "996027 - Disclosure - Capital Structure - Schedule of Securities Warrants are Convertible (Details)",
     "shortName": "Capital Structure - Schedule of Securities Warrants are Convertible (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c39",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c39",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
     "longName": "996028 - Disclosure - Capital Structure - Schedule of Fair Value of Warrants (Details)",
     "shortName": "Capital Structure - Schedule of Fair Value of Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c133",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c133",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable",
     "longName": "996029 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details)",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://cyngn.com/role/StockBasedCompensationExpenseDetails",
     "longName": "996030 - Disclosure - Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable",
     "longName": "996031 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details)",
     "shortName": "Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable",
     "longName": "996032 - Disclosure - Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details)",
     "shortName": "Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c169",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c169",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable",
     "longName": "996033 - Disclosure - Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details)",
     "shortName": "Stock-Based Compensation Expense - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:SharePrice",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:SharePrice",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://cyngn.com/role/IncomeTaxesDetails",
     "longName": "996034 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable",
     "longName": "996035 - Disclosure - Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details)",
     "shortName": "Income Taxes - Schedule of Domestic and International Pre-Tax Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable",
     "longName": "996036 - Disclosure - Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details)",
     "shortName": "Income Taxes - Schedule of Federal Statutory Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable",
     "longName": "996037 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c3",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable",
     "longName": "996038 - Disclosure - Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Gross Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://cyngn.com/role/CommitmentsandContingenciesDetails",
     "longName": "996039 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c180",
      "name": "us-gaap:LossContingencyAccrualPayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c180",
      "name": "us-gaap:LossContingencyAccrualPayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://cyngn.com/role/SubsequentEventsDetails",
     "longName": "996040 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c182",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c182",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails",
     "longName": "996041 - Disclosure - Restatement of Previously Issued Audited Financial Statements (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c184",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c184",
      "name": "us-gaap:FairValueAdjustmentOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
     "longName": "996042 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c185",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c185",
      "name": "us-gaap:WarrantsAndRightsOutstanding",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable",
     "longName": "996043 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statements of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c184",
      "name": "cyngn:WarrantLiabilityIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c184",
      "name": "cyngn:WarrantLiabilityIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable",
     "longName": "996044 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders\u2019 Equity (Deficit) (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders\u2019 Equity (Deficit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c184",
      "name": "cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c184",
      "name": "cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
     "longName": "996045 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c184",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedIncomeStatementTableTextBlock",
       "cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c184",
      "name": "cyngn:WarrantIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable",
     "longName": "996046 - Disclosure - Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)",
     "shortName": "Restatement of Previously Issued Audited Financial Statements - Schedule of Balance Sheet and Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c185",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c185",
      "name": "us-gaap:AccountsPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0277796-10k_cyngn.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement of Previously Issued Audited Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and other receivables",
        "label": "Accounts and Other Receivables, Net, Current",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accrued expenses and other current liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts Payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r860"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r1167"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable [Member]",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r759",
      "r1058"
     ]
    },
    "cyngn_AccretionOnShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AccretionOnShorttermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accretion on short-term investments",
        "documentation": "Accretion on short-term investments.",
        "label": "Accretion On Shortterm Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Expenses and Other Current Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedPayrollTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll",
        "label": "Accrued Payroll Taxes, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r133",
      "r637"
     ]
    },
    "cyngn_AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued expenses",
        "documentation": "Acquisition of property and equipment included in accounts payable and accrued expenses.",
        "label": "Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of right-of-use asset in exchange for new operating lease obligation",
        "documentation": "Acquisition of right-of-use asset in exchange for new operating lease obligation.",
        "label": "Acquisition Of Rightofuse Asset In Exchange For New Operating Lease Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r860",
      "r1201"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "verboseLabel": "Additional paid in capital common stock",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r1047",
      "r1048",
      "r1049",
      "r1052",
      "r1141",
      "r1204"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1099",
      "r1101"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r814"
     ]
    },
    "cyngn_AegisCapitalCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AegisCapitalCorpMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aegis Capital Corp. [Member]",
        "label": "Aegis Capital Corp Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r916",
      "r932",
      "r967"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r908",
      "r919",
      "r935",
      "r970"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r962",
      "r971",
      "r975",
      "r983"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense (in Dollars)",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r437",
      "r446"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for credit losses",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r256",
      "r262",
      "r263",
      "r264",
      "r1168"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of interest and amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r801",
      "r802",
      "r1037",
      "r1149"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r159",
      "r273",
      "r279",
      "r769",
      "r773",
      "r774",
      "r776",
      "r778"
     ]
    },
    "us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmountOfDeferredCostsRelatedToLongTermContracts",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract costs",
        "label": "Amount of Deferred Costs Related to Long-Term Contracts",
        "documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_AsPreviouslyReportMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AsPreviouslyReportMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments [Member]",
        "label": "As Previously Report Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_AsRestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AsRestatedMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As Restated [Member]",
        "label": "As Restated Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patent impairment",
        "verboseLabel": "Impairment charge",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r18",
      "r861",
      "r862"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r88",
      "r135",
      "r174",
      "r176",
      "r177",
      "r221",
      "r234",
      "r247",
      "r248",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r514",
      "r516",
      "r571",
      "r622",
      "r623",
      "r628",
      "r712",
      "r791",
      "r792",
      "r803",
      "r860",
      "r866",
      "r867",
      "r878",
      "r1095",
      "r1096",
      "r1157"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT ASSETS",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r146",
      "r174",
      "r176",
      "r177",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r514",
      "r516",
      "r571",
      "r860",
      "r1095",
      "r1096",
      "r1157"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT ASSETS",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NON-CURRENT ASSETS",
        "label": "Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_AtTheMarketEquityFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "AtTheMarketEquityFinancingMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At the Market Equity Financing [Member]",
        "label": "At The Market Equity Financing Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AuctionMarketPreferredSecuritiesStockSeriesAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auction Market Preferred Securities, Stock Series [Axis]",
        "documentation": "Information by title of series or issue of auction market preferred securities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r25",
      "r40"
     ]
    },
    "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesTitleDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AuctionMarketPreferredSecuritiesStockSeriesTitleDomain",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auction Market Preferred Securities, Stock Series, Title [Domain]",
        "documentation": "Title of series or issue of auction market preferred securities based on rights (names are typically labeled by day of the week, duration between intervals, or combination of both)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r25",
      "r40"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AutomobilesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AutomobilesMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Automobiles (DMV-registered) [Member]",
        "label": "Automobiles [Member]",
        "documentation": "Vehicles that are used primarily for transporting people."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Domain]",
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r978"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r977"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r976"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "cyngn_BalanceSheetComponentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "BalanceSheetComponentsDetailsTable",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Components (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Components [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "cyngn_BlackScholesModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "BlackScholesModelMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Black-Scholes Model [Member]",
        "label": "Black Scholes Model Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r894",
      "r912"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of Business",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r1027",
      "r1038"
     ]
    },
    "cyngn_CapitalStructureDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CapitalStructureDetailsTable",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedComputerSoftwarePeriodIncreaseDecrease",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in capitalized software costs",
        "label": "Capitalized Computer Software, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in capitalized computer software costs."
       }
      }
     },
     "auth_ref": [
      "r1207"
     ]
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r631",
      "r687",
      "r707",
      "r860",
      "r866",
      "r867",
      "r878",
      "r1030"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r131",
      "r770"
     ]
    },
    "cyngn_CashAndShorttermInvestmentsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CashAndShorttermInvestmentsPolicyPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Short-term Investments",
        "documentation": "Disclosure of accounting policy regarding cash and short term investments.",
        "label": "Cash And Shortterm Investments Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Financial assets",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable."
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of year",
        "periodEndLabel": "Cash and cash equivalents, end of year",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r59",
      "r171"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation",
        "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r59"
     ]
    },
    "cyngn_CashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CashEquivalentsAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents:",
        "label": "Cash Equivalents Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r137",
      "r138",
      "r139",
      "r174",
      "r177",
      "r209",
      "r210",
      "r213",
      "r215",
      "r223",
      "r224",
      "r257",
      "r302",
      "r304",
      "r305",
      "r306",
      "r309",
      "r310",
      "r319",
      "r320",
      "r322",
      "r323",
      "r325",
      "r327",
      "r330",
      "r331",
      "r334",
      "r337",
      "r344",
      "r571",
      "r669",
      "r670",
      "r671",
      "r672",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r688",
      "r699",
      "r720",
      "r738",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r1012",
      "r1041",
      "r1042",
      "r1053"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r223",
      "r322",
      "r330",
      "r331",
      "r332",
      "r334",
      "r337",
      "r342",
      "r344",
      "r522",
      "r669",
      "r670",
      "r671",
      "r672",
      "r804",
      "r1012",
      "r1039",
      "r1041"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "verboseLabel": "Warrant nominal exercise price per share (in Dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r180",
      "r345"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Securities Warrants are Convertible [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants of common stock (in Shares)",
        "verboseLabel": "Warrants of common stock",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants outstanding",
        "verboseLabel": "Number of warrents in an unit",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "cyngn_CommissionProceedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CommissionProceedPercentage",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds, percentage",
        "documentation": "Commission Proceed Percentage.",
        "label": "Commission Proceed Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Note 12)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r77",
      "r630",
      "r698"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r294",
      "r295",
      "r760",
      "r1089",
      "r1091"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r761"
     ]
    },
    "cyngn_CommitmentsandContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CommitmentsandContingenciesDetailsTable",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock reserved and available for issuance",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/ShareholdersEquityType2or3",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock [Member]",
        "netLabel": "Common stock [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r868",
      "r869",
      "r870",
      "r872",
      "r873",
      "r874",
      "r875",
      "r1047",
      "r1048",
      "r1052",
      "r1141",
      "r1200",
      "r1204"
     ]
    },
    "cyngn_CommonStockOfferingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CommonStockOfferingsMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Offerings [Member]",
        "label": "Common Stock Offerings Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CommonStockOutstandingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CommonStockOutstandingPercentage",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock outstanding percentage",
        "documentation": "Percentage of common stock outstanding.",
        "label": "Common Stock Outstanding Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in Dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in Shares)",
        "verboseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r699"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in Shares)",
        "verboseLabel": "Common stock, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in Shares)",
        "verboseLabel": "Common stock, shares outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r699",
      "r718",
      "r1204",
      "r1205"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, Par $0.00001; 400,000,000 and 200,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 7,974,380 and 199,110 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r320",
      "r326",
      "r632",
      "r860"
     ]
    },
    "cyngn_CommonStockWarrantsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CommonStockWarrantsPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Warrants",
        "documentation": "Disclosure of accounting policy for common stock warrants.",
        "label": "Common Stock Warrants Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Unit, Issued",
        "label": "Common Unit, Issued",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computers and equipment [Member]",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed software [Member]",
        "label": "Computer Software, Intangible Asset [Member]",
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks."
       }
      }
     },
     "auth_ref": [
      "r765",
      "r844",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1080",
      "r1082",
      "r1085",
      "r1086"
     ]
    },
    "cyngn_ConcentrationOfSupplierRiskPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ConcentrationOfSupplierRiskPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Supplier Risk",
        "documentation": "Disclosure of accounting policy for concentration of supplier risk policy.",
        "label": "Concentration Of Supplier Risk Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r252",
      "r664",
      "r665",
      "r759",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r252",
      "r664",
      "r665",
      "r759",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r252",
      "r664",
      "r665",
      "r759",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r568"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/RisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties",
        "label": "Concentration Risk Disclosure [Text Block]",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r229",
      "r564",
      "r566",
      "r567",
      "r569",
      "r570",
      "r784",
      "r1056"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Percentages of Total Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r759",
      "r783",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentages of total revenue",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r252",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r759",
      "r783",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061"
     ]
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedBalanceSheetStatementTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheet Statement [Table]",
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restated Balance Sheet [Line Items]",
        "terseLabel": "Balance Sheet Components [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "srt_CondensedCashFlowStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedCashFlowStatementTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Cash Flow Statement [Table]",
        "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "srt_CondensedCashFlowStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedCashFlowStatementsCaptionsLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restated Statement of Cash Flows [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "srt_CondensedIncomeStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedIncomeStatementTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Income Statement [Table]",
        "documentation": "Disclosure of information about condensed income statement including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "srt_CondensedIncomeStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CondensedIncomeStatementsCaptionsLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restated Statements of Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r175",
      "r183",
      "r625",
      "r1014"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r780"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r350",
      "r369"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r348",
      "r350",
      "r369"
     ]
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Contractual Obligation",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r174",
      "r176",
      "r177",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r571",
      "r791",
      "r1095"
     ]
    },
    "cyngn_CostOfRevenuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CostOfRevenuePolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of Revenue",
        "documentation": "Disclosure of accounting policy for cost of revenue.",
        "label": "Cost Of Revenue Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL COSTS AND EXPENSES",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COSTS AND EXPENSES",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CreditCardPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CreditCardPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofAccruedExpensesandOtherCurrentLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit card payable",
        "documentation": "Represents the amount of credit card payable current.",
        "label": "Credit Card Payable Current"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CustomerAMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer A [Member]",
        "label": "Customer AMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CustomerBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CustomerBMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer B [Member]",
        "label": "Customer BMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CustomerCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CustomerCMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer C [Member]",
        "label": "Customer CMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk [Member]",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r1058"
     ]
    },
    "cyngn_CustomerDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CustomerDMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer D [Member]",
        "label": "Customer DMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_CustomerEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "CustomerEMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer E [Member]",
        "label": "Customer EMember"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]",
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r897",
      "r989"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Flag]",
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r990"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Processes Integrated [Text Block]",
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r898",
      "r990"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r988"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r988"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r988"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]",
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r899",
      "r991"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r901",
      "r993"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]",
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r901",
      "r993"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]",
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r900",
      "r992"
     ]
    },
    "us-gaap_DamagesFromProductDefectsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DamagesFromProductDefectsMember",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Damages from Product Defects [Member]",
        "label": "Damages from Product Defects [Member]",
        "documentation": "The risk of loss arises with respect to product defects and recalls, or improperly performed services which actually or allegedly resulted in damages suffered by the injured party, excluding major product liability matters."
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount (in Dollars)",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r584",
      "r585",
      "r799",
      "r800",
      "r858"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate During Period",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r313",
      "r1148"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r798",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualMaximumContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCompensationArrangementWithIndividualMaximumContractualTerm1",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual term",
        "label": "Deferred Compensation Arrangement with Individual, Maximum Contractual Term",
        "documentation": "Maximum term of the deferred compensation arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r26"
     ]
    },
    "us-gaap_DeferredCostsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract costs",
        "label": "Deferred Costs, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs on an equity transaction",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r1098",
      "r1147",
      "r1148",
      "r1150"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r75",
      "r479"
     ]
    },
    "us-gaap_DeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_DeferredTaxAssetDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetDomain",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Asset [Domain]",
        "documentation": "Identification of the deferred tax asset for which a valuation reserve exists."
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "cyngn_DeferredTaxAssetsCapitalizedResearchCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DeferredTaxAssetsCapitalizedResearchCosts",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research costs",
        "documentation": "The amount of capitalized research costs.",
        "label": "Deferred Tax Assets Capitalized Research Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsDeferredIncome",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Deferred Tax Assets, Deferred Income",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "cyngn_DeferredTaxAssetsFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DeferredTaxAssetsFixedAssets",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets",
        "documentation": "Fixed assets .",
        "label": "Deferred Tax Assets Fixed Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangibles",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development credits",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "cyngn_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "documentation": "The amount of lease liability.",
        "label": "Deferred Tax Assets Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal and state income tax",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal and state research credit carryforwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accruals and reserves",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred project costs",
        "label": "Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs classified as other."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "cyngn_DeferredTaxLiabilitiesRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right of use asset",
        "documentation": "The amount of right of use asset.",
        "label": "Deferred Tax Liabilities Right Of Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DefinedBenefitPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Savings Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r939"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Deposits",
        "label": "Deposits Assets, Current",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r19",
      "r158",
      "r773",
      "r774",
      "r776",
      "r778"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r160",
      "r221",
      "r237",
      "r248",
      "r773",
      "r791",
      "r792"
     ]
    },
    "us-gaap_DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DescriptionOfReorganizationOfLimitedLiabilityCompanyLLCOrLimitedLiabilityPartnershipLLPThroughBusinessCombinationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_DescriptionofBusinessDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DescriptionofBusinessDetailsLineItems",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_DescriptionofBusinessDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DescriptionofBusinessDetailsTable",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_DevelopedSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "DevelopedSoftwareMember",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Developed Software [Member]",
        "label": "Developed Software Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation Expense",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r398",
      "r429",
      "r430",
      "r432",
      "r813"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r924",
      "r925",
      "r939"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912",
      "r963"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912",
      "r963"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r952"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss Per Share Attributable to Common Stockholders [Abstract]",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders, basic (in Dollars per share)",
        "verboseLabel": "Basic",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r154",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206",
      "r209",
      "r213",
      "r214",
      "r215",
      "r220",
      "r318",
      "r435",
      "r504",
      "r513",
      "r547",
      "r548",
      "r621",
      "r642",
      "r782"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share attributable to common stockholders, diluted (in Dollars per share)",
        "verboseLabel": "Diluted",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r154",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r200",
      "r209",
      "r213",
      "r214",
      "r215",
      "r220",
      "r318",
      "r435",
      "r504",
      "r513",
      "r547",
      "r548",
      "r621",
      "r642",
      "r782"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r17",
      "r217"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share Attributable to Common Stockholders",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r216",
      "r218",
      "r219"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rate change, Amount",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r816"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails",
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Federal Statutory Tax Rate, Percentage",
        "verboseLabel": "Federal statutory income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r179",
      "r457",
      "r491",
      "r816"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Valuation Allowance, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r816",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrecognized tax benefits, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r816",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r461",
      "r816",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r816"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nondeductible items, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
        "documentation": "Percentage of reported income tax benefit (expense) from difference to income tax expense (benefit) computed by applying statutory federal (national) income tax rate to pretax income (loss) from continuing operation, attributable to other reconciling items. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1134"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred True Up. Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense."
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1045",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1129",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Income Taxes, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r816",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation [Table]",
        "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458",
      "r816"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax Credits, Percentage",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r466",
      "r1039",
      "r1045",
      "r1133"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding unvested stock options (in Dollars)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-Based Payment Arrangement, Option [Member]",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r912"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r994"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r115",
      "r122",
      "r123",
      "r150",
      "r151",
      "r152",
      "r184",
      "r185",
      "r186",
      "r189",
      "r198",
      "r201",
      "r203",
      "r222",
      "r258",
      "r261",
      "r289",
      "r317",
      "r346",
      "r435",
      "r486",
      "r487",
      "r500",
      "r501",
      "r502",
      "r505",
      "r512",
      "r513",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r546",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r586",
      "r589",
      "r605",
      "r641",
      "r651",
      "r652",
      "r653",
      "r675",
      "r738"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r905",
      "r916",
      "r932",
      "r967"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r929",
      "r964"
     ]
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails",
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Restatement of Previously Issued Audited Financial Statements [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r200",
      "r201",
      "r202",
      "r203",
      "r220"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "cyngn_ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with the public offering",
        "documentation": "Exercise of pre-funded warrants in connection with the public offering.",
        "label": "Exercise Of Prefunded Warrants In Connection With The Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 5.0
      },
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value of warrant liability",
        "negatedLabel": "Change in fair value of warrant liability",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Warrants [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r550",
      "r551",
      "r558",
      "r851"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r553",
      "r554",
      "r817",
      "r819",
      "r853"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Warrants",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r553",
      "r853"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r387",
      "r388",
      "r549",
      "r551",
      "r552",
      "r553",
      "r554",
      "r557",
      "r558",
      "r560",
      "r563",
      "r611",
      "r612",
      "r613",
      "r768",
      "r799",
      "r800",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r851",
      "r853",
      "r857"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1 [Member]",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r374",
      "r379",
      "r387",
      "r551",
      "r558",
      "r563",
      "r611",
      "r768",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r851",
      "r857"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r387",
      "r388",
      "r549",
      "r551",
      "r552",
      "r553",
      "r554",
      "r557",
      "r558",
      "r560",
      "r563",
      "r611",
      "r612",
      "r613",
      "r768",
      "r799",
      "r800",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r851",
      "r853",
      "r857"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r270",
      "r278",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r765",
      "r769"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails",
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r282",
      "r619",
      "r620",
      "r663",
      "r765",
      "r769",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "cyngn_FiniteLivedIntangibleAssetsFairMarketValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "FiniteLivedIntangibleAssetsFairMarketValueAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Market Value Adjustment",
        "documentation": "Represents the amount of finite lived intangible assets fair market value adjustment.",
        "label": "Finite Lived Intangible Assets Fair Market Value Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Amortization Expense for All Intangible Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r278",
      "r620",
      "r769"
     ]
    },
    "cyngn_FiniteLivedIntangibleAssetsImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "FiniteLivedIntangibleAssetsImpairment",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment",
        "documentation": "The amount of finite lived intangible assets impairment.",
        "label": "Finite Lived Intangible Assets Impairment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails",
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]",
        "terseLabel": "Intangible Assets, Net [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r278",
      "r281",
      "r282",
      "r285",
      "r619",
      "r765",
      "r769",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails",
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r282",
      "r663",
      "r765",
      "r769",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofEstimatedAmortizationExpenseforAllIntangibleAssetsTable",
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Intangible assets, net",
        "verboseLabel": "Net Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r619",
      "r1082"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite lived intangibles amortized",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r619"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Jurisdiction [Member]",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r458"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r971"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r971"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r893",
      "r923"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures [Member]",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on disposal assets",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "cyngn_GainLossOnIssuanceOfWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "GainLossOnIssuanceOfWarrant",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on the issuance of the Warrants",
        "documentation": "Loss issuance of the Warrants.",
        "label": "Gain Loss On Issuance Of Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposed assets",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of other assets."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r722"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IPOMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering [Member]",
        "verboseLabel": "IPO [Member]",
        "netLabel": "Public Offering [Member]",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r891",
      "r894",
      "r912"
     ]
    },
    "us-gaap_ImpairedIntangibleAssetMethodForFairValueDetermination": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairedIntangibleAssetMethodForFairValueDetermination",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of impairment charges",
        "label": "Impaired Intangible Asset, Method for Fair Value Determination",
        "documentation": "Description of the method used by the entity to determine the fair value of the impaired intangible asset."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Assets and Finite Lived Intangibles",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r64"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r178",
      "r456"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r83",
      "r87",
      "r622",
      "r624",
      "r639",
      "r775",
      "r777",
      "r779",
      "r787",
      "r791",
      "r1055",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofDomesticandInternationalPreTaxLossTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r178",
      "r456"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Domestic and International Pre-Tax Loss [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r291",
      "r293",
      "r518",
      "r519",
      "r520",
      "r521",
      "r555",
      "r556",
      "r559",
      "r572",
      "r573",
      "r574",
      "r646",
      "r648",
      "r723",
      "r765",
      "r768",
      "r817",
      "r818",
      "r849",
      "r850",
      "r852",
      "r857",
      "r1139",
      "r1140",
      "r1170"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r293",
      "r518",
      "r519",
      "r520",
      "r521",
      "r555",
      "r556",
      "r559",
      "r572",
      "r573",
      "r574",
      "r646",
      "r648",
      "r723",
      "r765",
      "r768",
      "r817",
      "r818",
      "r849",
      "r850",
      "r852",
      "r857",
      "r1139",
      "r1140",
      "r1170"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r457",
      "r458",
      "r471",
      "r484",
      "r816",
      "r1137"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r457",
      "r458",
      "r471",
      "r484",
      "r816",
      "r1137"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r179",
      "r451",
      "r457",
      "r467",
      "r468",
      "r469",
      "r476",
      "r483",
      "r492",
      "r494",
      "r495",
      "r496",
      "r627",
      "r662",
      "r674",
      "r816"
     ]
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExaminationLineItems",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total, Amount",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r98",
      "r174",
      "r202",
      "r203",
      "r221",
      "r238",
      "r248",
      "r455",
      "r457",
      "r493",
      "r644",
      "r775",
      "r777",
      "r779",
      "r816"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r453",
      "r454",
      "r476",
      "r477",
      "r482",
      "r485",
      "r668"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Valuation Allowance, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r816",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Effects, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r461",
      "r816",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Federal Statutory Tax Rate, Amount",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r816"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nondeductible items, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in unrecognized tax benefits, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r816",
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other. Amount",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying statutory federal (national) tax rate to pretax income (loss) from continuing operation attributable to other reconciling item. Excludes state and local income tax expense (benefit), federal tax expense (benefit), statutory income tax expense (benefit) outside of country of domicile, tax credit, nondeductible expense, deduction, income tax settlement, income tax contingency, and cross-border tax law."
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred True Up, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1133",
      "r1134"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Income Taxes, Amount",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r460",
      "r816",
      "r1133"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxReconciliationTaxCredits",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax Credits, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r466",
      "r1133"
     ]
    },
    "cyngn_IncomeTaxesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "IncomeTaxesDetailsTable",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts and other receivables",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts Payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses, lease liabilities, and other current liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_IncreaseDecreaseInDerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInDerivativeLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering-related issuance costs (in Dollars)",
        "label": "Increase (Decrease) in Derivative Liabilities",
        "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in equity balance",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r166"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses, operating lease right-of-use assets, and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r962",
      "r971",
      "r975",
      "r983"
     ]
    },
    "cyngn_InitialPublicOfferingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "InitialPublicOfferingWarrantsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering Warrants (Oct 2021) [Member]",
        "documentation": "Initial Public Offering Warrants [Member]",
        "label": "Initial Public Offering Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r987"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r987"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r895",
      "r987"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r283",
      "r286",
      "r764",
      "r765"
     ]
    },
    "cyngn_IntangibleAssetsNetDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "IntangibleAssetsNetDetailsTable",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income (expense), net",
        "label": "Interest Income (Expense), Nonoperating",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r848",
      "r1035",
      "r1064"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash paid during the period for interest and taxes",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r168",
      "r169"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internal-Use Software costs",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsDetails",
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r771",
      "r860"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r130",
      "r141",
      "r265",
      "r266",
      "r267",
      "r617",
      "r781"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r925",
      "r926",
      "r927",
      "r928"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "cyngn_IssuanceCostsForStockDividendAndRestrictedStockUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "IssuanceCostsForStockDividendAndRestrictedStockUnits",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuance costs for stock dividend and restricted stock units",
        "documentation": "The amount of issuance costs for stock dividend and restricted stock units .",
        "label": "Issuance Costs For Stock Dividend And Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrant exercisable",
        "documentation": "Issuance of common stock upon exercise of pre-funded warrants.",
        "label": "Issuance Of Common Stock Upon Exercise Of Prefunded Warrantsin Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly storage cost per unit",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r859"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Lease Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1152"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements [Member]",
        "verboseLabel": "Leasehold Improvements [Member]",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r599"
     ]
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesOperatingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Lease Payments under the Non-Cancellable Lease",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1153"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2031",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://cyngn.com/role/OperatingLeases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r588"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "terseLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r30",
      "r31",
      "r32",
      "r34",
      "r35",
      "r36",
      "r39",
      "r174",
      "r176",
      "r177",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r515",
      "r516",
      "r517",
      "r571",
      "r697",
      "r786",
      "r803",
      "r878",
      "r1095",
      "r1157",
      "r1158"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r78",
      "r634",
      "r860",
      "r866",
      "r867",
      "r1039",
      "r1043",
      "r1072",
      "r1146"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL CURRENT LIABILITIES",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r129",
      "r174",
      "r176",
      "r177",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r515",
      "r516",
      "r517",
      "r571",
      "r860",
      "r1095",
      "r1157",
      "r1158"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CURRENT LIABILITIES",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r296",
      "r297",
      "r298",
      "r301",
      "r447",
      "r661",
      "r797",
      "r1093",
      "r1094"
     ]
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyAccrualPayments",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrual expences",
        "label": "Loss Contingency Accrual, Payments",
        "documentation": "Amount of cash outflow reducing loss contingency liability."
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyLossInPeriod",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Complaint seeks in damage amount",
        "label": "Loss Contingency, Loss in Period",
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r1092"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r296",
      "r297",
      "r298",
      "r301",
      "r447",
      "r661",
      "r797",
      "r1093",
      "r1094"
     ]
    },
    "cyngn_LossOnIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "LossOnIssuanceOfWarrants",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on issuance of warrants",
        "negatedLabel": "Loss on issuance of warrants",
        "negatedTerseLabel": "Loss on issuance of warrants",
        "documentation": "Loss on issuance of warrants.",
        "label": "Loss On Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_MachineToolsAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "MachineToolsAndEquipmentMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery, tools and equipment [Member]",
        "label": "Machine Tools And Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery, tools and equipment [Member]",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r805",
      "r806",
      "r863",
      "r865",
      "r1169",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1193",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r111",
      "r112",
      "r232",
      "r297",
      "r298",
      "r299",
      "r300",
      "r393",
      "r424",
      "r425",
      "r426",
      "r447",
      "r554",
      "r616",
      "r645",
      "r647",
      "r661",
      "r689",
      "r690",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r762",
      "r763",
      "r796",
      "r804",
      "r812",
      "r817",
      "r819",
      "r820",
      "r853",
      "r854",
      "r855",
      "r856",
      "r864",
      "r1097",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years) [Member]",
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility [Member]",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r424",
      "r853",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate [Member]",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of underlying securities [Member]",
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r552",
      "r553",
      "r554",
      "r817",
      "r819",
      "r820",
      "r853"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r111",
      "r112",
      "r232",
      "r297",
      "r298",
      "r299",
      "r300",
      "r393",
      "r424",
      "r425",
      "r426",
      "r447",
      "r554",
      "r616",
      "r645",
      "r647",
      "r661",
      "r689",
      "r690",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r762",
      "r763",
      "r796",
      "r804",
      "r812",
      "r817",
      "r819",
      "r820",
      "r853",
      "r854",
      "r855",
      "r864",
      "r1097",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_MoneyMarketFundsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MoneyMarketFundsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable": {
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Money Market Funds, at Carrying Value",
        "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_MonteCarloPricingModelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "MonteCarloPricingModelMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monte Carlo Pricing Model [Member]",
        "label": "Monte Carlo Pricing Model Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES",
        "terseLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES",
        "negatedLabel": "Net cash used in operating activities",
        "terseLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r61"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable",
      "http://cyngn.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET LOSS",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r61",
      "r84",
      "r123",
      "r127",
      "r147",
      "r148",
      "r152",
      "r174",
      "r176",
      "r177",
      "r182",
      "r188",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r202",
      "r203",
      "r211",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r318",
      "r321",
      "r324",
      "r328",
      "r435",
      "r504",
      "r513",
      "r548",
      "r571",
      "r640",
      "r719",
      "r736",
      "r737",
      "r775",
      "r777",
      "r779",
      "r876",
      "r1095"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss attributable to common stockholders",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r155",
      "r193",
      "r194",
      "r196",
      "r197",
      "r206",
      "r207",
      "r212",
      "r215",
      "r321",
      "r324",
      "r328",
      "r513"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Basic and Diluted Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r161",
      "r162",
      "r163",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r196",
      "r204",
      "r220",
      "r253",
      "r254",
      "r258",
      "r259",
      "r260",
      "r261",
      "r288",
      "r289",
      "r292",
      "r315",
      "r316",
      "r317",
      "r318",
      "r433",
      "r434",
      "r435",
      "r436",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r561",
      "r562",
      "r586",
      "r587",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r666"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r925",
      "r926",
      "r927",
      "r928"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r909",
      "r920",
      "r936",
      "r962",
      "r971"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_NoninterestExpenseOfferingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NoninterestExpenseOfferingCost",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering expenses payable (in Dollars)",
        "verboseLabel": "Offering expenses payable",
        "label": "Offering Cost, Expense",
        "documentation": "Amount of expense for cost associated with issuance of security by investment company. Includes, but is not limited to, legal fee pertaining to share offered for sale, registration fee, underwriting, printing prospectus, and initial fee for listing on exchange."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r1203"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL OTHER INCOME (EXPENSE), NET",
        "terseLabel": "Total other income (expenses), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER INCOME (EXPENSE), NET",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_NontaxableOrNondeductibleItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "NontaxableOrNondeductibleItemsAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nontaxable or Nondeductible Items",
        "label": "Nontaxable Or Nondeductible Items Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segment",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r792",
      "r1063"
     ]
    },
    "cyngn_OfferingRelatedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "OfferingRelatedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering-related issuance costs",
        "documentation": "The amount of offering-related issuance costs.",
        "label": "Offering Related Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LOSS FROM OPERATIONS",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r775",
      "r779",
      "r787",
      "r1055",
      "r1064",
      "r1065",
      "r1066",
      "r1067"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Lease Payments Under the Non Cancellable Lease [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFutureLeasePaymentsundertheNonCancellableLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present value of lease liability",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current operating lease liability",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current operating lease liability",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r591"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly payments",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r595"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset, net",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/OperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://cyngn.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r597",
      "r859"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://cyngn.com/role/ScheduleofLeaseCostTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r596",
      "r859"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r860"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies [LIne Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other expenses",
        "label": "Other Expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r51",
      "r866",
      "r867"
     ]
    },
    "us-gaap_OtherLaborRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLaborRelatedExpenses",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other related expense (in Dollars)",
        "label": "Other Labor-related Expenses",
        "documentation": "Amount of labor-related expenses classified as other."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r848"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "cyngn_OtherPermanentDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "OtherPermanentDifferencesMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Permanent Differences [Member]",
        "label": "Other Permanent Differences Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_OtherReconcilingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "OtherReconcilingItemsAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Reconciling Items",
        "label": "Other Reconciling Items Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Other Research and Development Expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r907",
      "r918",
      "r934",
      "r969"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r910",
      "r921",
      "r937",
      "r972"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r910",
      "r921",
      "r937",
      "r972"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option [Member]",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PatentsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Patents [Member]",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1080",
      "r1082",
      "r1085",
      "r1086"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One-time payment",
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of intangible asset",
        "label": "Payments to Acquire Intangible Assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of short-term investments",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/RetirementSavingsPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Savings Plan",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r379",
      "r380",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r390",
      "r391",
      "r392",
      "r811"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r962"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "cyngn_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants [Member]",
        "label": "Pre Funded Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_PreFundedWarrantsPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PreFundedWarrantsPricePerShare",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre funded warrants price per share (in Dollars per share)",
        "documentation": "Pre-funded warrants price per share.",
        "label": "Pre Funded Warrants Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "verboseLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r868",
      "r869",
      "r872",
      "r873",
      "r874",
      "r875",
      "r1200",
      "r1204"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in Dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r330"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r699"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r330"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock shares outstanding",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r699",
      "r718",
      "r1204",
      "r1205"
     ]
    },
    "cyngn_PrefundedUnitsAtAPublicOfferingPrice": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PrefundedUnitsAtAPublicOfferingPrice",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded units at a public offering price",
        "documentation": "Pre-funded units at a public offering price.",
        "label": "Prefunded Units At APublic Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_PrefundedWarrantsToPurchaseSharesOfCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PrefundedWarrantsToPurchaseSharesOfCommonStock",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-funded warrants to purchase shares of common stock",
        "verboseLabel": "Pre-funded warrants to purchase shares of common stock (in Shares)",
        "documentation": "Pre-funded warrants to purchase shares of common stock.",
        "label": "Prefunded Warrants To Purchase Shares Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total prepaid and expenses and other current assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid Expenses and Other Current Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid Expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r268",
      "r269",
      "r772"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1028"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement [Member]",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_PrivatePlacementOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PrivatePlacementOfferingMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement Offering [Member]",
        "label": "Private Placement Offering Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_PrivatePlacementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "PrivatePlacementWarrantsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement Warrants (Apr 2022) [Member]",
        "documentation": "Private Placement Warrants [Member]",
        "label": "Private Placement Warrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from at-the-market equity financing, net of issuance costs",
        "documentation": "Proceeds from at-the-market equity financing, net of issuance costs.",
        "label": "Proceeds From Atthemarket Equity Financing Net Of Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the Notes, net of issuance costs",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of issuance costs",
        "verboseLabel": "Net proceeds (in Dollars)",
        "netLabel": "Net proceeds",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of offering costs",
        "verboseLabel": "Issuance of units at a public offering price (in Dollars)",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds received (in Dollars)",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of warrants",
        "verboseLabel": "Issuance of warrants (in Dollars)",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds (in Dollars)",
        "verboseLabel": "Net proceeds from sale",
        "label": "Proceeds from Issuance or Sale of Equity",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r669"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from maturity of short-term investments",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56"
     ]
    },
    "cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants",
        "documentation": "Proceeds from public issuance of common stock and pre-funded warrants .",
        "label": "Proceeds From Public Issuance Of Common Stock And Prefunded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants, net of issuance costs",
        "documentation": "Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants net of issuance costs .",
        "label": "Proceeds From Public Issuance Of Common Stock And Prefunded Warrants And Exercise Of Prefu"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants",
        "documentation": "Proceeds from public issuance of common stock and pre-funded warrants, net of offering costs.",
        "label": "Proceeds From Public Issuance Of Common Stock And Prefunded Warrants Net Of Offering Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal of assets",
        "label": "Proceeds from Sale of Productive Assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r599"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r132",
      "r638"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total property and equipment, net",
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r599",
      "r626",
      "r638",
      "r860"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r95",
      "r97",
      "r636"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r599"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, useful life",
        "verboseLabel": "Useful life of property and equipment",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "us-gaap_ProvisionForOtherCreditLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProvisionForOtherCreditLosses",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit losses",
        "label": "Provision for Other Credit Losses",
        "documentation": "Amount of expense related to credit loss from transactions other than loan and lease transactions."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r81"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r111",
      "r112",
      "r232",
      "r297",
      "r298",
      "r299",
      "r300",
      "r372",
      "r393",
      "r424",
      "r425",
      "r426",
      "r432",
      "r447",
      "r554",
      "r614",
      "r615",
      "r616",
      "r645",
      "r647",
      "r661",
      "r689",
      "r690",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r762",
      "r763",
      "r796",
      "r804",
      "r812",
      "r817",
      "r819",
      "r820",
      "r853",
      "r854",
      "r855",
      "r856",
      "r864",
      "r870",
      "r1090",
      "r1097",
      "r1144",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109",
      "r111",
      "r112",
      "r232",
      "r297",
      "r298",
      "r299",
      "r300",
      "r372",
      "r393",
      "r424",
      "r425",
      "r426",
      "r432",
      "r447",
      "r554",
      "r614",
      "r615",
      "r616",
      "r645",
      "r647",
      "r661",
      "r689",
      "r690",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r755",
      "r756",
      "r757",
      "r758",
      "r762",
      "r763",
      "r796",
      "r804",
      "r812",
      "r817",
      "r819",
      "r820",
      "r853",
      "r854",
      "r855",
      "r856",
      "r864",
      "r870",
      "r1090",
      "r1097",
      "r1144",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164"
     ]
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RealizedInvestmentGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Realized gain on short-term investments",
        "label": "Realized Investment Gains (Losses)",
        "documentation": "Amount of realized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_RecapitalizationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RecapitalizationCosts",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in estimate of capitalized software",
        "verboseLabel": "Decrease in capitalized software costs",
        "label": "Recapitalization Costs",
        "documentation": "Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r902",
      "r913",
      "r929",
      "r964"
     ]
    },
    "cyngn_RegisteredDirectOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RegisteredDirectOfferingMember",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registered Direct Offering [Member]",
        "label": "Registered Direct Offering Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r181",
      "r182",
      "r255",
      "r381",
      "r389",
      "r606",
      "r607",
      "r629",
      "r635",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r717",
      "r743",
      "r1202"
     ]
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r181",
      "r182",
      "r255",
      "r381",
      "r389",
      "r606",
      "r607",
      "r629",
      "r635",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r717",
      "r743",
      "r1156",
      "r1202"
     ]
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of the Notes",
        "label": "Repayments of Notes Payable",
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r450",
      "r765",
      "r775",
      "r776",
      "r791",
      "r1165"
     ]
    },
    "cyngn_ResearchAndDevelopmentExpenseIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ResearchAndDevelopmentExpenseIncreaseDecrease",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase to research and development expense",
        "documentation": "Amount of increase (decrease) in research and development expenses.",
        "label": "Research And Development Expense Increase Decrease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense [Member]",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs to Develop Software",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination."
       }
      }
     },
     "auth_ref": [
      "r1087",
      "r1131",
      "r1206"
     ]
    },
    "cyngn_RestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RestatedMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restated [Member]",
        "label": "Restated Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments [Member]",
        "verboseLabel": "Adjustment [Member]",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r200",
      "r201",
      "r220",
      "r546",
      "r547",
      "r587",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1023",
      "r1024",
      "r1051",
      "r1068"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails",
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r116",
      "r122",
      "r123",
      "r124",
      "r157",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r220",
      "r259",
      "r260",
      "r317",
      "r318",
      "r435",
      "r501",
      "r502",
      "r504",
      "r505",
      "r512",
      "r513",
      "r542",
      "r546",
      "r547",
      "r548",
      "r587",
      "r604",
      "r605",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r666",
      "r1068"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r903",
      "r914",
      "r930",
      "r965"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r904",
      "r915",
      "r931",
      "r966"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r911",
      "r922",
      "r938",
      "r973"
     ]
    },
    "cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement of Previously Issued Audited Financial Statements",
        "documentation": "The entire disclosure of previously issued interim financial statements.",
        "label": "Restatement Of Previously Issued Interim Financial Statements Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RestatementofPreviouslyIssuedAuditedFinancialStatementsDetailsTable",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement of Previously Issued Audited Financial Statements (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restated Statement of Stockholders\u2019 Equity (Deficit) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RestatementofPreviouslyIssuedAuditedFinancialStatementsScheduleofRestatedStatementofStockholdersEquityDeficitDetailsTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement of Previously Issued Audited Financial Statements - Schedule of Restated Statement of Stockholders\u2019 Equity (Deficit) (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs) [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficits",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r68",
      "r633",
      "r655",
      "r660",
      "r673",
      "r700",
      "r860"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r122",
      "r123",
      "r184",
      "r185",
      "r186",
      "r189",
      "r198",
      "r201",
      "r203",
      "r258",
      "r261",
      "r289",
      "r317",
      "r435",
      "r486",
      "r487",
      "r500",
      "r501",
      "r502",
      "r505",
      "r512",
      "r513",
      "r525",
      "r528",
      "r529",
      "r532",
      "r546",
      "r586",
      "r589",
      "r651",
      "r653",
      "r675",
      "r1204"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue and Contracts with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from customer",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r221",
      "r235",
      "r236",
      "r246",
      "r248",
      "r250",
      "r251",
      "r252",
      "r366",
      "r367",
      "r368",
      "r618"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r767"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomers"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue and Contracts with Customers",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r368",
      "r370"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligations",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining performance obligations, percentage",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r1020"
     ]
    },
    "cyngn_RevenueandContractswithCustomersDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RevenueandContractswithCustomersDetailsLineItems",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue and Contracts with Customers (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_RevenueandContractswithCustomersDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "RevenueandContractswithCustomersDetailsTable",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue and Contracts with Customers (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE",
        "verboseLabel": "Revenue",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r153",
      "r174",
      "r176",
      "r177",
      "r221",
      "r235",
      "r236",
      "r246",
      "r248",
      "r250",
      "r251",
      "r252",
      "r257",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r571",
      "r622",
      "r624",
      "r791",
      "r848",
      "r866",
      "r867",
      "r1095"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/SubsequentEventsDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of additional shares",
        "verboseLabel": "Share sold (in Shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering price (in Dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SalesAgreementWithAegisCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SalesAgreementWithAegisCapitalMember",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales Agreement with Aegis Capital [Member]",
        "label": "Sales Agreement With Aegis Capital Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesCommissionsAndFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesCommissionsAndFees",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commission fees (in Dollars)",
        "verboseLabel": "Payment of commission and fees",
        "label": "Sales Commissions and Fees",
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPercentagesofTotalRevenueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark [Member]",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r1058",
      "r1059"
     ]
    },
    "us-gaap_SalvageAndSubrogationRecoveriesValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SalvageAndSubrogationRecoveriesValue",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salvage value",
        "label": "Salvage and Subrogation Recoveries, Value",
        "documentation": "The estimated amount as of the balance sheet date to be received by an insurer from the sale of property (usually damaged) on which the insurer has paid a total claim to the insured and has obtained title to the property and the right of an insurer to pursue any course of recovery of damages, in its name or in the name of the policyholder, against a third party who is liable for costs relating to an insured event that have been paid by the insurer. Estimated salvage and subrogation is generally deducted from the liability for unpaid claims."
       }
      }
     },
     "auth_ref": [
      "r1171",
      "r1172"
     ]
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r1025"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsDetails",
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As Previously Reported [Member]",
        "verboseLabel": "As Previously Report [Member]",
        "netLabel": "Previously Reported [Member]",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r122",
      "r123",
      "r184",
      "r186",
      "r188",
      "r189",
      "r193",
      "r194",
      "r203",
      "r220",
      "r317",
      "r318",
      "r435",
      "r501",
      "r504",
      "r505",
      "r512",
      "r513",
      "r542",
      "r546",
      "r547",
      "r587",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r666",
      "r1021",
      "r1022",
      "r1023",
      "r1050",
      "r1051",
      "r1068",
      "r1073",
      "r1074",
      "r1142",
      "r1154",
      "r1155"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r125",
      "r126",
      "r204",
      "r394",
      "r1013"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfBalanceSheetAndCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfBalanceSheetAndCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Balance Sheet And Cash Flows Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restated Balance Sheet",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restated Statement of Cash Flows",
        "label": "Condensed Cash Flow Statement [Table Text Block]",
        "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "srt_ScheduleOfCondensedIncomeStatementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfCondensedIncomeStatementTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restated Statements of Operations",
        "label": "Condensed Income Statement [Table Text Block]",
        "documentation": "Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1040",
      "r1046",
      "r1166"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Federal Statutory Income Tax Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r816",
      "r1133"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofBalanceSheetandCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Error Correction [Table]",
        "documentation": "Disclosure of information about prior period adjustment to correct error in previously issued financial statement. Includes, but is not limited to, effect of correction on financial statement line item, affected per-share amount, cumulative effect of change on retained earnings and other appropriate component of equity or net assets in statement of financial position, and effect of prior period adjustment on net income of each prior period presented."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r200",
      "r201",
      "r202",
      "r203",
      "r220"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Balance Sheet and Cash Flows",
        "label": "Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]",
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r15"
     ]
    },
    "cyngn_ScheduleOfFairValueOfWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfFairValueOfWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of Warrants Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfFederalStatutoryIncomeTaxRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfFederalStatutoryIncomeTaxRateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Federal Statutory Income Tax Rate Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r278",
      "r281",
      "r282",
      "r285",
      "r619",
      "r765",
      "r769",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Gross Carrying Amount and Accumulated Amortization",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r1081"
     ]
    },
    "cyngn_ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfGrossCarryingAmountAndAccumulatedAmortizationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Gross Carrying Amount And Accumulated Amortization Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Domestic and International Pre-Tax Loss",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1039",
      "r1044"
     ]
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfPercentagesOfTotalRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfPercentagesOfTotalRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Percentages Of Total Revenue Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfPropertyAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfPropertyAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Property And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Asset\u2019s Estimated Useful Life",
        "documentation": "Tabular disclosure of property and equipment.",
        "label": "Schedule Of Property And Equipment Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r599"
     ]
    },
    "cyngn_ScheduleOfRestatedBalanceSheetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfRestatedBalanceSheetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restated Balance Sheet Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfRestatedStatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfRestatedStatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restated Statement Of Cash Flows Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfRestatedStatementOfStockholdersEquityDeficitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restated Statement Of Stockholders Equity Deficit Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfRestatedStatementsOfOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfRestatedStatementsOfOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restated Statements Of Operations Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfRestrictedStockUnitsAndActivityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfRestrictedStockUnitsAndActivityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restricted Stock Units And Activity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_ScheduleOfSecuritiesWarrantsAreConvertibleAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfSecuritiesWarrantsAreConvertibleAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Securities Warrants Are Convertible Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Units and Activity",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-Term Investments",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cyngn_ScheduleOfShortTermInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "ScheduleOfShortTermInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Short Term Investments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Securities Warrants are Convertible",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r1100"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/RestatementofPreviouslyIssuedAuditedFinancialStatementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restated Statement of Stockholders\u2019 Equity (Deficit)",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Gross Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r815"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Amortization Expense for All Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r1083"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Percentages of Total Revenue",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r1057",
      "r1062"
     ]
    },
    "cyngn_Section162mLimitationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "Section162mLimitationMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Section 162m Limitation [Member]",
        "label": "Section162m Limitation Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Deposit",
        "label": "Security Deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r790",
      "r795"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of CODM",
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r789",
      "r794"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r249",
      "r251",
      "r788",
      "r789",
      "r793"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative Expense",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_SeriesAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesAMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A [Member]",
        "label": "Series A [Member]",
        "documentation": "A classification of auction market preferred securities that may have different rights to other classifications of auction market preferred securities, for example Series B."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SeriesAWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SeriesAWarrantMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Warrant [Member]",
        "label": "Series AWarrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SeriesAWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SeriesAWarrantsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Warrants [Member]",
        "label": "Series AWarrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesBMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B [Member]",
        "label": "Series B [Member]",
        "documentation": "A classification of auction market preferred securities that may have different rights to other classifications of auction market preferred securities, for example Series A."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SeriesBWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SeriesBWarrantMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Warrant [Member]",
        "label": "Series BWarrant Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SeriesBWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SeriesBWarrantsMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Warrants [Member]",
        "label": "Series BWarrants Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SettlementAgreementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SettlementAgreementAmount",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlement agreement",
        "documentation": "The amount of  settlement agreement.",
        "label": "Settlement Agreement Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, RSUs forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value, RSUs forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, RSUs granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value, RSUs granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares, Unvested shares beginning balance",
        "periodEndLabel": "Shares, Unvested shares ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted-average grant date fair value, beginning balance",
        "periodEndLabel": "Weighted-average grant date fair value, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, RSUs vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Weighted-average grant date fair value, RSUs vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "verboseLabel": "Estimated dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Stock-based Compensation Expense [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397",
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r432"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized for issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares, Cancelled/forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Granted",
        "verboseLabel": "Aggregate intrinsic value, Granted",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average per share (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate intrinsic value, outstanding at Ending balance (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Shares, outstanding at Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Options Vested and Exercisable [Abstract]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted-average exercise price, outstanding at Ending balance (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r403",
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, vested and exercisable at ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options Vested and Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price, vested and exercisable at ending balance (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, vested and expected to vest at ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price, Exercised (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price, Cancelled/forfeited (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted- average exercise price, Granted (in Dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r402",
      "r421",
      "r422",
      "r423",
      "r424",
      "r427",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common stock (in Dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://cyngn.com/role/ScheduleofWeightedAverageAssumptionswereUsedinEstimatingtheGrantDateFairValuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value, Exercised (in Dollars)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining contractual term (years), outstanding at Ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average exercise price, vested and exercisable at ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining contractual term (years), vested and expected to vest at ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public offering price per unit (in Dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short-Term Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/DescriptionofBusinessDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "verboseLabel": "Short-term investment",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r80",
      "r1033"
     ]
    },
    "us-gaap_ShortTermInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShortTermInvestmentsAbstract",
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments:",
        "label": "Short-Term Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r173"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internal-Use Software [Member]",
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized software [Member]",
        "verboseLabel": "Internal-use Software [Member]",
        "netLabel": "Software [Member]",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs to Develop Software to be Sold, Leased or Otherwise Marketed",
        "label": "Software to be Sold, Leased, or Otherwise Marketed, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred to (1) establish the technological feasibility of a computer software product to be sold, leased, or otherwise marketed; and (2) produce product masters after establishing technological feasibility. This accounting policy also may apply to purchased computer software. This policy also may address the entity's amortization policy for its capitalized computer software costs and how it evaluates such capitalized costs for impairment."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r764",
      "r765"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r137",
      "r138",
      "r139",
      "r174",
      "r177",
      "r209",
      "r210",
      "r213",
      "r215",
      "r223",
      "r224",
      "r257",
      "r302",
      "r304",
      "r305",
      "r306",
      "r309",
      "r310",
      "r319",
      "r320",
      "r322",
      "r323",
      "r325",
      "r327",
      "r330",
      "r331",
      "r334",
      "r337",
      "r344",
      "r571",
      "r669",
      "r670",
      "r671",
      "r672",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r688",
      "r699",
      "r720",
      "r738",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r1012",
      "r1041",
      "r1042",
      "r1053"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3",
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r44",
      "r45",
      "r115",
      "r122",
      "r123",
      "r150",
      "r151",
      "r152",
      "r184",
      "r185",
      "r186",
      "r189",
      "r198",
      "r201",
      "r203",
      "r222",
      "r258",
      "r261",
      "r289",
      "r317",
      "r346",
      "r435",
      "r486",
      "r487",
      "r500",
      "r501",
      "r502",
      "r505",
      "r512",
      "r513",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r546",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r586",
      "r589",
      "r605",
      "r641",
      "r651",
      "r652",
      "r653",
      "r675",
      "r738"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r222",
      "r319",
      "r320",
      "r322",
      "r325",
      "r589",
      "r618",
      "r667",
      "r676",
      "r688",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r708",
      "r709",
      "r710",
      "r711",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r738",
      "r777",
      "r779",
      "r871",
      "r1202"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://cyngn.com/role/RevenueandContractswithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r125",
      "r126",
      "r204",
      "r394",
      "r1013",
      "r1015"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r186",
      "r222",
      "r255",
      "r319",
      "r320",
      "r322",
      "r325",
      "r589",
      "r618",
      "r667",
      "r676",
      "r688",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r699",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r708",
      "r709",
      "r710",
      "r711",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r721",
      "r722",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r738",
      "r777",
      "r779",
      "r871",
      "r1202"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r906",
      "r917",
      "r933",
      "r968"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120",
      "r1121",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127"
     ]
    },
    "cyngn_StockBasedCompensationExpenseDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "StockBasedCompensationExpenseDetailsTable",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation Expense (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "StockBasedCompensationExpenseScheduleofRestrictedStockUnitsandActivityDetailsTable",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestrictedStockUnitsandActivityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation Expense - Schedule of Restricted Stock Units and Activity (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with the public offering (in Shares)",
        "documentation": "Exercise of pre-funded warrants in connection with the public offering.",
        "label": "Stock Issued During Period Shares Exercise Of Prefunded Warrants In Connection With The Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of Series B warrants in connection with the public offering, net of issuance costs (in Shares)",
        "verboseLabel": "Issuance of units at a public offering price",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r68",
      "r669",
      "r738",
      "r750"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of at-the-market common stock, net of issuance costs (in Shares)",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options and vesting of restricted stock units (in Shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r68"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://cyngn.com/role/ScheduleofStockOptionsVestedandExercisableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares, Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r68",
      "r408"
     ]
    },
    "cyngn_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofStockholdersEquityDeficitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings",
        "documentation": "Issuance of common stock and pre-funded warrants in connection with the public offering, net of offering cost.",
        "label": "Stock Issued During Period Value Issuance Of Common Stock And Prefunded Warrants And Exercise Of Prefunded Warrants In Conn"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of Series B warrants in connection with the public offering, net of issuance costs",
        "verboseLabel": "Aggregate offering price (in Dollars)",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r68",
      "r675",
      "r738",
      "r750",
      "r877"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of at-the-market common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of Series A warrants to equity in connection with the public offering",
        "documentation": "Reclassification of Series A warrants to equity and exercise of Series B warrants in connection with the public offering.",
        "label": "Stock Issued During Period Value Reclassification Of Series AWarrants To Equity And Exercise Of Series BWarrants In Connection With The Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exercise of stock options and vesting of restricted stock units",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r40",
      "r41",
      "r68"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "terseLabel": "Total stockholders\u2019 equity (deficit)",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r44",
      "r45",
      "r62",
      "r701",
      "r718",
      "r739",
      "r740",
      "r860",
      "r878",
      "r1039",
      "r1042",
      "r1043",
      "r1072",
      "r1146",
      "r1204"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY (DEFICIT)",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Structure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://cyngn.com/role/CapitalStructure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Structure",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r329",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r343",
      "r346",
      "r522",
      "r537",
      "r741",
      "r742",
      "r754"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reverse stock split",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r609"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Member]",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r609"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r609"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SubsequentEventsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SubsequentEventsDetailsTable",
     "presentation": [
      "http://cyngn.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://cyngn.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r608",
      "r610"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership percentage",
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/SubsequentEventsDetails",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "SummaryofSignificantAccountingPoliciesScheduleofAssetsEstimatedUsefulLifeDetailsTable",
     "presentation": [
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetailsScheduleofAssetsEstimatedUsefulLife"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies - Schedule of Asset\u2019s Estimated Useful Life (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://cyngn.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "cyngn_TestingEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "TestingEquipmentMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofPropertyandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Testing equipment (Work in Progress) [Member]",
        "label": "Testing Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r953"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r960"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and Other Receivable",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1069",
      "r1070",
      "r1071"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TrademarksMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossCarryingAmountandAccumulatedAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademark [Member]",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r822",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1082",
      "r1084",
      "r1085",
      "r1086"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r981"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r986"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "cyngn_TwentyTwentyOneEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "TwentyTwentyOneEquityIncentivePlanMember",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Equity Incentive Plan [Member]",
        "label": "Twenty Twenty One Equity Incentive Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_TwoThousandTwentyOnePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "TwoThousandTwentyOnePlanMember",
     "presentation": [
      "http://cyngn.com/role/StockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Plan [Member]",
        "label": "Two Thousand Twenty One Plan Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_TwoZeroThreeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "TwoZeroThreeFourMember",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Zero Three Four [Member]",
        "label": "Two Zero Three Four Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentSecuritiesAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "USGovernmentSecuritiesAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable": {
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "US Government Securities, at Carrying Value",
        "documentation": "Debt (bills, notes or bonds) that are issued by the government of the United States which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r980"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails",
      "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of year",
        "periodEndLabel": "Balance at end of year",
        "terseLabel": "Unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r452",
      "r472",
      "r815"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in balance related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r815"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccruedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Gross Unrecognized Tax Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in balance related to settlement with tax authorities",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r470",
      "r815"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in balance related to tax positions taken during the current year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r815"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in balance related to tax positions taken during prior years",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r815"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r815"
     ]
    },
    "cyngn_UnrestrictedCashBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "UnrestrictedCashBalance",
     "crdr": "debit",
     "presentation": [
      "http://cyngn.com/role/DescriptionofBusinessDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrestricted cash balance",
        "documentation": "Unrestricted cash balance .",
        "label": "Unrestricted Cash Balance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://cyngn.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r226",
      "r230",
      "r231",
      "r232",
      "r622",
      "r624",
      "r785"
     ]
    },
    "us-gaap_ValuationAllowanceByDeferredTaxAssetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceByDeferredTaxAssetAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance by Deferred Tax Asset [Axis]",
        "documentation": "Information by type of deferred tax consequences attributable to deductible temporary differences."
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_ValuationTechniqueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueAxis",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Axis]",
        "documentation": "Information by valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r553",
      "r817",
      "r820",
      "r853",
      "r1145"
     ]
    },
    "us-gaap_ValuationTechniqueDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ValuationTechniqueDomain",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Approach and Technique [Domain]",
        "documentation": "Valuation approach and technique."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r553",
      "r817",
      "r820",
      "r853",
      "r1145"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "cyngn_WarrantIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://cyngn.com/role/ScheduleofRestatedStatementofCashFlowsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant issuance costs",
        "documentation": "Amount of warrant issuance costs.",
        "label": "Warrant Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_WarrantLiabilityIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantLiabilityIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://cyngn.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedCashFlow",
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofRestatedStatementsofOperationsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability issuance costs",
        "negatedLabel": "Warrant liability issuance costs",
        "documentation": "Warrant liability issuance costs.",
        "label": "Warrant Liability Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable",
      "http://cyngn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant [Member]",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r868",
      "r869",
      "r872",
      "r873",
      "r874",
      "r875"
     ]
    },
    "cyngn_WarrantRevaluationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantRevaluationMember",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFederalStatutoryIncomeTaxRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Revaluation [Member]",
        "label": "Warrant Revaluation Member"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_WarrantsAndRightOutstandingMaturityDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantsAndRightOutstandingMaturityDate",
     "presentation": [
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "documentation": "Expiration date.",
        "label": "Warrants And Right Outstanding Maturity Date"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://cyngn.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://cyngn.com/role/ConsolidatedBalanceSheet",
      "http://cyngn.com/role/ScheduleofRestatedBalanceSheetTable",
      "http://cyngn.com/role/ScheduleofSecuritiesWarrantsareConvertibleTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liability",
        "verboseLabel": "Fair value",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://cyngn.com/role/ScheduleofFairValueofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1143",
      "r1144",
      "r1145"
     ]
    },
    "cyngn_WarrantsToPurchase": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantsToPurchase",
     "presentation": [
      "http://cyngn.com/role/CapitalStructureDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant purchase",
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Warrants To Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "cyngn_WarrantsToPurchaseShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://cyngn.com/20251231",
     "localname": "WarrantsToPurchaseShares",
     "presentation": [
      "http://cyngn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase shares (in Shares)",
        "documentation": "Number of warrants to purchase shares.",
        "label": "Warrants To Purchase Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares)",
        "verboseLabel": "Diluted weighted average common shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r215"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://cyngn.com/role/ConsolidatedIncomeStatement",
      "http://cyngn.com/role/ScheduleofBasicandDilutedLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)",
        "verboseLabel": "Basic weighted average common shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r215"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482943/710-10-55-7"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479567/321-10-45-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "3",
   "Publisher": "SEC"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(d)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-23"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476151/220-40-65-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-19"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-2A"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-3A"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "31",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480095/942-10-S50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "942",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480035/942-10-S99-6"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/730/tableOfContent"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479224/944-40-30-2"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479224/944-40-30-3"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>102
<FILENAME>0001213900-26-034900-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-034900-xbrl.zip
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M'!$40%(PP_(BE2;W"Y-*%Q'7#TF$(?]C18>+):54.RIE(V8TFSEX$8ZOT21
M;-!Q MIVW3 ** HF Z;I+EO#%(9+LSJEC!:%]ZHHO(2X&"!7Y,&*/D@;J"=
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M.XMN8S:"*>Q!?&(N_C*2,//_!U!+ P04    " !$D7I</=.&GF$0  ">U
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MGH[S-&.[EZIY5@X M^_K.I"?]4G,EK^:0\G7X/B:/W,;A"%T0=@1J6:H_7G
M'7(>,R/@,7R(R"Q-299>:9R*7=\!/E*\YS#SHMN,YGZ64Z)6).TO@.Y6-L&+
M)$VO"17*=99E-'S(,X])($O8"EDF\6V6^)]+K:ODUG0\P).0#WO$%E' %S:)
M4V'NG;[R']52[O\V[!*X8:<4%8; K;=B2S^]9IM20[ET?0MT,11FRIWWJK%Q
MZY\%/FV7RS#C\TQ+1<HFRRX^.H=&WW?A5MI-F'[FX]\S34HS+V14-'CK_A;P
MT?N0DC]R-OW3E=9QL/,%4'9N2%I9O,GBFI)5F.1IM#Y/TYP$LSP(F6ET%L;L
M0 JY?BL_JG/,VHT+>+;L6B)':_'36LE]SU<=V&%W7#-#66/E8+#:LMMDT>2[
M]\N0MF/+CM%DK_M;P#I]QZ+19$[^3<"-U+9N-'F3? U.QQO:,9ILVXT*N4Y[
M[1Q=9: Q!J@=O[$TM%=N^QN A[_=X:/)^;#18<\/_XD$>408'X3ZC(KW2-)D
M<9>P?5=>= 59]7+1'0APS6QIWCXE-+LC='D>KYAPM^(RX%L^!@K+#/=G+PS*
M#<5MQGGV1.AQ3KF/JU#&QJ+7'A-K$=&$'7;9FE'FKKMG+D3S2<C&0,&!&3B4
M;3N)S"Y"[R&,PJRR>PSF83@P$B)G.3\YA>5Q[:W%HLYC=NPP5JZ2^)C;35'$
M&1 ?,9VCS>A($Q44CI/4>+VUO@AKUV[)?*3,)CCV*%TS2W"VY$8U6Q)LD>3+
M/.+^8_8[FH5_BF/6= X6@Z-LIM,T"Y=M>N4.6"1T%D5M>]-TIK84<(X=XN=4
M[.%?F>P][I"@;"FQ\X.QQJ@:'T%:XP%ZT[8;V0OI)R_*V8\5:6-=(!L":T<Q
MXY1?48.3,,K9@JC;W*:\*X?"D+FPL.?BF2;]Q"P.$O C[Y693V'JV:P>K?$P
M9L(-6AKZC*+@X3X.A6MNYF?ABK_?&4Y$:SBD8^17$CX^<?7"]APS89D*R9>%
M2%\()??L.A3&I0YBJI:=<Q_Y2C]A&FFS_HUW#AQ-T$ODAK\3=L]*,[%!F'(E
M-!9*UXNN^>YXY9O%=,:Z(V*ICC/"C)3B;I5G"5UO[I(W3*C&BD\]&-8\3LB"
M,',R8,2*PXX)=(#)JC4<TL83)LQ]3(F?/,;AGX*)(Q*316A^%*G'PMDHY<6^
M$;MBH_RZQT Q82IR6S=#LB@=EDS_V#+?-]HXTRB/PT8<"5O>H1]:(Z(_-M9V
M[^"DBCH9#M7.6#A[I+ZN^?.=+?_]XP CH/4P<L(8":.TY@$0.G1S8V$'^2*/
M+L*%QC2A"6+'))6LV(4F55\&77 F$H3% U+8JF CW0GHCC/&JYXNS_W?AN6T
M]4:GRZ+D:W!WK([G.5W>>KX*&\K1>J73Y4_VO=$>PK0WO\X@6"$Z^FCO? 52
MD#TQ-]IXJX> /K6;<2_ZRK[[>[!1J%9/@/KJ?M#PAOJ+\Y!661 ++WT0J1 I
MS3[PN7\@49;R?[WGXZ5"'D(6A 3+;W:GTAA S(9_EW_XP^EKQO8<5VFG<;XL
MKQ4789I9@-/-=)Z^?_2\YQKC[#<=?/>P70TA6-=BNV#<H[X)[QVI*U7F"<]9
M*5@-PB6GG,3O [+P\BC[ZEU)IL[Z9HPPSCZPKWPH/_-A]^OERD#F-5EZ86S-
M:O'MK4+&8/:)#4']_(&\WQ VX[=K .S%( 3S?DF6#X0:2K?QU<U>P^#2BR(S
MWO@7-ARQ=1K&8;&_XL\E!_QCQAE2C1D1OH,#$GPEEC^C$R5^XP,13SQ+:/6M
MR'L@T2]?E:K@WQL-.U]LM.YUD@H^9P^IL,>MM1/_S58Y&9'\8#<=?M>>%5=N
M[OQ8>1$_/&99]0 I/-+ \]&C6:V#QDJ8T>;DV,*IF"O7D.D&*+^]H,G2#N0L
M,99F0@-"?_GJ:S:$V#%_]:.$F:2_?,7L9V*+9%?,"_1"["*Q4<Y3 JI;6"4N
MWTAQV4S4#)K2O9#.RKB1&^(3MCAX"!B[R951),!8Z=&<XB;3E&8)YK>@FXPO
MEY@_#%T1:, :0T\1EZ9L2O%_!RK^9E!<M0 *GPC.-M*A.$D-J"7*$L3_!%>(
MB(AU83,U<+IA^%X.@]UF*H(S>5I:-JM%:,+KMEY2TX2H7WHE8C_ (M9T4=_P
M2)/YXCXMG,+ D/73VLY@,H IA%<B]F./JK.![(P+AUR$*UY3HB.]&10S!;%)
MGE,J 9:X_01]1)7QF^L3\LRYA+Y)M4:?)#0[(BJQ^!G'7$"Q$[:6Z&3$7DFC
MNJW"NA&JV]6UM^97*MS+:8O(%&\],GE5Z/0X$ZS\=>63_Z^U%_\JK&^- Y86
MR>EM(SU)5C#"NA%:BV9S^RK2C&IAFJ-L/S7Y:9KHYE*NT)9[+2 ,=^3]JB V
M25-#)< *N%Y/A15TZ)OQS6RWO@W5X[J W%!72>R/N:=J]*:)F88<*PA[?!E6
M$%:)94PMB\MX.L\S7@64ETL%1J^7U#2!ZY=>A1FT-Z.VQ?&TX 1MR89<*N'+
M71)VAO\FY&ZV4V4+V-Z74YKB#:U7<A58/3X+6[3*TC H$13MX:>W978E5#W8
M OLS@B L$Q*],#B/RU#E&GGHRY6:X 2]YSIBK  $CY^XX;&L,0E./1KS0HJU
M8@AEKA8PAAH$)XBACA@K#.7^#EM_^DZ:';1+?9? -$V[+DE5L$ [)FJ&"SL;
MT3%2DINB?:&6885>CW>"![Q^:$:\;B.(P2)A=^JWU\5Z"(R56'!,:',J: 7"
M5*G*B> 9=5**DW3>:8E2&1-KJ>%JQ 6E=)9G3PGEE03P\-NA-$6]UBLY9:@L
M"%9%DA,V3B65:5H+4IDIXU]A(,+SVO62>B-@=7GM>FP\/"MAIUF.Q#*PU,*M
MX9'L 1F5 <\_9;(]M(]M,ZS;=:R I7EYK 2!=U*G;#^5=,!U27WLR0B])1*L
M_)0;DA(V 9ZZ=,)H18D(9-UTX@!>^7VT''I5C/9"K[S4)Z\E3D7#P(B1G05+
M)AW.81:N" Y2*FKN?,X&4"E%IG7H6NDR[@VH*@8CJ+/&\)/ 8E<HZOR20<$!
M!6^\!"%6.$"-PC145Z=LU/DEUF9?1IB5FQ7$2MRODCBIN,!(H],@.8GMHB<\
MV$R3HJ9)&5RP"0?A5TKN0Q0;N(F7M"Y*_QA[;X%I"0(K9Z2J!#L+?L^+Y.3Y
MI@XS\';IIS4-G::0ETZ&B,4FX:IS'E<K0@:0='](OSZ1K2&?OD86B-6ISF-W
MZ^JOH1>A#_A^8D[=\":GO4)FZA02*ZC&0FGZ &E@ YQ PHP&-+.X.?;>*S*)
M2-0I'[;F<!5X4;UZB58%P!ATTYB$P2L1#U921IM<V3 "&8^*RF1VAU1,>#D7
MK28*5SF?R'RQ\V2"L7_,:$_EG#&4J$;:!B"NY8K"?D\TI>[RS7XXM'*AZB1T
M +\T"BX:05%W3'K?)O2[GH?&04%(C#%RSGX$+X&V2V" HMN,5E;,QV&UT:L!
M?#6+(H]=:UB.13/:L2F"W=?%),[8NCB-Q*=^^2HEC^4+-:!FVG!1K,YMB?+9
M:XBVA#II8<'46>6T%[;&FNR$K%M8&I=*.WNM2>VDK"P+:ZUUTL"RGG>JY/;B
MT;<T&P9;MYQ0BDYVTOKWUV.A@G0^[U9:Q@.&"POK7?^:EDV@1,319</>@*N/
MMTO"J57<JR9:%? ZI#-"'"H*$+OCN[1?M4'H$ M*:*DD?PD%BGY:#M]4M%%1
M2$LCP 4BS0L%' F126P6F8!0:JUB7\?WZ\*M>5F1WJ:AC=TO.%U.<5V4IE>!
MFT^"5A%.?Y)3WAR,T#"I7"K\:0T#DWZ"^Y!VJ@9((32T $D)<1$<,")@-7J3
MV5/]4E-'22)LL5;OZ-F+1P/1#G;,;2=G8MI;L4>X.E6_P;>G8[ 5/$Q]&ZO1
M[@W^-(^.ZEU[92-[,N?]S!8Y]_A7X4/LKI'$,?&Y='EEQKLG<IT_1*$_7[#+
M^HX5*@VOPJ._STL!7?;J:%.+M3+"<AB,^![##8)H7PRKI<.EBL5,[Q*)/Z&*
M\FAVXQ3+=R[Z"K-3BMGX:9B16T)7H4^*E7Q3-(//:F\88*Z;<;C>9R4R.H)8
M)=R_E% W/3B[H]S :K7W'CVE#>)'7IJ*EMM<.O,%6Q*\:$JEK>Z2XD8O4H0J
MG59\YF@D^V!,1O?\6-D#"6D])2-</*_(B_C3J!?-+=$I:!-=^6E$,2-<)D<&
ML$5S GYL/=EI14*/%2FF6[MJ8  04U,[+F;\\E4]-*V?$*YIXA,2I&=L@9R0
M!]Z8:K[H2>6#Z/*E(K@/9YX.PJU.7THY8D4-U&E7),^YV)@=WF/V@$+93W<O
M*L_: ZH0JDXL E)%'MY$^"Q*7N2*;J">JPBD^.IME]2 @_^+N];U0*6^X(&K
MI!/R3(D?"KN?_1P1(9(XF"T3FH5_>@A>&2V2>Z&(M(#2DZ#Z5=LZJF/'88,1
MVK%+9"_L8DV,9')""WWR(EY8<=N._".;4<IW,D+ML3Y:^V&A:6&D$)K.F[6%
MBXNWCQ([=AZ++O)9NXN\EO])-<J^%'KM!4)3(&COR1SNH@[!K1>1^:+6PAIX
MS_11FI):ZY68QDNPU4L0'_Y\^>R%E'-ZS#3K([A2DQ"9$C8R.0&_N5;D#E5F
M+##2*S73^YAJ:1_XQ8-;:1YBN&^Z:4S'K);(2/VZ>"B0-<P T*N2!54/Z"U7
M7S*3N[($4_^[F=597KNB;FI?QX]59<>3,"U:KD*?[KID)V$VFPL3J1;0><PL
M=W;'/2'%?\_CJF5NU2N7Z502KG@B,#2D9K0GA:NA6#5>V6# Y9>RF'T!OF5@
M/ZT)V7<*H:E+$<$@=4T)NP;PKEPB0;6L";9I8(UQP[5D8M+8ZHE97><(5O>6
M[<I'T[<5O6F8/@;RTVD^#:5;JS6$T[Y 36_JX.W(3ZM*$=S.8V,&S49N0@=L
M^V.C=3X>S,ZD5;"IZ-6=K2V?E#G_US19A0$)CM;W*7]6V+ P\[-PA0&^ >$I
MN3)-Y*ENEVVYS]DY4 6O^W_D(26,'<9 MKZ.V"V91Z:RWS[7NQU!!<_H$YX2
MJ";RU&BK#03J>9QY\6/(#GP4LUA-;UHGKX;\U'VXK<&K!5X5[T_L-T'.E0$2
M>FJ"$SH]=<2G[L$-LNO$0^]=W\LW_,[KI#EI!=HM1;06W/7U<^EE.14GL+@$
M%XPQ'7[L15'*"\.J(AM ]Z8--Q/3NT-EK],!W#J>LLM8*Z@[,'Z["$]IFYO(
M4Z,SN,WK6'VUS3)VFUIZ]#,I"Q5N'AI4"0'2US/KX2?AQA\JP@I3N=MI&*!%
MC/KVV:]60H\ID9T<\$8*GOBK!<K#:>Y_' &*I*O% -J?RYY'=.@GH:F'2[&"
M%;KU5U=J"EI4EH+8))2UKN JP(#"@+K('B?LA*<9OTKS-#%$L-J4IK#GM"16
MH03N-KK9V-GSQ562$:1'-BF9"7D9Y**J NIA2H@72KAA.YTE5*C<DY!;SG'
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M,!XR*M/>-E+9H:F[&Y*Q29'@U*,QVYOIS/?S91YQ57O"I.>#UYW1(.CH<(<
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MY%GXRG_".9%Z"(T?>#P0ICZA:?:>-P;J@K]K\$(9Y\MGFJR**$L4I/HH3?"
MZA6<3MU:6'?4[HL.MC.J1G$_=6+OTYZ6(-5F(1*&)R3U:2A"G>>+.T*7I_QA
M+@T?(G(:Y\NR>]OX2&ORM:>&S- %H8N*KGD*^"Q<8RU9'.4IFVE:O0++GW@-
ME5#A=>PCM2-AQ4NGWEA6><)]0YL\QJK'03N\))63C0#8/JUJ"&3P,^G!*V^P
M\'H\[(#]^0[^]8-__>!?WR=7\,&_/EG_^FY9R1NR8C\3\8?;YPB\L;D.12>
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MVZ>J!:P$R< F!48)WAA5X>36#@6""NTR7Z5O,C7<D<DI>HR@)L&JZ4XNU=)
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M!D!2&96H_ SMT5PT7'IWR75._2>/K8AB2R]J1JF^H]-DT/W>.79RTJA%#^*
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MX0N,JCI3Z<GSF4?L=^< D^L.5^K2)>S4V>-!K^X"8X_<J_[;KW[WW<??_KX
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M@<-3.9T<#![3A?2K:C4H;:^6YA1E,L[H>TH7,CH:?BW%.I:=O*Q!>*>/:^:
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M$JK@#GW@>:%,!44?_Y,F3#]JFM;T? P^V\>ND)2/RPP10QP<TB8 M1G>)?A
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M*4\:]/1H_ #V1#V8CW8PA@.)\U\X519/>$<0GL2*!YMQ"K]:Z&8>YK/=PU4
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M&%D45C!SVK][I)SPP MO[KX#7U]^^ND\A]NXP%'ZT3<LT'AYG\*3U^"A"7/
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M,3?\5/JX$6A;M5;J+/ A)Z:^NC(Z!YKJZ^-;]OB254601H]OJ.?#.B4/890
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M8Z5M^KTYLAV/R K>+<5%&>-<,;T(,=\:.4<"S<."XW%IJCF] :_2?64O0D1
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M8UT-'%ETRPS7U [+XBTN7Y95468[9 AI1:LJ=.DHMD2=,_X;.%(]'9O ;2<
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M#$=772.W&6G>(^]A\*8946^1?<,(O(CP-T6*JQQ(;NAJ.X1J IY!H[^6A?A
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M^.46@LQ+GM8./JWS!# .DBQ[F:_7%-P3B_**)E61)[?9R\?T,\U>;HKMIZ[
M9UX#;Z=98JV[:[U,^"4;0D2]#XR9YHU$O!*RICO/DN:UY!=X\;_B1?X.),KV
M8CJHO@*;UMQQFB?9)_81R"B9:$!F3]D6 \@GV"1TY% ,(K_(_^(NQB@&KY5#
M;*?O$4?0K ]QR-PD7ZXHL)EF*3<'>*_[GVA2ZK_;ZQ[>\V66/E%U $.V'OC(
M29LFTQ]0)4#6>)16,VFL1?7L#! $KM.!<@QK8ZD41-G^KS?A4CX752-;<\:D
MCK(U.$>Z-Q.#G=E)=7^:%<][S-O!B(99%&.F-BIIAQMV4+_,24WKNC5$R5[I
M.C:A!3IK48OAYCZ%7I)E_;* !$-P<;(KX-D*P,!4L3U'R:LJ6@TTYSAMPHD3
M39V[JMKTB7X!8KC%MML&"ZC72!LI\I"19$?3GROZD*2Y\!=HWX ($7UC[Q<)
MY-YQ>IWD+DA*4#3;SI>M<%V,$V:D(+"3:">9!K7X.M4(W$\TJ 2#CXB<<(2S
MX3(2,(:#)G"XT*LNZ#/_DQ4/0>1:B.%$C)>?T$RZ4: TYED\4<6^#_GQBGKS
M!T@IE+F$WL7S1 3;F\V\*&%]517X[L1^SSVO^8H_S'Z\8=9BXH'7B3I/U/N,
M\Q3Z9.E7SHCQTAD_B-5[B7PQ^<5R98Y]#.]%FA[^D[WI+.2^(2\W^AAA'P13
M_ .'#;O-TCMUGBRA'/O.>K>39,SSV*!$&E(STA"+Z4(?R#>VF8P2W41,,=-:
MD$$ <"3</!>C#+$9 2++[1C83+AC&-68JAXEAH%F6)\\PSIDKJAH$G^6/U'1
M+14Z/E;04<SN:5.#2#.*\&'DC1CX-GH6N(,K_ /M%4/ Y"F=_'M.$\!$YD<%
M]\R*_^T]N(V\;(.$G^,ZQF?GRR_ZJ0T35C W2!]ZC6_6E+2J)P'WMB-@3PM=
M;)1+% /0'NT*=1*+DI/BFI&'YU,-Y]DFFL#42LM]=.@+GAXA741,ZWA3U<4#
M+4]ZR@[E8^1DJU0MB@ZV)MT5-LK5)&ZWC3OS?7['?K<:'/37]U;382R);7N$
MIW,/1?D><,-TR&W'A,)3NJ*E:$BQ84^_-)''I*:C]V0_JD$R549,S&./EG2(
M)M2)5D]LNQZD9VS?]I=<R!OO?+7B>;A)=IFDS.Z7U;?6\@_].('GH<Y'CHCM
MXK0P@IG*3I[#WCNW$4_-VH9>ZQA\BF*460 26Q$NEC!M](L@,%;.YO%1M$%)
M,A5"/LNYGVH[,Q<M(S"&-]%V8E! BZ<BQ07\>$4# T/$](J*)W^@%>1B [*]
M\,_=%/ KB7,/A:'SN[N2WK%-^RRORS2OTB6_=X<HL123XQ^^=A_6!?\U.!3U
M%&=$3Y+H60I/2/0E%TL_Z"*.NUB".F'ZV[Q;6G&3TZV4<3ZP 9J*:J#MO]E]
MZ/-FOEQ"MF7%EA=?,/F*EQZP7Y<;NC*P"8\W94E%-RY,4XH.D83X+B'*,B0M
M8A";$4DNLHMZ*/>H/3=*@K$1^/H,"86R-Z_9QG&[J;E.V6;/;K%P-*!&Q"1
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M%' YF4UDTW0[N*0A$,5[FTY!%;GE;S8\L9 3VGX742^+VYO\<$*T.VT/J+/
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MN@(]EV!"$\Z)[./9=;;X2BQ$VH1L*E')5F,K]U$RKXAZ< *GR/:LNP<(SE?
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MS!\[?*QL!K2AV%5I\[#)0-TG]+&D2U%-PG[.*'=@Y"L3#M=ZTW5<)Q5]8KX
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M=*@;)@&BTAG#R$9UHX\2Q"XN&42B(0M,MI.?_/HH=]._K!V4HZ=_]?5.]I%
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M0<[E=@1-M2=B9./>[L>)8FA$K4^H$2!"V-?^2,OZA1UM<%_@3;"[\734O6Y
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MAW<Q7_ZV22'KO&UU6@,UJ@5*71 YM%O/$=61U<<9ZL?R$T=X/*FTUKU5>,'
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M( R8IS' SK%BU<PX3CKH]%2L3Q.>E!(+[8:W.P#-D7===(,Z94.B:;?>GD>
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MF8=+?"I7F2'V;Y[K8/Z[[%V_",7?4="^ZSS0!/T>I ;T=5V7NA2'ZH _\-6
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M35'V0\LCK[ROO_3[D^=(Q]:AWEET.%',<GV(;E/J;[P8:0W$E7Y]#NI-OG?
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M%NGAM2S2I>[N_WYK:E.1(?A_KG?R/IO-\.A:YOE2O_#E*@X2QTXK1-20\(,
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M0W\:QDXQ6.LXU]YSYHS[6K,5SB09?#3VI5S%'BO#_V'^T6\[\^TJ53K.3KQ
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M0+MZ=>HU[ T\KITY[6#=#7BP.*W"/6C;DD72<HXKBQF4/=RWHL'-$)-^-''
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MHF.TJ41V"A=%8A/TR( LL4_<)_9!GS/@SAP[LBNJ07!2ZA Y[,G[F&E].O/
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MZUCMUC'$V*>4(3],M(IP#Z*$J8Y= 4]D7;J.]=I\)X"GK@%JN YGRD6^.IA
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M=1"N_NHJR')[J"B(%"/HH3BY#D%6BILKX5NA_HVL! X<TJZ<A!T#&5&6%?3
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M'YR:3D;NO#!!%H:FEF8H3E\L42-(7"/$737/]O_ P6HSS?[9N8=\Z^OB#+U
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M?@^[7@]3'ZA+G* UC:Y7)KR#0E0NL3(E4*NDE#*X*)&O0=[4>#W+A=R80?W
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M%!4M">#_C;<SCR=FDIP?9S7#4BK8>0J-]@>/[GEYE 3"]VVE]AM0^V7.'8N
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MIC+;E)C'UP &:RT,WG87F1$$$_G1ER;S$U#TJ'L>>K73]*QXS3&NO57OLY'
M=;R1**%"9V M.%\%0!X.CT.W6]8V>H68?=G\-_OZ/,)CI):C9QE++CDGQ7.Y
M.5N85!G$L62ULB"4\LE[%P8F[ZG]*,5=/9],0 _[@8H\;?'\?]%_4X40F-KU
MSDL_=102//OR^3?1_.*:+%,I';R_3:\!Y%EX0]N ?U*: U[_!XEX=$[+3".
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MVRUL+F4F3FO\'(MU#%.QL$QN(;2BF[SBV%@B'MLM!Z%#OGNJ)RRSSV(KRGM
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MW,7;6RQWU.?ERDAX>YLS'B/F\C61>(?Q^Q_"N*?4LQEO;U5V(@YNJ<^RDC.
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M"E/8AJ$/1\ A'UI4(S%<FSJ/HO:*0\%.-/O<<!96I-Z$16[P&,]_$AC2T$#
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MDO-U7 !AVU%0+&G8:_XAL!B[3?%4D5:,\H5%SCJ)/HR86@+3%LL[^(Y_)B-
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M\IE?^0/=H4=<?JKNP,/A7'@XE;7PML-9JR?)R]<.9ZV5XN9*#J4G!T4]=Q!
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M_9"S5_:?R._Q!"X<R"^FHL'M'D\TQ!NV4/?C4'2=XAYD_XG=0+:#GTS PY<
M.BZI%UX_OY6H,^/(]/R(6_EF#8TP)ZH RS+D%Y"IA$$M%OV[YV@#H$S>H_T$
M?FB,'+D#!_&<:$)KE7=B+(+ZF6"GR'=HPXLB\3W1=H6ZB?@CQL@K,)Z1S)O+
M2.X$)6*]7)>F^IT=]&S/"4O7/T;."^\5D] ,B%QEY"/H)@4FQ(**8,!U:I+$
M/=6P!2%-,#KNV>OVQ3!"$3'Q?[SH*$$1+DGM&PXLM5,P6&3UHR0UDL7T7.:/
M@=UW0T00/?E8XN'-&Q%2%&K<@&;2 YXK<![PQQY6%]C]QSA25 LA[9S6LYB_
M2 U:P@722J*-Y2>C$!O2C$!N[0&2Z'D/!J&/J(,HT=!HNXL]'0?4]1A_,.(^
MI%2Q1'R8*/;)1U!X"<TL&=:4-!Z;?W!C8(]15U@0A1L2.J,G55D5PH'A)4>^
M020NQ/$Y SYGH!921Y-WD&D';4FSR8.$CWL^'6E8U__$H%B&+U23,7=QWFL5
M/:PZ@7+[E&6?46C&E(@0%2.!C.U@Y#I$]<O4H?1#3_7>'L(Q!%&E#'\:CCMT
MA\2>Y[G871L9D,177,\E)J4ISI8O1//"M)1N &_4'\VUJ7APX8&PCZ+H2/6^
M!2WP4^6XW#)["7YP#.8*/52,FO#!R+DJF0!1Q5FR85+$!)]TEIB*N(1O-F1'
M<E%OA ]%.?/H?>IU@B8*Q))\1]3: Z>G\Q]_P2%]<I]2*T@,+=HT74^KJ11)
M3((8X@6"LT\728*!A+ /?+,]'+HCEWI98(F2@Q'=GUKE<D(SK-#>VN[!\'SX
M%YR,0/%KVJF5I_,*VD*H&M"8D>$.M6H"DBK0ZH/9\8VP4@I1EH1&<; N$E6/
MNB,#A)*PG(6.IF>/S<NAQ52J7"QFBMD/G+X;"K9XO@>,88QE!MIM8&ECFQD6
M5WQ-C8O@G %?X'@JQ.]YS/"A@5:P22P_,P]$#<[R(^JW9S\B'D[B(QJJ;Z(5
M4E%T#=EF>+_8TCX+Q_9HY 3:M3]MH8T=VU-,0-,'0*[J0LF?C.)0$&+*RLJ$
MF#)=IH@T,G$X+63XW<N;:T0AD1#P04\=(R%10@U)!83X*>T;%>T;FGX9,\$>
M>GS(F<<=99V!,7W>R)2<,CY-L8#FS +BN7)<,A"E@EYZY<2$#1Y^M5'6@=A$
MO[7N2:?5NT!%\[B-I<<]NU&H0U#;D" N6#N]]!J54W(]&GGL_909PMILVEZ4
M[!>:P9HR'[DC.@X3;2%I\,^,V-!,J#O1"!8[; M%.7^&,ZZ)*.*%L8Z8N2%Z
M]O5=TG>& :MHT^N%-(9F(@M[NLNB<:MLL0L?O(%*N?0_[%V%X'",[. 53V7>
M+-#7(8=DUOHWEK'^=U_J0_^Q37?PUR/[7^5*#<-6]LG&(PJ7L%UFJWML_A\L
M(G=A^X@D ([=_T&K6/S[3*UJ:'1[/OB*@E_BU@W__&B-;-"'4M090BYOU6D\
MG;J\(F0FI566NDS"P;5S[[++)MWL8M9U3$EH?3T2.AO7#!A-6,X*=&9%O5.E
M; 1('-J@4UY^63P )?Y&^]B\4*6 =VDG_RZ>""9<=%3.[,AF<1>U<+N2^CR!
M[,['"60WWU,@>XW,Y#TUD$VHZ*S,RGH/@$27PT2D 3$T+[6XXVT2=[SAJ$%7
M1::,"S<8;^-RTD:YR>6>HQON!>^+UD2$--=7'RP>7*\SHD+SR61[G_?TT<GI
M/Z]^N\)F>[LWY-P?OX O<A6#,4LA>0^_?>L,_WK4+Q\IQV#0C?YZ]*\N&M!^
M<,UE]O?PP:\C["?>+_\+/_BORI'I@,D]084:Q,Z1Z8'F^^O1P'%_F?/5([J?
MW1]/I7JYW#S:I.DH7BW;NF1=H>H@_)Q:E:WERQ8=1QB1V P1_Q_DVI"-#?</
MCCLJIXK"%7WAK+''DW 7&)+:(7QT&%^6G( 4/5O:'/TLHGUSNJ8EY H:2X+F
MTJ'CK7$Z9/0M,D1E!;-^"%Z+?*5FUHR!S+U6/F'MDT-!-^K+.W0"D8D2_;;$
M3+/8'.2TCXU+]D8%H84E M$9_ _2"<8J[M$+$Q^/J"T=;"7%.$)PLJ-P^A&2
M?F6Z;4IZP8VLV6*023%23K414"WZEEE(;B4&GQW+'E)ZPD:PUHW EQ.D+I@B
MZO>19U#E0)'K'/Y%1YG&UJ63:Q^KXZP?GOV^4TA5?*7L$*ZO./P;LYEV8R50
M*#U3XFU*7) @3K"*FBF'C#ELC E/S+%Y'0=3WT)/%B,Y/_ 843K-3]\2TX_+
M')&B0*+8(NI#C'X:'+*;DU_6,M"*DTV8A/(H)J:A>8VI)_0SA9GT*27OGU7_
MOYO3[O771'EB$7;@&'HZO.>D$N'T;J$CIBGWJ48;^=](<ZM18FM,<^@,B%Y)
M8\T=V<\)IX^6]0_BD4@MP)SCD5 6,C.>?!^_>OZC_VA[#S0&R>@G'TESV[V]
MM+GK%%-8,75F5'(T9P^,)$,MUI$7Q[R?RE^+G9=-";@5#B$$G #U+>\5O0G!
M&4S$A07,/E,BV6$8!_1JF\)HSX\.Q>=3=XDQ=3B'V/X4QJ7N(-Q)^1%+/4.4
M1\/UB+FH +X& TG3.T[%F22< Z$> ;,?/&,:\ %.^(#X]'E61 $A !Q\2[V"
MX4CBM 0YF-B!2M7Q8T0 7A^(6"S9K)/6'+TX?YC_;0KW(N_)21Q,?*YH$3I)
ML,=.J25G.&03PQ,DCEFZ2@[#R#%IDC'XZXAS E(A8C]7Q$>(U[_;TW>M'3C1
ME$G($EL@?M\98#29S;B0,TP@#V[X9SA7U!-HP>R=\<HQL/1#.CT$/,M\C9'0
M,V:%AG)LWL74(E1]6$W'^6'#@ZAVF)JZ1HB%((B)93I(O("'/$D[D%Z@E",K
MYB3X&TJ3*VM:QT:RDI0V3=Z/N3!;\7%GVG=,!T.L;[ ]E!C"YC2"NCMD_N'>
MBW:G6XQP0V[U4'L%;0Y*.YK"PD*V=6LW<^R8L>PY(]=Y$@HS.?^"G(*3K$H[
M]I0-IMGJ>Y4,%]'HDY_#G\U7(@$SKCQ&-77WO=;.BFTC.M#&L5%*K-2W)^'1
MR>G7R__'.+T!57MS?'J<,+6EG>Y-!:US#U.N^L;&@>M@:NOP7F?Z2@@A=(*G
MN?VH^03Z@0%7(:@H\!@KYB>ZE)@GT?Z35!(J9M8I0K^DR(7H1Q'KO!@>)&[-
M[W;0C\=FSD4:C29BA9 9*KUWR8VLM2ID8IC/[WACCUZ+'\YHC6^""R[1')5:
MLU8Y.KF#Z5R@K0DWC6^9IXAQ] //M6?T I)^&*RWOA.=J^BHT]S@-#>M@,E^
M-R_/S*O?OW\]OUU:&6/NX'*07M3JT4FETYE>OHU+1$$ZUS9 ZUPS?N47?(.
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M6B _?:4@7GTVA-=)1?#R1>[J;Q$:^!*Q$(R<7#B4I9ZQE8!=OL.,@=^R56Z
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M4Y*$,$<\"M)U8GC-L9F_K41GB1X4;5!'5[[J($%_3(NVDSKNRZW\]4Q"?Q*
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M8,TX)*KD9J8U=A+:QA4%WZH+#;HZ3F;JB=1L,I*5D:Z<6G:C(#HFXV(JTY8
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MLV%Z;/>#R^#*HU"FWETO-GL8_9>PHV(I-N0UI9H*J0NHPHTCJT;D58=39!V
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M,87X3\=,E**)V*DM04XQ8@+DE9M*P=NP#HX%5>4?M %*H(,6A(DC5#*,(X;
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M801S8NK117G'8!976.Y'%W\5KI$\EZ<%3WX!XHM-87/V,G >77@L<;*F=\H
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M/-BUZ72J![!/PHH>G4<X.:T>^(\??Y!EL6S]"6;&C7BJ!?=<B'X?K.0B\!]
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M4$%OP/!@.'<!.!QSU&-^\(L9W-V^Z74&5J\_L7K#X=ND;A&*;=C[*3G=I;.
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M%W2H&=6J>OZ^@$U&!97>FW@K4)OA-I/[C&MI2%6$=[T="@3JZ7 <;/O>T@*
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M[1K#TPO*U@H6+.*AJYFVJJW,[G?!,.[<6Y_?>;/UAVIJ)?^1#ECAO]/2]>W
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M>+(&]7.[=SV?6FB)>V^(+> <[,OF)\B,[#@9W-F(Z3"B'F2P'FY*N%$ 7\=
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M-.4( N<T5>'J=8H*U1=#H A23P'E1YA>^X1R$]L:MQ9T;UL'RKL5:]N\BQ.
M5,2.PUT32-G9UF@]+9AM_9II^QHQM2EE4Q*3TVCNC[#+D"U8(<O(-J7-+ 4?
M#*'6#HY02V^]ON'6]\O9%EH\*R@G%M.ISQG=E&-'^<K)]"Z,9*%A"=MEG3*0
MG(U47N5=;Z6U\=Q8B.<%!EO9?;]@F#6W"[-M\LR%%\(P9@6[[XO,V/T@+6>"
M;8:O'17(/LHP:Z,!W*BVG&YOM6'V+&[8'I#U5-Z*SCK>BD==;;.4+HT\["ZL
M?'"IRW,!I2G5^:=E8Q2,L!<&(ZC49WGX[JDN?'?9A2^1F/Q4M-];1OO%-0O#
M4,BT"4X1H[PQ.4YIF,:I0TQ^"EP?%:F% 49G[^C\>N=._Q4F_O"24@1T&A \
M\@74PE)0:U>78EL&LIFX%Q*S8WLC(VP+T,5=I?G6,H,A*"JULX3.7L(E,1LF
M4[)H"TR,D/E'G'\3"9UW$X0V?A=A_I@1"<0+EH!N$$U=3);)^ )D]DP B+%K
M=7L,.+H#K!952:JD&ET"B_LII I3$^>7+[KWF+) [(/_M_D"\L],;(T\GU"@
M$TTB,4VB().TE*GQN'?!Y$UBF9=G%O/&;,C  S.J(X8'DBD7D1D)(UEB\6+[
M%B -B_LS) X_!)*(S(Q#W)/X[JHR6:Y>XWPY-K[A&4KB,:O:= &;Y/E5^E:F
M$LKO'%AV(";(2VQ%>2HS9>!%@V2,F8X#\1(R#O\>/F!>D6-F:(ZH@'D^)Q<+
M""EE""%GEF5X6.4M"S, 4E0PG,&^HZ%(J4R@YD\CKY]P%!W?*09W 9H4@&G,
M$P<P,QHQPQ?V"0S"0#L797/!,V>@P(T5]RX(:Z (2IZ2QC)^"S;\+68TFC^3
MM*.V(?0Q='T)/!%.TIS$(H[R^>I7 Q)S!2^C*!Q;6$#-Y\AGRQJ[X<+B2 C[
M#=(I59W!/Q3(B#3CMV;:A$H^TC7CG&[(V8DIPI1(M# K=^!-D,2YLAN^G(24
M\^1R&E:Z'5FLPPR?!L!2QE<P-7@_;1%N73# WRM^S&F2Z/.CBRT3>E22XK$J
M)U^5TSU6Y2RIRND=JW*V4)6S82H9\!"0=\00SH/A!=U;$,<#4) *BGF,]+$N
M.NUV=KWZ9[5ZQ38V1RPXL[V??^B?[59DPBX4P/?PJI^]LU_%+=S1ZR@<"(%F
M/IS1.]O]R_>A?F!LR :K@/4 ^-]L&3$+3M) O> ^],&6PQX=/@%DD@($- 4O
MYOIKKFW &BK0-H'FDXB[;_03>$#$(,V_P*^CH8]9V92;/\7U'1L[C'%:/0CS
M0)L\[A#4HU@8X@]47%"6+)G/C%G/5)62>NTIJ14T*@]_*6MKQF83GQAV-1"4
MD'W+Z=:3I.^#C)[.T+J=)*P1NRB'HS$MSXG<LGL+RWE.B,8E+>YV\W GZ"F7
M]32/RFGZG.**LMF-8<V^/]-U%9P-G_TQU4_0[RDC.U*%4^GGL"Y;<K1". )%
M0F$GMDR-X8]D>$LG=OL 95MV J+ZN#A-Q)<(8&- H4"9]1Z:&V@G4L6)-@1?
M@.)]&=B?@+K9W^"2#T%0#O(T(B3KS'.^"A::8T.;2P)]  $UZ,',KUL;)1W
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MR]$\.6M5G6I!\(1@G<UOP^QE-U"S?*>@;L7\L(-@27Q"$4#6Q;-0T)'^&@S
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ME[ZAE"TY0"SZUPE;IL# L)<3D!^_:CU_.+S"V,77Y:?@0^+[+8FU(B<MYD?
MK:#&/.@U,BA5:4AK[(_QQ@9P!52KF7+1(&)4P&J-!5FDQ>C?0*+R@CN@=8::
MJXB>LFL3M%U)*+ :EYCK:7L93FL5,D] Z4@1GX$IZ51_+*I(7>2C8/H*^LE
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M.5#V%?P;BQKJU5J[8G_$)F[_2 )!?V,RE/F]8ZM-9#:0:PG"&Y .(NRIR1O
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M)^1W\OQ9T6D52*Y%$X&DK&2>Q:>JU54/IAON]RUGAB\7C=P4#DATT>"$D1+
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MIHTEJQIPO0:/ )UI\?II5S"-#;@^A($7,@'(\+; P:P1O-'1_)5$=/R$>[&
M(0?M'Z@6''A6%/?R<D;5\NZ&EU$JM.;N:+@XHG5W0\522;X1:B1O]6>4U4%^
M D$^X:Y7$G3JL]!R\%70_ XM>>/[1YFMXI_AO%9-%%*%B\F!77 =SEY1]97N
MT:RW6XF(O$:7Z"Y:5?009NM^];NWJ2BY9GJF+#Q$<Y411 Q(6MH_)A@()=$,
MU!(:&;0Q5O7WOBIS^)'JY<&J?.$X-MF3H]$;!0D31/ZVOE60>9\"43\">L;I
MN-P(%<OF (H9_ UW^#IDX-2XQD/0=)V-O-5LJWG 7:9(9<H6*=KA MS0)ZH*
M=W2+:7@65ZO",>&=IDH+R<9@GRU<M'"^ 3#"C_>;&83-)?9G.*;8+@C7BX#O
M%54'Q9G*5S8CTE$JU+ 9!)4^W2NJ.G0Z]-'"J\;VU&RDU<2UFH5TF2G?XRM(
M:$T5'$3G-@+).;+H](E&A;MCL1ZLYJL2WMX21!H1FBM=P2";&V(!*/?"!4$\
M8PDTT5LBQ&&ASED%30YLMF O?$WI7/@%Q.SS)+\@?+R04%U(,\9LL;C0T)X1
M+EK&01\%N$8&0([B67KRVR3P3=X><URJAQO2^>9IT$8UTD[PCU@7 :DNV^)V
M[M30Q@4N:2D%38M=F E5O341BFEC:Y>_T!K%B=NG(%S>9=MNW.5\N&\<3! +
M6YDLOFJ2-VBA&8(;<W06^K-?ZTP:H<;M5?SDQ#%U,$T$B2O"]$0U;7H;'<'?
M-TP2AXXPN]W=/^/W++(V[79H[5&W0__0[?!6FJ7_*)(Z_NL'Y=^-9A/)3?F2
M>XCI"EQ6N,IC=X/)0KH-KEMV0TIGM/H1W=P:_SL)]F^>0TL_W@O]\^#+>HPN
M >T5V?P+QUHR;[L7I PQ<[N\32=ND"/88T)VJV@S=$-Y0P\UX4W9J!.>#3([
M+&\[C>@[OF1#TZ&-O-ALC**<]PTN JN_,5\[K_E/UQ*V@,M\"SA^<:0I%CT[
M]LX?>$,?PN-E)JC1[P>Q]#74([-$U?U0\Q:F8B]?@B[$O_N9#XK2T1&D^'+4
M\/&YQ16\9@PU,5+ 0X:NM+_%SK^.6HK+QECA$&M@_ >J/$INCLFJ\OP0$QQS
M#\R' +K@4!>O([Y.EIP@RT((R:PB&[4&/@VH=<54-;2%05<KXEX"Y(!&*>TO
MIRB8,$V/^98B?*4E(*ASE6_Q^-\8MXV2$8+-GY((!$?I302%^=Y7RY4B%*M2
M;/=I>!.X]IJO,R'[V'C!=QMX;8RO73>)JM%$-NR D>T]T[6LW6^"V<%-[."7
M:_RWWN+[X!..I=/$XV$D-$3H>%?>:Q4KT N+?EG@3(0[\@XQYC&B:"<J8U9S
M3SOV3H-KG[%_E.0E/X2PW[H-;K394R#8IZD(?>CD>7)F=+='>=Q&?[55+C,X
MH."+*B8:CG5A3,(7:QSC!.*Q],UC7+0(Q3'0U1^R*+*C6/:N4IFQ (DC#6EH
M5=)[7E3*-! -,A%M4,9C4X1ND'$UU?)Z=H4[0*[>B2&=+_0G'1L9CNN2W&JW
MI4<&QP'5HVF*= KNO0.^]3=,,*%8_ 6\H;IT?BH-VHUVJ\!LYAN42Q4;Y<+0
MN<;7,,'VC%W,1)F!4/J\#LS81@PP2]#"1)+S[0YNEW [PM^7X8*9MD-@W3&2
M&@8R/AI*<=%44>/[#?F_SP("B/\&3SS>Y,05NH4[D&?P7# ?19,?WQI6X[<C
M!:Z'>O0_RI]XDWZ:Z]BBR3+;P_VH?OGJ6R*@JL5@2NOSCR=JJB.LPM[2.NC,
MZ&/S-Q33W=+K_CE+,G2W@G$*:WH4%D?-EG7@:3XU2"[]SNZ4W7ZSX".5Y."K
MVP+^=_-+V:J8/L,#1<;?<K)MK2#;U#)@.=]G!WWK+1#N#.I$,BE \F5XA&\*
M@*-+=\PV%3#:K=)32F/O*247.@@W=I+P:%=%>.!>FCVGB1U)CV@C!=%-IS)T
M<Y EN5 %C@N(+='EOL[7< SV)XK!?NR(<)/UJ?0TTVMTWQ'19/?\/X<6E>8D
MN/*YY#<\-=LW[9IO?QQ^.8OFBZB*U(L,=_[\^<TAI_>%B!TIW@O=%CF@"=9G
M^*7(%[,YMD^<6EC^[*=@Z]+UW;'$]7.W,OJYWNJ)MNT*2ERY<;S$P,A;ZA;9
M]99;QF-3,%=6KD2R),FYCQ7<'EM.Y)V_%@\,-8Z;'55/FKVP>M<W#V,G;?O>
MZ.;YPWYETE1YIIIKK,7&NFA%&XG*6F]0MQ=GI]Z"A%J!&GQ8;M6[#9!E?=E-
MT5(=((7B>8>*X=A4)$B93/0BS=%4D@=N!MV%1601ESPDT-4BGBJ*WC!57,,R
M8E%CIBW<C"?1CY\ I1\C65/J80J"(Y*809!%\>>02=&"!J^T4QBH-<Q*NK6:
M02B3*CNQ<-/Q*CN#=QTL#@@DPNFFQNJ8JDOQLD3VW;TP'^0Z /+"@$KKV[\X
MD/+G;P_)*A(F84F2D2!))3,.DF,CR=',4')<\=IV2VJU8ZQ:XS0_99I;3B/Z
MG3K][C*^QAXF0A=-Y*?*XD"]0IS5J6-@)4?7(@*F3(1[(-F4)-O*D&3OF:BA
MLI91K(/%3!KU731]:C-0:HZF2D#&1C5;N&"=U_D@@6*M#N,MB\EJB9H9^4/]
ME]>\0FY_:OP0=U2LH?BH2CU0? 4IOIV'D!YP)*01U'Q_@DO^15%_+<!Z&U(_
M/YI@@:!=<."&ZG-#IQ3<(!^XX< -Z\H>:;GADBH0E_[CP=3,@CP\8+>T'"6Q
MI2!'< +&EA>@XX,*QE)P' O9\FZ?0J!J_<YEL],GDXF1"+@61\%*>BP QK)H
M4;)M3":,!L^(#C(_N-"KBU5H]";<$S0!UMHH'NI-+^&?<>>7<)>:,Z7XMNNP
M6&ZY-N^Y]^JU%<>>&E0.'NW!H)+P8$7T(]^/IN/0!<WONQ.%T/3J52#+@*31
M=S8!Q@''_4Y3_E  4XYJ,TEN-CIUPN-OAOG=_Q<2?K-Q7%RDL(0]-I3;"-#@
M*4?8'V+"QQ6ZJ-AR0=)9C,@);PS#*2GI&I7Z!016(U.S2MJN1$MQ &B+=N0$
MU@#Z#=AXJ^+6.<=AI#+0)"/Z#X1XX<TZL6EEO+O'G7#A]N:+^0,T>X#6$>JH
M;MB8>H5<W>MR-CQ[@AL6B5]I+1=Q:@ 2/E0G! [-0+"H+)II-/S#MQQH&!6W
M'G@=-TV% 17/CXR-O#6:"_#,8XRAGH>PI;&^?:$(DBM&H:?M<\BQ>R'6.9LX
MO!_E@72.8TH,<Q$U86.??^ON@BU 3"[3OW'$4$"^O\"G;PZ(;?#_'8I-(8+0
M,7+'?Q$(W?%?!(+2XA><L[Q^([$O@T9[('3N_@RE_!LC,KOU7^D3;'PD[@(H
M$\/Q[F7RWX)5,$IQK_RG-9<[W*/+74K28DFL=X/*LZ)J)*8F-,P M\GZ9![0
M_RRP.B>NKL05LU=WO)/_1OXGDTTT-A+]G'!R9Z9G3/.%]%-TVRFVA<B-^)1E
M&7TB*E)8JO%#FL]MI13:+WI%>8_77])J,&BVET)2Z&Z /VT&M]RJMWN=XUZ_
M'-!O<_7+NC)6!X&.EL23-MZ&$':*LG2+-AH1TMZC$2&#]S\B9%,;/?4PD%:A
MPT!:Q][8#YKH@3;)5)U;P1D?M<? M,EZJ.Y7NO(65(]8D>YT"88]A:>,8G"'
M9GGP,1(X$H!;'_R>9>FC7T(=C$1\HLYYD]&$ ?1W<88$#HDRL56>_XEF=9C&
MG&)F=@@9?"+="^.CI##0I8K]W< VIKVH 6*]^:"2,L..>@QU&=HSC=X8,49;
MOL47^2_$*G/+XJ, _B2+!>ABNI2H0''=6M?\%5ZRC>O4<*0J3C=1^)S;*:OA
M3*PC(!2OP 7G3DOVB\&G"#*TKP)3J 6=>;,8J+IE$ITKDC 9! >\^H5/ 0\<
MJUYKHNK5?=1(F:LV37,%;YVF9]$TNMF,C3'F*/&8JC]ZG3XB1BE@;,"MR9D:
MCL7P710PK+O0\G(?G)'PK(X=10.(IPI>-A\)2T54BA<;->F3]&]OSJL[:JVP
MF$'Q<Z]/9WQ2&A<X-%=W#&(%@[%P)??D!OFQY8K*F+C\6")H(CKC5T89*61E
ME0^_#(7AP=8V, X5N$+3O4)57&&->Y*2XH7GQ_1W+^R&,^F:#1G^2W8!?17Y
MSIV$[+Y,\$PPLA6<BHOC1[&*603-!=LBN\^8S[0X*-J/Z5-4SF+A:!G5"^&3
M-#%+FL.?- Z)9QC,8!&DZ@V>\>.7"#8XCC9R%)_ 6?,R$?#%6P",+J))\4?Y
M'3-;9,B\-U45A;([T>L.]884U/D59;JDUZWG0;_65AD;<TH$$Q$K&FA;$T>4
MZM[P3:YB0\.X^91X;T(Y"'XWV!R>V8W4'-!DH<E6 :TU0>7F*5R3]VXLFT'%
MYP$3#W@\9HF1SDH8:&D&IR4[(>"ZXT,5X&;;F\;*CC&_%\@!JNX)Q<"?\*?)
MB*C1Y=D\,08X6!#78FQ]""#9"R(V/N'4S;UQ(,3@I+%J^3^+E%X8]I ))/)\
M@?Q]\,^U(;-?<"J7XXXC%@_B#6I2V#QZ>L+I7_8R0XFL"Y$S8*]S'A3">:M)
M5M-']1.G9==\0I,0AZ.)&2B;&5(;64W>H93(>='(K+FVWB;FAW1I>*/$1#XC
M0 FQU[A&Z!CL,&^!C4OM ;.M)L@>[5T<7,Y#>?X':3(=0VC<?J7$655B3+A7
MVH%JB5,]S2FW5'0^^?@\$ AZ8-S8S+!PQNF(:CQJ_IWB90H+E-AIB4F88KIM
M-<1B@JK8WL6K\BZAY>E0/DF=X41G%*M\^GC@:G#H&=%<D)29)H:0AS@@D%#D
MXZ^3YP3>*-98^:]T#28.DNP]#NV+RN/0-+^9\A\J6W!'YW.074DO1*D/L^TK
M($^(\NHD8@VF!#DE"9BZEP7U9S&^3 U@.) G>@U!."4%X4UTKTLW>#N*5W5Q
M[LV?_LF?/^V/IN<?29Y:C\>BK1K#("("ARJ(.9-)I@P!"AP4323@E[&)'#>-
MZ.-U-@$CQ)V15)="XR,XFB.S 8YI6YGX!!\0:Q[[?R9%_*/Z)071X9BLVG+"
M"U%<A!IY*OX;[=#8N2B.Q/':A<;QVB 8O#*D4[Z:"X7$)1/&/CST&0?'%V?+
MQXBR71*^2%'<,L%K W-5XX;Q^=G5[]+YW:DEW1V?'XMQR.;(F4G7UW>>;18T
MQ"+CW_W:ENAOVL*'MMPYKHY]9$R.YE@69M?0RM0M%/LXA(&@&HO-2.Z\6@K\
MX:Z9H"6?8)L'^"/OB':%1U\F9:1SS:!W/ZQX8%+69GW6YS=</W!!],<3U4&:
M*S9C';_@A%.N/Q%(L>**<S+# _)[Z>LVLCQM+,->%'%]\:6Q"T(VXR^C@R3R
M>FX5)VIRTQYU4G1JZ^J\?6&E$ZMG0L9V(E>C'*33KK?;L?7)&Q=%;#*29B4W
M9TY11VXLR:>LI&FMZ^%:@9'UQ6II*6"S)RU;Q[U$3J8%HG(7(,M Q8T8%6]U
M#?F*SGC!W!(@PS5S U$R]T@Q7%\[$4WO!'LQ.;-'E)O-V9O=?KT?%[UO(MJ<
M&G8J[YAM.(@K[)^_=Q/P8."Y'-D>U!O][8VAG1IRS7:]'U>!.1ARVZB]@ZF7
MD:73ZL$-9Z,S*GP+G4Y=;A9M[FUBS"59;9&@;]!T2SN$<(ED2!)E_6Z]U8I=
MT3JL9 ^(W!O4!W%<E4$8A9'TEHM()NVU^CH?K.0*3#[LLH'O4W6/9PEC5D*"
M9W,#[7:_WNN^7[]G#X?U9#F9U/<2O 9ZK%MDO*JT-C>-":,]EEAG+Y+0DHGI
M4=-MJ=1U427CE;XHNNY@\1L]VZOPTHE(N<6H8JF(2K7[\ NL:[;JHB88*PO=
M+_W744P;)_34L%(:<ZGC]0]R%Z!;CF;SEA@L$U9X5IV6HO)%M_[,Q, V=B_U
MNG9RSX$ZDZDSR^F7<3\C0*4UETJE[:C4<H;NCE9!;O?!@O0'GZ#@ITO#G$D/
M1_VZ^Z\6_U?MX4@F@F/ZD[=@>3Q3=>]!18V 6K()<$D57IJ>Q\XFC8Y)37WE
M[G,$I5A\GV.WW)O04]='=7*LCPK0[MWI_:-T]4NAA:LI;Z!;:(58YUBZ>)VJ
M0Q45Y:6G]3PA)3V,IFR,17:EN*MWK10_G"3$_+;5ETJ&ZC*!+JR=:)_]I8^L
MR2-+6_\RR5A&^PELGYI;S8Z5OV+SMZCHQ?K+UV [=-]K(1D;(P<?4]R8RP-!
MO9&@,C7/L:HU3E22Y>HB6A1A4 4K%KR.%,>B5AY.9M@OK\SG&MP.(*]./WO-
M2Z(JU\3Q/]R(IS8^,LU5G"QNO.@NA29Z@?  >" 37?BVL1L[?'\E8>::<I@A
MY;JVU+NFB21T)]4'Y#B^+V%?O9=878<CL'T%FOB*>3Y:;-G&L\URP>O!3')%
M7= ;:6#_2I7^-"<N"G.*N#XQVUM+GE(R0^LX]<K6U6]1I*G))G_],+7M^>>3
MDY>7EV.+C8Z?C.>34W,T59^9=<+&3XIY,E9LY43N]]J-0>^DT6C(3;DU:#2:
M<J/=;0\Z)Q-+QEY^]MHZDO\]6NA/NJJ/CJ?V;*V- [:,/942QU+@J!QU K=L
M4Z_&E3X2[6LB!.2&?ZAUV/T;[\B 8X$2H494PW7$)+@W-V0HK"?LB9)[/UC\
M_:0+Q0>20TN!R)(L?;PQCJ56JW74[ R:O?XG4&N:.S@9'_%P<1Z<=R!WO'D'
M G?*9M25$>TDKJPO">TT-Z*="'W$<%@L;36K3%N%2:[4J^IW0'VMC:CO@4^#
M*1<1MJI,A!F16+O$)-;>B,0>IZI9-@IK5YG""A-SG1+38&<; ZU<1-BI,A%F
M1&*I-ZGG3V+=1G?0/)G(C?\V!IS&NIO1F#HICG:ZRVCGGV[Q CP4'N,3B=PX
M^N<2HK@QGGFOKU@@5 '1U"L+W;0: Z"<]@E3Y#[\W$&ZZ6?K &Q/5T'9@=MC
M4A)7/Q_!U.MT6HUE@LFCP6:?:+"U:\G4SY["K.U(K T$)O>:0&*-9F,@=UN-
M8(ABER3VUH#%.9\Q$Q55_:-_+*&2OSL@V+B0:I=?2 VR(:'5,;^WB[ .2/QF
MMT'TU1P,!DU.7X,@?>5%0;R@[N^*[N#0OU:#3SQ)+:D&2R45+P:,Z\!EE,5W
MBK7X^X\Y36T>.\TJ,MHHC?#IP+] YA!QM!J]7K\TPH>3SB4;FD0[/3$LIW"9
MY$$@-SWJ*;E@DDL4>N\TNEW9]>P4>7/[*9%RSA::\F*%;>M=VS^5<LSD'"+L
M6]L_;;G?&'#[I]-KM1M;I&A\U"$^B/M7$$Y=8I,)ENX^,] ,KG!IIZ:@[*0+
MOEUNE,7B@9.U=D\08 XW6NT>$42O/6@FZ:0U4N$</XD*Y3B(:M<.:7JK1;?$
M]_^[C6T;-H*ZQ[MA_?:Q_+_9LCZAJ=<;=!%-[2,Y#;L&\MAA(>YQ4F"5Y\[9
M8DTU7:/$J6XPB3?+5][B%'SIFF$WB^1.R@XNQ4:..X/?72O8/"/,-+ZV\X'-
M;1%I(B]?'J1C,%PGMO<Z&2^AS&2T6>(Q%1E]Q=Z:L72J/2LF^R-$2J@71:A(
M3DU$Y4XL%EN[6O0NL^[^[#+KRN]_EUGYJJCS+#Q<8B[\S_GYQ<7E92KQOD$-
M(DJJMU<;KH2!B@GST0.;50> $= 2V];1',<E/F"(TVKEM%*]PLG\K R#$E6+
M=%J-0=N+YS2))#9+UI-*WY(6*IU3+\X?R:&R8^O@3J/?:6#R01[(@V83/<3-
M')(09HEVWB!.VLL=C;4$TU_GV,MO#.-DA?T<BBZV#^UUNIV.&]J3VT>-9F$X
M3T+RG6F\+@+8C6+4#SJ@?W+Q.IHJ^I/8/B*Z^GG,KOE69!<G##*JI5B=I@S^
ME;X_9B.1R?E,77Z:JK,?HG^1=$-GJQ63^OK_C8W17U/GLV2YW^JTB>*Z_4Z_
M<=3_'HL;YD%9&\0#4Q&9-Z"_G92SW%'J$J@IA[J)+$V1S6JZ1'GTRGVCED!Q
M;.]H*%X16YV9VJ196NIU,&F"=)=1L45>=-?;L%X5\$49[S&;Z3P%CDCU:<NF
M'5;Q[:OADB\^) 8WC,'#5.Q/#>Z,]#=PI:7%7I5I,;-@?@[5&=N16A/^/>A2
M\6&GU>FTB-(V*,VXF,TU8T&(\2EKR&.O;DS6SY31K]U]7R'AYEJXW.9II2:G
M# O#! 3=-Q8/%I@2*DU.""ZLV6_TB(H&8!X%J2BEO+KPYU")D#XGC].YJ6IN
M.K6Y [H0 /"2P>;N14=I,CB)2-_,\7:55,!>O7/@[;@_U1<G;T[P[0KG!8J"
MTO03)E+%9HD]ERI^5<ST#0VK<G.5Y_G2!&<3L;M9N-[%;LB\BSD^;X[<[P'/
MEZ:Y+I$J-FVOXU1Q9[*C2X=<9<'^Z5V+I9'[RO-_:7K<6HUVN]/H(Z9[ [F'
M[L*FL?;';]*#@DMUE_H+T1J.7U33=M _-.&&+>GZ^KPNC$,,D[8V<QG>$)UO
MK2BP=*&H@-@H4^-;NT^- 7)_T.\V-O4][S1EQ(3K&7% EU#2*:)8.E?F*JU:
M '(Y%I3D!=?Z.W- /1#D-])29I12FD!L(J4TTU-*4+M,0MIE!\Y%9G@N4&;D
M$!K=.M_7;/1Z/>RR_HZ7QX7&=K'1!P;WJB"N43B<\QP)EG;#%TQ#V\(<E9>'
M-[=K)^NMRP&^[Y*_WAZ5_#4/)7^'DK\WE?PU$],*Y:OY:X,7T9=E7K/1;?6I
MK6,SVR^]Z%Z=C$BL#Z>.*9XK2I]DS;AA:ZW@+Z0JL%F:% /\W 6/D[>8-_K@
MA6Y,,^FBS9P$_($FS9W100R&#(-2FPBA-'12FJS$,CK9PENX,6SV9G+(SF_(
MBAPRPWEI<@[+<-[:'.>KH])O)8;L,A15D@VER5XLHY/VYG1R;8R^'_T\WVG&
MHG0"H30)B66([FP1,EH:9"P^+5$EIB]-RJ(MR_*@W^>TT.GV>J*'O+CH83N/
M('&S50Z>+TTV80F>M[#[,#2 ^:E-L9Q#B/B-6"Z"T4N3)%A" %L8@1%".-N4
M$+(S\TK'[J6ID4[$=A[Q@!TF LO/_:W2%#(OHX<-Y'\N^60Q$'<7 8.R"8]6
M>8*)LMQN]'@+5[/;;G3>ATWXYO;0XC+*K?($#)-HX9TIDM+T#;?*$S-<@O9=
MZPLQNVVG^J)*<J0TP<7$&<@8A-[  0GUP+V]M8J7D'0W&6M+/)IQ#4OWC4-M
M,Z.5W<<GY5Y[T.X!K6#7'9]'"C^V^V^R/RYW;'_\W=&9VZ'5"2)YY0E">TU+
M*%A*$\#L-#J#;KLMB*7=;%6?6-PI[?D22V:DL/L8YRJYD8>MNJ8B'W]VO[5!
M[W<!(J>DPF3W0=(U%+0CLY?C<5,+)3N3-Q,ZRHQ*2A-<350Y>RMGDK15.>5,
MNS3AV&44M,]RYJUTE!F5E"8.V\')?0-.)9U.M\F#,)L0R:E]]#AE1^!H?F>V
M=&59#A4%K^DPC+C-"73C=ACZ\\8[&RT6DC,40C$8WHN/U2Y-$+C3Z/6 ^#@A
MMMK=+8+ P7'D+O6<.D\ I+?6I[Z, &\ +$UETKUC64S3TM)8IF-.!*B=E<&:
M<+M1K,O#Z]U(T4$4^.QF/4']/>H):KWGGJ 4U%+=+I^M9.9F[3[MBHSX7B9<
M-U#SJ=M]"I.\&0X;"DO>*L3$!N591Y.<=AELHKFO=$L%MI<>305%C'0',G^T
M"&YU\@8(MC=:%S)8KI]WE$HIR+9KRN4AD'C#>%/><#;=M0K\B;$,9PB4HBI4
M%1A;CIR.*)HK/(.\>L2+D G-5KY;OYJM=&N_0"-8-+8%E,/9U>_2^=VI)=T=
MG^^>9>"&FO^;T]6(D>>!PR-I.#/I^OIN1_L?Y27TL/*9V5Q(2TY)*]YR6+$D
M[LX$'E;GP(,7KVSD<-G/Y]U*<\?$X *EYN\=#"_(+>5(;G]4/I$E(7?&XB<A
M&0*13V\ ]^D(+!3%DA0^#GKW1+D6B<T\F1H0E6I8_PI$7:HZV(4J_*N4B,H&
M#4W@I9TQ4S,'9D(\;(7#(6#-=%$XW 2%=8[\OO3S\0.H _P*02JW.HVR\^$@
M,0.=#_*SM+0&F\WE"?AFYYKR@I>;8(Q[77"]349U#0J?S%-,-%\^OKIY2"NB
MUSI"N$)#^M?9_35@P;+)X?YJ@!T!1D7NL>041WTX_UL.1WU47@W=F"V 5FRF
MTW:,A]&4S92WG3TS!)^?7A=SZG-%&SD:%^#7JOY]B,G:PO#_QEOZ>G%9S"U]
M91-55S.\I,RNX/KTK)@KN%:&3*L>B=S=7Q1S/W<F0S]L(TXJ=I!;1H'U%)F/
MY.A[),2^CD@2$5Z+1[MQ"(&JAS^OL4ET?50,GR'C^FV$=DDVPQ0L$+0;0KBN
M$;(/F-XIIK-$M6/JJC7= ;J7W-,R&J#_*)(Z_NL'Y=_@VWT0YFJ>L/PX_')E
M,S"DN\<!B_K!F<&7%S^>#!.RO@7?2BZO$[]4<7.]C60*5/KARXVAL^,\QFG&
MSI8F@S[8HPQZ^SUGT#,A7(Z#HMC$?=MJR0K"X^'JIYO3QY_O+QZXL!!RM1CH
M"A49:$Y*RF@$/$0>-\4;_/ 4#WA]'+O!KEHXPH6!"=-/0HT4QV)8.:M:\&L*
M:?!%;Q:\$OX C\0M;D,V5;0)1DOP^[0^DW^ 'F@R!]?!C1UM(2F./35,P,TX
M!P&VH<2N1CG(AY6>!3X?:?FO'YHIN.#\MYN?;J2K&\Q?!;C@#;W[XO#=QNK"
M$/&Q5KI/]<(?VQ2V+3RPL\7G53'1B$(:)BBDE8\_L4[\;LJW7'OBT38_K@M+
M"4 YGZILLB2F?SY55!,XSHW+GQF*.2X!S!]7)",^%0+?6[AC]=F^*C;\FP>E
M18E[<N]BK@RUS M8RV61"JQ"F.T-/E_%P.7,&DNPE8LE??"H&A\L(3 _L!)K
M)8>6P*\NSAQ$81JU^U1+)*UJ4P4M.J:[1MZ0:<:+:]Q-P)XQ7O ZYV#D&;J%
M-J"P_X28-L/K?E7>6C-2T/#QMH@;_+=87XFM6&-,]1Z,PLV-PO0259SGR,0Y
MQ #:<0N=S>V\*?BX8CLFBYJ14:C2OW.%H"KT:(^JK;W#8Z%:S\KF3P)KY4DK
M\H6U&-SVPK;#]"9.Q:;$NL5E;F_&?Q5KW7,'<AO>6&[I9LL>FSMD.\%C:M>F
M6AQ8$0E4G@O+3V1%7)Z=4_P2G^8@N=)=7]G0N:TC6"WVK(AX*L^%Y2?/_J&8
M#*LX1QHSQCLG_X/$6GM%12.LLCQ3D?.7Y\+R$S+W"E+L=^5Y<9 PY9<PA6*K
MLMQ2D?.7Y\+R$R]_5S"8_6WTU=#U,ACQ!QFS]HJ*1UEY^*;8DN<5M8]RH_&#
M=#O'TBKKLW2M6/9[+X#L;%, N9/-WF7_OSAMC%5KKBF+SY)NZ SPH[Y^GC(%
M".&+)-7H)W4\9KK[$WSJTE1X7=\(K@WHX!Y;+D?M#U2;S3]]-(&/'#4^2#J@
M\J\?'.OH25'FGQ^FAFD_,G-VI3\SR\9&$NN#Y.@J?X9CC3](KY;Z65<U(#'3
M07A.PB_]@AC>&!(Y!@EOMEU\97/#4NU"@&A&@;B=,]S2JC]=,\5BURI0OP8P
MW1CZB _@V1RLU4"UXD"UHD")J=K6J3[FNV-O'1O;*%%R%@!/.PK/N3&;J9Q4
M "0<E@2  /NK;'/2V1AEG=U!TXA#TW6AH89D%U,>W;B3(\\-:PNVVAB:7AB:
M:\.R;G47AMN)2T<9 ]*- ]*/BQG%9$OHUJ*_9<'A"9 ,8I#8QNC[U-"P-/GB
MOPX@*6L6ZB4(N[C<S0",-7#(<@(@<;&+@""-L/%7D+_ZTQVH56,L$(95V]NA
M:@O88M)X"6S491(%+2,E@4#$ (M)Y%T EJ1#8Z)Y%X EH3(FI5>2V3U8'J8Z
MLMF8/G;ZHICCGTR07H617G>3BTP#;I[DV"LKL$DD&E<%)0$VB0P&806ZDF@O
M7IDY4BW0JW<FX\OZ7 5[I9^C-TYO_56UIX]3=N<,-75$TWRWU'Z;'Z?9"!\G
M(XASI):F7&J(D^XXIK1.QUA;2O;HHW$Z'M-,!T6[4]0QP,RG@1,%G8&',<:Q
M,4RWJ*>?R$U$$>[!HU;!#6+@Y3ZK(\8I[YZ-C"<^):(86=.,J;[J'B^)WF(*
MM+K'2R+.F!J^8?:5/C)F[+HP==6,Z=:\@4CP89LQG9DW$)T$(/)QB[8 )!>O
M:.V5#!)B'<F.4?'^2!)L:7VE/*WK9@)'M4KA*"7=6%I':1=F?Q*\&_E/!1JG
MS83@3BNM3U4XL F:IU56ARJ1G\KJ4"51P<[\J2W8*YT[)2 =:8IE>:,^;R>8
MWF'6J6OO/QI<+YWJ8]\KX)\YVZ%/D,2I[<8>G#N!C]KR^S]W$IVWT^ICKO9N
MV O]:3LUMP5X&X4ODZ#+1D0DDLQ&&C@_V!+OK5/=:%#2<;IECJTD$D>OS! G
MWG%,.U<VGI"HV&)^8W6/ET!OG9@S6MGC)1%G)^;/YAP#22*A3DQ7Y@U$@G?2
MB6G$O(%("$EUXJHO_VA0(B#)CF7.T:"$L%0GYC3>,T7#&6%^<=)/BJI;B*2M
MC( M8(KYA@@!KZS =:"W$XJOG ) VQ1.;>S_=>(:!E]]-9OCB"2XH',@E*=M
M+F?SJXEI Q!I7":J?Y 0+*CLI1OQM[*MPMD"GH@?E%D=SA:@Q--3,\.T!7YN
M)Z(U4G^BNP%?ZZMJ47OD5MRU!7PQ27QG&B/&QM:E:<PX@\%OQLX(&]"WY;(M
MB+O;#N,P"!:W+'U\8@6:T/AP@U';M #ZCPGP(+19T-U6J(U)\R!48*Y32?Q0
M8U_9,/.RRB1X8I+\GLV5!1EWMY,;PV;6G;+ @O)" GG=?IC 0D+JTC")G+ZJ
MSRI\8XR5G^%0WL\ 85&(C,GY*ZPN!WC0#@;+*0<P$CBR%[/.=P-&1+B?CKAQ
M3^*4RG.-B6-Q476EN\.U *$W["5<77P+4N1)V<K^WQSJY@JH@2\!,!YJ@U_/
MD27 &M:<,5I>HE_>90[X$/P&X!I?O**W\S8[[,:9@3,TBE3])E10]I(4!4%]
MIX%,"X+^LP4"6+M6)R!9K)&ISODIL<A=[%* 8USH^&9^^U_$<J*)8@V/#?/I
M1+SB!)=B_H__.'S"[81P]XUV!;E'$Z=(4X.>X)?U$@JL=>S@X.#=J]9W\!CQ
M%\H3DP.W/7=,E@V9)_A(O81"ZX*A2J+CF%(I'*HDXHRIEOR@2N28I%KP>**(
M/2%[\.%^9/*-9U?@9X**<12-YIVA^6((L6#^9!K._-;D]?4V8]@#E)*!+-/F
MS$-#5;P!0F+>QG+FV:+D/::<0"X\J[@O!60N^6;G)ANK=H$^8S^FJ0J&J94$
M5"SZDY7CN Z8I/Z N%M2## )%-2/E[@5XE%W$R*0_9@J^/GA)P,,91T!\=<1
MGMKG8,LO@(DI+Y+Y-?62<!9)AUSBNBIV#6P-1H(-1@Y*!>ZA7<+-?5/,[\PF
M\/PH:L:&3B*8W=1@^BC.&JX$'='OE>_ZDL#L[_[Z$F*4_<$.;B^%H$UH.&H4
M<8'K04/]'X,MI@-60 =6OC/#O7UL'(P994V#26 VR\<J26"V=L\JO01_8M N
MW?7U$_3NH'SZ)!',$NB3A,KUP2[420JIDR01XRF+4 PZ"F_6+))T>_%$=I$@
M]9.ZNAH)7@.N'#9%Q(]G!WG]2?:)P6208OHB":1<$Y;]!(*2&S'WH="K2@0I
M(3Y5\%4E==\UDI/,L7*%4\P,/#&4"F<+_R-W/#Y.=:.BF"%P!. 24]4M=;2M
M$[*%MR8WXMGJ-Y[H)U%!Q,LRMB] W^(L\2KI=6>Q-CK,KPP#TF# @0NI/#&W
M@.K.5$<1?,'G<SUIO,2ZNEA+6X+->3Y8">0B8"NIM!V[Q%M]WDIB[B'RIK)M
MO"\Y8=("OG"XGM"&JX^+N8^PP)/S=WOEA'D-%9+?B2>*%TN_\42_, N)3Z>$
M%"9('PW\5>"@IT]/)GL"3_:M)][BN/'BZWR.&R#3@HXK]Y($3L),BFT/S$O/
MKG0+ .1I>@R=/TX5/5$';"E3MSME=E;(AJ>,"%OZ(RYU02\O <T;2MRM[F)S
M*V;KN[@TS D#1W?\-J1O=<SL3)BTQW3@/#GB>]TM),X/2NYASN46;@PJ^V3C
M&P<3ACFT220?<7.3Z>U'+(:MTR:/Y69V9I1W@E,PD&>N3254%S-G\M(CO"TS
M+#=CMI-?XBU*T&Q5=\ ^$'4Y -@9;>3FGWM47AER(F FAPK]A!2M'!\F4B:(
M$^\X9MYXD&!_@SY2-97@%%#Y?P7:_JIB<P[0B:IH^5=)RO%A'QXTHI3IC.EL
MDL?HR41DQTR(<EQ=(JPQ%5_8U25%M>+3/+Z*6!L Y)9]J\QR?RM@Y)47;H4Z
M"K*MZL&W<0/BHS\"$/,8<P#NK8H9M[C&F*(K&*@D+HU/!/E9-WFKU!\$F* T
M,(A')I;BX1@)1\.")JK-!J/0Y*8A?-8M9BJF-U^.3PQ9 OM7ME/8DU@\/E2D
MG+ GWGM,"RVG&2ZU[IBN:%1)HX_=,F(A)8HI(Y;CLT=V!?,RHY!#-V;JYPO0
M,_;BG H:M2M]S%[_P1;\3.KK\Y'<;@_:'[XT&@VYWVLW!KV8 9?^5:=@-X[1
M=KS4E*?P*SH?ODP4S6()YF'ZYW\U1F2)7ZK62-$XP5["[ZSPN[H?OES^%G]1
MC7[%\>B]E_(\./W<^O*CINK?/UNC*9LI\'+IE7Z>F@0'YFF/L"H2K";Y^)7P
M1'^W%W. SE)G<XU]..'8"CS4>XUE.";\0GJ=:;H%Y,2++E]>7HY?AZ9&A9?-
M1J-UHNH8^!HAXNE[&K<4I^K<_>H':0(\"Q!:T5)D*5P#'/ZQ&_X1M+!M\(>H
MK_]N_'MB&+9NV'@&G\#6O9Y_$YXGP;]D^E?HL7+TL;4?\;3J9X%C_YF(/T V
MX462Q*<8D>X7^I7W2^RIL-6)RDR)<,5"EVFQT?&3\7QR?O6/,%%'O\S!P>GV
MD7<%WC\G"HN\']!CDG?W!<GAJ"'#_[L/\?\FB<<'SC+VOR0WCUJR_V;^ER T
MWIN1:D-7]F7E#<H?O'.5^ HYC=OB KM'K8;W</&7+.ZB6;6[Z!XU6D>XC"3[
MNVA5[2XB/)+E7;2K=A?M_.ZB4XF["(G<]C8BMYV?R.WNX@K]J^%](8'#BS^-
M 9#7N::.5)NW;$AC=8;M'X8>S'W#+>#W>:P3@X.&3LL87E7KPY?D:ABW R3Q
M+=ZQ3R+PO9$'6OGQ0._](S#0Y+P.>]7#7__]XV_)])HUN*P:(@?O'Y'WS%94
MG8TO%%-7]2?K_7&CS)VXTML4!=V&O)/;V _SH-1FH=S< \SOR*XH-^);>X#X
M71LDY:: ]AY0P"XMF7)CO[,'V"]!1"#'J)C<W0,4[CXFD"<&>WN P5TKX8)0
MV=\#5)8D+I G&@=[@,92>,)ERTDW=Q,1V@MM6F[$[T/P:]=*N-P4L ]!L-)X
MPJ7#_CY$PDK@">=8*]/<AU#6[CWA/#&X#^&H72OA@E"Y#V&IDGC">:*QDK$I
MR[0_WV.[*$<7_OA-U=69,]M=PK=[U.QL&O</?2E3:Z>2<:HDM"JO![3Z:-U-
MW.I]76*KDB&@THD\<O#\9HFT#E[H2YFBM9(!GM*)O-*A=3=1FW=VB94,?KQ1
MY&WB#RQ= 7.V>%S,6=@K># F]HMBXHX+]Y]?V3/3#/H&S0)X?XY"JY+!ES>*
MUP,)94I"E8[^5!F_I8[,MRH=27HW9%&VTL76/D:F<J>\ +FMI;3*Z9=]#'H=
M*.8M%%/I.K!S3;$L;QGOK4D[0\-(%'][9[FG=B4C>/F@;9,W/SA#2QVKBKG@
M^[#YHNE(!8'Z#!H<),2(I6+YZC%]NY*!PJ7[0,\69TP?36>*&4&ENV[WGHT8
M('6HL8/+X9) I4O!*DD"97,OVI4,B6YER9TZMC$SAJK&4GB7U1/GE0Q,;H7(
M;\IHJNK,#.U7?X\HW9] (58>.38STZ*S<JC<G^#>I6/JM&D!/GBIOM+.A?<7
MQ&]7,BRW%4*O<3CQU-#&5[.Y:3SSE5;O4=Q6-F[V3?F/89X[%M@WS!2UFWR+
MJ?O+T[3XRL< 1S\;K.]GICOLAF7NT"< DJ!BQ%7$/GQH"R+JKV0,\$#]U:3^
MLKG!G4J&4M-1_]F!^DM&_663_9U*AH(/U%]-ZB^=[*]D%#P=]9\?J+]DU%\Z
MV5_)!,"!^JM)_:63_97,FJ2C_J\'ZB\9]9=.]E<RP72@_FI2?^ED?R5S<NFH
M_^) _26C_M+)_DHF, _47TWJ+YWLKVRNUQO9\P!X5>#T?K^$^QO<;SY2K!WU
M*71SW(Q7V1QEZ;'6RP]KW<KFUDJ/M7Z.6*MD3L@K0E-4\Q=%<]C9POOGW^ U
MBCF:+JZQE2M2M.9^Z$J?.[9%GY!W@],<*YRZE<QTO .<YCC#O5O)^'U5"_CS
M1&0E0]$;(9)[::)\_]$P-&N#"O[*"=M*!E<KCL\\^;.2X<+J=F/DB<I*QKX.
MXPN6H;.2P9QJHS-/[JQDE*?JO5(Y(K17R0!0]7NE\D1II:-#&QBWC\RR5?TI
M?9MQU91GK](QH<IA,D^>K'0DZ%(%3<BNU6<VOM+A3I[4H<9.+8O9UMF"IWQQ
M8% 0H\((8MX0P74HS0ZCI4[M]RH=2:HP(90MR]VK= CJ2A\9,^;EX*Z-$14Q
M1%?36 P3 "#[ S[1Q>L<GI9BRL_>B(1*!Z\V$@F>:0!WE\KXKIS%5NGHU5:X
M?#25,<-"J[7HK!PR*QV[V@J9;G395=:1;[X_N[S2\:P*RMX<<=FO="BKBK(W
M3V16.HCE&<9BD&[B%-M-]N#F@S_Y2&[DA;]*AZXJ@K\<;9]^I0-6%<%?GO*S
MTG&F%?@3W23^"NK;"> QS>;;G%@0ET#V<D'A;B)$9;V-2D=)2D[0T?A8$(FI
M-P,&OY1E?*R_FYC*.[O$W<0RLKC$[C:7V,WE$BNRVS@FD;MY2.1!I?WMDDOD
M@E#X7KWL,J"PU*)L\%[]\S)@/N;B-7)AWMVXZ&6]C8/#6U@E10B)FU12Y+(Y
M?% 1/SE^B<UM+K&9SR7NQKU^LS!IYB-,*IW&]X0)UE/:"\SI&CKF_&*Y7E>D
M[#(9F!,&*YV[7[%_D:N#![@69IWFM83Q0$"C0:4K W(@H KA3FY@:.(](^[L
MP/DY4H]\H)YJLGVSJHA+L?;XZNYV=Q&,O!#6JBK"UG+:G<DN'7W,QN(C.RVX
MRPM][:JBKVS\EA ;:&T3&VCY;\XN-B W.E7%<[:+[/- =;FZDN1&MZJH+CE+
M-]I;L'3H2]GBN5<XGM_;#?:KRBGEMEU*CO7! >NY6ZPA]&5JL<J5#0RE4&]W
MIOH,A'ZG*2.6:HI"%1%8V=A,"@3>/C/S5-,,&U]S.\>.Z@(+TZ."MW/4V%SP
M!K^4J>"5BX_MO+<;K&RP907K<-5U:C].V3?%_,Y$X/I2U15]I.I/N^(?P.(
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MPK@'KDG/-97+F!X4S(%K=LXUA\3P7@1[OR'ZSQ53,_#]N/[A75+S>\].ETE
M'Z@Y;VJN7%Z\PK)YU['2/2'IRJ6O*RR@#R1="$E7+LM<82F]NZCCGA!SY3+
M%9;/!V+.F9@KEYVML&0N1;AN/^BZ6[E4:H6%](&NBZ/KXO.>;[F*%FZE;37R
MN8K*);.\^>":HM\HLQ#Y/KX8CU/#L11]_/@"CU[<ZMBDK*_EHUQ(N'W4Z.:&
MM\JF4Y+QALCR4,9WO%_I(P3A>0,,;@+'8:,\DE%E\QCE9_]<\5;9B'WY\9;G
MW-%N9</2IR^*.8Y;L1>SN68L&",!>3NG:<I%68OE7G/7K6RX=@FJ[\$I :?
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MG#HO #]3GI$'@P0FJOH?M>2$510X']7>M$;TR#*V $%Z!D-G!R)DY\K1X!;
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MX*[>7OT%(Q)^+4(QS&FR;/);^HDDXTQ_%C#7OTNR]Y9(@D:Q4:UI](5@4>_
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MOB#T+(Q$-*A('KSE,_(TX@B-G%*A9[";'#R:Y^0075+5,5_]T-,_MGO1QZQ
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MW[IL6ZXLSZTN(J "3+S48,V59 3E:*F4)%A-#V!V+0U'0;_C&H6I\#,-Q,M
M8"J)CXY#6ZS'"\X'[AI)O-F4LWB1_% OWF-*RU\JO7Y7VO![9X6Q7XCW*T()
M<Q:$,<IS!Z\!S7;<;!$O0;"B@.8&)@FL2L",GBM6"@E/@FM_F+P1"8J7;QX'
MLORM-=N!1!V75[?\]>W"B?<2@Z'Z[EJ;(@R9H W3YI[6II1:VN5+7&7K8J.?
MU?+?=U^=UWV;>6LLPX3$>Q'5U6TRUS&+2>!@K:.84EW7CW>+'&&>FA%K)?E;
MX8"A5].WTJ7E2*5C?/OB&!\^GQ49QP%6.A$/\P^!WX!*MU'8&=B)2;/ #+).
M!=JL)%E]?/5N!^6%)Z>]910Q3*Y\-+HVO[IX13ZB+N'[L<!,@@M,CB-2%TB7
M2@1S:8ISE3OY"!8,,#VY)BGAQ!2\FKV!N=.XWUZ<7@W6LO?3ST_V:+[YIL/K
MD5R_I@E2ZUA0UJ3B\(=WM<A!Z-(</T(X/B,&!@.$KFR"]!HQE2@).\?VSI-?
M="?[>KL!U8_?#E1,S3O[3L](VU\8:11AXYZ01LDML;>]Z]:7+BGXK@N[L"Y"
MB7;^$<A4W9;8=01CFFW3([M'@ 4R6UK;)HV<9%!FI8\,JS$143CW(M];^&.C
M@1,1ZL<AMF/ABT^4Z]KJR.WW2PS\;Z0@OAZ?Z+GRX59C8L\DS;9O6U*"RJL"
MZ[">X5)O61?E\_N7-9/*+5]E(H,3*Q/CW<^&V7]][MYK+^[EL3&N5A[6G]-A
MZO+*XDVI1-:K*'_MUT6<V:-73!P_*7GE&XL_6GD]'FQ$?4S8*S@/--N/!=CO
M$3U\7_=H2[6:O!WBM?!I37^H&W8^M/3K.<RNY8E2Z;%J%#KTQ@7@=/<,DWMJ
MFNYU9-X%V]<-W[=929%#3V2UP>ZUN35<8Q.2_.0F#6L5%T08NOM+O[[[@YE>
M[4D$^V#^!VC=^>![5_J=&B_7UW93E9$H/'P4KXG_A% RSMMQ+O_7PC@)F7+"
M!TMAO%_+T_;P6G>Q:J1TM(^L:4;=78ZJG&^M-Y&W,AZ]Q#_<QRW)8]NO0&Z]
MQ39;4N''1K7<XSB#78MI".=AP[5@^,^%M?#8L(L-.3-ZTWKM@6VM2LY].AM:
MD5EA4;K*2O-U4:YF3PM@L#O<<JFC"@>[JF!,4ARO/DO#9_6X7=KKO&@/TD+8
ML;:3H6'9,#TWUZ,_75^Y>MK9%OT)^?=9ZD-R4:,;RNO,PJHPAA"RPI!9Y,AT
ME.#$@<R^'@<(JZ];W=+3""F._>V=\Y,SVNNNR!GMB:PLM@W%,ES)8=;SI1X^
MOA8]>XWI_38'R6Z$>/U5KFK7W>#7[>FGB0U?]L)RX\./N1&T/4HZ]=4OW=6<
M2;$-^$"\ ?Z:;*:JP761,PLZ7D_Y??A#;1FN3PZGH/O]RP852-EGAFUUIQRS
M /H.3R6#H"=:B/#CIC/B0$:2B&&=9$%$5_31]22!.\? J]]ZR,C";+QV9<W!
MQ?EE\.VJY6J%HU$E+3E74XX]<O2=LDR7QH^*@!+[R:+G"FUTH_&X;@A%NT2W
M44U=S4+7.<_'^C!%EU1^I? 1;;C0K=%N3>?@9=I(^95JJX-VZ$+E%V0#8Y5(
M.^C+_EN]9QP=@R/N1:9B,BE7<QI;<SM.6SDHV65?:LRQ<#N+"3:.B]AYBD&6
M=SJ0%>FL7)J#PB@?;4F(<JBNG3J2\MFKW33'KD_8EP8,G=*K>'JA_?ZU![_*
M&7]"6)!:G\E)(HFP1.1?PK_+H28*CO)M<$>YA&YI="_C^ 0,6@(F?(C1X6H\
M";R7M=[0Q8M$>[^X_4U/?2@R<_EF@.V;YB>S-W\YJ'8WFZ6U1#3=22S<>?M5
M^BFL06_47 X?N0\F3I3Y]ED_1%P],[#5&F598JXW6"\U*4X,,$W;Y56MTM#Y
MW338QU%6SB[]</QMH\W,Z/Q/U;JD$K;;J_*^@X'YG\(#W.02&U,=3_O4CPS8
M#5B&!MO:>U3/M@5Z\K70*GT/X6:@B=N(C]9Z0U"TQ6;[-N.2TJ(%+W@QFE"X
MD(,KJ&H,/G(YW3=[(Z08'1EX+U6%K.R,7IUDKW=:R-,XOKT%;*;T@I=28G';
ML, YG+_SYA#,O-RP&(\A-$CWS!\;'='VO#[DMK#P_6M@VG7I6Z^M_O !)[O8
M'9S!.,,B4M31YK%OOU)#G S]47?+:*;R_T@>3WOO<_KLGTPTKYTU4<#C6_CS
MKQ$_JF22G0^YZ7=5[_CVSW9+S4\W.JU8-^0>"&17G_=. LW=&GJS.$671P.A
M4W[F1SMM=KRPIH[K#@]PASNO:V@?B-)UE,CT;%8V=D#FA#WVKUUE#GL_ "CZ
MV&_=7Y0R/H7I9^_*^ #&G=SX[J(B"5&S=LFR5SYW3??Z$;/P2CN4G?&!P"N&
M3^^4F@PH;23SI5%"E?;-(L+--"]UG9NM$'J'AH&-\X.E J7L84:[A]]"Y':;
M]G9*SB=D'85XT.H)J[TMXF2%+9+A\C]_\\&+X&['-+XCGI86H'?!N);!9Y^Y
MT9198! (SZVM:OIEA.%_N^G\K.^0\YTRYW)EX3*S;(/@@GRGH3CWA[H/,'1)
M^O06O&UX>EO*0'V+<_?[3WFPHU(!,#<)C>'QJH48F+9_0K&=2]E"C$3XV%J:
MR'8\_W(T^T[@8^5/KEGN=,X)\/%N]QS'FE,.XUDZRHEY,._+_Y;N.<YYFUDQ
MEG;,,K?6C5QPT*JLYDA/)$&FL1*$JX!M<UUFE').VBG^U4:0P/$DF6^>[XD^
M\TQ?;L$KC1H?89TUZSYJ]+XF^*GPIYYJJO=QPT/>R8=1A=*_H2G4 .A4[FQ&
M[V <4A&*D4V.P'Q>]QD?[41(DH_/>FB"-@"?$\S+OYY*QQ\%?=F<G+-@'KM#
MU26?28O,&>F+>(W:*'KF-3^O/_0EX_F6&*M21&9P0Q!/XX5NME%O(N-GCH T
M_GDA'7*@>)(#>K)>-(.T6=G.P>2-&R)*ZP>H=A>?_(26MC6T#<.\2S^78441
MF_130OXE)#ZZ;VE9Q.[W0$D.\Z$*@K:B@/,!=F7T.4G/$TB!Z2+=;NBD' ?C
M2^:)S3J]S-2[8.6L%7%Y&WMPK]^TNCW-3P:0'HPG[RKR!&<XLCN\L=Z6$Q"G
M'/6;Q\[C[Q/,B),]&MJ@7MD/.)2;U]0*]*[3\))<F>;868(2@XF]/F<#-*<*
ME/8Z[6."S[R2_R6-P.S99P\?K_0-,CFQ$*UK[=\6$QMO0R?L(/R-G))E-?=
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M%K\\<K0#^L8OR"WG&FH'*LZY)=<QRV+:7;%9_E+2!^M_CS>@NL3"$1Y?<+:
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M"JUX3U$H.:1_N^;G&E7N?2SO+(Q8[RW98>VA_XV#^.\VE'IF#Y3!Y(76@:'
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MYYBBJ#B_)98*5YU<LSC/2HS;$@L,!,T#3)8L9@?W"=\Q9EHYD+VX YM%N$A
ME;V205;BQMF!Q.!";,S5T55V;9#?$6 P9=4 __L<5[HV.8(H,3]'9UP=[DE#
M&F%GA7L@?"2VL-M/\06*N#V<*IN12FQ<3PK9$@N0W2%P;A6-.AHDP4M\^0@'
M*;7H)\/%T""JV$K6RN/@PUQW6IZY33O _PJ]3\J0F_+L*!Z,6UO6OFQT2HR
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M0LV( S_3..;+CJXM0T;\>]=B=,^%U'VAW:O[H"7?MH_B\0GT,W@'6C?0YUK
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M^F;J>:^>.E#8F:D#61?V[!W T_ ]!)%KNI4$4R<4XZYSL^/FP-$S!>7O1?2
MZ>K8UYP8 E/8^?8+BF%<!#=I&O.;6772XBQX<C*_9?Y]\J>CS3-$D4UB^&DU
M[?V[7K'"'OOIJ-I+VTO'#YZJ>.I"MQU]7#+K+6>79Q9RF9>IHU6@^'WYX(<O
M)S:.8G/==3Z&_DE7%<_\^^V4]_]A[CVCFHRZMD&LJ)30>U$!D:X"THF-+B @
MO41$2D ("$B 0$3I59&B*$1Z!Y$2:B)=07J34)-(;PDEWDH2/GS>[UUK9M::
M-6M^S*SWQ_F1DW.24_;9UW4E^]ZGV@I-X0DT;X4N$K?<<LW,\\T+9A__@=XQ
M2[?=[<CRT?\KO<MB)_B\H6%L<Y.W3[#PC1T!SW2=N:2)C:/\%6?V^OE^L1,.
MIA0^7E--RAX_ZS3+P+ $<X3)!9F2Z#/A1N=>RQ/T'[1:'KO,U2 >12,1-'$A
M3B![*7G5'8UR?-5IS%R37?$6!^@9DV8N??/^UIZ6OAYN 6%". &O2'N=TJYM
MP^)D^=Q3('EOMSTK,DO/DD:LHB<:;9[;SN_V^!R_V&<:]D0LT7/7)K%%##_+
M)2.A:M7KQRK&-\??0R[)?;L4/NB7]J2PG]G(9/Y70?;0LO;E_E;5]G;G6I,K
MA,U!C/ S4U"F;Q'O"<^T#TF&K%7([% /NP>_5C)8;Z38>1=E[B*/33T0F")F
M"U(Z:+D87L_F"H&8*'E-1WRE4T?7C>]/7N/@(3U$?7CXM^^<6@GKO",G5--3
M=3-+?W8*4OXEK(N@CRZP'!-(;#RX5J4#$E<+V'=@.6!5%G:C3^0D"H;7.6>Z
M2^^=F!\NG"O3=.^_DSOCUS[(2[\ )K7@CQTZ.(ZN!0SA6\#<T!Q9LIB]01#^
MVW*-B)#]EG;'E.%+^W-6LPXV'92&!ZT-)8,I*N]5WK\W3/E>S>2%40>\GVTV
MGQX3^R;:UQA-] C4B..X([BD^HN[)YAQ;#?\!K[J<L=$!9%963/LONF4P^Z?
MAW##VFS#VO+@OI3Z2.GFK4--/64G&P6//Q_T#K#1\Y=]DX->NRI]66_,>J>)
M/1/95X;W#]2-U@:=>9D?D[*]%!=0-IA0S+.!Y^A4DS%O;L.Z8CU2DLI)Z*]T
MEO=41X48]QR-,/"WT8 $82^;<7IOD;ULC8U.271M/1KMSC$[[Y#O^RCNE,9K
M;=41S VJ:1/0@G?D.&(@L*S$M_(24\Y[9F'>G*%D%ZYM:884Q946)C44>WO!
M?**]'.^P"RYEJ)TD/1?8=83U"KAOG8(5]),5#<GA$66 S>S=8G1DP+N="N50
MP>*DI2_9]5*Y]DP+-Q0R]M^[7/C%][/L5=\\W)I@4DN4 7'!O4Q3.D=6>2AV
MUE$!>S(0@T(/7, 57!]3QCES@GO2O%'O1=E:XTN6)UME/T3@H_#(LHF^&[,F
ML-@DP^IK-L&FW*;L3I4A$]Q/+2U9[90^%!NRQ5MEMC%ZH3?=12Z7DBMJOA!D
MITZEX<<_3]SXZ*0(TI,KC>P<[1AM'U+HM ATM^:,+1< LNH). K4K.IMDKK?
MP<))Q-G)B@/[PP5>+W;H36O?(26C0N."?N'":8UTL5'94]TLC8]=KE>."ZH\
M*1=:&<+(KPN@D\(OK])9A@,.QBL1PH7M>;8&0<\SK-"\Z ?M2K^7=;-.1XH%
MZ\<_"51@=YM-_!92&LZ#<":SWP"J>[0O7OOBDS':=[<(MWG*+^DRFKU<7OVL
MN4G(JTG**Q+Q_G#5I9L44^6OSACH]')CA@YX0\1 146<01OFUVO26OZRYH@!
M9Z0RX+DX3M3[V1/-*H09J.=6*VTRZ/,O:E(K# OS\7<3D7R2]AD[/2UTO=[3
M\%E).4%J(EVM3R5=6<WTIYHN9]W6F="@G[1Y6M0.PHAD3PDFN4<H3V]Y!P9.
M!0K[_-72WM;2G1"T'9=S.D%I\5_2[YF\:MN07?,-\=G@+':LMGUH&5#IN,'Y
M5C(Z0%)R*CS=8WHEQW\>VW>WW:[\IT<.[Z',@"==-X6SS%3)V<&(P;LO9N68
M:S"S3G<CRU5>&&B?(%W7?'NL9UE2PPQ&GGJM^8?XYC,+2T/+ M;ZV,R#4LW,
M#'<PF<]'MV:,1$#,!#+?^OLB!0[\5HU->FSI)OZ[:4[^V[>10@5$P=6W;T,;
MMJ?)4U2N4,KRR+\[1E&U(J6']S<6F%MMR<C[(]0PTD*[BLA9DOCGZ@38%($Q
M?O_XBY67X[R55$1Q0<T.0:F0[@(=/I3%M;!4_LNIMXA$!2%D.XQ^?E5$;F2G
ME7M1SIK@OGF@G7EX$:CN6JACC-$T*"I*P8LRT*?HU\B0SAT6 &M)^I$QZOFF
M?1'"[R'P/(GHK0ZMK Y 3XJ'IC6H6^)45JNW@@[EUD3KL9W8LU2M281S&?S*
M0CM**)P)X=LPH91T<\@RYXC!#+A.;)/LM1(1::K'9)VS,)VJ4BH8@VU;YGB%
M0G^E7BWP9:,*XU' 997--CR(%]E^3Z&.Q=3I"^!Z[$8Y2&=1BSO\5#XCC>N+
M"U$"=19 OLU$JP6I.S4@TX@^<4P;?! PQA@BNFYT'\9^=V6M1[5(2C0VS+F8
M_(I^80T/B4;6#5:2F.X!B@0%83BL$UFGT'[$, WK@O $'#%P0+.0,5L81:H%
M8$_8210XIHLSY[>*4)9@$%7LDT<_H2AZ21P]T6KJ^DA,%_T^)8GZ[WXTW(;(
M%1*J_=^-N\)8%X@PXCQ@=O@0<">(5!Y>HYHG$&(BZ&* ?6^.#(DWJM6,* .+
M<5)%#XO53F)XX:@>.]%(Y5*JS!6T<VB1TZQMOXO$+Q7GRTACD@*5O?HKAAE@
M/%1$\+< 9.(.-Y"YJ+)E6D*?RE$%NJM7!72&DL*UJ=:32@H\<'\+#/F'VY]/
M8ZU;HET9 HYM$^D#2]U5F?@PD>]W2U)OKT#.'AM/K,SB @M5B 3JP<XH$JJW
M&$EHB@L)W24G2'D,.)8BU $DZ7?[ A/"E'C$< '(;\\G2,:*D;ZB;(%< NK\
MJI/\Y$52'E!LDW)_S+TI=6\3]JS_,H,/5>=X(180"H#?(N2G8F](<3M28-T*
MTJ#0B6*D^@")64[5Q::\FS4DE>[FJ9>:HKS=D+B@Z)F^\58M*!$FZI$C!-O$
M>\LNLQAN*\Q.Z\ML[N#RZ1?.D,HI=X$I$A,>U?T-/ZP)(G_XNB"*N>2%Y5,6
MMI.!,5.52;^_@ID\M*].R <F:<MX51I9:U],<4+7C%D866?[O#%S;@PF)-*1
M:PLDF.EF-@'&"+SJ!->!$S7]#V^MGS]40D@=BSHN>()YRZ2VZ!#)'3_4@3KK
MX'&3$P[3)\'BY?;#D#:3K8Z!DEW>AA!.>X@=2PB+]H2<W>0/11HO^?@,/48)
MM"H?2D'GM6B?ZF$<\'**'2T'(X\XD=#M) U8+F+Y;!!6KPA#G?_B'K0QY)B4
M8U4GTS)P<N_!V*:F'!3I7ZC:^F7R@*F\J>I)@YON+1"$K$#E5J1(D8(ZVD!$
MO3BZ.+Q%!PBM7J=?&LF;5 @_1X7%KQAD=K#]=(07FY.UT_]MU+JV (D2X5IF
MX[0 )-B][-<YE.A%>8?Z?IZ-53]B ."]F\]0?%0IDC21*(]R)6*%H0U9F:_D
MZQ68X6.&)%#\Y!%#AUCOI)63")!? H3,X)>KRQP 262\V%@%0D_K^ZASX\=/
MH=!\2!_-G\[R>ZP>&X4D58C3:L,E]/+7U3-[0K/].]X"K%JFB_,H%W)*!T:8
M5$$Y]D/A')ZB;&[U0%@I_ X(A,G'5YJUZA$T0AV-'*;<C*6YVFP(JW+@Q1<Y
M9U $]TX%'J"3\@F(.E:?5.4IJEJE'5RA:YYE;%OSMG_1ZA'#*9_PTPL HS[Y
M+SQ_@%3<&;IU=G?/?I2JF _ ADCTIB!_38%*@BK#J7VQ3@C)(F5:A:#7 <8Q
M$7G;D7SP5T2>5X=J5$TR;]<0#Y3.00(E5^RTFN+;F PGE67L%V*"M,6/)4<A
M?,64S)PEDNN2YZ4MB!FO*V_*A5K]FGEL!?0O+E!Y].R <E(?.#XKI1T4&<Y&
M"B\G[+RP4XAIM2P*GUHX3Y<"0HR0R1B-,82$%Q[",T-5;YA 6"Z"$T*$DX!Q
MQI>M!OA^+Q9SFJ!^0A?/7J]8]12R5F\33':GA /\A)3I%<OC915'W"*=07>R
MJ!RCR-?R&63T C,"1 1%:#,/!U3>U2'1!F)B P84+$4TR3[OBV:ADS$.9..4
MGSXN(Y7BWAP:'Q*FM[6%7M'/Z>7!8WIYL=SALN'CS0M)X5>5>]N9O$0Y 95%
MR0[82US8=@3)GE"%(C]F)V*9J.J.8$/@%3&%>QWGVI!= NS9'&KUO'GD<S:J
MP/;#^XFOVF^0@+PIE>- ;-P-B7OVXW81SFG]BXFV ,(^E:D:Y/'W8"4:84R8
MDU]6.-764+ZXP.AEI7)36Y'L'5D+(#MV\Z[4E-C5C433+(?K*V6ZFJ^D$+08
M']1.["NP04/"T7F>N("UP.+U9MUR* O]0ZG-;(^A@^V"K2G+0-TWPW[FDG7?
M#BR?YO5C"?T0",.GQ-#/D4Z#A1&N0=Z+J)_%E#9:_-:!%/42_J!I7%/ET!%Q
M.Y-P%DO\$)OQ)U7.O1UM?L3@#E77],&%EYZ4Z]XD&1I6;[BW8V-N8ADQ;/_2
MJKJ4SGH]!S-I"P*"^.Z,^N#35NBLMN((ZO5"X/',PY;ZB%\O<2L/8HR,2K?P
M;PC1MG:J<V_NLH'T_P\)7?^[G,HB9_70V<CF?2T$&(L7X>&N<<_JX%NX,.+%
M;=2S5,V/K^2?GV2R_J.(;+^M>9<TY$A>Z<">!1CQ<K3?"6Y3".-<G&TO7MBH
M/5-$H7&JNE6K"/J<(B"1UO=R5TMW9.MBW#:3;,@+:-79K]8T-X3;>5),_(0K
MS_8\_U2'R4"],VSSPU<)MU\EB=E++U1G<B;HGJBSWE33TG\/AQRKB6R9!V3>
ME]I2&QDU5+\).B\TH=S.$V>")D<K7/#JQ5>_I.H5;$@5V4-L/3$*HYIJ4E^:
M4YF@3IO\/JDJP;P[JMHPEDPRC_,YLU+K4S&=$\4"X]*3O].\#$GI2D13FW8C
MG"1/M>N/-^0_2P*!C3'1+G:\!?/.%](O>4P67HB/=-\LPD6Z7E7/6#%/0-4N
M&PIM:X,)J!?86NT$5[RW:-?\R2D8-10_Q]%K1,[(QD-B1Y$=@D5 -(X[X<&H
M24T95&"K!ZO][JZ-D[ TBX9IS;ASVMK?P?)SW_:R12F:M/<(,^&#E)=UQ\@B
M<DTJ#(F'7  2>BCJOZ-:30E2X."S*5Z$>R-*<GKWQF%=7NYY:R'YCE#TU&XL
M*]I9:]Q <M^Z@-Y[Q$"R.&(X 7_U-5R<C-W4.;P"CVHU)AGU8M0GMC7/D/3P
MT4V\D72%@<*Y_D73& C[]@$L5@ 672$?72^*JO"D<WUI&\[[W#RVB=L.'6]N
MU$K#"AXC<-$"T['S!+,>F)ZF?_V7K-:4(!H]KS1^D,( /]6.K,V.0D=2PW$\
M:+]%41;J+;)V*5G/H+Z%S)- $#06-!Q7 IU>=580-/]R,R0)Q]3_#LG1[QEV
M288,^=N?0!8]$_L53_9IQB>*,A-JIH4U,=DZ4H^6&'6L<Q7*[Z8>LTO*ZP^!
MA?4I^Z>TR(*KLJW7\K\B5/8=B7'D^[LV^ T@_P,\]U4_4(1BTQ05WXN'.["*
MBJ8^_KR ,R8@OZPOC5^SO-;0V?.P'%D/_L7Q$PZY;_3N$F!;T1GZ9/=NJ5[I
M]PK[6=R04*:9TXSD-(S_8M;YQ]?26AJ:K\HF'^S=F#A@;(?PP4T[Z*HC@=:
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ME$3/#G(/YEXO;]9;$T7'4#DG]RB#Y".&33P9?!>8\"8A>T1KW0K)(H>=Q3:
MXB(DV8F'+ 3F:%7QQE=:S3B1@KJ88I6L0IGL'S:.R7=9&)_YOL<+94"E*(&
M2]'O20OMZKH1)&M*!U!*&NIN_GTLWA,@#'1-^#A" P@D), 2L.<QBL"&!1!#
MJ&:%A[:KI[>AH^DL1OE>S?,UC"^?D#2]B^#^QMA0]Y$#R?CSC^GQX)CD6@*8
MRMM/404"2\.GLSQ&,-) ";TWAYM4'>]3+\H,9^JVRWA%]ESH5A<*^2&SB&6W
M7S5?M7.,5 AT\?*J!E /Q@(</7&;7G9:2_,IS.B$U9Q_,>\#]/[F;2S9A]@S
MI8[JA$7GG"#U;DY7P,'=(90XPD8*'^+!U!&#Q\+YC7FI42HOOCIR,H</)CI
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M6N-[$>/:"BLS]7P^5$B/669#L'+]IZQ H73,4.M;)R_JMQQ%=N2<L0Z,JTG
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MU)NMLD\TV(\M557Y14F:VGS0IML=K$M2?=["9#'OD>*#^SJGS2(;Q9/8HH7
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M?#V/ <$)=<]-J7.HVJG2FGG8-.M;&9PP<>2]33[_^=@OE^[X[KL>K%QA@9I
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M+JX!-2<H![(^ ,7Y8'WP0;W,\>TLE,^HY>QC]QTYO!AIK[.#&0D^!47<(NV
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M#B <8D@^B1#X)AA>#OCC9[9W3JR04I1BZA6R*LFPI&D:'+S<D?A2!J/RK4J
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M>I&VF@X1.U_KS'HLY8L\:UQ07K<%"89^+NPFB-#D/L6G'#^X!=E3NP4)'=+
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M:LI:JFABN+/<AQ'>V/P6=8R+Y._5Z4')-"+$9K 87@8WNI<(W_>#VF \U)4
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MA>/NHCK%U7W0NQ,0%I\/C=<M2[J_WH1V;:OT$T O!M8I\RU$P+4.$RH.%!4
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M*KA='7MH_7!OZV&PZ+5HQ(.U0NW:B_$J*OF'_FJ253]X0^-3Y2(UJ.[5$_=
M \N(RL+.#XKFZ;[W<\,:>/*X=8/8H-VA):52#73?Q%C0#_:/_P!02P,$%
M  @ 1)%Z7))$!,VAG@$ UJ\! !0   !E83 R-S<W.38P,5]I;6<R+FIP9Z2[
M>3Q4_]\_?%1"1/8U4Q$542$E9BIE29I*4<14*EN2D,&84UG&[E,JA4PEJ:2I
MD+*-7:4:6R;$;)4]9RS386;.W,?G\_U>U^_[NZX_[L=]\Y@'SHSS?JW/Q2+Y
M)F$#*_8Y.#L 4E)2P$GT'9#T _8+7_W_>ENXR?_?>TA)Z@!E6:GM4M!BJ37
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MES.P. RIG[[4L4S#T)*SEK^0VM^9_;]+[-K_I\S^*['_SJL/4%@LA39OL3*
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M!(#2*Q;FX^Z_CC'_^Q@F>LQ"\PXO++C2O/DV= ;0*9_>]M]9/$5[*902)$D
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MTCD9= ,^_Q=\#2'*MQ<VH--%N!6LW^<[)O0F!O&AL_1I?7V<^/Q1=,._XR3
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M9\,(9MDU8D%K=("-TBW]FE5\98^4S07^IYR2#9>NNYM&(4]^I\-[+3'STM]
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M>$LCOEPS.SLZ2]=$U]5VO6'I>^6+ZG*F0UJ+K]=9VN*YP2;U?4;%7+RR3W_
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M45K 6<G,DDS(BJ,^](?%$[G"(__=72PV\:T&X0>0(_S,C_==KU#,NC:-: '
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MP71]QCEJQE!DR^FF,Z-2W8;S,2B,:'79 :1KJW/G]Q.Y[[L!J4?U[U]]Z*3
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M7\;(&;L:Z9:U>[-FM-ESCV)]QBR48F7Q6B@I:G+'K!8YL,O5J]WI<7TAF'\
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M_*3)W), U 63+V4H)S#1MR)AU43FHK;B_8M2^.^>QR!D1\-ZD3\[=!0RF<8
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MG2)>__RRHX?GF1^/D8V7A\]#7<7\W*.7$U*#&_ASO=[<B70QZW8UZY&$=QY
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MERJ7Q0OKK6K#_/)K 0':7>K6IA19DQ?IW&8B P8"\(7H]DU%E!8[+'X0WH$
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M&SE)\ F,<UIIA__08G$++ZH+T-X"G;[A:.&T&V!4Q7Q=;9GWS2V/[R37^ Z
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MV,#G^-4=Q0EW=06+.>^_*C[OXVY8GETV50<,VM:32DB<<2R^?W?S(8"0H9[
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MZ[9%[Q:'6X,9-ZMY]L#'H%3.2@TJI_;#%%KL^)T;)NG=^3<D?DF*V.O(DQZ
M>1"JYN8M@=EB3-_EUR6.YTJU7,_\38JSO&%+JH</[BO_C33TS9VU'+GJ]37P
M8T YDZ3YP<0?*18*DJ(>/T\^1]Y]UOTHZ^!F18V]BUW<W;)XPZ:ZEKD?.-[N
MR1F<^ *Y$49]<9(KA+-<-0L.$7$D(FDR92]/+J]M#VYG/_$K6<\%2$_=;F&>
MD%2?43\O&QX;D7BU/9UPJVIA\773@+N?=</A(E2TCZJ$'*EE69?_LD-^@I<
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MPT77W!:49N&UB/.=\#B=@J>!TR>5 FK)J](^8]WVDD-%!5GC]<_KT\F(%K
ME_?4HNL.DS.U!@/!QQ?X<ST890=N'^-%4.376[=_W0JS_WQ%]YG?V[V]@0LZ
M24?7K]CQ$,1ITUDXVAWAX\0AUV][.U3F)E$7_PJ/$(IO@XO%):?2B+JU&V9=
M_JGY>+L>A4>EDG*I=F_WR_A5FA_K7*CBB8@I+[QQOOVRF</%A" SN7SW_9XE
MQ7,37M\?O-!(-E)(>K^HA\D9=C"SN2B0?8#WY>A"K\GN5M'>"_4D*[Z%SAFV
M" TA9.#W$:5%=XM%A5'BWWI^ $Q,ABH376B?+:%RY^ M3_I7C2T?1[?4W7P'
MYON]:)7G<55II<LV.>%,396NEO"['6?!+!<-_A?-MSM<,Z*4-&DV>3E97POY
M;F=E!IL9GTC-].X\MUH2TFZJ5URTJ4\DH&%XZFVY@_:G5NY]D/W0M(1K3*H/
MVQ+'-^^O 1=HT:>W_?*80@S5CP^\0N(M)K GW3.\S:0CUMIUU[ (AV)NOBOH
M)[=##WG2/M+:QGFATXN$LG! G.4OPX.LC4MX_(IL<+TL]WPO8VY$R0R/UALW
M*]T:6-'&S%U #$K.LP2<;QZV,LP7$],+DE7R:ENOONJ7G=M]WN52/';<WMF.
M [K*#<-_,DDA*R=R;1@*,?GTM805WCVQ)*9BMG+K'J9[/:)426PX77:U4S)J
MO^[TKAYD;)1]#$(_0P0W8;&A:NU@/L>R"TQEQA/BZ;(!L_&@F8>^8)T%7.CZ
M-P[H<%&?";-/)9"%>I"+N8G!A<;! 95S,0K,/J_P\/2VO7-Z-,C%IWM_:UL0
M,NN_+US\7P,X)RC5N'N,<>'B5NE G[]?Z@6\^$^[Z'=W'"%I?N#$Z>M9HV*L
MXE>,DS,2M5[5OJWE4S*U(2&IBC\'<76[^:'H#<L&;Z_P+/8 CFX#%V OM2*^
M3<>@C&"R*RY"C(SO.3&ZJ:9&I$W9A?&W;"BFZ2;S@=B?.OU]94"C:<.I3+"0
M,BW63.GX&QNT)<=XP2M%KU_ZI0HC53C\:[L.JFQY.=&V)[Z0<"HXAP!OT3J&
M:?+0/-\N!_"6'9AF*[' 23]I/CY6&-6&->95#NC$.(T#BE5K^5*P4-23MZ<%
M61D6'2RWGJU<+NUC<#/E9>#J*#.O2MCB?'V60X27 S.+ _K#'EAQ5N@)07M[
MC2W&;&NS*M!0<Q@Y'^,>ACN&-)X_&<:="&E5,[6.1^?4TEH,/WM15R;KV'XY
MR7ZYB!ZV'= _:@EXDO:5^=__2$0XU4Q@*"I!;V(F2Y9\]COOGI+,@=KIGUC'
MJ'8P1?$FM)#&Q/ :*E2E[XCN0BN*Y+<W0&"*IABC,&VO&0=?^(,8WE&C!OZW
M_]WDIWO2-K#'F.B>K]W'!85RK%,+SQ61%OI;;'^,&UEE%GV/3S.OE'Y'- X7
M R-7-BU^,>!:J,>LVLP"0EAK;_X]106T^Y<L>D1]OHR#7TBYI:'8ZE))L:@8
M2$  !!(G\20=[:#:.O((W^]Z@5N3N<A;""/2#3WIOMRL[:F)V3LK<T8*TS?Y
M(6B+ [)GAQ=_H:LQ1:\U-L@R[D1]!#+))K%U"@5/TQ$/?S*$:WY@BPIR )T+
MWY8?YE'/7+ZRD(*0C*/+MOT6%41RL_X==>[D;:Q4S&[HFHW9^:=4/!H>K!W8
MPWUYC+' @-3_C",%P!";@*+SMI$J[E,!"6?%)]6"S/WB*@?,MV%^=7_",;9L
MS>=]'!#1AXGD@*(>>NQ\6AURNNK54]FHXI:P?M$$6I>P8R#8GF(]].#[]^KJ
M[(]5K_YB\O_*@#J<!$+?)@<D3?:@+989?]G$]&G:-NK'* XWMCX^2H#5>KKL
M.>Q!!G NC?N0DK#K16%J/BN:5=^WT1,Y:Q9A,$R8HV-& N,7=)&TJ;NSQP%E
MA0<XG"_HZ-F!BT-C$F0B>!F;,V^QK41Q3-,C _Z/R'2[ 90:/;<5K=RWXMV6
M5A5+'0YT5M<ZTMAI]Z;VP)#JW3?J.3?\6]C\EI\XH/ZCC /;'%!DK1'[-6Z$
MX-0,@"FKVGQPR5?D8P,1"6X2XY?-K6V!Q]9F^F;:W<<A=S"7G^"XE^RB3B=)
M_2_&_%2A[F!R^8Q-9#Z?HF;&K$UDVH2]A7?,(KP#-Q9 6EL!YV.>,&_2'^=\
MTRJ@YBW]^'S!X-J']#.K_4%Y_!=\?@HE+KY_,A45*TLJ9"5PS8O/BW4?5@;&
MP[/4I_D'QA#[HD%Y[+BS7T*B?-"O[E]%$P%*F[K4E-E+F";W"E<.2%.VU0_G
M(S;ONOE(4X$IFFZ,J*<K(%"8L+::HQ!@D6=OKJ%%B4[HJ*OBOZ )F!?(*F97
MTX'8P59;KWO*5VN2HWNTK4HTO<8O[6"[?L9W^'QR>1[_O 19_TBB>>(UTG6\
M'W>Y;&/&+S(SF& HNA;^Z/W*R7]=0%]E 5#(5R!FVXGNE@C]S<NT-)"G $WU
M,^LV7L_?.X[Z)V7%/64/8.@VQS'J &9;NT_3<774Y2(C_'M[KM3]@EI) 4&<
M]A5]7U0 &V+Y,03@PV/(B(\8AC"F9:%"=?J UAI3>5.-_5_]&A U=;8>\8JI
MJ^BPZK0E,EF9$D>LMILJ]9^X4^H%SN%RS0KYU!V$F;?"[:DX1@2JP>:YUFJN
MUVU\4/%BZ%\""$/ZA*@XHM*@Q@RBKS6M\?TM$@L%-WOI8$\IY9AC3_RTDQV[
M2QMH*&7A, ^F7W(MQK^_"+Q!^K1L /$=8E&':5@#C]I6J$*P\CN[C"NYIN*R
MRJ?:[=_L]BIO=!)(E:%&5+:P2>P)[H&425ZN34G C=*+;-G\%I\"N67"3^$#
M(S+;]B06EF,+>?!^S*76WW4:C"7)R!RAXTWKO]:?*XA=B_'H+\AXEU4I?^3O
M4'K-[F(%9;SB'7:"/"V)CJM^HO+D?\03^:T2[5C60TJ,36E.Z;IMVD+[ZJ*2
M9F!P.2SXC#7/\V0OD(#KUZ954 <9:_O6_G>LH+TWW 6^I<!,2@/4N'):V%]
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M%Y!VINUEQN[7?UDD<$J#+N0$V=%V=X5E9,#(FS6*'% &/P7B8N#\D>M";^3
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M:+_HCI9F/.[ "A:Y%2] +[/'AB(\7'2XQJ7*E -ZFQ!!.9#SA^C:%F9@&,?
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M1G?WF*/?OEEX^KWN_:5) \W047$R/12%]!&H>_(MKE .321M\6!9:WCN!2-
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MHMA?+NJY7.'^Z5^H!R!-!_$= 5+-XB:NWD1A_4LI ! KGFKB24=G@'=WL0W
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M=^L4_!8]4)26IU82/C<K$,T$M/PXIF.-XT7IKJR?$RT!(I?TE<OYZ;7O-N*
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M#/S;Q@R-<2Q[JY.)<B$V\"5!ZXF;R )>]/$-K8EBF$K? %@E@%]-+S":*',
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M\SUY<9BX_B O9'<DYE_+6.#N_)J8I69.9B..OL]C-8*Z:CO0C(.)LI-[N"H
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MAB>WOA7"5PX^-6XRR_9P5E5T$3^U^AO7$$>1)9'P8=O%-G_I: IYB>_6+9Z
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M<3$+(C-^ZF,ZK,E&,^]V:>;@0<%18J^P(7PD3C!$/BOP4-LLA<@Z#*7^9&=
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MHR;;2<K\?D):^/MG9TTP,M)[Q!AGV$E0#BO@N/:Q\+G"<74%Z"Y?3WD\W&U
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M^2U;Z!675'G;<+.9^Y7U_H<M/.7KGF72]NM(-?V@I8@QJ'?52;UAW9()#UZ
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MQ@%E<_V7/CL9O')!5GQJ '3*_,3:CB'&INLZLI0+CGV$WUR)_!N*6SN_^-K
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M/C6B[56=B&S"*K WE>!^7#]I.L0?3S S@9'H/HY@KR!2IGE:_+0)"]47OYH
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M?RW=6N6Z>)\1?\&M@G>GKW5^.^>Z8U]X=)CV1__3#VU(B09/)Y4T]@EX4/&
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M6((BLLR_Y//QM^>8T4H&:E;)F8&$RB=E[8-,1$(SSAIT&[*V &L*E7-%9"X
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MH"O84XRB7JW"3J,S\626S_;%24#CP1Z'&,JD'T%%+5])2N4_EE9RV_<H/V,
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M,' %HFOPI31(2<=6UH\IR1>NYI E7R/KOPK&_G[2=?]86!'E)8 :@A?_-I>
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M1??H,AVAG<86:Y \..\#?!NQ%],?/0-/][FL>Y$.?P+N7;^!]\F<4P*#Z"(
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MA\^%V ;5T#&Q1YXJ[ _LQI>^& S8_%VZ()<13=4=2M8:B'"0S\O[T15N-M\
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MS5\R3K5?(2T6 9BE)OXK$^R:*4AAZ<PN G_V?9#3RX$O?09/OB)VK#JU(!3
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MI@3NNV>*Q.T 0YOS+YV#7?UP<:.:8=KN^O(%M1Y:N"#4?HTY7_O.%1'O+CI
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MU._1$\R4 ,>=N>292;;I%2=T7SV.=<=S@/96U^Q3ME.KD;I(F[M\]=:W?SW
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M@[RRE,<Q%KSWU&0EQNKU%]JV*-66WB8^;$&(\F?= A\F.\W5%-L"4=XWR^S
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M\\O.NQ/BA/_I32_E186K]2W6CJO^MGV#;FP@^P5-X]6I]P,[EV=?\4Z$]R$
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M3<<VA:KK4TLN?W&Z8VZEMNUJ)&9"L_$W,9_+AS&75I<6*C],\F'9Z*5%TI#
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M16"^I#0@N&I*"7^O?*8AJDX\VR6L<>5/EUUWGRG*Y,LXB3&.'+E\-*8Z!*.
M=6Z53JJ)BCPW:#6<VO:FCRSRM&3<KZLP(FBFNR99S;+*5\?LYM=KZ<G.YRL=
MEQZY+DQW\&'"O^:H69>BT' NX[?!$F-E%DC(6U7 OCT-4).S.]KQB-<@(D4
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M$#3\/H">(E5+DH6Z:";[I \6($%$$M*S:M]#,UY!CTO%J?M6,Z-R?%A5J<'
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MT13AF& !=::+V\E\3H76X2?L!=3O8TTM:*/8;2<5P'G*?O%OJ@)8SDJ262F
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M+H$EH(*WO 5(6HE_%ZO-QIQ8*95;'ZU$S\X'3BF L>$/XZ=F@>/4]8NVW/:
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M&;D:UP2YVY5^(K84#TE%FK MI-%,,"K':4%,/E<X_^^UIY8ICGMK-EYFF6L
M';1',%&M2E7)>#J2+?YWCW6/:O,?E*VBW>)3R*L-(K>H7G0?E!.>]'@LEU/W
M7-)5>#P$<5Z]*VRG/_N0$N>[IG %U\<"VG>SG&^:,EVZNM+9VUX0=QJEL\<#
MP,++7B_\'EN7!D?8!;PJ4?KV2=GPY]EKGTRNQ4&>:&&^F.GSK59GJ-A5P+I5
M:_6,R"QG-T_%^= J6;(UV1:0<4NL@4@_X8:M]@C^Z8CO-"TI@T_0@^Z?Z:VU
M17KL'INA6D2[,(XD6S([%8#(<^"2H#E77?ZJXA7E6J%L?W4/+H24_A5K3HYJ
M'LW&ITE&<I70_4;8NQ4/W/BUZREFUSZXKGW_JODB]&2GT;R7L+J._I-[>H03
M/6!!V7FU=%=5XN%@Y]">+/>Z6G;6HP:PX42M!BE&Q/5G/ZU:&X/RZ:P]&A@!
M<M!]CB.R:C'+A?"U#3R"%AVUM8!79S6CRL&.Y'Z$#+AS[;JR*@7PV79&SN$[
M)_P".35>,[7K>-*I!8G8JH\I!X<+Z\#C2 2N4T;M?-)WVZ$J&HZ#>R?;S2>I
M(.KND"DI<A;]:(KP&2_<IP L_VF"6YWM%K+A-$3YW?('9=OGXV0R\.."V'4B
MQGEW^T*K\TOEQ:T)3(%\4XO/?__[WUV2[ZD]:#IN>!I]I\C>/_DMNITITZUJ
MBI@)XO9G=9P^T_!4ME^$3MT6J0#,&Q#Z_ZC*1ON_'\Y]P7#H  -H!N.]+\"5
M$)_3W[2 "R@O?P<C*;A#&,W$90U+T0I@F2&$X$=MN%$!:/>YJ#K.)\QY&7T)
M1W.R]<*%&F8_M'?-S=+3L8!L;VDO5H6"8]N?$H:4;"F/V?+YI-0_3/XJ3P$T
M)S/($MG5:X0OZ/T'LX^+'OF3[MQ/]1HUW"4LR$Y_MFCS30HF0"E,X4'CPR3I
M/S:R)_=CR@^*$,:%_\&IQ7XNY!)<^%Y7? =C4D"B?R"ZJVI&!N[!7?!#) <]
M8W"C:+<"<*OJV0SWYXMI+YVI3%(K0YO-)-*^CS<R=4.Q6J/^F[KGF"G*[D@E
MY,XT<;P1-M_* '^J4ED=X!JNS 'ZQ2L3Y_-P*1,DYMLYE-DI08,DN\KH1>T.
M6X@&GL_0J2HASE!52Z%8-/]+T<#CS)OYE+)W$_UE'B%%Q _S9I87BW2:<G3O
MQ^A]FJI:0->4479"X25$3WX1%X"L#K-#]]3 W%I19MJKRS>5J5#N@\U? !AJ
MW[V4?6B'WQ9/R#[X3?F4,"W:-3CPM?'!,>L73RXH9]3K?-VM? \8Q8LJ"TEO
M@CBQ11>ND5[[:G"_# 4P;J(/LOWJ8D!76%?>_F6PBLMF,Q_)GHI>[<P^S4C+
M!P=VG1"!R<O>Z(&BS"#F]UXV(:2L#&9UXLK>A&\U9%;J8=*WM1^>>;*L]:J;
MZAVL,:3:,N^(+>8SEY+Q+=G4Y$G& *^?K@T1W7KL;9;_N;NC/66UZ;(L5:5M
M3^Y630IZ(^GT$; Q8WQ\$2TJ;-LR-07^QO?D<7 WP 6=!VENG1,E4U-/2[N$
M]+EM\*-PXN7\PXSZH5(I"W'9AF-*0"9($*$3*@:L3G6$,U7)^%.=F".%\"H;
MVQ.B0>JKT>Q)H(E8;5>TA>%^9BOIC-F^J!-S<W(4=/B_(EX=YEDCY2XD_\_W
M*7\J@0TIN[O_O35PN>EPT[^W#<IP1-M2ZE)_*-"=*=K=V5VJSM&PE5G<NGYU
MYSTER^MA?BIQ/!J*?+GA"F7WLR"&:5?][_ZF1>^,%\'-PYAG&]Q89D\D_)J<
M_PJOQ*D%:U$E&DQ\>;DL1 'L WR5;Y'"EQ@L R(VUXFTC&E_J9]I_W="&><>
M3-YCWG@ SQG3J#C1<6;*H>^476+5Y#7OVUKKWD !37J!IFEH8?VVD:W8?.Q3
M$*,[GRQ;K2%0E6VFIA%$J7W<F$*\""W)Z]W"\E0 JXF,1\/36"XA8=34ZA\%
M4!%1\!.R:Y3@9N;XA,I,<'$(12#\PWP]!:VUC=N"L9>ND^GE!JERP@E:9%IK
MY*W9_I+QLR.YCYR45R9D.BO1?[H+9AWIS;0T?Q1T,>_W\,EJ^+.HI:"0!!V@
MA!>#.+:N7!K;PETA9.C*K$3SM]_DZ?5B#46(I#"\4/?/B)&C*@:,C((IAU3[
M1CODX-/";_]YXX8\U3*US$6 5AG76Z\D22.ZU;UKO29_H=;J';/MH^FU%M &
M5U[53$WAOK-AIV-6#DTI]Y/OXWLVRPX+\$GL2' &!0_@Q,[?P+<*8")  >RB
M(W6\ACF4QWSW%WH5Q>;EF:"K&B&7>D40K=&HQ 5N%Q]X8JIC'D?3?<O!'W(/
MN$_8UDS9^)?8?^4YNYACOO?&RH/I-B&ACW._>N0(MJ\@](I"VPI?5_>,1A/R
M8T)!,S-,F9C:VFX6I ",KIP56S5.I2QJ4>5IT7S4@LI85!+NMR;"8HU8D$\3
MS>-$:52Z=\4PO$F$9X'J8]D@:SDF0$(S(!.:LPEW)F9I*/"* KA$1E7)]BN
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MOWO,IUC"V4*'9S"<O)81BOL@(]1G>?0_4$L#!!0    ( $21>ERG.7)0T<T
M -C;   4    96$P,C<W-SDV,#%?:6UG-2YJ<&?LNW=44^O6+KX$%)$2*8*
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M;: 29@W'8&KL1=>41MD#U.#<_N*:E^>O+V.G'N)=WGW@V?9GS_X"BSR6*I'
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M^)H[SGBS%/3W(FI?!;E[CQSP?X%8U.V0 XI4.6!.W"]@?'3BI682-_,1RKB
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MRGH,:K*$ZKZ"4(E.<;O!"FHA1'6%.A=A&YTJBQ>OD /)>!0STL0UES^<,FP
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M*A8\T#.A$F?M+M'5H Z0<E3DT'HOL&T_09OO.X4H'H#TF'&*1$LH49 +BBO
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M8K>D86OOO-VEJ%#_=//1 8X$0YOX;);28N7?UY<7N)<^I35^>WCQ;_\W4-P
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M<BD7[A ;KD;B''<63"DLL)%M)/G>J3]H/+#E#'(J]1<KEE5#/R#0TD@M "S
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MB6]<+2YBUYR+#ZY/U'/&2D"H"35;O(7V0/;R2\)A>.+IUZ\:CYPJ%==IW\9
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MBV4 __O_/$UZCKY;?5#V&\@_*59*,N4D#FN)JGOZ@YLYFZ ]'>,BE7:]@R/
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M>#2LT_3W#0Z!#^B$@KXK9^55O,UW=_^%D[BPI# #_VNM826$?OI3@4+ ;W6
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MQ/ L$A'78.PNIUP0JQ;ZR5]+T-,8H5PI"]W(Q,SIM-O*0O':$%'^&/)] VT
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MC ,"3)^5IF]J5>S&OVZNZ"]RZ1>\$>_<^M<@#BLUJZ%#9.]AGVAY#(/&SRH
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M)O8 9NO P O-)WX##CIC*'9BI9J@1MYS+03XRD*AP0/ &UL.T H%$.XBUL?
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M\%7'WXR8M_VMI]YQ88UWHO?VG3GTU>]02P,$%     @ 1)%Z7.]'>*'7$0$
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M9'_HC)-YCPGG6Q2R^)\V]Q!9MB $](=R_X)=Y=C1!PN@B^=1*5 2.R91.,]
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MT^,CIG_!HG$/6.VF?-PJQ)R@PXU^JBTL.-_1XU#Q96:<$UA5^(H5#(1<]LY
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MYS0]%CS$VX+"G4^'4U!PQ-?G4T=0VW;7:ZV3 F9H-?I $446DEQ_(E9P\^[
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M-^^*+L')8_5S>1;8187:F!QN&<^KZ"U:UW1D:?]N2 K$S*2.0Y#+(_A\T-6
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MU]U;%/*F!]!5^ZD'$A\]E!W&5Z/.1@97IV'T4UE:S 5RW%_GD[H<#_6FS!T
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M4=V>\ OS!)5V:-YLR7.7K=?MMY^S:VOMM7<5X/_@JN\$N@[ESB.EA$Y<0>W
M:;O6Y/Q'GP5/#5;HL>!MJ,-WI_L!YHSWW:)O*3]'$ZAU%$[[M*D8LM:7-]:,
MD1D'L.7V#3S/1] A3 6K(L.2HQ]OZ]$AK*/46&1O3E2LGG.U7>VP3[-OI7P$
M%2/:"/IEM;)GUV+='7A?DZX?2*WU> ?W_^*@&FG;591>=^#:]U\V*1E9]^\&
M='DEG3%6*+&='(W[-/7X- HZYN"T+85_$S5R-8558A;A8HX++QE6TD^S4OE3
M<OQQ:$]JY_ACYKDA[_QY@7E3F*=U3GP.;L[4W[,G#IM44"-XP;0UM7C;O'@S
M46'KQ=*^75C?0@47U(($U'Q?T0N-F AE3M'Q_/[3J?^35]+H"9* H1;1*F$.
M<BUN8[=H->X",!8C.N3G:=H *+=C-@U,',(9@(=PBKG[TI')W*KD9!JV]'E6
M==+IC]@[KFMLUJ+._T^2B@[&H8L0#<$Y &/<]A9JS+ .4)7 AJYRX&IJ68!6
M;)*JIALCV(ITC&E$5INJE<ZXID=H$2F8S1+3+.->^,38T:6)UI=L8 8%^"'/
M@S5EO$8BF[ .>V>LK7$OL/\Y.P.&4@0;#*E;_=6R8/#^RLX T99D=M0V,#P3
MSJ3']+?&CG\6?F6@<[7/EJH1^0Y#@=3*0 DO8F;P^\SN]G0L>3EOTV17+^>?
ML_48&7%>!=X::0<:J"V?ZH\$W.(&>&BM;.UO,;EDG.N3&[(W]>,GK5\J7PT^
M(I*86IM3\XW3KI7T1^IAJ(SRETMOYOBOC?%KN@27;_'Z7;I^AS1<:;>I>0]X
MEN!,> G'>M%N_0(DO1AWEB#[V'#/PP2U%Q30\N?P;MX?0]M?,?!#;O@AE@+B
M,F^VQ4S_ 5+5CR<X_E?1W,A+8,'*Q0CX9N.\$G_1*M**EQ4#3GO]B?T&9B)!
M*@8M]/H3@](&,;N2\&7V:L\ PVT?9$](/3*=Z9\774F9+J02GB"F(Z<3O::$
M*+< N>C)RD:R?$_V ,'C@V V@=\(]+J9]Y-YOR<G O%:$H::B]11:S2RFU60
M$]:TW[>):8)I(#5W4=E[X4@N&3QVGQT@3Z-6&S<(TWSTXQ$;V1:%>IG/(R+\
M<L'I"]A;;8;0&<HZ++P%RFY&1 +/3U>I"/1#> E5C-2O'%9NX\5A5AZUNE20
MY)1^!)L]]^O^X/#P-R'%1.7(B:^AL&\?1N8>2SEV++<I5__H7!I:=IE?PPG0
M'RQT)Q"']8 WN;S"E=UCQWE4&ES##Z99"TQ?L7>@P16,A!''&4,7^QRBOWC"
M :F8U[R8]_V>&M$(EVUW$O;9Y:6U^<*KU^=P/=S$$ N>29.]P]DZ41]C7F_'
M2@OL %*S>[;2WC>#7KPO$T90  E'0_8A9+O!TVCPU$?K6VR]UZAQI;R@O(GP
MD-;?E<@,K]>#T"J/'_Z)AD*SEOUA'0<\CZ1=,@G]?C-8D'OH^?%->$;B]\2K
M:WJT'C;4RC:$Y8LAUUA/%W\LA86S1@-81P7,/@(F@2 [Y'M(0HS-VS**)A]C
MKTV/*XGV!1XE;\8.V?.4:G*FS(PK,C7C=NX50S9F1BLGU!LS4N/.GX!YWSGD
M4"@:0**Z%V;6V%%!UQSL[<&I$Q()S@9PY3D.\IXE551H9:>T%<\Z=EB#EPPH
MQU+9,.#->PF72M1X9R9GVG2$:F%D[F#9_;OBA1[Z/*-B2GAZM&@^PN/<E%UI
M+V5AL[=U'%QO7][:0*O0E8*C^^HJM6,ME<DF \4C5>NB.YD&5XX\LFV_:9#<
M>W7._LJ!!NH\A7J94!GF_A/G@YJQ+>SDM5N#T5F@5I-(M]>(I4B6&<3:' 5K
MC;09'WGX:FXJTH#93AL1:0!K]V9QT-*&IUY_'YIY,IT,[UQ@#776ZZTG0>.1
M"I6-E2%"<D0AEN  ?.AM)<54_E"WZ#?4#+5BVL1<06[;8%3<:"CWK+]I(JON
M\6C+T^6]/KO)=[17-/ASPO318@JRL^V'[>K9'XEWK8%D\L7@@MJ'*7F3S#0S
MSWR_P'R_Y:<E>5X$OUO753PG:CLN,\HVC#VY>?2P:&HD6M0YT(#K#PAFX?M[
M JUQ>KQ%/K,"J$[ K6'["=1SW ;!/W,.I3"]+N0.2A+N<'I50TY&J 6C8G<7
MXI!4+.[H73GN 0;61K1EFACZ2%%[%O-OIIZY@<T[1M&^X :=S_VGW_4$6J4^
M#?#S/_&NYW[!R.K3PW<#U]X.NM^2G/]/!I_3C$^@4D,DX7BJ$%;2;H'^[SS
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M"[NO_?UI]%M1<R8*)!8*" "ZE:XLV%,+^+0[1+,TZB'+Z)AZJ?Q)3W7>FQS
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M'NO7R:Y<5EQ>O?.A1=/:"#&$/ ?V5OR3QTY^QD>5$=L=I,'3#D2\++#8/&-
M6[9Y&(*2QP:TG0$#6FM1K72U\<'^I#%@N(Z-T<0.6?K^[#I%^6EI$H?0&O/
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MGO:3._)Z-/!&:&'H4MO!I>65!4'<"A[.C!]KJ!T:P_2..[N[AOLM9T'6W(7
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MEZ5QTZ!DQ9=A=JIF25WY%^5CJQ(C]_Q/<*?_GVHO+:7(.(RL8:_8PK8+K4-
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MH!'_+^3ZFAQ"\LQICL@^1/\&8_>;<;7W8'2*JM\9-^WU,I%=]W8/O</6YIS
MEGK]RG>E39D!9L?2W&(]^%,1#S-4NX/B-?G^@0675_?37^ LV*G=29D;7\SP
M-8NX,QO6M.XL!WY4/+T>= !_:]:>O&Q(U/WXH35735XD4[O(5&84/>"X=#GX
ML[BR'TW[PW_K/@]6#_-I=USQZ-39!^]5E9P2R=\7N?Z%09^)6&0TRB'T-3C:
M2$(# BG@1)6>@U9V$0.&\>!I0?B@Y]9,%%J!I1EW9T>15'-0"O<OG'A"?H\M
M8 W.3Q=\()?>):EKU+.F$(#C'+MG-':2&)SKZZ'26DJ5)Y#\@D^7=N)+*ED;
MP:X2!P"*?VGCMRI^2./Z+Z.^=9:Q[.NC36I33+#]^M/SQLL+&: 2[C4.C<!L
M#,SO(UND!^:W*(S?Q*GE1M.-=/>75!A3<KP?,?JU.9NMCN=S2RKP"B?/3\FN
M,BNN) ,X[B0DSU=F?]J;VX$Z/!3[JZOT8;M_ DT"4]Q6H1/CKF&_QG[2VV+-
M:G+@EX\&ZY8:GBWO)JJT)YU!J[<%D>5/XTL*O*P_MJ(L\YU]21L[NSY]Z"(J
M%FJS@,?>FP@%CL?Y10I.#>L/[F@J"O=_S0U>7+PS_BH97^[4=R?8CO9'W*KR
MH$[LZK?]O[NQZOX?RSLMX[.-F0B^'P\7DM+C=L+T>F0>U\>I3N?[-89SAI)+
M6FW",8^_%YMNN6JJ_RE01F W]JN!P5R-Z[QZ9>8NJ1%FV'O1?8Q3TP@^ANDK
M&.C'F9QU?T>6C0_;K:9^O9CUL>[TAIWR)@NW0&P.KUMS9[A=U_1,R;=KI31Y
MEXF*A8]AN03;"QQ=Z"<'\Z[$*Y%S!*_$&R$D-=Q[H6@7O3G;[U<VM%J<CE8A
M&O/7) YA97TJF.D&][,GA.BD;/B&B45(M=63DQ N_ICOHZ97^8(O$YUDT2H:
M5?6!78EZ>"/)ZIV/X<?>XN([I5-9=\I2NA8Y%4S,5/ XLV*>F=OF<*5X< :4
MP$X677SU*^8_HX3.KP-L_4ADX$_)UT]C^U])8!=)64NMY-?0E632 $60C>DD
M[[\()K X-AHE3*59442^D@<5TSLO-2&<PY<M_S5#0:DU@/(_HX7W]CK$T"UA
M2EC:%'PY0&P\ND0JO5*\!+5*8.68#G]R"N_()IM%Z^4F$6\. :U+>\9<58^'
M"Y<+M(8B4B6P:J8*>$]LK?M<\P7_,[U3%CTF@=TEIY.N2_GRU*M(1"13U@3!
MGPRB;Q;GY_9IPE-4!<-\D5YGD\ZXYX1#W,4^4X<WNZQ#$E2(QSN5DKK]4Q^T
M\8RR?HC@T9J+,K]WZT%S\M>J>H?6I[M-=[0Q4S"?["V[4=?R^GQZD.',#3:O
M^WL/=12H]=KRJ5&"HV\T@Y=<T A38&N*<YK,+\3AOUBYK.^5M9HFH!T0>P(H
MCR$I$5T[C,3G(5T/,WX9/?3E>(]W9^E/^8#E#3Q(ZPS1G(N1ESI:_<&D^TGT
MD832^3\[?NP#3<YUS BP,#G:EJ,O^L-BVCN@C?+J[/ S79B)M7"B4%-& S=$
MI@X 9^(#:O:3:S7"@#NC;'(/K2<9V]._O1OS6Y6V)/^GQM+7FAEL Q$SG\:O
M8%YSS94A''AO[^6VT<9QB*(KN_-<J9'CON>W'S[-G#+O,KC:[E3Q&Z(."L'"
MOS)MHV\].V?3^B#\CN_NMH@<]0%<GH]?E?TCHL/R!E('N0310-U*O,!OB8=4
M"#H#]6@MJ&=+,M. GQ)MI">//":!/=H2^WR^N@UC<$A%DZ8LVL1BNR:V2?F.
M/U"7^E1<EI@C@7U*S-8X-$ RA60Z[C?<PNJ*3HOSR3YI+0H_P=@:S?UM&*YR
M!=0D@9T",)'S?F;+F/.CIL;EA3B0;WR_\?0MT(EM.C.5N7QF7 +[ 4S0E-%:
M81D3W]Z6QNLZ,J%I^H<X1%KB(X6?6P:W.G8=P&?/1!T:_PVV;"9X4=SPJ2GR
M-R>"?,I#&TZ?='S\^PE>NV"79?^XR>QW!0/N]+;,^D,_=47ZCGF[T3OCTAPV
MYV2@'32]U.)G2U5*\V/>^YLB6M?0EK5(GQ%K4?O1*<-3CL-N@+B@A[<EF+P!
MO1LGE^=M^O+UF4 4^1,L<3%:57N3S96 )1=@L4:HF38<&LM#("[R0L@B+?(8
M2;.+548T>44>7*Q;64X4ASS0&R[ASWL<>.=^$QP8UBPGWSCX9IS<JX992(CY
M6'U->ST84#2XP6JM@HKC:+34/GY#4D3Q\/J*I_6<R'E645]?/]G'-\Q>5:!)
M.RENJ8'62PUTL==SOBZ"KZO^N_E;8]3C>,-VSF.]/AO<M:LE[M2$H5,'AO9F
MN*#EH(U7.@ONI \7I@3WF=WU:!1(NX]5]IVEGYD'B$>@+II8DP<I!4W1?F!&
M5"_3U,A?Y9869+;&0(N_I1U_XU:JOP"Z(8$!_LR<4:B5K#0X)ZC$Q;JK<RF]
MANENSE ;U"*!Q;22!47">?K\BQ0Q'IVUQ)G^Z9XN@;W%_+A;O/CQ20GK@)^9
MX=.>.[RLTM)R^R\HD\_*"GQEQ,C$EUENW^.8I.03?5UO:68<^L'@KHDS]-5\
MUF0-@!AR:F ]Q)18)Y"V>I-TP%[ H*-N00H5V_K=_\S(03\;?J3L8;I/"W=M
M'T5O\<":-3#A.J8W&,Y'+CP$1J?4 3BW_![+JQ*+(*[@]R<-\UCQ" VJU+)I
MB]0Z2U0RR2O'90>3(ODJ?%N;$@9VC_&%] G<R"ZS'J%05 EAM02A2'9Y8B[?
M8N$FZ,7'8YE\1,+>4GW;NI7LBNO1W&_G6IR@ED[&ND!]=\81(^KJ?3)?^#(B
M;>>P1E73O];_*F/)^"QO):Q9R5V@U9/,.XVPZW,C#?V4L965[3=0MKF@9_57
MY6, @6,(EZ\+=&[]%.GW$*'B?V8$[ZB.4$(Y#,DA8U+)% %K*X''S;W?^+"D
MRJ(VE?Z H2LE:#W"<&-LX9>>AOB"U4!CG*QWB7>)(;4V]PMZGVFOZ>''&O$C
M&*"=56*<=>MU([?E88]YI_ \(<VQTJT*,;2'_K A]B4XZHZ-3.76LJ)(VPE_
M@UK6>D-D.8QH^T?^^@\)5K/PN& )S'=6M![S Y._E$'-)S5*8/!2UBH>:059
MB<"=-'IF^ %?.(4WO/\:.QZB'&[$^LN[QW24';K5DOO-[\F[YA]:P$R<A>RJ
M&*-IS-69%2U<%>(*-&M8%[!Z5@"FG&MGH/Q+["HTJ/&!>$UOM''[FA*B,?&$
M$!$]CXS.V+_6O>OE]^P3'U8P')L6GH@S]Q*#\8-3YZLU-3I+EEG1:/-B]/:J
M=H8/M\_D*- 075 \EJKC7,01'4-K%/%-#>Z ]3?S2H^L? GH-N)[$/492$!4
M,<".0F%>34#K^%)NB[#/\Q$6A@_M)N)?@)7LILP(,*WP!= ?F;$76/,6Y9RA
MMK_/G<UU85[7W.NR/=9+D.]>.D"@+"-I0T&N7I.7 8[-^W<=\_'!]2$>(^UO
M1=8!KW3#YQOYS4\S<:XZE9D^I@LH4PMDI *%"V1H Z\CJFW^KMQP5I_ 6C@
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MU:;+W,Y-32H*7Q[NF10BK$!5(/Q86ZG^NA;NP,/I0+&3LUH_79S_<JSG4;?
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MRJZ[WW5$YA;FRZ_EN7[YU4(1Z<U%8-?2'\I=NI]<G5]&+DJ(BAV*=SK+-TY
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MS:,_M4D\2C)U8\.2YYIFAPN /X)8LX. YVBY10E.'W+$F,,R<UU'"Y#]Z><
M_UERVW(EXOSK$<5N,CF[9+*W;(ZR>6&O(A&NLOUKN-K%E(D^\3AR%B*Y?1S8
MT@6,-'$EHQAJB*U!>B?SIQ<M6G)BCBFWVMHOYJ^#  <,EG<QM#IH"SF/1ZYJ
M*1%>J>P.VY4"20NN=0NT/6T\=-YQ1HE8:CKM^U,N6Z"S8IQW:%&M,8_6']E(
MKJ62/\^AN^A1^K<B=@ZV;5UTO7DZV#^S^14PY!_[5EM] &(=]F.M+HYEJ7PK
M3]]?;/RCZ$4+R8DE$M(*@,CC0 -N#;IEM\P]T5&:RJ" "QRY\V[3=^]UJA-6
MQ.3<_P@2?NW:GGZDNKKZS1OJ\8U5557+D:[49E2"P7,1[]J%"TK$X5FJ:&Y$
MPCB8Z *CI0UUC"OLK<XR\NW/^07W@D*N\IE^4ETYSM%:^Z!NU3CHOG$LZB3I
MQ7M\89_3]H*R=A_&Y4O2:+5D2T53B*E0@;X20:?L6'EF%@ZV#A4Z9*Z,C+DM
M+_8U%6.E5T"\Z$GO\*K)0SP/;K"A-W!NK.+%YOJE2\N+Z3M/\^?\JM3T#%(>
M39P[9R;/ VI=,(.#P1C^Y>>%<@/0\8F/W N\&QSP,9QNF(D%[?D[2#KK%_'>
ML!'5D52/SAB]J]7>N;1ZPLBGW%@SS45GHH^9FW<GI6BA??Q.*8/>MC <T4B\
M8+Z=OY< >GTR=RD?LY^<[G2G;6R0^\X&[<(^5NB1VW 5V%I*SV*=%>>6W$E@
MK#IF97X#,T00$#3QJ)X<U8Y7:+?ER?BO$0;\/W@6RR_:DR/(33B1-ZN'(TT3
M7W[,)ZC)73MLG)[["#??3Z/PIS7&4*(B&V=&\LBB?^TRW%9B(OOU.\Y)_?S?
M5.030""RUT!Z3U' _'X6C?OD*D$*H:$RGB$+H? 7F6,Y*T1IZ1SY%3F2#WM&
MO@VF4^9^%TR%K=U1E,Y6N!^RL#M2)M[Q/"8P,@ 0L$]\ LHI^NC7,O?"XIX#
MB3NV&-YW61AWZJF(:-DW]"0W]NR]\-1F.F1UBOQ3HT#3=$L#ZG/41Z][@:(9
M;((@INS'V]D#T;RJ37)STM@VCA0G2JRGJ($S]3ABI%=YI3E+O(!/'H\FSK=A
MTEF'-PLA[K\6\-I!9M!9S$M KJ4G?:R@&I$P?$Z*Q>;T1DZ"#"<]>9^:A"G'
ME)"-B=@BX*6$L_!,Y5%3DBGO]A6#18(B^7M2;=YR3"!GY9AL.%Z@8]%0"7@U
M%WB9YH,COS5M%#==7="SM1R[<Q&ODLX/-<+U6 0/N)J7IJ64/I'<+RN[+ZEP
MB4W6W^1WJ6<W4K/.X_>\LZ^?F(SP>RN?WDWVT[_](>A]?L:E^^7^PL.S6 M8
M8V%GY^2[6#!B'L9P%/,GYW3\#HFWQ]<4\/O=7;KG8AC@;%4)$^;XV-$P+]T3
M ]1'2L2/HCPMK< =V;U=9B7X%SZ4\I35FN88[_B#G2FY40>\VX*<S'8,]1Z]
M0WI?Y7-(^(JSN TS.PVS-/ %79$-1S,;Y#<O[9%RC">(D<8IWI#VB_2&#%GL
M-TPD';P3@S<TFF^0E='Y'>3:/"$3-?'KQ8B9E6RC2RMKQWP^D] &&M"8_]F^
M/IK$;X28N+:6:9S@P5B+UO8X\6WCMGY[H\"RC?WZP*U#4"2Z!VJ$!2-U"_"A
M0(GXXQ3 26%\Y0D\*FHL144/11!P*WJ@<!]V^5@.'/CBKQ8$5;[>&D#>V#KG
MP)6T^'FA<]E7TO2L3SIK++L-"A=W K7^-3IR/&@MKAIR;\2N\ )7U:/4F:=%
M;^2JHKY!J)2UF10LUGL+E,8T8OQ_>A+@JV.L1_(7G_(7<9.9.PM*ZG3WWGCZ
MZE>=L,3NXIL][PNL<1W.TU^CD[;RO<_Z67XC63=;-H9VYQ=GG<BEF5<D"_)D
M4Q48?PQ_$\SC1SYPYYYA^)O;,*,:P0M(,8.#4H55AWT$H 5Q@17 .:D"%M2!
MA!_88L(@JQYY,X-Q"]I*1!X4#><-&CJ_S3%K):U84?7$XN9&:N+K;@C8\,,2
M[ V;O;=HT#IFQ1CC7WK[>6$SC'MVOS/?' 8Z(3AH/\$G8D1-1R$T%^=;)=E/
M!>WW860_>$*E0-TO,.-JW<65%&7^,W-6&=3: HP&W5(B3EB:0C>+8.[#_@$+
MG8*%@2B1& E=O0S?!\*Z;F5D(C"J18#+C;_\=V+[)U1I AZNP DY'0R>V<_J
M#%G]5QT 48,'&=V!]<V<LUQ@KN>_?S*CWSKY_= #')>EHO]8[@*;5=U+D85B
M53D+%A2>U4O_SMOECM9;>ZL!J.[[%DQ2(GP^R3&KSEKBYETW\IN#(W_ICWHZ
MPCK7]K12%W;='WFUK#DC+^A,.J0Q'<<:50E<@)M$V/K/U/8%RW 3%QA0?-I<
M5F&U[615U*DA#-\7Q$%7TGCI<,DTF.HAZWASRRJ4B"968Q7R'ZGBU"E_/4SY
MGMU1?OL=4*?!Y\F6]P'4ND*@3N<)T+JC;U:C8^&_<H])",;"*2WIY;7 1WI!
MQ' ?!WCX$:@S@V_?U3>#$KAA7NYC+(C*%0; /[NB6%:N545VC\X&W-CAU3(#
MUAW%:F#B,S 2SQ)"9F>"S3>QN+7!$NB-8$YN8/?/9VF+&%66U+N*ESD2"_F'
M;%E[JXY>E/&JNM2M G>\J/7QFL#+XM^)FX1]&!QM5NAU,IL&-*4PV@!Z ->1
M_ZVO^5MQ7!>OAD7\C_U__WTMV7SMMSE;6VO*".4#,ZFA-[2D1JOM#[O+*T([
M;)LZ; 1%*R6,/\;WHQ(%DQ[1:=05>?C0<Q<M["P7KLQODI?,%7UD:8H>W#<<
MFOS(JIS(K"!.I?L<;;[)WGTX.**D(B>UE[K7Y=_CD%R.$J%=-CW1OX+G')?_
M/ I*%RK23*&8\''[6,,A0_5YIS<SY[<F#W%4,H<L:^?T7G-4:+: #=I:R.6)
MBLEL%;T#;7/-QA]A!"_"2W55F[M#,^T;GNMK6=,B/MSO:)?MM_5ZY<;UT>)[
MAQ0_\-9SLB5HY'9/YG5$Q*;J_8O&A9N3][ ZSGP_%C''<A%'\^6-S&JP[<Q2
M1CR4B)(050FFA\KOF!MU"5_OP5E=H?N[)M=<"O,NYU)9M#H2EL6X0PK*HIKO
MYX:OI6,Q>-J3 27B(5@A*\@\T[4PD=U'ZM.GSX]F GJ=^WA;5"G3A2&.DI%9
MN347*6X,5M<QY@.4:0:=5<+<(L;6R8R3#544*P&-]Z"SX#%E,4?EUGY8C"\9
M.Z5$7%!,NP)8QD@?MQQ?JT0$3=_P]*6(TAMTU5G7AH='FG*TQ=B$<. 5T)Q
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MA!W$:UR^4;:HR0.]HL,&P1'MFH4V%'?DMMD0'L$ JVNR["U2D_P3:9=8_?J
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MI]<P5-J,I0G!2/GWP3GC*S"M]@)QCM\S>IL94,&[8\"%=F!XT^D7_I!^93>
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M76Z2"_[)(Q+LNL^+YJ*'K]OL'R)HJ@%LZ)?NN=M:<5YU\?)OC9I+T2&?W_<
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MB2U^<4VVLHBW&[6O+N18<T\'A59D78I2(K:%"D]*K+'[IK;.[)^^*J2$-N&
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M,_$EB>J[1#TK$2L],$,/Z$[!FC50X=G8M3G?(\^ZB? EW/\>ETT>G[T+E.>
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M_H4_MJ:A%#HQUBXZNFWFYA5;7(UR'DH_Z0%SL/LF!/M -\B&F \\M$WW0+
MH[QNV1CW1Y_E&C2V6RZ7+$"]]DT1_E/\%Y6\6B?H6AB6@\^_MC:+!JQ3B9[0
M?WI'>TE#6-JE9N G6X5[/)6P"=,&49] L)W=&*K=S?KC%5;D#\3BBS4)V#AG
M?$/0P]$>C(M(+&AC1D2V^W6<"!"U&1_4:==C%@VX52A$6(&BBA-*R>)0R[4M
M%8Z93,:^SP[> DO&Q!0F]$4I%)X%_UXRD6$>H#Y=_D&V2=8UYLOX%@>9U#\X
MFYE(.-O]LKCFPN;*YMZ%>PXL+Q14)$H*FHKMW+]"XJ&VM6/)7ORE6D*0R /4
MMB;Q53EK0_<D='D_JZ/F%Z5XO$@)_+: <5SVA#'\.W__C]29)X9M,MH[R"/C
M Z@:0Q(&(Q@S4&X 8GGI"704+?0ND18G4W;@K=1YK0[&1QPZ@\DJ_H29LW9N
M;.!#TE"LFJ6[#';S> 1Z#+;P>^/5;G"/BJS4>EL,T(0+<$<FXS?$Y@9KJU+T
MA%MYKY-H_KDWNTP/!.1<B"&9]+3]&N+:=><\>JQGERJ@G1(L.U':!3X7?H=0
M0]TQ[@A:-#*V.JR[Z46DW2[%0**+]TJ)UFN?L([ 19]GN;@X+SH@2AV0)<4)
MC:Z177-FF^BT^+]$MLF&;%$4SQ0\$T:KZK)HIKK@+52K)FPQ[%,ML(2_X/6Z
M^[C90/OJ)3\+'O<>M$:OG__W_*,39W?O)-\#C87=R8*YZ&VE'7G7*S17(4/O
MM?7?OW"!4T78H;5"O+-U3!?KWRIY@W\E?Z;UNEI5?[FYN?KDZZ^I9U/4Y-KZ
M55Y^D=_O2J."^+=A"YK"D00';#A2&#%D>_YI6GFLGW=D* S>AP8[#UC<&(RT
M(G@O .H1#HQ^#.K:[O90L&/0;).4/-(7-;H(_RW.+51#0PDC.2VE@*/@#$):
M)Y1V&+%)KO!!MC77DF>Y.B@D\XCCU8[=8=-Z(81*F''E87C\&D97L$BJ3Y7E
M&FF[\SAF'H2(Q+P9H\$.# NVA R7L RB=8DG%!+4T_5XQ,<H.62SK3%2AF83
M7F^6V15QN"P!Q7XR+2T_61IL_BA?3$EPA7=3\QXX\".XD/6GLQ7;X_$O5>X'
M+I3<*4YMSCG)50K(L]&Z8=OH019)J=O5-4 .K"B"S9**[0C&(UAZ82,>%YY1
MG$6 K$\-26,#+@#A#B:!G@^(:O8'OPQT)\D X4G>9=GTBIVLZ;E0]6OT4+?/
MC$/]74M+FLQ4FHRK3XU(_LH N-?@WM+PX91MOQ3F8@,$@9H-J6W0.,60,3JU
M%B)P/#T;S:Q*_90KY\UO:V>_+_N4J3;:MTUYNWQ:^.W;;[_-O?9&F7%V\.?C
MM&T'NIH27XV,OQ"$6586I-,(KT'H?/LA=(O BI D]BAA:ZXIZR#LTP%VIIQN
M$KQ)>$;*6JIDS TA"N&[+E]!-AAP/O- A@=F+(.[[%6?+_P02AW5_KHBZ@*\
MA6>8S[9CN:$;$.YVN"3G17_JRMLAB)G\Y.UNF7&_X6-RVJ$EJV]M@"=PLV-:
MGQU':]F3(J$ZAEOMLY#XX("OY5I@:Y&2AU0+E/N6;0^W1ER#N]*(_#@/T+_X
MSG/^>5'L/,6YK3[PAZO%[=3>:L6KI%," X>DUK*Z/:F-*N8(Q:XJN]0[)EOH
M0O[QV"/=8 8[70^0Z0%ZX)OT]78%_VK4;3^)0;6WS][2'MVZ9MR8"+M,5EI:
MLJ:25T.YW+XIMT?&^K69P#AB6*K/]<CDH!SIV%18%=\7$MHK9?/87;')9RII
M/[B;$W%/<:U0 \..>+9[PCC/N)1#EY,3(^,,Y90;;')5KN/5-'?$I.5F"6X@
MC:C*CT\W/"B=".=U6Q1,>*Q,F$BB:VM]_H0.G/6B][?Z/<>-^RLJ_I6U-QF3
M5"0$V'J..T&0V&C]HR ,]ZAD#=&WL%O$^*^&BCEXE&YV)S1H*"&\Z9()7+A#
M,31A:Q_JQTBI'@=OHCZXIP6_$=]*AU 0GQ6JC6)M@\E7!59,EVX(L\X@(?>3
MLU">**8X)\EU,<[+&GB-5R^:?.8^AA?#!IJAKQ&?(.40V*,'I/3V%,R8H4Y$
M76*U)%RRA'X=7\-RA+N$<NY,\IP!2TN$E+0QS''?/[BH5:(V@T8TTA%&LFM4
M[=>IHK8 ALAINR1'\J&O>IW/O5R7XH7?,SU#S4,K1R%ZRE'X[YR33=(#G?E1
MH?U2Z"T>6DQ&5WA@"]<L>J-+P4X;Z)P'+.=^YO 9\WM*LVVUH.X:YH@PJL@%
M0X,2.=TB), :3DERI<"%OS=&0K/-)8.=/MM:0./;J06D6N'5*%YP1KU")HJ=
M]':?)[IE 3)D;[A**CRE(^ON4V?UA1-ZW#!'_*.]0V0JZQ.8XZT5DH[7(.)"
MM">?]U8Z4DJ*LW+UEQ3Z//<1O:FR_IJMW.^_(HH=_"SOU*CTS8#B_&%+,[KJ
MSY]\1F1?&Y@NW,?3I0J#^(8LH\^N="1'T5);\AB)5VPJS.5Q3,N*NS]SKQ1D
M1GR;Y_J;Z'*<\_FM]!Y0_066J1P4/M=X"RD5MH'Y7[$MR+V>!-?UD8QY;:%@
M>U1[-B$CEG>&:L-%N+D>>!PN[:N%=I*+X@C[,,^!:^ ]S3<V+H?V>=3+Q<_O
MW^*;*4EG-K]]7[<;6.P*;*!O9N8=-&8^D>TJ$+PAT@M5J^-W-.J!9O#;\JQ>
M>LYB/+,!^W1BE*]<F^GX\3RGVF%)4CY[U\-2G_T?/]S/=T!L3D90EWZ@/D6X
M#IY/.VB^+G1_8?T3\ XI7O:*5BO\TBP?%W$3PM'MM3R"VD^1D@44<([ O.]
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MT@.O:WS^K#YZP [.\KEAZQO5:7M*:-]5 RNZ^O@I? \IAG$5CKAARPN\C5=
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M#$D%FO&1 #_R#PG!CRYD%_4 S%01IAWB.NN!+WTHX3'&@A)P1O<0J@=VX;?
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MDTJ\R.LI_LI\O-CG*UO?DG7;GCW'J?,F5\<MN%9\PVC%F _87N^W[,!VDKZ
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MM#AQ&Q:GW<QR^@A)+O9H5(\7F@-CP)-!DG\(6T;)3A&\RRK*)M@]?:*_#$P
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M529Y22'#/6N&X9*%XMH!-/,QY#/@F\AV:=@;(RI<SU-$C0'".PD YMX;$*2
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M<^J)8ON45E&.;]%!;2'9M)]:7HN%]49]9":Y,#,Z]F!K77VS3#E2#C_C$L\
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M.[DVTS.8$1HKQ@'-YFY>/^^:@?7XJ)P&OG-B$P6CXXUXW!**GFF<]V,ERH9
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M6S!=Z!H>^2:;I",JBT*MF.JA-).^YAQN60+W%W,J\P*-4CVJ16[B_:I!/9?
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M3Q.&4R7*(YG+SF0!!XK']=#Q=/,/M.\N>F'EI-.#/?=2XTJ/TO\G"+%B;M4
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M[500TY".*KZD&A9)^X*];Q!O9\6LD!DHT"Y@!&PD?$V]CBP/BW4%'NO?L>9
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MO*(C930\?+ :':YNK*E&N]"6 6!\*7(SEE1HI\'6$CC,]6EJ0G3M:C++$+O
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MV'S$M[V0V5PJ!OEUYAQ6SARV85=XY[V<\'I^2C*!80$GC9R>CG]GT/&/@)2
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M/TK>CA21]M"72N*5:]679M):3+CU0%ULI/L/O %PTJ+B0L D7>"A_J?S"#D
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M&KFW%(JZTN)K;=1YRET3[@U-?(S=+^%J_%N#?Z9_AGU=FG*?\5M&.CK!6!F
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MJJ:LLQ,Z90OB\_4R9)4)1S+AOO'T)R8DR(,3$4 @$0\_!Y73D^D(.-3LF<0
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M@=&H\\W$3HJ:+!X"^"0']E&TQX1+-6I<E84[U3MPP4O;%OE>?]PK_"HF'QT
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M+''Q;_FEMGK3D>6N7T4\O5^ZC:E\XY._W1TZMRXI\.%@O^Z!]&Z![Z H=H1
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M^ZM[FGYZ O&E(W4W:-3BZ<0!>5H%<0_&[]8$X]%4*T_T[S?)C(=(PP:N0"*
M_A:9[U@>!H0:W7VQE>BT^D=$$'3FP0Z)''UND5Z@)2_>8/!X%&$I[U/'R*SD
M@P%5)T7"REQAZ".-XPUS=DBDEO-Q2^1][*?.+Q^HG.55QV&Z&9P05^XIIUE
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M)K!D]75C0<ZFM*VCBI"-8>_:[VI.L7FQ4>F2+L3F'7S(]]TV6WP,SQ3# 'N
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MV^ ?O:NT U^;;JT@QJOUJ>ER.JC^&$? -Y"V4SZ;-8,11C(61AU^'50P<,O
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M#]BJ@)"_31I/.T-#^P*06^VX5AF EG(*C*OZ<@&-KPAQX@LQ34_*Y,\,E'*
M7CAW697UV,2;7<L917H]QFBX3(Z' TBB0;<J,]T\RA>6<E',KF*Y -:+I)++
M,7-GZ?5"R1K!/9&U?>ZY/X>NJ4&,\]-!:X.,*),MF"BH=^9BO!%ES&J-DAG
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M4K)3E,7]3TFZBRCMA"DZH)>3?/F3^H8F$6QRQ/3=5YI\QSBZYXLSX(0/^%=
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M.=]]O%'9V^F]G]XX[KC>\-#LQE66C<47Y*(.:=$MM.\;%#EM C_R6$BEHB8
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MX0NVQ U=6V2@MR^P-:WPW<5EPB'8!*LJTN^J#LLHB48Q7?T6^ K1V_&QU-J
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M,XO.:I>B'S*7'^_F$X$NP]R.O.34AM# %7G*A88_#$HT2>A4.+5%2%@!]L;
M2A3?NX]=$GUDDJ[Q(7'^.P%\R8U]9$\L?K!+R='V5!?^ YA7\/I8!Z]>A];"
M\RIGJ]_FGO<6J220PCJC_[>R."RYX4$^6F^-#OF_86:K<W[4<T+F6X;F8G!-
M^T9GP1UM:)M!@!T9*UR^DZ4@U!.Q!T90*4SO48DX;*^!FN:&' FDAK!?AU7&
M'+#@'@#;X/83SX5*]/I;VMD;W\J/L3^()TXOF/XU6(@G$M4\H_BP_7^)A1-
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M^)!9Y6!G,UFSTH([==$XEZP4JV#Z-.VKJQ;</A5">D21'[,,_B]02P,$%
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M2G0CTS#)(W0)0%:0X0',4B<SE@%/1 6B2)(LL5["S#P9&72*)'7LD46>P
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M3,0-05X=EQ9WD0E\W/THA  FJ9*,$DX<EEJES$)[HG6?0*S:7T51Q82!1*P
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M,3(S,2YX<V102P$"% ,4    " !$D7I</=.&GF$0  ">U   %@
M    @ &3%@  8WEN9VXM,C R-3$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( $21
M>ES$\?/C\U@  *6?!0 6              "  2@G  !C>6YG;BTR,#(U,3(S
M,5]D968N>&UL4$L! A0#%     @ 1)%Z7'0G/D*"S0  1#\* !8
M     ( !3X   &-Y;F=N+3(P,C4Q,C,Q7VQA8BYX;6Q02P$"% ,4    " !$
MD7I<C\;[86%<  !" @8 %@              @ $%3@$ 8WEN9VXM,C R-3$R
M,S%?<')E+GAM;%!+ 0(4 Q0    ( $21>EP,;:/(R94" (;5%  7
M      "  9JJ 0!E83 R-S<W.38M,3!K7V-Y;F=N+FAT;5!+ 0(4 Q0    (
M $21>ES5-4AI7:D! %[" 0 4              "  9A ! !E83 R-S<W.38P
M,5]I;6<Q+FIP9U!+ 0(4 Q0    ( $21>ER21 3-H9X! -:O 0 4
M      "  2?J!0!E83 R-S<W.38P,5]I;6<R+FIP9U!+ 0(4 Q0    ( $21
M>ERL8(8?^>D  +L! 0 4              "  ?J(!P!E83 R-S<W.38P,5]I
M;6<S+FIP9U!+ 0(4 Q0    ( $21>EQ%CA>=24<  /1*   4
M  "  25S" !E83 R-S<W.38P,5]I;6<T+FIP9U!+ 0(4 Q0    ( $21>ERG
M.7)0T<T  -C;   4              "  :"Z" !E83 R-S<W.38P,5]I;6<U
M+FIP9U!+ 0(4 Q0    ( $21>ESO1WBAUQ$!  4E 0 4              "
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M &5A,#(W-S<Y-C Q97@S,2TQ+FAT;5!+ 0(4 Q0    ( $21>EQ-W?_2:@<
M ,<K   5              "  4ZB"P!E83 R-S<W.38P,65X,S$M,BYH=&U0
M2P$"% ,4    " !$D7I<E%!6DT8$  #B$P  %0              @ 'KJ0L
M96$P,C<W-SDV,#%E>#,R+3$N:'1M4$L! A0#%     @ 1)%Z7,HHC/B-"
M B0  !0              ( !9*X+ &5A,#(W-S<Y-C Q97@T+3$N:'1M4$L%
3!@     3 !, ] 0  ".W"P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>ea0277796-10k_cyngn_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:cyngn="http://cyngn.com/20251231"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cyngn-20251231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2026-03-26</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-25</startDate>
            <endDate>2024-06-25</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-25</startDate>
            <endDate>2024-06-25</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-06-25</startDate>
            <endDate>2024-06-25</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-01-30</startDate>
            <endDate>2025-01-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cyngn:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-12-31</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2027-12-31</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2028-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AutomobilesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:MachineToolsAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:MachineToolsAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:TestingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cyngn:TestingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:DevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cyngn:DevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-27</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2025-06-27</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-06-27</startDate>
            <endDate>2025-06-27</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-06-26</startDate>
            <endDate>2025-06-26</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2025-06-26</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-26</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-26</startDate>
            <endDate>2025-06-26</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-30</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2024-12-30</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cyngn:CommonStockOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-30</startDate>
            <endDate>2024-12-30</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-12-20</startDate>
            <endDate>2024-12-20</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-23</startDate>
            <endDate>2024-12-23</endDate>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-23</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-23</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-03</startDate>
            <endDate>2024-05-03</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-05-03</startDate>
            <endDate>2024-05-03</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:AtTheMarketEquityFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-05</startDate>
            <endDate>2025-09-05</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-09-05</startDate>
            <endDate>2025-09-05</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:AegisCapitalCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:PrivatePlacementOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-12</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:PrivatePlacementOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-12</startDate>
            <endDate>2024-11-12</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AuctionMarketPreferredSecuritiesStockSeriesAxis">us-gaap:SeriesBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:InitialPublicOfferingWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:BlackScholesModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesAWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cyngn:SeriesBWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">cyngn:MonteCarloPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwentyTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cyngn:TwoThousandTwentyOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">cyngn:TwoZeroThreeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2023-12-31</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:Section162mLimitationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:WarrantRevaluationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowanceByDeferredTaxAssetAxis">cyngn:OtherPermanentDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:DamagesFromProductDefectsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cyngn:SalesAgreementWithAegisCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-19</startDate>
            <endDate>2026-03-19</endDate>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:RegisteredDirectOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-16</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cyngn:RegisteredDirectOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-16</startDate>
            <endDate>2026-03-16</endDate>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:AsPreviouslyReportMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">cyngn:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001874097</identifier>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-13613">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-35">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-13614">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-13615">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-13616">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-51">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-62">001-40932</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-71">CYNGN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-83">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-88">46-2007094</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-13617">1344 Terra Bella Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-13618">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-13619">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-109">94043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-13620">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-13621">924-5905</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-146">Common Stock, Par Value $0.00001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-150">CYN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-154">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-13622">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-13623">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-13624">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-13625">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-214">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-222">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-231">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-237">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-243">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-249">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c0" id="ixv-255">true</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-262">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c1" decimals="2" id="ixv-13626" unitRef="usd">101365430.4</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-13627"
      unitRef="shares">13608281</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c0" id="ixv-279">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;None&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c0" id="ixv-3207">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Risk management and strategy&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We recognize the critical
importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect
the confidentiality, integrity, and availability of our data.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Managing Material Risks &amp;amp; Integrated Overall
Risk Management&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have strategically integrated
cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management.
This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management
team works closely with our IT department to continuously evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Oversee Third-party Risk&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Because we are aware of the
risks associated with third-party service providers, we have implemented stringent processes to oversee and manage these risks. We conduct
thorough security assessments of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with
our cybersecurity standards. The monitoring includes annual assessments of the SOC reports of our providers and implementing complementary
controls. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Risks from Cybersecurity Threats&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have not encountered cybersecurity
challenges that have materially impaired our operations or financial standing.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c0" id="ixv-3225">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have strategically integrated
cybersecurity risk management into our broader risk management framework to promote a company-wide culture of cybersecurity risk management.
This integration ensures that cybersecurity considerations are an integral part of our decision-making processes at every level. Our management
team works closely with our IT department to continuously evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c0" id="ixv-13628">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c0" id="ixv-3236">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c0" id="ixv-13629">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="c0" id="ixv-3249">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;We have not encountered cybersecurity
challenges that have materially impaired our operations or financial standing.&lt;/p&gt;</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c0" id="ixv-13630">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorOpinionTextBlock contextRef="c0" id="ixv-4006">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Opinion on the Financial Statements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have audited the accompanying consolidated
balance sheet of CYNGN Inc. (the &#x201c;Company&#x201d;) as of December 31, 2025, the related consolidated statements of operations, stockholders&#x2019;
equity and cash flows for the year ended December 31, 2025, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December
31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles
generally accepted in the United States of America.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="c0" id="ixv-4038">CBIZ CPAs P.C.</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0" id="ixv-13631">San Francisco, California</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c0" id="ixv-13632">199</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="0" id="ixv-13633" unitRef="usd">990023</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="0" id="ixv-13634" unitRef="usd">23617733</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c3" decimals="0" id="ixv-13635" unitRef="usd">33736091</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c3" decimals="0" id="ixv-13636" unitRef="usd">1544213</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="c4" decimals="0" id="ixv-13637" unitRef="usd">1222891</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c3" decimals="0" id="ixv-13638" unitRef="usd">2039655</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="0" id="ixv-13639" unitRef="usd">150241</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="0" id="ixv-13640" unitRef="usd">1518430</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="0" id="ixv-13641" unitRef="usd">592090</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="0" id="ixv-13642" unitRef="usd">39828412</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c4" decimals="0" id="ixv-13643" unitRef="usd">25582955</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="0" id="ixv-13644" unitRef="usd">3268196</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="0" id="ixv-13645" unitRef="usd">2319402</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c3" decimals="0" id="ixv-13646" unitRef="usd">5971800</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c4" decimals="0" id="ixv-13647" unitRef="usd">297918</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="0" id="ixv-13648" unitRef="usd">466223</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c4" decimals="0" id="ixv-13649" unitRef="usd">1895074</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:SecurityDeposit contextRef="c3" decimals="0" id="ixv-13650" unitRef="usd">518584</us-gaap:SecurityDeposit>
    <us-gaap:Assets contextRef="c3" decimals="0" id="ixv-13651" unitRef="usd">50053215</us-gaap:Assets>
    <us-gaap:Assets contextRef="c4" decimals="0" id="ixv-13652" unitRef="usd">30095349</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c3" decimals="0" id="ixv-13653" unitRef="usd">217439</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c4" decimals="0" id="ixv-13654" unitRef="usd">247778</us-gaap:AccountsPayableCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c3" decimals="0" id="ixv-13655" unitRef="usd">1658015</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c4" decimals="0" id="ixv-13656" unitRef="usd">769180</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c3" decimals="0" id="ixv-13657" unitRef="usd">2615734</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c4" decimals="0" id="ixv-13658" unitRef="usd">2105036</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c3" decimals="0" id="ixv-13659" unitRef="usd">312365</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c4" decimals="0" id="ixv-13660" unitRef="usd">317344</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="0" id="ixv-13661" unitRef="usd">4803553</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c4" decimals="0" id="ixv-13662" unitRef="usd">3439338</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c3" decimals="0" id="ixv-13663" unitRef="usd">6495256</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c4" decimals="0" id="ixv-13664" unitRef="usd">27703927</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities contextRef="c3" decimals="0" id="ixv-13665" unitRef="usd">11298809</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c4" decimals="0" id="ixv-13666" unitRef="usd">31143265</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="5"
      id="ixv-13667"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c4"
      decimals="5"
      id="ixv-13668"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c3"
      decimals="0"
      id="ixv-13669"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c4"
      decimals="0"
      id="ixv-13670"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c3"
      decimals="0"
      id="ixv-13671"
      unitRef="shares">7974380</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="0"
      id="ixv-13672"
      unitRef="shares">7974380</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c4"
      decimals="0"
      id="ixv-13673"
      unitRef="shares">199110</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c4"
      decimals="0"
      id="ixv-13674"
      unitRef="shares">199110</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c3" decimals="0" id="ixv-13675" unitRef="usd">80</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c4" decimals="0" id="ixv-13676" unitRef="usd">2</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c3" decimals="0" id="ixv-13677" unitRef="usd">255576797</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c4" decimals="0" id="ixv-13678" unitRef="usd">192305280</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="0" id="ixv-13679" unitRef="usd">-216822471</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="0" id="ixv-13680" unitRef="usd">-193353198</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="0" id="ixv-13681" unitRef="usd">38754406</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" id="ixv-13682" unitRef="usd">-1047916</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="0" id="ixv-13683" unitRef="usd">50053215</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c4" decimals="0" id="ixv-13684" unitRef="usd">30095349</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="0" id="ixv-13685" unitRef="usd">218976</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c5" decimals="0" id="ixv-13686" unitRef="usd">368138</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c0" decimals="0" id="ixv-13687" unitRef="usd">135749</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c5" decimals="0" id="ixv-13688" unitRef="usd">535708</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" id="ixv-13689" unitRef="usd">12468687</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" id="ixv-13690" unitRef="usd">11259641</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="0" id="ixv-13691" unitRef="usd">13302781</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c5" decimals="0" id="ixv-13692" unitRef="usd">11400864</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c0" decimals="0" id="ixv-13693" unitRef="usd">25907217</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c5" decimals="0" id="ixv-13694" unitRef="usd">23196213</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="0" id="ixv-13695" unitRef="usd">-25688241</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c5" decimals="0" id="ixv-13696" unitRef="usd">-22828075</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c0" decimals="0" id="ixv-13697" unitRef="usd">197429</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c5" decimals="0" id="ixv-13698" unitRef="usd">-1117546</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <cyngn:WarrantLiabilityIssuanceCosts contextRef="c5" decimals="0" id="ixv-13699" unitRef="usd">-1739148</cyngn:WarrantLiabilityIssuanceCosts>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="0" id="ixv-13700" unitRef="usd">-1136677</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c5" decimals="0" id="ixv-13701" unitRef="usd">5359780</us-gaap:FairValueAdjustmentOfWarrants>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c5" decimals="0" id="ixv-13702" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c0" decimals="0" id="ixv-13703" unitRef="usd">884862</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c5" decimals="0" id="ixv-13704" unitRef="usd">53117</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c0" decimals="0" id="ixv-13705" unitRef="usd">2218968</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c5" decimals="0" id="ixv-13706" unitRef="usd">-10507504</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ixv-13707" unitRef="usd">-23469273</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" id="ixv-13708" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-13709"
      unitRef="usdPershares">-5.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-13710"
      unitRef="usdPershares">-5.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c5"
      decimals="2"
      id="ixv-13711"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c5"
      decimals="2"
      id="ixv-13712"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-13713"
      unitRef="shares">4540481</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-13714"
      unitRef="shares">4540481</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c5"
      decimals="0"
      id="ixv-13715"
      unitRef="shares">13221</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c5"
      decimals="0"
      id="ixv-13716"
      unitRef="shares">13221</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding
      contextRef="c7"
      decimals="INF"
      id="ixv-13717"
      unitRef="shares">5147</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="0" id="ixv-13718" unitRef="usd">170652808</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="0" id="ixv-13719" unitRef="usd">-160017619</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c10" decimals="0" id="ixv-13720" unitRef="usd">10635189</us-gaap:StockholdersEquity>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c5" decimals="0" id="ixv-13721" unitRef="usd">138572</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c12"
      decimals="INF"
      id="ixv-13722"
      unitRef="shares">4275</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c13" decimals="0" id="ixv-13723" unitRef="usd">6789427</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c5" decimals="0" id="ixv-13724" unitRef="usd">6789427</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c12"
      decimals="INF"
      id="ixv-13725"
      unitRef="shares">11</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c13" decimals="0" id="ixv-13726" unitRef="usd">597</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="c5" decimals="0" id="ixv-13727" unitRef="usd">597</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c5" decimals="0" id="ixv-13728" unitRef="usd">1864594</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c12"
      decimals="INF"
      id="ixv-13729"
      unitRef="shares">189677</cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c12" decimals="0" id="ixv-13730" unitRef="usd">2</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c13" decimals="0" id="ixv-13731" unitRef="usd">12414451</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c5" decimals="0" id="ixv-13732" unitRef="usd">12414453</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c13" decimals="0" id="ixv-13733" unitRef="usd">2449191</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c5" decimals="0" id="ixv-13734" unitRef="usd">2449191</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c14" decimals="0" id="ixv-13735" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" id="ixv-13736" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c16"
      decimals="INF"
      id="ixv-13737"
      unitRef="shares">199110</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="0" id="ixv-13738" unitRef="usd">2</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c17" decimals="0" id="ixv-13739" unitRef="usd">192305280</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c18" decimals="0" id="ixv-13740" unitRef="usd">-193353198</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c4" decimals="0" id="ixv-13741" unitRef="usd">-1047916</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c20"
      decimals="INF"
      id="ixv-13742"
      unitRef="shares">935114</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c20" decimals="0" id="ixv-13743" unitRef="usd">10</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c21" decimals="0" id="ixv-13744" unitRef="usd">5472691</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="0" id="ixv-13745" unitRef="usd">5472701</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20"
      decimals="INF"
      id="ixv-13746"
      unitRef="shares">15</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering contextRef="c21" decimals="0" id="ixv-13747" unitRef="usd">7634428</cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering>
    <cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering contextRef="c0" decimals="0" id="ixv-13748" unitRef="usd">7634428</cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20"
      decimals="INF"
      id="ixv-13749"
      unitRef="shares">1552796</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c20" decimals="0" id="ixv-13750" unitRef="usd">16</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c21" decimals="0" id="ixv-13751" unitRef="usd">18931781</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="0" id="ixv-13752" unitRef="usd">18931797</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c20"
      decimals="INF"
      id="ixv-13753"
      unitRef="shares">5287345</cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c20" decimals="0" id="ixv-13754" unitRef="usd">52</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c21" decimals="0" id="ixv-13755" unitRef="usd">29611625</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering contextRef="c0" decimals="0" id="ixv-13756" unitRef="usd">29611677</cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c21" decimals="0" id="ixv-13757" unitRef="usd">1620992</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="c0" decimals="0" id="ixv-13758" unitRef="usd">1620992</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c22" decimals="0" id="ixv-13759" unitRef="usd">-23469273</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ixv-13760" unitRef="usd">-23469273</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c24"
      decimals="INF"
      id="ixv-13761"
      unitRef="shares">7974380</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="0" id="ixv-13762" unitRef="usd">80</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="0" id="ixv-13763" unitRef="usd">255576797</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="0" id="ixv-13764" unitRef="usd">-216822471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="0" id="ixv-13765" unitRef="usd">38754406</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ixv-13766" unitRef="usd">-23469273</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" id="ixv-13767" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c0" decimals="0" id="ixv-13768" unitRef="usd">1189794</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c5" decimals="0" id="ixv-13769" unitRef="usd">669409</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="0" id="ixv-13770" unitRef="usd">1620992</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c5" decimals="0" id="ixv-13771" unitRef="usd">2449191</us-gaap:ShareBasedCompensation>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c0" decimals="0" id="ixv-13772" unitRef="usd">85117</us-gaap:RealizedInvestmentGainsLosses>
    <cyngn:AccretionOnShorttermInvestments contextRef="c0" decimals="0" id="ixv-13773" unitRef="usd">776163</cyngn:AccretionOnShorttermInvestments>
    <cyngn:AccretionOnShorttermInvestments contextRef="c5" decimals="0" id="ixv-13774" unitRef="usd">113072</cyngn:AccretionOnShorttermInvestments>
    <us-gaap:GainLossOnSaleOfOtherAssets contextRef="c0" decimals="0" id="ixv-13775" unitRef="usd">-16607</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:AssetImpairmentCharges contextRef="c5" decimals="0" id="ixv-13776" unitRef="usd">118831</us-gaap:AssetImpairmentCharges>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="0" id="ixv-13777" unitRef="usd">-1136677</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c5" decimals="0" id="ixv-13778" unitRef="usd">5359780</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:RecapitalizationCosts contextRef="c0" decimals="0" id="ixv-13779" unitRef="usd">1425689</us-gaap:RecapitalizationCosts>
    <cyngn:WarrantLiabilityIssuanceCosts contextRef="c5" decimals="0" id="ixv-13780" unitRef="usd">-1739148</cyngn:WarrantLiabilityIssuanceCosts>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c5" decimals="0" id="ixv-13781" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c5" decimals="0" id="ixv-13782" unitRef="usd">1177174</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c0" decimals="0" id="ixv-13783" unitRef="usd">321322</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c5" decimals="0" id="ixv-13784" unitRef="usd">452006</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="0" id="ixv-13785" unitRef="usd">1889414</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c5" decimals="0" id="ixv-13786" unitRef="usd">150241</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c0" decimals="0" id="ixv-13787" unitRef="usd">1421910</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c5" decimals="0" id="ixv-13788" unitRef="usd">44035</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c0" decimals="0" id="ixv-13789" unitRef="usd">-30339</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c5" decimals="0" id="ixv-13790" unitRef="usd">50815</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c0" decimals="0" id="ixv-13791" unitRef="usd">888834</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c5" decimals="0" id="ixv-13792" unitRef="usd">-667680</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c0" decimals="0" id="ixv-13793" unitRef="usd">411643</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c5" decimals="0" id="ixv-13794" unitRef="usd">1658037</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="0" id="ixv-13795" unitRef="usd">-23576656</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="0" id="ixv-13796" unitRef="usd">-19196081</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="0" id="ixv-13797" unitRef="usd">1230536</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c5" decimals="0" id="ixv-13798" unitRef="usd">1051481</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c0" decimals="0" id="ixv-13799" unitRef="usd">29061</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c5" decimals="0" id="ixv-13800" unitRef="usd">954229</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c5" decimals="0" id="ixv-13801" unitRef="usd">265940</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c0" decimals="0" id="ixv-13802" unitRef="usd">87387311</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c5" decimals="0" id="ixv-13803" unitRef="usd">7562761</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c0" decimals="0" id="ixv-13804" unitRef="usd">54512501</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c5" decimals="0" id="ixv-13805" unitRef="usd">12237761</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="0" id="ixv-13806" unitRef="usd">-34134407</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c5" decimals="0" id="ixv-13807" unitRef="usd">2935230</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts contextRef="c0" decimals="0" id="ixv-13808" unitRef="usd">5472701</cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts>
    <cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts contextRef="c5" decimals="0" id="ixv-13809" unitRef="usd">6789427</cyngn:ProceedsFromAtthemarketEquityFinancingNetOfIssuanceCosts>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu contextRef="c0" decimals="0" id="ixv-13810" unitRef="usd">29611677</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu contextRef="c5" decimals="0" id="ixv-13811" unitRef="usd">13811014</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefu>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant contextRef="c0" decimals="0" id="ixv-13812" unitRef="usd">-1025</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c5" decimals="0" id="ixv-13813" unitRef="usd">18260852</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c5" decimals="0" id="ixv-13814" unitRef="usd">1801265</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfNotesPayable contextRef="c5" decimals="0" id="ixv-13815" unitRef="usd">4375000</us-gaap:RepaymentsOfNotesPayable>
    <cyngn:IssuanceCostsForStockDividendAndRestrictedStockUnits contextRef="c5" decimals="0" id="ixv-13816" unitRef="usd">597</cyngn:IssuanceCostsForStockDividendAndRestrictedStockUnits>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="0" id="ixv-13817" unitRef="usd">35083353</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c5" decimals="0" id="ixv-13818" unitRef="usd">36286961</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c0" decimals="0" id="ixv-13819" unitRef="usd">-22627710</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c5" decimals="0" id="ixv-13820" unitRef="usd">20026110</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="0" id="ixv-13821" unitRef="usd">23617733</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c10" decimals="0" id="ixv-13822" unitRef="usd">3591623</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="0" id="ixv-13823" unitRef="usd">990023</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="0" id="ixv-13824" unitRef="usd">23617733</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <cyngn:AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation contextRef="c0" decimals="0" id="ixv-13825" unitRef="usd">6589332</cyngn:AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation>
    <cyngn:AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses contextRef="c0" decimals="0" id="ixv-13826" unitRef="usd">1875</cyngn:AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c0" id="ixv-6291">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;1. Description of Business&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cyngn Inc., together with its subsidiary (collectively,
&#x201c;Cyngn&#x201d; or the &#x201c;Company&#x201d;), was incorporated in Delaware in 2013. Our wholly owned subsidiary, Cyngn Singapore
PTE. LTD., is a Singaporean limited company organized in 2015. The Company is headquartered in Mountain View, CA.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cyngn develops and deploys scalable, differentiated
autonomous vehicle technology for industrial organizations. Our full-stack autonomous driving software, (&#x201c;DriveMod&#x201d;), can
be integrated onto vehicles manufactured by Original Equipment Manufacturers (&#x201c;OEM&#x201d;) by integration directly into vehicle
assembly. The Enterprise Autonomy Suite (&#x201c;EAS&#x201d;) is designed to be compatible with sensors and components from leading hardware
technology providers and integrate our proprietary Autonomous Vehicle (&#x201c;AV&#x201d;) software to produce differentiated autonomous
vehicles.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has been operating autonomous vehicles
in production environments and in 2023 began licensing EAS commercially. Built and tested in difficult and diverse real-world environments,
DriveMod, the fleet management system and our proprietary Software Development Kit (&#x201c;DriveMod Kit&#x201d;) combine to create a full-stack
advanced autonomy solution designed to be modular, extendable, and safe. The Company operates in one business segment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 25, 2024, the Company&#x2019;s stockholders
voted to authorize the Company&#x2019;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company&#x2019;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024. On January 30, 2025, the
Company&#x2019;s stockholders voted to authorize the Company&#x2019;s Board of Directors to effect a reverse stock split of the outstanding
shares of common stock within a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company&#x2019;s Board of Directors determined
to effect the reverse stock split of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February
18, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All share and per share amounts and exercise prices
of stock options and warrants in the accompanying consolidated financial statements and notes to the consolidated financial statements
have been retroactively adjusted to reflect the reverse stock splits for all periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has incurred losses from operations
since inception. The Company incurred net losses of approximately $23.5 million and $33.3 million for the years ended December 31, 2025
and 2024, respectively. Accumulated deficit amounted to approximately $216.8 million and $193.4 million as of December 31, 2025 and December
31, 2024, respectively. Net cash used in operating activities was approximately $23.6 million and $19.2 million for the year ended December
31, 2025 and 2024, respectively.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s liquidity is based on its
ability to increase its operating cash flow position, obtain capital financing from equity interest investors and borrow money to fund
its general operations, research and development activities, and capital expenditures. As of December 31, 2025, the Company&#x2019;s unrestricted
cash and cash equivalents balance was approximately $1.0 million and short-term investments of approximately $33.7 million. As of December
31, 2024, the Company&#x2019;s cash and cash equivalents balance was approximately $23.6 million and no short-terms investments.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Based on cash flow projections from operating,
investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the
Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations and related
commitments for the 12 months following the date these consolidated financial statements were issued.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c27" id="ixv-13827">1-for-5</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c28" id="ixv-13828">1-for-100</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c29" id="ixv-13829">1-for-100</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c30" id="ixv-13830">1-for-5</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c31" id="ixv-13831">1-for-150</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c32" id="ixv-13832">1-for-150</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" id="ixv-13833" unitRef="usd">-23500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-5" id="ixv-13834" unitRef="usd">-33300000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-5" id="ixv-13835" unitRef="usd">-216800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c4" decimals="-5" id="ixv-13836" unitRef="usd">-193400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-5" id="ixv-13837" unitRef="usd">-23600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="-5" id="ixv-13838" unitRef="usd">-19200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cyngn:UnrestrictedCashBalance contextRef="c3" decimals="-5" id="ixv-13839" unitRef="usd">1000000</cyngn:UnrestrictedCashBalance>
    <us-gaap:ShortTermInvestments contextRef="c3" decimals="-5" id="ixv-13840" unitRef="usd">33700000</us-gaap:ShortTermInvestments>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c4" decimals="-5" id="ixv-13841" unitRef="usd">23600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-6329">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;2. Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial statements
as of and for the years ended December 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted
in the United States (&#x201c;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).
The consolidated financial statements include all normal adjustments necessary for a fair presentation of the Company&#x2019;s financial
position at December 31, 2025 and 2024, and operating results and cash flows for the periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The functional and reporting currency for Cyngn
is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar
at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated
at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the consolidated
financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of consolidated financial statements
in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported
amounts of revenue and expenses during the reporting period. The Company&#x2019;s significant estimates and judgments include but are not
limited to internal-use software, warrants and share-based compensation. Management bases its estimates on historical experience and on
various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. Actual results could differ from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain prior period balances for the consolidated
financial statement for December 31, 2024 have been reclassified to conform with the current year presentation. These reclassifications
relate to inventory and accounts and other receivables that were previously presented as prepaid expenses and other current assets, as
well as deferred revenue that was previously presented as accrued expenses and other current liabilities. These reclassifications had
no impact on previously reported net loss, total assets, or total shareholders&#x2019; equity.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times
exceeds federally insured limits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cash maintained with domestic financial institutions
generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its
deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Supplier Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company generally utilizes suppliers for outside
development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of December
31, 2025 and December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Short-term Investments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers its bank accounts and all highly liquid investments
that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of December
31, 2025 and December 31, 2024, the Company had approximately $1.0 million of cash and $33.7 million in short-term investments and $23.6
million of cash and no short-term investments, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers short-term investments to include marketable
U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government
treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;)
Accounting Standards Codification Topic (&#x201c;ASC&#x201d;) 320, Investments - Debt and Equity Securities&lt;i&gt;,&lt;/i&gt; and recorded these securities
at amortized cost on the accompanying consolidated balance sheets as of December 31, 2025 and December 31, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Accounts and Other Receivable &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts receivables are recorded at the invoiced
amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status
of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was zero as of December 31,
2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic
conditions in order to determine expected trade credit losses on a prospective basis. &lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-80"&gt;No&lt;/span&gt;&lt;/span&gt; credit losses were recorded as of December 31,
2025 and December 31, 2024. Other receivables primarily consist of Employee Retention Credit (&#x201c;ERC&#x201d;) claims related to 2020
and 2021.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting guidance under ASC Topic 820, Fair
Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major
asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price
representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company uses the following fair value hierarchy
prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 1-Unadjusted quoted prices in
active markets for identical assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 2-Observable inputs other than
Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 3-Unobservable inputs that are
supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities are considered to be fair
valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily
result in a change in the amount recorded on the consolidated balance sheets, assets and liabilities are considered to be fair valued
on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of
cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value
on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon
initial recognition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of the Company&#x2019;s cash
and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company&#x2019;s
share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models
derived from independent external valuations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory consists of autonomous vehicle units, including tuggers equipped with DriveMod Kits (&#x201c;DMKs&#x201d;), which are integrated
with the Company&#x2019;s proprietary Enterprise Autonomy Suite (&#x201c;EAS&#x201d;) software and sold to customers as part of a fully integrated
autonomous vehicle solution. Substantially all assembly and integration activities are performed by third-party suppliers prior to receipt;
therefore, the Company classifies its inventory as finished goods and does not maintain separate classifications for raw materials or
work in process.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, and the Company is able to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;br/&gt;
The Company periodically reviews inventory for excess quantities, obsolescence, or other indicators that the carrying value may not be
recoverable. If the carrying value of inventory exceeds its net realizable value, the Company records a write-down to net realizable value,
with the adjustment recognized in cost of goods sold.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment is stated at cost less
accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the
Company&#x2019;s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date
depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over
each asset&#x2019;s estimated useful life. Repair and maintenance costs are expensed as incurred.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left"&gt;Property and Equipment&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center"&gt;Useful life&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Automobiles (DMV-registered)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Machinery, tools and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Internal-use software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;3 to 5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;7 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-73"&gt;Shorter of 3 years or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Operating Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for leases in accordance with ASC 842, Leases.
All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified
asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance
in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the consolidated
balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office
space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining
term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Costs to Develop Software&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company incurs costs related to internally
developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Internal-Use Software costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determined when to capitalize its
internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the
software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized
based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in
estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing
the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining
the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs,
as well as subscription server and consulting costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Internal-use software is classified as property
and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved
in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and
ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development
phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes
in circumstances occur that could impact the recoverability of these assets. &lt;span style="-sec-ix-hidden: hidden-fact-81"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-82"&gt;No&lt;/span&gt;&lt;/span&gt; impairment charges were associated with the Company&#x2019;s
internal-use software for the years ended December 31, 2025 and 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Costs to Develop Software to be Sold, Leased
or Otherwise Marketed &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for research costs of computer
software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once
technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred
to develop functionality for the Company&#x2019;s software and internally built software platforms, as well as certain upgrades and enhancements
that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility
of a product is established. Management has determined that technological feasibility is established when a working model is complete.
After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation
costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the
product or enhancement is available for general release to customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Computer software to be sold, leased or otherwise
marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount
computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that
product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated
economic life of the product, not to exceed three years to five years and recorded as cost of revenue.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025, management
completed a review of the Company&#x2019;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result, the Company revised its estimate regarding the point at
which technological feasibility is achieved for software development activities. This change in estimate was made to reflect management&#x2019;s
current expectations about the timing and certainty of future technological milestones.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The change in estimate was accounted for prospectively in accordance
with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements. For the
year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally capitalized in 2024 and $1.2
million related to costs capitalized during the first two quarters of 2025 as research and development expense resulting from this change.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Long-Lived Assets and Finite Lived Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has finite-lived intangible assets
consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives.
The patents and trademarks are amortized over 15 years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews its long-lived assets and
finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant
adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation
of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The
Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted
cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term
undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being
evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the
asset.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also identified that the long-lived
asset &#x201c;Patents&#x201d;, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and
identified expired international patent applications (&#x201c;expired assets&#x201d;) for the year ended December 31, 2024. The Company
determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying
value was set to its salvage value which is zero given no future cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2024, the Company
determined the existence of an impairment associated with the Company&#x2019;s intangible asset &#x201c;Patents&#x201d; and accordingly recorded
an impairment charge of $118,831 (see Note 6. Intangible Assets). For the year ended December 31, 2025, there were &lt;span style="-sec-ix-hidden: hidden-fact-83"&gt;no&lt;/span&gt; impairment charges.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes using the
asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A valuation allowance is provided when it is more
likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#x2019;s lack of earnings history,
the net deferred tax assets have been fully offset by a valuation allowance as of December 31, 2025 and December 31, 2024 (see Note 11.
Income Taxes).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no uncertain tax positions that would
require recognition in the consolidated financial statements. If the Company were to incur an income tax liability in the future, interest
on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management&#x2019;s
conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of
or changes in tax laws, regulations and interpretations thereof as well as other factors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 expands the annual disclosure
requirements for income taxes, primarily related to the rate reconciliation and income taxes paid. The Company has adopted this guidance
on a prospective basis, which did not have a significant impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company issued to its lead underwriter in
the Company&#x2019;s IPO warrants to purchase up to 9 shares of the Company&#x2019;s common stock. In addition, the Company issued 426 common
stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants
as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also applied the guidance in ASC 340-10-S99-1, Other Assets
and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities
may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as
directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;The Company issued Series A warrants and Series B warrants in connection
with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company&#x2019;s warrant
agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable.
The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in
consideration of the variable number of the issuer&#x2019;s equity shares in the warrant agreements. The resulting warrant liabilities
are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company&#x2019;s
consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and
the number of equity shares are now fixed. The Company concluded that these warrants are indexed to the Company&#x2019;s own stock, require
settlement in a fixed number of shares, and do not contain provisions that could require net cash settlement or settlement in a variable
number of shares. Additionally, the warrant agreements do not include provisions that would require the Company to transfer assets. Accordingly,
the warrants meet the criteria for equity classification. Therefore, in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification
of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants
are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the
Black Scholes model immediately before exercise and were fully exercised in February 2025 (see Note 7. Capital Structure).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes the cost of share-based
awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line
basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost
and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair
value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price
volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation
Expense&lt;b&gt;)&lt;/b&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Net Loss Per Share Attributable to Common Stockholders&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company computes loss per share attributable
to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding.
Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised
into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only
if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see
Note 8. Net Loss per Share Attributable to Common Stockholders).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Research and Development Expense&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research and development expenses consists primarily
of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company
personnel involved in the development of the Company&#x2019;s products and services, and allocated lease costs based on the approximate
square footage area used in research and development activities. Research and development costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;General and Administrative Expense&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;General and administrative expense consist primarily of personnel costs,
facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance
with ASC 720-35, Other Expense - Advertising Costs, other than trade show expenses which are deferred until occurrence of the future event.
&lt;i&gt;&#160;&lt;/i&gt;Advertising costs for the years ended December 31, 2025 and 2024 were $512,017 and $237,396, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes a liability with regard to loss contingencies
when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of
loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount
within the range is a better estimate than any other amount the Company accrues the minimum amount in the range (see Note 12. Commitments
and Contingencies).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company operates as one operating segment.
The Company&#x2019;s &lt;span style="-sec-ix-hidden: hidden-fact-78"&gt;chief operating decision maker&lt;/span&gt; is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources, making
operating decisions and evaluating financial performance.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The one operating segment generates revenues from
subscriptions to its Enterprise Autonomy Service (&#x201c;EAS&#x201d;), product sales or leases of hardware, and other professional services
(i.e., deployment costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent
phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod
software, and demonstrations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the Company&#x2019;s one segment, the executive
management team use revenue and net loss to allocate resources, both reported on the Consolidated Statement of Operations as Revenue and
Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to
evaluate the Company&#x2019;s performance, establish compensation, monitor budget versus actual results, and decide the level of investment
in various operating activities and other capital allocation activities. The measure of segment assets is reported on the Consolidated
Balance Sheet as Total assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for revenue in accordance
with ASC 606, Revenue from Contracts with Customers. &lt;span style="font-style: normal; font-weight: normal"&gt;The Company generates revenue
from vehicle units, including tuggers equipped with DriveMod Kits (&#x201c;DMKs&#x201d;), which are integrated with the Company&#x2019;s
proprietary Enterprise Autonomy Suite (&#x201c;EAS&#x201d;) software, or leases of hardware, and other professional services. These offerings
are highly interdependent and integrated to provide customers with a fully functional autonomous industrial vehicle solution. Because
these components are not separately identifiable from one another in the context of the contract, the Company accounts for these combined
goods and services as a single performance obligation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;General Recognition Principle.&lt;/i&gt; The Company
recognizes revenue when control of the combined autonomous vehicle and software solution is transferred to the customer in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for the goods and services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Method of Measuring Progress. &lt;/i&gt;Revenue associated
with the Company&#x2019;s integrated autonomous vehicle solution is generally recognized over time because the customer simultaneously
receives and consumes the benefits provided by the Company&#x2019;s performance as the services are performed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company measures progress toward satisfaction
of the performance obligation using an output method based on the passage of time, recognizing revenue ratably over the contractual term,
which is typically three years. In accordance with ASC 606-10-55-17 through 55-18, the output method reflects the pattern in which control
of the promised goods and services is delivered to the customer, who receives continuous access to the integrated autonomous vehicle functionality,
including the software-enabled operation, monitoring, updates, and support necessary for the system to function as intended.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management believes that recognizing revenue on
a straight-line basis over the contract period faithfully depicts the Company&#x2019;s performance in transferring control of the integrated
solution, as the customer receives and consumes the benefits of the solution evenly throughout the contract term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Payment Terms.&lt;/i&gt; Payment terms vary by customer
and contract but generally do not exceed 90 days.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Discounts.&lt;/i&gt; The Company may offer pricing
discounts to certain customers, primarily to establish relationships with new customers. These discounts are reflected in the contractual
transaction price at contract inception. Revenue is recognized based on the discounted contract price and is accounted for in the same
manner as other contracts. The Company recognizes revenue from these arrangements ratably over the contract term, consistent with the
pattern in which the customer receives and consumes the benefits of the integrated autonomous vehicle solution.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Stand-Alone Selling prices&lt;/i&gt;. The Company
also applies judgment in estimating stand-alone selling prices when allocating the transaction price to performance obligations. Stand-alone
selling prices are generally determined based on observable prices when available or, when not directly observable, are estimated using
management&#x2019;s assessment of expected pricing for similar goods and services and market conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Material Rights and Renewal Options.&lt;/i&gt; The Company&#x2019;s contracts
with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material
right, and therefore represent a separate performance obligation, requires judgment. The Company evaluates the pricing of each option
to determine whether it reflects the stand-alone selling price for the underlying goods or services or whether it provides the customer
with a discount that would not be available without entering into the initial contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In certain legacy customer contracts, the Company
has provided customers with the option to extend the contract term for an additional one-year period. Management evaluates these renewal
provisions to determine whether they provide a material right by comparing the renewal pricing to the expected stand-alone selling price
of the services at the time of renewal. This assessment requires judgment and includes consideration of expected pricing for similar services,
historical pricing practices, and market conditions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;If a material right exists, the Company allocates a portion of the
transaction price to the option and recognizes the related revenue when the option is exercised or expires.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Significant financing component.&lt;/i&gt; In certain
arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company&#x2019;s
contracts with customer prepayment terms do not include a significant financing component because the prepayment terms are designed to
provide customers with contractual protections and billing convenience, not to provide financing to the customer or receive financing
from the customer.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Contract modifications. &lt;/i&gt;The Company may modify contracts to
offer customers additional products or services. Each of the additional products and services is evaluated to determine whether it is
distinct from the goods or services transferred prior to the modification. The Company evaluates whether the contract price for the additional
products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these
cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification
does not reflect the stand-alone selling price for the modified goods or services, the Company accounts for the modification either (i)
on a prospective basis if the remaining goods and services are distinct from those already transferred, or (ii) on a cumulative catch-up
basis if the remaining goods and services are not distinct from those already transferred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Principal vs. Agent Considerations&lt;/i&gt;. Judgment
is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation
of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., &#x201c;gross&#x201d;),
or we arrange for other parties to provide the service to the end-user and are an agent (i.e., &#x201c;net&#x201d;). In making this determination,
the Company considers several factors, including whether the Company is primarily responsible for fulfilling the promise to provide the
specified goods or services, bears inventory risk before the goods are transferred, and has discretion in establishing pricing for the
specified goods or services. This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts
and promotions offered to end-users to the extent they are not customers.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In dealer transactions where the Company&#x2019;s
role is to supply hardware to the dealer, the Company does not obtain control of the hardware before it is transferred to the end-user
and is not primarily responsible for the dealer&#x2019;s fulfillment to end-users. Accordingly, hardware revenue in these arrangements
is recorded on a net basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In dealer and OEM transactions where our role
is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription
revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Cost to Obtain a Contract. &lt;/i&gt;The Company capitalizes incremental
costs incurred to obtain contracts, principally sales commissions and third-party referral fees. These costs are amortized on a straight-line
basis over the contractual term and recognized in general and administrative expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Costs to Fulfill a Contract&lt;/i&gt;. The Company capitalizes such costs
when they are (i) incremental to obtaining that specific contract, (ii) expected to be recovered, and (iii) subject to an amortization
period exceeding one year. Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which
corresponds to the contractual term, and are recognized in cost of revenue. The Company evaluates capitalized fulfillment costs for impairment
at each reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;Deferred contract costs totaled $767,007 and $120,793 as of December
31, 2025 and 2024, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. Amortization
of deferred contract costs recognized in cost of revenue during the years ended December 31, 2025 and 2024 was $106,480 and $21,413, respectively.
No impairment losses were recognized in either period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Taxes collected from customers&lt;/i&gt;. The Company
collects and remits certain taxes assessed by governmental authorities on its revenue transactions, including sales, use, value-added,
and excise taxes. These taxes are presented on a net basis and excluded from reported revenue. Shipping and handling fees billed to customers
are included in net sales; the related costs are included in cost of revenue.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Judgments and estimates. &lt;/i&gt;Accounting for contracts recognized over time requires judgment in
estimating the transaction price, the measure of progress, and expected contract costs. Due to uncertainties
inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the
near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Below 10%&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There was $209,452 from these customers in accounts
receivable as of December 31, 2025 and $274,699 from these customers in accounts receivable as of December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cost of Revenue &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost of revenue consists primarily of direct labor
and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the
contracts and hardware costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Disaggregation
of Income Statement Expenses,&#x201d; which requires the disaggregated disclosure of certain income statement items. ASU 2024-03 is effective
for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted.
The Company has not adopted this standard early and is currently evaluating the impact of this amendment on its consolidated financial
statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-6333">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial statements
as of and for the years ended December 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted
in the United States (&#x201c;GAAP&#x201d;) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;).
The consolidated financial statements include all normal adjustments necessary for a fair presentation of the Company&#x2019;s financial
position at December 31, 2025 and 2024, and operating results and cash flows for the periods presented.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-6341">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-6349">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Foreign Currency Translation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The functional and reporting currency for Cyngn
is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar
at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated
at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the consolidated
financial statements.&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-6361">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of consolidated financial statements
in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported
amounts of revenue and expenses during the reporting period. The Company&#x2019;s significant estimates and judgments include but are not
limited to internal-use software, warrants and share-based compensation. Management bases its estimates on historical experience and on
various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values
of assets and liabilities. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c0" id="ixv-6369">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain prior period balances for the consolidated
financial statement for December 31, 2024 have been reclassified to conform with the current year presentation. These reclassifications
relate to inventory and accounts and other receivables that were previously presented as prepaid expenses and other current assets, as
well as deferred revenue that was previously presented as accrued expenses and other current liabilities. These reclassifications had
no impact on previously reported net loss, total assets, or total shareholders&#x2019; equity.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c0" id="ixv-6379">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially subject
the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times
exceeds federally insured limits.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cash maintained with domestic financial institutions
generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its
deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <cyngn:ConcentrationOfSupplierRiskPolicyTextBlock contextRef="c0" id="ixv-6390">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Supplier Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company generally utilizes suppliers for outside
development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of December
31, 2025 and December 31, 2024.&lt;/p&gt;</cyngn:ConcentrationOfSupplierRiskPolicyTextBlock>
    <cyngn:CashAndShorttermInvestmentsPolicyPolicyTextBlock contextRef="c0" id="ixv-6400">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cash and Short-term Investments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers its bank accounts and all highly liquid investments
that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of December
31, 2025 and December 31, 2024, the Company had approximately $1.0 million of cash and $33.7 million in short-term investments and $23.6
million of cash and no short-term investments, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers short-term investments to include marketable
U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government
treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;)
Accounting Standards Codification Topic (&#x201c;ASC&#x201d;) 320, Investments - Debt and Equity Securities&lt;i&gt;,&lt;/i&gt; and recorded these securities
at amortized cost on the accompanying consolidated balance sheets as of December 31, 2025 and December 31, 2024.&lt;/p&gt;</cyngn:CashAndShorttermInvestmentsPolicyPolicyTextBlock>
    <us-gaap:Cash contextRef="c3" decimals="-5" id="ixv-13842" unitRef="usd">1000000</us-gaap:Cash>
    <us-gaap:ShortTermInvestments contextRef="c3" decimals="-5" id="ixv-13843" unitRef="usd">33700000</us-gaap:ShortTermInvestments>
    <us-gaap:Cash contextRef="c4" decimals="-5" id="ixv-13844" unitRef="usd">23600000</us-gaap:Cash>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c0" id="ixv-6427">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Accounts and Other Receivable &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts receivables are recorded at the invoiced
amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status
of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was zero as of December 31,
2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic
conditions in order to determine expected trade credit losses on a prospective basis. &lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-80"&gt;No&lt;/span&gt;&lt;/span&gt; credit losses were recorded as of December 31,
2025 and December 31, 2024. Other receivables primarily consist of Employee Retention Credit (&#x201c;ERC&#x201d;) claims related to 2020
and 2021.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c3" decimals="0" id="ixv-13845" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c4" decimals="0" id="ixv-13846" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-6437">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting guidance under ASC Topic 820, Fair
Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major
asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price
representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions
that market participants would use in pricing an asset or liability.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company uses the following fair value hierarchy
prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 1-Unadjusted quoted prices in
active markets for identical assets or liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 2-Observable inputs other than
Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs
that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"&gt;Level 3-Unobservable inputs that are
supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities are considered to be fair
valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily
result in a change in the amount recorded on the consolidated balance sheets, assets and liabilities are considered to be fair valued
on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of
cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value
on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon
initial recognition.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of the Company&#x2019;s cash
and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company&#x2019;s
share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models
derived from independent external valuations.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0" id="ixv-6465">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory consists of autonomous vehicle units, including tuggers equipped with DriveMod Kits (&#x201c;DMKs&#x201d;), which are integrated
with the Company&#x2019;s proprietary Enterprise Autonomy Suite (&#x201c;EAS&#x201d;) software and sold to customers as part of a fully integrated
autonomous vehicle solution. Substantially all assembly and integration activities are performed by third-party suppliers prior to receipt;
therefore, the Company classifies its inventory as finished goods and does not maintain separate classifications for raw materials or
work in process.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, and the Company is able to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;br/&gt;
The Company periodically reviews inventory for excess quantities, obsolescence, or other indicators that the carrying value may not be
recoverable. If the carrying value of inventory exceeds its net realizable value, the Company records a write-down to net realizable value,
with the adjustment recognized in cost of goods sold.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0" id="ixv-6495">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment is stated at cost less
accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the
Company&#x2019;s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date
depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over
each asset&#x2019;s estimated useful life. Repair and maintenance costs are expensed as incurred.&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left"&gt;Property and Equipment&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center"&gt;Useful life&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Automobiles (DMV-registered)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Machinery, tools and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Internal-use software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;3 to 5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;7 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-73"&gt;Shorter of 3 years or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <cyngn:ScheduleOfPropertyAndEquipmentTableTextBlock contextRef="c0" id="ixv-13847">Depreciation is recorded on a straight-line basis over
each asset&#x2019;s estimated useful life. Repair and maintenance costs are expensed as incurred.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 70%; font-weight: bold; text-align: left"&gt;Property and Equipment&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 29%; font-weight: bold; text-align: center"&gt;Useful life&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Automobiles (DMV-registered)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Machinery, tools and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Internal-use software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;3 to 5 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;7 years&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-73"&gt;Shorter of 3 years or lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</cyngn:ScheduleOfPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c43" id="ixv-13848">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c44" id="ixv-13849">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c45" id="ixv-13850">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c37" id="ixv-13851">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c38" id="ixv-13852">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c46" id="ixv-13853">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-6538">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Operating Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for leases in accordance with ASC 842, Leases.
All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified
asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance
in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the consolidated
balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office
space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining
term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="c0" id="ixv-6546">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Costs to Develop Software&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company incurs costs related to internally
developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:InternalUseSoftwarePolicy contextRef="c0" id="ixv-6558">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Internal-Use Software costs&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determined when to capitalize its
internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the
software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized
based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in
estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing
the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining
the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs,
as well as subscription server and consulting costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Internal-use software is classified as property
and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved
in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and
ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development
phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes
in circumstances occur that could impact the recoverability of these assets. &lt;span style="-sec-ix-hidden: hidden-fact-81"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-82"&gt;No&lt;/span&gt;&lt;/span&gt; impairment charges were associated with the Company&#x2019;s
internal-use software for the years ended December 31, 2025 and 2024.&lt;/p&gt;</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c33" id="ixv-13854">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c34" id="ixv-13855">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy contextRef="c0" id="ixv-6586">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Costs to Develop Software to be Sold, Leased
or Otherwise Marketed &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for research costs of computer
software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once
technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred
to develop functionality for the Company&#x2019;s software and internally built software platforms, as well as certain upgrades and enhancements
that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility
of a product is established. Management has determined that technological feasibility is established when a working model is complete.
After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation
costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the
product or enhancement is available for general release to customers.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Computer software to be sold, leased or otherwise
marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount
computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that
product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated
economic life of the product, not to exceed three years to five years and recorded as cost of revenue.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025, management
completed a review of the Company&#x2019;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result, the Company revised its estimate regarding the point at
which technological feasibility is achieved for software development activities. This change in estimate was made to reflect management&#x2019;s
current expectations about the timing and certainty of future technological milestones.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The change in estimate was accounted for prospectively in accordance
with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements. For the
year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally capitalized in 2024 and $1.2
million related to costs capitalized during the first two quarters of 2025 as research and development expense resulting from this change.&lt;/p&gt;</us-gaap:SoftwareToBeSoldLeasedOrOtherwiseMarketedPolicy>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c37" id="ixv-13857">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c38" id="ixv-13858">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <cyngn:ResearchAndDevelopmentExpenseIncreaseDecrease contextRef="c0" decimals="-5" id="ixv-13859" unitRef="usd">1400000</cyngn:ResearchAndDevelopmentExpenseIncreaseDecrease>
    <us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease contextRef="c0" decimals="-5" id="ixv-13860" unitRef="usd">1200000</us-gaap:CapitalizedComputerSoftwarePeriodIncreaseDecrease>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0" id="ixv-6606">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Long-Lived Assets and Finite Lived Intangibles&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has finite-lived intangible assets
consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives.
The patents and trademarks are amortized over 15 years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews its long-lived assets and
finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant
adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation
of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The
Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted
cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term
undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being
evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the
asset.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also identified that the long-lived
asset &#x201c;Patents&#x201d;, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and
identified expired international patent applications (&#x201c;expired assets&#x201d;) for the year ended December 31, 2024. The Company
determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying
value was set to its salvage value which is zero given no future cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2024, the Company
determined the existence of an impairment associated with the Company&#x2019;s intangible asset &#x201c;Patents&#x201d; and accordingly recorded
an impairment charge of $118,831 (see Note 6. Intangible Assets). For the year ended December 31, 2025, there were &lt;span style="-sec-ix-hidden: hidden-fact-83"&gt;no&lt;/span&gt; impairment charges.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c3" id="ixv-13861">P15Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AssetImpairmentCharges contextRef="c5" decimals="0" id="ixv-13862" unitRef="usd">118831</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-6639">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes using the
asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A valuation allowance is provided when it is more
likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company&#x2019;s lack of earnings history,
the net deferred tax assets have been fully offset by a valuation allowance as of December 31, 2025 and December 31, 2024 (see Note 11.
Income Taxes).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There are no uncertain tax positions that would
require recognition in the consolidated financial statements. If the Company were to incur an income tax liability in the future, interest
on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management&#x2019;s
conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of
or changes in tax laws, regulations and interpretations thereof as well as other factors.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 expands the annual disclosure
requirements for income taxes, primarily related to the rate reconciliation and income taxes paid. The Company has adopted this guidance
on a prospective basis, which did not have a significant impact on the Company&#x2019;s consolidated financial statements.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <cyngn:CommonStockWarrantsPolicyTextBlock contextRef="c0" id="ixv-6656">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company issued to its lead underwriter in
the Company&#x2019;s IPO warrants to purchase up to 9 shares of the Company&#x2019;s common stock. In addition, the Company issued 426 common
stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants
as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also applied the guidance in ASC 340-10-S99-1, Other Assets
and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities
may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as
directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.&lt;/p&gt;&lt;p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;The Company issued Series A warrants and Series B warrants in connection
with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing
Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company&#x2019;s warrant
agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable.
The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in
consideration of the variable number of the issuer&#x2019;s equity shares in the warrant agreements. The resulting warrant liabilities
are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company&#x2019;s
consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and
the number of equity shares are now fixed. The Company concluded that these warrants are indexed to the Company&#x2019;s own stock, require
settlement in a fixed number of shares, and do not contain provisions that could require net cash settlement or settlement in a variable
number of shares. Additionally, the warrant agreements do not include provisions that would require the Company to transfer assets. Accordingly,
the warrants meet the criteria for equity classification. Therefore, in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification
of Contracts, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants
are included in equity in the consolidated balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the
Black Scholes model immediately before exercise and were fully exercised in February 2025 (see Note 7. Capital Structure).&lt;/p&gt;</cyngn:CommonStockWarrantsPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c39"
      decimals="0"
      id="ixv-13863"
      unitRef="shares">9</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c40"
      decimals="0"
      id="ixv-13864"
      unitRef="shares">426</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c0" id="ixv-6687">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes the cost of share-based
awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line
basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost
and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair
value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price
volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation
Expense&lt;b&gt;)&lt;/b&gt;.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-6700">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Net Loss Per Share Attributable to Common Stockholders&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company computes loss per share attributable
to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding.
Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised
into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only
if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see
Note 8. Net Loss per Share Attributable to Common Stockholders).&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c0" id="ixv-6708">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Research and Development Expense&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research and development expenses consists primarily
of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company
personnel involved in the development of the Company&#x2019;s products and services, and allocated lease costs based on the approximate
square footage area used in research and development activities. Research and development costs are expensed as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c0" id="ixv-6718">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;General and Administrative Expense&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;General and administrative expense consist primarily of personnel costs,
facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance
with ASC 720-35, Other Expense - Advertising Costs, other than trade show expenses which are deferred until occurrence of the future event.
&lt;i&gt;&#160;&lt;/i&gt;Advertising costs for the years ended December 31, 2025 and 2024 were $512,017 and $237,396, respectively.&lt;/p&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c0" decimals="0" id="ixv-13865" unitRef="usd">512017</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c5" decimals="0" id="ixv-13866" unitRef="usd">237396</us-gaap:AdvertisingExpense>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0" id="ixv-6730">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Commitments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes a liability with regard to loss contingencies
when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of
loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount
within the range is a better estimate than any other amount the Company accrues the minimum amount in the range (see Note 12. Commitments
and Contingencies).&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-6742">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company operates as one operating segment.
The Company&#x2019;s &lt;span style="-sec-ix-hidden: hidden-fact-78"&gt;chief operating decision maker&lt;/span&gt; is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources, making
operating decisions and evaluating financial performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The one operating segment generates revenues from
subscriptions to its Enterprise Autonomy Service (&#x201c;EAS&#x201d;), product sales or leases of hardware, and other professional services
(i.e., deployment costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent
phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod
software, and demonstrations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the Company&#x2019;s one segment, the executive
management team use revenue and net loss to allocate resources, both reported on the Consolidated Statement of Operations as Revenue and
Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to
evaluate the Company&#x2019;s performance, establish compensation, monitor budget versus actual results, and decide the level of investment
in various operating activities and other capital allocation activities. The measure of segment assets is reported on the Consolidated
Balance Sheet as Total assets.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="c0" id="ixv-6751">The Company&#x2019;s chief operating decision maker is the executive management team, its Chief Executive Officer and Chief Financial Officer.
The executive management team manages operations and business as one operating segment for the purposes of allocating resources,</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:NumberOfOperatingSegments contextRef="c0" decimals="0" id="ixv-13867" unitRef="pure">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c0" id="ixv-6777">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for revenue in accordance
with ASC 606, Revenue from Contracts with Customers. &lt;span style="font-style: normal; font-weight: normal"&gt;The Company generates revenue
from vehicle units, including tuggers equipped with DriveMod Kits (&#x201c;DMKs&#x201d;), which are integrated with the Company&#x2019;s
proprietary Enterprise Autonomy Suite (&#x201c;EAS&#x201d;) software, or leases of hardware, and other professional services. These offerings
are highly interdependent and integrated to provide customers with a fully functional autonomous industrial vehicle solution. Because
these components are not separately identifiable from one another in the context of the contract, the Company accounts for these combined
goods and services as a single performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;General Recognition Principle.&lt;/i&gt; The Company
recognizes revenue when control of the combined autonomous vehicle and software solution is transferred to the customer in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for the goods and services.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Method of Measuring Progress. &lt;/i&gt;Revenue associated
with the Company&#x2019;s integrated autonomous vehicle solution is generally recognized over time because the customer simultaneously
receives and consumes the benefits provided by the Company&#x2019;s performance as the services are performed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company measures progress toward satisfaction
of the performance obligation using an output method based on the passage of time, recognizing revenue ratably over the contractual term,
which is typically three years. In accordance with ASC 606-10-55-17 through 55-18, the output method reflects the pattern in which control
of the promised goods and services is delivered to the customer, who receives continuous access to the integrated autonomous vehicle functionality,
including the software-enabled operation, monitoring, updates, and support necessary for the system to function as intended.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management believes that recognizing revenue on
a straight-line basis over the contract period faithfully depicts the Company&#x2019;s performance in transferring control of the integrated
solution, as the customer receives and consumes the benefits of the solution evenly throughout the contract term.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Payment Terms.&lt;/i&gt; Payment terms vary by customer
and contract but generally do not exceed 90 days.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Discounts.&lt;/i&gt; The Company may offer pricing
discounts to certain customers, primarily to establish relationships with new customers. These discounts are reflected in the contractual
transaction price at contract inception. Revenue is recognized based on the discounted contract price and is accounted for in the same
manner as other contracts. The Company recognizes revenue from these arrangements ratably over the contract term, consistent with the
pattern in which the customer receives and consumes the benefits of the integrated autonomous vehicle solution.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Stand-Alone Selling prices&lt;/i&gt;. The Company
also applies judgment in estimating stand-alone selling prices when allocating the transaction price to performance obligations. Stand-alone
selling prices are generally determined based on observable prices when available or, when not directly observable, are estimated using
management&#x2019;s assessment of expected pricing for similar goods and services and market conditions.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Material Rights and Renewal Options.&lt;/i&gt; The Company&#x2019;s contracts
with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material
right, and therefore represent a separate performance obligation, requires judgment. The Company evaluates the pricing of each option
to determine whether it reflects the stand-alone selling price for the underlying goods or services or whether it provides the customer
with a discount that would not be available without entering into the initial contract.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In certain legacy customer contracts, the Company
has provided customers with the option to extend the contract term for an additional one-year period. Management evaluates these renewal
provisions to determine whether they provide a material right by comparing the renewal pricing to the expected stand-alone selling price
of the services at the time of renewal. This assessment requires judgment and includes consideration of expected pricing for similar services,
historical pricing practices, and market conditions.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;If a material right exists, the Company allocates a portion of the
transaction price to the option and recognizes the related revenue when the option is exercised or expires.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Significant financing component.&lt;/i&gt; In certain
arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company&#x2019;s
contracts with customer prepayment terms do not include a significant financing component because the prepayment terms are designed to
provide customers with contractual protections and billing convenience, not to provide financing to the customer or receive financing
from the customer.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Contract modifications. &lt;/i&gt;The Company may modify contracts to
offer customers additional products or services. Each of the additional products and services is evaluated to determine whether it is
distinct from the goods or services transferred prior to the modification. The Company evaluates whether the contract price for the additional
products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these
cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification
does not reflect the stand-alone selling price for the modified goods or services, the Company accounts for the modification either (i)
on a prospective basis if the remaining goods and services are distinct from those already transferred, or (ii) on a cumulative catch-up
basis if the remaining goods and services are not distinct from those already transferred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Principal vs. Agent Considerations&lt;/i&gt;. Judgment
is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation
of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., &#x201c;gross&#x201d;),
or we arrange for other parties to provide the service to the end-user and are an agent (i.e., &#x201c;net&#x201d;). In making this determination,
the Company considers several factors, including whether the Company is primarily responsible for fulfilling the promise to provide the
specified goods or services, bears inventory risk before the goods are transferred, and has discretion in establishing pricing for the
specified goods or services. This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts
and promotions offered to end-users to the extent they are not customers.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In dealer transactions where the Company&#x2019;s
role is to supply hardware to the dealer, the Company does not obtain control of the hardware before it is transferred to the end-user
and is not primarily responsible for the dealer&#x2019;s fulfillment to end-users. Accordingly, hardware revenue in these arrangements
is recorded on a net basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In dealer and OEM transactions where our role
is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription
revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Cost to Obtain a Contract. &lt;/i&gt;The Company capitalizes incremental
costs incurred to obtain contracts, principally sales commissions and third-party referral fees. These costs are amortized on a straight-line
basis over the contractual term and recognized in general and administrative expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;&lt;i&gt;Costs to Fulfill a Contract&lt;/i&gt;. The Company capitalizes such costs
when they are (i) incremental to obtaining that specific contract, (ii) expected to be recovered, and (iii) subject to an amortization
period exceeding one year. Capitalized fulfillment costs are amortized on a straight-line basis over the expected period of benefit, which
corresponds to the contractual term, and are recognized in cost of revenue. The Company evaluates capitalized fulfillment costs for impairment
at each reporting date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;Deferred contract costs totaled $767,007 and $120,793 as of December
31, 2025 and 2024, respectively, and are included in prepaid expenses and other current assets in the consolidated balance sheets. Amortization
of deferred contract costs recognized in cost of revenue during the years ended December 31, 2025 and 2024 was $106,480 and $21,413, respectively.
No impairment losses were recognized in either period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Taxes collected from customers&lt;/i&gt;. The Company
collects and remits certain taxes assessed by governmental authorities on its revenue transactions, including sales, use, value-added,
and excise taxes. These taxes are presented on a net basis and excluded from reported revenue. Shipping and handling fees billed to customers
are included in net sales; the related costs are included in cost of revenue.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Judgments and estimates. &lt;/i&gt;Accounting for contracts recognized over time requires judgment in
estimating the transaction price, the measure of progress, and expected contract costs. Due to uncertainties
inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the
near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Below 10%&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There was $209,452 from these customers in accounts
receivable as of December 31, 2025 and $274,699 from these customers in accounts receivable as of December 31, 2024.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts contextRef="c3" decimals="0" id="ixv-13868" unitRef="usd">767007</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts contextRef="c4" decimals="0" id="ixv-13869" unitRef="usd">120793</us-gaap:AmountOfDeferredCostsRelatedToLongTermContracts>
    <us-gaap:ContractWithCustomerLiability contextRef="c3" decimals="0" id="ixv-13870" unitRef="usd">106480</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c4" decimals="0" id="ixv-13871" unitRef="usd">21413</us-gaap:ContractWithCustomerLiability>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="c0" id="ixv-6901">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the percentages
of total revenue for customers that represent 10% or more of the respective amounts for the year ended December 31, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Customer A&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;17.1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-74; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer B&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-75; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer C&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Customer D&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-76; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Customer E&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12.3&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-77; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Below 10%&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c48" decimals="3" id="ixv-13872" unitRef="pure">0.171</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c50" decimals="3" id="ixv-13873" unitRef="pure">0.368</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c52" decimals="3" id="ixv-13874" unitRef="pure">0.115</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c53" decimals="3" id="ixv-13875" unitRef="pure">0.732</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c54" decimals="3" id="ixv-13876" unitRef="pure">0.191</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c56" decimals="3" id="ixv-13877" unitRef="pure">0.123</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c41" decimals="0" id="ixv-13878" unitRef="usd">209452</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="c42" decimals="0" id="ixv-13879" unitRef="usd">274699</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <cyngn:CostOfRevenuePolicyTextBlock contextRef="c0" id="ixv-6984">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Cost of Revenue &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost of revenue consists primarily of direct labor
and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the
contracts and hardware costs.&lt;/p&gt;</cyngn:CostOfRevenuePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-6994">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;In November 2024, the FASB issued ASU 2024-03, &#x201c;Disaggregation
of Income Statement Expenses,&#x201d; which requires the disaggregated disclosure of certain income statement items. ASU 2024-03 is effective
for fiscal years beginning after December 15, 2026 and interim periods beginning after December 15, 2027, with early adoption permitted.
The Company has not adopted this standard early and is currently evaluating the impact of this amendment on its consolidated financial
statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-7007">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;3. Revenue and Contracts with Customers&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Contract Balances&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Timing differences between revenue recognized, billings, and customer
payments result in contract assets and contract liabilities. Contract assets represent revenue recognized in excess of amounts billed
to customers. Contract liabilities represent payments received from customers in advance of satisfying the related performance obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;The Company&#x2019;s contract balances consist primarily of accounts receivable
and deferred revenue (contract liabilities). Accounts receivable represents the Company&#x2019;s unconditional rights to consideration
for goods and services transferred to customers. Contract liabilities represent amounts billed or collected in advance of satisfying performance
obligations and are recognized as revenue as the related performance obligations are satisfied. As of December 31, 2025 and 2024, deferred
revenue related to tugger sales totaled $1,658,015 and $769,180, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognized from Prior Period Contract
Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the years ended December 31, 2025 and 2024,
the Company recognized revenue of $128,387 and $1,500, respectively, that was included in deferred revenue at the beginning of each respective
period. The Company did not recognize material revenue during the periods presented from performance obligations satisfied (or partially
satisfied) in prior periods other than amounts previously included in deferred revenue.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Remaining Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the remaining performance
obligations on existing contracts are $1,658,015, approximately 25% of which is expected to be recognized in 2026, 36% in 2027, 28% in
2028, and the remainder thereafter. This amount corresponds to the Company&#x2019;s contract liability balance as of December 31, 2025,
as all remaining obligations relate to the passage of time on active contracts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2025 and 2024,
revenue was $218,976 and $368,138, respectively.&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c3" decimals="0" id="ixv-13880" unitRef="usd">1658015</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c4" decimals="0" id="ixv-13881" unitRef="usd">769180</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DeferredCostsCurrent contextRef="c3" decimals="0" id="ixv-13882" unitRef="usd">128387</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent contextRef="c4" decimals="0" id="ixv-13883" unitRef="usd">1500</us-gaap:DeferredCostsCurrent>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c3" decimals="0" id="ixv-13884" unitRef="usd">1658015</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c58" decimals="2" id="ixv-13885" unitRef="pure">0.25</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c59" decimals="2" id="ixv-13886" unitRef="pure">0.36</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c60" decimals="2" id="ixv-13887" unitRef="pure">0.28</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:Revenues contextRef="c0" decimals="0" id="ixv-13888" unitRef="usd">218976</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c5" decimals="0" id="ixv-13889" unitRef="usd">368138</us-gaap:Revenues>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c0" id="ixv-7060">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;4. Balance Sheet Components&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Funds in the Company&#x2019;s investment brokerage
account were held in cash equivalents, consisting of a money market account, along with short-term investments consisting of U.S. government
treasury bills, which are accounted for as held-to-maturity (&#x201c;HTM&#x201d;) securities, and classified as Level 1 in the hierarchy
of fair value measurements. HTM securities are carried at amortized cost and, as a result, are not remeasured to fair value on a recurring
basis. All of the Company&#x2019;s short-term investments will mature within one year of December 31, 2025. The Company does not expect
a credit loss for its short-term investments.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom"&gt;Financial assets&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Cash equivalents:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Money market account&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;929,165&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;23,274,834&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Short-term investments:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;U.S. government treasury bills&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;33,736,091&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2012;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,665,255&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,274,834&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost or net
realizable value. Cost is determined using the specific identification method, as each autonomous vehicle is individually serialized and
tracked, allowing the Company to identify the specific cost associated with each unit. The specific cost of each vehicle is transferred
to deferred costs upon deployment.&lt;/p&gt;
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;As of December 31, 2025 and 2024, inventory totaled $2.0 million and
$0.2 million, respectively.&lt;/p&gt;


&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Prepaid expenses and other current assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Prepaid expenses and other current assets are comprised of the following:&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid Expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;668,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;303,803&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Short-term Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,006&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;775,334&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128,138&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total prepaid and expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,518,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;592,090&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment, Net&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment were reclassified to better
reflect their appropriate categories within the fixed asset register. These reclassifications did not have a significant impact on the
overall asset values or depreciation expense. Property and equipment is comprised of the following:&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Automobiles (DMV-registered)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;128,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Machinery, tools and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;692,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;660,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;389,007&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Capitalized software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,592,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;950,832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,417&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Testing equipment (Work in Progress)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;896,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;687,986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9.25pt"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,947,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,105,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(678,827&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(785,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,268,196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,319,402&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation expense for the years ended December
31, 2025 and 2024 was $234,909 and $214,494, respectively.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Accounts Payable &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts payable includes independent director
fees payable of $42,500 and $28,333 as of December 31, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Deferred Revenue&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred revenue consists primarily of amounts
billed to customers for tugger sales and related services for which revenue has not yet been recognized. Revenue is recognized as the
Company satisfies its performance obligations in accordance with its revenue recognition policy.&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025 and 2024, deferred revenue
related to tugger sales totaled $1,658,015 and $769,180, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Accrued Expenses and Other Current Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued expenses and other current liabilities
are comprised of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Credit card payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,169&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,050&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;788,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued payroll&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,035,795&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,314,038&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,615,734&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,105,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock contextRef="c0" id="ixv-13890">The Company does not expect
a credit loss for its short-term investments.&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom"&gt;Financial assets&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Cash equivalents:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Money market account&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;929,165&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;23,274,834&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Short-term investments:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;U.S. government treasury bills&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;33,736,091&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;1&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-84; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2012;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;34,665,255&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,274,834&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="c61" decimals="0" id="ixv-13891" unitRef="usd">929165</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:MoneyMarketFundsAtCarryingValue contextRef="c62" decimals="0" id="ixv-13892" unitRef="usd">23274834</us-gaap:MoneyMarketFundsAtCarryingValue>
    <us-gaap:USGovernmentSecuritiesAtCarryingValue contextRef="c61" decimals="0" id="ixv-13893" unitRef="usd">33736091</us-gaap:USGovernmentSecuritiesAtCarryingValue>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c3" decimals="0" id="ixv-13894" unitRef="usd">34665255</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments contextRef="c4" decimals="0" id="ixv-13895" unitRef="usd">23274834</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:InventoryNet contextRef="c3" decimals="-5" id="ixv-13896" unitRef="usd">2000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c4" decimals="-5" id="ixv-13897" unitRef="usd">200000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c0" id="ixv-7208">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Prepaid expenses and other current assets are comprised of the following:&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid Expenses&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;668,090&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;303,803&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Short-term Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,006&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;160,149&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;775,334&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;128,138&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total prepaid and expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,518,430&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;592,090&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent contextRef="c3" decimals="0" id="ixv-13898" unitRef="usd">668090</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c4" decimals="0" id="ixv-13899" unitRef="usd">303803</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="c3" decimals="0" id="ixv-13900" unitRef="usd">75006</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="c4" decimals="0" id="ixv-13901" unitRef="usd">160149</us-gaap:DepositsAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c3" decimals="0" id="ixv-13902" unitRef="usd">775334</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c4" decimals="0" id="ixv-13903" unitRef="usd">128138</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c3" decimals="0" id="ixv-13904" unitRef="usd">1518430</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c4" decimals="0" id="ixv-13905" unitRef="usd">592090</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-13906">Property and equipment is comprised of the following:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December&#160;31,&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Automobiles (DMV-registered)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;28,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;128,862&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Machinery, tools and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;692,459&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;660,155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,552&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;389,007&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Capitalized software&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,592,092&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;950,832&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;66,182&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;175,417&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221,977&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Testing equipment (Work in Progress)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;896,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;687,986&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9.25pt"&gt;Property and equipment, gross&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,947,023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,105,001&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Less: accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(678,827&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(785,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,268,196&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,319,402&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c43" decimals="0" id="ixv-13907" unitRef="usd">28862</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c63" decimals="0" id="ixv-13908" unitRef="usd">128862</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c64" decimals="0" id="ixv-13909" unitRef="usd">692459</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c65" decimals="0" id="ixv-13910" unitRef="usd">660155</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c45" decimals="0" id="ixv-13911" unitRef="usd">488552</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c66" decimals="0" id="ixv-13912" unitRef="usd">389007</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c67" decimals="0" id="ixv-13913" unitRef="usd">1592092</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c68" decimals="0" id="ixv-13914" unitRef="usd">950832</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c46" decimals="0" id="ixv-13915" unitRef="usd">73494</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c69" decimals="0" id="ixv-13916" unitRef="usd">66182</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c47" decimals="0" id="ixv-13917" unitRef="usd">175417</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c70" decimals="0" id="ixv-13918" unitRef="usd">221977</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c71" decimals="0" id="ixv-13919" unitRef="usd">896147</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c72" decimals="0" id="ixv-13920" unitRef="usd">687986</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c3" decimals="0" id="ixv-13921" unitRef="usd">3947023</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c4" decimals="0" id="ixv-13922" unitRef="usd">3105001</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c3" decimals="0" id="ixv-13923" unitRef="usd">678827</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c4" decimals="0" id="ixv-13924" unitRef="usd">785599</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="0" id="ixv-13925" unitRef="usd">3268196</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c4" decimals="0" id="ixv-13926" unitRef="usd">2319402</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c0" decimals="0" id="ixv-13927" unitRef="usd">234909</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c5" decimals="0" id="ixv-13928" unitRef="usd">214494</us-gaap:Depreciation>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c3" decimals="0" id="ixv-13929" unitRef="usd">42500</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c4" decimals="0" id="ixv-13930" unitRef="usd">28333</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:DeferredRevenue contextRef="c3" decimals="0" id="ixv-13931" unitRef="usd">1658015</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue contextRef="c4" decimals="0" id="ixv-13932" unitRef="usd">769180</us-gaap:DeferredRevenue>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c0" id="ixv-7423">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accrued expenses and other current liabilities
are comprised of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Credit card payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;16,169&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,050&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;563,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;788,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued payroll&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,035,795&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,314,038&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9.25pt"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,615,734&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,105,036&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <cyngn:CreditCardPayableCurrent contextRef="c3" decimals="0" id="ixv-13933" unitRef="usd">16169</cyngn:CreditCardPayableCurrent>
    <cyngn:CreditCardPayableCurrent contextRef="c4" decimals="0" id="ixv-13934" unitRef="usd">2050</cyngn:CreditCardPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c3" decimals="0" id="ixv-13935" unitRef="usd">563770</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c4" decimals="0" id="ixv-13936" unitRef="usd">788948</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c3" decimals="0" id="ixv-13937" unitRef="usd">2035795</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c4" decimals="0" id="ixv-13938" unitRef="usd">1314038</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c3" decimals="0" id="ixv-13939" unitRef="usd">2615734</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c4" decimals="0" id="ixv-13940" unitRef="usd">2105036</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-7480">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;5. Operating Leases&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Operating lease right-of-use assets and lease
liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments
consist of the fixed payments under the arrangement, less any lease incentives, such as tenant improvement allowances. Variable costs,
such as maintenance and utilities based on actual usage, are not included in the measurement of right-of-use (&#x201c;ROU&#x201d;) assets
and lease liabilities but are expensed when the event determining the amount of variable consideration to be paid occurs. As the implicit
rate of the leases is not determinable, the Company uses an incremental borrowing rate (&#x201c;IBR&#x201d;) based on the information available
at the lease commencement date in determining the present value of lease payments. Rather than relying on a single rate source, the Company
evaluated three data points calculated from the three standard methods to determine a reasonable, supportable, and entity-specific IBR
consistent with ASC 842. Based on this analysis, the rate applied is the median of the available supportable rates, which reflects a secured
borrowing assumption and balances entity-specific credit risk and market benchmarks. Lease expenses are recognized on a straight-line
basis over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company leases its office space in Mountain
View, California, under an operating lease agreement dated March 25, 2025, originally signed for a term of six and one half years that
commenced in May 2025. Monthly payments are approximately $104,478. The lease includes common area maintenance costs that are paid separately
from rent based on actual costs incurred. The Company&#x2019;s previous lease in Menlo Park, California ended in May 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company also leases storage containers from
a third-party provider for use on-site in Mountain View, California, at a monthly rate of $141 per unit. These arrangements are on a month-to-month
basis and are cancelable upon thirty (30) days&#x2019; notice. Under the short-term lease practical expedient of ASC 842, the Company does not
recognize right-of-use assets or lease liabilities for these arrangements, and instead, lease payments are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s right-of-use asset, net balance
as of December 31, 2025 and 2024, respectively are presented on the Company&#x2019;s consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s future lease payments under
the non-cancellable lease as of December 31, 2025, which are presented as lease liabilities on the Company&#x2019;s consolidated balance
sheet, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Operating&lt;br/&gt; Lease&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 87%; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;692,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,434,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,506,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,551,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,594&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,367,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,341,632&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Present value of lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,807,621&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Weighted-average remaining lease term (in years)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Weighted-average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.87&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Lease expense was $1,170,932 and $678,037 for
the years ended December 31, 2025 and 2024, respectively. The amortization of the operating lease right-of-use assets, which is included
in the lease expense, totaled $915,451 and $694,373 for the years ended December 31, 2025 and 2024, respectively. The weighted average
discount rate is based on the incremental borrowing rate that is utilized to present value the remaining lease payments over the lease
term.&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="0" id="ixv-13941" unitRef="usd">104478</us-gaap:OperatingLeasePayments>
    <us-gaap:LeaseCost contextRef="c0" decimals="0" id="ixv-13942" unitRef="usd">141</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-7494">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s future lease payments under
the non-cancellable lease as of December 31, 2025, which are presented as lease liabilities on the Company&#x2019;s consolidated balance
sheet, are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Operating&lt;br/&gt; Lease&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 87%; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;692,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,434,193&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,506,260&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,551,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2030&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,594&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;2031&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,367,166&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,341,632&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Present value of lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;6,807,621&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c3" decimals="0" id="ixv-13943" unitRef="usd">692000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c3" decimals="0" id="ixv-13944" unitRef="usd">1434193</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c3" decimals="0" id="ixv-13945" unitRef="usd">1506260</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c3" decimals="0" id="ixv-13946" unitRef="usd">1551040</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c3" decimals="0" id="ixv-13947" unitRef="usd">1598594</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c3" decimals="0" id="ixv-13948" unitRef="usd">1367166</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c3" decimals="0" id="ixv-13949" unitRef="usd">1341632</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c3" decimals="0" id="ixv-13950" unitRef="usd">6807621</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="c0" id="ixv-7564">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Weighted-average remaining lease term (in years)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;5.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.42&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Weighted-average discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.60&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.87&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c3" id="ixv-13951">P5Y9M29D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c4" id="ixv-13952">P0Y5M1D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c3" decimals="4" id="ixv-13953" unitRef="pure">0.056</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c4" decimals="4" id="ixv-13954" unitRef="pure">0.0487</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense contextRef="c0" decimals="0" id="ixv-13955" unitRef="usd">1170932</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c5" decimals="0" id="ixv-13956" unitRef="usd">678037</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="0" id="ixv-13957" unitRef="usd">915451</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c5" decimals="0" id="ixv-13958" unitRef="usd">694373</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c0" id="ixv-7616">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;6. Intangible Assets, Net&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The gross carrying amount and accumulated amortization
of separately identifiable intangible assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Market Value Adjustment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Impairment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;521,302&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(71,079&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;450,223&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;566,302&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100,079&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; border-bottom: black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;466,223&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Market Value Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Carrying Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Developed software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,425,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-92"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,425,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(41,856&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(118,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;450,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(26,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-95"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,081,761&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(67,856&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(118,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,895,074&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Amortization expense for each of the years ended
December 31, 2025 and 2024 was $32,223 and $24,739, respectively. There was &lt;span style="-sec-ix-hidden: hidden-fact-98"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-99"&gt;no&lt;/span&gt;&lt;/span&gt; amortization expense for the developed software for the
years ended December 31, 2025 and 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 360, &lt;i style="font-style: normal; font-weight: normal"&gt;Property, Plant, and Equipment&lt;/i&gt;,
defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate
impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present. The Company determined
the Triggering Events in conjunction with preparation of its financial statements for the year ended December 31, 2025 provided such indication.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Next, the Company must review the long-lived assets
to define asset group(s) that would reflect the lowest level of assets to which discrete cash flows are identifiable, and test these asset
groups for impairment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In performing this review, the Company identified
that the long-lived asset &#x201c;Patents&#x201d;, which have international and U.S. based patents, as the asset group. The Company evaluated
its patents and identified expired international patent applications (&#x201c;expired assets&#x201d;) for the year ended December 31, 2024.
The Company determined there were no further plans to put resources toward these international patent applications. The group of expired
patents carrying value was set to its salvage value which is zero given no future cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2024, the Company
recorded a $118,831 impairment charge under gain (loss) on disposal assets, which is included in other income (expense) on its consolidated
statement of operations, to adjust the expiring assets salvage value of zero.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;It was determined for all remaining long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets were necessary as of December
31, 2025 and December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025, management
completed a review of the Company&#x2019;s capitalized software development projects. Based on this review, management determined that
projects previously capitalized as developed software no longer met the criteria for capitalization under ASC 985-20, External-Use Software,
resulting from new technical development issues that did not exist and could not have been reasonably anticipated in prior periods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result, the Company revised its estimate regarding the point at which technological feasibility is achieved for software development
activities. This change in estimate was made to reflect management&#x2019;s current expectations about the timing and certainty of future
technological milestones.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The change in estimate was accounted for prospectively
in accordance with ASC 250, Accounting Changes and Error Corrections, and did not require restatement of prior-period financial statements.
For the year ended December 31, 2025, the Company recognized a total of $1.4 million related to costs originally
capitalized in 2024 and $1.2 million related to costs capitalized during the first two quarters of 2025 as research and development expense
resulting from this change.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Estimated amortization expense for all intangible
assets subject to amortization in future years is expected to be:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Years ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2029&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;331,135&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;466,223&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c0" id="ixv-7620">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The gross carrying amount and accumulated amortization
of separately identifiable intangible assets are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Gross Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair Market Value Adjustment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Impairment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Patents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;521,302&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(71,079&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-85; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-86; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;450,223&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trademark&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(29,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-87; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-88; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;566,302&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(100,079&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-89; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; border-bottom: black 1.5pt solid"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-90"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;466,223&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="18" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As of December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross Carrying Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Market Value Adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Impairment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Net Carrying Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Developed software&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,425,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-91"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-92"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-93"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,425,689&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Patents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,072&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(41,856&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-94"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(118,831&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;450,385&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;45,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(26,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-95"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total intangible assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,081,761&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(67,856&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(118,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,895,074&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c76" decimals="0" id="ixv-13959" unitRef="usd">521302</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c76" decimals="0" id="ixv-13960" unitRef="usd">71079</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c76" decimals="0" id="ixv-13961" unitRef="usd">450223</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c77" decimals="0" id="ixv-13962" unitRef="usd">45000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c77" decimals="0" id="ixv-13963" unitRef="usd">29000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c77" decimals="0" id="ixv-13964" unitRef="usd">16000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c3" decimals="0" id="ixv-13965" unitRef="usd">566302</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c3" decimals="0" id="ixv-13966" unitRef="usd">100079</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="0" id="ixv-13967" unitRef="usd">466223</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c78" decimals="0" id="ixv-13968" unitRef="usd">1425689</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c78" decimals="0" id="ixv-13969" unitRef="usd">1425689</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c79" decimals="0" id="ixv-13970" unitRef="usd">611072</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c79" decimals="0" id="ixv-13971" unitRef="usd">41856</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cyngn:FiniteLivedIntangibleAssetsImpairment contextRef="c79" decimals="0" id="ixv-13972" unitRef="usd">118831</cyngn:FiniteLivedIntangibleAssetsImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c79" decimals="0" id="ixv-13973" unitRef="usd">450385</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c80" decimals="0" id="ixv-13974" unitRef="usd">45000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c80" decimals="0" id="ixv-13975" unitRef="usd">26000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c80" decimals="0" id="ixv-13976" unitRef="usd">19000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c4" decimals="0" id="ixv-13977" unitRef="usd">2081761</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c4" decimals="0" id="ixv-13978" unitRef="usd">67856</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cyngn:FiniteLivedIntangibleAssetsImpairment contextRef="c4" decimals="0" id="ixv-13979" unitRef="usd">118831</cyngn:FiniteLivedIntangibleAssetsImpairment>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c4" decimals="0" id="ixv-13980" unitRef="usd">1895074</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="0" id="ixv-13981" unitRef="usd">32223</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c5" decimals="0" id="ixv-13982" unitRef="usd">24739</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c5" decimals="0" id="ixv-13983" unitRef="usd">118831</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:SalvageAndSubrogationRecoveriesValue contextRef="c4" decimals="0" id="ixv-13984" unitRef="usd">0</us-gaap:SalvageAndSubrogationRecoveriesValue>
    <us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination contextRef="c5" id="ixv-13985">long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets</us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination>
    <us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination contextRef="c0" id="ixv-13986">long-lived
assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets</us-gaap:ImpairedIntangibleAssetMethodForFairValueDetermination>
    <us-gaap:OtherResearchAndDevelopmentExpense contextRef="c0" decimals="-5" id="ixv-13987" unitRef="usd">1400000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:RecapitalizationCosts contextRef="c75" decimals="-5" id="ixv-13988" unitRef="usd">1200000</us-gaap:RecapitalizationCosts>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c0" id="ixv-7910">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Estimated amortization expense for all intangible
assets subject to amortization in future years is expected to be:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Years ended December 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;2029&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,772&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;331,135&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;466,223&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c3" decimals="0" id="ixv-13989" unitRef="usd">33772</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c3" decimals="0" id="ixv-13990" unitRef="usd">33772</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c3" decimals="0" id="ixv-13991" unitRef="usd">33772</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c3" decimals="0" id="ixv-13992" unitRef="usd">33772</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c3" decimals="0" id="ixv-13993" unitRef="usd">331135</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c3" decimals="0" id="ixv-13994" unitRef="usd">466223</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-7960">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;7. Capital Structure&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025 and 2024, the Company
is authorized to issue 400,000,000 and 200,000,000 shares of common stock, respectively, with a par value of $0.00001 per share. As of
December 31, 2025 and 2024, the Company had 7,974,380 and 199,110 shares of common stock issued and outstanding, respectively. Holders
of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable
to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected
by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2021, the Company amended its Certificate
of Incorporation and revised the number of preferred stock shares authorized for issuance to 10,000,000 shares at a par value of $0.00001.
As of December 31, 2025 and December 31, 2024, there were &lt;span style="-sec-ix-hidden: hidden-fact-100"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-101"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-102"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-103"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of preferred stock issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Reverse Stock Split&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 25, 2024, the Company&#x2019;s stockholders
voted to authorize the Company&#x2019;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company&#x2019;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On January 30, 2025, the Company&#x2019;s stockholders
voted to authorize the Company&#x2019;s Board of Directors to effect a reverse stock split of the outstanding shares of common stock within
a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company&#x2019;s Board of Directors determined to effect the reverse stock split
of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February 18, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s primary reasons for effecting
the reverse stock splits was to increase the per share price of our common stock to meet Nasdaq&#x2019;s minimum bid price requirement
for continued listing on Nasdaq.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Offerings&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 27, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 313,564 shares of its common
stock, par value $0.00001 per share at a purchase price of $7.50 per share and 1,979,769 pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $7.49999 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#x2019; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 30, 2025. The Company received net proceeds of approximately $13.7 million from the offering,
after deducting the estimated offering expenses payable by the Company of $1.3 million, including the placement agent fees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 26, 2025, the Company entered into a securities
purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 192,496 shares of its common
stock, par value $0.00001 per share at a purchase price of $5.01 per share and 2,801,516 pre-funded warrants to purchase shares of Common
Stock, at a purchase price of $ of $5.00999 per pre-funded warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#x2019; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on June 27, 2025. The Company received net proceeds of approximately $15.9 million from the offering,
after deducting the estimated offering expenses payable by the Company of $1.3 million, including the placement agent fees.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 30, 2024, the Company entered into
a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 44,333 shares
of its common stock, par value $0.00001 per share at a purchase price of $90 per share and 55,667 pre-funded warrants to purchase shares
of Common Stock, at a purchase price of $89.985 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent
stockholders&#x2019; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated
the fair value. The offering closed on December 31, 2024. The Company received net proceeds of approximately $8.1 million from the Offering,
after deducting the estimated offering expenses payable by the Company, including the placement agent fees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 20, 2024, the Company entered into
a securities purchase agreement for the sale and issuance of (i) 20,507 units at a public offering price per Unit of $241.50 with each
Unit consisting of one share of common stock, par value $0.00001 per share, one Series A warrant to purchase one share of Common Stock
at an exercise price of $301.875 per share and one Series B warrant to purchase one share of Common Stock at an exercise price of $301.875&lt;sup&gt;)&lt;/sup&gt;
and (ii) 62,309 pre-funded units at a public offering price of $241.485 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one
pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.015 per share, one Series A Warrant and one Series
B Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders&#x2019; equity within additional paid-in capital
and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on December 23,
2024. The net proceeds to the Company from the Offering were approximately $18.2 million, after deducting placement agent&#x2019;s fees
and the payment of other estimated offering expenses associated with the offering that are payable by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At issuance, the aggregate fair value of the
warrant liabilities exceeded the net proceeds received in the transaction. The Company needed the net proceeds in order to continue
to run operations. Accordingly, the Company recognized a loss on issuance of warrants of approximately $2.3 million in its
consolidated statement of operations for the year ended December 31, 2024. This amount reflects the excess of the fair value of the
warrant liabilities over the residual proceeds allocable to the other securities issued in the transaction. Subsequently, the
warrant liabilities will continue to be remeasured at fair value through earnings until they are exercised, expire, or are otherwise
settled. After shareholder approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore,
in accordance with ASC 815-40-35-8, Derivatives and Hedging Reclassification of Contracts, the Series A warrants were re-measured
utilizing the Black Scholes model and reclassified into equity. The Series A warrants are included in equity in the consolidated
balance sheet as of December 31, 2025. The Series B warrants were re-measured utilizing the Black Scholes model immediately before
exercise and were fully exercised in February 2025. In addition, approximately $1.7 million of offering-related issuance costs
attributable to the warrant liabilities were recorded as expense in the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 23, 2024, the Company entered into an
underwritten Agreement with Aegis Capital Corp. (&#x201c;Aegis&#x201d;), pursuant to which Aegis acted as the Company&#x2019;s underwriter
on a firm commitment basis in connection with the sale by the Company of an aggregate of 3,333 shares of common stock in a public offering,
which included: (i) 1,320 shares of common stock, and (ii) pre-funded warrants to purchase 2,013 shares of common stock. The Pre-Funded
Warrants had a nominal exercise price of $0.15. Each share of common stock was sold at an offering price of $1,500, and each Pre-Funded
Warrant was sold at an offering price of $1,499.85. The Pre-Funded Warrants are classified as a component of permanent stockholders&#x2019;
equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value.
The Company determined the fair value of the Series A and Series B warrants using the Monte Carlo pricing model and treated the valuation
as a liability in consideration of the variable number of the issuer&#x2019;s equity shares in the warrant agreements. The offering closed
on April 25, 2024. On May 3 2024, the Company closed on the sale of an additional 136 shares of common stock, upon exercise by the underwriter
of the over-allotment option. The Company received net proceeds of approximately $4.6 million, after deducting the estimated offering
expenses payable by the Company, including the placement agent fees.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;At the Market Equity Financing &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On September 5, 2025, the Company entered into
an At-The-Market Issuance Sales Agreement (the &#x201c;Sales Agreement&#x201d;) with Aegis Capital Corp. (the &#x201c;Agent&#x201d;), under
which the Company may, from time to time, sell shares of the Company&#x2019;s common stock having an aggregate offering price of up to
$100,000,000 in &#x201c;at the market&#x201d; offerings through or to the Agent, as sales agent or principal. Sales of the shares of common
stock, if any, will be made at prevailing market prices at the time of sale, or as otherwise agreed with the Agent. The Agent will receive
a commission from the Company of up to 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. As of
December 31, 2025, a total of 935,114 shares of common stock were sold through Aegis Capital Corp. under the Sales Agreement. As of December
31, 2025, the Company has received net proceeds of $5,472,691 after payment of commission fees of $173,341 and other related expenses
of $131,990.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Private Placement Offering&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 12, 2024, the Company entered into
a Securities Purchase Agreement (&#x201c;SPA&#x201d;) with certain investors pursuant to which we sold, in a private placement, senior notes
with an aggregate principal amount of $4,375,000 (the &#x201c;Notes&#x201d;), and received proceeds before expenses of $3,500,000. The Notes
matured on February 12, 2025, with 20% interest rate. As consideration for entering into the SPA, we issued a total of 2,701 shares of
common stock of the Company to the Purchasers on November 13, 2024. The common stock and the Notes were recorded at the relative fair
values in accordance with ASC 470-20-25-2. The placement agent fee and other offering expenses were allocated based on the aforementioned
fair values as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. The amortization
of the debt discount and issuance costs was recorded in interest income (expense) on the consolidated statement of operations. As of December
31, 2024, the Notes were paid in full.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Common Stock Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following warrants were outstanding as of
December 31, 2025, each of which is exercisable on a one-for-one basis for shares of the Company&#x2019;s common stock (i.e., one warrant
for one share). All warrants contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock
dividends or other extraordinary dividends, or other similar changes in the Company&#x2019;s common stock or capital structure, and none
of which have any participating rights for any losses. All Series B warrants, which were issued as a part of the December 20, 2024 public
offering, were fully exercised as of February 11, 2025 utilizing the cashless exercise provision in the warrant agreement. In addition,
on March 31, 2025, the Company reclassified the Series A warrants from liability to equity upon determining that the warrants no longer
required liability classification.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Securities into which warrants are convertible&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrants&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Expiration&lt;br/&gt; Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair&lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; text-align: left"&gt;Common stock (Initial Public Offering)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;October 2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;170,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Common stock (Private Placement)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;140,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;April 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,071,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Common stock (Series A)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;517,598&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;48.30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;January 2030&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,634,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;518,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,875,939&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following warrants were outstanding as of
December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits,
stock dividends or other extraordinary dividends, or other similar changes in the Company&#x2019;s common stock or capital structure, and
none of which have any participating rights for any losses:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Securities into which warrants are convertible&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;br/&gt;
outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;br/&gt;
Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expiration&lt;br/&gt;
Date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair&lt;br/&gt;
value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Initial Public Offering)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,650&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October 2026&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,397&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Private Placement)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;426&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,625&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 2027&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,071,114&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Series A)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;277,778&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;90&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 2030&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,581,789&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Series B)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,816&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;301.875&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;July 2027&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,122,138&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;361,029&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,945,438&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for warrants in accordance
with ASC 480,&#160;&lt;i style="font-style: normal; font-weight: normal"&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, depending on the specific terms of the warrant agreement. The Company&#160;determined
the fair value of the Initial Public Offering and Private Placement warrants&#160;using the Black-Scholes pricing model and treated the
valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements. The warrants are not
marked-to-market each reporting period, and thus there is no impact to earnings. Any future exercises of the warrants will be recorded
as cash received and recorded in cash, with a corresponding increase to common stock and additional paid-in capital in stockholders&#x2019;
equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company used the following assumptions for
December 31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Initial&lt;br/&gt;
Public&lt;br/&gt; Offering&lt;br/&gt; Warrants&lt;/p&gt;&lt;p style="margin: 0pt 0"&gt;(Oct 2021)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Private&lt;br/&gt;
Placement Warrants&lt;/p&gt;

&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Apr 2022)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.37&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.92&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under ASC 815-40-35-8, &lt;i style="font-style: normal; font-weight: normal"&gt;Derivatives
and Hedging Reclassification of Contracts&lt;/i&gt;, shareholder approval on January 30, 2025, initiated the price reset period, resulting
in a fixed exercise price for the warrants. As such, the Series A warrants were reclassified to equity and remeasured utilizing the
Black Scholes model with the following assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series A&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;183.38&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series B warrants were re-measured
prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series B&lt;br/&gt;
Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 89%"&gt;&lt;span style="font-size: 10pt"&gt;Fair value of underlying securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6.01 &#x2013; 32.19 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;162.99 &#x2013; 190.53&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.46 &#x2013; 2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4.18 &#x2013; 4.30&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for warrants in accordance
with ASC 480,&#160;&lt;i style="font-style: normal; font-weight: normal"&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, depending on the specific terms of the warrant agreement. The Company
allocated the proceeds of the deal based on the fair values for the Series A and Series B warrants. The Company determined the fair value
of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of
the issuer&#x2019;s equity shares in the warrant agreements for the year-ended December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company used the following assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series A&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series B&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.29&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.29&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c3"
      decimals="0"
      id="ixv-13995"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c4"
      decimals="0"
      id="ixv-13996"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c3"
      decimals="5"
      id="ixv-13997"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="c3"
      decimals="0"
      id="ixv-13998"
      unitRef="shares">7974380</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="0"
      id="ixv-13999"
      unitRef="shares">7974380</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c16"
      decimals="0"
      id="ixv-14000"
      unitRef="shares">199110</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c16"
      decimals="0"
      id="ixv-14001"
      unitRef="shares">199110</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c81"
      decimals="0"
      id="ixv-14002"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c81"
      decimals="5"
      id="ixv-14003"
      unitRef="usdPershares">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c27" id="ixv-14004">1-for-5</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c28" id="ixv-14005">1-for-100</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c29" id="ixv-14006">1-for-100</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c30" id="ixv-14007">1-for-5</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c31" id="ixv-14008">1-for-150</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c32" id="ixv-14009">1-for-150</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:CommonStockSharesIssued
      contextRef="c84"
      decimals="0"
      id="ixv-14010"
      unitRef="shares">313564</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c84"
      decimals="5"
      id="ixv-14011"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c84"
      decimals="2"
      id="ixv-14012"
      unitRef="usdPershares">7.5</us-gaap:SaleOfStockPricePerShare>
    <cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock
      contextRef="c85"
      decimals="0"
      id="ixv-14013"
      unitRef="shares">1979769</cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock>
    <cyngn:PreFundedWarrantsPricePerShare
      contextRef="c85"
      decimals="5"
      id="ixv-14014"
      unitRef="usdPershares">7.49999</cyngn:PreFundedWarrantsPricePerShare>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c86" decimals="-5" id="ixv-14015" unitRef="usd">13700000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:NoninterestExpenseOfferingCost contextRef="c87" decimals="-5" id="ixv-14016" unitRef="usd">1300000</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c88"
      decimals="0"
      id="ixv-14017"
      unitRef="shares">192496</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c89"
      decimals="5"
      id="ixv-14018"
      unitRef="usdPershares">0.00001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c90"
      decimals="2"
      id="ixv-14019"
      unitRef="usdPershares">5.01</us-gaap:SharesIssuedPricePerShare>
    <cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock
      contextRef="c89"
      decimals="0"
      id="ixv-14020"
      unitRef="shares">2801516</cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock>
    <cyngn:PreFundedWarrantsPricePerShare
      contextRef="c89"
      decimals="5"
      id="ixv-14021"
      unitRef="usdPershares">5.00999</cyngn:PreFundedWarrantsPricePerShare>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c91" decimals="-5" id="ixv-14022" unitRef="usd">15900000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:NoninterestExpenseOfferingCost contextRef="c88" decimals="-5" id="ixv-14023" unitRef="usd">1300000</us-gaap:NoninterestExpenseOfferingCost>
    <us-gaap:CommonStockSharesIssued
      contextRef="c92"
      decimals="0"
      id="ixv-14024"
      unitRef="shares">44333</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c92"
      decimals="5"
      id="ixv-14025"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c92"
      decimals="0"
      id="ixv-14026"
      unitRef="usdPershares">90</us-gaap:SaleOfStockPricePerShare>
    <cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock
      contextRef="c93"
      decimals="0"
      id="ixv-14027"
      unitRef="shares">55667</cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock>
    <cyngn:PreFundedWarrantsPricePerShare
      contextRef="c93"
      decimals="3"
      id="ixv-14028"
      unitRef="usdPershares">89.985</cyngn:PreFundedWarrantsPricePerShare>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c94" decimals="-5" id="ixv-14029" unitRef="usd">8100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c95"
      decimals="0"
      id="ixv-14030"
      unitRef="shares">20507</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c96"
      decimals="2"
      id="ixv-14031"
      unitRef="usdPershares">241.5</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="c97"
      decimals="0"
      id="ixv-14032"
      unitRef="shares">1</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c97"
      decimals="5"
      id="ixv-14033"
      unitRef="usdPershares">0.00001</us-gaap:SharesIssuedPricePerShare>
    <cyngn:WarrantsToPurchase
      contextRef="c98"
      decimals="0"
      id="ixv-14034"
      unitRef="shares">1</cyngn:WarrantsToPurchase>
    <us-gaap:CommonStockSharesIssued
      contextRef="c98"
      decimals="0"
      id="ixv-14035"
      unitRef="shares">1</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c99"
      decimals="3"
      id="ixv-14036"
      unitRef="usdPershares">301.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c100"
      decimals="0"
      id="ixv-14037"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonUnitIssued
      contextRef="c100"
      decimals="0"
      id="ixv-14038"
      unitRef="shares">1</us-gaap:CommonUnitIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c101"
      decimals="3"
      id="ixv-14039"
      unitRef="usdPershares">301.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:PrefundedUnitsAtAPublicOfferingPrice
      contextRef="c96"
      decimals="0"
      id="ixv-14040"
      unitRef="shares">62309</cyngn:PrefundedUnitsAtAPublicOfferingPrice>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c102"
      decimals="3"
      id="ixv-14041"
      unitRef="usdPershares">241.485</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c103"
      decimals="0"
      id="ixv-14042"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="c103"
      decimals="0"
      id="ixv-14043"
      unitRef="shares">1</us-gaap:CommonStockSharesIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c96"
      decimals="3"
      id="ixv-14044"
      unitRef="usdPershares">0.015</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c99"
      decimals="0"
      id="ixv-14045"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c101"
      decimals="0"
      id="ixv-14046"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c104"
      decimals="-5"
      id="ixv-14047"
      unitRef="usd">18200000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c105"
      decimals="-5"
      id="ixv-14048"
      unitRef="usd">2300000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="c105"
      decimals="-5"
      id="ixv-14049"
      unitRef="usd">1700000</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c106"
      decimals="0"
      id="ixv-14050"
      unitRef="shares">3333</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares
      contextRef="c107"
      decimals="0"
      id="ixv-14051"
      unitRef="shares">1320</cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares>
    <cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares
      contextRef="c108"
      decimals="0"
      id="ixv-14052"
      unitRef="shares">2013</cyngn:IssuanceOfCommonStockUponExerciseOfPrefundedWarrantsinShares>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c109"
      decimals="2"
      id="ixv-14053"
      unitRef="usdPershares">0.15</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c110"
      decimals="0"
      id="ixv-14054"
      unitRef="usdPershares">1500</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c110"
      decimals="2"
      id="ixv-14055"
      unitRef="usdPershares">1499.85</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c111"
      decimals="0"
      id="ixv-14056"
      unitRef="shares">136</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c112"
      decimals="-5"
      id="ixv-14057"
      unitRef="usd">4600000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c113" decimals="0" id="ixv-14058" unitRef="usd">100000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <cyngn:CommissionProceedPercentage
      contextRef="c114"
      decimals="3"
      id="ixv-14059"
      unitRef="pure">0.03</cyngn:CommissionProceedPercentage>
    <us-gaap:CommonStockSharesIssued
      contextRef="c115"
      decimals="0"
      id="ixv-14060"
      unitRef="shares">935114</us-gaap:CommonStockSharesIssued>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c0" decimals="0" id="ixv-14061" unitRef="usd">5472691</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SalesCommissionsAndFees contextRef="c0" decimals="0" id="ixv-14062" unitRef="usd">173341</us-gaap:SalesCommissionsAndFees>
    <us-gaap:OtherLaborRelatedExpenses contextRef="c0" decimals="0" id="ixv-14063" unitRef="usd">131990</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c116" decimals="0" id="ixv-14064" unitRef="usd">4375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c117" decimals="0" id="ixv-14065" unitRef="usd">3500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c117" id="ixv-14066">2025-02-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="c117"
      decimals="2"
      id="ixv-14067"
      unitRef="pure">0.20</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:CommonStockSharesIssued
      contextRef="c116"
      decimals="0"
      id="ixv-14068"
      unitRef="shares">2701</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c0" id="ixv-14069">In addition,
on March 31, 2025, the Company reclassified the Series A warrants from liability to equity upon determining that the warrants no longer
required liability classification.&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Securities into which warrants are convertible&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Warrants&lt;br/&gt; outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Expiration&lt;br/&gt; Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair&lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 52%; text-align: left"&gt;Common stock (Initial Public Offering)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;40,650&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;October 2026&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;170,397&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Common stock (Private Placement)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;140,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;April 2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,071,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Common stock (Series A)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;517,598&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;48.30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;January 2030&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,634,428&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;518,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,875,939&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following warrants were outstanding as of
December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits,
stock dividends or other extraordinary dividends, or other similar changes in the Company&#x2019;s common stock or capital structure, and
none of which have any participating rights for any losses:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Securities into which warrants are convertible&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;br/&gt;
outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;br/&gt;
Price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expiration&lt;br/&gt;
Date&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair&lt;br/&gt;
value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Initial Public Offering)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,650&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 11%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;October 2026&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;170,397&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Private Placement)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;426&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;140,625&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 2027&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,071,114&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Series A)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;277,778&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;90&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 2030&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6,581,789&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Common stock (Series B)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;82,816&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;301.875&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;July 2027&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,122,138&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;361,029&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;33,945,438&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c118"
      decimals="0"
      id="ixv-14070"
      unitRef="shares">9</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c118"
      decimals="0"
      id="ixv-14071"
      unitRef="usdPershares">40650</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c119" id="ixv-14072">October 2026</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c118" decimals="0" id="ixv-14073" unitRef="usd">170397</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c120"
      decimals="0"
      id="ixv-14074"
      unitRef="shares">426</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c120"
      decimals="0"
      id="ixv-14075"
      unitRef="usdPershares">140625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c121" id="ixv-14076">April 2027</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c120" decimals="0" id="ixv-14077" unitRef="usd">6071114</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c122"
      decimals="0"
      id="ixv-14078"
      unitRef="shares">517598</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c122"
      decimals="2"
      id="ixv-14079"
      unitRef="usdPershares">48.3</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c123" id="ixv-14080">January 2030</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c122" decimals="0" id="ixv-14081" unitRef="usd">7634428</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c39"
      decimals="0"
      id="ixv-14082"
      unitRef="shares">518033</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c39" decimals="0" id="ixv-14083" unitRef="usd">13875939</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c124"
      decimals="0"
      id="ixv-14084"
      unitRef="shares">9</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c124"
      decimals="0"
      id="ixv-14085"
      unitRef="usdPershares">40650</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c125" id="ixv-8199">October 2026</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c124" decimals="0" id="ixv-14086" unitRef="usd">170397</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c126"
      decimals="0"
      id="ixv-14087"
      unitRef="shares">426</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c126"
      decimals="0"
      id="ixv-14088"
      unitRef="usdPershares">140625</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c127" id="ixv-8223">April 2027</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c126" decimals="0" id="ixv-14089" unitRef="usd">6071114</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c128"
      decimals="0"
      id="ixv-14090"
      unitRef="shares">277778</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c128"
      decimals="0"
      id="ixv-14091"
      unitRef="usdPershares">90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c129" id="ixv-8246">January 2030</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c128" decimals="0" id="ixv-14092" unitRef="usd">6581789</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c130"
      decimals="0"
      id="ixv-14093"
      unitRef="shares">82816</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c130"
      decimals="3"
      id="ixv-14094"
      unitRef="usdPershares">301.875</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cyngn:WarrantsAndRightOutstandingMaturityDate contextRef="c131" id="ixv-8269">July 2027</cyngn:WarrantsAndRightOutstandingMaturityDate>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c130" decimals="0" id="ixv-14095" unitRef="usd">21122138</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c132"
      decimals="0"
      id="ixv-14096"
      unitRef="shares">361029</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c132" decimals="0" id="ixv-14097" unitRef="usd">33945438</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c0" id="ixv-8315">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company used the following assumptions for
December 31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Initial&lt;br/&gt;
Public&lt;br/&gt; Offering&lt;br/&gt; Warrants&lt;/p&gt;&lt;p style="margin: 0pt 0"&gt;(Oct 2021)&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Private&lt;br/&gt;
Placement Warrants&lt;/p&gt;

&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;(Apr 2022)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.88&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.37&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.13&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.92&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;As such, the Series A warrants were reclassified to equity and remeasured utilizing the
Black Scholes model with the following assumptions:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series A&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;14.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;183.38&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Series B warrants were re-measured
prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series B&lt;br/&gt;
Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 89%"&gt;&lt;span style="font-size: 10pt"&gt;Fair value of underlying securities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;6.01 &#x2013; 32.19 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;162.99 &#x2013; 190.53&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;2.46 &#x2013; 2.49&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;4.18 &#x2013; 4.30&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company used the following assumptions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series A&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Series B&lt;br/&gt; Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Fair value of underlying securities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161.78&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.29&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.29&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c133"
      decimals="2"
      id="ixv-14098"
      unitRef="pure">2.88</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c134"
      decimals="2"
      id="ixv-14099"
      unitRef="pure">1.37</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c135"
      decimals="1"
      id="ixv-14100"
      unitRef="pure">51</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c136"
      decimals="1"
      id="ixv-14101"
      unitRef="pure">45</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c137"
      decimals="1"
      id="ixv-14102"
      unitRef="pure">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c138"
      decimals="1"
      id="ixv-14103"
      unitRef="pure">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c139"
      decimals="2"
      id="ixv-14104"
      unitRef="pure">1.13</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c140"
      decimals="2"
      id="ixv-14105"
      unitRef="pure">2.92</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c141"
      decimals="2"
      id="ixv-14107"
      unitRef="pure">14.75</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c142"
      decimals="2"
      id="ixv-14108"
      unitRef="pure">183.38</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c143"
      decimals="2"
      id="ixv-14109"
      unitRef="pure">4.96</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c144"
      decimals="2"
      id="ixv-14110"
      unitRef="pure">4.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c145"
      decimals="2"
      id="ixv-14111"
      unitRef="pure">6.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c146"
      decimals="2"
      id="ixv-14112"
      unitRef="pure">32.19</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c147"
      decimals="2"
      id="ixv-14113"
      unitRef="pure">162.99</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c148"
      decimals="2"
      id="ixv-14114"
      unitRef="pure">190.53</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c149"
      decimals="2"
      id="ixv-14115"
      unitRef="pure">2.46</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c150"
      decimals="2"
      id="ixv-14116"
      unitRef="pure">2.49</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c151"
      decimals="2"
      id="ixv-14117"
      unitRef="pure">4.18</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c152"
      decimals="2"
      id="ixv-14118"
      unitRef="pure">4.3</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c153"
      decimals="2"
      id="ixv-14119"
      unitRef="pure">0.85</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c154"
      decimals="2"
      id="ixv-14120"
      unitRef="pure">0.85</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c155"
      decimals="2"
      id="ixv-14121"
      unitRef="pure">161.78</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c156"
      decimals="2"
      id="ixv-14122"
      unitRef="pure">161.78</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c157"
      decimals="1"
      id="ixv-14123"
      unitRef="pure">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c158"
      decimals="1"
      id="ixv-14124"
      unitRef="pure">5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c159"
      decimals="2"
      id="ixv-14125"
      unitRef="pure">4.29</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c160"
      decimals="2"
      id="ixv-14126"
      unitRef="pure">4.29</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-8532">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;8. Net Loss Per Share Attributable to Common Stockholders&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with ASC 260, basic and diluted
earnings per shares amounts, and weighted-average shares outstanding have been restated for all periods presented to reflect the effect
of these stock dividends. The following table summarizes the computation of basic and diluted loss per share:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Years Ended&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024 &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Net loss attributable to common stockholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;4,540,481&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,221&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;(5.17&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,521.41&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic loss per share is based upon the weighted
average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect of unvested restricted
stock awards and the convertible preferred stock; however, such items were not considered in the calculation of the diluted weighted average
common shares outstanding since they would be anti-dilutive.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Unless otherwise expressly provided in this Annual
Report, all historical per share data, number of shares issued and outstanding, stock awards, and other common stock equivalents set forth
herein relating to our common stock have been adjusted to give effect to a reverse stock split of our common stock in a ratio of 1-for-100
effected on July 3, 2024 and 1-for-150 effected on February 18, 2025.&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-14127">The following table summarizes the computation of basic and diluted loss per share:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Years Ended&lt;br/&gt; December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024 &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Net loss attributable to common stockholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;span style="font-size: 10pt"&gt;Basic and diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;4,540,481&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,221&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Loss per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;(5.17&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,521.41&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="0" id="ixv-14128" unitRef="usd">-23469273</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c5" decimals="0" id="ixv-14129" unitRef="usd">-33335579</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-14130"
      unitRef="shares">4540481</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-14131"
      unitRef="shares">4540481</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c5"
      decimals="0"
      id="ixv-14132"
      unitRef="shares">13221</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c5"
      decimals="0"
      id="ixv-14133"
      unitRef="shares">13221</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-14134"
      unitRef="usdPershares">-5.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-14135"
      unitRef="usdPershares">-5.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c5"
      decimals="2"
      id="ixv-14136"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c5"
      decimals="2"
      id="ixv-14137"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0" id="ixv-8625">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;9. Stock-based Compensation Expense&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Stock-Based Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company uses stock-based compensation, including
restricted stock units, to provide long-term performance incentives for its employees and board directors. The Company measures employee
and director stock-based compensation awards based on the award&#x2019;s estimated fair value on the date of grant. Forfeitures are recognized
as they occur. Expense associated with these awards is recognized using the straight-line attribution method over the requisite service
period for stock options, restricted stock units (&#x201c;RSUs&#x201d;) and restricted stock and is reported in our consolidated statements
of stockholders&#x2019; equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&#x2019;s stock options
is estimated using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period
during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as
they occur. Stock options generally vest over four years and have a contractual term of ten years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Determining the grant date fair value of options
requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different assumptions had
been used, stock-based compensation expense could have been materially different from the amounts recorded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The assumptions and estimates for valuing stock
options are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;Fair value per share of Company&#x2019;s
common stock.&lt;/i&gt; Because there was no public market for Cyngn&#x2019;s common stock prior to the IPO, its Board of Directors, with the
assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock options by
considering a number of objective and subjective factors, including its actual operating and financial performance, market conditions
and performance of comparable publicly traded companies, developments and milestones in the company, and the likelihood of achieving
a liquidity event among other factors. Since the Company&#x2019;s common stock began publicly trading on the Nasdaq, the value of its
common stock underlying stock options or RSUs have been valued based on prevailing market prices.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;Expected volatility&lt;/i&gt;. Because
the Company&#x2019;s common stock had no publicly traded history prior to the IPO, it estimated the expected volatility using a combination
of its stock price volatility and the stock price volatility of peer companies, for a period equal to the expected term of the options.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;Expected term.&lt;/i&gt; The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company estimates the expected term of options granted based upon the &#x201c;simplified method&#x201d; provided under &lt;i&gt;Staff Accounting Bulletin, Topic 14&lt;/i&gt;, or SAB Topic 14.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;Risk-free interest rate. &lt;/i&gt;The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;i&gt;Estimated dividend yield. &lt;/i&gt;The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Equity Incentive Plans&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2013, the Company&#x2019;s Board of
Directors adopted the 2013 Equity Incentive Plan (&#x201c;2013 Plan&#x201d;). The 2013 Plan authorizes the award of stock options, stock
appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2021, the Company&#x2019;s Board of
Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). The 2021 Plan replaces the 2013 Plan. However,
awards outstanding under the 2013 Plan will continue to be governed by their existing terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In November 2023, the shareholders of the Company
approved an amendment to the Company&#x2019;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 334
shares of common stock. In June 2024, the shareholders of the Company approved an amendment to allow an annual increase to the 2021 Plan
equal to the least of (i) 15% of the outstanding common stock on a fully diluted basis as of the end of the Company&#x2019;s immediately
preceding fiscal year, or (ii) such lesser amount as determined by the Board. In December 2025, the shareholders of the Company approved
an amendment to the Company&#x2019;s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 4,000,000 shares
of common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025 and December 31, 2024,
approximately 55,770 and 614 shares of common stock were reserved and available for issuance under the 2021 Plan, respectively. Options
issued under the Plans generally vest based on continuous service provided by the option holder over a four-year period. Compensation
expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant
date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes information about
the Company&#x2019;s stock options outstanding as well as stock options vested and exercisable as of December 31, 2025, and activity during
the year end then ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;br/&gt;
average &lt;br/&gt;
exercise&lt;br/&gt;
price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;br/&gt;
average remaining&lt;br/&gt;
contractual&lt;br/&gt;
term&lt;br/&gt;
(years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;
intrinsic&lt;br/&gt;
value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,151&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,665.36&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.37&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(227&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,438.45&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;924&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,475.78&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.41&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested and expected to vest at December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;924&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,475.78&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.41&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested and exercisable at December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;764&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,264.58&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.95&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes information about
the Company&#x2019;s RSUs as of December 31, 2025, and activity during the year then ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt; average&lt;br/&gt; grant date&lt;br/&gt; fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Unvested shares at December 31, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,957.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;RSUs granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;RSUs vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,957.75&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;RSUs forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Unvested Shares at December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of a stock option is estimated
using the Black-Scholes option-pricing model that takes into account as of the grant date the exercise price and expected life of the
option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free interest
rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all option grants
based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized in the
financial statements upon satisfaction of the requisite service or vesting requirements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were no shares issued in 2025,
therefore no fair value was determined. The weighted average per share grant-date fair value of options granted during the year
ended December 31, 2025 and 2024 was $0 and $5.59, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following weighted average assumptions were
used in estimating the grant date fair values in December 31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%"&gt;Fair value of common stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,521.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.76&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We recorded stock-based compensation expense
from stock options and RSUs of approximately $1,620,992 and $2,449,191, during the years ended December 31, 2025 and 2024, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, total stock-based compensation
cost related to outstanding unvested stock options that are expected to vest was $1.4 million. This unrecognized stock-based compensation
cost is expected to be recognized over a weighted-average period of approximately 1.3 years. Income tax benefits recognized from stock-based
compensation expense recognized for the year ended December 31, 2025 were immaterial due to cumulative losses and valuation allowances.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c0" id="ixv-14138">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1 contextRef="c0" id="ixv-14139">P10Y</us-gaap:DeferredCompensationArrangementWithIndividualMaximumContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-14140" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c161"
      decimals="0"
      id="ixv-14141"
      unitRef="shares">334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <cyngn:CommonStockOutstandingPercentage
      contextRef="c162"
      decimals="2"
      id="ixv-14142"
      unitRef="pure">0.15</cyngn:CommonStockOutstandingPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c163"
      decimals="0"
      id="ixv-14143"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c164"
      decimals="0"
      id="ixv-14144"
      unitRef="shares">55770</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c165"
      decimals="0"
      id="ixv-14145"
      unitRef="shares">614</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock contextRef="c0" id="ixv-8718">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes information about
the Company&#x2019;s stock options outstanding as well as stock options vested and exercisable as of December 31, 2025, and activity during
the year end then ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;br/&gt;
average &lt;br/&gt;
exercise&lt;br/&gt;
price&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;br/&gt;
average remaining&lt;br/&gt;
contractual&lt;br/&gt;
term&lt;br/&gt;
(years)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;br/&gt;
intrinsic&lt;br/&gt;
value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="width: 52%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,151&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,665.36&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7.37&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-104; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Granted&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-105; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-106; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exercised&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cancelled/forfeited&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(227&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,438.45&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;924&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,475.78&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.41&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested and expected to vest at December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;924&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,475.78&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4.41&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Vested and exercisable at December 31, 2025&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;764&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13,264.58&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.95&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c4"
      decimals="INF"
      id="ixv-14146"
      unitRef="shares">1151</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c4"
      decimals="2"
      id="ixv-14147"
      unitRef="usdPershares">14665.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c168" id="ixv-8770">P7Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c0"
      decimals="INF"
      id="ixv-14148"
      unitRef="shares">227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      decimals="2"
      id="ixv-14149"
      unitRef="usdPershares">19438.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c3"
      decimals="INF"
      id="ixv-14150"
      unitRef="shares">924</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c3"
      decimals="2"
      id="ixv-14151"
      unitRef="usdPershares">13475.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c0" id="ixv-8862">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c3"
      decimals="INF"
      id="ixv-14152"
      unitRef="shares">924</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c3"
      decimals="2"
      id="ixv-14153"
      unitRef="usdPershares">13475.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-8888">P4Y4M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c3"
      decimals="INF"
      id="ixv-14154"
      unitRef="shares">764</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c3"
      decimals="2"
      id="ixv-14155"
      unitRef="usdPershares">13264.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c0" id="ixv-8914">P3Y11M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c0" id="ixv-8939">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes information about
the Company&#x2019;s RSUs as of December 31, 2025, and activity during the year then ended:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Weighted-&lt;br/&gt; average&lt;br/&gt; grant date&lt;br/&gt; fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%"&gt;Unvested shares at December 31, 2024&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;20&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21,957.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;RSUs granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;RSUs vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21,957.75&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;RSUs forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Unvested Shares at December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c169"
      decimals="INF"
      id="ixv-14156"
      unitRef="shares">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c169"
      decimals="2"
      id="ixv-14157"
      unitRef="usdPershares">21957.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c170"
      decimals="INF"
      id="ixv-14158"
      unitRef="shares">20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c170"
      decimals="2"
      id="ixv-14159"
      unitRef="usdPershares">21957.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c0"
      decimals="0"
      id="ixv-14160"
      unitRef="usdPershares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c5"
      decimals="2"
      id="ixv-14161"
      unitRef="usdPershares">5.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-9015">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following weighted average assumptions were
used in estimating the grant date fair values in December 31, 2025 and 2024:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%"&gt;Fair value of common stock&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,521.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54.76&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="c3"
      decimals="2"
      id="ixv-14162"
      unitRef="usdPershares">0</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="c4"
      decimals="2"
      id="ixv-14163"
      unitRef="usdPershares">1521</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c5" id="ixv-14164">P6Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="2" id="ixv-14165" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c5" decimals="4" id="ixv-14166" unitRef="pure">0.0396</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c0" decimals="2" id="ixv-14167" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c5" decimals="4" id="ixv-14168" unitRef="pure">0.5476</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="2" id="ixv-14169" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c5" decimals="2" id="ixv-14170" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c166" decimals="0" id="ixv-14171" unitRef="usd">1620992</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c167" decimals="0" id="ixv-14172" unitRef="usd">2449191</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c3" decimals="-5" id="ixv-14173" unitRef="usd">1400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c0" id="ixv-14174">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c0" id="ixv-9103">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;10. Retirement Savings Plan&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective November 17, 2017, the Company established
the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the intention to provide a
measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement Income Security Act of
1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. The Company did not offer and has not provided a company
match for its 401(k) Plan.&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-9111">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;11. Income Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Domestic and international pre-tax loss consists of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024 &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;International&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2025 and 2024,
income tax expense attributable to operations is immaterial.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income tax expense differed from the amount computed
by applying the federal statutory income tax rate of 21% to pretax income for the years ended December 31, 2025 and 2024 as a result of
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Percent&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;US Federal Statutory Tax Rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,928,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State and Local Income Taxes (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(211,513&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign Tax Effects&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Tax Credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,010,247&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in Valuation Allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,421,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18.84&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Nontaxable or Nondeductible Items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Section 162m Limitation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;262,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Warrant Revaluation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;248,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;236,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.01&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in unrecognized tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.29&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other Reconciling Items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Deferred True Up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;622,366&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.65&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;55,184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.24&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, &lt;br/&gt;
2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Federal tax at statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(6,142,980&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(218,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Foreign taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,039,015&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Nondeductible items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,327,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Deferred true up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,165,581&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rate change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;717,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other items&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes.
Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred tax assets: &lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 76%; padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,820,615&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,178,997&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,713,764&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,006,591&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;616,331&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;880,481&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(365,067&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(181,103&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,813&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;452,339&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;441,240&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281,367&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;155,914&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,751&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,491,200&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;69,025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized research costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,761,293&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,280,797&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;223&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,639&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,663,326&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,998,884&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 18.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(54,355,211&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(49,934,084&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 16.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred project costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 16.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management regularly assesses the ability to realize
deferred tax assets recorded based upon the weight of available evidence, including such factors as recent earnings history and expected
future taxable income on a jurisdiction by jurisdiction basis. In the event that the Company changes its determination as to the amount
of realizable deferred tax assets, the Company will adjust its valuation allowance with a corresponding impact to the provision for income
taxes in the period in which such determination is made. The Company&#x2019;s management believes that, based on a number of factors, it
is more likely than not, that all or some portion of the deferred tax assets will not be realized; and accordingly, for the year ended
December 31, 2025, the Company has provided a valuation allowance against the Company&#x2019;s U.S. net deferred tax assets. The net change
in the valuation allowance for the years ended December 31, 2025 and 2024 was an increase of $4,421,241 and $5,327,800, respectively.&lt;/p&gt;

&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company had net operating loss carryforwards
for federal and state income tax purposes of approximately $161,732,697 and $120,845,916, respectively, which will begin to expire in
2034 and 2035 with $126,395,500 of our federal net operating loss carryforward lasting indefinitely.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company had
federal and state research credit carryforwards of approximately $7,526,906 and $4,421,211, respectively. The federal research
credit carryforwards will begin to expire in 2033 while the California research credits carry forward have an indefinite life.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Internal Revenue Code of 1986, as amended,
imposes restrictions on the utilization of net operating losses in the event of an &#x201c;ownership change&#x201d; of a corporation. Accordingly,
a company&#x2019;s ability to use net operating losses may be limited as prescribed under Internal Revenue Code Section 382 (&#x201c;IRC
Section 382&#x201d;). Events which may cause limitations in the amount of the net operating losses that the Company may use in any one
year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the federal
and state net operating losses may be subject to substantial annual limitation due to the ownership change limitations provided by the
IRC Section 382 and similar state provisions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective for tax years beginning after December
31, 2021, the Tax Cuts and Jobs Act of 2017 eliminates the option to deduct research and development expenditures currently and requires
taxpayers to amortize such costs over a period of five or fifteen years. While it is possible that Congress may modify, defer, or repeal
such provision, we have no assurance that the provision will be modified, deferred or repealed. This legislation has accelerated the utilization
of our net operating losses in the U.S., but it has not impacted our current tax obligations.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In response to the COVID-19 pandemic, the Coronavirus
Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide
additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions
related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations,
and an option to defer payroll tax payments for a limited period. In 2023, we assessed our eligibility to claim a refund of employer taxes
available under the Employee Retention Credit provisions of the CARES Act. For the year ended December 31, 2023, we calculated eligible
credits of approximately $763,624 provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses.
As of December 31, 2025 and 2024, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects changes in gross
unrecognized tax benefits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,002,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,545,189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Increase in balance related to tax positions taken during the current year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;445,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Increase in balance related to tax positions taken during prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Decrease in balance related to prior year tax positions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Decrease in balance related to settlement with tax authorities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Balance at end of year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,305,899&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,002,825&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025 and 2024, the total amount
of gross unrecognized tax benefits was $3,305,899 and $3,002,825, respectively, which does not include any reserved interest or penalties.
As of December 31, 2025, $3,305,899 of the total unrecognized tax benefits, if recognized, would have an impact on the Company&#x2019;s
effective tax rate. The Company estimates that there will be no material changes in its uncertain tax positions in the next 12 months.
The Company&#x2019;s has not recorded any interest or penalties related to its unrecognized tax benefits for 2025 or 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company files income tax returns in the U.S.
federal and various state jurisdictions with varying statutes of limitations. The Company is generally no longer subject to tax examinations
for years prior to 2021 for federal purposes and 2020 for state purposes, except in certain limited circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;However, due to the fact that the Company had loss and credits carried
forward in some jurisdictions, certain items attributable to technically closed years are still subject to adjustment by the relevant
taxing authority through an adjustment to tax attributes carried forward to open years. The Company&#x2019;s NOL and credit carryforwards from
all years may be subject to adjustment for three (or four for certain states) following the year in which utilized. The Company does not
anticipate that any potential tax adjustments will have a significant impact on our financial position or results of operations.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c0" id="ixv-9116">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Domestic and international pre-tax loss consists of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024 &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;International&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(23,469,273&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c0" decimals="0" id="ixv-14175" unitRef="usd">-23469273</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c5" decimals="0" id="ixv-14176" unitRef="usd">-33335579</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="0" id="ixv-14177" unitRef="usd">-23469273</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c5" decimals="0" id="ixv-14178" unitRef="usd">-33335579</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0" id="ixv-9169">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income tax expense differed from the amount computed
by applying the federal statutory income tax rate of 21% to pretax income for the years ended December 31, 2025 and 2024 as a result of
the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Percent&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;US Federal Statutory Tax Rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(4,928,547&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;21.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State and Local Income Taxes (1)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(211,513&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.90&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Foreign Tax Effects&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Tax Credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,010,247&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in Valuation Allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,421,241&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18.84&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Nontaxable or Nondeductible Items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Section 162m Limitation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;262,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Warrant Revaluation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;248,946&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.06&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;236,687&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.01&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in unrecognized tax benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.29&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Other Reconciling Items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 9pt"&gt;Deferred True Up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;622,366&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.65&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 9pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;55,184&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(0.24&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;i&gt;For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.&lt;/i&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31, &lt;br/&gt;
2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Federal tax at statutory rate&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(6,142,980&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;State income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(218,456&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Foreign taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax credits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,039,015&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Nondeductible items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,327,801&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Deferred true up&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,165,581&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Rate change&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;717,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other items&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(18,029&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-126"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" id="ixv-14179" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="0" id="ixv-14180" unitRef="usd">-4928547</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="4" id="ixv-14181" unitRef="pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="0" id="ix_0_fact" unitRef="usd">-211513</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="4" id="ix_1_fact" unitRef="pure">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="4" id="ixv-14184" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationTaxCredits contextRef="c0" decimals="0" id="ixv-14185" unitRef="usd">1010247</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits contextRef="c0" decimals="4" id="ixv-14186" unitRef="pure">-0.043</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="0" id="ixv-14187" unitRef="usd">4421241</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c0" decimals="4" id="ixv-14188" unitRef="pure">-0.1884</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c176" decimals="0" id="ixv-14189" unitRef="usd">262808</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c176"
      decimals="4"
      id="ixv-14190"
      unitRef="pure">-0.0112</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c177" decimals="0" id="ixv-14191" unitRef="usd">248946</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c177"
      decimals="4"
      id="ixv-14192"
      unitRef="pure">-0.0106</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c178" decimals="0" id="ixv-14193" unitRef="usd">236687</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="c178"
      decimals="4"
      id="ixv-14194"
      unitRef="pure">-0.0101</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c0" decimals="0" id="ixv-14195" unitRef="usd">303074</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="c0" decimals="4" id="ixv-14196" unitRef="pure">-0.0129</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c0" decimals="0" id="ixv-14197" unitRef="usd">622366</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes contextRef="c0" decimals="4" id="ixv-14198" unitRef="pure">-0.0265</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c0" decimals="0" id="ixv-14199" unitRef="usd">55184</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent contextRef="c0" decimals="4" id="ixv-14200" unitRef="pure">-0.0024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="4" id="ixv-14201" unitRef="pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c5" decimals="0" id="ixv-14202" unitRef="usd">-6142980</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c5" decimals="0" id="ixv-14203" unitRef="usd">-218456</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c5" decimals="0" id="ixv-14204" unitRef="usd">180319</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationTaxCredits contextRef="c5" decimals="0" id="ixv-14205" unitRef="usd">1039015</us-gaap:IncomeTaxReconciliationTaxCredits>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="c5" decimals="0" id="ixv-14206" unitRef="usd">26970</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c5" decimals="0" id="ixv-14207" unitRef="usd">5327801</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c5" decimals="0" id="ixv-14208" unitRef="usd">1165581</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="0" id="ixv-14209" unitRef="usd">717809</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c5" decimals="0" id="ixv-14210" unitRef="usd">-18029</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0" id="ixv-14211">Significant components of our deferred tax assets and liabilities as of December 31, 2025 and 2024 are as following:&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred tax assets: &lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 76%; padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;41,820,615&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;36,178,997&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,713,764&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,006,591&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;616,331&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;880,481&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fixed assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(365,067&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(181,103&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;27,813&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;452,339&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;441,240&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;281,367&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;155,914&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21,751&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,491,200&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;69,025&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized research costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,761,293&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,280,797&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;223&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,639&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;55,663,326&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;49,998,884&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 18.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(54,355,211&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(49,934,084&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 16.45pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9.25pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred project costs&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 8.35pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,308,115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(64,800&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 16.45pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c3" decimals="0" id="ixv-14212" unitRef="usd">41820615</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c4" decimals="0" id="ixv-14213" unitRef="usd">36178997</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c3" decimals="0" id="ixv-14214" unitRef="usd">7713764</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c4" decimals="0" id="ixv-14215" unitRef="usd">7006591</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c3" decimals="0" id="ixv-14216" unitRef="usd">616331</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c4" decimals="0" id="ixv-14217" unitRef="usd">880481</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <cyngn:DeferredTaxAssetsFixedAssets contextRef="c3" decimals="0" id="ixv-14218" unitRef="usd">-365067</cyngn:DeferredTaxAssetsFixedAssets>
    <cyngn:DeferredTaxAssetsFixedAssets contextRef="c4" decimals="0" id="ixv-14219" unitRef="usd">-181103</cyngn:DeferredTaxAssetsFixedAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c3" decimals="0" id="ixv-14220" unitRef="usd">27813</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c4" decimals="0" id="ixv-14221" unitRef="usd">452339</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves contextRef="c3" decimals="0" id="ixv-14222" unitRef="usd">441240</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves contextRef="c4" decimals="0" id="ixv-14223" unitRef="usd">281367</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="c3" decimals="0" id="ixv-14224" unitRef="usd">155914</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="c4" decimals="0" id="ixv-14225" unitRef="usd">21751</us-gaap:DeferredTaxAssetsDeferredIncome>
    <cyngn:DeferredTaxAssetsLeaseLiability contextRef="c3" decimals="0" id="ixv-14226" unitRef="usd">1491200</cyngn:DeferredTaxAssetsLeaseLiability>
    <cyngn:DeferredTaxAssetsLeaseLiability contextRef="c4" decimals="0" id="ixv-14227" unitRef="usd">69025</cyngn:DeferredTaxAssetsLeaseLiability>
    <cyngn:DeferredTaxAssetsCapitalizedResearchCosts contextRef="c3" decimals="0" id="ixv-14228" unitRef="usd">3761293</cyngn:DeferredTaxAssetsCapitalizedResearchCosts>
    <cyngn:DeferredTaxAssetsCapitalizedResearchCosts contextRef="c4" decimals="0" id="ixv-14229" unitRef="usd">5280797</cyngn:DeferredTaxAssetsCapitalizedResearchCosts>
    <us-gaap:DeferredTaxAssetsOther contextRef="c3" decimals="0" id="ixv-14230" unitRef="usd">223</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c4" decimals="0" id="ixv-14231" unitRef="usd">8639</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c3" decimals="0" id="ixv-14232" unitRef="usd">55663326</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c4" decimals="0" id="ixv-14233" unitRef="usd">49998884</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="0" id="ixv-14234" unitRef="usd">54355211</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c4" decimals="0" id="ixv-14235" unitRef="usd">49934084</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c3" decimals="0" id="ixv-14236" unitRef="usd">1308115</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c4" decimals="0" id="ixv-14237" unitRef="usd">64800</us-gaap:DeferredTaxAssetsNet>
    <cyngn:DeferredTaxLiabilitiesRightOfUseAsset contextRef="c3" decimals="0" id="ixv-14238" unitRef="usd">1308115</cyngn:DeferredTaxLiabilitiesRightOfUseAsset>
    <cyngn:DeferredTaxLiabilitiesRightOfUseAsset contextRef="c4" decimals="0" id="ixv-14239" unitRef="usd">64800</cyngn:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c3" decimals="0" id="ixv-14240" unitRef="usd">1308115</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c4" decimals="0" id="ixv-14241" unitRef="usd">64800</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c5" decimals="0" id="ixv-14242" unitRef="usd">4421241</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c0" decimals="0" id="ixv-14243" unitRef="usd">5327800</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c172" decimals="0" id="ixv-14244" unitRef="usd">161732697</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c173" decimals="0" id="ixv-14245" unitRef="usd">120845916</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal contextRef="c174" decimals="0" id="ixv-14246" unitRef="usd">126395500</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c172" decimals="0" id="ixv-14247" unitRef="usd">7526906</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c173" decimals="0" id="ixv-14248" unitRef="usd">4421211</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions contextRef="c0" decimals="2" id="ixv-14249" unitRef="pure">0.50</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:OtherExpenses contextRef="c175" decimals="0" id="ixv-14250" unitRef="usd">763624</us-gaap:OtherExpenses>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c0" id="ixv-9730">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects changes in gross
unrecognized tax benefits:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,002,825&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,545,189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Increase in balance related to tax positions taken during the current year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;303,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;445,293&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Increase in balance related to tax positions taken during prior years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-130"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,343&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Decrease in balance related to prior year tax positions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-131"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-132"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Decrease in balance related to settlement with tax authorities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-133"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-134"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Balance at end of year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,305,899&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,002,825&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c4" decimals="0" id="ixv-14251" unitRef="usd">3002825</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c10" decimals="0" id="ixv-14252" unitRef="usd">2545189</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c0" decimals="0" id="ixv-14253" unitRef="usd">303074</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c5" decimals="0" id="ixv-14254" unitRef="usd">445293</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c5" decimals="0" id="ixv-14255" unitRef="usd">12343</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c3" decimals="0" id="ixv-14256" unitRef="usd">3305899</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c4" decimals="0" id="ixv-14257" unitRef="usd">3002825</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c3" decimals="0" id="ixv-14258" unitRef="usd">3305899</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c4" decimals="0" id="ixv-14259" unitRef="usd">3002825</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c3" decimals="0" id="ixv-14260" unitRef="usd">3305899</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-9833">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;12. Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Legal Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Company may become involved
in legal proceedings arising in the ordinary course of business. Regardless of outcome, litigation can have an adverse impact on us due
to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors. The assessment
as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves
significant judgment about future events, and the outcome of litigation, which is inherently uncertain.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In May 2025, a former contractor of the Company
filed a complaint alleging breach of contract and related claims arising from certain professional services agreements entered into between
2021 and 2024. The complaint seeks approximately $59,760&#160;in damages, plus interest, attorneys&#x2019; fees, and costs. The matter
is in its early stages, and the Company is evaluating the claims and intends to respond accordingly. The Company has recorded an accrual
of approximately $33,000 in connection with the foregoing matters .&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August 2025, a former employee filed a complaint with the U.S. Department
of Labor, Occupational Safety and Health Administration (&#x201c;OSHA&#x201d;), alleging retaliation in connection with the employee&#x2019;s
internal reporting. To avoid litigation and minimize costs, the Company has agreed in principle, subject to final documentation, to a
one-time payment of $80,000&#160;to settle a contract dispute, which payment is included in accrued expenses as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under the terms of a settlement agreement with a former placement agent,
the Company may be obligated to pay a maximum of $2.3&#160;million cash fee and issue&#160;370,114&#160;warrants to purchase shares of
the Company&#x2019;s common stock in connection with the June 27 Offering and the June 26 Offering. However, the Company has informed the
former placement agent that it does not believe there is a basis for these obligations. The Company has not received a response from the
former placement agent and a resolution has not been reached as of the date of this filing. Since the Company is contesting the matter
and it has not accrued any liability related to it. While an unfavorable outcome is reasonably possible, the Company is unable to estimate
the possible loss at this time.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is subject to legal and regulatory actions that arise from
time to time. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss
is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. To avoid
litigation and minimize costs, the Company agreed in principle, subject to final documentation, to a one-time payment of $500,000 to settle
a contract dispute, of which payment was included in accrued expenses as of December 31, 2024 and paid out in March 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There was no other material pending or threatened
litigation against the Company that remains outstanding as of December 31, 2025.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyLossInPeriod contextRef="c179" decimals="0" id="ixv-14261" unitRef="usd">59760</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyAccrualPayments contextRef="c180" decimals="0" id="ixv-14262" unitRef="usd">33000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:ContractualObligation contextRef="c3" decimals="0" id="ixv-14263" unitRef="usd">80000</us-gaap:ContractualObligation>
    <cyngn:SettlementAgreementAmount contextRef="c0" decimals="-5" id="ixv-14264" unitRef="usd">2300000</cyngn:SettlementAgreementAmount>
    <cyngn:WarrantsToPurchaseShares
      contextRef="c0"
      decimals="0"
      id="ixv-14265"
      unitRef="shares">370114</cyngn:WarrantsToPurchaseShares>
    <us-gaap:PaymentsForLegalSettlements contextRef="c5" decimals="0" id="ixv-14266" unitRef="usd">500000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0" id="ixv-9856">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;13. Risks and Uncertainties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s business operations, operating
results, and financial condition are vulnerable to certain risks and uncertainties including:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Inflation and its related impact
on costs and expenditures on domestic and foreign-sourced materials and services;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Rising interest rates and its
impact on the equity markets, investment valuations, and interest rate-sensitive calculations such as discount rate assumptions used
in cash flow projections and going concern assessments;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Effects of the Russia-Ukraine
conflict such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Other factors beyond its control
such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is unable to predict and quantify
at this time the extent of the related potential adverse effects but continuously monitors these risks and uncertainties on its future
operations and financial performance.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-9913">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;14. Subsequent Events&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;ATM &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 19, 2026, the Company has sold 3,922,113
additional shares under the ATM Sales Agreement, for net proceeds of $9,166,427 after payment of commission and fees of $283,498.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Registered Direct Offering&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 16, 2026, the Company entered into a
securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 1,686,788 shares
of its common stock, par value $0.00001 per share at a purchase price of $1.93 per share and 3,313,212 pre-funded warrants to purchase
shares of Common Stock, at a purchase price of $ of $1.92999 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component
of permanent stockholders&#x2019; equity within additional paid-in capital and were recorded at the issuance date concluding the purchase
price approximated the fair value. The offering closed on March 17, 2026. The Company received net proceeds of approximately $8.8 million
from the offering, after deducting the estimated offering expenses payable by the Company of $0.85 million, including the placement agent
fees.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c181"
      decimals="0"
      id="ixv-14267"
      unitRef="shares">3922113</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity contextRef="c181" decimals="0" id="ixv-14268" unitRef="usd">9166427</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:SalesCommissionsAndFees contextRef="c181" decimals="0" id="ixv-14269" unitRef="usd">283498</us-gaap:SalesCommissionsAndFees>
    <us-gaap:CommonStockSharesIssued
      contextRef="c182"
      decimals="0"
      id="ixv-14270"
      unitRef="shares">1686788</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c182"
      decimals="5"
      id="ixv-14271"
      unitRef="usdPershares">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c182"
      decimals="2"
      id="ixv-14272"
      unitRef="usdPershares">1.93</us-gaap:SaleOfStockPricePerShare>
    <cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock
      contextRef="c182"
      decimals="0"
      id="ixv-14273"
      unitRef="shares">3313212</cyngn:PrefundedWarrantsToPurchaseSharesOfCommonStock>
    <cyngn:PreFundedWarrantsPricePerShare
      contextRef="c182"
      decimals="5"
      id="ixv-14274"
      unitRef="usdPershares">1.92999</cyngn:PreFundedWarrantsPricePerShare>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="c183"
      decimals="-5"
      id="ixv-14275"
      unitRef="usd">8800000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:NoninterestExpenseOfferingCost
      contextRef="c183"
      decimals="-4"
      id="ixv-14276"
      unitRef="usd">850000</us-gaap:NoninterestExpenseOfferingCost>
    <cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock contextRef="c0" id="ixv-9931">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;15. Restatement of Previously Issued Audited
Financial Statements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company restated its previously reported financial
statements for each of the period ended December 31, 2024. The adjustment resulted in an increase to warrant liability by $12.7 million,
a decrease in equity balance by $12.7 million and an adjustment from operating activities to financing activities on the statement of
cash flow as of December 31, 2024. The Company recognized a loss on the issuance of the Warrants of approximately $2.3 million and offering-related
issuance costs of approximately $1.7 million as of December 31, 2024.&lt;/p&gt;

&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;br/&gt;
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated
balances as of December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Balance Sheet&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;15,012,361&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;12,691,566&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;27,703,927&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,501,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,641,566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;31,143,265&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Additional paid-in capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,863,551&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;192,305,280&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated deficits&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(189,269,903&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(193,353,198&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total stockholders&#x2019; equity (deficit)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,593,650&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,641,566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,047,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Warrant liability issuance costs&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,739,148&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,739,148&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other income (expenses), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,424,209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,507,504&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,212.56&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(308.85&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,521.41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Stockholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt"&gt;Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;20,972,722&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,270&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;12,414,453&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Warrant issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,739,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,739,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses, lease liabilities, and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,642,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,652,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;990,357&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,493,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,702,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,196,081&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt"&gt;Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22,369,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,811,014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Proceeds from issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,260,852&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,260,852&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,584,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,702,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,286,961&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Following this review, the Company completed a
comprehensive review of its previously issued financial statements. The Company is adjusting for certain out-of-period errors that were
not material, individually or in the aggregate, and are being corrected as part of the restatement. The Company corrected a duplicate
bill of $50,000 for issuance costs on an equity transaction, resulting in a decrease in accounts payable and an increase in additional
paid-in-capital. The Company also corrected for an immaterial reallocation of proceeds from equity issuances among common stock, common
warrants, and pre-funded warrants, related to a previous issuance in 2022, resulting in a reclassification within additional paid-in-capital
sub-accounts of $88,024. This correction has no impact on total additional paid-in-capital, net loss, or total stockholders&#x2019; equity.
The Company believes the adjustments were not material to any prior period, individually or in the aggregate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Balance Sheet&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts Payable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;297,778&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;247,778&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts Payable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;100,815&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;50,815&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cyngn:RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c184"
      decimals="-5"
      id="ixv-14277"
      unitRef="usd">12700000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="c184"
      decimals="-5"
      id="ixv-14278"
      unitRef="usd">12700000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <cyngn:GainLossOnIssuanceOfWarrant
      contextRef="c184"
      decimals="-5"
      id="ixv-14279"
      unitRef="usd">2300000</cyngn:GainLossOnIssuanceOfWarrant>
    <cyngn:OfferingRelatedIssuanceCosts
      contextRef="c184"
      decimals="-5"
      id="ixv-14280"
      unitRef="usd">1700000</cyngn:OfferingRelatedIssuanceCosts>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c0" id="ixv-9936">&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;br/&gt;
The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated
balances as of December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Balance Sheet&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Warrant liability&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;15,012,361&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;12,691,566&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;27,703,927&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,501,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;12,641,566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;31,143,265&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Additional paid-in capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;200,863,551&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;192,305,280&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated deficits&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(189,269,903&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(193,353,198&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total stockholders&#x2019; equity (deficit)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,593,650&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(12,641,566&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,047,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c185" decimals="0" id="ixv-14281" unitRef="usd">15012361</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c186" decimals="0" id="ixv-14282" unitRef="usd">12691566</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c187" decimals="0" id="ixv-14283" unitRef="usd">27703927</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:Liabilities contextRef="c185" decimals="0" id="ixv-14284" unitRef="usd">18501699</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c186" decimals="0" id="ixv-14285" unitRef="usd">12641566</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c187" decimals="0" id="ixv-14286" unitRef="usd">31143265</us-gaap:Liabilities>
    <us-gaap:AdditionalPaidInCapital contextRef="c185" decimals="0" id="ixv-14287" unitRef="usd">200863551</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c186" decimals="0" id="ixv-14288" unitRef="usd">-8558271</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c187" decimals="0" id="ixv-14289" unitRef="usd">192305280</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c185" decimals="0" id="ixv-14290" unitRef="usd">-189269903</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c186" decimals="0" id="ixv-14291" unitRef="usd">-4083295</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c187" decimals="0" id="ixv-14292" unitRef="usd">-193353198</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c185" decimals="0" id="ixv-14293" unitRef="usd">11593650</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c186" decimals="0" id="ixv-14294" unitRef="usd">-12641566</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c187" decimals="0" id="ixv-14295" unitRef="usd">-1047916</us-gaap:StockholdersEquity>
    <srt:ScheduleOfCondensedIncomeStatementTableTextBlock contextRef="c0" id="ixv-10025">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Warrant liability issuance costs&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,739,148&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,739,148&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total other income (expenses), net&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(6,424,209&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(10,507,504&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,212.56&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(308.85&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,521.41&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedIncomeStatementTableTextBlock>
    <cyngn:WarrantLiabilityIssuanceCosts contextRef="c184" decimals="0" id="ixv-14296" unitRef="usd">0</cyngn:WarrantLiabilityIssuanceCosts>
    <cyngn:WarrantLiabilityIssuanceCosts contextRef="c188" decimals="0" id="ixv-14297" unitRef="usd">-1739148</cyngn:WarrantLiabilityIssuanceCosts>
    <cyngn:WarrantLiabilityIssuanceCosts contextRef="c189" decimals="0" id="ixv-14298" unitRef="usd">-1739148</cyngn:WarrantLiabilityIssuanceCosts>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c184" decimals="0" id="ixv-14299" unitRef="usd">0</cyngn:LossOnIssuanceOfWarrants>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c188" decimals="0" id="ixv-14300" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c189" decimals="0" id="ixv-14301" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <us-gaap:NonoperatingIncomeExpense contextRef="c184" decimals="0" id="ixv-14302" unitRef="usd">-6424209</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c188" decimals="0" id="ixv-14303" unitRef="usd">-4083295</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c189" decimals="0" id="ixv-14304" unitRef="usd">-10507504</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c184" decimals="0" id="ixv-14305" unitRef="usd">-29252284</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c188" decimals="0" id="ixv-14306" unitRef="usd">-4083295</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c189" decimals="0" id="ixv-14307" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c184"
      decimals="2"
      id="ixv-14308"
      unitRef="usdPershares">-2212.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c184"
      decimals="2"
      id="ixv-14309"
      unitRef="usdPershares">-2212.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c188"
      decimals="2"
      id="ixv-14310"
      unitRef="usdPershares">-308.85</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c188"
      decimals="2"
      id="ixv-14311"
      unitRef="usdPershares">-308.85</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c189"
      decimals="2"
      id="ixv-14312"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c189"
      decimals="2"
      id="ixv-14313"
      unitRef="usdPershares">-2521.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0" id="ixv-10126">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Stockholders&#x2019; Equity (Deficit)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt"&gt;Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;20,972,722&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,270&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;12,414,453&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn contextRef="c184" decimals="0" id="ixv-14314" unitRef="usd">20972722</cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn>
    <cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn contextRef="c190" decimals="0" id="ixv-14315" unitRef="usd">-8558270</cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn>
    <cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn contextRef="c191" decimals="0" id="ixv-14316" unitRef="usd">12414453</cyngn:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsAndExerciseOfPrefundedWarrantsInConn>
    <us-gaap:NetIncomeLoss contextRef="c184" decimals="0" id="ixv-14317" unitRef="usd">-29252284</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c190" decimals="0" id="ixv-14318" unitRef="usd">-4083295</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c191" decimals="0" id="ixv-14319" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <srt:ScheduleOfCondensedCashFlowStatementTableTextBlock contextRef="c0" id="ixv-10170">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,252,284&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(4,083,295&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(33,335,579&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss on issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,344,147&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Warrant issuance costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,739,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,739,148&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses, lease liabilities, and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,642,938&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(9,652,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;990,357&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,493,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,702,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,196,081&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10.25pt"&gt;Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;22,369,285&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(8,558,271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,811,014&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Proceeds from issuance of warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,260,852&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;18,260,852&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;26,584,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;9,702,581&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36,286,961&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedCashFlowStatementTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c184" decimals="0" id="ixv-14320" unitRef="usd">-29252284</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c190" decimals="0" id="ixv-14321" unitRef="usd">-4083295</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c189" decimals="0" id="ixv-14322" unitRef="usd">-33335579</us-gaap:NetIncomeLoss>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c184" decimals="0" id="ixv-14323" unitRef="usd">0</cyngn:LossOnIssuanceOfWarrants>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c190" decimals="0" id="ixv-14324" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <cyngn:LossOnIssuanceOfWarrants contextRef="c189" decimals="0" id="ixv-14325" unitRef="usd">-2344147</cyngn:LossOnIssuanceOfWarrants>
    <cyngn:WarrantIssuanceCosts contextRef="c184" decimals="0" id="ixv-14326" unitRef="usd">0</cyngn:WarrantIssuanceCosts>
    <cyngn:WarrantIssuanceCosts contextRef="c190" decimals="0" id="ixv-14327" unitRef="usd">1739148</cyngn:WarrantIssuanceCosts>
    <cyngn:WarrantIssuanceCosts contextRef="c189" decimals="0" id="ixv-14328" unitRef="usd">1739148</cyngn:WarrantIssuanceCosts>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c184" decimals="0" id="ixv-14329" unitRef="usd">10642938</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c190" decimals="0" id="ixv-14330" unitRef="usd">-9652581</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c189" decimals="0" id="ixv-14331" unitRef="usd">990357</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c184" decimals="0" id="ixv-14332" unitRef="usd">-9493500</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c190" decimals="0" id="ixv-14333" unitRef="usd">-9702581</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c189" decimals="0" id="ixv-14334" unitRef="usd">-19196081</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts contextRef="c184" decimals="0" id="ixv-14335" unitRef="usd">22369285</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts contextRef="c190" decimals="0" id="ixv-14336" unitRef="usd">-8558271</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts contextRef="c189" decimals="0" id="ixv-14337" unitRef="usd">13811014</cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrantsNetOfOfferingCosts>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c184" decimals="0" id="ixv-14338" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c190" decimals="0" id="ixv-14339" unitRef="usd">18260852</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c189" decimals="0" id="ixv-14340" unitRef="usd">18260852</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c184" decimals="0" id="ixv-14341" unitRef="usd">26584380</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c190" decimals="0" id="ixv-14342" unitRef="usd">9702581</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c189" decimals="0" id="ixv-14343" unitRef="usd">36286961</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:DeferredFinanceCostsNet contextRef="c185" decimals="0" id="ixv-14344" unitRef="usd">50000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c185" decimals="0" id="ixv-14345" unitRef="usd">88024</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="c0" id="ixv-10300">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Balance Sheet&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts Payable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;297,778&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;247,778&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;Statement of Cash Flows&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As&lt;br/&gt; Previously&lt;br/&gt; Reported&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts Payable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;100,815&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(50,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;50,815&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:AccountsPayableCurrent contextRef="c185" decimals="0" id="ixv-14346" unitRef="usd">297778</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c186" decimals="0" id="ixv-14347" unitRef="usd">-50000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c187" decimals="0" id="ixv-14348" unitRef="usd">247778</us-gaap:AccountsPayableCurrent>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c184" decimals="0" id="ixv-14349" unitRef="usd">100815</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c188" decimals="0" id="ixv-14350" unitRef="usd">-50000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c189" decimals="0" id="ixv-14351" unitRef="usd">50815</us-gaap:IncreaseDecreaseInAccountsPayable>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c192" id="ixv-14352">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c192" id="ixv-14353">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c192" id="ixv-14354">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c192" id="ixv-14355">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-14356">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <us-gaap:ShortTermInvestments
      contextRef="c4"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityDeposit
      contextRef="c4"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c4"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="c3"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:WarrantLiabilityIssuanceCosts
      contextRef="c0"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:LossOnIssuanceOfWarrants
      contextRef="c0"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c6"
      id="hidden-fact-8"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c6"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c7"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c11"
      id="hidden-fact-11"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c11"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c12"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c14"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c11"
      id="hidden-fact-15"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c11"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c12"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c14"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c11"
      id="hidden-fact-19"
      unitRef="shares"
      xsi:nil="true"/>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c11"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c14"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c11"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c12"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c14"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c11"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c12"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c13"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c15"
      id="hidden-fact-28"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c15"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c19"
      id="hidden-fact-30"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c19"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c22"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c19"
      id="hidden-fact-33"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c19"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c21"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c22"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c0"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering
      contextRef="c19"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering
      contextRef="c20"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:StockIssuedDuringPeriodValueReclassificationOfSeriesAWarrantsToEquityAndExerciseOfSeriesBWarrantsInConnectionWithThePublicOffering
      contextRef="c22"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c19"
      id="hidden-fact-42"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c19"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c22"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:StockIssuedDuringPeriodSharesExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c19"
      id="hidden-fact-45"
      unitRef="shares"
      xsi:nil="true"/>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c19"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:ExerciseOfPrefundedWarrantsInConnectionWithThePublicOffering
      contextRef="c22"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c19"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c20"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="c22"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c19"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c20"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c21"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c23"
      id="hidden-fact-54"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c23"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="c5"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="c5"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="c0"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RecapitalizationCosts
      contextRef="c5"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:WarrantLiabilityIssuanceCosts
      contextRef="c0"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:LossOnIssuanceOfWarrants
      contextRef="c0"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="c0"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="c0"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:ProceedsFromPublicIssuanceOfCommonStockAndPrefundedWarrant
      contextRef="c5"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="c0"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="c0"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="c0"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:IssuanceCostsForStockDividendAndRestrictedStockUnits
      contextRef="c0"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c0"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c5"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:AcquisitionOfRightofuseAssetInExchangeForNewOperatingLeaseObligation
      contextRef="c5"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:AcquisitionOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
      contextRef="c5"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration contextRef="c47" id="hidden-fact-73">http://fasb.org/us-gaap/2025#UsefulLifeTermOfLeaseMember</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c49"
      id="hidden-fact-74"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c51"
      id="hidden-fact-75"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c55"
      id="hidden-fact-76"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c57"
      id="hidden-fact-77"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="c0" id="hidden-fact-78">http://fasb.org/srt/2025#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:ProvisionForOtherCreditLosses
      contextRef="c0"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProvisionForOtherCreditLosses
      contextRef="c5"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="c35"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="c36"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="c0"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:USGovernmentSecuritiesAtCarryingValue
      contextRef="c62"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c76"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsImpairment
      contextRef="c76"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c77"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsImpairment
      contextRef="c77"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c3"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsImpairment
      contextRef="c3"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c78"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c78"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsImpairment
      contextRef="c78"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c79"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c80"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsImpairment
      contextRef="c80"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <cyngn:FiniteLivedIntangibleAssetsFairMarketValueAdjustment
      contextRef="c4"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c73"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="c74"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c82"
      id="hidden-fact-100"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c82"
      id="hidden-fact-101"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c83"
      id="hidden-fact-102"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c83"
      id="hidden-fact-103"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c4"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c0"
      id="hidden-fact-105"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      id="hidden-fact-106"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c0"
      id="hidden-fact-107"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-108"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c0"
      id="hidden-fact-109"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="c3"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c3"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="c3"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c3"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c170"
      id="hidden-fact-114"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c170"
      id="hidden-fact-115"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c170"
      id="hidden-fact-116"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c170"
      id="hidden-fact-117"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c171"
      id="hidden-fact-118"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c171"
      id="hidden-fact-119"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c0" id="hidden-fact-120" xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c0"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c5"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c0"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c0"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="c5"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c5"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts
      contextRef="c4"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c3"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c4"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="c0"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="c0"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="c5"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="c0"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="c5"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-14494">0001874097</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-14495">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-14496">FY</dei:DocumentFiscalPeriodFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-76"
          xlink:label="hidden-fact-76"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-77"
          xlink:label="hidden-fact-77"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-75"
          xlink:label="hidden-fact-75"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-74"
          xlink:label="hidden-fact-74"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt">Below 10%</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-76"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-77"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-75"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-74"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:i>For the year ended December 31, 2025, state and local income taxes in California made up the majority (greater than 50 percent)
of the tax effect in this category.</xhtml:i></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
